Query psy2148
Match_columns 1884
No_of_seqs 597 out of 6124
Neff 10.3
Searched_HMMs 46136
Date Fri Aug 16 17:28:46 2013
Command hhsearch -i /work/01045/syshi/Psyhhblits/psy2148.a3m -d /work/01045/syshi/HHdatabase/Cdd.hhm -o /work/01045/syshi/hhsearch_cdd/2148hhsearch_cdd -cpu 12 -v 0
No Hit Prob E-value P-value Score SS Cols Query HMM Template HMM
1 KOG3513|consensus 100.0 3.3E-56 7.1E-61 544.3 70.9 547 426-1378 59-616 (1051)
2 KOG3513|consensus 100.0 2.8E-56 6E-61 544.9 68.4 581 325-1208 59-664 (1051)
3 KOG4221|consensus 100.0 2.9E-38 6.3E-43 381.6 57.9 454 718-1518 151-609 (1381)
4 KOG4221|consensus 100.0 1.2E-38 2.6E-43 384.9 41.4 558 915-1837 40-613 (1381)
5 KOG4222|consensus 100.0 5.7E-39 1.2E-43 385.5 29.1 480 1048-1836 26-512 (1281)
6 KOG4222|consensus 100.0 2.2E-38 4.9E-43 380.5 28.9 548 914-1823 29-609 (1281)
7 KOG4194|consensus 100.0 1.3E-27 2.7E-32 268.5 22.1 282 1423-1836 502-799 (873)
8 KOG4194|consensus 99.9 1.7E-26 3.6E-31 259.5 22.6 290 1263-1731 502-797 (873)
9 KOG3515|consensus 99.9 8.7E-24 1.9E-28 254.5 29.0 645 718-1830 18-686 (741)
10 PHA02785 IL-beta-binding prote 99.9 1.4E-23 3.1E-28 245.0 29.9 254 1437-1825 38-319 (326)
11 PHA02785 IL-beta-binding prote 99.9 3.9E-23 8.4E-28 241.4 29.5 256 718-1138 37-318 (326)
12 KOG3515|consensus 99.9 1.8E-21 3.9E-26 234.7 28.1 646 219-1145 20-687 (741)
13 TIGR00864 PCC polycystin catio 99.8 9.3E-10 2E-14 150.3 116.8 402 1275-1837 1708-2129(2740)
14 PHA02826 IL-1 receptor-like pr 99.8 4.2E-18 9E-23 184.9 20.2 159 1646-1822 29-212 (227)
15 TIGR00864 PCC polycystin catio 99.8 7.3E-09 1.6E-13 141.9 131.6 705 719-1818 1523-2338(2740)
16 PHA02826 IL-1 receptor-like pr 99.7 4.4E-17 9.6E-22 176.9 19.4 165 923-1138 29-214 (227)
17 cd05762 Ig8_MLCK Eighth immuno 99.7 2.7E-16 5.9E-21 147.4 14.0 96 1743-1838 1-96 (98)
18 cd05762 Ig8_MLCK Eighth immuno 99.7 3.8E-16 8.3E-21 146.4 13.5 96 917-1014 1-96 (98)
19 cd05851 Ig3_Contactin-1 Third 99.5 4.8E-14 1.1E-18 129.6 11.1 88 916-1009 1-88 (88)
20 PF07679 I-set: Immunoglobulin 99.5 9.5E-14 2.1E-18 130.3 13.1 90 917-1008 1-90 (90)
21 cd05747 Ig5_Titin_like M5, fif 99.5 8E-14 1.7E-18 130.2 12.4 91 915-1007 2-92 (92)
22 cd05851 Ig3_Contactin-1 Third 99.5 5.9E-14 1.3E-18 129.0 11.3 88 1742-1833 1-88 (88)
23 cd05747 Ig5_Titin_like M5, fif 99.5 1.5E-13 3.2E-18 128.4 12.8 91 1741-1831 2-92 (92)
24 cd05894 Ig_C5_MyBP-C C5 immuno 99.5 2.2E-13 4.8E-18 124.3 12.4 83 924-1008 3-86 (86)
25 PF07679 I-set: Immunoglobulin 99.5 2.8E-13 6.1E-18 127.1 13.3 90 1743-1832 1-90 (90)
26 cd05894 Ig_C5_MyBP-C C5 immuno 99.5 3E-13 6.5E-18 123.4 12.8 82 1751-1832 4-86 (86)
27 cd05892 Ig_Myotilin_C C-termin 99.5 1.8E-13 4E-18 120.1 10.4 73 934-1008 1-75 (75)
28 cd05737 Ig_Myomesin_like_C C-t 99.5 3.8E-13 8.2E-18 125.5 12.7 86 1747-1832 6-92 (92)
29 cd04975 Ig4_SCFR_like Fourth i 99.5 3E-13 6.4E-18 126.6 11.6 84 924-1009 11-100 (101)
30 cd05737 Ig_Myomesin_like_C C-t 99.5 3.7E-13 8E-18 125.6 12.1 84 923-1008 8-92 (92)
31 cd05892 Ig_Myotilin_C C-termin 99.5 2.4E-13 5.3E-18 119.4 10.2 73 1760-1832 1-75 (75)
32 cd05852 Ig5_Contactin-1 Fifth 99.5 2.1E-13 4.5E-18 119.6 9.6 73 1757-1832 1-73 (73)
33 cd05745 Ig3_Peroxidasin Third 99.4 3.3E-13 7.1E-18 120.0 9.5 74 1756-1832 1-74 (74)
34 cd05852 Ig5_Contactin-1 Fifth 99.4 3.7E-13 8E-18 118.0 9.5 73 931-1008 1-73 (73)
35 cd04975 Ig4_SCFR_like Fourth i 99.4 6.8E-13 1.5E-17 124.2 11.8 84 1750-1833 11-100 (101)
36 cd05893 Ig_Palladin_C C-termin 99.4 6.2E-13 1.3E-17 117.1 10.1 73 934-1008 1-75 (75)
37 cd05735 Ig8_DSCAM Eight immuno 99.4 1.3E-12 2.8E-17 120.1 12.5 81 1757-1837 1-86 (88)
38 cd05893 Ig_Palladin_C C-termin 99.4 8E-13 1.7E-17 116.4 10.2 73 1760-1832 1-75 (75)
39 cd05870 Ig5_NCAM-2 Fifth immun 99.4 1.1E-12 2.4E-17 124.1 11.8 90 916-1008 2-98 (98)
40 cd05728 Ig4_Contactin-2-like F 99.4 8.9E-13 1.9E-17 120.7 10.5 84 919-1008 2-85 (85)
41 cd04972 Ig_TrkABC_d4 Fourth do 99.4 1.6E-12 3.5E-17 120.9 12.4 87 920-1008 4-90 (90)
42 cd05735 Ig8_DSCAM Eight immuno 99.4 1.6E-12 3.5E-17 119.4 12.1 81 931-1013 1-86 (88)
43 cd05745 Ig3_Peroxidasin Third 99.4 6.6E-13 1.4E-17 118.0 9.0 74 930-1008 1-74 (74)
44 cd05870 Ig5_NCAM-2 Fifth immun 99.4 1.6E-12 3.5E-17 123.0 12.2 90 1742-1832 2-98 (98)
45 cd05730 Ig3_NCAM-1_like Third 99.4 1.6E-12 3.4E-17 122.7 12.1 91 1742-1834 1-94 (95)
46 cd05853 Ig6_Contactin-4 Sixth 99.4 9.5E-13 2.1E-17 117.5 9.8 81 932-1012 1-85 (85)
47 cd05748 Ig_Titin_like Immunogl 99.4 1.6E-12 3.4E-17 115.9 11.2 74 933-1008 1-74 (74)
48 cd04972 Ig_TrkABC_d4 Fourth do 99.4 2.2E-12 4.8E-17 119.9 12.6 86 1747-1832 5-90 (90)
49 cd05869 Ig5_NCAM-1 Fifth immun 99.4 2.3E-12 4.9E-17 121.7 12.8 91 1742-1832 2-97 (97)
50 cd05748 Ig_Titin_like Immunogl 99.4 1.8E-12 3.8E-17 115.6 11.3 74 1759-1832 1-74 (74)
51 cd05865 Ig1_NCAM-1 First immun 99.4 2.3E-12 4.9E-17 119.7 12.3 86 921-1008 5-95 (96)
52 cd05866 Ig1_NCAM-2 First immun 99.4 2.4E-12 5.1E-17 118.1 12.2 86 920-1008 4-91 (92)
53 cd05723 Ig4_Neogenin Fourth im 99.4 1.6E-12 3.6E-17 114.1 10.6 71 1759-1832 1-71 (71)
54 cd05869 Ig5_NCAM-1 Fifth immun 99.4 2.3E-12 4.9E-17 121.7 12.3 91 916-1008 2-97 (97)
55 cd05728 Ig4_Contactin-2-like F 99.4 1.5E-12 3.2E-17 119.3 10.6 84 1745-1832 2-85 (85)
56 cd05859 Ig4_PDGFR-alpha Fourth 99.4 2.7E-12 5.7E-17 120.6 12.2 83 1751-1833 12-100 (101)
57 cd04968 Ig3_Contactin_like Thi 99.4 3.1E-12 6.8E-17 118.6 12.3 88 1742-1833 1-88 (88)
58 cd05865 Ig1_NCAM-1 First immun 99.4 3.4E-12 7.4E-17 118.5 12.4 85 1748-1832 6-95 (96)
59 cd05859 Ig4_PDGFR-alpha Fourth 99.4 2.2E-12 4.8E-17 121.1 10.9 83 925-1009 12-100 (101)
60 cd05744 Ig_Myotilin_C_like Imm 99.4 2.8E-12 6E-17 113.8 10.9 73 1760-1832 1-75 (75)
61 cd05744 Ig_Myotilin_C_like Imm 99.4 2.6E-12 5.6E-17 113.9 10.7 73 934-1008 1-75 (75)
62 cd05730 Ig3_NCAM-1_like Third 99.4 3.4E-12 7.4E-17 120.4 12.0 91 916-1010 1-94 (95)
63 cd05866 Ig1_NCAM-2 First immun 99.4 5.7E-12 1.2E-16 115.6 12.9 85 1747-1832 5-91 (92)
64 cd05854 Ig6_Contactin-2 Sixth 99.4 3.8E-12 8.2E-17 115.9 11.7 81 932-1012 1-85 (85)
65 cd05732 Ig5_NCAM-1_like Fifth 99.4 3.1E-12 6.7E-17 121.4 11.4 90 916-1008 2-96 (96)
66 cd05863 Ig2_VEGFR-3 Second imm 99.4 2.2E-12 4.9E-17 109.5 9.0 66 1760-1833 1-66 (67)
67 cd05723 Ig4_Neogenin Fourth im 99.4 3.5E-12 7.5E-17 112.1 10.5 71 933-1008 1-71 (71)
68 cd04968 Ig3_Contactin_like Thi 99.4 4.2E-12 9.1E-17 117.7 11.6 88 916-1009 1-88 (88)
69 cd04969 Ig5_Contactin_like Fif 99.4 3.6E-12 7.9E-17 113.0 10.1 73 1757-1832 1-73 (73)
70 cd05732 Ig5_NCAM-1_like Fifth 99.4 5.4E-12 1.2E-16 119.7 11.8 90 1742-1832 2-96 (96)
71 cd05863 Ig2_VEGFR-3 Second imm 99.4 2.4E-12 5.3E-17 109.3 8.3 66 934-1009 1-66 (67)
72 cd05743 Ig_Perlecan_D2_like Im 99.3 5.8E-12 1.3E-16 113.2 10.9 76 931-1008 1-76 (78)
73 cd05743 Ig_Perlecan_D2_like Im 99.3 7.4E-12 1.6E-16 112.6 11.3 76 1757-1832 1-76 (78)
74 cd05891 Ig_M-protein_C C-termi 99.3 9.3E-12 2E-16 115.6 12.2 85 1748-1832 7-92 (92)
75 cd05867 Ig4_L1-CAM_like Fourth 99.3 8E-12 1.7E-16 111.8 11.4 73 1757-1833 1-76 (76)
76 cd05891 Ig_M-protein_C C-termi 99.3 8.4E-12 1.8E-16 116.0 11.7 84 923-1008 8-92 (92)
77 cd04971 Ig_TrKABC_d5 Fifth dom 99.3 3.6E-12 7.9E-17 114.1 8.7 67 2-68 6-79 (81)
78 cd05848 Ig1_Contactin-5 First 99.3 1.2E-11 2.6E-16 115.3 12.3 83 916-1002 1-87 (94)
79 cd05854 Ig6_Contactin-2 Sixth 99.3 1.2E-11 2.6E-16 112.6 11.7 78 1758-1835 1-84 (85)
80 cd05857 Ig2_FGFR Second immuno 99.3 1.2E-11 2.7E-16 114.0 11.9 82 925-1008 3-85 (85)
81 cd05867 Ig4_L1-CAM_like Fourth 99.3 1.1E-11 2.4E-16 110.8 11.1 72 931-1008 1-75 (76)
82 cd05868 Ig4_NrCAM Fourth immun 99.3 7.9E-12 1.7E-16 111.3 10.0 74 931-1008 1-75 (76)
83 cd07693 Ig1_Robo First immunog 99.3 1.3E-11 2.9E-16 118.7 12.4 91 916-1008 1-99 (100)
84 cd05868 Ig4_NrCAM Fourth immun 99.3 8.6E-12 1.9E-16 111.1 10.1 75 1757-1833 1-76 (76)
85 cd05746 Ig4_Peroxidasin Fourth 99.3 5.4E-12 1.2E-16 110.2 8.6 69 1760-1831 1-69 (69)
86 cd04969 Ig5_Contactin_like Fif 99.3 8.1E-12 1.7E-16 110.8 9.8 73 931-1008 1-73 (73)
87 cd07693 Ig1_Robo First immunog 99.3 1.7E-11 3.7E-16 117.9 12.6 91 1742-1832 1-99 (100)
88 cd05848 Ig1_Contactin-5 First 99.3 2E-11 4.3E-16 113.9 12.3 82 1743-1826 2-87 (94)
89 cd05855 Ig_TrkB_d5 Fifth domai 99.3 9.2E-12 2E-16 109.4 9.4 70 936-1007 3-77 (79)
90 cd05857 Ig2_FGFR Second immuno 99.3 1.8E-11 3.8E-16 113.0 11.8 81 1752-1832 4-85 (85)
91 cd05773 Ig8_hNephrin_like Eigh 99.3 2E-11 4.3E-16 117.3 12.4 96 915-1012 3-108 (109)
92 cd05853 Ig6_Contactin-4 Sixth 99.3 1E-11 2.2E-16 110.8 9.1 81 723-803 1-85 (85)
93 cd05855 Ig_TrkB_d5 Fifth domai 99.3 1.4E-11 3.1E-16 108.2 9.7 71 1761-1831 2-77 (79)
94 cd04973 Ig1_FGFR First immunog 99.3 1.5E-11 3.3E-16 110.6 10.1 79 923-1008 1-79 (79)
95 cd04978 Ig4_L1-NrCAM_like Four 99.3 1.5E-11 3.3E-16 110.6 9.7 75 1757-1833 1-76 (76)
96 cd05746 Ig4_Peroxidasin Fourth 99.3 1E-11 2.3E-16 108.4 8.3 69 934-1007 1-69 (69)
97 cd05773 Ig8_hNephrin_like Eigh 99.3 3.2E-11 7E-16 115.8 12.3 96 1741-1836 3-108 (109)
98 cd05864 Ig2_VEGFR-2 Second imm 99.3 1.2E-11 2.7E-16 106.7 8.3 69 934-1009 1-69 (70)
99 cd04971 Ig_TrKABC_d5 Fifth dom 99.3 2.4E-11 5.3E-16 108.8 10.4 71 1761-1831 2-79 (81)
100 cd05876 Ig3_L1-CAM Third immun 99.3 1.6E-11 3.5E-16 107.8 9.1 70 1760-1832 1-70 (71)
101 cd05864 Ig2_VEGFR-2 Second imm 99.3 1.5E-11 3.2E-16 106.2 8.6 69 1760-1833 1-69 (70)
102 cd05849 Ig1_Contactin-1 First 99.3 4.8E-11 1E-15 110.6 12.5 86 1742-1831 1-92 (93)
103 cd05739 Ig3_RPTP_IIa_LAR_like 99.3 2.7E-11 5.9E-16 104.9 10.2 69 1757-1831 1-69 (69)
104 cd05740 Ig_CEACAM_D4 Fourth im 99.3 4.1E-11 8.9E-16 110.5 11.9 86 917-1008 2-90 (91)
105 cd04970 Ig6_Contactin_like Six 99.3 2.7E-11 5.9E-16 111.3 10.7 81 932-1012 1-85 (85)
106 cd04976 Ig2_VEGFR Second immun 99.3 2E-11 4.4E-16 106.9 9.2 70 1760-1833 1-70 (71)
107 cd04978 Ig4_L1-NrCAM_like Four 99.3 2.2E-11 4.9E-16 109.5 9.8 74 931-1008 1-75 (76)
108 cd05739 Ig3_RPTP_IIa_LAR_like 99.3 2.9E-11 6.2E-16 104.8 9.9 69 931-1007 1-69 (69)
109 cd05850 Ig1_Contactin-2 First 99.3 7.4E-11 1.6E-15 110.2 13.2 84 1743-1830 2-92 (94)
110 cd04973 Ig1_FGFR First immunog 99.3 2.9E-11 6.3E-16 108.8 10.1 79 1749-1832 1-79 (79)
111 cd04976 Ig2_VEGFR Second immun 99.3 2.1E-11 4.6E-16 106.7 8.8 70 934-1009 1-70 (71)
112 cd05849 Ig1_Contactin-1 First 99.3 6E-11 1.3E-15 110.0 12.2 85 916-1006 1-91 (93)
113 cd05740 Ig_CEACAM_D4 Fourth im 99.3 4.7E-11 1E-15 110.1 11.4 87 1743-1833 2-91 (91)
114 cd05726 Ig4_Robo Fhird immunog 99.2 3.3E-11 7.3E-16 112.0 10.4 76 1757-1835 1-84 (90)
115 cd05850 Ig1_Contactin-2 First 99.2 8E-11 1.7E-15 109.9 13.0 85 916-1006 1-92 (94)
116 cd05876 Ig3_L1-CAM Third immun 99.2 2.3E-11 4.9E-16 106.9 8.6 71 934-1009 1-71 (71)
117 cd05758 Ig5_KIRREL3-like Fifth 99.2 7E-11 1.5E-15 111.8 12.4 88 916-1006 2-97 (98)
118 cd05763 Ig_1 Subgroup of the i 99.2 3.5E-11 7.5E-16 107.5 9.3 72 1760-1833 1-75 (75)
119 cd05764 Ig_2 Subgroup of the i 99.2 4.7E-11 1E-15 106.5 10.1 73 1757-1832 1-74 (74)
120 cd05760 Ig2_PTK7 Second immuno 99.2 5.5E-11 1.2E-15 106.4 10.3 72 1760-1833 1-75 (77)
121 cd05758 Ig5_KIRREL3-like Fifth 99.2 8.8E-11 1.9E-15 111.1 12.3 88 1742-1830 2-97 (98)
122 cd05760 Ig2_PTK7 Second immuno 99.2 5E-11 1.1E-15 106.6 10.0 71 934-1008 1-72 (77)
123 cd05725 Ig3_Robo Third immunog 99.2 4.2E-11 9E-16 104.9 9.0 69 1760-1832 1-69 (69)
124 cd05736 Ig2_Follistatin_like S 99.2 5.2E-11 1.1E-15 106.8 9.7 75 1760-1834 1-75 (76)
125 cd05738 Ig2_RPTP_IIa_LAR_like 99.2 5.1E-11 1.1E-15 105.7 9.3 70 1760-1832 1-73 (74)
126 cd05764 Ig_2 Subgroup of the i 99.2 7.7E-11 1.7E-15 105.2 10.2 73 931-1008 1-74 (74)
127 cd05763 Ig_1 Subgroup of the i 99.2 5.9E-11 1.3E-15 106.0 9.4 71 934-1008 1-74 (75)
128 cd04977 Ig1_NCAM-1_like First 99.2 1.2E-10 2.6E-15 108.2 11.7 86 920-1008 4-92 (92)
129 cd05722 Ig1_Neogenin First imm 99.2 9.3E-11 2E-15 110.5 11.1 85 1745-1832 2-95 (95)
130 cd05724 Ig2_Robo Second immuno 99.2 8.3E-11 1.8E-15 109.0 10.6 81 923-1008 3-86 (86)
131 cd05749 Ig2_Tyro3_like Second 99.2 7E-11 1.5E-15 105.4 9.4 78 919-1006 1-80 (81)
132 cd05736 Ig2_Follistatin_like S 99.2 7.4E-11 1.6E-15 105.8 9.5 75 934-1010 1-75 (76)
133 cd05749 Ig2_Tyro3_like Second 99.2 8.2E-11 1.8E-15 105.0 9.6 77 1746-1830 2-80 (81)
134 cd05725 Ig3_Robo Third immunog 99.2 6.6E-11 1.4E-15 103.7 8.9 69 934-1008 1-69 (69)
135 cd05738 Ig2_RPTP_IIa_LAR_like 99.2 6.6E-11 1.4E-15 105.0 8.9 70 934-1008 1-73 (74)
136 cd05722 Ig1_Neogenin First imm 99.2 1.1E-10 2.4E-15 109.9 11.0 85 919-1008 2-95 (95)
137 cd05726 Ig4_Robo Fhird immunog 99.2 8.2E-11 1.8E-15 109.4 9.9 76 931-1011 1-84 (90)
138 cd04970 Ig6_Contactin_like Six 99.2 1.1E-10 2.5E-15 107.1 10.6 78 1758-1835 1-84 (85)
139 cd04977 Ig1_NCAM-1_like First 99.2 2.1E-10 4.7E-15 106.5 12.3 85 1747-1832 5-92 (92)
140 cd05724 Ig2_Robo Second immuno 99.2 1.5E-10 3.2E-15 107.3 11.0 81 1749-1832 3-86 (86)
141 cd04974 Ig3_FGFR Third immunog 99.2 5.8E-11 1.3E-15 110.0 8.1 77 1757-1833 1-90 (90)
142 cd04974 Ig3_FGFR Third immunog 99.2 5.9E-11 1.3E-15 110.0 8.0 76 931-1008 1-89 (90)
143 cd05856 Ig2_FGFRL1-like Second 99.2 9.2E-11 2E-15 107.7 9.3 79 1752-1832 4-82 (82)
144 cd05858 Ig3_FGFR-2 Third immun 99.2 1.2E-10 2.6E-15 108.2 9.8 77 1757-1833 1-90 (90)
145 cd05731 Ig3_L1-CAM_like Third 99.2 9.9E-11 2.1E-15 103.7 8.8 71 1760-1833 1-71 (71)
146 cd05856 Ig2_FGFRL1-like Second 99.2 9.1E-11 2E-15 107.7 8.9 79 926-1008 4-82 (82)
147 cd05898 Ig5_KIRREL3 Fifth immu 99.2 2.9E-10 6.4E-15 104.5 11.7 88 1742-1830 2-97 (98)
148 cd05858 Ig3_FGFR-2 Third immun 99.2 1.5E-10 3.2E-15 107.6 9.9 76 931-1008 1-89 (90)
149 cd05750 Ig_Pro_neuregulin Immu 99.1 1.6E-10 3.5E-15 103.7 9.0 71 934-1005 1-74 (75)
150 cd07702 Ig2_VEGFR-1 Second imm 99.1 2.3E-10 5E-15 98.8 9.4 69 1760-1832 1-70 (72)
151 cd05731 Ig3_L1-CAM_like Third 99.1 1.9E-10 4.1E-15 101.9 8.4 70 934-1008 1-70 (71)
152 cd05771 IgC_Tapasin_R Tapasin- 99.1 1.2E-09 2.7E-14 111.3 15.3 117 1696-1822 2-132 (139)
153 cd05756 Ig1_IL1R_like First im 99.1 1.8E-10 3.9E-15 106.7 8.2 81 1647-1729 7-94 (94)
154 cd05750 Ig_Pro_neuregulin Immu 99.1 2.8E-10 6E-15 102.2 9.2 70 1760-1829 1-74 (75)
155 cd05898 Ig5_KIRREL3 Fifth immu 99.1 7.7E-10 1.7E-14 101.7 12.0 89 916-1006 2-97 (98)
156 cd07702 Ig2_VEGFR-1 Second imm 99.1 3.2E-10 6.9E-15 97.9 9.0 68 934-1007 1-69 (72)
157 cd05756 Ig1_IL1R_like First im 99.1 2.5E-10 5.5E-15 105.8 8.7 81 1750-1832 7-94 (94)
158 cd05765 Ig_3 Subgroup of the i 99.1 2.6E-10 5.6E-15 104.2 8.6 73 1757-1832 1-81 (81)
159 cd05895 Ig_Pro_neuregulin-1 Im 99.1 4.5E-10 9.7E-15 100.7 9.4 71 934-1005 1-75 (76)
160 cd04967 Ig1_Contactin First Ig 99.1 7.4E-10 1.6E-14 103.2 11.1 80 917-1002 2-87 (91)
161 cd05765 Ig_3 Subgroup of the i 99.1 4.1E-10 8.8E-15 102.9 9.1 76 931-1008 1-81 (81)
162 cd04967 Ig1_Contactin First Ig 99.1 9.5E-10 2.1E-14 102.5 11.5 80 1743-1826 2-87 (91)
163 cd05733 Ig6_L1-CAM_like Sixth 99.1 5.3E-10 1.1E-14 100.0 8.2 65 1760-1826 1-71 (77)
164 cd05752 Ig1_FcgammaR_like Frst 99.0 4.7E-10 1E-14 99.6 7.5 77 917-1008 1-78 (78)
165 cd05874 Ig6_NrCAM Sixth immuno 99.0 7.7E-10 1.7E-14 98.5 9.0 65 1760-1826 1-71 (77)
166 cd05733 Ig6_L1-CAM_like Sixth 99.0 6E-10 1.3E-14 99.7 8.2 65 934-1002 1-71 (77)
167 cd05742 Ig1_VEGFR_like First i 99.0 8.2E-10 1.8E-14 101.2 8.9 79 931-1009 1-84 (84)
168 cd05873 Ig_Sema4D_like Immunog 99.0 1.9E-09 4.2E-14 96.7 10.6 68 923-997 3-71 (87)
169 cd05874 Ig6_NrCAM Sixth immuno 99.0 1.3E-09 2.9E-14 97.0 9.1 65 934-1002 1-71 (77)
170 cd05734 Ig7_DSCAM Seventh immu 99.0 1.1E-09 2.4E-14 98.9 8.5 70 1760-1832 1-79 (79)
171 cd05895 Ig_Pro_neuregulin-1 Im 99.0 1.6E-09 3.4E-14 97.1 9.4 71 1760-1830 1-76 (76)
172 cd05875 Ig6_hNeurofascin_like 99.0 1.5E-09 3.3E-14 96.6 9.1 66 1760-1827 1-72 (77)
173 cd05742 Ig1_VEGFR_like First i 99.0 1.4E-09 3E-14 99.7 9.1 76 1757-1832 1-83 (84)
174 cd05861 Ig1_PDGFR-alphabeta Fr 99.0 2.3E-09 4.9E-14 97.5 10.3 77 1757-1833 1-83 (84)
175 cd05771 IgC_Tapasin_R Tapasin- 99.0 7E-09 1.5E-13 105.8 15.0 118 367-491 2-132 (139)
176 cd05752 Ig1_FcgammaR_like Frst 99.0 9.9E-10 2.1E-14 97.5 7.6 76 1743-1831 1-77 (78)
177 cd05861 Ig1_PDGFR-alphabeta Fr 99.0 3E-09 6.6E-14 96.7 10.5 77 931-1009 1-83 (84)
178 cd07701 Ig1_Necl-3 First (N-te 99.0 3.6E-09 7.7E-14 98.6 10.9 83 1749-1832 4-95 (95)
179 cd07701 Ig1_Necl-3 First (N-te 99.0 3.1E-09 6.8E-14 99.0 10.4 83 923-1008 4-95 (95)
180 cd05729 Ig2_FGFR_like Second i 99.0 6E-09 1.3E-13 96.5 11.8 81 926-1008 4-85 (85)
181 cd05754 Ig3_Perlecan_like Thir 99.0 3.3E-09 7.1E-14 97.5 9.8 80 920-1006 5-84 (85)
182 cd05729 Ig2_FGFR_like Second i 99.0 7.2E-09 1.6E-13 96.0 12.1 81 1752-1832 4-85 (85)
183 cd05875 Ig6_hNeurofascin_like 99.0 3.5E-09 7.7E-14 94.3 9.4 68 1657-1724 1-72 (77)
184 cd05873 Ig_Sema4D_like Immunog 98.9 6.7E-09 1.5E-13 93.3 10.8 68 1749-1821 3-71 (87)
185 cd05882 Ig1_Necl-1 First (N-te 98.9 7.4E-09 1.6E-13 95.8 11.4 82 924-1008 5-95 (95)
186 cd05734 Ig7_DSCAM Seventh immu 98.9 3.1E-09 6.6E-14 96.0 7.9 70 934-1008 1-79 (79)
187 cd05757 Ig2_IL1R_like Second i 98.9 4.1E-09 8.8E-14 96.9 8.6 80 926-1009 5-87 (92)
188 cd05882 Ig1_Necl-1 First (N-te 98.9 1.2E-08 2.6E-13 94.4 11.6 82 1750-1832 5-95 (95)
189 cd05754 Ig3_Perlecan_like Thir 98.9 6.3E-09 1.4E-13 95.7 9.7 77 1748-1830 7-84 (85)
190 cd05757 Ig2_IL1R_like Second i 98.9 9.9E-09 2.1E-13 94.3 9.1 79 1751-1833 4-87 (92)
191 cd04979 Ig_Semaphorin_C Immuno 98.8 1.4E-08 3E-13 94.3 9.6 80 923-1009 3-87 (89)
192 cd04979 Ig_Semaphorin_C Immuno 98.8 2.1E-08 4.6E-13 93.0 9.9 80 1750-1834 4-88 (89)
193 cd05862 Ig1_VEGFR First immuno 98.8 2.1E-08 4.6E-13 91.5 9.2 79 931-1009 1-85 (86)
194 cd05727 Ig2_Contactin-2-like S 98.8 1.5E-08 3.3E-13 92.2 6.9 74 924-1000 11-86 (96)
195 cd05860 Ig4_SCFR Fourth immuno 98.8 8.1E-08 1.7E-12 87.2 11.3 84 1750-1833 11-100 (101)
196 cd05753 Ig2_FcgammaR_like Seco 98.8 2.3E-08 4.9E-13 90.6 7.7 67 925-1000 8-74 (83)
197 cd07690 Ig1_CD4 First immunogl 98.7 5.5E-08 1.2E-12 89.2 8.7 73 1753-1825 3-92 (94)
198 cd07690 Ig1_CD4 First immunogl 98.7 5.4E-08 1.2E-12 89.2 8.5 73 926-1000 2-91 (94)
199 cd05717 Ig1_Necl-1-3_like Firs 98.7 1E-07 2.2E-12 89.8 10.7 83 923-1008 4-95 (95)
200 cd05727 Ig2_Contactin-2-like S 98.7 3.2E-08 6.8E-13 90.1 6.8 73 1433-1508 11-85 (96)
201 cd05897 Ig2_IL1R2_like Second 98.7 5E-08 1.1E-12 89.1 8.1 74 926-1001 5-82 (95)
202 cd05897 Ig2_IL1R2_like Second 98.7 6E-08 1.3E-12 88.6 8.4 80 1752-1833 5-94 (95)
203 cd05717 Ig1_Necl-1-3_like Firs 98.7 1.3E-07 2.8E-12 89.1 10.7 82 1750-1832 5-95 (95)
204 cd05871 Ig_Semaphorin_classIII 98.7 1.2E-07 2.7E-12 87.2 10.3 79 1751-1834 5-90 (91)
205 cd05862 Ig1_VEGFR First immuno 98.7 8.9E-08 1.9E-12 87.4 9.2 80 722-801 1-86 (86)
206 cd05871 Ig_Semaphorin_classIII 98.7 1.2E-07 2.7E-12 87.2 10.2 78 925-1009 5-89 (91)
207 cd05845 Ig2_L1-CAM_like Second 98.7 3.8E-08 8.2E-13 89.4 6.5 72 1749-1823 10-84 (95)
208 cd05845 Ig2_L1-CAM_like Second 98.7 4.3E-08 9.3E-13 89.1 6.7 78 917-999 3-84 (95)
209 smart00409 IG Immunoglobulin. 98.7 3.2E-07 6.8E-12 85.3 12.9 83 924-1008 2-85 (86)
210 smart00410 IG_like Immunoglobu 98.7 3.2E-07 6.8E-12 85.3 12.9 83 924-1008 2-85 (86)
211 cd05753 Ig2_FcgammaR_like Seco 98.7 7.4E-08 1.6E-12 87.2 8.0 73 1751-1831 8-82 (83)
212 PF13895 Ig_2: Immunoglobulin 98.7 1.4E-07 3.1E-12 86.1 10.1 78 917-1008 2-80 (80)
213 cd05860 Ig4_SCFR Fourth immuno 98.7 2.2E-07 4.8E-12 84.3 10.9 83 925-1009 12-100 (101)
214 smart00409 IG Immunoglobulin. 98.7 3.6E-07 7.9E-12 84.8 13.0 83 1750-1832 2-85 (86)
215 smart00410 IG_like Immunoglobu 98.7 3.6E-07 7.9E-12 84.8 13.0 83 1750-1832 2-85 (86)
216 PF13895 Ig_2: Immunoglobulin 98.6 1.4E-07 3.1E-12 86.0 9.8 78 1743-1832 2-80 (80)
217 smart00408 IGc2 Immunoglobulin 98.6 1.7E-07 3.6E-12 80.9 8.5 63 930-998 1-63 (63)
218 smart00408 IGc2 Immunoglobulin 98.6 1.9E-07 4.1E-12 80.6 8.8 63 1756-1822 1-63 (63)
219 cd05885 Ig2_Necl-4 Second immu 98.6 1.8E-07 4E-12 81.9 7.7 65 934-1000 2-69 (80)
220 cd05872 Ig_Sema4B_like Immunog 98.6 3E-07 6.5E-12 81.9 9.0 78 924-1009 4-81 (85)
221 cd05885 Ig2_Necl-4 Second immu 98.5 3.4E-07 7.3E-12 80.2 8.1 65 725-791 2-69 (80)
222 cd05881 Ig1_Necl-2 First (N-te 98.5 1E-06 2.2E-11 80.8 11.5 70 924-995 5-83 (95)
223 cd05896 Ig1_IL1RAPL-1_like Fir 98.5 4.9E-07 1.1E-11 82.3 9.1 82 925-1008 9-104 (104)
224 cd05896 Ig1_IL1RAPL-1_like Fir 98.5 3.6E-07 7.9E-12 83.1 8.2 81 1647-1729 8-104 (104)
225 PHA03376 BARF1; Provisional 98.5 1E-06 2.3E-11 86.7 11.8 125 1647-1781 19-163 (221)
226 cd05881 Ig1_Necl-2 First (N-te 98.5 1.1E-06 2.4E-11 80.6 11.1 71 1646-1716 4-83 (95)
227 PHA03376 BARF1; Provisional 98.5 4.9E-06 1.1E-10 82.1 15.8 123 319-449 22-162 (221)
228 PF00047 ig: Immunoglobulin do 98.5 3.3E-07 7.1E-12 79.0 7.1 62 931-993 1-64 (64)
229 PF00047 ig: Immunoglobulin do 98.4 5.1E-07 1.1E-11 77.8 6.9 61 1757-1817 1-64 (64)
230 cd05872 Ig_Sema4B_like Immunog 98.4 1.2E-06 2.6E-11 78.1 8.6 78 1750-1833 4-83 (85)
231 cd05759 Ig2_KIRREL3-like Secon 98.4 1.6E-06 3.4E-11 79.0 8.9 72 933-1005 1-77 (82)
232 cd04983 IgV_TCR_alpha_like Imm 98.3 4.1E-06 8.8E-11 81.6 10.5 76 921-998 3-94 (109)
233 cd05759 Ig2_KIRREL3-like Secon 98.3 4E-06 8.7E-11 76.3 8.7 72 1760-1831 2-81 (82)
234 cd04983 IgV_TCR_alpha_like Imm 98.2 8.5E-06 1.8E-10 79.4 9.2 75 1748-1822 4-94 (109)
235 cd05713 Ig_MOG_like Immunoglob 98.1 1.5E-05 3.2E-10 76.0 10.5 78 931-1008 1-99 (100)
236 cd05877 Ig_LP_like Immunoglobu 98.1 1.5E-05 3.3E-10 76.9 10.4 81 930-1010 1-104 (106)
237 cd05877 Ig_LP_like Immunoglobu 98.1 1.7E-05 3.6E-10 76.6 10.5 79 1756-1834 1-104 (106)
238 cd05900 Ig_Aggrecan Immunoglob 98.1 1.6E-05 3.5E-10 75.9 10.1 79 1756-1834 1-110 (112)
239 PF13927 Ig_3: Immunoglobulin 98.1 4.5E-06 9.8E-11 74.9 6.1 75 916-995 1-75 (75)
240 cd05713 Ig_MOG_like Immunoglob 98.1 1.7E-05 3.6E-10 75.7 10.3 76 1757-1832 1-99 (100)
241 cd05774 Ig_CEACAM_D1 First imm 98.1 1.3E-05 2.9E-10 75.4 9.3 81 923-1008 5-105 (105)
242 cd05714 Ig_CSPGs_LP Immunoglob 98.1 2E-05 4.3E-10 76.1 10.8 79 1756-1834 1-104 (106)
243 cd05899 IgV_TCR_beta Immunoglo 98.1 1.3E-05 2.9E-10 77.8 9.4 75 921-998 3-96 (110)
244 cd05900 Ig_Aggrecan Immunoglob 98.1 1.8E-05 3.9E-10 75.6 10.0 81 930-1010 1-110 (112)
245 cd05714 Ig_CSPGs_LP Immunoglob 98.1 2.2E-05 4.8E-10 75.7 10.9 81 930-1010 1-104 (106)
246 cd05883 Ig2_Necl-2 Second immu 98.1 2.7E-05 5.8E-10 68.6 9.9 75 934-1009 2-80 (82)
247 cd05774 Ig_CEACAM_D1 First imm 98.1 1.7E-05 3.6E-10 74.8 9.2 80 1750-1832 6-105 (105)
248 cd05899 IgV_TCR_beta Immunoglo 98.1 1.2E-05 2.7E-10 78.0 8.7 74 1748-1822 4-96 (110)
249 cd05751 Ig1_LILRB1_like First 98.1 9.1E-06 2E-10 75.4 7.2 73 707-787 3-75 (91)
250 PF13927 Ig_3: Immunoglobulin 98.1 5.4E-06 1.2E-10 74.4 5.6 74 1742-1819 1-75 (75)
251 cd05751 Ig1_LILRB1_like First 98.1 1.1E-05 2.5E-10 74.7 7.7 67 316-388 9-75 (91)
252 cd05879 Ig_P0 Immunoglobulin ( 98.0 3.9E-05 8.4E-10 74.0 11.1 86 922-1007 4-115 (116)
253 cd00099 IgV Immunoglobulin var 98.0 1.5E-05 3.3E-10 77.1 8.4 72 926-998 1-91 (105)
254 cd04980 IgV_L_kappa Immunoglob 98.0 2.1E-05 4.5E-10 75.8 9.1 75 1746-1820 4-93 (106)
255 cd04980 IgV_L_kappa Immunoglob 98.0 2.2E-05 4.8E-10 75.7 9.0 76 919-996 3-93 (106)
256 cd05718 Ig1_PVR_like First imm 98.0 4.1E-05 9E-10 72.8 10.0 76 1758-1833 1-98 (98)
257 cd05883 Ig2_Necl-2 Second immu 98.0 4.4E-05 9.5E-10 67.3 8.9 74 725-799 2-79 (82)
258 cd00099 IgV Immunoglobulin var 98.0 2.5E-05 5.4E-10 75.5 8.3 70 1753-1822 2-91 (105)
259 cd05755 Ig2_ICAM-1_like Second 98.0 3.4E-05 7.3E-10 71.1 8.4 77 922-999 7-87 (100)
260 cd05878 Ig_Aggrecan_like Immun 97.9 5.5E-05 1.2E-09 72.8 10.2 80 931-1010 2-108 (110)
261 cd05718 Ig1_PVR_like First imm 97.9 5.5E-05 1.2E-09 71.9 10.1 75 1655-1729 1-97 (98)
262 KOG0613|consensus 97.9 3.3E-05 7.1E-10 99.3 10.9 299 724-1132 207-513 (1205)
263 cd05761 Ig2_Necl-1-4_like Seco 97.9 5.3E-05 1.2E-09 68.6 9.1 65 934-999 2-70 (82)
264 cd05879 Ig_P0 Immunoglobulin ( 97.9 9.8E-05 2.1E-09 71.2 11.1 82 1750-1831 6-115 (116)
265 cd05880 Ig_EVA1 Immunoglobulin 97.9 8.5E-05 1.8E-09 72.3 10.1 84 1749-1832 5-115 (115)
266 cd05775 Ig_SLAM-CD84_like_N N- 97.9 3.8E-05 8.3E-10 72.1 7.4 78 1652-1729 2-96 (97)
267 cd04982 IgV_TCR_gamma Immunogl 97.9 5.1E-05 1.1E-09 74.7 8.7 74 922-995 4-98 (116)
268 cd04982 IgV_TCR_gamma Immunogl 97.9 5.2E-05 1.1E-09 74.7 8.5 71 1749-1819 5-98 (116)
269 cd05878 Ig_Aggrecan_like Immun 97.8 0.0001 2.2E-09 70.9 9.8 96 1279-1374 2-107 (110)
270 cd05880 Ig_EVA1 Immunoglobulin 97.8 9.5E-05 2.1E-09 71.9 9.7 75 1645-1719 4-103 (115)
271 cd07705 Ig2_Necl-1 Second immu 97.8 0.00013 2.8E-09 65.9 9.9 65 934-999 2-71 (83)
272 cd05741 Ig_CEACAM_D1_like Firs 97.8 6.9E-05 1.5E-09 70.2 8.4 73 1757-1832 1-92 (92)
273 cd05775 Ig_SLAM-CD84_like_N N- 97.8 5.8E-05 1.3E-09 70.9 7.6 78 1755-1832 2-96 (97)
274 cd05761 Ig2_Necl-1-4_like Seco 97.8 8.4E-05 1.8E-09 67.3 8.3 66 725-791 2-71 (82)
275 cd05755 Ig2_ICAM-1_like Second 97.8 0.0001 2.2E-09 68.0 8.4 77 1747-1823 6-87 (100)
276 cd05715 Ig_P0-like Immunoglobu 97.8 0.00013 2.9E-09 71.5 9.8 83 1749-1831 5-115 (116)
277 cd07705 Ig2_Necl-1 Second immu 97.8 0.00013 2.8E-09 65.9 8.9 66 725-791 2-72 (83)
278 cd04984 IgV_L_lambda Immunoglo 97.8 9.8E-05 2.1E-09 70.0 8.5 70 927-996 2-85 (98)
279 cd05741 Ig_CEACAM_D1_like Firs 97.8 9E-05 1.9E-09 69.5 8.0 74 1654-1728 1-91 (92)
280 cd04984 IgV_L_lambda Immunoglo 97.7 9.2E-05 2E-09 70.1 7.9 68 1753-1820 2-85 (98)
281 cd05715 Ig_P0-like Immunoglobu 97.7 0.00016 3.4E-09 71.0 9.5 77 922-998 4-104 (116)
282 cd05902 Ig_Neurocan Immunoglob 97.7 0.00028 6E-09 67.2 10.2 80 931-1010 2-108 (110)
283 cd05902 Ig_Neurocan Immunoglob 97.7 0.00029 6.2E-09 67.1 10.3 78 1654-1731 2-108 (110)
284 cd00098 IgC Immunoglobulin Con 97.7 9.6E-05 2.1E-09 69.8 7.1 71 929-999 11-87 (95)
285 KOG0613|consensus 97.7 0.00015 3.3E-09 93.4 10.8 214 1577-1834 204-429 (1205)
286 cd07694 Ig2_CD4 Second immunog 97.7 0.00032 6.9E-09 61.4 9.3 78 1751-1834 8-87 (88)
287 cd05711 Ig_FcalphaRI Immunoglo 97.7 0.00016 3.5E-09 67.3 8.2 75 409-488 2-76 (94)
288 PHA03269 envelope glycoprotein 97.7 0.0026 5.7E-08 72.8 18.7 205 366-582 289-511 (566)
289 PHA02987 Ig domain OX-2-like p 97.6 0.00025 5.5E-09 71.6 9.4 86 1750-1835 23-124 (189)
290 cd07694 Ig2_CD4 Second immunog 97.6 0.00053 1.2E-08 60.0 10.1 76 718-799 10-85 (88)
291 cd05901 Ig_Versican Immunoglob 97.6 0.0006 1.3E-08 64.8 11.3 78 1757-1834 2-115 (117)
292 cd05888 Ig1_Nectin-4_like Frst 97.6 0.00028 6E-09 66.8 9.3 74 1759-1832 2-99 (100)
293 cd05884 Ig2_Necl-3 Second immu 97.6 0.00025 5.4E-09 63.9 8.5 64 934-998 2-70 (83)
294 cd05901 Ig_Versican Immunoglob 97.6 0.00047 1E-08 65.5 10.5 96 1279-1374 2-114 (117)
295 cd05886 Ig1_Nectin-1_like Firs 97.6 0.00027 5.9E-09 65.9 8.6 92 1281-1374 2-99 (99)
296 PF07686 V-set: Immunoglobulin 97.6 0.00054 1.2E-08 67.5 11.6 103 1269-1373 6-114 (114)
297 cd05886 Ig1_Nectin-1_like Firs 97.6 0.00048 1E-08 64.3 10.1 38 1481-1518 61-99 (99)
298 PF07686 V-set: Immunoglobulin 97.6 0.00051 1.1E-08 67.7 11.2 85 1748-1832 7-114 (114)
299 cd05711 Ig_FcalphaRI Immunoglo 97.6 0.00024 5.1E-09 66.2 8.0 74 1743-1818 2-75 (94)
300 cd07706 IgV_TCR_delta Immunogl 97.6 0.00031 6.7E-09 69.1 9.2 76 920-996 3-94 (116)
301 cd05888 Ig1_Nectin-4_like Frst 97.5 0.00056 1.2E-08 64.7 9.9 74 1656-1729 2-99 (100)
302 cd07706 IgV_TCR_delta Immunogl 97.5 0.00042 9E-09 68.1 9.3 73 1747-1819 4-93 (116)
303 PHA02987 Ig domain OX-2-like p 97.5 0.00054 1.2E-08 69.3 9.8 85 1647-1731 23-123 (189)
304 cd05884 Ig2_Necl-3 Second immu 97.5 0.0003 6.5E-09 63.4 7.3 65 725-790 2-71 (83)
305 cd05846 Ig1_MRC-OX-2_like Firs 97.5 0.00034 7.5E-09 65.9 8.0 76 1757-1832 1-96 (97)
306 cd05846 Ig1_MRC-OX-2_like Firs 97.5 0.00039 8.4E-09 65.6 8.2 93 1279-1374 1-97 (97)
307 cd05887 Ig1_Nectin-3_like Firs 97.5 0.00084 1.8E-08 61.9 9.7 75 1655-1729 1-95 (96)
308 cd05887 Ig1_Nectin-3_like Firs 97.4 0.00064 1.4E-08 62.7 8.7 91 1280-1373 1-95 (96)
309 cd05716 Ig_pIgR Immunoglobulin 97.4 0.00064 1.4E-08 64.5 8.4 70 1752-1821 2-87 (98)
310 cd00098 IgC Immunoglobulin Con 97.4 0.0004 8.6E-09 65.6 7.0 71 517-587 11-87 (95)
311 cd07698 IgC_MHC_I_alpha3 Class 97.4 0.001 2.2E-08 62.0 9.5 79 916-997 2-83 (93)
312 cd05772 IgC_SIRP Signal-regula 97.4 0.0013 2.8E-08 62.9 10.0 79 507-585 9-92 (111)
313 cd07700 IgV_CD8_beta Immunoglo 97.4 0.00065 1.4E-08 65.4 8.1 67 1753-1819 2-93 (107)
314 cd05716 Ig_pIgR Immunoglobulin 97.3 0.00078 1.7E-08 63.8 8.3 71 926-997 2-87 (98)
315 cd05772 IgC_SIRP Signal-regula 97.3 0.0018 3.9E-08 61.9 10.4 70 421-491 18-93 (111)
316 KOG1480|consensus 97.3 8.5E-05 1.8E-09 89.1 1.6 191 1263-1518 23-219 (909)
317 cd05720 Ig_CD8_alpha Immunoglo 97.3 0.00067 1.5E-08 64.7 7.4 67 1753-1819 2-90 (104)
318 PHA03270 envelope glycoprotein 97.3 0.061 1.3E-06 61.5 23.5 174 364-550 180-364 (466)
319 PHA03273 envelope glycoprotein 97.3 0.011 2.4E-07 68.0 17.7 169 366-544 198-376 (486)
320 cd07699 IgC_L Immunoglobulin C 97.3 0.001 2.2E-08 62.6 8.0 83 707-790 2-91 (100)
321 PF08205 C2-set_2: CD80-like C 97.3 0.0012 2.6E-08 61.2 8.5 68 931-999 14-86 (89)
322 cd07700 IgV_CD8_beta Immunoglo 97.2 0.00096 2.1E-08 64.2 7.9 68 927-995 2-93 (107)
323 cd07698 IgC_MHC_I_alpha3 Class 97.2 0.0022 4.7E-08 59.8 9.8 68 424-491 14-84 (93)
324 cd05766 IgC_MHC_II_beta Class 97.2 0.0026 5.7E-08 58.9 10.2 71 421-491 11-84 (94)
325 KOG1480|consensus 97.2 0.00015 3.3E-09 87.1 2.1 174 1638-1824 23-209 (909)
326 cd05712 Ig_Siglec_N Immunoglob 97.2 0.0018 3.9E-08 63.7 9.1 75 922-996 5-102 (119)
327 cd05712 Ig_Siglec_N Immunoglob 97.2 0.0022 4.8E-08 63.1 9.7 73 1645-1717 5-102 (119)
328 cd05720 Ig_CD8_alpha Immunoglo 97.2 0.0011 2.4E-08 63.2 7.3 67 1650-1716 2-90 (104)
329 cd05766 IgC_MHC_II_beta Class 97.1 0.0041 8.8E-08 57.7 10.5 72 719-790 11-85 (94)
330 PHA03270 envelope glycoprotein 97.1 0.07 1.5E-06 61.0 21.5 173 262-454 181-363 (466)
331 cd07699 IgC_L Immunoglobulin C 97.1 0.0016 3.6E-08 61.3 7.6 82 409-490 2-89 (100)
332 smart00407 IGc1 Immunoglobulin 97.1 0.0028 6.1E-08 56.2 8.6 65 933-997 1-71 (75)
333 cd05770 IgC_beta2m Class I maj 97.1 0.0048 1E-07 56.7 10.1 69 421-490 12-83 (93)
334 cd05767 IgC_MHC_II_alpha Class 97.0 0.004 8.7E-08 57.4 9.4 66 422-490 13-84 (94)
335 PF08205 C2-set_2: CD80-like C 97.0 0.0047 1E-07 57.3 10.1 68 1757-1824 14-87 (89)
336 PHA03269 envelope glycoprotein 97.0 0.057 1.2E-06 62.4 20.1 201 262-488 288-512 (566)
337 cd05767 IgC_MHC_II_alpha Class 97.0 0.0036 7.9E-08 57.7 9.0 65 929-996 13-83 (94)
338 cd05770 IgC_beta2m Class I maj 97.0 0.0046 9.9E-08 56.8 9.5 67 929-996 13-82 (93)
339 cd00096 Ig Immunoglobulin doma 97.0 0.0024 5.3E-08 56.2 7.8 63 1760-1822 1-67 (74)
340 PHA03273 envelope glycoprotein 97.0 0.059 1.3E-06 62.3 19.9 162 263-449 198-376 (486)
341 cd00096 Ig Immunoglobulin doma 97.0 0.0027 5.8E-08 55.9 7.9 63 934-998 1-67 (74)
342 cd05769 IgC_TCR_beta T cell re 97.0 0.0041 8.9E-08 59.6 9.1 85 707-792 3-96 (115)
343 cd05847 IgC_CH2_IgE CH2 domain 96.9 0.005 1.1E-07 56.9 8.9 70 930-999 13-88 (94)
344 cd05889 Ig1_DNAM-1_like First 96.9 0.005 1.1E-07 57.0 8.7 89 1280-1371 1-93 (96)
345 cd05768 IgC_CH4 CH4 domain (fo 96.9 0.0034 7.5E-08 59.2 7.8 73 718-790 12-93 (102)
346 cd05889 Ig1_DNAM-1_like First 96.8 0.0082 1.8E-07 55.6 9.6 73 1655-1727 1-93 (96)
347 smart00407 IGc1 Immunoglobulin 96.8 0.0047 1E-07 54.8 7.8 65 521-585 1-71 (75)
348 PHA03271 envelope glycoprotein 96.8 0.067 1.4E-06 60.5 18.0 172 365-549 206-389 (490)
349 cd05768 IgC_CH4 CH4 domain (fo 96.8 0.0053 1.1E-07 58.0 8.3 70 421-490 13-91 (102)
350 cd04981 IgV_H Immunoglobulin ( 96.8 0.0053 1.1E-07 60.0 8.6 71 1749-1819 4-97 (117)
351 cd04981 IgV_H Immunoglobulin ( 96.8 0.0049 1.1E-07 60.2 8.2 71 1646-1716 4-97 (117)
352 cd05719 Ig2_PVR_like Second im 96.7 0.0083 1.8E-07 55.6 8.9 66 931-1000 15-85 (95)
353 cd05847 IgC_CH2_IgE CH2 domain 96.7 0.0054 1.2E-07 56.7 7.6 71 518-588 13-89 (94)
354 smart00406 IGv Immunoglobulin 96.7 0.0049 1.1E-07 56.0 7.1 60 933-992 1-80 (81)
355 cd07697 IgC_TCR_gamma T cell r 96.7 0.007 1.5E-07 55.9 7.8 67 421-490 13-85 (96)
356 cd05769 IgC_TCR_beta T cell re 96.6 0.0086 1.9E-07 57.4 8.5 86 308-393 3-96 (115)
357 cd07696 IgC_CH3 CH3 domain (th 96.6 0.0058 1.3E-07 56.8 6.9 75 717-791 9-89 (96)
358 cd07697 IgC_TCR_gamma T cell r 96.6 0.0081 1.8E-07 55.5 7.5 69 718-788 12-85 (96)
359 cd07692 Ig_CD3_epsilon Immunog 96.5 0.0072 1.6E-07 49.7 5.8 52 1755-1820 5-56 (65)
360 PHA02914 Immunoglobulin-like d 96.5 1.6 3.5E-05 49.5 25.3 161 1647-1823 272-469 (500)
361 cd07696 IgC_CH3 CH3 domain (th 96.5 0.0086 1.9E-07 55.7 7.1 75 512-586 7-87 (96)
362 cd07703 Ig2_Nectin-2_like Seco 96.4 0.015 3.3E-07 53.6 8.5 70 932-1003 16-88 (95)
363 PHA02633 hypothetical protein; 96.4 0.009 1.9E-07 47.9 5.7 41 1693-1733 16-56 (63)
364 PF07654 C1-set: Immunoglobuli 96.4 0.012 2.6E-07 53.5 7.6 70 422-491 6-78 (83)
365 PF07654 C1-set: Immunoglobuli 96.4 0.015 3.3E-07 52.8 8.2 67 518-587 7-79 (83)
366 smart00406 IGv Immunoglobulin 96.3 0.0095 2.1E-07 54.1 6.5 77 1281-1358 1-81 (81)
367 cd07704 Ig2_Nectin-3-4_like Se 96.3 0.015 3.2E-07 53.4 7.5 72 717-790 11-86 (97)
368 cd07692 Ig_CD3_epsilon Immunog 96.2 0.0071 1.5E-07 49.7 4.4 52 929-996 5-56 (65)
369 cd04986 IgC_CH2 CH2 domain (se 96.1 0.017 3.7E-07 53.3 6.9 83 707-790 4-91 (99)
370 cd07691 Ig_CD3_gamma_delta Imm 96.1 0.0096 2.1E-07 49.2 4.6 59 931-1009 6-64 (69)
371 cd05719 Ig2_PVR_like Second im 96.1 0.032 6.9E-07 51.7 8.6 65 1757-1824 15-85 (95)
372 cd07691 Ig_CD3_gamma_delta Imm 95.9 0.016 3.6E-07 47.9 5.0 59 1069-1147 6-64 (69)
373 PHA03271 envelope glycoprotein 95.9 0.4 8.6E-06 54.6 17.2 117 1696-1823 208-337 (490)
374 cd04986 IgC_CH2 CH2 domain (se 95.8 0.033 7.2E-07 51.5 7.5 71 419-491 14-90 (99)
375 cd07703 Ig2_Nectin-2_like Seco 95.8 0.042 9E-07 50.8 8.1 72 723-796 16-90 (95)
376 cd05721 IgV_CTLA-4 Immunoglobu 95.8 0.055 1.2E-06 50.9 8.8 71 923-993 5-93 (115)
377 cd07689 Ig2_VCAM-1 Second immu 95.8 0.036 7.7E-07 50.4 7.3 69 421-491 12-87 (99)
378 cd04985 IgC_CH1 CH1 domain (fi 95.6 0.056 1.2E-06 50.2 8.3 67 930-997 15-87 (95)
379 cd04985 IgC_CH1 CH1 domain (fi 95.6 0.053 1.2E-06 50.3 8.0 67 423-490 15-87 (95)
380 cd05721 IgV_CTLA-4 Immunoglobu 95.6 0.047 1E-06 51.3 7.5 85 1270-1359 4-94 (115)
381 PHA02633 hypothetical protein; 95.3 0.062 1.3E-06 43.3 6.0 38 1799-1836 19-56 (63)
382 PF08204 V-set_CD47: CD47 immu 95.2 0.045 9.7E-07 52.8 6.1 93 1276-1373 24-119 (130)
383 cd07689 Ig2_VCAM-1 Second immu 95.0 0.097 2.1E-06 47.7 7.4 67 1437-1505 12-85 (99)
384 cd07704 Ig2_Nectin-3-4_like Se 94.9 0.12 2.5E-06 47.7 7.7 71 1433-1506 9-84 (97)
385 PF08204 V-set_CD47: CD47 immu 94.2 0.055 1.2E-06 52.2 4.2 79 1439-1518 26-120 (130)
386 PHA02982 hypothetical protein; 94.1 0.23 4.9E-06 50.8 8.3 93 513-606 33-145 (251)
387 KOG4597|consensus 94.1 0.078 1.7E-06 61.0 5.7 92 1743-1834 197-293 (560)
388 PHA02982 hypothetical protein; 93.4 2.8 6E-05 43.3 14.4 121 1647-1782 32-173 (251)
389 KOG4597|consensus 93.4 0.12 2.6E-06 59.6 5.5 91 917-1009 197-292 (560)
390 PHA03283 envelope glycoprotein 93.2 1.9 4.2E-05 51.3 15.0 40 1482-1521 133-172 (542)
391 PF07354 Sp38: Zona-pellucida- 93.1 0.11 2.3E-06 55.9 4.5 47 7-56 11-58 (271)
392 PF07354 Sp38: Zona-pellucida- 92.1 0.18 4E-06 54.2 4.6 48 946-996 11-59 (271)
393 PF11465 Receptor_2B4: Natural 91.0 2.3 5.1E-05 39.2 9.6 73 1759-1833 29-107 (108)
394 PHA03283 envelope glycoprotein 90.1 6.6 0.00014 47.1 14.9 37 975-1011 135-171 (542)
395 PF11465 Receptor_2B4: Natural 89.6 1.1 2.4E-05 41.2 6.4 59 1671-1729 46-106 (108)
396 KOG1026|consensus 88.6 0.42 9.1E-06 60.5 4.3 166 1648-1836 201-366 (774)
397 PF02124 Marek_A: Marek's dise 88.4 9.4 0.0002 40.7 13.2 105 440-547 6-117 (211)
398 PHA03042 CD47-like protein; Pr 87.1 2.4 5.2E-05 46.1 8.1 74 1753-1833 27-105 (286)
399 PHA02914 Immunoglobulin-like d 86.9 67 0.0015 37.3 33.8 90 1272-1361 272-368 (500)
400 PF02124 Marek_A: Marek's dise 86.2 26 0.00057 37.5 14.9 104 339-452 6-117 (211)
401 PHA03042 CD47-like protein; Pr 84.9 3.7 7.9E-05 44.7 8.1 68 1440-1517 31-104 (286)
402 PHA03282 envelope glycoprotein 84.3 13 0.00028 43.8 12.5 24 365-388 332-355 (540)
403 PHA03281 envelope glycoprotein 84.2 17 0.00037 43.6 13.7 38 1484-1521 299-337 (642)
404 PF06328 Lep_receptor_Ig: Ig-l 84.0 5.9 0.00013 36.1 8.0 67 1749-1817 10-81 (89)
405 PF06328 Lep_receptor_Ig: Ig-l 83.8 4.7 0.0001 36.8 7.3 70 922-993 9-81 (89)
406 PF02480 Herpes_gE: Alphaherpe 83.2 0.93 2E-05 55.2 3.4 37 1483-1519 89-126 (439)
407 PHA02865 MHC-like TNF binding 83.0 4 8.7E-05 46.8 8.0 37 407-448 202-238 (338)
408 PHA02865 MHC-like TNF binding 83.0 3.7 8.1E-05 47.1 7.7 37 915-955 202-238 (338)
409 PHA03282 envelope glycoprotein 81.9 13 0.00028 43.8 11.4 36 1484-1519 125-162 (540)
410 PHA03286 envelope glycoprotein 81.6 20 0.00044 42.2 12.7 37 1483-1519 127-164 (492)
411 PF06832 BiPBP_C: Penicillin-B 78.8 20 0.00044 32.9 9.9 75 1422-1510 8-85 (89)
412 PF05790 C2-set: Immunoglobuli 77.4 16 0.00035 32.6 8.3 52 1771-1832 26-78 (80)
413 PF03921 ICAM_N: Intercellular 77.1 23 0.00049 32.4 9.2 86 1266-1378 5-90 (91)
414 PF05790 C2-set: Immunoglobuli 76.5 13 0.00029 33.1 7.5 52 1457-1518 27-79 (80)
415 PRK14081 triple tyrosine motif 75.5 2.6E+02 0.0055 36.3 26.0 230 319-581 301-550 (667)
416 PF02480 Herpes_gE: Alphaherpe 75.4 4.8 0.0001 49.2 6.0 85 1694-1780 88-191 (439)
417 PF06832 BiPBP_C: Penicillin-B 74.0 33 0.00072 31.5 9.9 74 1741-1826 9-86 (89)
418 PHA03052 Hypothetical protein; 70.7 14 0.00031 30.8 5.6 37 924-960 5-42 (69)
419 PHA03281 envelope glycoprotein 64.2 2.6E+02 0.0055 34.4 16.2 82 366-447 298-394 (642)
420 KOG1026|consensus 63.7 7.5 0.00016 49.9 4.4 165 925-1150 201-366 (774)
421 PF03921 ICAM_N: Intercellular 61.7 1.3E+02 0.0029 27.6 12.3 83 920-1012 7-89 (91)
422 PHA03286 envelope glycoprotein 58.8 87 0.0019 37.3 11.1 86 1694-1779 126-226 (492)
423 PF11141 DUF2914: Protein of u 53.1 78 0.0017 27.1 7.3 58 9-69 7-65 (66)
424 PF02440 Adeno_E3_CR1: Adenovi 52.1 27 0.00059 29.3 4.3 21 928-954 2-22 (63)
425 cd05890 Ig2_Nectin-1_like Seco 50.7 46 0.001 30.4 5.7 67 725-797 23-96 (98)
426 PHA03189 UL14 tegument protein 48.8 1.1E+02 0.0024 34.3 9.4 74 924-998 60-157 (348)
427 smart00089 PKD Repeats in poly 46.8 1.5E+02 0.0033 26.2 8.9 64 1755-1832 12-78 (79)
428 PHA03052 Hypothetical protein; 46.4 59 0.0013 27.4 5.2 35 1570-1604 5-42 (69)
429 PHA03112 IL-18 binding protein 42.3 57 0.0012 32.3 5.5 69 1755-1823 36-121 (141)
430 PF09191 CD4-extracel: CD4, ex 40.8 1.5E+02 0.0032 27.5 7.3 34 1696-1729 75-108 (108)
431 PHA03240 envelope glycoprotein 40.5 42 0.00092 35.0 4.5 95 1752-1846 33-159 (258)
432 cd05890 Ig2_Nectin-1_like Seco 40.0 76 0.0016 29.1 5.4 71 1759-1832 22-98 (98)
433 PHA03189 UL14 tegument protein 38.2 1.7E+02 0.0037 32.9 8.9 26 1340-1365 133-159 (348)
434 PHA03240 envelope glycoprotein 35.2 40 0.00088 35.2 3.5 83 925-1009 32-144 (258)
435 PF00801 PKD: PKD domain; Int 31.3 1.3E+02 0.0029 25.8 5.8 60 1752-1825 6-68 (69)
436 KOG0200|consensus 30.9 6.3E+02 0.014 33.3 14.4 110 366-488 13-138 (609)
437 PRK14081 triple tyrosine motif 29.8 1.4E+03 0.03 30.0 37.6 188 1648-1880 395-603 (667)
438 KOG0200|consensus 28.7 1.8E+02 0.0038 38.3 8.9 125 1693-1833 11-152 (609)
439 PF00801 PKD: PKD domain; Int 28.1 2E+02 0.0043 24.7 6.3 59 927-1001 7-68 (69)
440 PHA03112 IL-18 binding protein 26.4 1.6E+02 0.0034 29.5 5.6 28 516-544 35-63 (141)
441 PF11141 DUF2914: Protein of u 25.9 4.2E+02 0.009 22.8 7.5 57 1773-1832 8-65 (66)
442 PF02440 Adeno_E3_CR1: Adenovi 25.5 1.6E+02 0.0036 24.9 4.8 54 1651-1708 2-63 (63)
No 1
>KOG3513|consensus
Probab=100.00 E-value=3.3e-56 Score=544.26 Aligned_cols=547 Identities=24% Similarity=0.350 Sum_probs=405.8
Q ss_pred eEEEEEEEeeCCCCCCeEEEeeCCEEccccCcEEEEecCCEEEEEEcccC-CCCcEEEEEEEEeCceecCCcceEEeec-
Q psy2148 426 SAHFECTLTPVNDPELKVEWFHNGKPIFHKNRVKMVSDFGFVVMDIAYVQ-SHDSGEYVCRAWNNFIFIPPFPIFIFHQ- 503 (1884)
Q Consensus 426 ~v~L~C~~~~~~~p~~~i~W~k~g~~l~~~~~~~~~~~~~~~~L~i~~v~-~~d~G~Y~C~a~n~~~~~~~~~~~~~~~- 503 (1884)
.+.|.|.+. |+|.++++|+|||.+............+| +|.|.+.. ..|.|.|+|.|+|..|.+.+....+...
T Consensus 59 ~v~l~C~A~--G~P~Psy~W~kng~~~d~~~~~~~~~~~G--~lvI~~p~~~~d~G~YqC~AsN~~Gta~S~~~~l~~~~ 134 (1051)
T KOG3513|consen 59 SVTLNCEAN--GNPEPSYRWTKNGTEFDPTEYPRVSVLGG--TLVITNPDAALDQGIYQCFASNKLGTAVSREARLQFGF 134 (1051)
T ss_pred cEEEEEEec--CCCCceeEEEECCeecccccccceeeecC--ceEecCCcchhhcceeEEEeecccceeeccceeecccc
Confidence 499999998 89999999999999876533222222244 47777666 8899999999999999865554433322
Q ss_pred -ccCCCCCCCccccCCCCeEEEEEEEeeCCCCccEEEEeeCCeeec-CC--CceEEEeeCceEEEEEccccccccEEEEE
Q psy2148 504 -IRLPSPSQDNLDVPEAGKVHFDCRLEPKSDPTMRIDWFFNGRPFA-TG--SRVKTVYDFGFISLDMDYVYARDSGEYIC 579 (1884)
Q Consensus 504 -~~~~~~~~~~~~v~~g~~~~L~C~~~~~~~p~~~i~W~~~~~~l~-~~--~~~~~~~~~~~~~L~i~~~~~~d~G~Y~C 579 (1884)
..++......+.+.+|+.+.|.|... .+.|.+++.|+.+..+-- .. .++. .... ..|-|.++..+|.+.|.|
T Consensus 135 i~~F~~e~~~~v~v~eG~~~~L~C~pP-~~~P~l~~~W~~~~~~~~~~~~~~r~~-~~~~--G~Lyfs~V~~~D~~~Y~C 210 (1051)
T KOG3513|consen 135 IPKFKKEERSPVEVEEGDGVVLPCNPP-AHFPPLRYYWMLNEFPHFVQIDNRRVF-SQEN--GNLYFSNVETSDFGNYIC 210 (1051)
T ss_pred cccCccccCCcEEEEeCCceEEeCCCC-CCCCCccEEehhccCCcccccCcceeE-eccc--ceEEEeecchhhcCceEE
Confidence 23334455678899999999999875 467889999998754421 11 1222 1122 247777777777777777
Q ss_pred EEEcCceeeeeeEEEEEEeeeeEEEEEEcCeecCCCCeEEEEeeecEEEEEeecccccCceEEEEEEEeCCcceeEEEEE
Q psy2148 580 RATNKWGTAMTKAKVICKVLTVIVEWFYNGKKLPHGHRYRTFHDFGIVILDILYCYEENSGVYECRATNKYGSDVTKASL 659 (1884)
Q Consensus 580 ~a~n~~g~~~~~~~l~c~~~~~~v~W~~~g~~l~~~~~~~~~~~~~~~~l~i~~~~~~d~G~Y~C~a~n~~G~~~~~~~l 659 (1884)
.|.+..... .. .+....|.+ ..
T Consensus 211 ~a~~~~~~~-----------------------~v---------~~~~~~L~~-------------~~------------- 232 (1051)
T KOG3513|consen 211 SATFPSTQT-----------------------IV---------QGPPFPLIV-------------RS------------- 232 (1051)
T ss_pred EEEchhhcc-----------------------cc---------cCCceeEEE-------------cc-------------
Confidence 776521100 00 000001111 00
Q ss_pred EEeeecceeeccCCCCCcccccceeechhhhccccccccccccccCCCeeeecCCCccccCCCCcEEEEEEEeecCCCCC
Q psy2148 660 KCVSKTNLILESQLPEGMEGGLEKIQTLEDAAHLRRTETADIEHRQAPVFTVPLSNIDDLREGENAHFEARLTPTDDPKL 739 (1884)
Q Consensus 660 ~v~~~~~~~l~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~v~~G~~~~l~C~~~~~g~p~~ 739 (1884)
.......+|.+..+++.......|+.+.|.|-+. |.|.|
T Consensus 233 ---------------------------------------~~~~~~~~P~i~~~~p~~~~a~~G~~v~LECfA~--G~P~P 271 (1051)
T KOG3513|consen 233 ---------------------------------------NNVMREYAPKILVPFPETETALKGQSVKLECFAL--GNPTP 271 (1051)
T ss_pred ---------------------------------------cccccccCCccccCCCCcccccCCCeEEEEEEec--CCCCC
Confidence 0001124556666666555778999999999987 79999
Q ss_pred eEEEeeCCc-cCCCCCCeEEEeeCCEEEEEEcccCcCCCeEEEEEEEecCceEEEEEEEEEecceeeEEeccCCCCceEE
Q psy2148 740 KVEWFWNGK-PMKTGSRFRTFCDFGFVILEISPVYPEDCGQYSCRAYNDYGEAVTSASMKVQGKRSIILESQLPKGMEVF 818 (1884)
Q Consensus 740 ~v~W~k~g~-~l~~~~~~~~~~~~~~~~L~i~~~~~~d~G~Y~C~a~N~~g~~~~~~~l~V~~~p~~~~~~~~~~g~~~~ 818 (1884)
++.|.|.|. ++.. +....+ ...+|.|.+++.+|+|.|.|.|+|..|.....+.|.|+
T Consensus 272 ~i~W~k~~g~~~~~--r~~~~~--~~~vL~I~nv~~~D~G~Y~C~AeN~~G~~~~~~~v~v~------------------ 329 (1051)
T KOG3513|consen 272 QIKWRKVDGKPPPR--RATYSN--YGKVLKIPNVQYEDAGEYECIAENSRGSATHSGHVTVY------------------ 329 (1051)
T ss_pred cEEEEeCCCCCCCc--ceeeec--cccEEEecccCcCCCeEEEEEEecccccceeeEEEEEe------------------
Confidence 999999766 4432 222222 23589999999999999999999999988888877774
Q ss_pred EEEeeecCCCcCCCceeEEEEEccccceeEEEEEEEecccceEEeecCCCCcccccceeeecccCCcccccchhhhhhhh
Q psy2148 819 ISFHEISPVYPEDCGQYSCRAYNDYGEAVTSASMKVQGKRSIILESQLPKGMEGTIDKIAELEGYGHEREDRTIDKIAEL 898 (1884)
Q Consensus 819 ~~~~~i~~~~~~d~g~y~c~a~n~~g~~~~s~~l~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 898 (1884)
T Consensus 330 -------------------------------------------------------------------------------- 329 (1051)
T KOG3513|consen 330 -------------------------------------------------------------------------------- 329 (1051)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred ccCCCCcccccccccCCCCeeeecCCceeecCCCeEEEEEEEeeCCCCCcEEEEeeCCEEccCCCc---EEEEeeCCeEE
Q psy2148 899 EGYGHEREDRIEEDLGKAPEFLTTPTDLTLAESTLAHFECRLTPTNDPSMTVEWFHNGKALSAGSR---IKTINDFGFVI 975 (1884)
Q Consensus 899 ~~~~~~~~~~~~~~~~~~p~~~~~~~~~~v~~G~~v~l~C~v~~~~~P~~~v~W~~~g~~i~~~~~---~~~~~~~~~~~ 975 (1884)
.+|.++..+++..+..|++++|+|.+. |.|.|+|+|+|||.+|....+ +.+.. + +
T Consensus 330 ----------------a~P~w~~~~~d~~~~~gs~v~~eC~a~--g~P~p~v~WlkNg~pl~~~~r~~~~~i~~--g--~ 387 (1051)
T KOG3513|consen 330 ----------------APPYWLQKPQDTEADTGSNVTLECKAS--GKPNPTVKWLKNGEPLEPAERDPRYKIDD--G--T 387 (1051)
T ss_pred ----------------cCchhhcccceeEecCCCCeEEEEEec--CCCCCceEEeeCCeecCccCCCcceEEeC--C--E
Confidence 456777788899999999999999998 889999999999999987776 66543 2 6
Q ss_pred EEEccCCCCCCeEEEEEEEcCCeeEEEEEEEEEEeecccccccchhHhHhcchhhHHHHHHhhcccCcCCCCCCCCCCCc
Q psy2148 976 LEINDVYLRDSGLYTCKATNKHGEATTSCKLTVKGRQGIDVEPQVSAIFANATKNIQKLEEALYRKDELIPDEEKPNPPV 1055 (1884)
Q Consensus 976 L~I~~~~~~D~G~Y~C~a~N~~G~~~~~~~l~V~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~ 1055 (1884)
|.|.+++..|+|.|.|.|+|.+|...+++.|.|... +|.
T Consensus 388 L~is~v~~~dsg~YQC~A~Nk~G~i~anA~L~V~a~-----------------------------------------~P~ 426 (1051)
T KOG3513|consen 388 LIISNVQESDSGVYQCIAENKYGTIYANAELKVLAS-----------------------------------------APV 426 (1051)
T ss_pred EEEEecccccCeEEEeeeecccceEeeeeEEEEEcc-----------------------------------------CCC
Confidence 999999999999999999999999999999999853 233
Q ss_pred eee-ecCCCcCcCCCCcEEEEEEEeeCCCCCcEEEEEECCEeccCCCceEEEeeCcEEEEEEcccCcCCcEEEEEEEEcC
Q psy2148 1056 FTS-QLQDNLDVPEAGKVHFDCRLEPKSDPTMRIDWFFNGRPFATGSRVKTVYDFGFISLDMDYVYARDSGEYICRATNK 1134 (1884)
Q Consensus 1056 ~~~-~~~~~~~v~~g~~~~l~C~v~~~~~p~~~v~W~k~~~~l~~~~~~~~~~~~~~~~l~i~~~~~~d~G~Y~C~a~n~ 1134 (1884)
|.. ++...+.+..|.++.|.|... +.|.+.++|.|+++.+..+.|+.+..+ | +|.|.+++.+|+|.|+|.|+|.
T Consensus 427 f~~~p~~~~~~a~~g~~v~i~C~~~--asP~p~~~W~k~~~~~~~~~r~~i~ed-G--tL~I~n~t~~DaG~YtC~A~N~ 501 (1051)
T KOG3513|consen 427 FPLNPVERKVMAVVGGTVTIDCKPF--ASPKPKVSWLKGGEKLLQSGRIRILED-G--TLEISNVTRSDAGKYTCVAENK 501 (1051)
T ss_pred CCCCccceEEEEEeCCeEEEeeccC--CCCcceEEEEcCCcccccCceEEECCC-C--cEEecccCcccCcEEEEEEEcc
Confidence 322 222235667899999999997 899999999999997777888766544 4 6999999999999999999999
Q ss_pred CeeeEEEEEEEEeeccccccccccCCcccHHHHHhhhccCCCCccccCCCCCCCCccccchhcccccccccccchhhhhh
Q psy2148 1135 WGTAMTKAKVICKAKHDIVTESQLPDSMSAEKLKELEKNYTPEEIEEDEIPEEPPRLNQSRYKKQNQSAWYDSELSEYQK 1214 (1884)
Q Consensus 1135 ~G~~~~~~~l~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~ 1214 (1884)
+|.+...+.|.|+.++
T Consensus 502 ~G~a~~~~~L~Vkd~t---------------------------------------------------------------- 517 (1051)
T KOG3513|consen 502 LGKAESTGNLIVKDAT---------------------------------------------------------------- 517 (1051)
T ss_pred cCccceEEEEEEecCc----------------------------------------------------------------
Confidence 9999999999988543
Q ss_pred hccccccccccccccccccCCCchhHHHHHhhhccCCCccccccCCCCCCCeeEeecceeeeecCCcEEEEEEEeecCCC
Q psy2148 1215 ERANESTELEKHDIVTESQLPDSMSAEKLKELEKNYTPEEIEEDEIPEEPPRFITEIESVTVQEAEPVRFETRVEPRVDP 1294 (1884)
Q Consensus 1215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~v~~g~~v~l~c~v~~~~~p 1294 (1884)
+|...|....+..|+.++|.|++.--...
T Consensus 518 ---------------------------------------------------ri~~~P~~~~v~~g~~v~l~Ce~shD~~l 546 (1051)
T KOG3513|consen 518 ---------------------------------------------------RITLAPSNTDVKVGESVTLTCEASHDPSL 546 (1051)
T ss_pred ---------------------------------------------------eEEeccchhhhccCceEEEEeecccCCCc
Confidence 34445567789999999999998844556
Q ss_pred cceEEEecccccccccccccceEEEeeccceeeeeeeeeeeeceEEEEEeeecccCceEEEEEEEccccceeeeEEEEEe
Q psy2148 1295 RLRVECSLSTAFFFPFINISTAFLIFNFCLHAVIFSHPIFDLGFVSLDIDYVYPEDQGEYVCRAYNDHGEAFTKATISCK 1374 (1884)
Q Consensus 1295 ~~~~~W~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~I~~~~~~d~G~Y~C~a~n~~g~~~~~~~l~v~ 1374 (1884)
...|.|.++|..++..... ..++.....+...|+|.+++..|+|.|+|+|.....+..+.+.|.|.
T Consensus 547 d~~f~W~~nG~~id~~~~~--------------~~~~~~~~~~~g~L~i~nv~l~~~G~Y~C~aqT~~Ds~s~~A~l~V~ 612 (1051)
T KOG3513|consen 547 DITFTWKKNGRPIDFNPDG--------------DHFEINDGSDSGRLTIANVSLEDSGKYTCVAQTALDSASARADLLVR 612 (1051)
T ss_pred ceEEEEEECCEEhhccCCC--------------CceEEeCCcCccceEEEeeccccCceEEEEEEEeecchhcccceEEe
Confidence 6789999999977654221 11111111122579999999999999999999766666777888888
Q ss_pred ecCc
Q psy2148 1375 KIPT 1378 (1884)
Q Consensus 1375 ~~p~ 1378 (1884)
.+|.
T Consensus 613 gpPg 616 (1051)
T KOG3513|consen 613 GPPG 616 (1051)
T ss_pred cCCC
Confidence 7764
No 2
>KOG3513|consensus
Probab=100.00 E-value=2.8e-56 Score=544.88 Aligned_cols=581 Identities=24% Similarity=0.391 Sum_probs=429.0
Q ss_pred eEEEEEEEEEcCCCceEEEEeeCCEeeccccceEEEeeCCeEEEEEcCCC-CCCCEEEEEEEEcCCeeeE-EEEEEEEee
Q psy2148 325 IAHFEASLIPVGDQTMTVEFLYNGKPIEASHRIRTVHAFGMVVLEILGTK-IEDTGVYTCRATNKWGQAE-ISVNLECVD 402 (1884)
Q Consensus 325 ~~~l~c~~~~~g~p~~~i~W~k~g~~i~~~~~~~~~~~~~~~~L~I~~~~-~~D~G~Y~C~a~n~~g~~~-~~~~l~V~~ 402 (1884)
.+.|.|.+ .|+|.|++.|+|||..+............ .+|.|.+.. ..|.|.|+|.|+|..|.+. ..+.|..
T Consensus 59 ~v~l~C~A--~G~P~Psy~W~kng~~~d~~~~~~~~~~~--G~lvI~~p~~~~d~G~YqC~AsN~~Gta~S~~~~l~~-- 132 (1051)
T KOG3513|consen 59 SVTLNCEA--NGNPEPSYRWTKNGTEFDPTEYPRVSVLG--GTLVITNPDAALDQGIYQCFASNKLGTAVSREARLQF-- 132 (1051)
T ss_pred cEEEEEEe--cCCCCceeEEEECCeecccccccceeeec--CceEecCCcchhhcceeEEEeecccceeeccceeecc--
Confidence 48999986 79999999999999998654432222223 357777666 8899999999999999863 3344443
Q ss_pred cCCCCCCceEeccCCccCccCCCeEEEEEEEeeCCCCCCeEEEeeCCEEc-ccc--CcEEEEecCCEEEEEEcccCCCCc
Q psy2148 403 KSKGQPPKFTSHIKSLEGLKDGDSAHFECTLTPVNDPELKVEWFHNGKPI-FHK--NRVKMVSDFGFVVMDIAYVQSHDS 479 (1884)
Q Consensus 403 ~~~~~~p~~~~~~~~~~~v~~G~~v~L~C~~~~~~~p~~~i~W~k~g~~l-~~~--~~~~~~~~~~~~~L~i~~v~~~d~ 479 (1884)
...+.|...-.+...+.+|+.+.|.|... .+.|.+.+.|+.+..+- ... .++.+..+ | .|.|.++..+|.
T Consensus 133 ---~~i~~F~~e~~~~v~v~eG~~~~L~C~pP-~~~P~l~~~W~~~~~~~~~~~~~~r~~~~~~-G--~Lyfs~V~~~D~ 205 (1051)
T KOG3513|consen 133 ---GFIPKFKKEERSPVEVEEGDGVVLPCNPP-AHFPPLRYYWMLNEFPHFVQIDNRRVFSQEN-G--NLYFSNVETSDF 205 (1051)
T ss_pred ---cccccCccccCCcEEEEeCCceEEeCCCC-CCCCCccEEehhccCCcccccCcceeEeccc-c--eEEEeecchhhc
Confidence 24555554445555689999999999975 47888999999876442 222 24433333 3 599999999999
Q ss_pred EEEEEEEEeCcee----cCCcceEE-------eecccCCCCCCCccccCCCCeEEEEEEEeeCCCCccEEEEeeCCee-e
Q psy2148 480 GEYVCRAWNNFIF----IPPFPIFI-------FHQIRLPSPSQDNLDVPEAGKVHFDCRLEPKSDPTMRIDWFFNGRP-F 547 (1884)
Q Consensus 480 G~Y~C~a~n~~~~----~~~~~~~~-------~~~~~~~~~~~~~~~v~~g~~~~L~C~~~~~~~p~~~i~W~~~~~~-l 547 (1884)
+.|.|.|.+.... .....+.+ ...+.++...+.......|+.+.|.|-+. |.|.|+|.|.|.+.. +
T Consensus 206 ~~Y~C~a~~~~~~~~v~~~~~~L~~~~~~~~~~~~P~i~~~~p~~~~a~~G~~v~LECfA~--G~P~P~i~W~k~~g~~~ 283 (1051)
T KOG3513|consen 206 GNYICSATFPSTQTIVQGPPFPLIVRSNNVMREYAPKILVPFPETETALKGQSVKLECFAL--GNPTPQIKWRKVDGKPP 283 (1051)
T ss_pred CceEEEEEchhhcccccCCceeEEEcccccccccCCccccCCCCcccccCCCeEEEEEEec--CCCCCcEEEEeCCCCCC
Confidence 9999999985433 11112221 11233333445567788999999999985 789999999997764 3
Q ss_pred cCCCceEEEeeCceEEEEEccccccccEEEEEEEEcCceeeeeeEEEEEEeeeeEEEEEEcCeecCCCCeEEEEeeecEE
Q psy2148 548 ATGSRVKTVYDFGFISLDMDYVYARDSGEYICRATNKWGTAMTKAKVICKVLTVIVEWFYNGKKLPHGHRYRTFHDFGIV 627 (1884)
Q Consensus 548 ~~~~~~~~~~~~~~~~L~i~~~~~~d~G~Y~C~a~n~~g~~~~~~~l~c~~~~~~v~W~~~g~~l~~~~~~~~~~~~~~~ 627 (1884)
.....+ .. ...
T Consensus 284 ~~r~~~----~~-----------------------------------------------------------------~~~ 294 (1051)
T KOG3513|consen 284 PRRATY----SN-----------------------------------------------------------------YGK 294 (1051)
T ss_pred Ccceee----ec-----------------------------------------------------------------ccc
Confidence 321111 00 011
Q ss_pred EEEeecccccCceEEEEEEEeCCcceeEEEEEEEeeecceeeccCCCCCcccccceeechhhhccccccccccccccCCC
Q psy2148 628 ILDILYCYEENSGVYECRATNKYGSDVTKASLKCVSKTNLILESQLPEGMEGGLEKIQTLEDAAHLRRTETADIEHRQAP 707 (1884)
Q Consensus 628 ~l~i~~~~~~d~G~Y~C~a~n~~G~~~~~~~l~v~~~~~~~l~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p 707 (1884)
+|.|.+++.+|+|.|+|.|+|..|.......++|. .+|
T Consensus 295 vL~I~nv~~~D~G~Y~C~AeN~~G~~~~~~~v~v~------------------------------------------a~P 332 (1051)
T KOG3513|consen 295 VLKIPNVQYEDAGEYECIAENSRGSATHSGHVTVY------------------------------------------APP 332 (1051)
T ss_pred EEEecccCcCCCeEEEEEEecccccceeeEEEEEe------------------------------------------cCc
Confidence 36666677777777777777777755555544442 234
Q ss_pred eeeecCCCccccCCCCcEEEEEEEeecCCCCCeEEEeeCCccCCCCCC---eEEEeeCCEEEEEEcccCcCCCeEEEEEE
Q psy2148 708 VFTVPLSNIDDLREGENAHFEARLTPTDDPKLKVEWFWNGKPMKTGSR---FRTFCDFGFVILEISPVYPEDCGQYSCRA 784 (1884)
Q Consensus 708 ~~~~~~~~~~~v~~G~~~~l~C~~~~~g~p~~~v~W~k~g~~l~~~~~---~~~~~~~~~~~L~i~~~~~~d~G~Y~C~a 784 (1884)
.+...+.+. .+..|++++|.|.+. |.|.|.++|+|||.+|....+ +++.. ..|+|.+++.+|+|.|.|.|
T Consensus 333 ~w~~~~~d~-~~~~gs~v~~eC~a~--g~P~p~v~WlkNg~pl~~~~r~~~~~i~~----g~L~is~v~~~dsg~YQC~A 405 (1051)
T KOG3513|consen 333 YWLQKPQDT-EADTGSNVTLECKAS--GKPNPTVKWLKNGEPLEPAERDPRYKIDD----GTLIISNVQESDSGVYQCIA 405 (1051)
T ss_pred hhhccccee-EecCCCCeEEEEEec--CCCCCceEEeeCCeecCccCCCcceEEeC----CEEEEEecccccCeEEEeee
Confidence 444444443 688999999999998 799999999999999987776 66644 37999999999999999999
Q ss_pred EecCceEEEEEEEEEecceeeEEeccCCCCceEEEEEeeecCCCcCCCceeEEEEEccccceeEEEEEEEecccceEEee
Q psy2148 785 YNDYGEAVTSASMKVQGKRSIILESQLPKGMEVFISFHEISPVYPEDCGQYSCRAYNDYGEAVTSASMKVQGKRSIILES 864 (1884)
Q Consensus 785 ~N~~g~~~~~~~l~V~~~p~~~~~~~~~~g~~~~~~~~~i~~~~~~d~g~y~c~a~n~~g~~~~s~~l~v~~~~~~~~~~ 864 (1884)
+|..|...+++.|.|...
T Consensus 406 ~Nk~G~i~anA~L~V~a~-------------------------------------------------------------- 423 (1051)
T KOG3513|consen 406 ENKYGTIYANAELKVLAS-------------------------------------------------------------- 423 (1051)
T ss_pred ecccceEeeeeEEEEEcc--------------------------------------------------------------
Confidence 999999999999998653
Q ss_pred cCCCCcccccceeeecccCCcccccchhhhhhhhccCCCCcccccccccCCCCeeeecCC--ceeecCCCeEEEEEEEee
Q psy2148 865 QLPKGMEGTIDKIAELEGYGHEREDRTIDKIAELEGYGHEREDRIEEDLGKAPEFLTTPT--DLTLAESTLAHFECRLTP 942 (1884)
Q Consensus 865 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~--~~~v~~G~~v~l~C~v~~ 942 (1884)
+|.|...+- ...+..|.++.|.|+..
T Consensus 424 ---------------------------------------------------~P~f~~~p~~~~~~a~~g~~v~i~C~~~- 451 (1051)
T KOG3513|consen 424 ---------------------------------------------------APVFPLNPVERKVMAVVGGTVTIDCKPF- 451 (1051)
T ss_pred ---------------------------------------------------CCCCCCCccceEEEEEeCCeEEEeeccC-
Confidence 222322221 24567899999999998
Q ss_pred CCCCCcEEEEeeCCEEccCCCcEEEEeeCCeEEEEEccCCCCCCeEEEEEEEcCCeeEEEEEEEEEEeecccccccchhH
Q psy2148 943 TNDPSMTVEWFHNGKALSAGSRIKTINDFGFVILEINDVYLRDSGLYTCKATNKHGEATTSCKLTVKGRQGIDVEPQVSA 1022 (1884)
Q Consensus 943 ~~~P~~~v~W~~~g~~i~~~~~~~~~~~~~~~~L~I~~~~~~D~G~Y~C~a~N~~G~~~~~~~l~V~~~~~~~~~p~~~~ 1022 (1884)
+.|.|.+.|.|++..+..+.|+.+..++ +|.|.+++.+|+|.|+|.|+|..|.+...+.|.|.+++.|...|
T Consensus 452 -asP~p~~~W~k~~~~~~~~~r~~i~edG---tL~I~n~t~~DaG~YtC~A~N~~G~a~~~~~L~Vkd~tri~~~P---- 523 (1051)
T KOG3513|consen 452 -ASPKPKVSWLKGGEKLLQSGRIRILEDG---TLEISNVTRSDAGKYTCVAENKLGKAESTGNLIVKDATRITLAP---- 523 (1051)
T ss_pred -CCCcceEEEEcCCcccccCceEEECCCC---cEEecccCcccCcEEEEEEEcccCccceEEEEEEecCceEEecc----
Confidence 8899999999999988889999988776 59999999999999999999999999999999999765544332
Q ss_pred hHhcchhhHHHHHHhhcccCcCCCCCCCCCCCceeeecCCCcCcCCCCcEEEEEEEeeCCCCCcEEEEEECCEeccC---
Q psy2148 1023 IFANATKNIQKLEEALYRKDELIPDEEKPNPPVFTSQLQDNLDVPEAGKVHFDCRLEPKSDPTMRIDWFFNGRPFAT--- 1099 (1884)
Q Consensus 1023 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~v~~g~~~~l~C~v~~~~~p~~~v~W~k~~~~l~~--- 1099 (1884)
.+..+..|++++|+|.+..+......|.|.+||..+..
T Consensus 524 ---------------------------------------~~~~v~~g~~v~l~Ce~shD~~ld~~f~W~~nG~~id~~~~ 564 (1051)
T KOG3513|consen 524 ---------------------------------------SNTDVKVGESVTLTCEASHDPSLDITFTWKKNGRPIDFNPD 564 (1051)
T ss_pred ---------------------------------------chhhhccCceEEEEeecccCCCcceEEEEEECCEEhhccCC
Confidence 24778899999999999877778888999999998753
Q ss_pred CCceEEEeeCcEEEEEEcccCcCCcEEEEEEEEcCCeeeEEEEEEEEeeccccccccccCCcccHHHHHhhhccCCCCcc
Q psy2148 1100 GSRVKTVYDFGFISLDMDYVYARDSGEYICRATNKWGTAMTKAKVICKAKHDIVTESQLPDSMSAEKLKELEKNYTPEEI 1179 (1884)
Q Consensus 1100 ~~~~~~~~~~~~~~l~i~~~~~~d~G~Y~C~a~n~~G~~~~~~~l~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1179 (1884)
+..+..........|+|.+++..|+|.|.|+|.-...+.++.+.|.|.++|..+.... .+. .........|
T Consensus 565 ~~~~~~~~~~~~g~L~i~nv~l~~~G~Y~C~aqT~~Ds~s~~A~l~V~gpPgpP~~v~------~~~---i~~t~~~lsW 635 (1051)
T KOG3513|consen 565 GDHFEINDGSDSGRLTIANVSLEDSGKYTCVAQTALDSASARADLLVRGPPGPPPDVH------VDD---ISDTTARLSW 635 (1051)
T ss_pred CCceEEeCCcCccceEEEeeccccCceEEEEEEEeecchhcccceEEecCCCCCCcee------Eee---eccceEEEEe
Confidence 3343333322235799999999999999999999888999999999999887543211 111 1111223445
Q ss_pred ccCCCCCCCCccccchhcccccccccccc
Q psy2148 1180 EEDEIPEEPPRLNQSRYKKQNQSAWYDSE 1208 (1884)
Q Consensus 1180 ~~~~~~~~~~~~~~~~~~~~~~~~w~~~~ 1208 (1884)
.+..+..+++..|..+.++.....|....
T Consensus 636 ~~g~dn~SpI~~Y~iq~rt~~~~~W~~v~ 664 (1051)
T KOG3513|consen 636 SPGSDNNSPIEKYTIQFRTPFPGKWKAVT 664 (1051)
T ss_pred ecCCCCCCCceEEeEEecCCCCCcceEee
Confidence 55556656788899999999999997665
No 3
>KOG4221|consensus
Probab=100.00 E-value=2.9e-38 Score=381.65 Aligned_cols=454 Identities=19% Similarity=0.242 Sum_probs=324.5
Q ss_pred ccCCCCcEEEEEEEeecCCCCCeEEEeeCCccCCCCCCeEEEeeCCEEEEEEcccCcCCCeEEEEEEEecCce-EEEEEE
Q psy2148 718 DLREGENAHFEARLTPTDDPKLKVEWFWNGKPMKTGSRFRTFCDFGFVILEISPVYPEDCGQYSCRAYNDYGE-AVTSAS 796 (1884)
Q Consensus 718 ~v~~G~~~~l~C~~~~~g~p~~~v~W~k~g~~l~~~~~~~~~~~~~~~~L~i~~~~~~d~G~Y~C~a~N~~g~-~~~~~~ 796 (1884)
.+..|+++.|.|.+. +.|.+.+.|.||..+|..++++...-++ .|.|.++...|.|.|+|.|+|..-. .+..+.
T Consensus 151 t~~~g~ta~f~c~vn--~e~~p~i~w~kn~~pl~~~~r~i~lpsG---~L~I~~~qp~d~g~yrc~vt~g~~~r~S~~a~ 225 (1381)
T KOG4221|consen 151 TLLYGQTALFSCEVN--AEPVPTIMWLKNDQPLPLDSRVIVLPSG---ALEISGLQPSDTGEYRCVVTGGASQRTSNEAE 225 (1381)
T ss_pred eEecCCcEEEEEEEc--CccCceeEEecccccccCCCcEEEcCCC---cEEecccccCCCceEEEEEecCCcCCccceeE
Confidence 688999999999998 4788899999999999888876665543 6999999999999999999986533 245566
Q ss_pred EEEecceeeEEeccCCCCceEEEEEeeecCCCcCCCceeEEEEEccccceeEEEEEEEecccceEEeecCCCCcccccce
Q psy2148 797 MKVQGKRSIILESQLPKGMEVFISFHEISPVYPEDCGQYSCRAYNDYGEAVTSASMKVQGKRSIILESQLPKGMEGTIDK 876 (1884)
Q Consensus 797 l~V~~~p~~~~~~~~~~g~~~~~~~~~i~~~~~~d~g~y~c~a~n~~g~~~~s~~l~v~~~~~~~~~~~~~~~~~~~~~~ 876 (1884)
|+|...+...
T Consensus 226 ltv~s~~~~~---------------------------------------------------------------------- 235 (1381)
T KOG4221|consen 226 LTVLSDPGAL---------------------------------------------------------------------- 235 (1381)
T ss_pred EEecCCcccc----------------------------------------------------------------------
Confidence 6554221110
Q ss_pred eeecccCCcccccchhhhhhhhccCCCCcccccccccCCCCeeeecCCceeecCCCeEEEEEEEeeCCCCCcEEEEeeCC
Q psy2148 877 IAELEGYGHEREDRTIDKIAELEGYGHEREDRIEEDLGKAPEFLTTPTDLTLAESTLAHFECRLTPTNDPSMTVEWFHNG 956 (1884)
Q Consensus 877 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~v~~G~~v~l~C~v~~~~~P~~~v~W~~~g 956 (1884)
..-.|...+.+.++.+|+.+.|+|.+. +.|.|.|+|.|||
T Consensus 236 --------------------------------------~~~~fl~~p~~~~v~~g~~v~leCvvs--~~p~p~v~Wlrng 275 (1381)
T KOG4221|consen 236 --------------------------------------NKLVFLDEPSNAVVVEGDDVVLECVVS--GVPKPSVKWLRNG 275 (1381)
T ss_pred --------------------------------------cceeeecCCCccccccCCcEEEEEEec--CCCCCceEEeeCC
Confidence 112356677888999999999999998 8899999999999
Q ss_pred EEccCCCcEEEEeeCCeEEEEEccCCCCCCeEEEEEEEcCCeeEEEEEEEEEEeecccccccchhHhHhcchhhHHHHHH
Q psy2148 957 KALSAGSRIKTINDFGFVILEINDVYLRDSGLYTCKATNKHGEATTSCKLTVKGRQGIDVEPQVSAIFANATKNIQKLEE 1036 (1884)
Q Consensus 957 ~~i~~~~~~~~~~~~~~~~L~I~~~~~~D~G~Y~C~a~N~~G~~~~~~~l~V~~~~~~~~~p~~~~~~~~~~~~~~~~~~ 1036 (1884)
..|.-+. +++.-.+ ...|.|.+++..|+|.|+|+|+|......+.+.|+|..+|.+...
T Consensus 276 ~~i~~ds-~rivl~g-~~slliS~a~~~dSg~YtC~Atn~~D~idasaev~V~a~P~~~~~------------------- 334 (1381)
T KOG4221|consen 276 EKISVDS-YRIVLVG-GSSLLISNATDDDSGKYTCRATNTNDSIDASAEVTVLAPPGFTKA------------------- 334 (1381)
T ss_pred eeeeecc-eEEEEec-ccceEEeccccccCceEEEEecCCCcccccceEEEEEcCCCCCCC-------------------
Confidence 9997665 4444332 236999999999999999999997777778888999865554322
Q ss_pred hhcccCcCCCCCCCCCCCceeeecCCCcCcCCCCcEEEEEEEeeCCCCCcEEEEEECCEeccCCCceEEEeeCcEEEEEE
Q psy2148 1037 ALYRKDELIPDEEKPNPPVFTSQLQDNLDVPEAGKVHFDCRLEPKSDPTMRIDWFFNGRPFATGSRVKTVYDFGFISLDM 1116 (1884)
Q Consensus 1037 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~v~~g~~~~l~C~v~~~~~p~~~v~W~k~~~~l~~~~~~~~~~~~~~~~l~i 1116 (1884)
... ....++.++.|+|.+. |.|.+.+.|||||..+..++.+++..+.. |.|
T Consensus 335 -----------------------p~~-l~A~e~~die~ec~~~--g~p~p~v~w~kNgd~~ipsdy~ki~~~~~---lrI 385 (1381)
T KOG4221|consen 335 -----------------------PTT-LVAHESMDIEFECPVS--GKPIPTVRWYKNGDRIIPSDYFKIVGGGN---LRI 385 (1381)
T ss_pred -----------------------Ccc-eeeeeccceeEeCCCC--CCCcceEEEEecCcccCcccceEecCCCC---cEE
Confidence 222 4556788999999998 77999999999999888776666554433 777
Q ss_pred cccCcCCcEEEEEEEEcCCeeeEEEEEEEEeeccccccccccCCcccHHHHHhhhccCCCCccccCCCCCCCCccccchh
Q psy2148 1117 DYVYARDSGEYICRATNKWGTAMTKAKVICKAKHDIVTESQLPDSMSAEKLKELEKNYTPEEIEEDEIPEEPPRLNQSRY 1196 (1884)
Q Consensus 1117 ~~~~~~d~G~Y~C~a~n~~G~~~~~~~l~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1196 (1884)
..+...|.|.|.|.|+|+.|.+...+.|.+...+.+....
T Consensus 386 lgi~~sdeg~yQcvaen~~G~a~a~a~l~vv~~p~~~~s~---------------------------------------- 425 (1381)
T KOG4221|consen 386 LGIVKSDEGFYQCVAENDAGSAQAAAQLEVVPQPASASSD---------------------------------------- 425 (1381)
T ss_pred EEEecccchhhhhhhccCcccccchhhheeccCCcccccC----------------------------------------
Confidence 8888999999999999999999999998766432221100
Q ss_pred cccccccccccchhhhhhhccccccccccccccccccCCCchhHHHHHhhhccCCCccccccCCCCCCCeeEeecceeee
Q psy2148 1197 KKQNQSAWYDSELSEYQKERANESTELEKHDIVTESQLPDSMSAEKLKELEKNYTPEEIEEDEIPEEPPRFITEIESVTV 1276 (1884)
Q Consensus 1197 ~~~~~~~w~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~v 1276 (1884)
..+..|+.++..+.....
T Consensus 426 --------------------------------------------------------------~~~sap~~lv~~~~~srf 443 (1381)
T KOG4221|consen 426 --------------------------------------------------------------LLPSAPRDLVANLVSSRF 443 (1381)
T ss_pred --------------------------------------------------------------ccccCCcceeccccccee
Confidence 011122222222222111
Q ss_pred ecCCcEEEEEEEeecCCCcceEEEecccccccccccccceEEEeeccceeeeeeeeeeeeceEEEEEeeecccCceEEEE
Q psy2148 1277 QEAEPVRFETRVEPRVDPRLRVECSLSTAFFFPFINISTAFLIFNFCLHAVIFSHPIFDLGFVSLDIDYVYPEDQGEYVC 1356 (1884)
Q Consensus 1277 ~~g~~v~l~c~v~~~~~p~~~~~W~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~I~~~~~~d~G~Y~C 1356 (1884)
..=+-. ..|.. ..+...+.|+......... + ......-| ..+.+.++.+.-.+.++|
T Consensus 444 i~~tw~-~p~~~---~g~i~~~~v~~~~~~~~re---------------r---~~~tss~g-~~~tv~nl~p~t~Y~~rv 500 (1381)
T KOG4221|consen 444 IQLTWR-PPAQI---SGNISTYTVFYKVEGDVRE---------------R---LQNTSSPG-IQVTVQNLSPLTMYFFRV 500 (1381)
T ss_pred EEEeec-Ccccc---CCCcceEEEEEecCCchhh---------------h---heeccCCc-eEEEeeecccceeEEEEE
Confidence 111111 33422 3366778887543322111 0 00011223 567888888888888888
Q ss_pred EEEccccceeeeEEEEEeecCceeecccCCcchhhhHHHHHHHHhhhcccccccccCCccCCcccCCCCeEEEccCCccc
Q psy2148 1357 RAYNDHGEAFTKATISCKKIPTIQLQNQVPKGMLKTEALIQMEAAIKKYTSEIYLTEDDLYEPEKKQPPRFVTQIKTQDQ 1436 (1884)
Q Consensus 1357 ~a~n~~g~~~~~~~l~v~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~pP~~~~~~~~~~~ 1436 (1884)
+|.|.+|...+++.|.|..+|+ +|..
T Consensus 501 ~A~n~~g~g~sS~pLkV~t~pE---------------------------------------------gp~~--------- 526 (1381)
T KOG4221|consen 501 RAKNEAGSGESSAPLKVTTQPE---------------------------------------------GPVQ--------- 526 (1381)
T ss_pred eccCcccCCccCCceEEecCCC---------------------------------------------CCcc---------
Confidence 8899999999999999976654 1111
Q ss_pred cccccceEEEEEEeeCCCCCC----eEEEeecCeecCCCCCceeeeeCceEEEEEeeeccCCCeEEEEEEEecCcceEEE
Q psy2148 1437 LVEMQSTKFECQLAPVGDPNM----KVEWFLNGKPLPHKNRFNPIYDFGYVAMNFGWVYPEDSGEYLCRATNLYGMDETR 1512 (1884)
Q Consensus 1437 v~~g~~~~l~C~~~~~g~p~~----~i~W~~~~~~l~~~~~~~~~~~~~~~~L~i~~~~~~d~G~Y~c~a~n~~G~~~~~ 1512 (1884)
+..+..-.++|.+. +.|++ .|+|||........ ......+.+...++|.++...+...|.|+|+|.+|...++
T Consensus 527 ~~a~ats~~ti~v~--WepP~~~n~~I~~yk~~ys~~~~-~~~~~~~~n~~e~ti~gL~k~TeY~~~vvA~N~~G~g~sS 603 (1381)
T KOG4221|consen 527 LQAYATSPTTILVT--WEPPPFGNGPITGYKLFYSEDDT-GKELRVENNATEYTINGLEKYTEYSIRVVAYNSAGSGVSS 603 (1381)
T ss_pred ccccccCcceEEEE--ecCCCCCCCCceEEEEEEEcCCC-CceEEEecCccEEEeecCCCccceEEEEEEecCCCCCCCC
Confidence 23344456677775 77777 89999987666532 2344566666789999999999999999999999999998
Q ss_pred EEEEEe
Q psy2148 1513 AILKTT 1518 (1884)
Q Consensus 1513 ~~l~V~ 1518 (1884)
..+.|.
T Consensus 604 ~~i~V~ 609 (1381)
T KOG4221|consen 604 ADITVR 609 (1381)
T ss_pred CceEEE
Confidence 888775
No 4
>KOG4221|consensus
Probab=100.00 E-value=1.2e-38 Score=384.88 Aligned_cols=558 Identities=21% Similarity=0.238 Sum_probs=387.5
Q ss_pred CCCeeeecCCceeecCCCeEEEEEEEeeCCCCCcEEEEeeCCEEccCC--CcEEEEeeCCeEEEEEccCCC-----CCCe
Q psy2148 915 KAPEFLTTPTDLTLAESTLAHFECRLTPTNDPSMTVEWFHNGKALSAG--SRIKTINDFGFVILEINDVYL-----RDSG 987 (1884)
Q Consensus 915 ~~p~~~~~~~~~~v~~G~~v~l~C~v~~~~~P~~~v~W~~~g~~i~~~--~~~~~~~~~~~~~L~I~~~~~-----~D~G 987 (1884)
.+-.|+..++|. .+|.++-|+|.....+.+.+.|.|.|||..+... .+.+..+++ .|-|.++.. -|.|
T Consensus 40 ~~~~f~~ep~d~--~~~~svlLecs~~~~~~~~~~i~wkkDg~~l~e~~d~~~~~LsNg---Sl~i~~v~~~kh~~~~eg 114 (1381)
T KOG4221|consen 40 TPLQFLLEPSDA--MEGSSVLLECSAYAAGGTSVKIEWKKDGSQLNEVYDDRRQLLSNG---SLYISSVLASKHNKVDEG 114 (1381)
T ss_pred CcceEEeccccc--ccccceEEeccccccCCCCeeEEEccCchhhhhhhhhHHhhccCC---ceeEeeecccccccccCc
Confidence 456677777755 8999999999987555457899999999988554 455555555 366766665 7899
Q ss_pred EEEEEEEcC-Cee-EEEEEEEEEEeecccccccchhHhHhcchhhHHHHHHhhcccCcCCCCCCCCCCCceeeecCCCcC
Q psy2148 988 LYTCKATNK-HGE-ATTSCKLTVKGRQGIDVEPQVSAIFANATKNIQKLEEALYRKDELIPDEEKPNPPVFTSQLQDNLD 1065 (1884)
Q Consensus 988 ~Y~C~a~N~-~G~-~~~~~~l~V~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~ 1065 (1884)
.|+|.|+-. .|+ .+..+.|.+.+ .+.|.....+ .+
T Consensus 115 ~Yqc~atv~~~gsi~Sr~a~v~~a~------------------------------------------~~~f~~~~~~-~t 151 (1381)
T KOG4221|consen 115 VYQCLATVEDVGSILSRTAKVALAG------------------------------------------LADFALQPES-TT 151 (1381)
T ss_pred eEEEEEEccccceeecceEEEEecc------------------------------------------cCccccCccc-ee
Confidence 999999865 444 34556666653 2334443433 77
Q ss_pred cCCCCcEEEEEEEeeCCCCCcEEEEEECCEeccCCCceEEEeeCcEEEEEEcccCcCCcEEEEEEEEcCCeee-EEEEEE
Q psy2148 1066 VPEAGKVHFDCRLEPKSDPTMRIDWFFNGRPFATGSRVKTVYDFGFISLDMDYVYARDSGEYICRATNKWGTA-MTKAKV 1144 (1884)
Q Consensus 1066 v~~g~~~~l~C~v~~~~~p~~~v~W~k~~~~l~~~~~~~~~~~~~~~~l~i~~~~~~d~G~Y~C~a~n~~G~~-~~~~~l 1144 (1884)
+..|+++.|+|.+. +.|-+.+.|.||++++..+.++....++ .|.|.++++.|.|.|+|.++|..-.. +..+.|
T Consensus 152 ~~~g~ta~f~c~vn--~e~~p~i~w~kn~~pl~~~~r~i~lpsG---~L~I~~~qp~d~g~yrc~vt~g~~~r~S~~a~l 226 (1381)
T KOG4221|consen 152 LLYGQTALFSCEVN--AEPVPTIMWLKNDQPLPLDSRVIVLPSG---ALEISGLQPSDTGEYRCVVTGGASQRTSNEAEL 226 (1381)
T ss_pred EecCCcEEEEEEEc--CccCceeEEecccccccCCCcEEEcCCC---cEEecccccCCCceEEEEEecCCcCCccceeEE
Confidence 88999999999997 6777789999999999888866554443 69999999999999999999875433 334666
Q ss_pred EEeeccccccccccCCcccHHHHHhhhccCCCCccccCCCCCCCCccccchhcccccccccccchhhhhhhccccccccc
Q psy2148 1145 ICKAKHDIVTESQLPDSMSAEKLKELEKNYTPEEIEEDEIPEEPPRLNQSRYKKQNQSAWYDSELSEYQKERANESTELE 1224 (1884)
Q Consensus 1145 ~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~~~~ 1224 (1884)
+|...+..
T Consensus 227 tv~s~~~~------------------------------------------------------------------------ 234 (1381)
T KOG4221|consen 227 TVLSDPGA------------------------------------------------------------------------ 234 (1381)
T ss_pred EecCCccc------------------------------------------------------------------------
Confidence 65521110
Q ss_pred cccccccccCCCchhHHHHHhhhccCCCccccccCCCCCCCeeEeecceeeeecCCcEEEEEEEeecCCCcceEEEeccc
Q psy2148 1225 KHDIVTESQLPDSMSAEKLKELEKNYTPEEIEEDEIPEEPPRFITEIESVTVQEAEPVRFETRVEPRVDPRLRVECSLST 1304 (1884)
Q Consensus 1225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~v~~g~~v~l~c~v~~~~~p~~~~~W~~~~ 1304 (1884)
...-.|..++....+.+|+++.|.|.|. +.|.+.|.|.+++
T Consensus 235 -------------------------------------~~~~~fl~~p~~~~v~~g~~v~leCvvs--~~p~p~v~Wlrng 275 (1381)
T KOG4221|consen 235 -------------------------------------LNKLVFLDEPSNAVVVEGDDVVLECVVS--GVPKPSVKWLRNG 275 (1381)
T ss_pred -------------------------------------ccceeeecCCCccccccCCcEEEEEEec--CCCCCceEEeeCC
Confidence 0001267778889999999999999998 4699999999999
Q ss_pred ccccccccccceEEEeeccceeeeeeeeeeeeceEEEEEeeecccCceEEEEEEEccccceeeeEEEEEeecCceeeccc
Q psy2148 1305 AFFFPFINISTAFLIFNFCLHAVIFSHPIFDLGFVSLDIDYVYPEDQGEYVCRAYNDHGEAFTKATISCKKIPTIQLQNQ 1384 (1884)
Q Consensus 1305 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~I~~~~~~d~G~Y~C~a~n~~g~~~~~~~l~v~~~p~~~~~~~ 1384 (1884)
..+.-. . ......+...|.|.+++.+|+|.|+|+|+|......++++|+|..+|.
T Consensus 276 ~~i~~d-------------s------~rivl~g~~slliS~a~~~dSg~YtC~Atn~~D~idasaev~V~a~P~------ 330 (1381)
T KOG4221|consen 276 EKISVD-------------S------YRIVLVGGSSLLISNATDDDSGKYTCRATNTNDSIDASAEVTVLAPPG------ 330 (1381)
T ss_pred eeeeec-------------c------eEEEEecccceEEeccccccCceEEEEecCCCcccccceEEEEEcCCC------
Confidence 866533 1 112334566899999999999999999998555566778888875554
Q ss_pred CCcchhhhHHHHHHHHhhhcccccccccCCccCCcccCCCCeEEEccCCccccccccceEEEEEEeeCCCCCCeEEEeec
Q psy2148 1385 VPKGMLKTEALIQMEAAIKKYTSEIYLTEDDLYEPEKKQPPRFVTQIKTQDQLVEMQSTKFECQLAPVGDPNMKVEWFLN 1464 (1884)
Q Consensus 1385 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~pP~~~~~~~~~~~v~~g~~~~l~C~~~~~g~p~~~i~W~~~ 1464 (1884)
|+..+... ...++.++.|.|.+. |+|.|.+.|+||
T Consensus 331 ------------------------------------------~~~~p~~l-~A~e~~die~ec~~~--g~p~p~v~w~kN 365 (1381)
T KOG4221|consen 331 ------------------------------------------FTKAPTTL-VAHESMDIEFECPVS--GKPIPTVRWYKN 365 (1381)
T ss_pred ------------------------------------------CCCCCcce-eeeeccceeEeCCCC--CCCcceEEEEec
Confidence 44333332 356789999999997 999999999999
Q ss_pred CeecCCCCCceeeeeCceEEEEEeeeccCCCeEEEEEEEecCcceEEEEEEEEeCCCccccccCCCccchhHHHHHHhhc
Q psy2148 1465 GKPLPHKNRFNPIYDFGYVAMNFGWVYPEDSGEYLCRATNLYGMDETRAILKTTGKPGIIYESQLPKGMKSIEKIREMEA 1544 (1884)
Q Consensus 1465 ~~~l~~~~~~~~~~~~~~~~L~i~~~~~~d~G~Y~c~a~n~~G~~~~~~~l~V~~~p~~~~~~~~~~~~~~~~~~~~~~~ 1544 (1884)
|..+..++.+.+ ..++. |.|..+-..|.|.|-|.++|++|...+.+.+.|-..|....
T Consensus 366 gd~~ipsdy~ki-~~~~~--lrIlgi~~sdeg~yQcvaen~~G~a~a~a~l~vv~~p~~~~------------------- 423 (1381)
T KOG4221|consen 366 GDRIIPSDYFKI-VGGGN--LRILGIVKSDEGFYQCVAENDAGSAQAAAQLEVVPQPASAS------------------- 423 (1381)
T ss_pred CcccCcccceEe-cCCCC--cEEEEEecccchhhhhhhccCcccccchhhheeccCCcccc-------------------
Confidence 999988655543 33332 77778889999999999999999999888886533221110
Q ss_pred ccccCCccccccCCCCCCCeEecCCcccccccCCceEEEEEEecCCCCeEEEEEcCEEeeeeeEEEEeeccceeeeecce
Q psy2148 1545 SWQHTPEQLVEDEKPKEAPVFVSQPEAQKVQEGEPARFCTRVTGYPRPRVMWLINGHTIVNEIVRKITATETTEMEHKGK 1624 (1884)
Q Consensus 1545 ~~~~~~~~~~~~~~~~~~P~~~~~~~~~~v~~g~~~~l~C~~~g~p~~~v~W~~~g~~i~~~~~~~~~~~~~~~~~~~~~ 1624 (1884)
-+.+-..+.+..+..-+...+.|.. .
T Consensus 424 -----------------s~~~~sap~~lv~~~~~srfi~~tw----------~--------------------------- 449 (1381)
T KOG4221|consen 424 -----------------SDLLPSAPRDLVANLVSSRFIQLTW----------R--------------------------- 449 (1381)
T ss_pred -----------------cCccccCCcceecccccceeEEEee----------c---------------------------
Confidence 0112222222222222222222221 1
Q ss_pred eeEEEEecCCCCCCCCeeeecCCceeecCCCeEEEEEEEeccCCCeEEEEeCCeecCCCCCeEEEEeCceeEEEEccccc
Q psy2148 1625 IQERVVDASEKPAKPPVFTKKIQPCRAFEQDQARFEVEFDGDPLPTIKWFREDFPITSSPDFQIHTFSTKSILIMRQVFM 1704 (1884)
Q Consensus 1625 ~~~~~~~~~~~~~~~p~~~~~~~~~~v~~G~~~~l~C~~~g~p~~~i~W~~~~~~~~~~~~~~~~~~~~~~~L~i~~v~~ 1704 (1884)
..| ..+.+-+.++|+......... + .+...+.+ |.+.....
T Consensus 450 ----------------------------------~p~-~~~g~i~~~~v~~~~~~~~re-r-~~~tss~g--~~~tv~nl 490 (1381)
T KOG4221|consen 450 ----------------------------------PPA-QISGNISTYTVFYKVEGDVRE-R-LQNTSSPG--IQVTVQNL 490 (1381)
T ss_pred ----------------------------------Ccc-ccCCCcceEEEEEecCCchhh-h-heeccCCc--eEEEeeec
Confidence 122 223455667776543221111 1 11122222 44444445
Q ss_pred CCCeEEEE--EEEeCCceEEEEEEEEEEecccCCCCCCCCCeEEeccCceEEcCCceEEEEEEEecCCCc----EEEEEe
Q psy2148 1705 EDSGVFAV--IAENRGGKAKCSANLVVEEKRQGGRGGVVPPSFLTTISSAVINVGQLARFDAKISATKPL----DVYWLK 1778 (1884)
Q Consensus 1705 ~DsG~Y~C--~a~n~~g~~~~~~~l~V~~~~~~~~~~~~~P~~~~~~~~~~~~~G~~~~l~C~~~g~p~p----~v~W~k 1778 (1884)
..++.|.| .|.|..|.-..+..|.|...++ .... ...+...-++|.+.+.|++ .|+|||
T Consensus 491 ~p~t~Y~~rv~A~n~~g~g~sS~pLkV~t~pE--------------gp~~-~~a~ats~~ti~v~WepP~~~n~~I~~yk 555 (1381)
T KOG4221|consen 491 SPLTMYFFRVRAKNEAGSGESSAPLKVTTQPE--------------GPVQ-LQAYATSPTTILVTWEPPPFGNGPITGYK 555 (1381)
T ss_pred ccceeEEEEEeccCcccCCccCCceEEecCCC--------------CCcc-ccccccCcceEEEEecCCCCCCCCceEEE
Confidence 55565555 5778899999999999996432 1222 5566777889999998887 799999
Q ss_pred CCEecCCCCCeEEeecCCeEEEEEccCCCCCCEEEEEEEEeCCeeEEEEEEEEEEecCC
Q psy2148 1779 NGKKIIPDIRYKTLEEDNLFTLLIIEAVVEDSGAYECVAMNNAGEARCEAELVVQSKKA 1837 (1884)
Q Consensus 1779 ~~~~l~~~~~~~~~~~~~~~~L~i~~~~~~d~G~Y~C~a~N~~G~~~~~~~l~V~~~~~ 1837 (1884)
.........+ .+..+.+...++|.++.+.+...|.|+|.|.+|....+..++|.....
T Consensus 556 ~~ys~~~~~~-~~~~~~n~~e~ti~gL~k~TeY~~~vvA~N~~G~g~sS~~i~V~Tlsd 613 (1381)
T KOG4221|consen 556 LFYSEDDTGK-ELRVENNATEYTINGLEKYTEYSIRVVAYNSAGSGVSSADITVRTLSD 613 (1381)
T ss_pred EEEEcCCCCc-eEEEecCccEEEeecCCCccceEEEEEEecCCCCCCCCCceEEEeccC
Confidence 9877653332 223334445999999999999999999999999999999999886543
No 5
>KOG4222|consensus
Probab=100.00 E-value=5.7e-39 Score=385.54 Aligned_cols=480 Identities=25% Similarity=0.395 Sum_probs=361.4
Q ss_pred CCCCCCCceeeecCCCcCcCCCCcEEEEEEEeeCCCCCcEEEEEECCEeccCC--CceEEEeeCc-EEEEEEcccC--cC
Q psy2148 1048 EEKPNPPVFTSQLQDNLDVPEAGKVHFDCRLEPKSDPTMRIDWFFNGRPFATG--SRVKTVYDFG-FISLDMDYVY--AR 1122 (1884)
Q Consensus 1048 ~~~~~~p~~~~~~~~~~~v~~g~~~~l~C~v~~~~~p~~~v~W~k~~~~l~~~--~~~~~~~~~~-~~~l~i~~~~--~~ 1122 (1884)
.....+|.++....+ ..+.-|+.++|.|.+. |.|.|+|.|||+|+....+ ..+++...++ ...|.+.+-. ..
T Consensus 26 r~qd~~p~iiehp~d-~vvs~~~patlnc~as--G~ppPti~w~k~G~~~~~~e~~shR~~lp~gsLf~l~~ahg~~a~~ 102 (1281)
T KOG4222|consen 26 RAQDQPPRIIEHPHD-LVVSKGEPATLNCKAS--GDPPPTIEWYKDGENVFKGEPGSHRFLLPDGSLFLLRLAHGKKAGH 102 (1281)
T ss_pred ccccCCCceEecchh-hhccCCCCceeecCCC--CCCCCceecccCCcccCCCCCCCcceecCCccEEEEecccCCcccC
Confidence 344578999888877 6788899999999997 9999999999999654332 1122333333 2223332221 22
Q ss_pred CcEEEEEEEEcCCeeeEE-EEEEEEeeccccccccccCCcccHHHHHhhhccCCCCccccCCCCCCCCccccchhccccc
Q psy2148 1123 DSGEYICRATNKWGTAMT-KAKVICKAKHDIVTESQLPDSMSAEKLKELEKNYTPEEIEEDEIPEEPPRLNQSRYKKQNQ 1201 (1884)
Q Consensus 1123 d~G~Y~C~a~n~~G~~~~-~~~l~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1201 (1884)
|.|.|+|.|+|.+|.+.+ .+.|.+..-++
T Consensus 103 d~G~y~cvasn~~g~avSr~a~L~vavlrd-------------------------------------------------- 132 (1281)
T KOG4222|consen 103 DHGVYSCVASNRLGEAVSRGASLIVAVLRD-------------------------------------------------- 132 (1281)
T ss_pred CCceeEeeecCccceeeecCceEEEEEech--------------------------------------------------
Confidence 899999999999997765 35555442111
Q ss_pred ccccccchhhhhhhccccccccccccccccccCCCchhHHHHHhhhccCCCccccccCCCCCCCeeEeecceeeeecCCc
Q psy2148 1202 SAWYDSELSEYQKERANESTELEKHDIVTESQLPDSMSAEKLKELEKNYTPEEIEEDEIPEEPPRFITEIESVTVQEAEP 1281 (1884)
Q Consensus 1202 ~~w~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~v~~g~~ 1281 (1884)
.|...+.+..+..|+.
T Consensus 133 ----------------------------------------------------------------dfrv~prd~~~a~ge~ 148 (1281)
T KOG4222|consen 133 ----------------------------------------------------------------DFRVSPRDVQAAVGEE 148 (1281)
T ss_pred ----------------------------------------------------------------hcccCcccccccccce
Confidence 1233345678899999
Q ss_pred EEEEEEEeecCCCcceEEEecccccccccccccceEEEeeccceeeeeeeeeeeeceEEEEEeeecccCceEEEEEEEcc
Q psy2148 1282 VRFETRVEPRVDPRLRVECSLSTAFFFPFINISTAFLIFNFCLHAVIFSHPIFDLGFVSLDIDYVYPEDQGEYVCRAYND 1361 (1884)
Q Consensus 1282 v~l~c~v~~~~~p~~~~~W~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~I~~~~~~d~G~Y~C~a~n~ 1361 (1884)
+.|.|.-.. +.|.+.+.|.|++.++... .... .. ...+| .|.|.+++..|+|.|.|.++|-
T Consensus 149 avlEcgpP~-ghpeptvSw~Kdg~pl~~~-------------~~~~--~~-lisgG--~LlIsnvrksD~GtY~CVatNm 209 (1281)
T KOG4222|consen 149 AVLECGPPR-GHPEPTVSWVKDGKPLDHY-------------DVPI--IA-LISGG--NLLISNVRKSDEGTYACVATNM 209 (1281)
T ss_pred eEEeccCCC-CCCCCcceeecCCCccccc-------------ccee--EE-EecCC--cEEEeccccCCCceeeeeeccc
Confidence 999998543 7888999999999987622 1110 11 12334 7999999999999999999999
Q ss_pred ccceeee-EEEEEeecCceeecccCCcchhhhHHHHHHHHhhhcccccccccCCccCCcccCCCCeEEEccCCccccccc
Q psy2148 1362 HGEAFTK-ATISCKKIPTIQLQNQVPKGMLKTEALIQMEAAIKKYTSEIYLTEDDLYEPEKKQPPRFVTQIKTQDQLVEM 1440 (1884)
Q Consensus 1362 ~g~~~~~-~~l~v~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~pP~~~~~~~~~~~v~~g 1440 (1884)
+|+..+. +.|+|++ +|.|...+.+.. +.+|
T Consensus 210 vG~ReS~~A~lsv~e------------------------------------------------~P~f~~rp~~~~-v~~g 240 (1281)
T KOG4222|consen 210 VGERESIPARLSVQE------------------------------------------------KPWFWKRPKDLA-VLVG 240 (1281)
T ss_pred ccccccccceeeecc------------------------------------------------CCccccccccce-eecc
Confidence 9987655 7888764 455666666654 7788
Q ss_pred cceEEEEEEeeCCCCCCeEEEeecCeecCCCCCceeeeeCceEEEEEeeeccCCCeEEEEEEEecCcceEEEEEEEEeCC
Q psy2148 1441 QSTKFECQLAPVGDPNMKVEWFLNGKPLPHKNRFNPIYDFGYVAMNFGWVYPEDSGEYLCRATNLYGMDETRAILKTTGK 1520 (1884)
Q Consensus 1441 ~~~~l~C~~~~~g~p~~~i~W~~~~~~l~~~~~~~~~~~~~~~~L~i~~~~~~d~G~Y~c~a~n~~G~~~~~~~l~V~~~ 1520 (1884)
..+.|.|.+. |.|.|.|.|.+++..++. .+|.+..+ ..+|.|.+.+..|.|.|.|.|.|..|..++++.++|+.
T Consensus 241 ~~~~f~c~v~--GdP~P~Vrwkk~~~~~P~-~ry~i~~d--~qtl~i~r~tp~deg~y~C~a~n~vG~l~asa~ltV~a- 314 (1281)
T KOG4222|consen 241 AAAEFDCRVG--GDPQPTVRWKKDDPSLPR-SRYSILDD--TQTLRIDRVTPTDEGTYVCPAENLVGGLEASATLTVQA- 314 (1281)
T ss_pred cccccccccC--CCCCCceeeeccCCCCCc-cceeeeec--cccccccccCCCcccceeeeccccccccccccceEEec-
Confidence 9999999995 999999999998888764 56665443 23799999999999999999999999999999999965
Q ss_pred CccccccCCCccchhHHHHHHhhcccccCCccccccCCCCCCCeEecCCcccccccCCceEEEEEEecCCCCeEEEEEcC
Q psy2148 1521 PGIIYESQLPKGMKSIEKIREMEASWQHTPEQLVEDEKPKEAPVFVSQPEAQKVQEGEPARFCTRVTGYPRPRVMWLING 1600 (1884)
Q Consensus 1521 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~P~~~~~~~~~~v~~g~~~~l~C~~~g~p~~~v~W~~~g 1600 (1884)
+|.|...+.++.+..|..++|.|.+.|+|.|.+.|.+.|
T Consensus 315 -----------------------------------------pP~f~kkp~dq~v~lg~~vt~pc~~~gnP~PavfW~keg 353 (1281)
T KOG4222|consen 315 -----------------------------------------PPSFGKKPRDQKVALGGTVTFPCETLGNPPPAVFWLKEG 353 (1281)
T ss_pred -----------------------------------------CcccccccCccccccCceEEeeeecCCCCCcceEEeccC
Confidence 566888899999999999999999999999999999877
Q ss_pred EEeeeeeEEEEeeccceeeeecceeeEEEEecCCCCCCCCeeeecCCceeecCCCeEEEEEEEeccCCCeEEEEeCCeec
Q psy2148 1601 HTIVNEIVRKITATETTEMEHKGKIQERVVDASEKPAKPPVFTKKIQPCRAFEQDQARFEVEFDGDPLPTIKWFREDFPI 1680 (1884)
Q Consensus 1601 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~v~~G~~~~l~C~~~g~p~~~i~W~~~~~~~ 1680 (1884)
..-.. . |. .+.
T Consensus 354 ~q~ll------------------------------------------------------------f------~~---~p~ 364 (1281)
T KOG4222|consen 354 SQDLL------------------------------------------------------------F------SA---SPP 364 (1281)
T ss_pred cceec------------------------------------------------------------c------cC---CCC
Confidence 54210 0 00 000
Q ss_pred CCCCCeEEEEeCceeEEEEcccccCCCeEEEEEEEeCCceEEEEEEEEEEecccCCCCCCCCCeEEeccCceEEcCCceE
Q psy2148 1681 TSSPDFQIHTFSTKSILIMRQVFMEDSGVFAVIAENRGGKAKCSANLVVEEKRQGGRGGVVPPSFLTTISSAVINVGQLA 1760 (1884)
Q Consensus 1681 ~~~~~~~~~~~~~~~~L~i~~v~~~DsG~Y~C~a~n~~g~~~~~~~l~V~~~~~~~~~~~~~P~~~~~~~~~~~~~G~~~ 1760 (1884)
....+..+. ...+|+|.++...|.|.|.|...+..|.......+.+.+..-.. ..+|.+...+.+++..+|..+
T Consensus 365 ~~~~r~svs---~~g~L~it~v~~~d~g~Yvcq~~~~~~ss~~~a~~~qt~~~~~~---rPpp~i~~g~~nQtl~v~s~a 438 (1281)
T KOG4222|consen 365 SSNGRGSVS---PTGTLTITNVRQSDEGYYVCQTQTSAGSSLTKAYLEQTDVLTDS---RPPPIIEQGPANQTLPVGSTA 438 (1281)
T ss_pred CcCccceec---CCCCcccccccccccceEeecccccccccccceeEEEEeeeccC---CCCceeeecccccccccCccc
Confidence 111122222 22369999999999999999998888877666666655432211 147888888999999999999
Q ss_pred EEEEEEecCCCcEEEEEeCCEecCCCCCeEEeecCCeEEEEEccCCCCCCEEEEEEEEeCCeeEEEEEEEEEEecC
Q psy2148 1761 RFDAKISATKPLDVYWLKNGKKIIPDIRYKTLEEDNLFTLLIIEAVVEDSGAYECVAMNNAGEARCEAELVVQSKK 1836 (1884)
Q Consensus 1761 ~l~C~~~g~p~p~v~W~k~~~~l~~~~~~~~~~~~~~~~L~i~~~~~~d~G~Y~C~a~N~~G~~~~~~~l~V~~~~ 1836 (1884)
.|.|.+.|.|.|.+.|++++-.+........... ..+|+|.+....|.|.|+|.|.+..|+..-++.|+|.+.-
T Consensus 439 ~l~c~atg~P~p~i~wl~dg~~v~~~d~~~s~~~--~~~l~i~dl~~~DtG~YTc~as~~~ges~wSatl~v~~~~ 512 (1281)
T KOG4222|consen 439 SLPCSATGAPTPNISWLKDGCNVMNPDSRISQQE--IGSLRIRDLKGPDTGRYTCIASDESGESTWSATLTVEKAG 512 (1281)
T ss_pred ccChhhhCCCCCCchhhhcccccccCCcccceee--eceeeeeeeecCCCcceeeeccCcccccccceeeEhhhcC
Confidence 9999999999999999999987754443322222 2389999999999999999999999999999999998644
No 6
>KOG4222|consensus
Probab=100.00 E-value=2.2e-38 Score=380.48 Aligned_cols=548 Identities=22% Similarity=0.339 Sum_probs=380.1
Q ss_pred CCCCeeeecCCceeecCCCeEEEEEEEeeCCCCCcEEEEeeCCEEccCCC--cEEEEe-eCCeEEEEEc-cC-CCCCCeE
Q psy2148 914 GKAPEFLTTPTDLTLAESTLAHFECRLTPTNDPSMTVEWFHNGKALSAGS--RIKTIN-DFGFVILEIN-DV-YLRDSGL 988 (1884)
Q Consensus 914 ~~~p~~~~~~~~~~v~~G~~v~l~C~v~~~~~P~~~v~W~~~g~~i~~~~--~~~~~~-~~~~~~L~I~-~~-~~~D~G~ 988 (1884)
..+|.|+..+.++.+..|+.++|.|.++ |.|+|+|+|||+|.....+. ..++.. ++....|++. .. ...|.|.
T Consensus 29 d~~p~iiehp~d~vvs~~~patlnc~as--G~ppPti~w~k~G~~~~~~e~~shR~~lp~gsLf~l~~ahg~~a~~d~G~ 106 (1281)
T KOG4222|consen 29 DQPPRIIEHPHDLVVSKGEPATLNCKAS--GDPPPTIEWYKDGENVFKGEPGSHRFLLPDGSLFLLRLAHGKKAGHDHGV 106 (1281)
T ss_pred cCCCceEecchhhhccCCCCceeecCCC--CCCCCceecccCCcccCCCCCCCcceecCCccEEEEecccCCcccCCCce
Confidence 3689999999999999999999999999 88999999999997553322 122333 3333334432 11 1249999
Q ss_pred EEEEEEcCCeeE-EEEEEEEEEeecccccccchhHhHhcchhhHHHHHHhhcccCcCCCCCCCCCCCceeeecCCCcCcC
Q psy2148 989 YTCKATNKHGEA-TTSCKLTVKGRQGIDVEPQVSAIFANATKNIQKLEEALYRKDELIPDEEKPNPPVFTSQLQDNLDVP 1067 (1884)
Q Consensus 989 Y~C~a~N~~G~~-~~~~~l~V~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~v~ 1067 (1884)
|+|.|+|.+|.. +..+.|.|...+. .|-...++ +.+.
T Consensus 107 y~cvasn~~g~avSr~a~L~vavlrd-----------------------------------------dfrv~prd-~~~a 144 (1281)
T KOG4222|consen 107 YSCVASNRLGEAVSRGASLIVAVLRD-----------------------------------------DFRVSPRD-VQAA 144 (1281)
T ss_pred eEeeecCccceeeecCceEEEEEech-----------------------------------------hcccCccc-cccc
Confidence 999999999975 4556666653211 12333334 5566
Q ss_pred CCCcEEEEEEEeeCCCCCcEEEEEECCEeccCCCc-eEEEeeCcEEEEEEcccCcCCcEEEEEEEEcCCeeeEE-EEEEE
Q psy2148 1068 EAGKVHFDCRLEPKSDPTMRIDWFFNGRPFATGSR-VKTVYDFGFISLDMDYVYARDSGEYICRATNKWGTAMT-KAKVI 1145 (1884)
Q Consensus 1068 ~g~~~~l~C~v~~~~~p~~~v~W~k~~~~l~~~~~-~~~~~~~~~~~l~i~~~~~~d~G~Y~C~a~n~~G~~~~-~~~l~ 1145 (1884)
.|+.+.|+|.-. .|.|.+.+.|.|+|+++..... ......+| .|.|.++...|+|.|.|.|.|..|..++ -++|.
T Consensus 145 ~ge~avlEcgpP-~ghpeptvSw~Kdg~pl~~~~~~~~~lisgG--~LlIsnvrksD~GtY~CVatNmvG~ReS~~A~ls 221 (1281)
T KOG4222|consen 145 VGEEAVLECGPP-RGHPEPTVSWVKDGKPLDHYDVPIIALISGG--NLLISNVRKSDEGTYACVATNMVGERESIPARLS 221 (1281)
T ss_pred ccceeEEeccCC-CCCCCCcceeecCCCccccccceeEEEecCC--cEEEeccccCCCceeeeeecccccccccccceee
Confidence 899999999886 5889999999999999883322 12223344 6999999999999999999999997655 35666
Q ss_pred EeeccccccccccCCcccHHHHHhhhccCCCCccccCCCCCCCCccccchhcccccccccccchhhhhhhcccccccccc
Q psy2148 1146 CKAKHDIVTESQLPDSMSAEKLKELEKNYTPEEIEEDEIPEEPPRLNQSRYKKQNQSAWYDSELSEYQKERANESTELEK 1225 (1884)
Q Consensus 1146 v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~~~~~ 1225 (1884)
|..
T Consensus 222 v~e----------------------------------------------------------------------------- 224 (1281)
T KOG4222|consen 222 VQE----------------------------------------------------------------------------- 224 (1281)
T ss_pred ecc-----------------------------------------------------------------------------
Confidence 553
Q ss_pred ccccccccCCCchhHHHHHhhhccCCCccccccCCCCCCCeeEeecceeeeecCCcEEEEEEEeecCCCcceEEEecccc
Q psy2148 1226 HDIVTESQLPDSMSAEKLKELEKNYTPEEIEEDEIPEEPPRFITEIESVTVQEAEPVRFETRVEPRVDPRLRVECSLSTA 1305 (1884)
Q Consensus 1226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~v~~g~~v~l~c~v~~~~~p~~~~~W~~~~~ 1305 (1884)
+|.|.+.+.+..+.+|..+.+.|.|. ++|.+.+.|.|.+.
T Consensus 225 --------------------------------------~P~f~~rp~~~~v~~g~~~~f~c~v~--GdP~P~Vrwkk~~~ 264 (1281)
T KOG4222|consen 225 --------------------------------------KPWFWKRPKDLAVLVGAAAEFDCRVG--GDPQPTVRWKKDDP 264 (1281)
T ss_pred --------------------------------------CCccccccccceeecccccccccccC--CCCCCceeeeccCC
Confidence 45666777888999999999999987 67999999999776
Q ss_pred cccccccccceEEEeeccceeeeeeeeeeeeceEEEEEeeecccCceEEEEEEEccccceeeeEEEEEeecCceeecccC
Q psy2148 1306 FFFPFINISTAFLIFNFCLHAVIFSHPIFDLGFVSLDIDYVYPEDQGEYVCRAYNDHGEAFTKATISCKKIPTIQLQNQV 1385 (1884)
Q Consensus 1306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~I~~~~~~d~G~Y~C~a~n~~g~~~~~~~l~v~~~p~~~~~~~~ 1385 (1884)
.+... ++.+.. ...+|.|.++.+.|+|.|.|.|.|..|....++.++|+.+|
T Consensus 265 ~~P~~------------------ry~i~~--d~qtl~i~r~tp~deg~y~C~a~n~vG~l~asa~ltV~apP-------- 316 (1281)
T KOG4222|consen 265 SLPRS------------------RYSILD--DTQTLRIDRVTPTDEGTYVCPAENLVGGLEASATLTVQAPP-------- 316 (1281)
T ss_pred CCCcc------------------ceeeee--ccccccccccCCCcccceeeeccccccccccccceEEecCc--------
Confidence 54433 122222 22479999999999999999999999999999999997554
Q ss_pred CcchhhhHHHHHHHHhhhcccccccccCCccCCcccCCCCeEEEccCCccccccccceEEEEEEeeCCCCCCeEEEeecC
Q psy2148 1386 PKGMLKTEALIQMEAAIKKYTSEIYLTEDDLYEPEKKQPPRFVTQIKTQDQLVEMQSTKFECQLAPVGDPNMKVEWFLNG 1465 (1884)
Q Consensus 1386 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~pP~~~~~~~~~~~v~~g~~~~l~C~~~~~g~p~~~i~W~~~~ 1465 (1884)
.|...+.+.. +..|..++|.|.+. |+|.|.+.|.+.|
T Consensus 317 ----------------------------------------~f~kkp~dq~-v~lg~~vt~pc~~~--gnP~PavfW~keg 353 (1281)
T KOG4222|consen 317 ----------------------------------------SFGKKPRDQK-VALGGTVTFPCETL--GNPPPAVFWLKEG 353 (1281)
T ss_pred ----------------------------------------ccccccCccc-cccCceEEeeeecC--CCCCcceEEeccC
Confidence 4555555544 66788999999986 9999999999977
Q ss_pred eecC--------CCCCceeeeeCceEEEEEeeeccCCCeEEEEEEEecCcceEEEEEEEEeCCCccccccCCCccchhHH
Q psy2148 1466 KPLP--------HKNRFNPIYDFGYVAMNFGWVYPEDSGEYLCRATNLYGMDETRAILKTTGKPGIIYESQLPKGMKSIE 1537 (1884)
Q Consensus 1466 ~~l~--------~~~~~~~~~~~~~~~L~i~~~~~~d~G~Y~c~a~n~~G~~~~~~~l~V~~~p~~~~~~~~~~~~~~~~ 1537 (1884)
..-. ...+..+... + .|+|.+++..|.|.|.|...|.+|.......+.+.+.-
T Consensus 354 ~q~llf~~~p~~~~~r~svs~~-g--~L~it~v~~~d~g~Yvcq~~~~~~ss~~~a~~~qt~~~---------------- 414 (1281)
T KOG4222|consen 354 SQDLLFSASPPSSNGRGSVSPT-G--TLTITNVRQSDEGYYVCQTQTSAGSSLTKAYLEQTDVL---------------- 414 (1281)
T ss_pred cceecccCCCCCcCccceecCC-C--CcccccccccccceEeecccccccccccceeEEEEeee----------------
Confidence 4321 1122222222 2 79999999999999999999988877666666553210
Q ss_pred HHHHhhcccccCCccccccCCCCCCCeEecCCcccccccCCceEEEEEEecCCCCeEEEEEcCEEeeeeeEEEEeeccce
Q psy2148 1538 KIREMEASWQHTPEQLVEDEKPKEAPVFVSQPEAQKVQEGEPARFCTRVTGYPRPRVMWLINGHTIVNEIVRKITATETT 1617 (1884)
Q Consensus 1538 ~~~~~~~~~~~~~~~~~~~~~~~~~P~~~~~~~~~~v~~g~~~~l~C~~~g~p~~~v~W~~~g~~i~~~~~~~~~~~~~~ 1617 (1884)
| .
T Consensus 415 ----------------------------------------------~--~------------------------------ 416 (1281)
T KOG4222|consen 415 ----------------------------------------------T--D------------------------------ 416 (1281)
T ss_pred ----------------------------------------------c--c------------------------------
Confidence 0 0
Q ss_pred eeeecceeeEEEEecCCCCCCCCeeeecCCceeecCCCeEEEEEEEeccCCCeEEEEeCCeecCCCCCeEEEEeCceeEE
Q psy2148 1618 EMEHKGKIQERVVDASEKPAKPPVFTKKIQPCRAFEQDQARFEVEFDGDPLPTIKWFREDFPITSSPDFQIHTFSTKSIL 1697 (1884)
Q Consensus 1618 ~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~v~~G~~~~l~C~~~g~p~~~i~W~~~~~~~~~~~~~~~~~~~~~~~L 1697 (1884)
...+|.+...+.+++..+|..+.|.|.+.|.|.+.+.|+++|-.+..... .......+.|
T Consensus 417 ------------------~rPpp~i~~g~~nQtl~v~s~a~l~c~atg~P~p~i~wl~dg~~v~~~d~--~~s~~~~~~l 476 (1281)
T KOG4222|consen 417 ------------------SRPPPIIEQGPANQTLPVGSTASLPCSATGAPTPNISWLKDGCNVMNPDS--RISQQEIGSL 476 (1281)
T ss_pred ------------------CCCCceeeecccccccccCcccccChhhhCCCCCCchhhhcccccccCCc--ccceeeecee
Confidence 01233444455566666788888999999999999999999976544331 1122334679
Q ss_pred EEcccccCCCeEEEEEEEeCCceEEEEEEEEEEecccCCCCCCCCCeEEeccCceEEcCCceEEE--EEEEecCCCcEEE
Q psy2148 1698 IMRQVFMEDSGVFAVIAENRGGKAKCSANLVVEEKRQGGRGGVVPPSFLTTISSAVINVGQLARF--DAKISATKPLDVY 1775 (1884)
Q Consensus 1698 ~i~~v~~~DsG~Y~C~a~n~~g~~~~~~~l~V~~~~~~~~~~~~~P~~~~~~~~~~~~~G~~~~l--~C~~~g~p~p~v~ 1775 (1884)
+|.+....|.|.|+|.+.+..|...-++.|.|.+.... ....+-..+.......|..... .|. .-.+.
T Consensus 477 ~i~dl~~~DtG~YTc~as~~~ges~wSatl~v~~~~~s-----~q~~r~~D~S~~pS~p~~p~v~~v~~~-----~v~Ls 546 (1281)
T KOG4222|consen 477 RIRDLKGPDTGRYTCIASDESGESTWSATLTVEKAGSS-----QQFCRCEDPSALPSPPGTPGVVNVSRT-----SVTLS 546 (1281)
T ss_pred eeeeeecCCCcceeeeccCcccccccceeeEhhhcCcc-----cccccCCChhhCCCCCCCCccccCCCc-----eEEec
Confidence 99999999999999999999999999999999875432 0011111111111122221111 111 11344
Q ss_pred EEeCCE--ecCCC-------------CCeEEeecCCeEEEEEccCCCCCCEEEEEEEEeCCee
Q psy2148 1776 WLKNGK--KIIPD-------------IRYKTLEEDNLFTLLIIEAVVEDSGAYECVAMNNAGE 1823 (1884)
Q Consensus 1776 W~k~~~--~l~~~-------------~~~~~~~~~~~~~L~i~~~~~~d~G~Y~C~a~N~~G~ 1823 (1884)
|..... ....+ .....-..-...+..|..+...-...+.|.|.|..|-
T Consensus 547 W~~~s~sg~vP~s~yiieafs~~~~etw~~ta~~v~~t~~~I~gL~P~~sylf~vRa~n~~Gi 609 (1281)
T KOG4222|consen 547 WQPTSPSGAVPASGYIIEAFSPDLGETWQTTAGRVKTTTYAIRGLKPNLSYLFLVRAENEQGI 609 (1281)
T ss_pred ccCCCCCCccccchhHHHHhhhhhcccccccccccccceeeecCcCccceeeeeeeccccccc
Confidence 443322 11100 0000111112337888999999999999999999984
No 7
>KOG4194|consensus
Probab=99.95 E-value=1.3e-27 Score=268.48 Aligned_cols=282 Identities=26% Similarity=0.420 Sum_probs=216.0
Q ss_pred CCCeEEEccCCccccccccceEEEEEEeeCCCCCCeEEEeecCeecCC-----CCCceeeee--------CceEEEEEee
Q psy2148 1423 QPPRFVTQIKTQDQLVEMQSTKFECQLAPVGDPNMKVEWFLNGKPLPH-----KNRFNPIYD--------FGYVAMNFGW 1489 (1884)
Q Consensus 1423 ~pP~~~~~~~~~~~v~~g~~~~l~C~~~~~g~p~~~i~W~~~~~~l~~-----~~~~~~~~~--------~~~~~L~i~~ 1489 (1884)
.+|+++.+|.... ...|..++|+|.+.-.+..+.+|.|.++++.++. .-++..+.. .-...|.+.+
T Consensus 502 pkpqI~~qPe~~~-al~g~nirftC~a~sssasplsi~WR~dnevq~rv~ved~a~~~~q~r~~~~~e~~~~~~~L~L~n 580 (873)
T KOG4194|consen 502 PKPQIVTQPETVS-ALIGENIRFTCNAYSSSASPLSIEWRKDNEVQPRVDVEDFATFLSQNRNGTFGEREEYTAILHLDN 580 (873)
T ss_pred CCcceecCchHhh-hhhccceEEEEEeccCCCCCceeEeeeccccCcccchhcchhhhhhhccCccchhhhhhheeeeee
Confidence 4688887776654 5689999999998611255689999998874432 111111110 1135799999
Q ss_pred eccCCCeEEEEEEEecCcceEEE-EEEEEeCCCccccccCCCccchhHHHHHHhhcccccCCccccccCCCCCCCeEecC
Q psy2148 1490 VYPEDSGEYLCRATNLYGMDETR-AILKTTGKPGIIYESQLPKGMKSIEKIREMEASWQHTPEQLVEDEKPKEAPVFVSQ 1568 (1884)
Q Consensus 1490 ~~~~d~G~Y~c~a~n~~G~~~~~-~~l~V~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~P~~~~~ 1568 (1884)
++..|+|.|.|+++|.+|+..+. +.|.|.. .|.|+..
T Consensus 581 Vt~td~grYQCVvtN~FGStysqk~KltV~~------------------------------------------~PsFtkt 618 (873)
T KOG4194|consen 581 VTFTDEGRYQCVVTNHFGSTYSQKAKLTVNQ------------------------------------------APSFTKT 618 (873)
T ss_pred eecccCceEEEEEecccCcchhheeEEEeec------------------------------------------cCccccC
Confidence 99999999999999999976543 6666632 3445444
Q ss_pred CcccccccCCceEEEEEEecCCCCeEEEEEcCEEeeeeeEEEEeeccceeeeecceeeEEEEecCCCCCCCCeeeecCCc
Q psy2148 1569 PEAQKVQEGEPARFCTRVTGYPRPRVMWLINGHTIVNEIVRKITATETTEMEHKGKIQERVVDASEKPAKPPVFTKKIQP 1648 (1884)
Q Consensus 1569 ~~~~~v~~g~~~~l~C~~~g~p~~~v~W~~~g~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~ 1648 (1884)
|. +
T Consensus 619 P~-----------------------------------------------------------------------------d 621 (873)
T KOG4194|consen 619 PE-----------------------------------------------------------------------------D 621 (873)
T ss_pred cc-----------------------------------------------------------------------------c
Confidence 44 4
Q ss_pred eeecCCCeEEEEEEEeccCCCeEEEEeCCee-cCCCCCeEEEEeCceeEEEEcccccCCCeEEEEEEEeCCceEEEEEEE
Q psy2148 1649 CRAFEQDQARFEVEFDGDPLPTIKWFREDFP-ITSSPDFQIHTFSTKSILIMRQVFMEDSGVFAVIAENRGGKAKCSANL 1727 (1884)
Q Consensus 1649 ~~v~~G~~~~l~C~~~g~p~~~i~W~~~~~~-~~~~~~~~~~~~~~~~~L~i~~v~~~DsG~Y~C~a~n~~g~~~~~~~l 1727 (1884)
.++..|+.++|.|.++|.|.|+|.|.|+|.+ .+....-+++...++..+.|.||+.+|+|.|+|.|.|.+|..++.+.|
T Consensus 622 ltl~tg~mArl~CaAtG~P~PeIawqkdggtdFPAA~eRRl~Vmpedd~f~Itnvk~eD~GiYtC~A~n~AG~isanAtL 701 (873)
T KOG4194|consen 622 LTLRTGQMARLECAATGHPRPEIAWQKDGGTDFPAARERRLHVMPEDDVFFITNVKIEDQGIYTCTAQNVAGQISANATL 701 (873)
T ss_pred ceeecccceeeeeeccCCCCcceeehhcCCCCCchhhhheeeecCCCCEEEEecccccccceeEEeeeccccceeeceEE
Confidence 4555556666666666777777888887754 443333455555666679999999999999999999999999999999
Q ss_pred EEEecccCCCCCCCCCeEEeccCceEEcCCceEEEEEEEecCCC-cEEEEEeCCEecCCCCCeEEeecCCeEEEEEccCC
Q psy2148 1728 VVEEKRQGGRGGVVPPSFLTTISSAVINVGQLARFDAKISATKP-LDVYWLKNGKKIIPDIRYKTLEEDNLFTLLIIEAV 1806 (1884)
Q Consensus 1728 ~V~~~~~~~~~~~~~P~~~~~~~~~~~~~G~~~~l~C~~~g~p~-p~v~W~k~~~~l~~~~~~~~~~~~~~~~L~i~~~~ 1806 (1884)
+|.+ .|.|.....+..+..|+++.|.|.+.|.|. |.+.|+|++++|.-.+|..+...+ -.|++.+..
T Consensus 702 ~V~e----------~p~f~~PL~~~~V~~get~vlqC~a~~~~a~pr~~W~k~d~pil~t~rh~f~d~d--Qllvv~~~~ 769 (873)
T KOG4194|consen 702 TVLE----------TPSFSIPLEDQLVVVGETLVLQCLAEGAPADPRLEWFKEDKPILITERHTFPDGD--QLLVVKENL 769 (873)
T ss_pred EEec----------CCcccccccceEEEecceEEEEEecCCCCCCccccccCCCCceEEeecccCCCCC--eEEEEEehh
Confidence 9996 566777788999999999999999999887 999999999999777776654433 388899999
Q ss_pred CCCCEEEEEEEEeCCeeEEEEEEEEEEecC
Q psy2148 1807 VEDSGAYECVAMNNAGEARCEAELVVQSKK 1836 (1884)
Q Consensus 1807 ~~d~G~Y~C~a~N~~G~~~~~~~l~V~~~~ 1836 (1884)
.+|+|.|+|+..|..|.-...+.+.|..++
T Consensus 770 ~~daG~yTcem~~~~~~~~~~i~l~~~~~~ 799 (873)
T KOG4194|consen 770 VEDAGIYTCEMSNTLGTERIHICLLVYQKK 799 (873)
T ss_pred hhhcceEEEEEEeeccceeeEEEEEEeecC
Confidence 999999999999999999999998887654
No 8
>KOG4194|consensus
Probab=99.95 E-value=1.7e-26 Score=259.53 Aligned_cols=290 Identities=23% Similarity=0.380 Sum_probs=211.7
Q ss_pred CCCeeEeecceeeeecCCcEEEEEEEeecCCCcceEEEeccccccccccccc--ceEEEeeccceeeeeeeeeeeeceEE
Q psy2148 1263 EPPRFITEIESVTVQEAEPVRFETRVEPRVDPRLRVECSLSTAFFFPFINIS--TAFLIFNFCLHAVIFSHPIFDLGFVS 1340 (1884)
Q Consensus 1263 ~~p~~~~~~~~~~v~~g~~v~l~c~v~~~~~p~~~~~W~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~ 1340 (1884)
..|.+..+|+++.+..|+.++|.|.+.+....+.++.|.|++. +.+..++. ..+..++. +. ...........
T Consensus 502 pkpqI~~qPe~~~al~g~nirftC~a~sssasplsi~WR~dne-vq~rv~ved~a~~~~q~r--~~---~~~e~~~~~~~ 575 (873)
T KOG4194|consen 502 PKPQIVTQPETVSALIGENIRFTCNAYSSSASPLSIEWRKDNE-VQPRVDVEDFATFLSQNR--NG---TFGEREEYTAI 575 (873)
T ss_pred CCcceecCchHhhhhhccceEEEEEeccCCCCCceeEeeeccc-cCcccchhcchhhhhhhc--cC---ccchhhhhhhe
Confidence 4588999999999999999999999987667788999999987 33332221 11111110 00 00112233467
Q ss_pred EEEeeecccCceEEEEEEEccccceeee-EEEEEeecCceeecccCCcchhhhHHHHHHHHhhhcccccccccCCccCCc
Q psy2148 1341 LDIDYVYPEDQGEYVCRAYNDHGEAFTK-ATISCKKIPTIQLQNQVPKGMLKTEALIQMEAAIKKYTSEIYLTEDDLYEP 1419 (1884)
Q Consensus 1341 L~I~~~~~~d~G~Y~C~a~n~~g~~~~~-~~l~v~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1419 (1884)
|.+.++...|+|+|.|.++|..|+..++ +.|+|..
T Consensus 576 L~L~nVt~td~grYQCVvtN~FGStysqk~KltV~~-------------------------------------------- 611 (873)
T KOG4194|consen 576 LHLDNVTFTDEGRYQCVVTNHFGSTYSQKAKLTVNQ-------------------------------------------- 611 (873)
T ss_pred eeeeeeecccCceEEEEEecccCcchhheeEEEeec--------------------------------------------
Confidence 9999999999999999999999987554 8888864
Q ss_pred ccCCCCeEEEccCCccccccccceEEEEEEeeCCCCCCeEEEeecCee-cCCCCCce-eeeeCceEEEEEeeeccCCCeE
Q psy2148 1420 EKKQPPRFVTQIKTQDQLVEMQSTKFECQLAPVGDPNMKVEWFLNGKP-LPHKNRFN-PIYDFGYVAMNFGWVYPEDSGE 1497 (1884)
Q Consensus 1420 ~~~~pP~~~~~~~~~~~v~~g~~~~l~C~~~~~g~p~~~i~W~~~~~~-l~~~~~~~-~~~~~~~~~L~i~~~~~~d~G~ 1497 (1884)
.|.|+..|.+. ++..|+.++|.|.+. |.|.|.|.|.|+|.. .+.....+ .+..+.. .+.|.+++.+|.|.
T Consensus 612 ----~PsFtktP~dl-tl~tg~mArl~CaAt--G~P~PeIawqkdggtdFPAA~eRRl~Vmpedd-~f~Itnvk~eD~Gi 683 (873)
T KOG4194|consen 612 ----APSFTKTPEDL-TLRTGQMARLECAAT--GHPRPEIAWQKDGGTDFPAARERRLHVMPEDD-VFFITNVKIEDQGI 683 (873)
T ss_pred ----cCccccCcccc-eeecccceeeeeecc--CCCCcceeehhcCCCCCchhhhheeeecCCCC-EEEEecccccccce
Confidence 45566666654 488999999999986 999999999998865 54432222 2222222 57899999999999
Q ss_pred EEEEEEecCcceEEEEEEEEeCCCccccccCCCccchhHHHHHHhhcccccCCccccccCCCCCCCeEecCCcccccccC
Q psy2148 1498 YLCRATNLYGMDETRAILKTTGKPGIIYESQLPKGMKSIEKIREMEASWQHTPEQLVEDEKPKEAPVFVSQPEAQKVQEG 1577 (1884)
Q Consensus 1498 Y~c~a~n~~G~~~~~~~l~V~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~P~~~~~~~~~~v~~g 1577 (1884)
|+|+|.|.+|..++.++|.|.+.|.+ ..++.++.|.
T Consensus 684 YtC~A~n~AG~isanAtL~V~e~p~f------------------------------------------~~PL~~~~V~-- 719 (873)
T KOG4194|consen 684 YTCTAQNVAGQISANATLTVLETPSF------------------------------------------SIPLEDQLVV-- 719 (873)
T ss_pred eEEeeeccccceeeceEEEEecCCcc------------------------------------------cccccceEEE--
Confidence 99999999999999999999876543 2233344444
Q ss_pred CceEEEEEEecCCCCeEEEEEcCEEeeeeeEEEEeeccceeeeecceeeEEEEecCCCCCCCCeeeecCCceeecCCCeE
Q psy2148 1578 EPARFCTRVTGYPRPRVMWLINGHTIVNEIVRKITATETTEMEHKGKIQERVVDASEKPAKPPVFTKKIQPCRAFEQDQA 1657 (1884)
Q Consensus 1578 ~~~~l~C~~~g~p~~~v~W~~~g~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~v~~G~~~ 1657 (1884)
.|+++
T Consensus 720 ---------------------------------------------------------------------------~get~ 724 (873)
T KOG4194|consen 720 ---------------------------------------------------------------------------VGETL 724 (873)
T ss_pred ---------------------------------------------------------------------------ecceE
Confidence 45555
Q ss_pred EEEEEEeccCC-CeEEEEeCCeecCCCCCeEEEEeCceeEEEEcccccCCCeEEEEEEEeCCceEEEEEEEEEEe
Q psy2148 1658 RFEVEFDGDPL-PTIKWFREDFPITSSPDFQIHTFSTKSILIMRQVFMEDSGVFAVIAENRGGKAKCSANLVVEE 1731 (1884)
Q Consensus 1658 ~l~C~~~g~p~-~~i~W~~~~~~~~~~~~~~~~~~~~~~~L~i~~v~~~DsG~Y~C~a~n~~g~~~~~~~l~V~~ 1731 (1884)
.|.|.+.|.|+ |.+.|+|+++++.-.++.. ...++.-|++.+...+|+|.|+|+..|..|.......+.|..
T Consensus 725 vlqC~a~~~~a~pr~~W~k~d~pil~t~rh~--f~d~dQllvv~~~~~~daG~yTcem~~~~~~~~~~i~l~~~~ 797 (873)
T KOG4194|consen 725 VLQCLAEGAPADPRLEWFKEDKPILITERHT--FPDGDQLLVVKENLVEDAGIYTCEMSNTLGTERIHICLLVYQ 797 (873)
T ss_pred EEEEecCCCCCCccccccCCCCceEEeeccc--CCCCCeEEEEEehhhhhcceEEEEEEeeccceeeEEEEEEee
Confidence 55555555565 7888888888776555433 234566799999999999999999999999887777777764
No 9
>KOG3515|consensus
Probab=99.92 E-value=8.7e-24 Score=254.49 Aligned_cols=645 Identities=15% Similarity=0.140 Sum_probs=369.9
Q ss_pred ccCCCCcEEEEEEEeecCCCCCeEEEeeCCccCCCCCCeEEEeeCCEEEEEEcccCcCCCeEEEEEEEecCceEEE-EEE
Q psy2148 718 DLREGENAHFEARLTPTDDPKLKVEWFWNGKPMKTGSRFRTFCDFGFVILEISPVYPEDCGQYSCRAYNDYGEAVT-SAS 796 (1884)
Q Consensus 718 ~v~~G~~~~l~C~~~~~g~p~~~v~W~k~g~~l~~~~~~~~~~~~~~~~L~i~~~~~~d~G~Y~C~a~N~~g~~~~-~~~ 796 (1884)
.+++|+.+.|.|.+.+ +.|.+.+.|++.++.+. .++....+ .+|......++.-+.|.|+|.|..|.... ...
T Consensus 18 ~~~~g~~v~l~C~v~~-~pp~~~~eW~h~~~~~~--~~~~~~~~---~~~~~~~~~~~~~~~~~c~a~ns~~~~~~~~~~ 91 (741)
T KOG3515|consen 18 GLRLGEDVPLPCRVNS-NPPEIDVEWYHSTSGEH--GRYATIAD---PTLVTTGDVRDTVAELNCRAFNSVGMPSRCPMI 91 (741)
T ss_pred hhccCCcceeeeecCC-CCCCcceEEEecCcccc--cccccccC---CceeeecchhhhhhhhhhhhcccccCceeccee
Confidence 6899999999999986 57889999999888766 44444333 46888888888889999999887333211 111
Q ss_pred EEEecceeeEEeccCCCCceEEEEEeeecCCCcCCCceeEEEEEccccceeEEEEEEEecccceEEeecCCCCcccccce
Q psy2148 797 MKVQGKRSIILESQLPKGMEVFISFHEISPVYPEDCGQYSCRAYNDYGEAVTSASMKVQGKRSIILESQLPKGMEGTIDK 876 (1884)
Q Consensus 797 l~V~~~p~~~~~~~~~~g~~~~~~~~~i~~~~~~d~g~y~c~a~n~~g~~~~s~~l~v~~~~~~~~~~~~~~~~~~~~~~ 876 (1884)
+ .+.|.|.+
T Consensus 92 l----------------------------------~v~~~pa~------------------------------------- 100 (741)
T KOG3515|consen 92 L----------------------------------DVDYPPAC------------------------------------- 100 (741)
T ss_pred e----------------------------------ccccCccc-------------------------------------
Confidence 1 12222222
Q ss_pred eeecccCCcccccchhhhhhhhccCCCCcccccccccCCCCeeeecCCceeecCCCeEEEEEEEeeCCCCCcEEEEeeCC
Q psy2148 877 IAELEGYGHEREDRTIDKIAELEGYGHEREDRIEEDLGKAPEFLTTPTDLTLAESTLAHFECRLTPTNDPSMTVEWFHNG 956 (1884)
Q Consensus 877 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~v~~G~~v~l~C~v~~~~~P~~~v~W~~~g 956 (1884)
...+.......+..+.+.|.+...+.|.+.++|..++
T Consensus 101 -------------------------------------------~~~~~e~~~~~~~vvqi~c~~~~~~~P~~nlrW~~n~ 137 (741)
T KOG3515|consen 101 -------------------------------------------LPELGEIFQVDKGVVQIICSAKVAGRPNPNLRWGFNN 137 (741)
T ss_pred -------------------------------------------cccccchhhhcCCeEEEEEeecCCCCCCcceeeeecc
Confidence 2222233445678899999887778899999999998
Q ss_pred EEccCCCc--EEEE------eeCCeEEEEEccCCCCCCeEEEEEEEcC---CeeEEEEEEEEEEeecccccccchhHhHh
Q psy2148 957 KALSAGSR--IKTI------NDFGFVILEINDVYLRDSGLYTCKATNK---HGEATTSCKLTVKGRQGIDVEPQVSAIFA 1025 (1884)
Q Consensus 957 ~~i~~~~~--~~~~------~~~~~~~L~I~~~~~~D~G~Y~C~a~N~---~G~~~~~~~l~V~~~~~~~~~p~~~~~~~ 1025 (1884)
........ .... .....+.|.+...+.+|.|.|+|.|.|. .+..-....+.|.....
T Consensus 138 r~e~~~~~~~~~~~~~a~gss~t~~s~l~~~v~Rka~~g~~tC~A~nr~s~~l~~~~~~~i~v~~~~~------------ 205 (741)
T KOG3515|consen 138 RAELNAVNQRGRVGAGALGSSYTEPSLLKQTVSRKADNGNYTCPANNRNSPGLSFAKQLTIIVEAPCK------------ 205 (741)
T ss_pred EEeecccCCcccccccccCceeccccceeeEEEEecCCceeEcccccccCccccccceeEeecccccc------------
Confidence 76543221 1111 0011235788888899999999999995 33333333444432110
Q ss_pred cchhhHHHHHHhhcccCcCCCCCCCCCCCceeeecCCCcCcCCCCcEEEEEEEeeCCCCCcEEEEEECCEeccCCCceEE
Q psy2148 1026 NATKNIQKLEEALYRKDELIPDEEKPNPPVFTSQLQDNLDVPEAGKVHFDCRLEPKSDPTMRIDWFFNGRPFATGSRVKT 1105 (1884)
Q Consensus 1026 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~v~~g~~~~l~C~v~~~~~p~~~v~W~k~~~~l~~~~~~~~ 1105 (1884)
...+..........+|+.+.|.|.+. .|+|.+.++||++...+..++....
T Consensus 206 ----------------------------~~~~~~~~~~qsF~~g~~inlvc~~~-gg~P~~~~~w~~~s~~~~~~sl~~~ 256 (741)
T KOG3515|consen 206 ----------------------------GIGITGAQEQQSFTEGQTINLVCNAQ-GGNPSQQQTWYKDSRPQSESSLLSQ 256 (741)
T ss_pred ----------------------------cceecchhhcCcccccceEEEEehhh-cCCcchhhhhccccccchhhhcccC
Confidence 11111111124566899999999776 5999999999999888765422111
Q ss_pred EeeCc--EEEEEEcccCcCCcEEEEEEEEcCCeeeEEEEEEEEeeccccccccccCCcccHHHHHhhhccCCCCccccCC
Q psy2148 1106 VYDFG--FISLDMDYVYARDSGEYICRATNKWGTAMTKAKVICKAKHDIVTESQLPDSMSAEKLKELEKNYTPEEIEEDE 1183 (1884)
Q Consensus 1106 ~~~~~--~~~l~i~~~~~~d~G~Y~C~a~n~~G~~~~~~~l~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1183 (1884)
...+. ...+.+..-..++.-...|.|.| .+.... .+.+..++....
T Consensus 257 ~~sg~~v~~~~~~~~~r~~~~~~~kc~a~n-~~~~~~--~tav~~~~~~~~----------------------------- 304 (741)
T KOG3515|consen 257 EPSGDTVSSTLVLRVGRQDLQAQLKCKASN-LLAASQ--ITAVQVKPTAVP----------------------------- 304 (741)
T ss_pred CCCCCcccccccccccccchhhhhhccccC-ccccce--eeeccccccccc-----------------------------
Confidence 11111 12233333333344556699988 232222 222221111000
Q ss_pred CCCCCCccccchhcccccccccccchhhhhhhccccccccccccccccccCCCchhHHHHHhhhccCCCccccccCCCCC
Q psy2148 1184 IPEEPPRLNQSRYKKQNQSAWYDSELSEYQKERANESTELEKHDIVTESQLPDSMSAEKLKELEKNYTPEEIEEDEIPEE 1263 (1884)
Q Consensus 1184 ~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1263 (1884)
T Consensus 305 -------------------------------------------------------------------------------- 304 (741)
T KOG3515|consen 305 -------------------------------------------------------------------------------- 304 (741)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCeeEeecceeeeecCCcEEEEEEEeecCCCcceEEEecccccccccccccceEEEeeccceeeeeeeeeeeeceEEEEE
Q psy2148 1264 PPRFITEIESVTVQEAEPVRFETRVEPRVDPRLRVECSLSTAFFFPFINISTAFLIFNFCLHAVIFSHPIFDLGFVSLDI 1343 (1884)
Q Consensus 1264 ~p~~~~~~~~~~v~~g~~v~l~c~v~~~~~p~~~~~W~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~I 1343 (1884)
+-.....+..|+...+.|.-.+ .+|...+.|+++............ . ...........+..
T Consensus 305 -----Ist~~~~ls~g~s~r~~c~~ss-s~p~~~i~w~~~~~~~~~~~~~~~----------~---t~~~~~v~~~~~~~ 365 (741)
T KOG3515|consen 305 -----ISTSDSGLSSGRSARSSCVSSS-SKPPAHIAWYKDTKMPKGSQKASS----------K---TSNMGGVAVISHYA 365 (741)
T ss_pred -----ccCcccccccccccccceeccC-CCCccceeeeccCcccccccCccc----------C---CCcccceeeEEeee
Confidence 0001123567788888887665 678889999996554433211110 0 01111122334556
Q ss_pred eeecccCceEEEEEEEccccceeeeEEEEEeecCceeecccCCcchhhhHHHHHHHHhhhcccccccccCCccCCcccCC
Q psy2148 1344 DYVYPEDQGEYVCRAYNDHGEAFTKATISCKKIPTIQLQNQVPKGMLKTEALIQMEAAIKKYTSEIYLTEDDLYEPEKKQ 1423 (1884)
Q Consensus 1344 ~~~~~~d~G~Y~C~a~n~~g~~~~~~~l~v~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1423 (1884)
......|.|.|+|.|.|..+....+....+... .
T Consensus 366 q~~~~~~~g~v~c~a~~~~~~~~sss~~~l~~l----------------------------------------------~ 399 (741)
T KOG3515|consen 366 QPSSQQDGGQVTCPADNLELAHSSSSSFLLPVL----------------------------------------------P 399 (741)
T ss_pred cccchhcCceEEccccccccccccccceecccc----------------------------------------------C
Confidence 677888999999999987754444333322211 2
Q ss_pred CCeEEEccCCccccccccceEEEEEEeeCCCC-CCeEEEeecCeecCCCCCceeeeeCceEEEEEeeeccCCCeEEEEEE
Q psy2148 1424 PPRFVTQIKTQDQLVEMQSTKFECQLAPVGDP-NMKVEWFLNGKPLPHKNRFNPIYDFGYVAMNFGWVYPEDSGEYLCRA 1502 (1884)
Q Consensus 1424 pP~~~~~~~~~~~v~~g~~~~l~C~~~~~g~p-~~~i~W~~~~~~l~~~~~~~~~~~~~~~~L~i~~~~~~d~G~Y~c~a 1502 (1884)
+|.|+..-.......+++.......+. |+| .+.+.|.+++.++............+...+.+.++.+.|.|.|.|+|
T Consensus 400 ~p~~L~~~~~~v~~~e~d~~~~~~~~~--~~p~~~~~~w~~~~~~~~~~~g~~~~v~~~~~~~s~~~v~~~d~g~y~~ta 477 (741)
T KOG3515|consen 400 SPAFLVRHKTAVVAMEQDHQAAPLPVR--GAPAERTFYWTFRLYKLSQVDGGVVRVGAGAGLGSGVNVSRSDGGSYGLTA 477 (741)
T ss_pred CchhhhhcccceeeccCccccccCccc--CCCcccchhheecceecccccCceEEeeccccccccceeeeccCCcceeee
Confidence 333333322323333444333333333 444 48899999999887655433333333333446678999999999999
Q ss_pred EecCcceEEEEEEEEeCCCccccccCCCccchhHHHHHHhhcccccCCccccccCCCCCCCeEecCCcccccccCCceEE
Q psy2148 1503 TNLYGMDETRAILKTTGKPGIIYESQLPKGMKSIEKIREMEASWQHTPEQLVEDEKPKEAPVFVSQPEAQKVQEGEPARF 1582 (1884)
Q Consensus 1503 ~n~~G~~~~~~~l~V~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~P~~~~~~~~~~v~~g~~~~l 1582 (1884)
+|..|.......+.+...|. +..........+|+++..
T Consensus 478 tns~gg~~~~~~~~~~~sp~------------------------------------------~~~~~~~~~~~~~ns~~~ 515 (741)
T KOG3515|consen 478 TNSPGGAQAYLLLGVHTSPH------------------------------------------NHHLQDQVEGATGNSVDG 515 (741)
T ss_pred ccCCCceeeEEeeccccCCc------------------------------------------ccccccccccCCCCcccc
Confidence 99999877776655544332 222223334455666667
Q ss_pred EEEEecCCCC--eEEEEEcCEEeeeeeEEEEeeccceeeeecceeeEEEEecCCCCCCCCeeeecCCceeecCCCeEEEE
Q psy2148 1583 CTRVTGYPRP--RVMWLINGHTIVNEIVRKITATETTEMEHKGKIQERVVDASEKPAKPPVFTKKIQPCRAFEQDQARFE 1660 (1884)
Q Consensus 1583 ~C~~~g~p~~--~v~W~~~g~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~v~~G~~~~l~ 1660 (1884)
.|.....|.- .+.|.+.|+...-+.
T Consensus 516 ~~~q~~~~~~~~m~~~~r~ge~~~~~~----------------------------------------------------- 542 (741)
T KOG3515|consen 516 ECMQDEQPQDQQMHHEPRSGEPPSDQI----------------------------------------------------- 542 (741)
T ss_pred eeeccccccchhhhcccccCCCCcccc-----------------------------------------------------
Confidence 7776655432 445555443321000
Q ss_pred EEEeccCCCeEEEEeCCeecCCCCCeEEEEeCceeEEEEcccccCCCeEEEEEEEeCCceEEEEEEEEEEecccCCCCCC
Q psy2148 1661 VEFDGDPLPTIKWFREDFPITSSPDFQIHTFSTKSILIMRQVFMEDSGVFAVIAENRGGKAKCSANLVVEEKRQGGRGGV 1740 (1884)
Q Consensus 1661 C~~~g~p~~~i~W~~~~~~~~~~~~~~~~~~~~~~~L~i~~v~~~DsG~Y~C~a~n~~g~~~~~~~l~V~~~~~~~~~~~ 1740 (1884)
+.+-..........|.+......-+|.|.|.+.+..-.+.....+.+..
T Consensus 543 ----------------------~~~~~~~~~~~~a~~~~~~~~~~~~~~~~~~~d~~~~pA~~~~~l~~~s--------- 591 (741)
T KOG3515|consen 543 ----------------------DQDAPQQQLMAHAQLLVSGNSSLQASETACVVDGSSPPAGLSLVLKAYS--------- 591 (741)
T ss_pred ----------------------cccccccccCCccceeecccccccccceEEeecCCCCccccceEEEecc---------
Confidence 0000001112233466667777788999999988333344455555542
Q ss_pred CCCeEEeccCceEE-cC-CceEEEEEEEecCCCcEEEEEeCCEecCCCCCeEEe-----ecCCeEEEEEccCCCCCCEEE
Q psy2148 1741 VPPSFLTTISSAVI-NV-GQLARFDAKISATKPLDVYWLKNGKKIIPDIRYKTL-----EEDNLFTLLIIEAVVEDSGAY 1813 (1884)
Q Consensus 1741 ~~P~~~~~~~~~~~-~~-G~~~~l~C~~~g~p~p~v~W~k~~~~l~~~~~~~~~-----~~~~~~~L~i~~~~~~d~G~Y 1813 (1884)
+|........... .+ +..++..|.+.|.|.+.++|-|+......+.++... ..+......+..+...|.+ .
T Consensus 592 -~~~v~~~tp~~~~~~~g~v~as~~~~a~~~~~~~~~~~k~p~~~~~~~~~~~~~~~~~~~~s~~~~~~~~~~~~~y~-~ 669 (741)
T KOG3515|consen 592 -ALIVTVRTPNMYTAQEGCVNASDDCVASGVPSTSFTTAKTPLQTTEGPHIREKATQQGQTHSSSEWILNHIDGSDYE-N 669 (741)
T ss_pred -cccccccCCceeeeccCcccccccceecccccceeecccCCCcccCCceEEEeeeeccccccccccccCCcchhhhc-c
Confidence 3333322222222 11 227899999999999999999998875555433211 1122224444444455555 8
Q ss_pred EEEEEeCCeeEEEEEEE
Q psy2148 1814 ECVAMNNAGEARCEAEL 1830 (1884)
Q Consensus 1814 ~C~a~N~~G~~~~~~~l 1830 (1884)
.|.+.|..|..-.+..+
T Consensus 670 ~c~t~n~lg~~~v~~~~ 686 (741)
T KOG3515|consen 670 GCTTQNLLGSDHVSGAI 686 (741)
T ss_pred eeeecccCCCcccccee
Confidence 99999999986555433
No 10
>PHA02785 IL-beta-binding protein; Provisional
Probab=99.92 E-value=1.4e-23 Score=245.05 Aligned_cols=254 Identities=19% Similarity=0.243 Sum_probs=178.1
Q ss_pred cccccceEEEEEEe---eCCCCCCeEEEeecCeecCCCCCceeeeeCceEEEEEeeeccCCCeEEEEEEEecCcceEEEE
Q psy2148 1437 LVEMQSTKFECQLA---PVGDPNMKVEWFLNGKPLPHKNRFNPIYDFGYVAMNFGWVYPEDSGEYLCRATNLYGMDETRA 1513 (1884)
Q Consensus 1437 v~~g~~~~l~C~~~---~~g~p~~~i~W~~~~~~l~~~~~~~~~~~~~~~~L~i~~~~~~d~G~Y~c~a~n~~G~~~~~~ 1513 (1884)
+.+|+.+.|.|.+. ..|.|.++|+|+|+|.... + .....++. .|.|.++..+|+|.|+|.|.|..|....++
T Consensus 38 ~~~ge~~~l~C~~~~~~~~g~p~~~i~W~K~g~~~~---~-~~~~~~g~-~l~i~~~~~~DsG~Y~C~a~N~~g~~~~s~ 112 (326)
T PHA02785 38 ELENEPVILPCPQINTLSSGYNILDILWEKRGADND---R-IIPIDNGS-NMLILNPTQSDSGIYICITKNETYCDMMSL 112 (326)
T ss_pred hhcCCCEEEECCCccccccCCCCceEEEEECCCccc---e-EEEccCCc-eEEEcccCcccCeEEEEEEECCCcceEEEE
Confidence 56899999999861 0389999999999985422 1 22223332 477899999999999999999999888888
Q ss_pred EEEEeCCCccccccCCCccchhHHHHHHhhcccccCCccccccCCCCCCCeEecCCcccccccCCceEEEEEEecCCCCe
Q psy2148 1514 ILKTTGKPGIIYESQLPKGMKSIEKIREMEASWQHTPEQLVEDEKPKEAPVFVSQPEAQKVQEGEPARFCTRVTGYPRPR 1593 (1884)
Q Consensus 1514 ~l~V~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~P~~~~~~~~~~v~~g~~~~l~C~~~g~p~~~ 1593 (1884)
.|.|.... +|.|...+..
T Consensus 113 ~L~V~~~~----------------------------------------~~~~~~~~~~---------------------- 130 (326)
T PHA02785 113 NLTIVSVS----------------------------------------ESNIDLISYP---------------------- 130 (326)
T ss_pred EEEEEecC----------------------------------------CCccceeecc----------------------
Confidence 88885321 1111111111
Q ss_pred EEEEEcCEEeeeeeEEEEeeccceeeeecceeeEEEEecCCCCCCCCeeeecCCceeecCCCeEEEEEE-----EeccCC
Q psy2148 1594 VMWLINGHTIVNEIVRKITATETTEMEHKGKIQERVVDASEKPAKPPVFTKKIQPCRAFEQDQARFEVE-----FDGDPL 1668 (1884)
Q Consensus 1594 v~W~~~g~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~v~~G~~~~l~C~-----~~g~p~ 1668 (1884)
..+.+|+.+.|.|. ..++|.
T Consensus 131 -------------------------------------------------------~~~~~g~~~~i~C~~~~~~~~~~~~ 155 (326)
T PHA02785 131 -------------------------------------------------------QIVNERSTGEMVCPNINAFIASNVN 155 (326)
T ss_pred -------------------------------------------------------ceecccCcEEEECCChhhcccCCCC
Confidence 12345566666664 246788
Q ss_pred CeEEEEeCCeecCCCCCeEEEEeCceeEEEEcccccCCCeEEEEEEEeCCceEEE----EEEEEEEecccCCCCCCCCCe
Q psy2148 1669 PTIKWFREDFPITSSPDFQIHTFSTKSILIMRQVFMEDSGVFAVIAENRGGKAKC----SANLVVEEKRQGGRGGVVPPS 1744 (1884)
Q Consensus 1669 ~~i~W~~~~~~~~~~~~~~~~~~~~~~~L~i~~v~~~DsG~Y~C~a~n~~g~~~~----~~~l~V~~~~~~~~~~~~~P~ 1744 (1884)
+.|+|++++. + ...++.. ...+.|.|.+++.+|+|.|+|.|.|..|.... .+.|.|..+. .||.
T Consensus 156 ~~i~W~k~~~-~-~~~r~~~---~~~~~L~i~~v~~~d~G~Y~C~~~n~~g~~~~~~t~~v~l~V~~~~-------~pp~ 223 (326)
T PHA02785 156 ADIIWSGHRR-L-RNKRLKQ---RTPGIITIEDVRKNDAGYYTCVLKYIYGDKTYNVTRIVKLEVRDRI-------IPPT 223 (326)
T ss_pred ceEEEccCCc-c-CCcceEe---cCCCeEEEeecChhhCeEEEEEEEeccCCEEEeEEEEEEEEEeccC-------CCce
Confidence 9999998653 2 2223222 23457999999999999999999999876543 3456665421 4665
Q ss_pred EEeccCceEEcCCceEEEEEEEecCCC---cEEEEEeCCEecCCCC-----CeEEeec-----C---CeEEEEEccCCCC
Q psy2148 1745 FLTTISSAVINVGQLARFDAKISATKP---LDVYWLKNGKKIIPDI-----RYKTLEE-----D---NLFTLLIIEAVVE 1808 (1884)
Q Consensus 1745 ~~~~~~~~~~~~G~~~~l~C~~~g~p~---p~v~W~k~~~~l~~~~-----~~~~~~~-----~---~~~~L~i~~~~~~ 1808 (1884)
+ ..|....+..|+.++|.|.+.|.|. |.|.|+|||..|.... ++..... . ....|.|.++..+
T Consensus 224 ~-~~p~~~~~~~G~~v~L~C~a~g~P~~~~~~v~W~kng~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~I~~V~~~ 302 (326)
T PHA02785 224 M-QLPEGVVTSIGSNLTIACRVSLRPPTTDADVFWISNGMYYEEDDEDGDGRISVANKIYTTDKRRVITSRLNINPVKEE 302 (326)
T ss_pred e-cCCCcEEecCCCcEEEEEEEECCCCCCCceEEEEECCEECCCcCCCCceeEEEecCccccccceeeeEEEEECCcchh
Confidence 4 4567788888999999999999886 4899999999885431 3322211 0 1348999999999
Q ss_pred CCEEEEEEEEeCCeeEE
Q psy2148 1809 DSGAYECVAMNNAGEAR 1825 (1884)
Q Consensus 1809 d~G~Y~C~a~N~~G~~~ 1825 (1884)
|.|.|+|.|.|..|...
T Consensus 303 D~G~Y~C~A~n~~~~~~ 319 (326)
T PHA02785 303 DATTFTCMAFTIPSISK 319 (326)
T ss_pred cCeeeEEEEEeccCceE
Confidence 99999999999986443
No 11
>PHA02785 IL-beta-binding protein; Provisional
Probab=99.92 E-value=3.9e-23 Score=241.44 Aligned_cols=256 Identities=19% Similarity=0.273 Sum_probs=175.4
Q ss_pred ccCCCCcEEEEEEEe---ecCCCCCeEEEeeCCccCCCCCCeEEEeeCCEEEEEEcccCcCCCeEEEEEEEecCceEEEE
Q psy2148 718 DLREGENAHFEARLT---PTDDPKLKVEWFWNGKPMKTGSRFRTFCDFGFVILEISPVYPEDCGQYSCRAYNDYGEAVTS 794 (1884)
Q Consensus 718 ~v~~G~~~~l~C~~~---~~g~p~~~v~W~k~g~~l~~~~~~~~~~~~~~~~L~i~~~~~~d~G~Y~C~a~N~~g~~~~~ 794 (1884)
.+.+|+.+.|.|.+. +.|.|.++++|+|+|.... +.....+ + ..|.|.++..+|+|.|+|.|.|..|....+
T Consensus 37 ~~~~ge~~~l~C~~~~~~~~g~p~~~i~W~K~g~~~~---~~~~~~~-g-~~l~i~~~~~~DsG~Y~C~a~N~~g~~~~s 111 (326)
T PHA02785 37 MELENEPVILPCPQINTLSSGYNILDILWEKRGADND---RIIPIDN-G-SNMLILNPTQSDSGIYICITKNETYCDMMS 111 (326)
T ss_pred hhhcCCCEEEECCCccccccCCCCceEEEEECCCccc---eEEEccC-C-ceEEEcccCcccCeEEEEEEECCCcceEEE
Confidence 356899999999862 1368889999999985321 2122222 2 247799999999999999999999888888
Q ss_pred EEEEEecceeeEEeccCCCCceEEEEEeeecCCCcCCCceeEEEEEccccceeEEEEEEEecccceEEeecCCCCccccc
Q psy2148 795 ASMKVQGKRSIILESQLPKGMEVFISFHEISPVYPEDCGQYSCRAYNDYGEAVTSASMKVQGKRSIILESQLPKGMEGTI 874 (1884)
Q Consensus 795 ~~l~V~~~p~~~~~~~~~~g~~~~~~~~~i~~~~~~d~g~y~c~a~n~~g~~~~s~~l~v~~~~~~~~~~~~~~~~~~~~ 874 (1884)
+.|+|.....
T Consensus 112 ~~L~V~~~~~---------------------------------------------------------------------- 121 (326)
T PHA02785 112 LNLTIVSVSE---------------------------------------------------------------------- 121 (326)
T ss_pred EEEEEEecCC----------------------------------------------------------------------
Confidence 8877743210
Q ss_pred ceeeecccCCcccccchhhhhhhhccCCCCcccccccccCCCCeeeecCCceeecCCCeEEEEEEEe---eCCCCCcEEE
Q psy2148 875 DKIAELEGYGHEREDRTIDKIAELEGYGHEREDRIEEDLGKAPEFLTTPTDLTLAESTLAHFECRLT---PTNDPSMTVE 951 (1884)
Q Consensus 875 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~v~~G~~v~l~C~v~---~~~~P~~~v~ 951 (1884)
|.|...+.+..+.+|..+.|.|... ..+.|++.|+
T Consensus 122 ------------------------------------------~~~~~~~~~~~~~~g~~~~i~C~~~~~~~~~~~~~~i~ 159 (326)
T PHA02785 122 ------------------------------------------SNIDLISYPQIVNERSTGEMVCPNINAFIASNVNADII 159 (326)
T ss_pred ------------------------------------------CccceeeccceecccCcEEEECCChhhcccCCCCceEE
Confidence 0111111223466899999999621 1256889999
Q ss_pred EeeCCEEccCCCcEEEEeeCCeEEEEEccCCCCCCeEEEEEEEcCCeeEEEE----EEEEEEeecccccccchhHhHhcc
Q psy2148 952 WFHNGKALSAGSRIKTINDFGFVILEINDVYLRDSGLYTCKATNKHGEATTS----CKLTVKGRQGIDVEPQVSAIFANA 1027 (1884)
Q Consensus 952 W~~~g~~i~~~~~~~~~~~~~~~~L~I~~~~~~D~G~Y~C~a~N~~G~~~~~----~~l~V~~~~~~~~~p~~~~~~~~~ 1027 (1884)
|+|++. + .+.++..... ..|.|.+++.+|+|.|+|.|.|.+|..... +.|.|..+.
T Consensus 160 W~k~~~-~-~~~r~~~~~~---~~L~i~~v~~~d~G~Y~C~~~n~~g~~~~~~t~~v~l~V~~~~--------------- 219 (326)
T PHA02785 160 WSGHRR-L-RNKRLKQRTP---GIITIEDVRKNDAGYYTCVLKYIYGDKTYNVTRIVKLEVRDRI--------------- 219 (326)
T ss_pred EccCCc-c-CCcceEecCC---CeEEEeecChhhCeEEEEEEEeccCCEEEeEEEEEEEEEeccC---------------
Confidence 998653 3 3345443322 279999999999999999999998876543 345454211
Q ss_pred hhhHHHHHHhhcccCcCCCCCCCCCCCceeeecCCCcCcCCCCcEEEEEEEeeCCCCC---cEEEEEECCEeccCCC---
Q psy2148 1028 TKNIQKLEEALYRKDELIPDEEKPNPPVFTSQLQDNLDVPEAGKVHFDCRLEPKSDPT---MRIDWFFNGRPFATGS--- 1101 (1884)
Q Consensus 1028 ~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~v~~g~~~~l~C~v~~~~~p~---~~v~W~k~~~~l~~~~--- 1101 (1884)
.||.+..+ ..+.+..|+.++|.|.+. |.|. +.|.|+|||+.|....
T Consensus 220 ------------------------~pp~~~~p--~~~~~~~G~~v~L~C~a~--g~P~~~~~~v~W~kng~~i~~~~~~~ 271 (326)
T PHA02785 220 ------------------------IPPTMQLP--EGVVTSIGSNLTIACRVS--LRPPTTDADVFWISNGMYYEEDDEDG 271 (326)
T ss_pred ------------------------CCceecCC--CcEEecCCCcEEEEEEEE--CCCCCCCceEEEEECCEECCCcCCCC
Confidence 23433222 235667899999999998 5554 4899999999886431
Q ss_pred --ceEEEee----C----cEEEEEEcccCcCCcEEEEEEEEcCCeee
Q psy2148 1102 --RVKTVYD----F----GFISLDMDYVYARDSGEYICRATNKWGTA 1138 (1884)
Q Consensus 1102 --~~~~~~~----~----~~~~l~i~~~~~~d~G~Y~C~a~n~~G~~ 1138 (1884)
++..... . ....|.|.+++.+|+|.|+|.|.|..|..
T Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~L~I~~V~~~D~G~Y~C~A~n~~~~~ 318 (326)
T PHA02785 272 DGRISVANKIYTTDKRRVITSRLNINPVKEEDATTFTCMAFTIPSIS 318 (326)
T ss_pred ceeEEEecCccccccceeeeEEEEECCcchhcCeeeEEEEEeccCce
Confidence 2221110 0 13579999999999999999999988543
No 12
>KOG3515|consensus
Probab=99.89 E-value=1.8e-21 Score=234.71 Aligned_cols=646 Identities=13% Similarity=0.107 Sum_probs=365.1
Q ss_pred cccceeeeeeeeeecCCCCeeEEEECCeecCCCCcEEEeccCcEEEEEEccCCcCCCeEEEEEEEcCCeeEEEEEEEEEE
Q psy2148 219 HDFGYVALDIELMLKTLVPFTEWFVNNKPLPAGAKFKTTHDFGYVALDIVGAYAEDSGIYTVKATNSKGSATTSGTLKCL 298 (1884)
Q Consensus 219 ~~~~~~~~~~~~~~~~p~p~i~W~k~g~~i~~~~~~~~~~~~~~~~L~I~~~~~~d~G~Y~C~a~n~~g~~~~~~~l~V~ 298 (1884)
..+..+.+.|.+..+.|.+.+.|++.+..+. .++....+ .+|..+....+.-+.|.|+|.|..+........
T Consensus 20 ~~g~~v~l~C~v~~~pp~~~~eW~h~~~~~~--~~~~~~~~---~~~~~~~~~~~~~~~~~c~a~ns~~~~~~~~~~--- 91 (741)
T KOG3515|consen 20 RLGEDVPLPCRVNSNPPEIDVEWYHSTSGEH--GRYATIAD---PTLVTTGDVRDTVAELNCRAFNSVGMPSRCPMI--- 91 (741)
T ss_pred ccCCcceeeeecCCCCCCcceEEEecCcccc--cccccccC---CceeeecchhhhhhhhhhhhcccccCceeccee---
Confidence 3456677888888888999999999888776 33332222 378888998999999999999996543322111
Q ss_pred eeeccccCCCceeeccccccccCCCceEEEEEEEEEcCCCceEEEEeeCCEeecccc--ceEEE--ee----CCeEEEEE
Q psy2148 299 ERLFVNHNYPLFSLQFQHLSNLSEGEIAHFEASLIPVGDQTMTVEFLYNGKPIEASH--RIRTV--HA----FGMVVLEI 370 (1884)
Q Consensus 299 ~~l~v~~~~p~~~~~~~~~~~v~~g~~~~l~c~~~~~g~p~~~i~W~k~g~~i~~~~--~~~~~--~~----~~~~~L~I 370 (1884)
+.+. .+|. ............+..+.+.|.....+.|.+.+.|+.++.-..... +.... .. .....|.+
T Consensus 92 --l~v~-~~pa-~~~~~~e~~~~~~~vvqi~c~~~~~~~P~~nlrW~~n~r~e~~~~~~~~~~~~~a~gss~t~~s~l~~ 167 (741)
T KOG3515|consen 92 --LDVD-YPPA-CLPELGEIFQVDKGVVQIICSAKVAGRPNPNLRWGFNNRAELNAVNQRGRVGAGALGSSYTEPSLLKQ 167 (741)
T ss_pred --eccc-cCcc-ccccccchhhhcCCeEEEEEeecCCCCCCcceeeeeccEEeecccCCcccccccccCceeccccceee
Confidence 1111 1221 111122233567888999998777788999999999876543222 11100 00 11244778
Q ss_pred cCCCCCCCEEEEEEEEcCC---eeeEEEEEEEEeecCCCCCCceEeccCCccCccCCCeEEEEEEEeeCCCCCCeEEEee
Q psy2148 371 LGTKIEDTGVYTCRATNKW---GQAEISVNLECVDKSKGQPPKFTSHIKSLEGLKDGDSAHFECTLTPVNDPELKVEWFH 447 (1884)
Q Consensus 371 ~~~~~~D~G~Y~C~a~n~~---g~~~~~~~l~V~~~~~~~~p~~~~~~~~~~~v~~G~~v~L~C~~~~~~~p~~~i~W~k 447 (1884)
...+.+|.|.|+|.|.|.. +.......+.|.. ......+ ..........+|+.+.|.|.+.+ +.|...++||+
T Consensus 168 ~v~Rka~~g~~tC~A~nr~s~~l~~~~~~~i~v~~--~~~~~~~-~~~~~~qsF~~g~~inlvc~~~g-g~P~~~~~w~~ 243 (741)
T KOG3515|consen 168 TVSRKADNGNYTCPANNRNSPGLSFAKQLTIIVEA--PCKGIGI-TGAQEQQSFTEGQTINLVCNAQG-GNPSQQQTWYK 243 (741)
T ss_pred EEEEecCCceeEcccccccCccccccceeEeeccc--cccccee-cchhhcCcccccceEEEEehhhc-CCcchhhhhcc
Confidence 8888999999999999953 3333333333321 1111111 12222245789999999998775 89999999999
Q ss_pred CCEEccccCcEEEEecCC--EEEEEEcccCCCCcEEEEEEEEeCceecCCcceEEeecccCCCCCCCccccCCCCeEEEE
Q psy2148 448 NGKPIFHKNRVKMVSDFG--FVVMDIAYVQSHDSGEYVCRAWNNFIFIPPFPIFIFHQIRLPSPSQDNLDVPEAGKVHFD 525 (1884)
Q Consensus 448 ~g~~l~~~~~~~~~~~~~--~~~L~i~~v~~~d~G~Y~C~a~n~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~g~~~~L~ 525 (1884)
+......+........+. .+++.+..-..++.-...|.+.| ....... +.+...+....+......+..|+...+.
T Consensus 244 ~s~~~~~~sl~~~~~sg~~v~~~~~~~~~r~~~~~~~kc~a~n-~~~~~~~-tav~~~~~~~~Ist~~~~ls~g~s~r~~ 321 (741)
T KOG3515|consen 244 DSRPQSESSLLSQEPSGDTVSSTLVLRVGRQDLQAQLKCKASN-LLAASQI-TAVQVKPTAVPISTSDSGLSSGRSARSS 321 (741)
T ss_pred ccccchhhhcccCCCCCCcccccccccccccchhhhhhccccC-cccccee-eecccccccccccCcccccccccccccc
Confidence 988776542222222221 12233333333344477799998 1111111 1111112222233344458899999999
Q ss_pred EEEeeCCCCccEEEEeeCCeeecCCCceEEEeeCceEEEEEccccccccEEEEEEEEcCceeeeeeEEEEEEeeeeEEEE
Q psy2148 526 CRLEPKSDPTMRIDWFFNGRPFATGSRVKTVYDFGFISLDMDYVYARDSGEYICRATNKWGTAMTKAKVICKVLTVIVEW 605 (1884)
Q Consensus 526 C~~~~~~~p~~~i~W~~~~~~l~~~~~~~~~~~~~~~~L~i~~~~~~d~G~Y~C~a~n~~g~~~~~~~l~c~~~~~~v~W 605 (1884)
|... .++|.+.+.|+|+............. ..+.|.-
T Consensus 322 c~~s-ss~p~~~i~w~~~~~~~~~~~~~~~~--------------t~~~~~v---------------------------- 358 (741)
T KOG3515|consen 322 CVSS-SSKPPAHIAWYKDTKMPKGSQKASSK--------------TSNMGGV---------------------------- 358 (741)
T ss_pred eecc-CCCCccceeeeccCcccccccCcccC--------------CCcccce----------------------------
Confidence 9876 47889999999955443322211000 0000000
Q ss_pred EEcCeecCCCCeEEEEeeecEEEEEeecccccCceEEEEEEEeCCcceeEEEEEEEeeecceeeccCCCCCcccccceee
Q psy2148 606 FYNGKKLPHGHRYRTFHDFGIVILDILYCYEENSGVYECRATNKYGSDVTKASLKCVSKTNLILESQLPEGMEGGLEKIQ 685 (1884)
Q Consensus 606 ~~~g~~l~~~~~~~~~~~~~~~~l~i~~~~~~d~G~Y~C~a~n~~G~~~~~~~l~v~~~~~~~l~~~~p~~~~~~~~~~~ 685 (1884)
....+........|.|.|+|.|-|..+....+..+.+ .+.
T Consensus 359 -------------------~~~~~~~q~~~~~~~g~v~c~a~~~~~~~~sss~~~l--------~~l------------- 398 (741)
T KOG3515|consen 359 -------------------AVISHYAQPSSQQDGGQVTCPADNLELAHSSSSSFLL--------PVL------------- 398 (741)
T ss_pred -------------------eeEEeeecccchhcCceEEccccccccccccccceec--------ccc-------------
Confidence 0111334445677888899998876543333322221 111
Q ss_pred chhhhccccccccccccccCCCeeeecCCCccccCCCCcEEEEEEEeecCCCCCeEEEeeCCccCCCCCC--eEEEeeCC
Q psy2148 686 TLEDAAHLRRTETADIEHRQAPVFTVPLSNIDDLREGENAHFEARLTPTDDPKLKVEWFWNGKPMKTGSR--FRTFCDFG 763 (1884)
Q Consensus 686 ~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~v~~G~~~~l~C~~~~~g~p~~~v~W~k~g~~l~~~~~--~~~~~~~~ 763 (1884)
.+|.|...-.......+++.......+.+ ..+.+.+.|.+++..+..... +.+...
T Consensus 399 -------------------~~p~~L~~~~~~v~~~e~d~~~~~~~~~~-~p~~~~~~w~~~~~~~~~~~g~~~~v~~~-- 456 (741)
T KOG3515|consen 399 -------------------PSPAFLVRHKTAVVAMEQDHQAAPLPVRG-APAERTFYWTFRLYKLSQVDGGVVRVGAG-- 456 (741)
T ss_pred -------------------CCchhhhhcccceeeccCccccccCcccC-CCcccchhheecceecccccCceEEeecc--
Confidence 11222111111111223333333222222 345679999999888765543 333222
Q ss_pred EEEEEEcccCcCCCeEEEEEEEecCceEEEEEEEEEecceeeEEeccCCCCceEEEEEeeecCCCcCCCceeEEEEEccc
Q psy2148 764 FVILEISPVYPEDCGQYSCRAYNDYGEAVTSASMKVQGKRSIILESQLPKGMEVFISFHEISPVYPEDCGQYSCRAYNDY 843 (1884)
Q Consensus 764 ~~~L~i~~~~~~d~G~Y~C~a~N~~g~~~~~~~l~V~~~p~~~~~~~~~~g~~~~~~~~~i~~~~~~d~g~y~c~a~n~~ 843 (1884)
...+.+-++.+.|.|.|.|+|+|..|.+.....+.+...|.
T Consensus 457 ~~~~s~~~v~~~d~g~y~~tatns~gg~~~~~~~~~~~sp~--------------------------------------- 497 (741)
T KOG3515|consen 457 AGLGSGVNVSRSDGGSYGLTATNSPGGAQAYLLLGVHTSPH--------------------------------------- 497 (741)
T ss_pred ccccccceeeeccCCcceeeeccCCCceeeEEeeccccCCc---------------------------------------
Confidence 12333566888999999999999888876666544432221
Q ss_pred cceeEEEEEEEecccceEEeecCCCCcccccceeeecccCCcccccchhhhhhhhccCCCCcccccccccCCCCeeeecC
Q psy2148 844 GEAVTSASMKVQGKRSIILESQLPKGMEGTIDKIAELEGYGHEREDRTIDKIAELEGYGHEREDRIEEDLGKAPEFLTTP 923 (1884)
Q Consensus 844 g~~~~s~~l~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~ 923 (1884)
+....
T Consensus 498 ---------------------------------------------------------------------------~~~~~ 502 (741)
T KOG3515|consen 498 ---------------------------------------------------------------------------NHHLQ 502 (741)
T ss_pred ---------------------------------------------------------------------------ccccc
Confidence 11111
Q ss_pred CceeecCCCeEEEEEEEeeCCCCCcEEEEeeCCEEccCCCcEEE--EeeCCeEEEEEccCCCCCCeEEEEEEEcCCeeEE
Q psy2148 924 TDLTLAESTLAHFECRLTPTNDPSMTVEWFHNGKALSAGSRIKT--INDFGFVILEINDVYLRDSGLYTCKATNKHGEAT 1001 (1884)
Q Consensus 924 ~~~~v~~G~~v~l~C~v~~~~~P~~~v~W~~~g~~i~~~~~~~~--~~~~~~~~L~I~~~~~~D~G~Y~C~a~N~~G~~~ 1001 (1884)
.......|+++.++|.....+.-+-.+.|.+.|........... ........|.+......-+|+|.|.+.|..--+.
T Consensus 503 ~~~~~~~~ns~~~~~~q~~~~~~~~m~~~~r~ge~~~~~~~~~~~~~~~~~~a~~~~~~~~~~~~~~~~~~~d~~~~pA~ 582 (741)
T KOG3515|consen 503 DQVEGATGNSVDGECMQDEQPQDQQMHHEPRSGEPPSDQIDQDAPQQQLMAHAQLLVSGNSSLQASETACVVDGSSPPAG 582 (741)
T ss_pred cccccCCCCcccceeeccccccchhhhcccccCCCCcccccccccccccCCccceeecccccccccceEEeecCCCCccc
Confidence 22344567778999999855555557899998876633211100 0111123577777777778999999998322233
Q ss_pred EEEEEEEEeecccccccchhHhHhcchhhHHHHHHhhcccCcCCCCCCCCCCCceeeecCCCcCcCCCCcEEEEEEEeeC
Q psy2148 1002 TSCKLTVKGRQGIDVEPQVSAIFANATKNIQKLEEALYRKDELIPDEEKPNPPVFTSQLQDNLDVPEAGKVHFDCRLEPK 1081 (1884)
Q Consensus 1002 ~~~~l~V~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~v~~g~~~~l~C~v~~~ 1081 (1884)
-...|.+..++.. . ..+|.+...... . ..++..|.+.
T Consensus 583 ~~~~l~~~s~~~v--~---------------------------------~~tp~~~~~~~g-----~-v~as~~~~a~-- 619 (741)
T KOG3515|consen 583 LSLVLKAYSALIV--T---------------------------------VRTPNMYTAQEG-----C-VNASDDCVAS-- 619 (741)
T ss_pred cceEEEecccccc--c---------------------------------ccCCceeeeccC-----c-ccccccceec--
Confidence 3334444322211 0 123332221111 1 1889999765
Q ss_pred CCCCcEEEEEECCEeccCCCceEEEe-e----CcEEEEEEcccCcCCcEEEEEEEEcCCeeeEEEEEEE
Q psy2148 1082 SDPTMRIDWFFNGRPFATGSRVKTVY-D----FGFISLDMDYVYARDSGEYICRATNKWGTAMTKAKVI 1145 (1884)
Q Consensus 1082 ~~p~~~v~W~k~~~~l~~~~~~~~~~-~----~~~~~l~i~~~~~~d~G~Y~C~a~n~~G~~~~~~~l~ 1145 (1884)
+.|.+.+.|-|+......+.++.... . .......+..+...|-+ ..|.+.|.+|.+-.+..+.
T Consensus 620 ~~~~~~~~~~k~p~~~~~~~~~~~~~~~~~~~~s~~~~~~~~~~~~~y~-~~c~t~n~lg~~~v~~~~~ 687 (741)
T KOG3515|consen 620 GVPSTSFTTAKTPLQTTEGPHIREKATQQGQTHSSSEWILNHIDGSDYE-NGCTTQNLLGSDHVSGAIH 687 (741)
T ss_pred ccccceeecccCCCcccCCceEEEeeeeccccccccccccCCcchhhhc-ceeeecccCCCccccceec
Confidence 89999999999988865554433211 1 11223344444444444 8999999999887665553
No 13
>TIGR00864 PCC polycystin cation channel protein. Note: this model has been restricted to the amino half because for technical reasons.
Probab=99.83 E-value=9.3e-10 Score=150.33 Aligned_cols=402 Identities=12% Similarity=0.052 Sum_probs=220.7
Q ss_pred eeecCCcEEEEEEEeecCCCcceEEEecccccccccccccceEEEeeccceeeeeeeeeeeeceEEEEEeeecccCceEE
Q psy2148 1275 TVQEAEPVRFETRVEPRVDPRLRVECSLSTAFFFPFINISTAFLIFNFCLHAVIFSHPIFDLGFVSLDIDYVYPEDQGEY 1354 (1884)
Q Consensus 1275 ~v~~g~~v~l~c~v~~~~~p~~~~~W~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~I~~~~~~d~G~Y 1354 (1884)
.+..|+++.|...++ ......+.|..++...... + .. .+ .-.-...|.|
T Consensus 1708 ~aavn~~V~fs~~lt--~GS~vty~W~~gdG~s~~~---s---------~p--------------~~---tHtf~~~G~y 1756 (2740)
T TIGR00864 1708 PAAVNALINLSAELA--EGSGLQYRWFLEEGDDLET---S---------EP--------------FM---SHSFPSAGLH 1756 (2740)
T ss_pred cccCCCeEEEEEEec--CCCCcEEEEEECCCCCccc---C---------CC--------------ce---EEEccCCceE
Confidence 456688899888665 4577899999776521100 0 00 00 0123456777
Q ss_pred EEEE--EccccceeeeEEEEEeecCceeecccCCcchhhhHHHHHHHHhhhcccccccccCCccCCcccCCCCeEEEc-c
Q psy2148 1355 VCRA--YNDHGEAFTKATISCKKIPTIQLQNQVPKGMLKTEALIQMEAAIKKYTSEIYLTEDDLYEPEKKQPPRFVTQ-I 1431 (1884)
Q Consensus 1355 ~C~a--~n~~g~~~~~~~l~v~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~pP~~~~~-~ 1431 (1884)
...+ .|..|....+..+.|+.+..= ..|... +
T Consensus 1757 ~VtVta~N~vss~~~s~~V~VqepV~G---------------------------------------------L~i~~~~~ 1791 (2740)
T TIGR00864 1757 LVTMKAFNELGSANASEEVDVQEPISG---------------------------------------------LKIRAADA 1791 (2740)
T ss_pred EEEEEEEccccccceeEEEEEEecccc---------------------------------------------ceEecCCC
Confidence 7655 588888877777777655421 011000 0
Q ss_pred CCccccccccceEEEEEEeeCCCCCCeEEEeecCeecCCCCCceeeeeCceEEEEEeeeccCCCeEEEE--EEEecCcce
Q psy2148 1432 KTQDQLVEMQSTKFECQLAPVGDPNMKVEWFLNGKPLPHKNRFNPIYDFGYVAMNFGWVYPEDSGEYLC--RATNLYGMD 1509 (1884)
Q Consensus 1432 ~~~~~v~~g~~~~l~C~~~~~g~p~~~i~W~~~~~~l~~~~~~~~~~~~~~~~L~i~~~~~~d~G~Y~c--~a~n~~G~~ 1509 (1884)
....-+..|..+.|.-.++ .|.+. ...|..++..-.. +.... .+..++|.|+. .|.|..+..
T Consensus 1792 ~~~~~~~ag~~v~F~a~vs-tGsnV-sw~W~f~~g~s~~---------gk~v~-----~Tf~~aG~ytV~L~AsN~vs~~ 1855 (2740)
T TIGR00864 1792 GEQNFFAADSSVCFQGELA-TGTNV-SWCWAIDGGSSKM---------GKHAC-----MTFPDAGTFAIRLNASNAVSGK 1855 (2740)
T ss_pred CcccceecCcEEEEEEEcc-CCCee-EEEEEeCCCCccc---------cceeE-----EecCCCeEEEEEEEEEcccCcc
Confidence 0001244677788887776 56653 6667665432111 11111 34678999986 567999999
Q ss_pred EEEEEEEEeCCCccccccCCCccchhHHHHHHhhcccccCCccccccCCCCCCCeEecCCcccccccCCceEEEEEEecC
Q psy2148 1510 ETRAILKTTGKPGIIYESQLPKGMKSIEKIREMEASWQHTPEQLVEDEKPKEAPVFVSQPEAQKVQEGEPARFCTRVTGY 1589 (1884)
Q Consensus 1510 ~~~~~l~V~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~P~~~~~~~~~~v~~g~~~~l~C~~~g~ 1589 (1884)
..+..+.|++++.- +........+..|+.++|.+.+...
T Consensus 1856 ~~s~~~~VQe~I~~-----------------------------------------L~L~as~~~~~~n~~v~fsa~l~~G 1894 (2740)
T TIGR00864 1856 SASREFFAEEPIFG-----------------------------------------LELKASKKIAAIGEKVEFQILLAAG 1894 (2740)
T ss_pred eeeeeEEEEEecce-----------------------------------------EEEecccccccCCCEEEEEEEecCC
Confidence 89999999875421 1222233356789999999998877
Q ss_pred CCCeEEEEEc-CEEeee--eeEEEEeeccceee--e--ecceeeEEEEecCCCCCCCCeeeecCC--ceeecCCCeEEEE
Q psy2148 1590 PRPRVMWLIN-GHTIVN--EIVRKITATETTEM--E--HKGKIQERVVDASEKPAKPPVFTKKIQ--PCRAFEQDQARFE 1660 (1884)
Q Consensus 1590 p~~~v~W~~~-g~~i~~--~~~~~~~~~~~~~~--~--~~~~~~~~~~~~~~~~~~~p~~~~~~~--~~~v~~G~~~~l~ 1660 (1884)
+.....|... |..... ...........+.+ . .............+.+..+-.-+.... ...+..|+...|.
T Consensus 1895 S~Vtf~w~fGdgs~~~~t~~~t~~HsY~~~G~Y~VtV~A~N~Vs~~~a~~~V~Vle~V~gL~I~~~c~~~~~~g~~~tF~ 1974 (2740)
T TIGR00864 1895 SAVNFRLQIGGAAPEVLQPGPRFSHSFPRVDDHMVNLRAKNEVSCAQANLHIEVLEAVRGLQIPDCCAAGIATGEEKNFT 1974 (2740)
T ss_pred CceEEEEEeCCCCceeecCCCeEEeecCCCCcEEEEEEEEeccceeeeeEEEEEEEeccceEecCCcccceecCceEEEE
Confidence 8888899764 433321 11111111111110 0 000000000000111111111111111 1126789999999
Q ss_pred EEEeccCCCeEEEEeCCeecCCCCCeEEEEeCceeEEEEcccccCCCeEEEEE--EEeCCceEEEEEEEEEEecccCCCC
Q psy2148 1661 VEFDGDPLPTIKWFREDFPITSSPDFQIHTFSTKSILIMRQVFMEDSGVFAVI--AENRGGKAKCSANLVVEEKRQGGRG 1738 (1884)
Q Consensus 1661 C~~~g~p~~~i~W~~~~~~~~~~~~~~~~~~~~~~~L~i~~v~~~DsG~Y~C~--a~n~~g~~~~~~~l~V~~~~~~~~~ 1738 (1884)
..+...-.-.+.|++.-+.+..+.. +...+..-+.++ ...|.|... |.|..|.......+.|+....
T Consensus 1975 A~v~~g~~V~f~W~f~~~~~~g~~~--~~~~G~~vty~~-----~~~G~~~I~v~A~N~l~s~n~t~~i~VQ~~i~---- 2043 (2740)
T TIGR00864 1975 ANVQRGKPVAFAWTFDLHHLHGDSL--VIHMGKDVSYTA-----EAAGLLEIQLGAFNALGAENITLQLEAQDALM---- 2043 (2740)
T ss_pred EEEecCCceEEEEEeeecccCCCcc--eeecCCceEEcc-----CCCcEEEEEEEEEcccCcccccEEEEEEehee----
Confidence 9886555557899977544433322 111122212222 468988775 788888887778888885321
Q ss_pred CCCCCeEEeccCceEEcCCceEEEEEEEecCCC-cEEEEEeCCEecCCC-CCeEEeecCCeEEEEEccCCCCCCEEEEEE
Q psy2148 1739 GVVPPSFLTTISSAVINVGQLARFDAKISATKP-LDVYWLKNGKKIIPD-IRYKTLEEDNLFTLLIIEAVVEDSGAYECV 1816 (1884)
Q Consensus 1739 ~~~~P~~~~~~~~~~~~~G~~~~l~C~~~g~p~-p~v~W~k~~~~l~~~-~~~~~~~~~~~~~L~i~~~~~~d~G~Y~C~ 1816 (1884)
.............+..++|+|.+...+. ..+.|-+++...... ....+ ..+ ..-.|.|...
T Consensus 2044 -----~~~L~~~p~~~~~n~~v~f~~~~~~~~~~v~~~WDFGDGt~~~~T~~~~~-------sHt-----Y~r~G~Y~V~ 2106 (2740)
T TIGR00864 2044 -----DAALQAGPQDCFTNKMAQFEAATSPKPNFMACHWDFGDGSAGQDTDEPRA-------EHE-----YLHPGDYRVQ 2106 (2740)
T ss_pred -----eEEEeecCcceecCceEEEEEEEccCCCcEEEEEEecCCCCccccCCcee-------EEE-----ecCCccEEEE
Confidence 0111112344556889999999976553 579998875433111 11111 111 1234888655
Q ss_pred --EEeCCeeEEEEEEEEEEecCC
Q psy2148 1817 --AMNNAGEARCEAELVVQSKKA 1837 (1884)
Q Consensus 1817 --a~N~~G~~~~~~~l~V~~~~~ 1837 (1884)
|.|......++++|.|...+.
T Consensus 2107 V~a~N~VS~~~a~~~i~V~vl~C 2129 (2740)
T TIGR00864 2107 VNASNLVSFFSAHAEINVQVLAC 2129 (2740)
T ss_pred EEEEcceeeeeeEEEEEEEEecC
Confidence 589999888888888887553
No 14
>PHA02826 IL-1 receptor-like protein; Provisional
Probab=99.79 E-value=4.2e-18 Score=184.90 Aligned_cols=159 Identities=18% Similarity=0.201 Sum_probs=123.8
Q ss_pred CCceeecCCCeEEEEEEEeccC-----------CCeEEEEeCCeec--CC-CCC---e--EEEE-eCceeEEEEcccccC
Q psy2148 1646 IQPCRAFEQDQARFEVEFDGDP-----------LPTIKWFREDFPI--TS-SPD---F--QIHT-FSTKSILIMRQVFME 1705 (1884)
Q Consensus 1646 ~~~~~v~~G~~~~l~C~~~g~p-----------~~~i~W~~~~~~~--~~-~~~---~--~~~~-~~~~~~L~i~~v~~~ 1705 (1884)
+..+.+.+|+++.|.|.+.+.| .+.+.|+|++... .. ..+ . .... ......|.|.+++.+
T Consensus 29 ~~~~~v~eGe~v~L~C~~~~~~~~~~~~~~~~~~~~V~W~k~~s~~~v~~~~~~~~~~~i~~~~~~~r~~~L~I~~v~~~ 108 (227)
T PHA02826 29 LTPVYAKFGDPMVLLCTGKHYKKSIFFDKTFITSYNVTWSKTDSLAFVRDSGARTKIKKITHNEIGDRSENLWIGNVINI 108 (227)
T ss_pred cceEEecCCCCEEEEccccccccccccccccCCCccEEEEeCCeEEEEEcCCCccccccccccceecCCCeEEECCCChH
Confidence 4667899999999999998754 4599999998642 11 111 0 0000 122468999999999
Q ss_pred CCeEEEEEEEeCCceEEEEEEEEEEecccCCCCCCCCCeEEeccCceEEcCCceEEEEEEEec-----CCCcEEEEEeCC
Q psy2148 1706 DSGVFAVIAENRGGKAKCSANLVVEEKRQGGRGGVVPPSFLTTISSAVINVGQLARFDAKISA-----TKPLDVYWLKNG 1780 (1884)
Q Consensus 1706 DsG~Y~C~a~n~~g~~~~~~~l~V~~~~~~~~~~~~~P~~~~~~~~~~~~~G~~~~l~C~~~g-----~p~p~v~W~k~~ 1780 (1884)
|+|.|.|.|.|..|....++.|.|.. ++ .+..+.+|+.++|.|.+.+ .|.|.|+|+|||
T Consensus 109 DsG~Y~C~a~N~~~~~~~~i~L~V~~----------~~------~~~~~~~G~~v~L~C~~~~~~~~~~p~p~I~WyKng 172 (227)
T PHA02826 109 DEGIYICTISSGNICEESTIRLTFDS----------GT------INYQFNSGKDSKLHCYGTDGISSTFKDYTLTWYKNG 172 (227)
T ss_pred HCEEEEEEEEECCcceEEEEEEEEec----------CC------ccceEecCCCEEEEeeCCCCccccCCCceEEEEECC
Confidence 99999999999999888888888853 11 2345678999999999863 467999999999
Q ss_pred EecCCCCCeEEeecCCeEEEEEccCCCCCCEEEEEEEEeCCe
Q psy2148 1781 KKIIPDIRYKTLEEDNLFTLLIIEAVVEDSGAYECVAMNNAG 1822 (1884)
Q Consensus 1781 ~~l~~~~~~~~~~~~~~~~L~i~~~~~~d~G~Y~C~a~N~~G 1822 (1884)
++|..+.++.+..++. .|.|.+++.+|+|.|+|.|....+
T Consensus 173 ~~l~~~~r~~~~~~~~--~L~I~~V~~~DsG~YtC~a~~~~~ 212 (227)
T PHA02826 173 NIVLYTDRIQLRNNNS--TLVIKSATHDDSGIYTCNLRFNKN 212 (227)
T ss_pred EECCCCCCEEEeCCCC--EEEECcCCHHhCEEEEEEEEEeEC
Confidence 9998777877654443 899999999999999999998753
No 15
>TIGR00864 PCC polycystin cation channel protein. Note: this model has been restricted to the amino half because for technical reasons.
Probab=99.78 E-value=7.3e-09 Score=141.88 Aligned_cols=705 Identities=15% Similarity=0.132 Sum_probs=367.3
Q ss_pred cCCCCcEEEEEEEeecCCCCCeEEEeeCCccCC-CCCCeEEEeeCCEEEEEEcccCcCCCeEEE--EEEEecCceEEEEE
Q psy2148 719 LREGENAHFEARLTPTDDPKLKVEWFWNGKPMK-TGSRFRTFCDFGFVILEISPVYPEDCGQYS--CRAYNDYGEAVTSA 795 (1884)
Q Consensus 719 v~~G~~~~l~C~~~~~g~p~~~v~W~k~g~~l~-~~~~~~~~~~~~~~~L~i~~~~~~d~G~Y~--C~a~N~~g~~~~~~ 795 (1884)
+..+.++.|+..... |.+ ..++|..++.-.. .... .... +....|.|+ .+|.|..|....+.
T Consensus 1523 vpl~~sV~Fta~~s~-Gs~-v~ysWdFGDg~ts~~~np--------t~~y-----TY~spGtYtVtLTvtN~~Gs~~~T~ 1587 (2740)
T TIGR00864 1523 VPLNGSVHFEAHLDA-GDD-VRFSWILCDHCTPIFGGN--------TIFY-----TFRSVGTFNIIVTAENDVGAAQASI 1587 (2740)
T ss_pred ccccceEEEEEEccC-CCc-eeEEEEeCCCCccccCCC--------ceEE-----eecCCceEEEEEEEecCCCccceeE
Confidence 455667888865543 443 6899987543211 1111 0111 124568886 55779999998888
Q ss_pred EEEEeccee-----------------------------eEEeccCCCCceEEEEEeeec----------------CCCcC
Q psy2148 796 SMKVQGKRS-----------------------------IILESQLPKGMEVFISFHEIS----------------PVYPE 830 (1884)
Q Consensus 796 ~l~V~~~p~-----------------------------~~~~~~~~~g~~~~~~~~~i~----------------~~~~~ 830 (1884)
.+.|+.+-. +.+...+.+|..+..+|.-+. .....
T Consensus 1588 ~i~V~~~I~GlqI~~~~~~gg~~~~~~~~~~~~~t~~~v~l~~~~~~GTnvsysW~~~~~n~~dg~~~~~tGk~~~vt~~ 1667 (2740)
T TIGR00864 1588 FLFVLQEIEGLQILGETAEGGGGGVQELDGCYFETNHTVQFHAGFKDGTNLSFSWNAILDNEPDGPAFAGSGKGAKLNPL 1667 (2740)
T ss_pred EEEEeecccceEEEeecccccCCcccccccceeccCCEEEeeeccCCCCeeEEEEEEecCCCCCCccccccCceeEEecC
Confidence 888875311 112223455666655553321 11233
Q ss_pred CCcee--EEEEEccccceeEEEEEEEecccceEEeecCCCCcccccceeeecccCCcccccchhhhhhhhccCCCCcccc
Q psy2148 831 DCGQY--SCRAYNDYGEAVTSASMKVQGKRSIILESQLPKGMEGTIDKIAELEGYGHEREDRTIDKIAELEGYGHEREDR 908 (1884)
Q Consensus 831 d~g~y--~c~a~n~~g~~~~s~~l~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 908 (1884)
+.|.| +..|.|..|....+..+.+.++-.-+
T Consensus 1668 ~pG~Y~VtL~aSN~vG~~t~s~~i~v~epi~~L----------------------------------------------- 1700 (2740)
T TIGR00864 1668 EAGPCDIFLQAANLLGQATADCTIDFLEPAGNL----------------------------------------------- 1700 (2740)
T ss_pred CCceEEEEEEEeecccceeeEEEEEEEEEcCce-----------------------------------------------
Confidence 44554 44666888888777777776421111
Q ss_pred cccccCCCCeeeecCCceeecCCCeEEEEEEEeeCCCCCcEEEEeeCCEE-cc-CCCcEEEEeeCCeEEEEEccCCCCCC
Q psy2148 909 IEEDLGKAPEFLTTPTDLTLAESTLAHFECRLTPTNDPSMTVEWFHNGKA-LS-AGSRIKTINDFGFVILEINDVYLRDS 986 (1884)
Q Consensus 909 ~~~~~~~~p~~~~~~~~~~v~~G~~v~l~C~v~~~~~P~~~v~W~~~g~~-i~-~~~~~~~~~~~~~~~L~I~~~~~~D~ 986 (1884)
......-.+..|+.|.|.-.+. .-....++|..++.. .. ....+ +- +....
T Consensus 1701 -----------~L~aS~~~aavn~~V~fs~~lt--~GS~vty~W~~gdG~s~~~s~p~~---------tH-----tf~~~ 1753 (2740)
T TIGR00864 1701 -----------MLQASDNPAAVNALINLSAELA--EGSGLQYRWFLEEGDDLETSEPFM---------SH-----SFPSA 1753 (2740)
T ss_pred -----------EEeccCCcccCCCeEEEEEEec--CCCCcEEEEEECCCCCcccCCCce---------EE-----EccCC
Confidence 1111223445689999998776 335668999986632 11 11111 01 13357
Q ss_pred eEEEE--EEEcCCeeEEEEEEEEEEeecccccccchhHhHhcchhhHHHHHHhhcccCcCCCCCCCCCCCceeeecC-CC
Q psy2148 987 GLYTC--KATNKHGEATTSCKLTVKGRQGIDVEPQVSAIFANATKNIQKLEEALYRKDELIPDEEKPNPPVFTSQLQ-DN 1063 (1884)
Q Consensus 987 G~Y~C--~a~N~~G~~~~~~~l~V~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~-~~ 1063 (1884)
|.|.. .|.|..|+...+..+.|+.+-. +. .|...-. ..
T Consensus 1754 G~y~VtVta~N~vss~~~s~~V~VqepV~---GL------------------------------------~i~~~~~~~~ 1794 (2740)
T TIGR00864 1754 GLHLVTMKAFNELGSANASEEVDVQEPIS---GL------------------------------------KIRAADAGEQ 1794 (2740)
T ss_pred ceEEEEEEEEccccccceeEEEEEEeccc---cc------------------------------------eEecCCCCcc
Confidence 88877 6889999988888888875321 10 0100000 00
Q ss_pred cCcCCCCcEEEEEEEeeCCCCCcEEEEEECCEeccCCCceEEEeeCcEEEEEEcccCcCCcEEEEE--EEEcCCeeeEEE
Q psy2148 1064 LDVPEAGKVHFDCRLEPKSDPTMRIDWFFNGRPFATGSRVKTVYDFGFISLDMDYVYARDSGEYIC--RATNKWGTAMTK 1141 (1884)
Q Consensus 1064 ~~v~~g~~~~l~C~v~~~~~p~~~v~W~k~~~~l~~~~~~~~~~~~~~~~l~i~~~~~~d~G~Y~C--~a~n~~G~~~~~ 1141 (1884)
.-+..|.++.|.-.+. .|. ...+.|..+|..-..+.. .. .+..++|.|+. .|.|..|....+
T Consensus 1795 ~~~~ag~~v~F~a~vs-tGs-nVsw~W~f~~g~s~~gk~---------v~-----~Tf~~aG~ytV~L~AsN~vs~~~~s 1858 (2740)
T TIGR00864 1795 NFFAADSSVCFQGELA-TGT-NVSWCWAIDGGSSKMGKH---------AC-----MTFPDAGTFAIRLNASNAVSGKSAS 1858 (2740)
T ss_pred cceecCcEEEEEEEcc-CCC-eeEEEEEeCCCCccccce---------eE-----EecCCCeEEEEEEEEEcccCcceee
Confidence 1234577788887775 354 457788776543222211 11 23567888865 779999999888
Q ss_pred EEEEEeeccccccccccCCcccHHHHHhhhccCCCCccccCCCCCCCCccccchhcccccccccccchhhhhhhcccccc
Q psy2148 1142 AKVICKAKHDIVTESQLPDSMSAEKLKELEKNYTPEEIEEDEIPEEPPRLNQSRYKKQNQSAWYDSELSEYQKERANEST 1221 (1884)
Q Consensus 1142 ~~l~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~ 1221 (1884)
..+.|+.+..-.
T Consensus 1859 ~~~~VQe~I~~L-------------------------------------------------------------------- 1870 (2740)
T TIGR00864 1859 REFFAEEPIFGL-------------------------------------------------------------------- 1870 (2740)
T ss_pred eeEEEEEecceE--------------------------------------------------------------------
Confidence 888887542110
Q ss_pred ccccccccccccCCCchhHHHHHhhhccCCCccccccCCCCCCCeeEeecceeeeecCCcEEEEEEEeecCCCcceEEEe
Q psy2148 1222 ELEKHDIVTESQLPDSMSAEKLKELEKNYTPEEIEEDEIPEEPPRFITEIESVTVQEAEPVRFETRVEPRVDPRLRVECS 1301 (1884)
Q Consensus 1222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~v~~g~~v~l~c~v~~~~~p~~~~~W~ 1301 (1884)
........+..|+.++|.+.+.. .+...+.|.
T Consensus 1871 ----------------------------------------------~L~as~~~~~~n~~v~fsa~l~~--GS~Vtf~w~ 1902 (2740)
T TIGR00864 1871 ----------------------------------------------ELKASKKIAAIGEKVEFQILLAA--GSAVNFRLQ 1902 (2740)
T ss_pred ----------------------------------------------EEecccccccCCCEEEEEEEecC--CCceEEEEE
Confidence 01112336778999999998874 358999999
Q ss_pred cccccccccccccceEEEeeccceeeeeeeeeeeeceEEEEEeeecccCceEEEEEEEccccceeeeEEEEEeecCceee
Q psy2148 1302 LSTAFFFPFINISTAFLIFNFCLHAVIFSHPIFDLGFVSLDIDYVYPEDQGEYVCRAYNDHGEAFTKATISCKKIPTIQL 1381 (1884)
Q Consensus 1302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~I~~~~~~d~G~Y~C~a~n~~g~~~~~~~l~v~~~p~~~~ 1381 (1884)
.++...... ..+ ....+.-..-....-+..|.|..+.......+.|..+-.- +
T Consensus 1903 fGdgs~~~~------------------------t~~--~t~~HsY~~~G~Y~VtV~A~N~Vs~~~a~~~V~Vle~V~g-L 1955 (2740)
T TIGR00864 1903 IGGAAPEVL------------------------QPG--PRFSHSFPRVDDHMVNLRAKNEVSCAQANLHIEVLEAVRG-L 1955 (2740)
T ss_pred eCCCCceee------------------------cCC--CeEEeecCCCCcEEEEEEEEeccceeeeeEEEEEEEeccc-e
Confidence 876521110 000 0111333344444555566788877666666666433110 0
Q ss_pred cccCCcchhhhHHHHHHHHhhhcccccccccCCccCCcccCCCCeEEEccCCccccccccceEEEEEEeeCCCCCCeEEE
Q psy2148 1382 QNQVPKGMLKTEALIQMEAAIKKYTSEIYLTEDDLYEPEKKQPPRFVTQIKTQDQLVEMQSTKFECQLAPVGDPNMKVEW 1461 (1884)
Q Consensus 1382 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~pP~~~~~~~~~~~v~~g~~~~l~C~~~~~g~p~~~i~W 1461 (1884)
.....-...+..|+...|...+. .|.|- .+.|
T Consensus 1956 ----------------------------------------------~I~~~c~~~~~~g~~~tF~A~v~-~g~~V-~f~W 1987 (2740)
T TIGR00864 1956 ----------------------------------------------QIPDCCAAGIATGEEKNFTANVQ-RGKPV-AFAW 1987 (2740)
T ss_pred ----------------------------------------------EecCCcccceecCceEEEEEEEe-cCCce-EEEE
Confidence 00000001146788899999987 67764 6889
Q ss_pred eecCeecCCCCCceeeeeCceEEEEEeeeccCCCeEEEE--EEEecCcceEEEEEEEEeCCCccccccCCCccchhHHHH
Q psy2148 1462 FLNGKPLPHKNRFNPIYDFGYVAMNFGWVYPEDSGEYLC--RATNLYGMDETRAILKTTGKPGIIYESQLPKGMKSIEKI 1539 (1884)
Q Consensus 1462 ~~~~~~l~~~~~~~~~~~~~~~~L~i~~~~~~d~G~Y~c--~a~n~~G~~~~~~~l~V~~~p~~~~~~~~~~~~~~~~~~ 1539 (1884)
+.+-..+..+.. ....+...+.. ....|.|+. .|.|..|.......+.|+.+....
T Consensus 1988 ~f~~~~~~g~~~--~~~~G~~vty~-----~~~~G~~~I~v~A~N~l~s~n~t~~i~VQ~~i~~~--------------- 2045 (2740)
T TIGR00864 1988 TFDLHHLHGDSL--VIHMGKDVSYT-----AEAAGLLEIQLGAFNALGAENITLQLEAQDALMDA--------------- 2045 (2740)
T ss_pred EeeecccCCCcc--eeecCCceEEc-----cCCCcEEEEEEEEEcccCcccccEEEEEEeheeeE---------------
Confidence 865333322222 11222222222 347899886 566988887777777876532110
Q ss_pred HHhhcccccCCccccccCCCCCCCeEecCCcccccccCCceEEEEEEecCCC-CeEEEEE-cCEEeeee--eEEEEeecc
Q psy2148 1540 REMEASWQHTPEQLVEDEKPKEAPVFVSQPEAQKVQEGEPARFCTRVTGYPR-PRVMWLI-NGHTIVNE--IVRKITATE 1615 (1884)
Q Consensus 1540 ~~~~~~~~~~~~~~~~~~~~~~~P~~~~~~~~~~v~~g~~~~l~C~~~g~p~-~~v~W~~-~g~~i~~~--~~~~~~~~~ 1615 (1884)
.+... ......+..+.|.|.+...+. ....|.. ||...... .....+...
T Consensus 2046 ------------------------~L~~~--p~~~~~n~~v~f~~~~~~~~~~v~~~WDFGDGt~~~~T~~~~~sHtY~r 2099 (2740)
T TIGR00864 2046 ------------------------ALQAG--PQDCFTNKMAQFEAATSPKPNFMACHWDFGDGSAGQDTDEPRAEHEYLH 2099 (2740)
T ss_pred ------------------------EEeec--CcceecCceEEEEEEEccCCCcEEEEEEecCCCCccccCCceeEEEecC
Confidence 01111 223445778999999865553 4789976 45554221 111111111
Q ss_pred ceee----eecceee----EEEEecCCCCCCCC-eeeecCCceeecCCCeEEEEEEEecc----CCCeEEEEeCCee---
Q psy2148 1616 TTEM----EHKGKIQ----ERVVDASEKPAKPP-VFTKKIQPCRAFEQDQARFEVEFDGD----PLPTIKWFREDFP--- 1679 (1884)
Q Consensus 1616 ~~~~----~~~~~~~----~~~~~~~~~~~~~p-~~~~~~~~~~v~~G~~~~l~C~~~g~----p~~~i~W~~~~~~--- 1679 (1884)
.+.+ ....... ...+...+..-.+| .-+..+..+.+...+.+.|+..+.-+ -...+.|..-...
T Consensus 2100 ~G~Y~V~V~a~N~VS~~~a~~~i~V~vl~C~~P~V~i~~~~~~~i~RSq~~~lEa~V~l~~ci~y~~~y~W~v~~~~~~~ 2179 (2740)
T TIGR00864 2100 PGDYRVQVNASNLVSFFSAHAEINVQVLACEEPEVDVVLALQLAIRRSQPNLLEAHVDLKDCLRYGAEYLWEILRAASCD 2179 (2740)
T ss_pred CccEEEEEEEEcceeeeeeEEEEEEEEecCCCCCcEeccCceeEEEecCcceEEEEEccccccccccEEEEEEEeccccc
Confidence 1111 1111111 01111122222223 22333334455566666665555211 1457788742211
Q ss_pred ---------cCCCCC-eE-----EEEeCceeEEEEcccccCCCeEEEEEEEeCC----ceEEEEEEEEEEecccCCCCCC
Q psy2148 1680 ---------ITSSPD-FQ-----IHTFSTKSILIMRQVFMEDSGVFAVIAENRG----GKAKCSANLVVEEKRQGGRGGV 1740 (1884)
Q Consensus 1680 ---------~~~~~~-~~-----~~~~~~~~~L~i~~v~~~DsG~Y~C~a~n~~----g~~~~~~~l~V~~~~~~~~~~~ 1740 (1884)
+....| +- ....-....|.|.+-.+ ..|.|...+.-.. ......+.|.|...
T Consensus 2180 ~~~~~~~~~~~g~~~~~p~i~lp~~v~~~~~~L~IPk~tL-p~G~Y~~~~~Vs~~~tpl~~sa~~~L~V~~s-------- 2250 (2740)
T TIGR00864 2180 NDGHFARGALNGATRSFPVIPLPAEVDVQRLQLSLPKLAL-AAGHYCFVFSLSFEDTPLKKAACANLGVAAA-------- 2250 (2740)
T ss_pred cccccccccccccccccccccccccccccCceEeccCccc-CcceEEEEEEEEEcceEeeeEEEEEEEEEcC--------
Confidence 111000 00 00112345688877654 4678887765321 23445567777742
Q ss_pred CCCe-EEeccCceEEcCCceEEEEEEEecCCC--------cEEEEEeCCEecCCC----CCeEEeecCCeEEEEEccCCC
Q psy2148 1741 VPPS-FLTTISSAVINVGQLARFDAKISATKP--------LDVYWLKNGKKIIPD----IRYKTLEEDNLFTLLIIEAVV 1807 (1884)
Q Consensus 1741 ~~P~-~~~~~~~~~~~~G~~~~l~C~~~g~p~--------p~v~W~k~~~~l~~~----~~~~~~~~~~~~~L~i~~~~~ 1807 (1884)
+.. ++.......+..++.+.|.-.-+-+|. ..+.|+---...... ..+.+ ......|.|..-..
T Consensus 2251 -~LvAVI~GGt~Rtvs~~~~L~LDGS~SyDPD~~~~~~~~L~Y~W~C~~~~~~~~~~c~~~~~~--~ss~svltIp~~~L 2327 (2740)
T TIGR00864 2251 -RLMPIIEGGSYRVWSDTQDLQLDAEESYDPNLDDDDQSLLHFHWACQASSKGEAGCCALNFGL--GGKGPTLGIPGEEL 2327 (2740)
T ss_pred -CcEEEEcCCCcEEeccCccEEEeCccccCCCCCCCCCCCcEEEEEEEECCCCCCCccccCccc--cccCceEEEcHHHc
Confidence 222 333445566777888888777655554 358886321111000 11111 22234788887666
Q ss_pred CCCEEEEEEEE
Q psy2148 1808 EDSGAYECVAM 1818 (1884)
Q Consensus 1808 ~d~G~Y~C~a~ 1818 (1884)
....+|+-...
T Consensus 2328 ~~g~~Y~F~L~ 2338 (2740)
T TIGR00864 2328 AAGIEYTFKLS 2338 (2740)
T ss_pred CCCcEEEEEEE
Confidence 66667776663
No 16
>PHA02826 IL-1 receptor-like protein; Provisional
Probab=99.75 E-value=4.4e-17 Score=176.92 Aligned_cols=165 Identities=18% Similarity=0.228 Sum_probs=120.9
Q ss_pred CCceeecCCCeEEEEEEEeeCC---------CCCcEEEEeeCCEEc--c-CCCcE--E-EE-e--eCCeEEEEEccCCCC
Q psy2148 923 PTDLTLAESTLAHFECRLTPTN---------DPSMTVEWFHNGKAL--S-AGSRI--K-TI-N--DFGFVILEINDVYLR 984 (1884)
Q Consensus 923 ~~~~~v~~G~~v~l~C~v~~~~---------~P~~~v~W~~~g~~i--~-~~~~~--~-~~-~--~~~~~~L~I~~~~~~ 984 (1884)
+..+.+.+|++|.|.|.+.+.. ...+.|.|+|++... . .+.+. . +. . ......|.|.+++.+
T Consensus 29 ~~~~~v~eGe~v~L~C~~~~~~~~~~~~~~~~~~~~V~W~k~~s~~~v~~~~~~~~~~~i~~~~~~~r~~~L~I~~v~~~ 108 (227)
T PHA02826 29 LTPVYAKFGDPMVLLCTGKHYKKSIFFDKTFITSYNVTWSKTDSLAFVRDSGARTKIKKITHNEIGDRSENLWIGNVINI 108 (227)
T ss_pred cceEEecCCCCEEEEccccccccccccccccCCCccEEEEeCCeEEEEEcCCCccccccccccceecCCCeEEECCCChH
Confidence 3567889999999999986321 234589999998652 1 11110 0 00 0 011237999999999
Q ss_pred CCeEEEEEEEcCCeeEEEEEEEEEEeecccccccchhHhHhcchhhHHHHHHhhcccCcCCCCCCCCCCCceeeecCCCc
Q psy2148 985 DSGLYTCKATNKHGEATTSCKLTVKGRQGIDVEPQVSAIFANATKNIQKLEEALYRKDELIPDEEKPNPPVFTSQLQDNL 1064 (1884)
Q Consensus 985 D~G~Y~C~a~N~~G~~~~~~~l~V~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~ 1064 (1884)
|+|.|+|.|+|..|..+.++.|.|...+ . ..
T Consensus 109 DsG~Y~C~a~N~~~~~~~~i~L~V~~~~------------------------------------------~-------~~ 139 (227)
T PHA02826 109 DEGIYICTISSGNICEESTIRLTFDSGT------------------------------------------I-------NY 139 (227)
T ss_pred HCEEEEEEEEECCcceEEEEEEEEecCC------------------------------------------c-------cc
Confidence 9999999999999998888888884210 0 13
Q ss_pred CcCCCCcEEEEEEEeeC---CCCCcEEEEEECCEeccCCCceEEEeeCcEEEEEEcccCcCCcEEEEEEEEcCCeee
Q psy2148 1065 DVPEAGKVHFDCRLEPK---SDPTMRIDWFFNGRPFATGSRVKTVYDFGFISLDMDYVYARDSGEYICRATNKWGTA 1138 (1884)
Q Consensus 1065 ~v~~g~~~~l~C~v~~~---~~p~~~v~W~k~~~~l~~~~~~~~~~~~~~~~l~i~~~~~~d~G~Y~C~a~n~~G~~ 1138 (1884)
.+.+|+.+.|.|.+.+. +.|.|+|+|+|||++|..+.++....++ ..|.|.+++.+|+|.|+|.|...++..
T Consensus 140 ~~~~G~~v~L~C~~~~~~~~~~p~p~I~WyKng~~l~~~~r~~~~~~~--~~L~I~~V~~~DsG~YtC~a~~~~~g~ 214 (227)
T PHA02826 140 QFNSGKDSKLHCYGTDGISSTFKDYTLTWYKNGNIVLYTDRIQLRNNN--STLVIKSATHDDSGIYTCNLRFNKNSN 214 (227)
T ss_pred eEecCCCEEEEeeCCCCccccCCCceEEEEECCEECCCCCCEEEeCCC--CEEEECcCCHHhCEEEEEEEEEeECCE
Confidence 45689999999998631 3468999999999999877666544332 379999999999999999999875433
No 17
>cd05762 Ig8_MLCK Eighth immunoglobulin (Ig)-like domain of human myosin light-chain kinase (MLCK). Ig8_MLCK: the eighth immunoglobulin (Ig)-like domain of human myosin light-chain kinase (MLCK). MLCK is a key regulator of different forms of cell motility involving actin and myosin II. Agonist stimulation of smooth muscle cells increases cytosolic Ca2+, which binds calmodulin. This Ca2+-calmodulin complex in turn binds to and activates MLCK. Activated MLCK leads to the phosphorylation of the 20 kDa myosin regulatory light chain (RLC) of myosin II and the stimulation of actin-activated myosin MgATPase activity. MLCK is widely present in vertebrate tissues; it phosphorylates the 20 kDa RLC of both smooth and nonmuscle myosin II. Phosphorylation leads to the activation of the myosin motor domain and altered structural properties of myosin II. In smooth muscle MLCK it is involved in initiating contraction. In nonmuscle cells, MLCK may participate in cell division and cell motility; it has
Probab=99.69 E-value=2.7e-16 Score=147.38 Aligned_cols=96 Identities=24% Similarity=0.369 Sum_probs=90.1
Q ss_pred CeEEeccCceEEcCCceEEEEEEEecCCCcEEEEEeCCEecCCCCCeEEeecCCeEEEEEccCCCCCCEEEEEEEEeCCe
Q psy2148 1743 PSFLTTISSAVINVGQLARFDAKISATKPLDVYWLKNGKKIIPDIRYKTLEEDNLFTLLIIEAVVEDSGAYECVAMNNAG 1822 (1884)
Q Consensus 1743 P~~~~~~~~~~~~~G~~~~l~C~~~g~p~p~v~W~k~~~~l~~~~~~~~~~~~~~~~L~i~~~~~~d~G~Y~C~a~N~~G 1822 (1884)
|.|...+.+..+..|+.++|.|.+.|.|.|.+.|+|+|++|..+.++.+......+.|.|.++.++|+|.|+|.|.|.+|
T Consensus 1 p~~~~~p~~~~v~~G~~v~l~C~~~G~p~p~v~W~kdg~~l~~~~~~~~~~~~~~s~L~I~~~~~~D~G~Ytc~a~N~~G 80 (98)
T cd05762 1 PQIIQFPEDMKVRAGESVELFCKVTGTQPITCTWMKFRKQIQEGEGIKIENTENSSKLTITEGQQEHCGCYTLEVENKLG 80 (98)
T ss_pred CceEECCcCEEEECCCEEEEEEEEcccCCCceEEEECCEEecCCCcEEEEecCCeeEEEECCCChhhCEEEEEEEEcCCC
Confidence 67888999999999999999999999999999999999999888888888777778999999999999999999999999
Q ss_pred eEEEEEEEEEEecCCC
Q psy2148 1823 EARCEAELVVQSKKAP 1838 (1884)
Q Consensus 1823 ~~~~~~~l~V~~~~~~ 1838 (1884)
...++++|.|+++|.|
T Consensus 81 ~~~~~~~l~V~~~P~p 96 (98)
T cd05762 81 SRQAQVNLTVVDKPDP 96 (98)
T ss_pred ceeEEEEEEEecCCCC
Confidence 9999999999998764
No 18
>cd05762 Ig8_MLCK Eighth immunoglobulin (Ig)-like domain of human myosin light-chain kinase (MLCK). Ig8_MLCK: the eighth immunoglobulin (Ig)-like domain of human myosin light-chain kinase (MLCK). MLCK is a key regulator of different forms of cell motility involving actin and myosin II. Agonist stimulation of smooth muscle cells increases cytosolic Ca2+, which binds calmodulin. This Ca2+-calmodulin complex in turn binds to and activates MLCK. Activated MLCK leads to the phosphorylation of the 20 kDa myosin regulatory light chain (RLC) of myosin II and the stimulation of actin-activated myosin MgATPase activity. MLCK is widely present in vertebrate tissues; it phosphorylates the 20 kDa RLC of both smooth and nonmuscle myosin II. Phosphorylation leads to the activation of the myosin motor domain and altered structural properties of myosin II. In smooth muscle MLCK it is involved in initiating contraction. In nonmuscle cells, MLCK may participate in cell division and cell motility; it has
Probab=99.68 E-value=3.8e-16 Score=146.37 Aligned_cols=96 Identities=24% Similarity=0.390 Sum_probs=89.2
Q ss_pred CeeeecCCceeecCCCeEEEEEEEeeCCCCCcEEEEeeCCEEccCCCcEEEEeeCCeEEEEEccCCCCCCeEEEEEEEcC
Q psy2148 917 PEFLTTPTDLTLAESTLAHFECRLTPTNDPSMTVEWFHNGKALSAGSRIKTINDFGFVILEINDVYLRDSGLYTCKATNK 996 (1884)
Q Consensus 917 p~~~~~~~~~~v~~G~~v~l~C~v~~~~~P~~~v~W~~~g~~i~~~~~~~~~~~~~~~~L~I~~~~~~D~G~Y~C~a~N~ 996 (1884)
|.|+..++++.+..|+.+.|.|.+. |.|+|.|.|+|+|.+|..+.++++...+..+.|.|.++..+|+|.|+|.|+|.
T Consensus 1 p~~~~~p~~~~v~~G~~v~l~C~~~--G~p~p~v~W~kdg~~l~~~~~~~~~~~~~~s~L~I~~~~~~D~G~Ytc~a~N~ 78 (98)
T cd05762 1 PQIIQFPEDMKVRAGESVELFCKVT--GTQPITCTWMKFRKQIQEGEGIKIENTENSSKLTITEGQQEHCGCYTLEVENK 78 (98)
T ss_pred CceEECCcCEEEECCCEEEEEEEEc--ccCCCceEEEECCEEecCCCcEEEEecCCeeEEEECCCChhhCEEEEEEEEcC
Confidence 6788899999999999999999998 78999999999999998888888877777789999999999999999999999
Q ss_pred CeeEEEEEEEEEEeeccc
Q psy2148 997 HGEATTSCKLTVKGRQGI 1014 (1884)
Q Consensus 997 ~G~~~~~~~l~V~~~~~~ 1014 (1884)
+|..++++.|+|.++|.+
T Consensus 79 ~G~~~~~~~l~V~~~P~p 96 (98)
T cd05762 79 LGSRQAQVNLTVVDKPDP 96 (98)
T ss_pred CCceeEEEEEEEecCCCC
Confidence 999999999999988754
No 19
>cd05851 Ig3_Contactin-1 Third Ig domain of contactin-1. Ig3_Contactin-1: Third Ig domain of the neural cell adhesion molecule contactin-1. Contactins are comprised of six Ig domains followed by four fibronectin type III (FnIII) domains anchored to the membrane by glycosylphosphatidylinositol. Contactin-1 is differentially expressed in tumor tissues and may through a RhoA mechanism, facilitate invasion and metastasis of human lung adenocarcinoma.
Probab=99.53 E-value=4.8e-14 Score=129.62 Aligned_cols=88 Identities=19% Similarity=0.341 Sum_probs=78.0
Q ss_pred CCeeeecCCceeecCCCeEEEEEEEeeCCCCCcEEEEeeCCEEccCCCcEEEEeeCCeEEEEEccCCCCCCeEEEEEEEc
Q psy2148 916 APEFLTTPTDLTLAESTLAHFECRLTPTNDPSMTVEWFHNGKALSAGSRIKTINDFGFVILEINDVYLRDSGLYTCKATN 995 (1884)
Q Consensus 916 ~p~~~~~~~~~~v~~G~~v~l~C~v~~~~~P~~~v~W~~~g~~i~~~~~~~~~~~~~~~~L~I~~~~~~D~G~Y~C~a~N 995 (1884)
||.|...+++..+.+|+.+.|.|.+. |.|.|.|+|+|++..+....++.. .++ .|.|.+++.+|+|.|+|.|.|
T Consensus 1 ~p~i~~~~~~~~~~~G~~v~l~C~~~--G~P~P~v~W~k~~~~~~~~~~~~~--~~~--~L~I~~v~~~D~G~Y~C~A~N 74 (88)
T cd05851 1 PADINVKFKDTYALKGQNVTLECFAL--GNPVPVIRWRKILEPMPATAEISM--SGA--VLKIFNIQPEDEGTYECEAEN 74 (88)
T ss_pred CCceEEccccEEEeCCCcEEEEEEec--ccCCCEEEEEECCcCCCCCCEEec--CCC--EEEECcCChhhCEEEEEEEEc
Confidence 68999999999999999999999998 789999999999998877655433 222 699999999999999999999
Q ss_pred CCeeEEEEEEEEEE
Q psy2148 996 KHGEATTSCKLTVK 1009 (1884)
Q Consensus 996 ~~G~~~~~~~l~V~ 1009 (1884)
.+|..+..+.|.|+
T Consensus 75 ~~G~~~~~~~l~V~ 88 (88)
T cd05851 75 IKGKDKHQARVYVQ 88 (88)
T ss_pred CCCceEEEEEEEEC
Confidence 99999999999874
No 20
>PF07679 I-set: Immunoglobulin I-set domain; InterPro: IPR013098 The basic structure of immunoglobulin (Ig) molecules is a tetramer of two light chains and two heavy chains linked by disulphide bonds. There are two types of light chains: kappa and lambda, each composed of a constant domain (CL) and a variable domain (VL). There are five types of heavy chains: alpha, delta, epsilon, gamma and mu, all consisting of a variable domain (VH) and three (in alpha, delta and gamma) or four (in epsilon and mu) constant domains (CH1 to CH4). Ig molecules are highly modular proteins, in which the variable and constant domains have clear, conserved sequence patterns. The domains in Ig and Ig-like molecules are grouped into four types: V-set (variable; IPR013106 from INTERPRO), C1-set (constant-1; IPR003597 from INTERPRO), C2-set (constant-2; IPR008424 from INTERPRO) and I-set (intermediate; IPR013098 from INTERPRO) []. Structural studies have shown that these domains share a common core Greek-key beta-sandwich structure, with the types differing in the number of strands in the beta-sheets as well as in their sequence patterns [, ]. Immunoglobulin-like domains that are related in both sequence and structure can be found in several diverse protein families. Ig-like domains are involved in a variety of functions, including cell-cell recognition, cell-surface receptors, muscle structure and the immune system []. This entry represents I-set domains, which are found in several cell adhesion molecules, including vascular (VCAM), intercellular (ICAM), neural (NCAM) and mucosal addressin (MADCAM) cell adhesion molecules, as well as junction adhesion molecules (JAM). I-set domains are also present in several other diverse protein families, including several tyrosine-protein kinase receptors, the hemolymph protein hemolin, the muscle proteins titin, telokin, and twitchin, the neuronal adhesion molecule axonin-1 [], and the signalling molecule semaphorin 4D that is involved in axonal guidance, immune function and angiogenesis [].; PDB: 3MTR_A 2EDK_A 3DMK_B 1KOA_A 3NCM_A 2NCM_A 2V9Q_A 2CR3_A 3QQN_A 3QR2_A ....
Probab=99.53 E-value=9.5e-14 Score=130.29 Aligned_cols=90 Identities=40% Similarity=0.697 Sum_probs=85.4
Q ss_pred CeeeecCCceeecCCCeEEEEEEEeeCCCCCcEEEEeeCCEEccCCCcEEEEeeCCeEEEEEccCCCCCCeEEEEEEEcC
Q psy2148 917 PEFLTTPTDLTLAESTLAHFECRLTPTNDPSMTVEWFHNGKALSAGSRIKTINDFGFVILEINDVYLRDSGLYTCKATNK 996 (1884)
Q Consensus 917 p~~~~~~~~~~v~~G~~v~l~C~v~~~~~P~~~v~W~~~g~~i~~~~~~~~~~~~~~~~L~I~~~~~~D~G~Y~C~a~N~ 996 (1884)
|.|...+.++.+.+|+++.|.|.+. +.|.+.+.|+++|..|..+.++.+...++.++|.|.++..+|+|.|+|.|.|.
T Consensus 1 P~~~~~~~~~~v~~G~~~~l~c~~~--~~p~~~v~W~~~~~~l~~~~~~~~~~~~~~~~L~I~~v~~~D~G~Y~C~~~n~ 78 (90)
T PF07679_consen 1 PVFTKKPKDVTVKEGESVTLECEVS--GNPPPTVTWYKNGRPLTSSQRYQIESDGGSSSLTIKNVTREDAGTYTCVASNS 78 (90)
T ss_dssp EEEEEESSEEEEETTSEEEEEEEEE--ESSSSEEEEEETTEEEESSSSEEEEEETTEEEEEESSESGGGSEEEEEEEEET
T ss_pred CEEEEecCCEEEeCCCEEEEEEEEE--eCCCCcccccccccceeeeeeeeeecccceeEEccCCCChhhCEEEEEEEEEC
Confidence 7888999999999999999999999 56889999999999999999999998889999999999999999999999999
Q ss_pred CeeEEEEEEEEE
Q psy2148 997 HGEATTSCKLTV 1008 (1884)
Q Consensus 997 ~G~~~~~~~l~V 1008 (1884)
.|..+..+.|.|
T Consensus 79 ~g~~~~~~~l~V 90 (90)
T PF07679_consen 79 SGEATASVNLTV 90 (90)
T ss_dssp TEEEEEEEEEEE
T ss_pred CCEEEEEEEEEC
Confidence 999999999886
No 21
>cd05747 Ig5_Titin_like M5, fifth immunoglobulin (Ig)-like domain of human titin C terminus and similar proteins. Ig5_Titin_like: domain similar to the M5, fifth immunoglobulin (Ig)-like domain from the human titin C terminus. Titin (also called connectin) is a fibrous sarcomeric protein specifically found in vertebrate striated muscle. Titin is gigantic; depending on isoform composition it ranges from 2970 to 3700 kDa, and is of a length that spans half a sarcomere. Titin largely consists of multiple repeats of Ig-like and fibronectin type 3 (FN-III)-like domains. Titin connects the ends of myosin thick filaments to Z disks and extends along the thick filament to the H zone, and appears to function similar to an elastic band, keeping the myosin filaments centered in the sarcomere during muscle contraction or stretching.
Probab=99.53 E-value=8e-14 Score=130.24 Aligned_cols=91 Identities=29% Similarity=0.489 Sum_probs=83.0
Q ss_pred CCCeeeecCCceeecCCCeEEEEEEEeeCCCCCcEEEEeeCCEEccCCCcEEEEeeCCeEEEEEccCCCCCCeEEEEEEE
Q psy2148 915 KAPEFLTTPTDLTLAESTLAHFECRLTPTNDPSMTVEWFHNGKALSAGSRIKTINDFGFVILEINDVYLRDSGLYTCKAT 994 (1884)
Q Consensus 915 ~~p~~~~~~~~~~v~~G~~v~l~C~v~~~~~P~~~v~W~~~g~~i~~~~~~~~~~~~~~~~L~I~~~~~~D~G~Y~C~a~ 994 (1884)
.||+|+..+++..+.+|+.+.|.|.+. +.|.|.+.|+|+|..+..+.++.+......+.|.|.++..+|+|.|+|.|+
T Consensus 2 ~~~~~~~~p~~~~~~~G~~~~L~C~~~--g~P~p~v~W~k~g~~l~~~~~~~~~~~~~~~~L~i~~~~~~D~G~Y~C~a~ 79 (92)
T cd05747 2 LPATILTKPRSLTVSEGESARFSCDVD--GEPAPTVTWMREGQIIVSSQRHQITSTEYKSTFEISKVQMSDEGNYTVVVE 79 (92)
T ss_pred CCCcccccCccEEEeCCCcEEEEEEEe--ecCCCEEEEEECCEECCCCCcEEEEEcCCeeEEEECCCCcccCEeEEEEEE
Confidence 479999999999999999999999998 788899999999999988888887766666789999999999999999999
Q ss_pred cCCeeEEEEEEEE
Q psy2148 995 NKHGEATTSCKLT 1007 (1884)
Q Consensus 995 N~~G~~~~~~~l~ 1007 (1884)
|.+|..+.++.|+
T Consensus 80 N~~G~~~~~~~l~ 92 (92)
T cd05747 80 NSEGKQEAQFTLT 92 (92)
T ss_pred cCCCCEeEEEEeC
Confidence 9999999888774
No 22
>cd05851 Ig3_Contactin-1 Third Ig domain of contactin-1. Ig3_Contactin-1: Third Ig domain of the neural cell adhesion molecule contactin-1. Contactins are comprised of six Ig domains followed by four fibronectin type III (FnIII) domains anchored to the membrane by glycosylphosphatidylinositol. Contactin-1 is differentially expressed in tumor tissues and may through a RhoA mechanism, facilitate invasion and metastasis of human lung adenocarcinoma.
Probab=99.53 E-value=5.9e-14 Score=129.05 Aligned_cols=88 Identities=22% Similarity=0.270 Sum_probs=78.3
Q ss_pred CCeEEeccCceEEcCCceEEEEEEEecCCCcEEEEEeCCEecCCCCCeEEeecCCeEEEEEccCCCCCCEEEEEEEEeCC
Q psy2148 1742 PPSFLTTISSAVINVGQLARFDAKISATKPLDVYWLKNGKKIIPDIRYKTLEEDNLFTLLIIEAVVEDSGAYECVAMNNA 1821 (1884)
Q Consensus 1742 ~P~~~~~~~~~~~~~G~~~~l~C~~~g~p~p~v~W~k~~~~l~~~~~~~~~~~~~~~~L~i~~~~~~d~G~Y~C~a~N~~ 1821 (1884)
||.|...+.+..+.+|+.++|.|.+.|.|.|.|+|+|++..+....++.. .+. .|.|.++..+|+|.|+|.|.|..
T Consensus 1 ~p~i~~~~~~~~~~~G~~v~l~C~~~G~P~P~v~W~k~~~~~~~~~~~~~--~~~--~L~I~~v~~~D~G~Y~C~A~N~~ 76 (88)
T cd05851 1 PADINVKFKDTYALKGQNVTLECFALGNPVPVIRWRKILEPMPATAEISM--SGA--VLKIFNIQPEDEGTYECEAENIK 76 (88)
T ss_pred CCceEEccccEEEeCCCcEEEEEEecccCCCEEEEEECCcCCCCCCEEec--CCC--EEEECcCChhhCEEEEEEEEcCC
Confidence 58899999999999999999999999999999999999998866544432 332 89999999999999999999999
Q ss_pred eeEEEEEEEEEE
Q psy2148 1822 GEARCEAELVVQ 1833 (1884)
Q Consensus 1822 G~~~~~~~l~V~ 1833 (1884)
|....++.|.|+
T Consensus 77 G~~~~~~~l~V~ 88 (88)
T cd05851 77 GKDKHQARVYVQ 88 (88)
T ss_pred CceEEEEEEEEC
Confidence 999999999884
No 23
>cd05747 Ig5_Titin_like M5, fifth immunoglobulin (Ig)-like domain of human titin C terminus and similar proteins. Ig5_Titin_like: domain similar to the M5, fifth immunoglobulin (Ig)-like domain from the human titin C terminus. Titin (also called connectin) is a fibrous sarcomeric protein specifically found in vertebrate striated muscle. Titin is gigantic; depending on isoform composition it ranges from 2970 to 3700 kDa, and is of a length that spans half a sarcomere. Titin largely consists of multiple repeats of Ig-like and fibronectin type 3 (FN-III)-like domains. Titin connects the ends of myosin thick filaments to Z disks and extends along the thick filament to the H zone, and appears to function similar to an elastic band, keeping the myosin filaments centered in the sarcomere during muscle contraction or stretching.
Probab=99.51 E-value=1.5e-13 Score=128.44 Aligned_cols=91 Identities=24% Similarity=0.432 Sum_probs=84.2
Q ss_pred CCCeEEeccCceEEcCCceEEEEEEEecCCCcEEEEEeCCEecCCCCCeEEeecCCeEEEEEccCCCCCCEEEEEEEEeC
Q psy2148 1741 VPPSFLTTISSAVINVGQLARFDAKISATKPLDVYWLKNGKKIIPDIRYKTLEEDNLFTLLIIEAVVEDSGAYECVAMNN 1820 (1884)
Q Consensus 1741 ~~P~~~~~~~~~~~~~G~~~~l~C~~~g~p~p~v~W~k~~~~l~~~~~~~~~~~~~~~~L~i~~~~~~d~G~Y~C~a~N~ 1820 (1884)
.||.|...|.+..+.+|+.+.|.|.+.|.|.|.+.|+|+|..+..+.++.+........|.|.++..+|+|.|+|.|.|.
T Consensus 2 ~~~~~~~~p~~~~~~~G~~~~L~C~~~g~P~p~v~W~k~g~~l~~~~~~~~~~~~~~~~L~i~~~~~~D~G~Y~C~a~N~ 81 (92)
T cd05747 2 LPATILTKPRSLTVSEGESARFSCDVDGEPAPTVTWMREGQIIVSSQRHQITSTEYKSTFEISKVQMSDEGNYTVVVENS 81 (92)
T ss_pred CCCcccccCccEEEeCCCcEEEEEEEeecCCCEEEEEECCEECCCCCcEEEEEcCCeeEEEECCCCcccCEeEEEEEEcC
Confidence 47899999999999999999999999999999999999999998888888877666789999999999999999999999
Q ss_pred CeeEEEEEEEE
Q psy2148 1821 AGEARCEAELV 1831 (1884)
Q Consensus 1821 ~G~~~~~~~l~ 1831 (1884)
.|..+.++.|+
T Consensus 82 ~G~~~~~~~l~ 92 (92)
T cd05747 82 EGKQEAQFTLT 92 (92)
T ss_pred CCCEeEEEEeC
Confidence 99999888874
No 24
>cd05894 Ig_C5_MyBP-C C5 immunoglobulin (Ig) domain of cardiac myosin binding protein C (MyBP-C). Ig_C5_MyBP_C : the C5 immunoglobulin (Ig) domain of cardiac myosin binding protein C (MyBP-C). MyBP_C consists of repeated domains, Ig and fibronectin type 3, and various linkers. Three isoforms of MYBP_C exist and are included in this group: cardiac(c), and fast and slow skeletal muscle (s) MyBP_C. cMYBP_C has insertions between and inside domains and an additional cardiac-specific Ig domain at the N-terminus. For cMYBP_C an interaction has been demonstrated between this C5 domain and the Ig C8 domain.
Probab=99.50 E-value=2.2e-13 Score=124.29 Aligned_cols=83 Identities=22% Similarity=0.361 Sum_probs=73.4
Q ss_pred CceeecCCCeEEEEEEEeeCCCCCcEEEEeeCCEEccCC-CcEEEEeeCCeEEEEEccCCCCCCeEEEEEEEcCCeeEEE
Q psy2148 924 TDLTLAESTLAHFECRLTPTNDPSMTVEWFHNGKALSAG-SRIKTINDFGFVILEINDVYLRDSGLYTCKATNKHGEATT 1002 (1884)
Q Consensus 924 ~~~~v~~G~~v~l~C~v~~~~~P~~~v~W~~~g~~i~~~-~~~~~~~~~~~~~L~I~~~~~~D~G~Y~C~a~N~~G~~~~ 1002 (1884)
..+.+.+|+.+.|.|.+. |.|.|.|+|+|+|.++... .++.+......+.|.|.++..+|+|.|+|.|.|..|+++.
T Consensus 3 ~~~~v~~G~~v~l~c~~~--G~P~P~v~W~k~~~~i~~~~~r~~~~~~~~~~~L~I~~~~~~D~G~Y~c~a~N~~G~~~~ 80 (86)
T cd05894 3 NTIVVVAGNKLRLDVPIS--GEPAPTVTWSRGDKAFTETEGRVRVESYKDLSSFVIEGAEREDEGVYTITVTNPVGEDHA 80 (86)
T ss_pred CEEEEEcCCEEEEEeeEe--ecCCCeEEEEECCEECccCCCeEEEEEcCCeEEEEECCCccCcCEEEEEEEEeCCCcEEE
Confidence 356889999999999998 7899999999999999754 4777766666778999999999999999999999999999
Q ss_pred EEEEEE
Q psy2148 1003 SCKLTV 1008 (1884)
Q Consensus 1003 ~~~l~V 1008 (1884)
++.|.|
T Consensus 81 ~~~l~V 86 (86)
T cd05894 81 SLFVKV 86 (86)
T ss_pred EEEEEC
Confidence 988875
No 25
>PF07679 I-set: Immunoglobulin I-set domain; InterPro: IPR013098 The basic structure of immunoglobulin (Ig) molecules is a tetramer of two light chains and two heavy chains linked by disulphide bonds. There are two types of light chains: kappa and lambda, each composed of a constant domain (CL) and a variable domain (VL). There are five types of heavy chains: alpha, delta, epsilon, gamma and mu, all consisting of a variable domain (VH) and three (in alpha, delta and gamma) or four (in epsilon and mu) constant domains (CH1 to CH4). Ig molecules are highly modular proteins, in which the variable and constant domains have clear, conserved sequence patterns. The domains in Ig and Ig-like molecules are grouped into four types: V-set (variable; IPR013106 from INTERPRO), C1-set (constant-1; IPR003597 from INTERPRO), C2-set (constant-2; IPR008424 from INTERPRO) and I-set (intermediate; IPR013098 from INTERPRO) []. Structural studies have shown that these domains share a common core Greek-key beta-sandwich structure, with the types differing in the number of strands in the beta-sheets as well as in their sequence patterns [, ]. Immunoglobulin-like domains that are related in both sequence and structure can be found in several diverse protein families. Ig-like domains are involved in a variety of functions, including cell-cell recognition, cell-surface receptors, muscle structure and the immune system []. This entry represents I-set domains, which are found in several cell adhesion molecules, including vascular (VCAM), intercellular (ICAM), neural (NCAM) and mucosal addressin (MADCAM) cell adhesion molecules, as well as junction adhesion molecules (JAM). I-set domains are also present in several other diverse protein families, including several tyrosine-protein kinase receptors, the hemolymph protein hemolin, the muscle proteins titin, telokin, and twitchin, the neuronal adhesion molecule axonin-1 [], and the signalling molecule semaphorin 4D that is involved in axonal guidance, immune function and angiogenesis [].; PDB: 3MTR_A 2EDK_A 3DMK_B 1KOA_A 3NCM_A 2NCM_A 2V9Q_A 2CR3_A 3QQN_A 3QR2_A ....
Probab=99.49 E-value=2.8e-13 Score=127.09 Aligned_cols=90 Identities=30% Similarity=0.558 Sum_probs=86.3
Q ss_pred CeEEeccCceEEcCCceEEEEEEEecCCCcEEEEEeCCEecCCCCCeEEeecCCeEEEEEccCCCCCCEEEEEEEEeCCe
Q psy2148 1743 PSFLTTISSAVINVGQLARFDAKISATKPLDVYWLKNGKKIIPDIRYKTLEEDNLFTLLIIEAVVEDSGAYECVAMNNAG 1822 (1884)
Q Consensus 1743 P~~~~~~~~~~~~~G~~~~l~C~~~g~p~p~v~W~k~~~~l~~~~~~~~~~~~~~~~L~i~~~~~~d~G~Y~C~a~N~~G 1822 (1884)
|.|...+.+..+.+|++++|.|.+.|.|.|.+.|+++|..+..+.++.+...+..+.|.|.++..+|+|.|+|.|.|..|
T Consensus 1 P~~~~~~~~~~v~~G~~~~l~c~~~~~p~~~v~W~~~~~~l~~~~~~~~~~~~~~~~L~I~~v~~~D~G~Y~C~~~n~~g 80 (90)
T PF07679_consen 1 PVFTKKPKDVTVKEGESVTLECEVSGNPPPTVTWYKNGRPLTSSQRYQIESDGGSSSLTIKNVTREDAGTYTCVASNSSG 80 (90)
T ss_dssp EEEEEESSEEEEETTSEEEEEEEEEESSSSEEEEEETTEEEESSSSEEEEEETTEEEEEESSESGGGSEEEEEEEEETTE
T ss_pred CEEEEecCCEEEeCCCEEEEEEEEEeCCCCcccccccccceeeeeeeeeecccceeEEccCCCChhhCEEEEEEEEECCC
Confidence 67888899999999999999999999999999999999999999999998888999999999999999999999999999
Q ss_pred eEEEEEEEEE
Q psy2148 1823 EARCEAELVV 1832 (1884)
Q Consensus 1823 ~~~~~~~l~V 1832 (1884)
..++++.|.|
T Consensus 81 ~~~~~~~l~V 90 (90)
T PF07679_consen 81 EATASVNLTV 90 (90)
T ss_dssp EEEEEEEEEE
T ss_pred EEEEEEEEEC
Confidence 9999999987
No 26
>cd05894 Ig_C5_MyBP-C C5 immunoglobulin (Ig) domain of cardiac myosin binding protein C (MyBP-C). Ig_C5_MyBP_C : the C5 immunoglobulin (Ig) domain of cardiac myosin binding protein C (MyBP-C). MyBP_C consists of repeated domains, Ig and fibronectin type 3, and various linkers. Three isoforms of MYBP_C exist and are included in this group: cardiac(c), and fast and slow skeletal muscle (s) MyBP_C. cMYBP_C has insertions between and inside domains and an additional cardiac-specific Ig domain at the N-terminus. For cMYBP_C an interaction has been demonstrated between this C5 domain and the Ig C8 domain.
Probab=99.49 E-value=3e-13 Score=123.43 Aligned_cols=82 Identities=26% Similarity=0.335 Sum_probs=74.2
Q ss_pred ceEEcCCceEEEEEEEecCCCcEEEEEeCCEecCCC-CCeEEeecCCeEEEEEccCCCCCCEEEEEEEEeCCeeEEEEEE
Q psy2148 1751 SAVINVGQLARFDAKISATKPLDVYWLKNGKKIIPD-IRYKTLEEDNLFTLLIIEAVVEDSGAYECVAMNNAGEARCEAE 1829 (1884)
Q Consensus 1751 ~~~~~~G~~~~l~C~~~g~p~p~v~W~k~~~~l~~~-~~~~~~~~~~~~~L~i~~~~~~d~G~Y~C~a~N~~G~~~~~~~ 1829 (1884)
...+.+|+.+.|.|.+.|.|.|.+.|+|+++++... .++.+......+.|.|.++.++|+|.|+|.|.|..|..+++++
T Consensus 4 ~~~v~~G~~v~l~c~~~G~P~P~v~W~k~~~~i~~~~~r~~~~~~~~~~~L~I~~~~~~D~G~Y~c~a~N~~G~~~~~~~ 83 (86)
T cd05894 4 TIVVVAGNKLRLDVPISGEPAPTVTWSRGDKAFTETEGRVRVESYKDLSSFVIEGAEREDEGVYTITVTNPVGEDHASLF 83 (86)
T ss_pred EEEEEcCCEEEEEeeEeecCCCeEEEEECCEECccCCCeEEEEEcCCeEEEEECCCccCcCEEEEEEEEeCCCcEEEEEE
Confidence 467789999999999999999999999999999764 4777776666789999999999999999999999999999999
Q ss_pred EEE
Q psy2148 1830 LVV 1832 (1884)
Q Consensus 1830 l~V 1832 (1884)
|.|
T Consensus 84 l~V 86 (86)
T cd05894 84 VKV 86 (86)
T ss_pred EEC
Confidence 876
No 27
>cd05892 Ig_Myotilin_C C-terminal immunoglobulin (Ig)-like domain of myotilin. Ig_Myotilin_C: C-terminal immunoglobulin (Ig)-like domain of myotilin. Mytolin belongs to the palladin-myotilin-myopalladin family. Proteins belonging to the latter family contain multiple Ig-like domains and function as scaffolds, modulating actin cytoskeleton. Myotilin is most abundant in skeletal and cardiac muscle, and is involved in maintaining sarcomere integrity. It binds to alpha-actinin, filamin and actin. Mutations in myotilin lead to muscle disorders.
Probab=99.48 E-value=1.8e-13 Score=120.15 Aligned_cols=73 Identities=33% Similarity=0.523 Sum_probs=63.9
Q ss_pred EEEEEEEeeCCCCCcEEEEeeCCEEccC-CCcEEEEee-CCeEEEEEccCCCCCCeEEEEEEEcCCeeEEEEEEEEE
Q psy2148 934 AHFECRLTPTNDPSMTVEWFHNGKALSA-GSRIKTIND-FGFVILEINDVYLRDSGLYTCKATNKHGEATTSCKLTV 1008 (1884)
Q Consensus 934 v~l~C~v~~~~~P~~~v~W~~~g~~i~~-~~~~~~~~~-~~~~~L~I~~~~~~D~G~Y~C~a~N~~G~~~~~~~l~V 1008 (1884)
|.|+|.+. |.|.|.|+|+|+|..|.. +.++.+..+ ++.++|.|.++..+|+|.|+|.|.|.+|+.++.+.|.|
T Consensus 1 v~l~C~v~--G~P~P~i~W~k~~~~i~~~~~r~~~~~~~~g~~~L~I~~~~~~D~G~Y~C~A~N~~G~~~~~a~L~V 75 (75)
T cd05892 1 VKLECQIS--AIPPPKIFWKRNNEMVQYNTDRISLYQDNSGRVTLLIKNVNKKDAGWYTVSAVNEAGVATCHARLDV 75 (75)
T ss_pred CEEEEEEE--ecCCCeEEEEECCEECcCCCCeEEEEEcCCCcEEEEECCCChhhCEEEEEEEEcCcCeEEEEEEEeC
Confidence 57999998 789999999999999974 467776544 45568999999999999999999999999999999876
No 28
>cd05737 Ig_Myomesin_like_C C-temrinal immunoglobulin (Ig)-like domain of myomesin and M-protein. Ig_Myomesin_like_C: domain similar to the C-temrinal immunoglobulin (Ig)-like domain of myomesin and M-protein. Myomesin and M-protein are both structural proteins localized to the M-band, a transverse structure in the center of the sarcomere, and are candidates for M-band bridges. Both proteins are modular, consisting mainly of repetitive Ig-like and fibronectin type III (FnIII) domains. Myomesin is expressed in all types of vertebrate striated muscle; M-protein has a muscle-type specific expression pattern. Myomesin is present in both slow and fast fibers; M-protein is present only in fast fibers. It has been suggested that myomesin acts as a molecular spring with alternative splicing as a means of modifying its elasticity.
Probab=99.48 E-value=3.8e-13 Score=125.52 Aligned_cols=86 Identities=23% Similarity=0.302 Sum_probs=76.3
Q ss_pred eccCceEEcCCceEEEEEEEecCCCcEEEEEeCCEecCCCCCeEEeec-CCeEEEEEccCCCCCCEEEEEEEEeCCeeEE
Q psy2148 1747 TTISSAVINVGQLARFDAKISATKPLDVYWLKNGKKIIPDIRYKTLEE-DNLFTLLIIEAVVEDSGAYECVAMNNAGEAR 1825 (1884)
Q Consensus 1747 ~~~~~~~~~~G~~~~l~C~~~g~p~p~v~W~k~~~~l~~~~~~~~~~~-~~~~~L~i~~~~~~d~G~Y~C~a~N~~G~~~ 1825 (1884)
..|....+.+|++++|.|.+.|.|.|.|.|+|++.++..+.++.+... +....|.|.++..+|+|.|+|.|.|..|..+
T Consensus 6 ~lp~~v~v~~G~~v~L~C~v~G~P~p~v~W~k~g~~l~~~~~~~~~~~~~~~~~L~I~~v~~~D~G~Y~C~a~N~~G~~~ 85 (92)
T cd05737 6 GLPDVVTIMEGKTLNLTCTVFGDPDPEVSWLKNDQALALSDHYNVKVEQGKYASLTIKGVSSEDSGKYGIVVKNKYGGET 85 (92)
T ss_pred cCCceEEEeCCCcEEEEEEEEecCCCeEEEEECCEECccCCCEEEEEcCCCEEEEEEccCChhhCEEEEEEEEECCCcce
Confidence 345567889999999999999999999999999999988888777644 4467899999999999999999999999999
Q ss_pred EEEEEEE
Q psy2148 1826 CEAELVV 1832 (1884)
Q Consensus 1826 ~~~~l~V 1832 (1884)
..+.|.|
T Consensus 86 ~~~~v~v 92 (92)
T cd05737 86 VDVTVSV 92 (92)
T ss_pred EEEEEeC
Confidence 9988875
No 29
>cd04975 Ig4_SCFR_like Fourth immunoglobulin (Ig)-like domain of stem cell factor receptor (SCFR) and similar proteins. Ig4_SCFR_like; fourth immunoglobulin (Ig)-like domain of stem cell factor receptor (SCFR). In addition to SCFR this group also includes the fourth Ig domain of platelet-derived growth factor receptors (PDGFR), alpha and beta, the fourth Ig domain of macrophage colony stimulating factor (M-CSF), and the Ig domain of the receptor tyrosine kinase KIT. SCFR and the PDGFR alpha and beta have similar organization: an extracellular component having five Ig-like domains, a transmembrane segment, and a cytoplasmic portion having protein tyrosine kinase activity. SCFR and its ligand SCF are critical for normal hematopoiesis, mast cell development, melanocytes and gametogenesis. SCF binds to the second and third Ig-like domains of SCFR, this fourth Ig-like domain participates in SCFR dimerization, which follows ligand binding. Deletion of this fourth SCFR_Ig-like domain abolishes
Probab=99.47 E-value=3e-13 Score=126.61 Aligned_cols=84 Identities=14% Similarity=0.201 Sum_probs=72.4
Q ss_pred CceeecCCCeEEEEEEEeeCC-CCCcEEEEeeCCEEccCCCcEEEEeeC-----CeEEEEEccCCCCCCeEEEEEEEcCC
Q psy2148 924 TDLTLAESTLAHFECRLTPTN-DPSMTVEWFHNGKALSAGSRIKTINDF-----GFVILEINDVYLRDSGLYTCKATNKH 997 (1884)
Q Consensus 924 ~~~~v~~G~~v~l~C~v~~~~-~P~~~v~W~~~g~~i~~~~~~~~~~~~-----~~~~L~I~~~~~~D~G~Y~C~a~N~~ 997 (1884)
..+.+.+|++++|+|.+. | .|+|.|+|+|||.+|....+..+...+ ....|.|.++..+|+|.|+|.|+|..
T Consensus 11 ~~~~v~~G~~v~L~c~v~--g~~P~p~v~W~Kdg~~i~~~~~~~~~~~~~~~~~~~~~L~i~~v~~~D~G~Ytc~A~N~~ 88 (101)
T cd04975 11 TTIFVNLGENLNLVVEVE--AYPPPPHINWTYDNRTLTNKLTEIVTSENESEYRYVSELKLVRLKESEAGTYTFLASNSD 88 (101)
T ss_pred ceEEEECCCCEEEEEEEE--ecCCCCccEEEeCCeeCCCCcceeEEEeccCcceEEEEEEEeecCHhhCeeEEEEEECCC
Confidence 467899999999999999 6 788999999999999876554443331 23579999999999999999999999
Q ss_pred eeEEEEEEEEEE
Q psy2148 998 GEATTSCKLTVK 1009 (1884)
Q Consensus 998 G~~~~~~~l~V~ 1009 (1884)
|..+..+.|.|.
T Consensus 89 G~~~~t~~L~V~ 100 (101)
T cd04975 89 ASKSLTFELYVN 100 (101)
T ss_pred ccEEEEEEEEEE
Confidence 999999999986
No 30
>cd05737 Ig_Myomesin_like_C C-temrinal immunoglobulin (Ig)-like domain of myomesin and M-protein. Ig_Myomesin_like_C: domain similar to the C-temrinal immunoglobulin (Ig)-like domain of myomesin and M-protein. Myomesin and M-protein are both structural proteins localized to the M-band, a transverse structure in the center of the sarcomere, and are candidates for M-band bridges. Both proteins are modular, consisting mainly of repetitive Ig-like and fibronectin type III (FnIII) domains. Myomesin is expressed in all types of vertebrate striated muscle; M-protein has a muscle-type specific expression pattern. Myomesin is present in both slow and fast fibers; M-protein is present only in fast fibers. It has been suggested that myomesin acts as a molecular spring with alternative splicing as a means of modifying its elasticity.
Probab=99.47 E-value=3.7e-13 Score=125.61 Aligned_cols=84 Identities=27% Similarity=0.442 Sum_probs=74.0
Q ss_pred CCceeecCCCeEEEEEEEeeCCCCCcEEEEeeCCEEccCCCcEEEEee-CCeEEEEEccCCCCCCeEEEEEEEcCCeeEE
Q psy2148 923 PTDLTLAESTLAHFECRLTPTNDPSMTVEWFHNGKALSAGSRIKTIND-FGFVILEINDVYLRDSGLYTCKATNKHGEAT 1001 (1884)
Q Consensus 923 ~~~~~v~~G~~v~l~C~v~~~~~P~~~v~W~~~g~~i~~~~~~~~~~~-~~~~~L~I~~~~~~D~G~Y~C~a~N~~G~~~ 1001 (1884)
+..+++.+|+++.|.|.+. |.|.|.|.|+|+|.++....++.+... +..+.|.|.+++.+|+|.|+|.|+|..|..+
T Consensus 8 p~~v~v~~G~~v~L~C~v~--G~P~p~v~W~k~g~~l~~~~~~~~~~~~~~~~~L~I~~v~~~D~G~Y~C~a~N~~G~~~ 85 (92)
T cd05737 8 PDVVTIMEGKTLNLTCTVF--GDPDPEVSWLKNDQALALSDHYNVKVEQGKYASLTIKGVSSEDSGKYGIVVKNKYGGET 85 (92)
T ss_pred CceEEEeCCCcEEEEEEEE--ecCCCeEEEEECCEECccCCCEEEEEcCCCEEEEEEccCChhhCEEEEEEEEECCCcce
Confidence 3457899999999999998 778899999999999988888777644 4456899999999999999999999999999
Q ss_pred EEEEEEE
Q psy2148 1002 TSCKLTV 1008 (1884)
Q Consensus 1002 ~~~~l~V 1008 (1884)
..+.|.|
T Consensus 86 ~~~~v~v 92 (92)
T cd05737 86 VDVTVSV 92 (92)
T ss_pred EEEEEeC
Confidence 9888875
No 31
>cd05892 Ig_Myotilin_C C-terminal immunoglobulin (Ig)-like domain of myotilin. Ig_Myotilin_C: C-terminal immunoglobulin (Ig)-like domain of myotilin. Mytolin belongs to the palladin-myotilin-myopalladin family. Proteins belonging to the latter family contain multiple Ig-like domains and function as scaffolds, modulating actin cytoskeleton. Myotilin is most abundant in skeletal and cardiac muscle, and is involved in maintaining sarcomere integrity. It binds to alpha-actinin, filamin and actin. Mutations in myotilin lead to muscle disorders.
Probab=99.47 E-value=2.4e-13 Score=119.38 Aligned_cols=73 Identities=32% Similarity=0.519 Sum_probs=64.5
Q ss_pred EEEEEEEecCCCcEEEEEeCCEecCC-CCCeEEeec-CCeEEEEEccCCCCCCEEEEEEEEeCCeeEEEEEEEEE
Q psy2148 1760 ARFDAKISATKPLDVYWLKNGKKIIP-DIRYKTLEE-DNLFTLLIIEAVVEDSGAYECVAMNNAGEARCEAELVV 1832 (1884)
Q Consensus 1760 ~~l~C~~~g~p~p~v~W~k~~~~l~~-~~~~~~~~~-~~~~~L~i~~~~~~d~G~Y~C~a~N~~G~~~~~~~l~V 1832 (1884)
++|.|.+.|.|.|.|.|+|+|..|.. +.++.+..+ .+..+|.|.++..+|+|.|+|.|.|.+|.+++++.|.|
T Consensus 1 v~l~C~v~G~P~P~i~W~k~~~~i~~~~~r~~~~~~~~g~~~L~I~~~~~~D~G~Y~C~A~N~~G~~~~~a~L~V 75 (75)
T cd05892 1 VKLECQISAIPPPKIFWKRNNEMVQYNTDRISLYQDNSGRVTLLIKNVNKKDAGWYTVSAVNEAGVATCHARLDV 75 (75)
T ss_pred CEEEEEEEecCCCeEEEEECCEECcCCCCeEEEEEcCCCcEEEEECCCChhhCEEEEEEEEcCcCeEEEEEEEeC
Confidence 57999999999999999999999974 467777554 34468999999999999999999999999999999986
No 32
>cd05852 Ig5_Contactin-1 Fifth Ig domain of contactin-1. Ig5_Contactin-1: fifth Ig domain of the neural cell adhesion molecule contactin-1. Contactins are comprised of six Ig domains followed by four fibronectin type III (FnIII) domains anchored to the membrane by glycosylphosphatidylinositol. Contactin-1 is differentially expressed in tumor tissues and may through a RhoA mechanism, facilitate invasion and metastasis of human lung adenocarcinoma.
Probab=99.47 E-value=2.1e-13 Score=119.56 Aligned_cols=73 Identities=26% Similarity=0.419 Sum_probs=67.6
Q ss_pred CceEEEEEEEecCCCcEEEEEeCCEecCCCCCeEEeecCCeEEEEEccCCCCCCEEEEEEEEeCCeeEEEEEEEEE
Q psy2148 1757 GQLARFDAKISATKPLDVYWLKNGKKIIPDIRYKTLEEDNLFTLLIIEAVVEDSGAYECVAMNNAGEARCEAELVV 1832 (1884)
Q Consensus 1757 G~~~~l~C~~~g~p~p~v~W~k~~~~l~~~~~~~~~~~~~~~~L~i~~~~~~d~G~Y~C~a~N~~G~~~~~~~l~V 1832 (1884)
|+++.|.|.+.|.|.|+|+|+|++..+..+.++.+..++ +|.|.++..+|+|.|+|.|.|..|++..++.|+|
T Consensus 1 G~~~~l~C~~~g~P~p~v~W~k~~~~l~~~~r~~~~~~g---~L~I~~v~~~D~G~Y~C~A~N~~G~~~~~~~l~~ 73 (73)
T cd05852 1 GGRVIIECKPKAAPKPKFSWSKGTELLVNNSRISIWDDG---SLEILNITKLDEGSYTCFAENNRGKANSTGVLSV 73 (73)
T ss_pred CCeEEEEEecceeCCCEEEEEeCCEecccCCCEEEcCCC---EEEECcCChhHCEEEEEEEECCCCceeEEEEEEC
Confidence 788999999999999999999999998888888876655 7999999999999999999999999999999976
No 33
>cd05745 Ig3_Peroxidasin Third immunoglobulin (Ig)-like domain of peroxidasin. Ig3_Peroxidasin: the third immunoglobulin (Ig)-like domain in peroxidasin. Peroxidasin has a peroxidase domain and interacting extracellular motifs containing four Ig-like domains. It has been suggested that peroxidasin is secreted and has functions related to the stabilization of the extracellular matrix. It may play a part in various other important processes such as removal and destruction of cells which have undergone programmed cell death, and protection of the organism against non-self.
Probab=99.45 E-value=3.3e-13 Score=119.98 Aligned_cols=74 Identities=32% Similarity=0.461 Sum_probs=67.0
Q ss_pred CCceEEEEEEEecCCCcEEEEEeCCEecCCCCCeEEeecCCeEEEEEccCCCCCCEEEEEEEEeCCeeEEEEEEEEE
Q psy2148 1756 VGQLARFDAKISATKPLDVYWLKNGKKIIPDIRYKTLEEDNLFTLLIIEAVVEDSGAYECVAMNNAGEARCEAELVV 1832 (1884)
Q Consensus 1756 ~G~~~~l~C~~~g~p~p~v~W~k~~~~l~~~~~~~~~~~~~~~~L~i~~~~~~d~G~Y~C~a~N~~G~~~~~~~l~V 1832 (1884)
+|+++.|.|.+.|.|.|.|+|+|++..+....++.+...+ .|.|.++..+|+|.|+|.|.|..|+.+.+++|.|
T Consensus 1 eG~~v~l~C~~~g~P~p~i~W~k~g~~~~~~~~~~~~~~~---~L~I~~v~~~D~G~Y~C~A~N~~G~~~~~~~L~V 74 (74)
T cd05745 1 EGQTVDFLCEAQGYPQPVIAWTKGGSQLSVDRRHLVLSSG---TLRISRVALHDQGQYECQAVNIVGSQRTVAQLTV 74 (74)
T ss_pred CCCeEEEEeECCEecCCEEEEEECCEECCCCCCeEEccCC---eEEEeeCCHHhCEEEEEEEEeCCCceeEEEEEeC
Confidence 5899999999999999999999999999877666654443 8999999999999999999999999999999986
No 34
>cd05852 Ig5_Contactin-1 Fifth Ig domain of contactin-1. Ig5_Contactin-1: fifth Ig domain of the neural cell adhesion molecule contactin-1. Contactins are comprised of six Ig domains followed by four fibronectin type III (FnIII) domains anchored to the membrane by glycosylphosphatidylinositol. Contactin-1 is differentially expressed in tumor tissues and may through a RhoA mechanism, facilitate invasion and metastasis of human lung adenocarcinoma.
Probab=99.45 E-value=3.7e-13 Score=118.00 Aligned_cols=73 Identities=32% Similarity=0.465 Sum_probs=66.1
Q ss_pred CCeEEEEEEEeeCCCCCcEEEEeeCCEEccCCCcEEEEeeCCeEEEEEccCCCCCCeEEEEEEEcCCeeEEEEEEEEE
Q psy2148 931 STLAHFECRLTPTNDPSMTVEWFHNGKALSAGSRIKTINDFGFVILEINDVYLRDSGLYTCKATNKHGEATTSCKLTV 1008 (1884)
Q Consensus 931 G~~v~l~C~v~~~~~P~~~v~W~~~g~~i~~~~~~~~~~~~~~~~L~I~~~~~~D~G~Y~C~a~N~~G~~~~~~~l~V 1008 (1884)
|+.+.|.|.+. |.|.|.|+|+|++..+..+.++.+..++ .|.|.+++.+|+|.|+|.|+|..|+.+.++.|+|
T Consensus 1 G~~~~l~C~~~--g~P~p~v~W~k~~~~l~~~~r~~~~~~g---~L~I~~v~~~D~G~Y~C~A~N~~G~~~~~~~l~~ 73 (73)
T cd05852 1 GGRVIIECKPK--AAPKPKFSWSKGTELLVNNSRISIWDDG---SLEILNITKLDEGSYTCFAENNRGKANSTGVLSV 73 (73)
T ss_pred CCeEEEEEecc--eeCCCEEEEEeCCEecccCCCEEEcCCC---EEEECcCChhHCEEEEEEEECCCCceeEEEEEEC
Confidence 78999999998 6788999999999999888888775543 6999999999999999999999999999999875
No 35
>cd04975 Ig4_SCFR_like Fourth immunoglobulin (Ig)-like domain of stem cell factor receptor (SCFR) and similar proteins. Ig4_SCFR_like; fourth immunoglobulin (Ig)-like domain of stem cell factor receptor (SCFR). In addition to SCFR this group also includes the fourth Ig domain of platelet-derived growth factor receptors (PDGFR), alpha and beta, the fourth Ig domain of macrophage colony stimulating factor (M-CSF), and the Ig domain of the receptor tyrosine kinase KIT. SCFR and the PDGFR alpha and beta have similar organization: an extracellular component having five Ig-like domains, a transmembrane segment, and a cytoplasmic portion having protein tyrosine kinase activity. SCFR and its ligand SCF are critical for normal hematopoiesis, mast cell development, melanocytes and gametogenesis. SCF binds to the second and third Ig-like domains of SCFR, this fourth Ig-like domain participates in SCFR dimerization, which follows ligand binding. Deletion of this fourth SCFR_Ig-like domain abolishes
Probab=99.44 E-value=6.8e-13 Score=124.19 Aligned_cols=84 Identities=17% Similarity=0.326 Sum_probs=72.7
Q ss_pred CceEEcCCceEEEEEEEec-CCCcEEEEEeCCEecCCCCCeEEeecC-----CeEEEEEccCCCCCCEEEEEEEEeCCee
Q psy2148 1750 SSAVINVGQLARFDAKISA-TKPLDVYWLKNGKKIIPDIRYKTLEED-----NLFTLLIIEAVVEDSGAYECVAMNNAGE 1823 (1884)
Q Consensus 1750 ~~~~~~~G~~~~l~C~~~g-~p~p~v~W~k~~~~l~~~~~~~~~~~~-----~~~~L~i~~~~~~d~G~Y~C~a~N~~G~ 1823 (1884)
....+.+|++++|.|.+.| .|+|.+.|+|||.+|....+..+...+ ....|.|.++..+|+|.|+|.|+|..|.
T Consensus 11 ~~~~v~~G~~v~L~c~v~g~~P~p~v~W~Kdg~~i~~~~~~~~~~~~~~~~~~~~~L~i~~v~~~D~G~Ytc~A~N~~G~ 90 (101)
T cd04975 11 TTIFVNLGENLNLVVEVEAYPPPPHINWTYDNRTLTNKLTEIVTSENESEYRYVSELKLVRLKESEAGTYTFLASNSDAS 90 (101)
T ss_pred ceEEEECCCCEEEEEEEEecCCCCccEEEeCCeeCCCCcceeEEEeccCcceEEEEEEEeecCHhhCeeEEEEEECCCcc
Confidence 4677889999999999999 899999999999999866554433321 2468999999999999999999999999
Q ss_pred EEEEEEEEEE
Q psy2148 1824 ARCEAELVVQ 1833 (1884)
Q Consensus 1824 ~~~~~~l~V~ 1833 (1884)
++.++.|.|.
T Consensus 91 ~~~t~~L~V~ 100 (101)
T cd04975 91 KSLTFELYVN 100 (101)
T ss_pred EEEEEEEEEE
Confidence 9999999986
No 36
>cd05893 Ig_Palladin_C C-terminal immunoglobulin (Ig)-like domain of palladin. Ig_Palladin_C: C-terminal immunoglobulin (Ig)-like domain of palladin. Palladin belongs to the palladin-myotilin-myopalladin family. Proteins belonging to this family contain multiple Ig-like domains and function as scaffolds, modulating actin cytoskeleton. Palladin binds to alpha-actinin ezrin, vasodilator-stimulated phosphoprotein VASP, SPIN90 (DIP, mDia interacting protein), and Src. Palladin also binds F-actin directly, via its Ig3 domain. Palladin is expressed as several alternatively spliced isoforms, having various combinations of Ig-like domains, in a cell-type-specific manner. It has been suggested that palladin's different Ig-like domains may be specialized for distinct functions.
Probab=99.43 E-value=6.2e-13 Score=117.15 Aligned_cols=73 Identities=27% Similarity=0.531 Sum_probs=63.2
Q ss_pred EEEEEEEeeCCCCCcEEEEeeCCEEccC-CCcEEEEeeC-CeEEEEEccCCCCCCeEEEEEEEcCCeeEEEEEEEEE
Q psy2148 934 AHFECRLTPTNDPSMTVEWFHNGKALSA-GSRIKTINDF-GFVILEINDVYLRDSGLYTCKATNKHGEATTSCKLTV 1008 (1884)
Q Consensus 934 v~l~C~v~~~~~P~~~v~W~~~g~~i~~-~~~~~~~~~~-~~~~L~I~~~~~~D~G~Y~C~a~N~~G~~~~~~~l~V 1008 (1884)
|+|+|.+. |.|.|.|+|+|++..+.. ..++.+..++ +..+|.|.++..+|+|.|+|.|.|.+|+.++++.|.|
T Consensus 1 v~l~C~v~--G~P~P~v~W~k~~~~l~~~~~~~~~~~~~~~~~~L~I~~v~~~D~G~Y~C~A~N~~G~~~~~a~L~V 75 (75)
T cd05893 1 VRLECRVS--GVPHPQIFWKKENESLTHNTDRVSMHQDNCGYICLLIQGATKEDAGWYTVSAKNEAGIVSCTARLDV 75 (75)
T ss_pred CEEEEEEe--EecCCEEEEEECCEECCCCCCeEEEEEcCCCEEEEEECCCCHHHCEEEEEEEEcCCCEEEEEEEEeC
Confidence 57999999 789999999999999975 3566665443 4557999999999999999999999999999999876
No 37
>cd05735 Ig8_DSCAM Eight immunoglobulin (Ig) domain of Down Syndrome Cell Adhesion molecule (DSCAM). Ig8_DSCAM: the eight immunoglobulin (Ig) domain of Down Syndrome Cell Adhesion molecule (DSCAM). DSCAM is a cell adhesion molecule expressed largely in the developing nervous system. The gene encoding DSCAM is located at human chromosome 21q22, the locus associated with the mental retardation phenotype of Down Syndrome. DSCAM is predicted to be the largest member of the IG superfamily. It has been demonstrated that DSCAM can mediate cation-independent homophilic intercellular adhesion.
Probab=99.43 E-value=1.3e-12 Score=120.05 Aligned_cols=81 Identities=35% Similarity=0.508 Sum_probs=70.1
Q ss_pred CceEEEEEEEecCCCcEEEEEeCCEecCCC-CCeEEee--c--CCeEEEEEccCCCCCCEEEEEEEEeCCeeEEEEEEEE
Q psy2148 1757 GQLARFDAKISATKPLDVYWLKNGKKIIPD-IRYKTLE--E--DNLFTLLIIEAVVEDSGAYECVAMNNAGEARCEAELV 1831 (1884)
Q Consensus 1757 G~~~~l~C~~~g~p~p~v~W~k~~~~l~~~-~~~~~~~--~--~~~~~L~i~~~~~~d~G~Y~C~a~N~~G~~~~~~~l~ 1831 (1884)
|+.++|.|.+.|.|+|.++|+|++..+..+ .++.+.. . ...+.|.|.++..+|+|.|+|.|.|.+|..+.++.|.
T Consensus 1 g~~~~l~C~~~g~p~~~i~W~k~~~~i~~~~~r~~~~~~~~~~~~~s~L~I~~~~~~D~G~YtC~A~N~~G~~~~~~~L~ 80 (88)
T cd05735 1 GQKKEMSCTAHGEKPIIVRWEKEDRIINPEMSRYLVSTKEVGDEVISTLQILPTVREDSGFFSCHAINSYGEDRGIIQLT 80 (88)
T ss_pred CCeEEEEEEEECCCCCEEEEeeCCEECCCCCCcEEEEEecCCCcEEEEEEECCCCcccCEEEEEEEEcCCCcceEEEEEE
Confidence 789999999999999999999999988654 4666543 1 2236899999999999999999999999999999999
Q ss_pred EEecCC
Q psy2148 1832 VQSKKA 1837 (1884)
Q Consensus 1832 V~~~~~ 1837 (1884)
|.++|.
T Consensus 81 V~~~P~ 86 (88)
T cd05735 81 VQEPPD 86 (88)
T ss_pred EeCCCC
Confidence 998654
No 38
>cd05893 Ig_Palladin_C C-terminal immunoglobulin (Ig)-like domain of palladin. Ig_Palladin_C: C-terminal immunoglobulin (Ig)-like domain of palladin. Palladin belongs to the palladin-myotilin-myopalladin family. Proteins belonging to this family contain multiple Ig-like domains and function as scaffolds, modulating actin cytoskeleton. Palladin binds to alpha-actinin ezrin, vasodilator-stimulated phosphoprotein VASP, SPIN90 (DIP, mDia interacting protein), and Src. Palladin also binds F-actin directly, via its Ig3 domain. Palladin is expressed as several alternatively spliced isoforms, having various combinations of Ig-like domains, in a cell-type-specific manner. It has been suggested that palladin's different Ig-like domains may be specialized for distinct functions.
Probab=99.42 E-value=8e-13 Score=116.43 Aligned_cols=73 Identities=29% Similarity=0.500 Sum_probs=63.9
Q ss_pred EEEEEEEecCCCcEEEEEeCCEecCCC-CCeEEeecC-CeEEEEEccCCCCCCEEEEEEEEeCCeeEEEEEEEEE
Q psy2148 1760 ARFDAKISATKPLDVYWLKNGKKIIPD-IRYKTLEED-NLFTLLIIEAVVEDSGAYECVAMNNAGEARCEAELVV 1832 (1884)
Q Consensus 1760 ~~l~C~~~g~p~p~v~W~k~~~~l~~~-~~~~~~~~~-~~~~L~i~~~~~~d~G~Y~C~a~N~~G~~~~~~~l~V 1832 (1884)
++|.|.+.|.|.|.|+|+|++..+..+ .++.+...+ +...|.|.++..+|+|.|+|.|.|.+|+.++++.|.|
T Consensus 1 v~l~C~v~G~P~P~v~W~k~~~~l~~~~~~~~~~~~~~~~~~L~I~~v~~~D~G~Y~C~A~N~~G~~~~~a~L~V 75 (75)
T cd05893 1 VRLECRVSGVPHPQIFWKKENESLTHNTDRVSMHQDNCGYICLLIQGATKEDAGWYTVSAKNEAGIVSCTARLDV 75 (75)
T ss_pred CEEEEEEeEecCCEEEEEECCEECCCCCCeEEEEEcCCCEEEEEECCCCHHHCEEEEEEEEcCCCEEEEEEEEeC
Confidence 579999999999999999999999754 566665543 3447999999999999999999999999999999986
No 39
>cd05870 Ig5_NCAM-2 Fifth immunoglobulin (Ig)-like domain of Neural Cell Adhesion Molecule NCAM-2 (also known as OCAM/mamFas II and RNCAM). Ig5_NCAM-2: the fifth immunoglobulin (Ig)-like domain of Neural Cell Adhesion Molecule NCAM-2 (also known as OCAM/mamFas II and RNCAM). NCAM-2 is organized similarly to NCAM , including five N-terminal Ig-like domains and two fibronectin type III domains. NCAM-2 is differentially expressed in the developing and mature olfactory epithelium (OE), and may function like NCAM, as an adhesion molecule.
Probab=99.42 E-value=1.1e-12 Score=124.14 Aligned_cols=90 Identities=29% Similarity=0.522 Sum_probs=75.0
Q ss_pred CCeeeecCCceeecCCCeEEEEEEEeeCCCCCcEEEEee--CCEEccC-----CCcEEEEeeCCeEEEEEccCCCCCCeE
Q psy2148 916 APEFLTTPTDLTLAESTLAHFECRLTPTNDPSMTVEWFH--NGKALSA-----GSRIKTINDFGFVILEINDVYLRDSGL 988 (1884)
Q Consensus 916 ~p~~~~~~~~~~v~~G~~v~l~C~v~~~~~P~~~v~W~~--~g~~i~~-----~~~~~~~~~~~~~~L~I~~~~~~D~G~ 988 (1884)
+|+|.. +++.++.+|++++|.|.+. |.|.|.|+|+| +|..+.. +.++.+....+...|.|.+++.+|+|.
T Consensus 2 ~p~i~~-~~~~~~~~G~~v~l~C~~~--G~P~p~i~W~k~~~g~~~~~~~~~~~~r~~v~~~~~~~~L~I~~v~~~D~G~ 78 (98)
T cd05870 2 QPHIIQ-LKNETTVENGAATLSCKAE--GEPIPEITWKRASDGHTFSEGDKSPDGRIEVKGQHGESSLHIKDVKLSDSGR 78 (98)
T ss_pred CCEEEe-eccEEEcCCCcEEEEEecc--cCCCCeEEEEECCCCceeccCCcCcCceEEEeecCCeeEEEEeeCCcCCCEE
Confidence 577754 7899999999999999998 78889999999 4555532 346666555556689999999999999
Q ss_pred EEEEEEcCCeeEEEEEEEEE
Q psy2148 989 YTCKATNKHGEATTSCKLTV 1008 (1884)
Q Consensus 989 Y~C~a~N~~G~~~~~~~l~V 1008 (1884)
|+|.|.|.+|..+.++.|.|
T Consensus 79 Y~C~A~N~~G~~~~~~~l~~ 98 (98)
T cd05870 79 YDCEAASRIGGHQKSMYLDI 98 (98)
T ss_pred EEEEEeccCCcceeEEEEeC
Confidence 99999999999999888875
No 40
>cd05728 Ig4_Contactin-2-like Fourth Ig domain of the neural cell adhesion molecule contactin-2 and similar proteins. Ig4_Contactin-2-like: fourth Ig domain of the neural cell adhesion molecule contactin-2. Contactins are comprised of six Ig domains followed by four fibronectin type III (FnIII) domains anchored to the membrane by glycosylphosphatidylinositol. Contactin-2 (aliases TAG-1, axonin-1) facilitates cell adhesion by homophilic binding between molecules in apposed membranes. The first four Ig domains form the intermolecular binding fragment which arranges as a compact U-shaped module by contacts between Ig domains 1 and 4, and domains 2 and 3. It has been proposed that a linear zipper-like array forms, from contactin-2 molecules alternatively provided by the two apposed membranes.
Probab=99.42 E-value=8.9e-13 Score=120.72 Aligned_cols=84 Identities=33% Similarity=0.626 Sum_probs=74.4
Q ss_pred eeecCCceeecCCCeEEEEEEEeeCCCCCcEEEEeeCCEEccCCCcEEEEeeCCeEEEEEccCCCCCCeEEEEEEEcCCe
Q psy2148 919 FLTTPTDLTLAESTLAHFECRLTPTNDPSMTVEWFHNGKALSAGSRIKTINDFGFVILEINDVYLRDSGLYTCKATNKHG 998 (1884)
Q Consensus 919 ~~~~~~~~~v~~G~~v~l~C~v~~~~~P~~~v~W~~~g~~i~~~~~~~~~~~~~~~~L~I~~~~~~D~G~Y~C~a~N~~G 998 (1884)
|+..|.+..+.+|+.+.|.|.+. |.|.|.+.|+|+|.++....++.... + .|.|.++..+|+|.|+|.|.|..|
T Consensus 2 ~~~~p~~~~~~~G~~~~l~C~~~--g~p~p~v~W~k~g~~~~~~~~~~~~~--~--~L~i~~~~~~D~G~Y~C~a~N~~G 75 (85)
T cd05728 2 WLKVISDTEADIGSSLRWECKAS--GNPRPAYRWLKNGQPLASENRIEVEA--G--DLRITKLSLSDSGMYQCVAENKHG 75 (85)
T ss_pred ccccCCccEEcCCCcEEEEEEee--EeCCCEEEEEECCEECCCCCeEEEeC--C--EEEEeeCCHHHCEEEEEEEECCCC
Confidence 55678889999999999999998 67888999999999998877766532 2 699999999999999999999999
Q ss_pred eEEEEEEEEE
Q psy2148 999 EATTSCKLTV 1008 (1884)
Q Consensus 999 ~~~~~~~l~V 1008 (1884)
..++++.|.|
T Consensus 76 ~~~~~~~l~V 85 (85)
T cd05728 76 TIYASAELAV 85 (85)
T ss_pred eEEEEEEEEC
Confidence 9999998875
No 41
>cd04972 Ig_TrkABC_d4 Fourth domain (immunoglobulin-like) of Trk receptors TrkA, TrkB and TrkC. TrkABC_d4: the fourth domain of Trk receptors TrkA, TrkB and TrkC, this is an immunoglobulin (Ig)-like domain which binds to neurotrophin. The Trk family of receptors are tyrosine kinase receptors. They are activated by dimerization, leading to autophosphorylation of intracellular tyrosine residues, and triggering the signal transduction pathway. TrkA, TrkB, and TrkC share significant sequence homology and domain organization. The first three domains are leucine-rich domains. The fourth and fifth domains are Ig-like domains playing a part in ligand binding. TrkA, Band C mediate the trophic effects of the neurotrophin Nerve growth factor (NGF) family. TrkA is recognized by NGF. TrKB is recognized by brain-derived neurotrophic factor (BDNF) and neurotrophin (NT)-4. TrkC is recognized by NT-3. NT-3 is promiscuous as in some cell systems it activates TrkA and TrkB receptors. TrkA is a receptor fo
Probab=99.42 E-value=1.6e-12 Score=120.87 Aligned_cols=87 Identities=22% Similarity=0.330 Sum_probs=73.7
Q ss_pred eecCCceeecCCCeEEEEEEEeeCCCCCcEEEEeeCCEEccCCCcEEEEeeCCeEEEEEccCCCCCCeEEEEEEEcCCee
Q psy2148 920 LTTPTDLTLAESTLAHFECRLTPTNDPSMTVEWFHNGKALSAGSRIKTINDFGFVILEINDVYLRDSGLYTCKATNKHGE 999 (1884)
Q Consensus 920 ~~~~~~~~v~~G~~v~l~C~v~~~~~P~~~v~W~~~g~~i~~~~~~~~~~~~~~~~L~I~~~~~~D~G~Y~C~a~N~~G~ 999 (1884)
+.++.+..+.+|+.+.|.|.+. |.|.|.|+|+++|..+...............+|.|.++..+|.|.|+|.|.|.+|+
T Consensus 4 v~~p~~~~v~~G~~v~l~C~~~--G~P~p~v~W~~~g~~~~~~~~~~~~~~~~~~~L~I~~v~~~D~g~Y~C~A~N~~G~ 81 (90)
T cd04972 4 VDGPNATVVYEGGTATIRCTAE--GSPLPKVEWIIAGLIVIQTRTDTLETTVDIYNLQLSNITSETQTTVTCTAENPVGQ 81 (90)
T ss_pred ccCCcCEEEcCCCcEEEEEEEE--EcCCCeEEEEECCEEccCCccEEEEecCCEEEEEEecCCcccCEEEEEEEECCCCc
Confidence 4556777899999999999999 78999999999999987665543333344568999999999999999999999999
Q ss_pred EEEEEEEEE
Q psy2148 1000 ATTSCKLTV 1008 (1884)
Q Consensus 1000 ~~~~~~l~V 1008 (1884)
.+.++.|.|
T Consensus 82 ~~~~~~L~v 90 (90)
T cd04972 82 ANVSVQVTV 90 (90)
T ss_pred eeEEEEEeC
Confidence 999998875
No 42
>cd05735 Ig8_DSCAM Eight immunoglobulin (Ig) domain of Down Syndrome Cell Adhesion molecule (DSCAM). Ig8_DSCAM: the eight immunoglobulin (Ig) domain of Down Syndrome Cell Adhesion molecule (DSCAM). DSCAM is a cell adhesion molecule expressed largely in the developing nervous system. The gene encoding DSCAM is located at human chromosome 21q22, the locus associated with the mental retardation phenotype of Down Syndrome. DSCAM is predicted to be the largest member of the IG superfamily. It has been demonstrated that DSCAM can mediate cation-independent homophilic intercellular adhesion.
Probab=99.42 E-value=1.6e-12 Score=119.42 Aligned_cols=81 Identities=22% Similarity=0.366 Sum_probs=69.0
Q ss_pred CCeEEEEEEEeeCCCCCcEEEEeeCCEEccCC-CcEEEEee----CCeEEEEEccCCCCCCeEEEEEEEcCCeeEEEEEE
Q psy2148 931 STLAHFECRLTPTNDPSMTVEWFHNGKALSAG-SRIKTIND----FGFVILEINDVYLRDSGLYTCKATNKHGEATTSCK 1005 (1884)
Q Consensus 931 G~~v~l~C~v~~~~~P~~~v~W~~~g~~i~~~-~~~~~~~~----~~~~~L~I~~~~~~D~G~Y~C~a~N~~G~~~~~~~ 1005 (1884)
|+.++|.|.+. |.|++.|+|+|++..|... .++.+... ...++|.|.++..+|+|.|+|.|.|.+|..+..+.
T Consensus 1 g~~~~l~C~~~--g~p~~~i~W~k~~~~i~~~~~r~~~~~~~~~~~~~s~L~I~~~~~~D~G~YtC~A~N~~G~~~~~~~ 78 (88)
T cd05735 1 GQKKEMSCTAH--GEKPIIVRWEKEDRIINPEMSRYLVSTKEVGDEVISTLQILPTVREDSGFFSCHAINSYGEDRGIIQ 78 (88)
T ss_pred CCeEEEEEEEE--CCCCCEEEEeeCCEECCCCCCcEEEEEecCCCcEEEEEEECCCCcccCEEEEEEEEcCCCcceEEEE
Confidence 78999999999 7799999999999998654 46655421 22368999999999999999999999999999999
Q ss_pred EEEEeecc
Q psy2148 1006 LTVKGRQG 1013 (1884)
Q Consensus 1006 l~V~~~~~ 1013 (1884)
|.|.++|.
T Consensus 79 L~V~~~P~ 86 (88)
T cd05735 79 LTVQEPPD 86 (88)
T ss_pred EEEeCCCC
Confidence 99997764
No 43
>cd05745 Ig3_Peroxidasin Third immunoglobulin (Ig)-like domain of peroxidasin. Ig3_Peroxidasin: the third immunoglobulin (Ig)-like domain in peroxidasin. Peroxidasin has a peroxidase domain and interacting extracellular motifs containing four Ig-like domains. It has been suggested that peroxidasin is secreted and has functions related to the stabilization of the extracellular matrix. It may play a part in various other important processes such as removal and destruction of cells which have undergone programmed cell death, and protection of the organism against non-self.
Probab=99.41 E-value=6.6e-13 Score=118.03 Aligned_cols=74 Identities=32% Similarity=0.523 Sum_probs=65.4
Q ss_pred CCCeEEEEEEEeeCCCCCcEEEEeeCCEEccCCCcEEEEeeCCeEEEEEccCCCCCCeEEEEEEEcCCeeEEEEEEEEE
Q psy2148 930 ESTLAHFECRLTPTNDPSMTVEWFHNGKALSAGSRIKTINDFGFVILEINDVYLRDSGLYTCKATNKHGEATTSCKLTV 1008 (1884)
Q Consensus 930 ~G~~v~l~C~v~~~~~P~~~v~W~~~g~~i~~~~~~~~~~~~~~~~L~I~~~~~~D~G~Y~C~a~N~~G~~~~~~~l~V 1008 (1884)
+|+++.|.|.+. |.|.|.|+|+|+|..+....++.+...+ +|.|.+++.+|+|.|+|.|.|.+|..+.++.|.|
T Consensus 1 eG~~v~l~C~~~--g~P~p~i~W~k~g~~~~~~~~~~~~~~~---~L~I~~v~~~D~G~Y~C~A~N~~G~~~~~~~L~V 74 (74)
T cd05745 1 EGQTVDFLCEAQ--GYPQPVIAWTKGGSQLSVDRRHLVLSSG---TLRISRVALHDQGQYECQAVNIVGSQRTVAQLTV 74 (74)
T ss_pred CCCeEEEEeECC--EecCCEEEEEECCEECCCCCCeEEccCC---eEEEeeCCHHhCEEEEEEEEeCCCceeEEEEEeC
Confidence 689999999998 7789999999999999877666554332 7999999999999999999999999999998876
No 44
>cd05870 Ig5_NCAM-2 Fifth immunoglobulin (Ig)-like domain of Neural Cell Adhesion Molecule NCAM-2 (also known as OCAM/mamFas II and RNCAM). Ig5_NCAM-2: the fifth immunoglobulin (Ig)-like domain of Neural Cell Adhesion Molecule NCAM-2 (also known as OCAM/mamFas II and RNCAM). NCAM-2 is organized similarly to NCAM , including five N-terminal Ig-like domains and two fibronectin type III domains. NCAM-2 is differentially expressed in the developing and mature olfactory epithelium (OE), and may function like NCAM, as an adhesion molecule.
Probab=99.41 E-value=1.6e-12 Score=123.02 Aligned_cols=90 Identities=19% Similarity=0.310 Sum_probs=75.5
Q ss_pred CCeEEeccCceEEcCCceEEEEEEEecCCCcEEEEEeC--CEecCC-----CCCeEEeecCCeEEEEEccCCCCCCEEEE
Q psy2148 1742 PPSFLTTISSAVINVGQLARFDAKISATKPLDVYWLKN--GKKIIP-----DIRYKTLEEDNLFTLLIIEAVVEDSGAYE 1814 (1884)
Q Consensus 1742 ~P~~~~~~~~~~~~~G~~~~l~C~~~g~p~p~v~W~k~--~~~l~~-----~~~~~~~~~~~~~~L~i~~~~~~d~G~Y~ 1814 (1884)
+|.|.. +.+..+.+|++++|.|.+.|.|.|.|+|+|+ +..+.. +.|+.+....+...|.|.++..+|+|.|+
T Consensus 2 ~p~i~~-~~~~~~~~G~~v~l~C~~~G~P~p~i~W~k~~~g~~~~~~~~~~~~r~~v~~~~~~~~L~I~~v~~~D~G~Y~ 80 (98)
T cd05870 2 QPHIIQ-LKNETTVENGAATLSCKAEGEPIPEITWKRASDGHTFSEGDKSPDGRIEVKGQHGESSLHIKDVKLSDSGRYD 80 (98)
T ss_pred CCEEEe-eccEEEcCCCcEEEEEecccCCCCeEEEEECCCCceeccCCcCcCceEEEeecCCeeEEEEeeCCcCCCEEEE
Confidence 577765 6789999999999999999999999999994 444432 24666655555678999999999999999
Q ss_pred EEEEeCCeeEEEEEEEEE
Q psy2148 1815 CVAMNNAGEARCEAELVV 1832 (1884)
Q Consensus 1815 C~a~N~~G~~~~~~~l~V 1832 (1884)
|.|.|.+|....++.|.|
T Consensus 81 C~A~N~~G~~~~~~~l~~ 98 (98)
T cd05870 81 CEAASRIGGHQKSMYLDI 98 (98)
T ss_pred EEEeccCCcceeEEEEeC
Confidence 999999999999998875
No 45
>cd05730 Ig3_NCAM-1_like Third immunoglobulin (Ig)-like domain of Neural Cell Adhesion Molecule NCAM-1 (NCAM). Ig3_NCAM-1_like: domain similar to the third immunoglobulin (Ig)-like domain of Neural Cell Adhesion Molecule NCAM-1 (NCAM). NCAM plays important roles in the development and regeneration of the central nervous system, in synaptogenesis and neural migration. NCAM mediates cell-cell and cell-substratum recognition and adhesion via homophilic (NCAM-NCAM), and heterophilic (NCAM-non-NCAM), interactions. NCAM is expressed as three major isoforms having different intracellular extensions. The extracellular portion of NCAM has five N-terminal Ig-like domains and two fibronectin type III domains. The double zipper adhesion complex model for NCAM homophilic binding involves Ig1, Ig2, and Ig3. By this model, Ig1,and Ig2 mediate dimerization of NCAM molecules situated on the same cell surface (cis interactions), and Ig3 domains mediate interactions between NCAM molecules expressed on the
Probab=99.41 E-value=1.6e-12 Score=122.74 Aligned_cols=91 Identities=26% Similarity=0.409 Sum_probs=75.6
Q ss_pred CCeEEecc--CceEEcCCceEEEEEEEecCCCcEEEEEeCCEecCCC-CCeEEeecCCeEEEEEccCCCCCCEEEEEEEE
Q psy2148 1742 PPSFLTTI--SSAVINVGQLARFDAKISATKPLDVYWLKNGKKIIPD-IRYKTLEEDNLFTLLIIEAVVEDSGAYECVAM 1818 (1884)
Q Consensus 1742 ~P~~~~~~--~~~~~~~G~~~~l~C~~~g~p~p~v~W~k~~~~l~~~-~~~~~~~~~~~~~L~i~~~~~~d~G~Y~C~a~ 1818 (1884)
||.|.... .+..+..|++++|.|.+.|.|.|.|.|+|+|..+... .++.+... ...|.|.++..+|.|.|+|.|.
T Consensus 1 pp~i~~~~~~~~~~~~~G~~v~L~C~~~g~P~p~v~W~k~g~~~~~~~~~~~~~~~--~~~L~I~~v~~~D~G~Y~C~a~ 78 (95)
T cd05730 1 PPTIRARQSEVNATANLGQSVTLACDADGFPEPTMTWTKDGEPIESGEEKYSFNED--GSEMTILDVDKLDEAEYTCIAE 78 (95)
T ss_pred CCccccCCcccceEEeCCCCEEEEEeccEeCCCEEEEEECCEECcCCCCEEEEeCC--CCEEEECCCChhhCEEEEEEEE
Confidence 34454433 4557889999999999999999999999999998765 44544333 3479999999999999999999
Q ss_pred eCCeeEEEEEEEEEEe
Q psy2148 1819 NNAGEARCEAELVVQS 1834 (1884)
Q Consensus 1819 N~~G~~~~~~~l~V~~ 1834 (1884)
|..|..+.++.|.|..
T Consensus 79 N~~G~~~~~~~L~V~~ 94 (95)
T cd05730 79 NKAGEQEAEIHLKVFA 94 (95)
T ss_pred cCCCeEEEEEEEEEEe
Confidence 9999999999999975
No 46
>cd05853 Ig6_Contactin-4 Sixth Ig domain of contactin-4. Ig6_Contactin-4: sixth Ig domain of the neural cell adhesion molecule contactin-4. Contactins are neural cell adhesion molecules, and are comprised of six Ig domains followed by four fibronectin type III (FnIII) domains anchored to the membrane by glycosylphosphatidylinositol. The different contactins show different expression patterns in the central nervous system. Highest expresson of contactin-4 is in testes, thyroid, small intestine, uterus and brain. Contactin-4 plays a role in the response of neuroblastoma cells to differentiating agents, such as retinoids. The contactin 4 gene is associated with cerebellar degeneration in spinocerebellar ataxia type 16.
Probab=99.41 E-value=9.5e-13 Score=117.46 Aligned_cols=81 Identities=17% Similarity=0.383 Sum_probs=66.7
Q ss_pred CeEEEEEEEeeCCCCCcEEEEeeCCEEccC---CCcEEEEee-CCeEEEEEccCCCCCCeEEEEEEEcCCeeEEEEEEEE
Q psy2148 932 TLAHFECRLTPTNDPSMTVEWFHNGKALSA---GSRIKTIND-FGFVILEINDVYLRDSGLYTCKATNKHGEATTSCKLT 1007 (1884)
Q Consensus 932 ~~v~l~C~v~~~~~P~~~v~W~~~g~~i~~---~~~~~~~~~-~~~~~L~I~~~~~~D~G~Y~C~a~N~~G~~~~~~~l~ 1007 (1884)
+++.|.|.+.+.+.+++.|.|+|||++|.. +.+|..... .....|+|.+++..|+|+|+|.|+|.+++.++++.|+
T Consensus 1 ~~~~l~C~v~~d~~l~~~~~W~~dg~~i~~~~~~~~~~~~~~~~~~~~L~I~nv~~~dsG~YtC~a~n~~~~~~a~a~L~ 80 (85)
T cd05853 1 ESIVLPCQVSHDHSLDIVFTWSFNGHLIDFQKDGDHFERVGGQDSAGDLMIRSIQLKHAGKYVCMVQTSVDKLSAAADLI 80 (85)
T ss_pred CcEEEEEEeccCCCCCcEEEEEECCEECcccCCCccEEEeccCCCCCcEEEecCCHHHCEEEEEEEEcccCceEEEEEEE
Confidence 478999999866778899999999999962 335544321 1122699999999999999999999999999999999
Q ss_pred EEeec
Q psy2148 1008 VKGRQ 1012 (1884)
Q Consensus 1008 V~~~~ 1012 (1884)
|.++|
T Consensus 81 V~~pP 85 (85)
T cd05853 81 VRGPP 85 (85)
T ss_pred EecCC
Confidence 99865
No 47
>cd05748 Ig_Titin_like Immunoglobulin (Ig)-like domain of titin and similar proteins. Ig_Titin_like: immunoglobulin (Ig)-like domain found in titin-like proteins. Titin (also called connectin) is a fibrous sarcomeric protein specifically found in vertebrate striated muscle. Titin is gigantic, depending on isoform composition it ranges from 2970 to 3700 kDa, and is of a length that spans half a sarcomere. Titin largely consists of multiple repeats of Ig-like and fibronectin type 3 (FN-III)-like domains. Titin connects the ends of myosin thick filaments to Z disks and extends along the thick filament to the H zone. It appears to function similarly to an elastic band, keeping the myosin filaments centered in the sarcomere during muscle contraction or stretching. Within the sarcomere, titin is also attached to or is associated with myosin binding protein C (MyBP-C). MyBP-C appears to contribute to the generation of passive tension by titin, and similar to titin has repeated Ig-like and FN-
Probab=99.41 E-value=1.6e-12 Score=115.94 Aligned_cols=74 Identities=27% Similarity=0.417 Sum_probs=67.2
Q ss_pred eEEEEEEEeeCCCCCcEEEEeeCCEEccCCCcEEEEeeCCeEEEEEccCCCCCCeEEEEEEEcCCeeEEEEEEEEE
Q psy2148 933 LAHFECRLTPTNDPSMTVEWFHNGKALSAGSRIKTINDFGFVILEINDVYLRDSGLYTCKATNKHGEATTSCKLTV 1008 (1884)
Q Consensus 933 ~v~l~C~v~~~~~P~~~v~W~~~g~~i~~~~~~~~~~~~~~~~L~I~~~~~~D~G~Y~C~a~N~~G~~~~~~~l~V 1008 (1884)
.+.|.|.+. |.|.|.++|+|+|..+..+.++.+...+..+.|.|.++..+|+|.|+|.|.|.+|.++.++.|.|
T Consensus 1 ~~~l~c~~~--G~P~p~v~W~k~g~~l~~~~~~~~~~~~~~~~L~I~~~~~~D~G~Y~C~a~N~~G~~~~~~~l~V 74 (74)
T cd05748 1 SVRLEVPIS--GRPTPTVTWSKDGKPLKLSGRVQIETTASSTSLVIKNAERSDSGKYTLTLKNPAGEKSATINVKV 74 (74)
T ss_pred CEEEEeeEe--eeCCCeEEEEECCEEcCCCCeEEEEECCCeEEEEECCCCcCcCEEEEEEEECCCccEEEEEEEEC
Confidence 478999998 78999999999999998888888777667789999999999999999999999999999998875
No 48
>cd04972 Ig_TrkABC_d4 Fourth domain (immunoglobulin-like) of Trk receptors TrkA, TrkB and TrkC. TrkABC_d4: the fourth domain of Trk receptors TrkA, TrkB and TrkC, this is an immunoglobulin (Ig)-like domain which binds to neurotrophin. The Trk family of receptors are tyrosine kinase receptors. They are activated by dimerization, leading to autophosphorylation of intracellular tyrosine residues, and triggering the signal transduction pathway. TrkA, TrkB, and TrkC share significant sequence homology and domain organization. The first three domains are leucine-rich domains. The fourth and fifth domains are Ig-like domains playing a part in ligand binding. TrkA, Band C mediate the trophic effects of the neurotrophin Nerve growth factor (NGF) family. TrkA is recognized by NGF. TrKB is recognized by brain-derived neurotrophic factor (BDNF) and neurotrophin (NT)-4. TrkC is recognized by NT-3. NT-3 is promiscuous as in some cell systems it activates TrkA and TrkB receptors. TrkA is a receptor fo
Probab=99.41 E-value=2.2e-12 Score=119.91 Aligned_cols=86 Identities=17% Similarity=0.261 Sum_probs=73.6
Q ss_pred eccCceEEcCCceEEEEEEEecCCCcEEEEEeCCEecCCCCCeEEeecCCeEEEEEccCCCCCCEEEEEEEEeCCeeEEE
Q psy2148 1747 TTISSAVINVGQLARFDAKISATKPLDVYWLKNGKKIIPDIRYKTLEEDNLFTLLIIEAVVEDSGAYECVAMNNAGEARC 1826 (1884)
Q Consensus 1747 ~~~~~~~~~~G~~~~l~C~~~g~p~p~v~W~k~~~~l~~~~~~~~~~~~~~~~L~i~~~~~~d~G~Y~C~a~N~~G~~~~ 1826 (1884)
..+.+..+..|+.++|.|.+.|.|.|.+.|+|+|..+................|.|.++..+|.|.|+|.|.|..|+...
T Consensus 5 ~~p~~~~v~~G~~v~l~C~~~G~P~p~v~W~~~g~~~~~~~~~~~~~~~~~~~L~I~~v~~~D~g~Y~C~A~N~~G~~~~ 84 (90)
T cd04972 5 DGPNATVVYEGGTATIRCTAEGSPLPKVEWIIAGLIVIQTRTDTLETTVDIYNLQLSNITSETQTTVTCTAENPVGQANV 84 (90)
T ss_pred cCCcCEEEcCCCcEEEEEEEEEcCCCeEEEEECCEEccCCccEEEEecCCEEEEEEecCCcccCEEEEEEEECCCCceeE
Confidence 34456778999999999999999999999999999887655444444445669999999999999999999999999999
Q ss_pred EEEEEE
Q psy2148 1827 EAELVV 1832 (1884)
Q Consensus 1827 ~~~l~V 1832 (1884)
+++|.|
T Consensus 85 ~~~L~v 90 (90)
T cd04972 85 SVQVTV 90 (90)
T ss_pred EEEEeC
Confidence 999875
No 49
>cd05869 Ig5_NCAM-1 Fifth immunoglobulin (Ig)-like domain of Neural Cell Adhesion Molecule NCAM-1 (NCAM). Ig5_NCAM-1: The fifth immunoglobulin (Ig)-like domain of Neural Cell Adhesion Molecule NCAM-1 (NCAM). NCAM plays important roles in the development and regeneration of the central nervous system, in synaptogenesis and neural migration. NCAM mediates cell-cell and cell-substratum recognition and adhesion via homophilic (NCAM-NCAM) and heterophilic (NCAM-non-NCAM) interactions. NCAM is expressed as three major isoforms having different intracellular extensions. The extracellular portion of NCAM has five N-terminal Ig-like domains and two fibronectin type III domains. The double zipper adhesion complex model for NCAM homophilic binding involves Ig1, Ig2, and Ig3. By this model, Ig1 and Ig2 mediate dimerization of NCAM molecules situated on the same cell surface (cis interactions), and Ig3 domains mediate interactions between NCAM molecules expressed on the surface of opposing cells (tr
Probab=99.41 E-value=2.3e-12 Score=121.74 Aligned_cols=91 Identities=15% Similarity=0.225 Sum_probs=76.2
Q ss_pred CCeEEeccCceEEcCCceEEEEEEEecCCCcEEEEEeCCEecCCC-----CCeEEeecCCeEEEEEccCCCCCCEEEEEE
Q psy2148 1742 PPSFLTTISSAVINVGQLARFDAKISATKPLDVYWLKNGKKIIPD-----IRYKTLEEDNLFTLLIIEAVVEDSGAYECV 1816 (1884)
Q Consensus 1742 ~P~~~~~~~~~~~~~G~~~~l~C~~~g~p~p~v~W~k~~~~l~~~-----~~~~~~~~~~~~~L~i~~~~~~d~G~Y~C~ 1816 (1884)
.|.|...+....+..|+.++|.|.+.|.|.|.|+|++++..+... .++.+........|.|.++..+|+|.|+|.
T Consensus 2 ~p~i~~~~~~~~~~~g~~v~l~C~~~G~P~P~v~W~~~~~~~~~~~~~~~~~~~v~~~~~~~~L~I~~v~~~D~G~Y~C~ 81 (97)
T cd05869 2 KPKITYVENQTAMELEEQITLTCEASGDPIPSITWRTSTRNISSEEKTLDGHIVVRSHARVSSLTLKYIQYTDAGEYLCT 81 (97)
T ss_pred CceEEEccCceEEEcCCCEEEEEEeeEeCCCEEEEEECCccccCCccccCccEEEEcCccEEEEEEecCccCcCEEEEEE
Confidence 577877776666777999999999999999999999999877543 234444444556899999999999999999
Q ss_pred EEeCCeeEEEEEEEEE
Q psy2148 1817 AMNNAGEARCEAELVV 1832 (1884)
Q Consensus 1817 a~N~~G~~~~~~~l~V 1832 (1884)
|.|..|..+.++.|.|
T Consensus 82 A~N~~G~~~~~~~l~v 97 (97)
T cd05869 82 ASNTIGQDSQSMYLEV 97 (97)
T ss_pred EecCCCCeeEEEEEEC
Confidence 9999999999999876
No 50
>cd05748 Ig_Titin_like Immunoglobulin (Ig)-like domain of titin and similar proteins. Ig_Titin_like: immunoglobulin (Ig)-like domain found in titin-like proteins. Titin (also called connectin) is a fibrous sarcomeric protein specifically found in vertebrate striated muscle. Titin is gigantic, depending on isoform composition it ranges from 2970 to 3700 kDa, and is of a length that spans half a sarcomere. Titin largely consists of multiple repeats of Ig-like and fibronectin type 3 (FN-III)-like domains. Titin connects the ends of myosin thick filaments to Z disks and extends along the thick filament to the H zone. It appears to function similarly to an elastic band, keeping the myosin filaments centered in the sarcomere during muscle contraction or stretching. Within the sarcomere, titin is also attached to or is associated with myosin binding protein C (MyBP-C). MyBP-C appears to contribute to the generation of passive tension by titin, and similar to titin has repeated Ig-like and FN-
Probab=99.41 E-value=1.8e-12 Score=115.63 Aligned_cols=74 Identities=28% Similarity=0.341 Sum_probs=68.4
Q ss_pred eEEEEEEEecCCCcEEEEEeCCEecCCCCCeEEeecCCeEEEEEccCCCCCCEEEEEEEEeCCeeEEEEEEEEE
Q psy2148 1759 LARFDAKISATKPLDVYWLKNGKKIIPDIRYKTLEEDNLFTLLIIEAVVEDSGAYECVAMNNAGEARCEAELVV 1832 (1884)
Q Consensus 1759 ~~~l~C~~~g~p~p~v~W~k~~~~l~~~~~~~~~~~~~~~~L~i~~~~~~d~G~Y~C~a~N~~G~~~~~~~l~V 1832 (1884)
++.|.|.+.|.|.|.+.|+|+|..+..+.++.+........|.|.++..+|+|.|+|.|.|..|.++.+++|.|
T Consensus 1 ~~~l~c~~~G~P~p~v~W~k~g~~l~~~~~~~~~~~~~~~~L~I~~~~~~D~G~Y~C~a~N~~G~~~~~~~l~V 74 (74)
T cd05748 1 SVRLEVPISGRPTPTVTWSKDGKPLKLSGRVQIETTASSTSLVIKNAERSDSGKYTLTLKNPAGEKSATINVKV 74 (74)
T ss_pred CEEEEeeEeeeCCCeEEEEECCEEcCCCCeEEEEECCCeEEEEECCCCcCcCEEEEEEEECCCccEEEEEEEEC
Confidence 37899999999999999999999998888888877777889999999999999999999999999999999876
No 51
>cd05865 Ig1_NCAM-1 First immunoglobulin (Ig)-like domain of neural cell adhesion molecule NCAM-1. Ig1_NCAM-1: first immunoglobulin (Ig)-like domain of neural cell adhesion molecule NCAM-1. NCAM-1 plays important roles in the development and regeneration of the central nervous system, in synaptogenesis and neural migration. NCAM mediates cell-cell and cell-substratum recognition and adhesion via homophilic (NCAM-NCAM), and heterophilic (NCAM-nonNCAM), interactions. NCAM is expressed as three major isoforms having different intracellular extensions. The extracellular portion of NCAM has five N-terminal Ig-like domains and two fibronectin type III domains. The double zipper adhesion complex model for NCAM homophilic binding involves the Ig1, Ig2, and Ig3 domains. By this model, Ig1 and Ig2 mediate dimerization of NCAM molecules situated on the same cell surface (cis interactions), and Ig3 domains mediate interactions between NCAM molecules expressed on the surface of opposing cells (trans
Probab=99.40 E-value=2.3e-12 Score=119.73 Aligned_cols=86 Identities=23% Similarity=0.544 Sum_probs=70.9
Q ss_pred ecCCceeecCCCeEEEEEEEeeCCCC-CcEEEEee-CCEEccC-CCcEEEEe-eCCeEEEEEccCCCCCCeEEEEEEEcC
Q psy2148 921 TTPTDLTLAESTLAHFECRLTPTNDP-SMTVEWFH-NGKALSA-GSRIKTIN-DFGFVILEINDVYLRDSGLYTCKATNK 996 (1884)
Q Consensus 921 ~~~~~~~v~~G~~v~l~C~v~~~~~P-~~~v~W~~-~g~~i~~-~~~~~~~~-~~~~~~L~I~~~~~~D~G~Y~C~a~N~ 996 (1884)
..|.+..+.+|++++|.|.+. |.| +|.|+|++ ||..+.. +.++.+.. ++..++|.|.+++.+|+|.|+|.|+|.
T Consensus 5 ~~p~~~~v~~G~~v~l~C~v~--G~P~~p~i~W~~~~g~~l~~~~~r~~v~~~~~~~~~L~I~~v~~~D~G~YtC~A~N~ 82 (96)
T cd05865 5 IVPSQGEISVGESKFFLCQVA--GEAKDKDISWFSPNGEKLTPNQQRISVVRNDDYSSTLTIYNANIDDAGIYKCVVSNE 82 (96)
T ss_pred EeCCccEECCCCeEEEEEEEe--CCCCCCEEEEECCCCcCccccCCeEEEEeCCCCceEEEEeccChhhCEEEEEEEEcC
Confidence 456777899999999999998 677 47999998 8887765 44555443 344578999999999999999999999
Q ss_pred C-eeEEEEEEEEE
Q psy2148 997 H-GEATTSCKLTV 1008 (1884)
Q Consensus 997 ~-G~~~~~~~l~V 1008 (1884)
+ |..++++.|.|
T Consensus 83 ~~g~~~~s~~l~v 95 (96)
T cd05865 83 DEGESEATVNVKI 95 (96)
T ss_pred CCCcEEEEEEEEE
Confidence 7 88888888876
No 52
>cd05866 Ig1_NCAM-2 First immunoglobulin (Ig)-like domain of neural cell adhesion molecule NCAM-2. Ig1_NCAM-2: first immunoglobulin (Ig)-like domain of neural cell adhesion molecule NCAM-2 (OCAM/mamFas II, RNCAM). NCAM-2 is organized similarly to NCAM , including five N-terminal Ig-like domains and two fibronectin type III domains. NCAM-2 is differentially expressed in the developing and mature olfactory epithelium (OE), and may function like NCAM, as an adhesion molecule.
Probab=99.40 E-value=2.4e-12 Score=118.13 Aligned_cols=86 Identities=20% Similarity=0.506 Sum_probs=73.5
Q ss_pred eecCCceeecCCCeEEEEEEEeeCCCCCcEEEEee-CCEEccCCCcEEEEeeCCeEEEEEccCCCCCCeEEEEEEEcCCe
Q psy2148 920 LTTPTDLTLAESTLAHFECRLTPTNDPSMTVEWFH-NGKALSAGSRIKTINDFGFVILEINDVYLRDSGLYTCKATNKHG 998 (1884)
Q Consensus 920 ~~~~~~~~v~~G~~v~l~C~v~~~~~P~~~v~W~~-~g~~i~~~~~~~~~~~~~~~~L~I~~~~~~D~G~Y~C~a~N~~G 998 (1884)
...+.+..+.+|+++.|.|.+. |.|. .|+|++ +|..+..+.++.+..++..+.|.|.++..+|+|.|+|.|+|..|
T Consensus 4 ~~~~~~~~v~~G~~v~l~C~~~--G~P~-~v~W~k~~g~~~~~~~r~~~~~~g~~~~L~I~~v~~~D~G~Y~C~A~N~~G 80 (92)
T cd05866 4 SISLSKVELSVGESKFFTCTAI--GEPE-SIDWYNPQGEKIVSSQRVVVQKEGVRSRLTIYNANIEDAGIYRCQATDAKG 80 (92)
T ss_pred EEEecceEEcCCCeEEEEEEEE--EeCC-eEEEEeCCCeEecCCCCEEEEeCCCeeEEEEecCChHHCEEEEEEEEcCCC
Confidence 4567888999999999999998 6777 899998 58888888888887666677899999999999999999999999
Q ss_pred eE-EEEEEEEE
Q psy2148 999 EA-TTSCKLTV 1008 (1884)
Q Consensus 999 ~~-~~~~~l~V 1008 (1884)
.. ..++.|.|
T Consensus 81 ~~~~~~i~l~~ 91 (92)
T cd05866 81 QTQEATVVLEI 91 (92)
T ss_pred cEEEEEEEEEE
Confidence 85 55666654
No 53
>cd05723 Ig4_Neogenin Fourth immunoglobulin (Ig)-like domain in neogenin and similar proteins. Ig4_Neogenin: fourth immunoglobulin (Ig)-like domain in neogenin and related proteins. Neogenin is a cell surface protein which is expressed in the developing nervous system of vertebrate embryos in the growing nerve cells. It is also expressed in other embryonic tissues, and may play a general role in developmental processes such as cell migration, cell-cell recognition, and tissue growth regulation. Included in this group is the tumor suppressor protein DCC, which is deleted in colorectal carcinoma . DCC and neogenin each have four Ig-like domains followed by six fibronectin type III domains, a transmembrane domain, and an intracellular domain.
Probab=99.40 E-value=1.6e-12 Score=114.13 Aligned_cols=71 Identities=30% Similarity=0.631 Sum_probs=64.5
Q ss_pred eEEEEEEEecCCCcEEEEEeCCEecCCCCCeEEeecCCeEEEEEccCCCCCCEEEEEEEEeCCeeEEEEEEEEE
Q psy2148 1759 LARFDAKISATKPLDVYWLKNGKKIIPDIRYKTLEEDNLFTLLIIEAVVEDSGAYECVAMNNAGEARCEAELVV 1832 (1884)
Q Consensus 1759 ~~~l~C~~~g~p~p~v~W~k~~~~l~~~~~~~~~~~~~~~~L~i~~~~~~d~G~Y~C~a~N~~G~~~~~~~l~V 1832 (1884)
.+.|.|.+.|.|.|.++|+|+|..+..+.++.+..++ .|.|.++..+|+|.|+|.|.|..|+++.+++|.|
T Consensus 1 ~v~l~C~~~G~P~p~v~W~k~g~~~~~~~~~~~~~~~---~l~i~~v~~~D~G~Y~C~A~N~~G~~~~~~~L~V 71 (71)
T cd05723 1 DVIFECEVTGKPTPTVKWVKNGDMVIPSDYFKIVKEH---NLQVLGLVKSDEGFYQCIAENDVGNVQASAQLII 71 (71)
T ss_pred CEEEEEEEEEeCCCEEEEEECCeECCCCCCEEEEecC---CEEEEcCCcccCEEEEEEEEcCCCEEEEEEEEEC
Confidence 4789999999999999999999999888888776655 5888899999999999999999999999999976
No 54
>cd05869 Ig5_NCAM-1 Fifth immunoglobulin (Ig)-like domain of Neural Cell Adhesion Molecule NCAM-1 (NCAM). Ig5_NCAM-1: The fifth immunoglobulin (Ig)-like domain of Neural Cell Adhesion Molecule NCAM-1 (NCAM). NCAM plays important roles in the development and regeneration of the central nervous system, in synaptogenesis and neural migration. NCAM mediates cell-cell and cell-substratum recognition and adhesion via homophilic (NCAM-NCAM) and heterophilic (NCAM-non-NCAM) interactions. NCAM is expressed as three major isoforms having different intracellular extensions. The extracellular portion of NCAM has five N-terminal Ig-like domains and two fibronectin type III domains. The double zipper adhesion complex model for NCAM homophilic binding involves Ig1, Ig2, and Ig3. By this model, Ig1 and Ig2 mediate dimerization of NCAM molecules situated on the same cell surface (cis interactions), and Ig3 domains mediate interactions between NCAM molecules expressed on the surface of opposing cells (tr
Probab=99.40 E-value=2.3e-12 Score=121.71 Aligned_cols=91 Identities=20% Similarity=0.369 Sum_probs=74.8
Q ss_pred CCeeeecCCceeecCCCeEEEEEEEeeCCCCCcEEEEeeCCEEccCC-----CcEEEEeeCCeEEEEEccCCCCCCeEEE
Q psy2148 916 APEFLTTPTDLTLAESTLAHFECRLTPTNDPSMTVEWFHNGKALSAG-----SRIKTINDFGFVILEINDVYLRDSGLYT 990 (1884)
Q Consensus 916 ~p~~~~~~~~~~v~~G~~v~l~C~v~~~~~P~~~v~W~~~g~~i~~~-----~~~~~~~~~~~~~L~I~~~~~~D~G~Y~ 990 (1884)
.|+|...+....+..|+.++|.|.+. |.|.|.|+|++++..+... .++.+........|.|.+++.+|+|.|+
T Consensus 2 ~p~i~~~~~~~~~~~g~~v~l~C~~~--G~P~P~v~W~~~~~~~~~~~~~~~~~~~v~~~~~~~~L~I~~v~~~D~G~Y~ 79 (97)
T cd05869 2 KPKITYVENQTAMELEEQITLTCEAS--GDPIPSITWRTSTRNISSEEKTLDGHIVVRSHARVSSLTLKYIQYTDAGEYL 79 (97)
T ss_pred CceEEEccCceEEEcCCCEEEEEEee--EeCCCEEEEEECCccccCCccccCccEEEEcCccEEEEEEecCccCcCEEEE
Confidence 47777776666666789999999999 6788999999999887543 2444444445568999999999999999
Q ss_pred EEEEcCCeeEEEEEEEEE
Q psy2148 991 CKATNKHGEATTSCKLTV 1008 (1884)
Q Consensus 991 C~a~N~~G~~~~~~~l~V 1008 (1884)
|.|.|..|.++.++.|.|
T Consensus 80 C~A~N~~G~~~~~~~l~v 97 (97)
T cd05869 80 CTASNTIGQDSQSMYLEV 97 (97)
T ss_pred EEEecCCCCeeEEEEEEC
Confidence 999999999999998876
No 55
>cd05728 Ig4_Contactin-2-like Fourth Ig domain of the neural cell adhesion molecule contactin-2 and similar proteins. Ig4_Contactin-2-like: fourth Ig domain of the neural cell adhesion molecule contactin-2. Contactins are comprised of six Ig domains followed by four fibronectin type III (FnIII) domains anchored to the membrane by glycosylphosphatidylinositol. Contactin-2 (aliases TAG-1, axonin-1) facilitates cell adhesion by homophilic binding between molecules in apposed membranes. The first four Ig domains form the intermolecular binding fragment which arranges as a compact U-shaped module by contacts between Ig domains 1 and 4, and domains 2 and 3. It has been proposed that a linear zipper-like array forms, from contactin-2 molecules alternatively provided by the two apposed membranes.
Probab=99.40 E-value=1.5e-12 Score=119.28 Aligned_cols=84 Identities=33% Similarity=0.534 Sum_probs=74.8
Q ss_pred EEeccCceEEcCCceEEEEEEEecCCCcEEEEEeCCEecCCCCCeEEeecCCeEEEEEccCCCCCCEEEEEEEEeCCeeE
Q psy2148 1745 FLTTISSAVINVGQLARFDAKISATKPLDVYWLKNGKKIIPDIRYKTLEEDNLFTLLIIEAVVEDSGAYECVAMNNAGEA 1824 (1884)
Q Consensus 1745 ~~~~~~~~~~~~G~~~~l~C~~~g~p~p~v~W~k~~~~l~~~~~~~~~~~~~~~~L~i~~~~~~d~G~Y~C~a~N~~G~~ 1824 (1884)
|...|.+..+..|+.++|.|.+.|.|.|.+.|+|+|..+....++... .+ .|.|.++..+|+|.|+|.|.|..|..
T Consensus 2 ~~~~p~~~~~~~G~~~~l~C~~~g~p~p~v~W~k~g~~~~~~~~~~~~-~~---~L~i~~~~~~D~G~Y~C~a~N~~G~~ 77 (85)
T cd05728 2 WLKVISDTEADIGSSLRWECKASGNPRPAYRWLKNGQPLASENRIEVE-AG---DLRITKLSLSDSGMYQCVAENKHGTI 77 (85)
T ss_pred ccccCCccEEcCCCcEEEEEEeeEeCCCEEEEEECCEECCCCCeEEEe-CC---EEEEeeCCHHHCEEEEEEEECCCCeE
Confidence 455678889999999999999999999999999999999877776543 22 79999999999999999999999999
Q ss_pred EEEEEEEE
Q psy2148 1825 RCEAELVV 1832 (1884)
Q Consensus 1825 ~~~~~l~V 1832 (1884)
.+++.|+|
T Consensus 78 ~~~~~l~V 85 (85)
T cd05728 78 YASAELAV 85 (85)
T ss_pred EEEEEEEC
Confidence 99999876
No 56
>cd05859 Ig4_PDGFR-alpha Fourth immunoglobulin (Ig)-like domain of platelet-derived growth factor receptor (PDGFR) alpha. IG4_PDGFR-alpha: The fourth immunoglobulin (Ig)-like domain of platelet-derived growth factor receptor (PDGFR) alpha. PDGF is a potent mitogen for connective tissue cells. PDGF-stimulated processes are mediated by three different PDGFs (PDGF-A,-B, and C). PDGFR alpha binds to all three PDGFs, whereas the PDGFR beta (not included in this group) binds only to PDGF-B. PDGF alpha is organized as an extracellular component having five Ig-like domains, a transmembrane segment, and a cytoplasmic portion having protein tyrosine kinase activity. In mice, PDGFR alpha and PDGFR beta are essential for normal development.
Probab=99.39 E-value=2.7e-12 Score=120.59 Aligned_cols=83 Identities=27% Similarity=0.401 Sum_probs=71.4
Q ss_pred ceEEcCCceEEEEEEEecCCCcEEEEEeCCEecCCCCCeEEeec------CCeEEEEEccCCCCCCEEEEEEEEeCCeeE
Q psy2148 1751 SAVINVGQLARFDAKISATKPLDVYWLKNGKKIIPDIRYKTLEE------DNLFTLLIIEAVVEDSGAYECVAMNNAGEA 1824 (1884)
Q Consensus 1751 ~~~~~~G~~~~l~C~~~g~p~p~v~W~k~~~~l~~~~~~~~~~~------~~~~~L~i~~~~~~d~G~Y~C~a~N~~G~~ 1824 (1884)
...+..|+.++|.|.+.|+|.|.|.|+|||.+|..+.+...... ...+.|+|.++..+|+|.|+|.|.|..|.+
T Consensus 12 ~~~~~~~~~~~l~~~v~g~P~P~v~W~kdg~~l~~~~~~~~~~~~~~~~~~~~s~L~I~~v~~~D~G~Ytc~A~N~~g~~ 91 (101)
T cd05859 12 LEFANLHEVKEFVVEVEAYPPPQIRWLKDNRTLIENLTEITTSEHNVQETRYVSKLKLIRAKEEDSGLYTALAQNEDAVK 91 (101)
T ss_pred eEEEecCCcEEEEEEEEEeCCCceEEEECCEECcCCcceEEeccccccceeeccEEEEeeCCHHHCEEEEEEEEcCCceE
Confidence 56788899999999999999999999999999986654433211 123589999999999999999999999999
Q ss_pred EEEEEEEEE
Q psy2148 1825 RCEAELVVQ 1833 (1884)
Q Consensus 1825 ~~~~~l~V~ 1833 (1884)
+.+++|.|+
T Consensus 92 ~~t~~l~V~ 100 (101)
T cd05859 92 SYTFALQIQ 100 (101)
T ss_pred EEEEEEEEE
Confidence 999999986
No 57
>cd04968 Ig3_Contactin_like Third Ig domain of contactin. Ig3_Contactin_like: Third Ig domain of contactins. Contactins are neural cell adhesion molecules and are comprised of six Ig domains followed by four fibronectin type III(FnIII) domains anchored to the membrane by glycosylphosphatidylinositol. The first four Ig domains form the intermolecular binding fragment, which arranges as a compact U-shaped module via contacts between Ig domains 1 and 4, and between Ig domains 2 and 3. Contactin-2 (TAG-1, axonin-1) may play a part in the neuronal processes of neurite outgrowth, axon guidance and fasciculation, and neuronal migration. This group also includes contactin-1 and contactin-5. The different contactins show different expression patterns in the central nervous system. During development and in adulthood, contactin-2 is transiently expressed in subsets of central and peripheral neurons. Contactin-5 is expressed specifically in the rat postnatal nervous system, peaking at about 3 week
Probab=99.39 E-value=3.1e-12 Score=118.56 Aligned_cols=88 Identities=20% Similarity=0.252 Sum_probs=76.1
Q ss_pred CCeEEeccCceEEcCCceEEEEEEEecCCCcEEEEEeCCEecCCCCCeEEeecCCeEEEEEccCCCCCCEEEEEEEEeCC
Q psy2148 1742 PPSFLTTISSAVINVGQLARFDAKISATKPLDVYWLKNGKKIIPDIRYKTLEEDNLFTLLIIEAVVEDSGAYECVAMNNA 1821 (1884)
Q Consensus 1742 ~P~~~~~~~~~~~~~G~~~~l~C~~~g~p~p~v~W~k~~~~l~~~~~~~~~~~~~~~~L~i~~~~~~d~G~Y~C~a~N~~ 1821 (1884)
||.+...+.+..+.+|+.++|.|.+.|.|.|.++|+|++..+.....+. ..+ ..|.|.+++.+|+|.|+|.|.|..
T Consensus 1 p~~~~~~p~~~~~~~g~~v~l~C~~~g~P~p~v~W~k~~~~~~~~~~~~--~~~--~~L~i~~v~~~D~G~Y~C~a~N~~ 76 (88)
T cd04968 1 PSIIVVFPKDTYALKGQNVTLECFALGNPVPQIKWRKVDGSMPSSAEIS--MSG--AVLKIPNIQFEDEGTYECEAENIK 76 (88)
T ss_pred CCcEEECCCceEEeCCCcEEEEEEeeEeCCCEEEEEECCCcCCCccEEE--EeC--CEEEECCCCcccCEEEEEEEEECC
Confidence 4667788889999999999999999999999999999988776554433 222 389999999999999999999999
Q ss_pred eeEEEEEEEEEE
Q psy2148 1822 GEARCEAELVVQ 1833 (1884)
Q Consensus 1822 G~~~~~~~l~V~ 1833 (1884)
|..+.++.|+|+
T Consensus 77 G~~~~~~~l~V~ 88 (88)
T cd04968 77 GKDTHQGRIYVQ 88 (88)
T ss_pred CcEEEEEEEEEC
Confidence 999999999884
No 58
>cd05865 Ig1_NCAM-1 First immunoglobulin (Ig)-like domain of neural cell adhesion molecule NCAM-1. Ig1_NCAM-1: first immunoglobulin (Ig)-like domain of neural cell adhesion molecule NCAM-1. NCAM-1 plays important roles in the development and regeneration of the central nervous system, in synaptogenesis and neural migration. NCAM mediates cell-cell and cell-substratum recognition and adhesion via homophilic (NCAM-NCAM), and heterophilic (NCAM-nonNCAM), interactions. NCAM is expressed as three major isoforms having different intracellular extensions. The extracellular portion of NCAM has five N-terminal Ig-like domains and two fibronectin type III domains. The double zipper adhesion complex model for NCAM homophilic binding involves the Ig1, Ig2, and Ig3 domains. By this model, Ig1 and Ig2 mediate dimerization of NCAM molecules situated on the same cell surface (cis interactions), and Ig3 domains mediate interactions between NCAM molecules expressed on the surface of opposing cells (trans
Probab=99.39 E-value=3.4e-12 Score=118.54 Aligned_cols=85 Identities=29% Similarity=0.547 Sum_probs=70.9
Q ss_pred ccCceEEcCCceEEEEEEEecCCC-cEEEEEe-CCEecCC-CCCeEEee-cCCeEEEEEccCCCCCCEEEEEEEEeCC-e
Q psy2148 1748 TISSAVINVGQLARFDAKISATKP-LDVYWLK-NGKKIIP-DIRYKTLE-EDNLFTLLIIEAVVEDSGAYECVAMNNA-G 1822 (1884)
Q Consensus 1748 ~~~~~~~~~G~~~~l~C~~~g~p~-p~v~W~k-~~~~l~~-~~~~~~~~-~~~~~~L~i~~~~~~d~G~Y~C~a~N~~-G 1822 (1884)
.|....+..|++++|.|.+.|.|. |.|+|++ ++..+.. +.++.+.. ++..++|.|.++..+|+|.|+|.|+|.+ |
T Consensus 6 ~p~~~~v~~G~~v~l~C~v~G~P~~p~i~W~~~~g~~l~~~~~r~~v~~~~~~~~~L~I~~v~~~D~G~YtC~A~N~~~g 85 (96)
T cd05865 6 VPSQGEISVGESKFFLCQVAGEAKDKDISWFSPNGEKLTPNQQRISVVRNDDYSSTLTIYNANIDDAGIYKCVVSNEDEG 85 (96)
T ss_pred eCCccEECCCCeEEEEEEEeCCCCCCEEEEECCCCcCccccCCeEEEEeCCCCceEEEEeccChhhCEEEEEEEEcCCCC
Confidence 456677899999999999999995 7999998 7776655 44555543 3345699999999999999999999997 9
Q ss_pred eEEEEEEEEE
Q psy2148 1823 EARCEAELVV 1832 (1884)
Q Consensus 1823 ~~~~~~~l~V 1832 (1884)
.+++++.|.|
T Consensus 86 ~~~~s~~l~v 95 (96)
T cd05865 86 ESEATVNVKI 95 (96)
T ss_pred cEEEEEEEEE
Confidence 9999999987
No 59
>cd05859 Ig4_PDGFR-alpha Fourth immunoglobulin (Ig)-like domain of platelet-derived growth factor receptor (PDGFR) alpha. IG4_PDGFR-alpha: The fourth immunoglobulin (Ig)-like domain of platelet-derived growth factor receptor (PDGFR) alpha. PDGF is a potent mitogen for connective tissue cells. PDGF-stimulated processes are mediated by three different PDGFs (PDGF-A,-B, and C). PDGFR alpha binds to all three PDGFs, whereas the PDGFR beta (not included in this group) binds only to PDGF-B. PDGF alpha is organized as an extracellular component having five Ig-like domains, a transmembrane segment, and a cytoplasmic portion having protein tyrosine kinase activity. In mice, PDGFR alpha and PDGFR beta are essential for normal development.
Probab=99.38 E-value=2.2e-12 Score=121.15 Aligned_cols=83 Identities=18% Similarity=0.227 Sum_probs=70.7
Q ss_pred ceeecCCCeEEEEEEEeeCCCCCcEEEEeeCCEEccCCCcEEEEee------CCeEEEEEccCCCCCCeEEEEEEEcCCe
Q psy2148 925 DLTLAESTLAHFECRLTPTNDPSMTVEWFHNGKALSAGSRIKTIND------FGFVILEINDVYLRDSGLYTCKATNKHG 998 (1884)
Q Consensus 925 ~~~v~~G~~v~l~C~v~~~~~P~~~v~W~~~g~~i~~~~~~~~~~~------~~~~~L~I~~~~~~D~G~Y~C~a~N~~G 998 (1884)
..++..|+.+.|.|.+. |.|+|.|.|+|||.+|..+.+...... ...++|.|.++..+|+|.|+|.|+|..|
T Consensus 12 ~~~~~~~~~~~l~~~v~--g~P~P~v~W~kdg~~l~~~~~~~~~~~~~~~~~~~~s~L~I~~v~~~D~G~Ytc~A~N~~g 89 (101)
T cd05859 12 LEFANLHEVKEFVVEVE--AYPPPQIRWLKDNRTLIENLTEITTSEHNVQETRYVSKLKLIRAKEEDSGLYTALAQNEDA 89 (101)
T ss_pred eEEEecCCcEEEEEEEE--EeCCCceEEEECCEECcCCcceEEeccccccceeeccEEEEeeCCHHHCEEEEEEEEcCCc
Confidence 56788899999999999 678899999999999987665433221 1235899999999999999999999999
Q ss_pred eEEEEEEEEEE
Q psy2148 999 EATTSCKLTVK 1009 (1884)
Q Consensus 999 ~~~~~~~l~V~ 1009 (1884)
..+.++.|.|.
T Consensus 90 ~~~~t~~l~V~ 100 (101)
T cd05859 90 VKSYTFALQIQ 100 (101)
T ss_pred eEEEEEEEEEE
Confidence 99999999885
No 60
>cd05744 Ig_Myotilin_C_like Immunoglobulin (Ig)-like domain of myotilin, palladin, and myopalladin. Ig_Myotilin_like_C: immunoglobulin (Ig)-like domain in myotilin, palladin, and myopalladin. Myotilin, palladin, and myopalladin function as scaffolds that regulate actin organization. Myotilin and myopalladin are most abundant in skeletal and cardiac muscle; palladin is ubiquitously expressed in the organs of developing vertebrates and plays a key role in cellular morphogenesis. The three family members each interact with specific molecular partners: all three bind to alpha-actinin; in addition, palladin also binds to vasodilator-stimulated phosphoprotein (VASP) and ezrin, myotilin binds to filamin and actin, and myopalladin also binds to nebulin and cardiac ankyrin repeat protein (CARP).
Probab=99.38 E-value=2.8e-12 Score=113.76 Aligned_cols=73 Identities=33% Similarity=0.525 Sum_probs=63.8
Q ss_pred EEEEEEEecCCCcEEEEEeCCEecCC-CCCeEEeec-CCeEEEEEccCCCCCCEEEEEEEEeCCeeEEEEEEEEE
Q psy2148 1760 ARFDAKISATKPLDVYWLKNGKKIIP-DIRYKTLEE-DNLFTLLIIEAVVEDSGAYECVAMNNAGEARCEAELVV 1832 (1884)
Q Consensus 1760 ~~l~C~~~g~p~p~v~W~k~~~~l~~-~~~~~~~~~-~~~~~L~i~~~~~~d~G~Y~C~a~N~~G~~~~~~~l~V 1832 (1884)
++|.|.+.|.|.|.|.|+|++..+.. ..++.+... .+..+|.|.+++.+|+|.|+|.|.|.+|++++++.|.|
T Consensus 1 v~L~C~v~G~P~P~v~W~k~~~~i~~~~~r~~~~~~~~~~~~L~I~~~~~~D~G~Y~C~a~N~~G~~~~~~~l~v 75 (75)
T cd05744 1 VRLECRVSAIPPPQIFWKKNNEMLTYNTDRISLYQDNCGRICLLIQNANKEDAGWYTVSAVNEAGVVSCNARLDV 75 (75)
T ss_pred CEEEEEEeecCCCeEEEEECCEECCCCCCcEEEEEcCCCeEEEEECCCCcccCEEEEEEEEcCCCcEEEEEEEeC
Confidence 47999999999999999999999974 356666544 34568999999999999999999999999999999876
No 61
>cd05744 Ig_Myotilin_C_like Immunoglobulin (Ig)-like domain of myotilin, palladin, and myopalladin. Ig_Myotilin_like_C: immunoglobulin (Ig)-like domain in myotilin, palladin, and myopalladin. Myotilin, palladin, and myopalladin function as scaffolds that regulate actin organization. Myotilin and myopalladin are most abundant in skeletal and cardiac muscle; palladin is ubiquitously expressed in the organs of developing vertebrates and plays a key role in cellular morphogenesis. The three family members each interact with specific molecular partners: all three bind to alpha-actinin; in addition, palladin also binds to vasodilator-stimulated phosphoprotein (VASP) and ezrin, myotilin binds to filamin and actin, and myopalladin also binds to nebulin and cardiac ankyrin repeat protein (CARP).
Probab=99.38 E-value=2.6e-12 Score=113.93 Aligned_cols=73 Identities=30% Similarity=0.518 Sum_probs=63.0
Q ss_pred EEEEEEEeeCCCCCcEEEEeeCCEEccC-CCcEEEEee-CCeEEEEEccCCCCCCeEEEEEEEcCCeeEEEEEEEEE
Q psy2148 934 AHFECRLTPTNDPSMTVEWFHNGKALSA-GSRIKTIND-FGFVILEINDVYLRDSGLYTCKATNKHGEATTSCKLTV 1008 (1884)
Q Consensus 934 v~l~C~v~~~~~P~~~v~W~~~g~~i~~-~~~~~~~~~-~~~~~L~I~~~~~~D~G~Y~C~a~N~~G~~~~~~~l~V 1008 (1884)
++|+|.+. |.|.|.|.|+|+|..|.. ..++.+... .+.++|.|.+++.+|+|.|+|.|.|.+|+.++.+.|.|
T Consensus 1 v~L~C~v~--G~P~P~v~W~k~~~~i~~~~~r~~~~~~~~~~~~L~I~~~~~~D~G~Y~C~a~N~~G~~~~~~~l~v 75 (75)
T cd05744 1 VRLECRVS--AIPPPQIFWKKNNEMLTYNTDRISLYQDNCGRICLLIQNANKEDAGWYTVSAVNEAGVVSCNARLDV 75 (75)
T ss_pred CEEEEEEe--ecCCCeEEEEECCEECCCCCCcEEEEEcCCCeEEEEECCCCcccCEEEEEEEEcCCCcEEEEEEEeC
Confidence 57999998 789999999999999974 456666543 45568999999999999999999999999999998875
No 62
>cd05730 Ig3_NCAM-1_like Third immunoglobulin (Ig)-like domain of Neural Cell Adhesion Molecule NCAM-1 (NCAM). Ig3_NCAM-1_like: domain similar to the third immunoglobulin (Ig)-like domain of Neural Cell Adhesion Molecule NCAM-1 (NCAM). NCAM plays important roles in the development and regeneration of the central nervous system, in synaptogenesis and neural migration. NCAM mediates cell-cell and cell-substratum recognition and adhesion via homophilic (NCAM-NCAM), and heterophilic (NCAM-non-NCAM), interactions. NCAM is expressed as three major isoforms having different intracellular extensions. The extracellular portion of NCAM has five N-terminal Ig-like domains and two fibronectin type III domains. The double zipper adhesion complex model for NCAM homophilic binding involves Ig1, Ig2, and Ig3. By this model, Ig1,and Ig2 mediate dimerization of NCAM molecules situated on the same cell surface (cis interactions), and Ig3 domains mediate interactions between NCAM molecules expressed on the
Probab=99.38 E-value=3.4e-12 Score=120.44 Aligned_cols=91 Identities=25% Similarity=0.364 Sum_probs=74.6
Q ss_pred CCeeeec--CCceeecCCCeEEEEEEEeeCCCCCcEEEEeeCCEEccCC-CcEEEEeeCCeEEEEEccCCCCCCeEEEEE
Q psy2148 916 APEFLTT--PTDLTLAESTLAHFECRLTPTNDPSMTVEWFHNGKALSAG-SRIKTINDFGFVILEINDVYLRDSGLYTCK 992 (1884)
Q Consensus 916 ~p~~~~~--~~~~~v~~G~~v~l~C~v~~~~~P~~~v~W~~~g~~i~~~-~~~~~~~~~~~~~L~I~~~~~~D~G~Y~C~ 992 (1884)
||.|... +.+..+..|+++.|.|.+. |.|.|.|.|+|+|..+... .++.....+ +.|.|.+++.+|+|.|+|.
T Consensus 1 pp~i~~~~~~~~~~~~~G~~v~L~C~~~--g~P~p~v~W~k~g~~~~~~~~~~~~~~~~--~~L~I~~v~~~D~G~Y~C~ 76 (95)
T cd05730 1 PPTIRARQSEVNATANLGQSVTLACDAD--GFPEPTMTWTKDGEPIESGEEKYSFNEDG--SEMTILDVDKLDEAEYTCI 76 (95)
T ss_pred CCccccCCcccceEEeCCCCEEEEEecc--EeCCCEEEEEECCEECcCCCCEEEEeCCC--CEEEECCCChhhCEEEEEE
Confidence 4555543 3456889999999999998 6788999999999999776 455443332 3799999999999999999
Q ss_pred EEcCCeeEEEEEEEEEEe
Q psy2148 993 ATNKHGEATTSCKLTVKG 1010 (1884)
Q Consensus 993 a~N~~G~~~~~~~l~V~~ 1010 (1884)
|+|.+|..+.++.|.|..
T Consensus 77 a~N~~G~~~~~~~L~V~~ 94 (95)
T cd05730 77 AENKAGEQEAEIHLKVFA 94 (95)
T ss_pred EEcCCCeEEEEEEEEEEe
Confidence 999999999999999863
No 63
>cd05866 Ig1_NCAM-2 First immunoglobulin (Ig)-like domain of neural cell adhesion molecule NCAM-2. Ig1_NCAM-2: first immunoglobulin (Ig)-like domain of neural cell adhesion molecule NCAM-2 (OCAM/mamFas II, RNCAM). NCAM-2 is organized similarly to NCAM , including five N-terminal Ig-like domains and two fibronectin type III domains. NCAM-2 is differentially expressed in the developing and mature olfactory epithelium (OE), and may function like NCAM, as an adhesion molecule.
Probab=99.38 E-value=5.7e-12 Score=115.61 Aligned_cols=85 Identities=25% Similarity=0.431 Sum_probs=73.8
Q ss_pred eccCceEEcCCceEEEEEEEecCCCcEEEEEe-CCEecCCCCCeEEeecCCeEEEEEccCCCCCCEEEEEEEEeCCeeE-
Q psy2148 1747 TTISSAVINVGQLARFDAKISATKPLDVYWLK-NGKKIIPDIRYKTLEEDNLFTLLIIEAVVEDSGAYECVAMNNAGEA- 1824 (1884)
Q Consensus 1747 ~~~~~~~~~~G~~~~l~C~~~g~p~p~v~W~k-~~~~l~~~~~~~~~~~~~~~~L~i~~~~~~d~G~Y~C~a~N~~G~~- 1824 (1884)
..+.+..+..|+++.|.|.+.|.|. .++|++ ++..+..+.++.+..++..+.|.|.++..+|+|.|+|.|+|..|..
T Consensus 5 ~~~~~~~v~~G~~v~l~C~~~G~P~-~v~W~k~~g~~~~~~~r~~~~~~g~~~~L~I~~v~~~D~G~Y~C~A~N~~G~~~ 83 (92)
T cd05866 5 ISLSKVELSVGESKFFTCTAIGEPE-SIDWYNPQGEKIVSSQRVVVQKEGVRSRLTIYNANIEDAGIYRCQATDAKGQTQ 83 (92)
T ss_pred EEecceEEcCCCeEEEEEEEEEeCC-eEEEEeCCCeEecCCCCEEEEeCCCeeEEEEecCChHHCEEEEEEEEcCCCcEE
Confidence 4457788999999999999999998 999998 5778877788888777777899999999999999999999999985
Q ss_pred EEEEEEEE
Q psy2148 1825 RCEAELVV 1832 (1884)
Q Consensus 1825 ~~~~~l~V 1832 (1884)
.+++.|.|
T Consensus 84 ~~~i~l~~ 91 (92)
T cd05866 84 EATVVLEI 91 (92)
T ss_pred EEEEEEEE
Confidence 56677765
No 64
>cd05854 Ig6_Contactin-2 Sixth Ig domain of contactin-2. Ig6_Contactin-2: Sixth Ig domain of the neural cell adhesion molecule contactin-2-like. Contactins are comprised of six Ig domains followed by four fibronectin type III (FnIII) domains anchored to the membrane by glycosylphosphatidylinositol. Contactin-2 (TAG-1, axonin-1) facilitates cell adhesion by homophilic binding between molecules in apposed membranes. It may play a part in the neuronal processes of neurite outgrowth, axon guidance and fasciculation, and neuronal migration. The first four Ig domains form the intermolecular binding fragment, which arranges as a compact U-shaped module by contacts between IG domains 1 and 4, and domains 2 and 3. The different contactins show different expression patterns in the central nervous system. During development and in adulthood, contactin-2 is transiently expressed in subsets of central and peripheral neurons. Contactin-2 is also expressed in retinal amacrine cells in the developing c
Probab=99.38 E-value=3.8e-12 Score=115.87 Aligned_cols=81 Identities=20% Similarity=0.326 Sum_probs=64.3
Q ss_pred CeEEEEEEEeeCCCCCcEEEEeeCCEEccCC---CcEEEEe-eCCeEEEEEccCCCCCCeEEEEEEEcCCeeEEEEEEEE
Q psy2148 932 TLAHFECRLTPTNDPSMTVEWFHNGKALSAG---SRIKTIN-DFGFVILEINDVYLRDSGLYTCKATNKHGEATTSCKLT 1007 (1884)
Q Consensus 932 ~~v~l~C~v~~~~~P~~~v~W~~~g~~i~~~---~~~~~~~-~~~~~~L~I~~~~~~D~G~Y~C~a~N~~G~~~~~~~l~ 1007 (1884)
++++|.|.+.|.+.|.+.|+|+|||..|... .++.+.. ......|.|.+++.+|+|.|+|.|.|.+|+.++++.|.
T Consensus 1 ~~~~L~C~a~g~P~p~~~v~W~~~g~~i~~~~~~~~~~~~~~~~~~~~L~I~~v~~~D~G~YtC~A~n~~g~~~~~~~L~ 80 (85)
T cd05854 1 ENLTLQCHASHDPTMDLTFTWSLDDFPIDLDKPNGHYRRMEVKETIGDLVIVNAQLSHAGTYTCTAQTVVDSASASATLV 80 (85)
T ss_pred CcEEEEEEEecCCCCCeEEEEEECCeEccccCCCCcEEEEEecceEeEEEEccCChhhCeEEEEEEecCCCCEEEEEEEE
Confidence 4689999999544444578999999998643 3443222 12335899999999999999999999999999999999
Q ss_pred EEeec
Q psy2148 1008 VKGRQ 1012 (1884)
Q Consensus 1008 V~~~~ 1012 (1884)
|.++|
T Consensus 81 V~~~P 85 (85)
T cd05854 81 VRGPP 85 (85)
T ss_pred EECCC
Confidence 98754
No 65
>cd05732 Ig5_NCAM-1_like Fifth immunoglobulin (Ig)-like domain of Neural Cell Adhesion Molecule NCAM-1 (NCAM) and similar proteins. Ig5_NCAM-1 like: domain similar to the fifth immunoglobulin (Ig)-like domain of Neural Cell Adhesion Molecule NCAM-1 (NCAM). NCAM plays important roles in the development and regeneration of the central nervous system, in synaptogenesis and neural migration. NCAM mediates cell-cell and cell-substratum recognition and adhesion via homophilic (NCAM-NCAM), and heterophilic (NCAM-non-NCAM), interactions. NCAM is expressed as three major isoforms having different intracellular extensions. The extracellular portion of NCAM has five N-terminal Ig-like domains and two fibronectin type III domains. The double zipper adhesion complex model for NCAM homophilic binding involves Ig1, Ig2, and Ig3. By this model, Ig1 and Ig2 mediate dimerization of NCAM molecules situated on the same cell surface (cis interactions), and Ig3 domains mediate interactions between NCAM mole
Probab=99.37 E-value=3.1e-12 Score=121.38 Aligned_cols=90 Identities=28% Similarity=0.447 Sum_probs=75.3
Q ss_pred CCeeeecCCceeecCCCeEEEEEEEeeCCCCCcEEEEeeCCEEccCC-----CcEEEEeeCCeEEEEEccCCCCCCeEEE
Q psy2148 916 APEFLTTPTDLTLAESTLAHFECRLTPTNDPSMTVEWFHNGKALSAG-----SRIKTINDFGFVILEINDVYLRDSGLYT 990 (1884)
Q Consensus 916 ~p~~~~~~~~~~v~~G~~v~l~C~v~~~~~P~~~v~W~~~g~~i~~~-----~~~~~~~~~~~~~L~I~~~~~~D~G~Y~ 990 (1884)
+|+|. .+.+.++.+|+.+.|.|.+. |.|.|.|.|++++..+... .++.+......++|.|.+++.+|+|.|+
T Consensus 2 ~P~i~-~~~~~~~~~g~~v~l~C~~~--g~p~p~v~W~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~I~~v~~~D~G~Y~ 78 (96)
T cd05732 2 QPKIT-YLENQTAVELEQITLTCEAE--GDPIPEITWRRATRNFSEGDKSLDGRIVVRGHARVSSLTLKDVQLTDAGRYD 78 (96)
T ss_pred Cccce-ecCceeEecCCcEEEEEEEe--EcCCCcEEEEECCcccCCCCccccceEEEeCCccEEEEEECcCCcCcCEEeE
Confidence 46775 56788999999999999998 6788899999999777543 3455544455678999999999999999
Q ss_pred EEEEcCCeeEEEEEEEEE
Q psy2148 991 CKATNKHGEATTSCKLTV 1008 (1884)
Q Consensus 991 C~a~N~~G~~~~~~~l~V 1008 (1884)
|.|+|..|..+.++.|.|
T Consensus 79 C~a~N~~G~~~~s~~l~v 96 (96)
T cd05732 79 CEASNRIGGDQQSMYLEV 96 (96)
T ss_pred EEEEeCCCCcEEEEEEeC
Confidence 999999999999888875
No 66
>cd05863 Ig2_VEGFR-3 Second immunoglobulin (Ig)-like domain of vascular endothelial growth factor receptor 3 (VEGFR-3). Ig2_VEGFR-3: Second immunoglobulin (Ig)-like domain of vascular endothelial growth factor receptor 3 (VEGFR-3). The VEGFRs have an extracellular component with seven Ig-like domains, a transmembrane segment, and an intracellular tyrosine kinase domain interrupted by a kinase-insert domain. VEGFRs bind VEGFs with high affinity at the Ig-like domains. VEGFR-3 (Flt-4) binds two members of the VEGF family (VEGF-C and -D) and is involved in tumor angiogenesis and growth.
Probab=99.37 E-value=2.2e-12 Score=109.52 Aligned_cols=66 Identities=24% Similarity=0.374 Sum_probs=57.2
Q ss_pred EEEEEEEecCCCcEEEEEeCCEecCCCCCeEEeecCCeEEEEEccCCCCCCEEEEEEEEeCCeeEEEEEEEEEE
Q psy2148 1760 ARFDAKISATKPLDVYWLKNGKKIIPDIRYKTLEEDNLFTLLIIEAVVEDSGAYECVAMNNAGEARCEAELVVQ 1833 (1884)
Q Consensus 1760 ~~l~C~~~g~p~p~v~W~k~~~~l~~~~~~~~~~~~~~~~L~i~~~~~~d~G~Y~C~a~N~~G~~~~~~~l~V~ 1833 (1884)
++|.|.+.|.|.|.++|+|||++|... .....|.|.++..+|+|.|+|.|+|..|..+.++.|+|.
T Consensus 1 ~~l~c~v~g~P~P~v~W~kdg~~l~~~--------~~~~~L~i~~v~~~D~G~YtC~a~N~~g~~~~~~~~~l~ 66 (67)
T cd05863 1 VKLPVKVAAYPPPEFQWYKDGKLISGK--------HSQHSLQIKDVTEASAGTYTLVLWNSAAGLEKRISLELI 66 (67)
T ss_pred CEEEEEEEEeCCCEEEEEECCEECccc--------CCcCEEEECCCCHHHCEEEEEEEEECCccEEEEEEEEEE
Confidence 479999999999999999999999532 123489999999999999999999999988888777764
No 67
>cd05723 Ig4_Neogenin Fourth immunoglobulin (Ig)-like domain in neogenin and similar proteins. Ig4_Neogenin: fourth immunoglobulin (Ig)-like domain in neogenin and related proteins. Neogenin is a cell surface protein which is expressed in the developing nervous system of vertebrate embryos in the growing nerve cells. It is also expressed in other embryonic tissues, and may play a general role in developmental processes such as cell migration, cell-cell recognition, and tissue growth regulation. Included in this group is the tumor suppressor protein DCC, which is deleted in colorectal carcinoma . DCC and neogenin each have four Ig-like domains followed by six fibronectin type III domains, a transmembrane domain, and an intracellular domain.
Probab=99.37 E-value=3.5e-12 Score=112.07 Aligned_cols=71 Identities=30% Similarity=0.591 Sum_probs=62.6
Q ss_pred eEEEEEEEeeCCCCCcEEEEeeCCEEccCCCcEEEEeeCCeEEEEEccCCCCCCeEEEEEEEcCCeeEEEEEEEEE
Q psy2148 933 LAHFECRLTPTNDPSMTVEWFHNGKALSAGSRIKTINDFGFVILEINDVYLRDSGLYTCKATNKHGEATTSCKLTV 1008 (1884)
Q Consensus 933 ~v~l~C~v~~~~~P~~~v~W~~~g~~i~~~~~~~~~~~~~~~~L~I~~~~~~D~G~Y~C~a~N~~G~~~~~~~l~V 1008 (1884)
.+.|+|.+. |.|.|.|+|+|+|..+....++.+..++ .|.|.+++.+|+|.|+|.|+|.+|+.++++.|.|
T Consensus 1 ~v~l~C~~~--G~P~p~v~W~k~g~~~~~~~~~~~~~~~---~l~i~~v~~~D~G~Y~C~A~N~~G~~~~~~~L~V 71 (71)
T cd05723 1 DVIFECEVT--GKPTPTVKWVKNGDMVIPSDYFKIVKEH---NLQVLGLVKSDEGFYQCIAENDVGNVQASAQLII 71 (71)
T ss_pred CEEEEEEEE--EeCCCEEEEEECCeECCCCCCEEEEecC---CEEEEcCCcccCEEEEEEEEcCCCEEEEEEEEEC
Confidence 478999998 7799999999999999887777765554 3788899999999999999999999999998875
No 68
>cd04968 Ig3_Contactin_like Third Ig domain of contactin. Ig3_Contactin_like: Third Ig domain of contactins. Contactins are neural cell adhesion molecules and are comprised of six Ig domains followed by four fibronectin type III(FnIII) domains anchored to the membrane by glycosylphosphatidylinositol. The first four Ig domains form the intermolecular binding fragment, which arranges as a compact U-shaped module via contacts between Ig domains 1 and 4, and between Ig domains 2 and 3. Contactin-2 (TAG-1, axonin-1) may play a part in the neuronal processes of neurite outgrowth, axon guidance and fasciculation, and neuronal migration. This group also includes contactin-1 and contactin-5. The different contactins show different expression patterns in the central nervous system. During development and in adulthood, contactin-2 is transiently expressed in subsets of central and peripheral neurons. Contactin-5 is expressed specifically in the rat postnatal nervous system, peaking at about 3 week
Probab=99.37 E-value=4.2e-12 Score=117.70 Aligned_cols=88 Identities=20% Similarity=0.411 Sum_probs=75.0
Q ss_pred CCeeeecCCceeecCCCeEEEEEEEeeCCCCCcEEEEeeCCEEccCCCcEEEEeeCCeEEEEEccCCCCCCeEEEEEEEc
Q psy2148 916 APEFLTTPTDLTLAESTLAHFECRLTPTNDPSMTVEWFHNGKALSAGSRIKTINDFGFVILEINDVYLRDSGLYTCKATN 995 (1884)
Q Consensus 916 ~p~~~~~~~~~~v~~G~~v~l~C~v~~~~~P~~~v~W~~~g~~i~~~~~~~~~~~~~~~~L~I~~~~~~D~G~Y~C~a~N 995 (1884)
||.+...+.+..+.+|+.+.|.|.+. |.|.|.|+|+|++..+....... ..+ ..|.|.+++.+|+|.|+|.|.|
T Consensus 1 p~~~~~~p~~~~~~~g~~v~l~C~~~--g~P~p~v~W~k~~~~~~~~~~~~--~~~--~~L~i~~v~~~D~G~Y~C~a~N 74 (88)
T cd04968 1 PSIIVVFPKDTYALKGQNVTLECFAL--GNPVPQIKWRKVDGSMPSSAEIS--MSG--AVLKIPNIQFEDEGTYECEAEN 74 (88)
T ss_pred CCcEEECCCceEEeCCCcEEEEEEee--EeCCCEEEEEECCCcCCCccEEE--EeC--CEEEECCCCcccCEEEEEEEEE
Confidence 46677788999999999999999998 67888999999988776554433 222 3799999999999999999999
Q ss_pred CCeeEEEEEEEEEE
Q psy2148 996 KHGEATTSCKLTVK 1009 (1884)
Q Consensus 996 ~~G~~~~~~~l~V~ 1009 (1884)
..|..+..+.|+|+
T Consensus 75 ~~G~~~~~~~l~V~ 88 (88)
T cd04968 75 IKGKDTHQGRIYVQ 88 (88)
T ss_pred CCCcEEEEEEEEEC
Confidence 99999999999884
No 69
>cd04969 Ig5_Contactin_like Fifth Ig domain of contactin. Ig5_Contactin_like: Fifth Ig domain of contactins. Contactins are neural cell adhesion molecules and are comprised of six Ig domains followed by four fibronectin type III(FnIII) domains anchored to the membrane by glycosylphosphatidylinositol. The first four Ig domains form the intermolecular binding fragment, which arranges as a compact U-shaped module via contacts between Ig domains 1 and 4, and between Ig domains 2 and 3. Contactin-2 (TAG-1, axonin-1) may play a part in the neuronal processes of neurite outgrowth, axon guidance and fasciculation, and neuronal migration. This group also includes contactin-1 and contactin-5. The different contactins show different expression patterns in the central nervous system. During development and in adulthood, contactin-2 is transiently expressed in subsets of central and peripheral neurons. Contactin-5 is expressed specifically in the rat postnatal nervous system, peaking at about 3 week
Probab=99.36 E-value=3.6e-12 Score=113.04 Aligned_cols=73 Identities=25% Similarity=0.351 Sum_probs=67.2
Q ss_pred CceEEEEEEEecCCCcEEEEEeCCEecCCCCCeEEeecCCeEEEEEccCCCCCCEEEEEEEEeCCeeEEEEEEEEE
Q psy2148 1757 GQLARFDAKISATKPLDVYWLKNGKKIIPDIRYKTLEEDNLFTLLIIEAVVEDSGAYECVAMNNAGEARCEAELVV 1832 (1884)
Q Consensus 1757 G~~~~l~C~~~g~p~p~v~W~k~~~~l~~~~~~~~~~~~~~~~L~i~~~~~~d~G~Y~C~a~N~~G~~~~~~~l~V 1832 (1884)
|+.+.|.|.+.|.|.|.++|+|++..+....++.+..++ .|.|.++..+|+|.|+|.|.|..|..+.++.|.|
T Consensus 1 G~~v~L~C~~~g~P~p~v~W~k~~~~~~~~~~~~~~~~~---~L~i~~v~~~D~G~Y~C~a~N~~G~~~~~~~l~V 73 (73)
T cd04969 1 GGDVIIECKPKAAPKPTISWSKGTELLTNSSRICIWPDG---SLEILNVTKSDEGKYTCFAENFFGKANSTGSLSV 73 (73)
T ss_pred CCeEEEEEeeeEcCCCEEEEEECCEEcccCCCEEECCCC---eEEEccCChhHCEEEEEEEECCCCceEEEEEEEC
Confidence 788999999999999999999999999888888765544 7999999999999999999999999999999876
No 70
>cd05732 Ig5_NCAM-1_like Fifth immunoglobulin (Ig)-like domain of Neural Cell Adhesion Molecule NCAM-1 (NCAM) and similar proteins. Ig5_NCAM-1 like: domain similar to the fifth immunoglobulin (Ig)-like domain of Neural Cell Adhesion Molecule NCAM-1 (NCAM). NCAM plays important roles in the development and regeneration of the central nervous system, in synaptogenesis and neural migration. NCAM mediates cell-cell and cell-substratum recognition and adhesion via homophilic (NCAM-NCAM), and heterophilic (NCAM-non-NCAM), interactions. NCAM is expressed as three major isoforms having different intracellular extensions. The extracellular portion of NCAM has five N-terminal Ig-like domains and two fibronectin type III domains. The double zipper adhesion complex model for NCAM homophilic binding involves Ig1, Ig2, and Ig3. By this model, Ig1 and Ig2 mediate dimerization of NCAM molecules situated on the same cell surface (cis interactions), and Ig3 domains mediate interactions between NCAM mole
Probab=99.35 E-value=5.4e-12 Score=119.71 Aligned_cols=90 Identities=14% Similarity=0.230 Sum_probs=76.1
Q ss_pred CCeEEeccCceEEcCCceEEEEEEEecCCCcEEEEEeCCEecCCC-----CCeEEeecCCeEEEEEccCCCCCCEEEEEE
Q psy2148 1742 PPSFLTTISSAVINVGQLARFDAKISATKPLDVYWLKNGKKIIPD-----IRYKTLEEDNLFTLLIIEAVVEDSGAYECV 1816 (1884)
Q Consensus 1742 ~P~~~~~~~~~~~~~G~~~~l~C~~~g~p~p~v~W~k~~~~l~~~-----~~~~~~~~~~~~~L~i~~~~~~d~G~Y~C~ 1816 (1884)
+|.|. .+.+..+.+|+.++|.|.+.|.|.|.|.|++++..+... .++.+........|+|.++..+|+|.|+|.
T Consensus 2 ~P~i~-~~~~~~~~~g~~v~l~C~~~g~p~p~v~W~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~I~~v~~~D~G~Y~C~ 80 (96)
T cd05732 2 QPKIT-YLENQTAVELEQITLTCEAEGDPIPEITWRRATRNFSEGDKSLDGRIVVRGHARVSSLTLKDVQLTDAGRYDCE 80 (96)
T ss_pred Cccce-ecCceeEecCCcEEEEEEEeEcCCCcEEEEECCcccCCCCccccceEEEeCCccEEEEEECcCCcCcCEEeEEE
Confidence 57775 456788999999999999999999999999999776543 244444445567999999999999999999
Q ss_pred EEeCCeeEEEEEEEEE
Q psy2148 1817 AMNNAGEARCEAELVV 1832 (1884)
Q Consensus 1817 a~N~~G~~~~~~~l~V 1832 (1884)
|.|..|.++.++.|.|
T Consensus 81 a~N~~G~~~~s~~l~v 96 (96)
T cd05732 81 ASNRIGGDQQSMYLEV 96 (96)
T ss_pred EEeCCCCcEEEEEEeC
Confidence 9999999999998875
No 71
>cd05863 Ig2_VEGFR-3 Second immunoglobulin (Ig)-like domain of vascular endothelial growth factor receptor 3 (VEGFR-3). Ig2_VEGFR-3: Second immunoglobulin (Ig)-like domain of vascular endothelial growth factor receptor 3 (VEGFR-3). The VEGFRs have an extracellular component with seven Ig-like domains, a transmembrane segment, and an intracellular tyrosine kinase domain interrupted by a kinase-insert domain. VEGFRs bind VEGFs with high affinity at the Ig-like domains. VEGFR-3 (Flt-4) binds two members of the VEGF family (VEGF-C and -D) and is involved in tumor angiogenesis and growth.
Probab=99.35 E-value=2.4e-12 Score=109.31 Aligned_cols=66 Identities=21% Similarity=0.340 Sum_probs=56.1
Q ss_pred EEEEEEEeeCCCCCcEEEEeeCCEEccCCCcEEEEeeCCeEEEEEccCCCCCCeEEEEEEEcCCeeEEEEEEEEEE
Q psy2148 934 AHFECRLTPTNDPSMTVEWFHNGKALSAGSRIKTINDFGFVILEINDVYLRDSGLYTCKATNKHGEATTSCKLTVK 1009 (1884)
Q Consensus 934 v~l~C~v~~~~~P~~~v~W~~~g~~i~~~~~~~~~~~~~~~~L~I~~~~~~D~G~Y~C~a~N~~G~~~~~~~l~V~ 1009 (1884)
++|.|.+. |.|+|.++|+|||++|.... ....|.|.++..+|+|.|+|.|+|..|..+.+..|+|.
T Consensus 1 ~~l~c~v~--g~P~P~v~W~kdg~~l~~~~--------~~~~L~i~~v~~~D~G~YtC~a~N~~g~~~~~~~~~l~ 66 (67)
T cd05863 1 VKLPVKVA--AYPPPEFQWYKDGKLISGKH--------SQHSLQIKDVTEASAGTYTLVLWNSAAGLEKRISLELI 66 (67)
T ss_pred CEEEEEEE--EeCCCEEEEEECCEECcccC--------CcCEEEECCCCHHHCEEEEEEEEECCccEEEEEEEEEE
Confidence 47999999 78999999999999996321 22379999999999999999999999988877777663
No 72
>cd05743 Ig_Perlecan_D2_like Immunoglobulin (Ig)-like domain II (D2) of the human basement membrane heparan sulfate proteoglycan perlecan, also known as HSPG2. Ig_Perlecan_D2_like: the immunoglobulin (Ig)-like domain II (D2) of the human basement membrane heparan sulfate proteoglycan perlecan, also known as HSPG2. Perlecan consists of five domains. Domain I has three putative heparan sulfate attachment sites; domain II has four LDL receptor-like repeats, and one Ig-like repeat; domain III resembles the short arm of laminin chains; domain IV has multiple Ig-like repeats (21 repeats in human perlecan); and domain V resembles the globular G domain of the laminin A chain and internal repeats of EGF. Perlecan may participate in a variety of biological functions including cell binding, LDL-metabolism, basement membrane assembly and selective permeability, calcium binding, and growth- and neurite-promoting activities.
Probab=99.35 E-value=5.8e-12 Score=113.25 Aligned_cols=76 Identities=26% Similarity=0.408 Sum_probs=67.8
Q ss_pred CCeEEEEEEEeeCCCCCcEEEEeeCCEEccCCCcEEEEeeCCeEEEEEccCCCCCCeEEEEEEEcCCeeEEEEEEEEE
Q psy2148 931 STLAHFECRLTPTNDPSMTVEWFHNGKALSAGSRIKTINDFGFVILEINDVYLRDSGLYTCKATNKHGEATTSCKLTV 1008 (1884)
Q Consensus 931 G~~v~l~C~v~~~~~P~~~v~W~~~g~~i~~~~~~~~~~~~~~~~L~I~~~~~~D~G~Y~C~a~N~~G~~~~~~~l~V 1008 (1884)
|+++.|.|.+. |.|.|.|+|+|++..+....++.+...++...|.|.+++.+|+|.|+|.|.|..|...+.+.+.+
T Consensus 1 G~~v~l~C~~~--g~P~p~v~W~~~~~~~~~~~~~~~~~~~~~~~L~I~~v~~~D~G~Y~C~a~N~~G~~~~~~~~~~ 76 (78)
T cd05743 1 GETVEFTCVAT--GVPTPIINWRLNWGHVPDSARVSITSEGGYGTLTIRDVKESDQGAYTCEAINTRGMVFGIPDGIL 76 (78)
T ss_pred CCEEEEEEEEE--EecCCEEEEEECCeECCCCCCEEEEECCCEEEEEECCCChHHCEEEEEEEEecCCEEEecccEEE
Confidence 78999999998 77889999999999998888888777777779999999999999999999999999887766554
No 73
>cd05743 Ig_Perlecan_D2_like Immunoglobulin (Ig)-like domain II (D2) of the human basement membrane heparan sulfate proteoglycan perlecan, also known as HSPG2. Ig_Perlecan_D2_like: the immunoglobulin (Ig)-like domain II (D2) of the human basement membrane heparan sulfate proteoglycan perlecan, also known as HSPG2. Perlecan consists of five domains. Domain I has three putative heparan sulfate attachment sites; domain II has four LDL receptor-like repeats, and one Ig-like repeat; domain III resembles the short arm of laminin chains; domain IV has multiple Ig-like repeats (21 repeats in human perlecan); and domain V resembles the globular G domain of the laminin A chain and internal repeats of EGF. Perlecan may participate in a variety of biological functions including cell binding, LDL-metabolism, basement membrane assembly and selective permeability, calcium binding, and growth- and neurite-promoting activities.
Probab=99.34 E-value=7.4e-12 Score=112.56 Aligned_cols=76 Identities=22% Similarity=0.289 Sum_probs=68.2
Q ss_pred CceEEEEEEEecCCCcEEEEEeCCEecCCCCCeEEeecCCeEEEEEccCCCCCCEEEEEEEEeCCeeEEEEEEEEE
Q psy2148 1757 GQLARFDAKISATKPLDVYWLKNGKKIIPDIRYKTLEEDNLFTLLIIEAVVEDSGAYECVAMNNAGEARCEAELVV 1832 (1884)
Q Consensus 1757 G~~~~l~C~~~g~p~p~v~W~k~~~~l~~~~~~~~~~~~~~~~L~i~~~~~~d~G~Y~C~a~N~~G~~~~~~~l~V 1832 (1884)
|++++|.|.+.|.|.|.|+|+|++..+....++.+...++...|+|.++..+|+|.|+|.|.|..|.....+.+.+
T Consensus 1 G~~v~l~C~~~g~P~p~v~W~~~~~~~~~~~~~~~~~~~~~~~L~I~~v~~~D~G~Y~C~a~N~~G~~~~~~~~~~ 76 (78)
T cd05743 1 GETVEFTCVATGVPTPIINWRLNWGHVPDSARVSITSEGGYGTLTIRDVKESDQGAYTCEAINTRGMVFGIPDGIL 76 (78)
T ss_pred CCEEEEEEEEEEecCCEEEEEECCeECCCCCCEEEEECCCEEEEEECCCChHHCEEEEEEEEecCCEEEecccEEE
Confidence 7899999999999999999999999998777887777777789999999999999999999999999877766554
No 74
>cd05891 Ig_M-protein_C C-terminal immunoglobulin (Ig)-like domain of M-protein (also known as myomesin-2). Ig_M-protein_C: the C-terminal immunoglobulin (Ig)-like domain of M-protein (also known as myomesin-2). M-protein is a structural protein localized to the M-band, a transverse structure in the center of the sarcomere, and is a candidate for M-band bridges. M-protein is modular consisting mainly of repetitive IG-like and fibronectin type III (FnIII) domains, and has a muscle-type specific expression pattern. M-protein is present in fast fibers.
Probab=99.34 E-value=9.3e-12 Score=115.63 Aligned_cols=85 Identities=21% Similarity=0.286 Sum_probs=73.9
Q ss_pred ccCceEEcCCceEEEEEEEecCCCcEEEEEeCCEecCCCCCeEEee-cCCeEEEEEccCCCCCCEEEEEEEEeCCeeEEE
Q psy2148 1748 TISSAVINVGQLARFDAKISATKPLDVYWLKNGKKIIPDIRYKTLE-EDNLFTLLIIEAVVEDSGAYECVAMNNAGEARC 1826 (1884)
Q Consensus 1748 ~~~~~~~~~G~~~~l~C~~~g~p~p~v~W~k~~~~l~~~~~~~~~~-~~~~~~L~i~~~~~~d~G~Y~C~a~N~~G~~~~ 1826 (1884)
.|....+.+|+.+.|.|.+.|.|.|.+.|+|++..+..+.++.+.. .+...+|.|.++..+|+|.|+|.|.|.+|.++.
T Consensus 7 ~p~~v~v~eG~~v~L~C~v~g~P~p~i~W~k~~~~~~~~~~~~~~~~~~~~~~L~I~~~~~~D~G~Y~C~a~N~~G~~~~ 86 (92)
T cd05891 7 LPDVVTIMEGKTLNLTCTVFGNPDPEVIWFKNDQDIELSEHYSVKLEQGKYASLTIKGVTSEDSGKYSINVKNKYGGETV 86 (92)
T ss_pred CCCcEEEcCCCEEEEEEEEEEeCCCeEEEEECCEECCCCCCEEEEEcCCCEEEEEECCCChhhCEEEEEEEEeCCCceee
Confidence 3456788999999999999999999999999999998777766543 333458999999999999999999999999999
Q ss_pred EEEEEE
Q psy2148 1827 EAELVV 1832 (1884)
Q Consensus 1827 ~~~l~V 1832 (1884)
++.|.|
T Consensus 87 ~~~v~~ 92 (92)
T cd05891 87 DVTVSV 92 (92)
T ss_pred EEEEEC
Confidence 988875
No 75
>cd05867 Ig4_L1-CAM_like Fourth immunoglobulin (Ig)-like domain of the L1 cell adhesion molecule (CAM). Ig4_L1-CAM_like: fourth immunoglobulin (Ig)-like domain of the L1 cell adhesion molecule (CAM). L1 is comprised of an extracellular region having six Ig-like domains and five fibronectin type III domains, a transmembrane region and an intracellular domain. L1 is primarily expressed in the nervous system and is involved in its development and function. L1 is associated with an X-linked recessive disorder, X-linked hydrocephalus, MASA syndrome, or spastic paraplegia type 1, that involves abnormalities of axonal growth. This group also contains the chicken neuron-glia cell adhesion molecule, Ng-CAM.
Probab=99.34 E-value=8e-12 Score=111.75 Aligned_cols=73 Identities=25% Similarity=0.435 Sum_probs=63.3
Q ss_pred CceEEEEEEEecCCCcEEEEEeCCEecCCCC---CeEEeecCCeEEEEEccCCCCCCEEEEEEEEeCCeeEEEEEEEEEE
Q psy2148 1757 GQLARFDAKISATKPLDVYWLKNGKKIIPDI---RYKTLEEDNLFTLLIIEAVVEDSGAYECVAMNNAGEARCEAELVVQ 1833 (1884)
Q Consensus 1757 G~~~~l~C~~~g~p~p~v~W~k~~~~l~~~~---~~~~~~~~~~~~L~i~~~~~~d~G~Y~C~a~N~~G~~~~~~~l~V~ 1833 (1884)
|+.++|.|.+.|.|.|.|+|+|+|.++.... ++.+ ..+ .|.|.+++.+|+|.|+|.|.|..|....++.|.|.
T Consensus 1 G~~v~l~C~~~G~P~p~i~W~k~g~~i~~~~~~~~~~~-~~~---~L~I~~~~~~D~G~Y~C~a~N~~G~~~~~~~l~V~ 76 (76)
T cd05867 1 GETARLDCQVEGIPTPNITWSINGAPIEGTDPDPRRHV-SSG---ALILTDVQPSDTAVYQCEARNRHGNLLANAHVHVV 76 (76)
T ss_pred CCeEEEEEEeeEeCCCeEEEEECCEECCCCCCCceEEe-eCC---EEEECCCChhhCEEEEEEEECCCCeEEEEEEEEEC
Confidence 7899999999999999999999999987543 3322 222 79999999999999999999999999999999873
No 76
>cd05891 Ig_M-protein_C C-terminal immunoglobulin (Ig)-like domain of M-protein (also known as myomesin-2). Ig_M-protein_C: the C-terminal immunoglobulin (Ig)-like domain of M-protein (also known as myomesin-2). M-protein is a structural protein localized to the M-band, a transverse structure in the center of the sarcomere, and is a candidate for M-band bridges. M-protein is modular consisting mainly of repetitive IG-like and fibronectin type III (FnIII) domains, and has a muscle-type specific expression pattern. M-protein is present in fast fibers.
Probab=99.34 E-value=8.4e-12 Score=115.95 Aligned_cols=84 Identities=25% Similarity=0.434 Sum_probs=72.3
Q ss_pred CCceeecCCCeEEEEEEEeeCCCCCcEEEEeeCCEEccCCCcEEEEee-CCeEEEEEccCCCCCCeEEEEEEEcCCeeEE
Q psy2148 923 PTDLTLAESTLAHFECRLTPTNDPSMTVEWFHNGKALSAGSRIKTIND-FGFVILEINDVYLRDSGLYTCKATNKHGEAT 1001 (1884)
Q Consensus 923 ~~~~~v~~G~~v~l~C~v~~~~~P~~~v~W~~~g~~i~~~~~~~~~~~-~~~~~L~I~~~~~~D~G~Y~C~a~N~~G~~~ 1001 (1884)
|..+++.+|+++.|.|.+. +.|.|.+.|+|+|..+....++.+... +..+.|.|.+++.+|+|.|+|.|.|.+|.++
T Consensus 8 p~~v~v~eG~~v~L~C~v~--g~P~p~i~W~k~~~~~~~~~~~~~~~~~~~~~~L~I~~~~~~D~G~Y~C~a~N~~G~~~ 85 (92)
T cd05891 8 PDVVTIMEGKTLNLTCTVF--GNPDPEVIWFKNDQDIELSEHYSVKLEQGKYASLTIKGVTSEDSGKYSINVKNKYGGET 85 (92)
T ss_pred CCcEEEcCCCEEEEEEEEE--EeCCCeEEEEECCEECCCCCCEEEEEcCCCEEEEEECCCChhhCEEEEEEEEeCCCcee
Confidence 4567899999999999998 678889999999999988777765433 3345799999999999999999999999999
Q ss_pred EEEEEEE
Q psy2148 1002 TSCKLTV 1008 (1884)
Q Consensus 1002 ~~~~l~V 1008 (1884)
.++.|.|
T Consensus 86 ~~~~v~~ 92 (92)
T cd05891 86 VDVTVSV 92 (92)
T ss_pred eEEEEEC
Confidence 8888765
No 77
>cd04971 Ig_TrKABC_d5 Fifth domain (immunoglobulin-like) of Trk receptors TrkA, TrkB and TrkC. TrkABC_d5: the fifth domain of Trk receptors TrkA, TrkB and TrkC, this is an immunoglobulin (Ig)-like domain which binds to neurotrophin. The Trk family of receptors are tyrosine kinase receptors. They are activated by dimerization, leading to autophosphorylation of intracellular tyrosine residues, and triggering the signal transduction pathway. TrkA, TrkB, and TrkC share significant sequence homology and domain organization. The first three domains are leucine-rich domains. The fourth and fifth domains are Ig-like domains playing a part in ligand binding. TrkA, Band C mediate the trophic effects of the neurotrophin Nerve growth factor (NGF) family. TrkA is recognized by NGF. TrkB is recognized by brain-derived neurotrophic factor (BDNF) and neurotrophin (NT)-4. TrkC is recognized by NT-3. NT-3 is promiscuous as in some cell systems it activates TrkA and TrkB receptors. TrkA is a receptor foun
Probab=99.33 E-value=3.6e-12 Score=114.12 Aligned_cols=67 Identities=21% Similarity=0.327 Sum_probs=56.2
Q ss_pred CCCCCCCCeeEEEECCeecCCCCcEEEEEe-------CCEEEEEECcCCCCCcEEEEEEEEeCceeEEEEEEEE
Q psy2148 2 EPRADPNLKIEWFKNGVPLSLGSRIRSTFD-------FGLVTLSINSLRADDSAIYTCKATNLLGEAVSTCTLK 68 (1884)
Q Consensus 2 ~~~g~P~~~v~W~k~g~~l~~~~~~~~~~~-------~~~~~L~I~~~~~~D~G~Y~C~a~n~~g~~~~~~~l~ 68 (1884)
.|+|+|.|+|+|||||++|..+.++..... ...+.|+|.+++.+|+|.|+|.|.|..|.+.++..|+
T Consensus 6 ~v~G~P~P~v~W~k~g~~i~~~~~~~~~~~~~~~~~~~~~~~L~I~~~~~~D~G~YtC~A~N~~G~~~~~~~~~ 79 (81)
T cd04971 6 TVRGNPKPTLTWYHNGAVLNESDYIRTEIHYEVTTPTEYHGCLQFDNPTHVNNGNYTLVASNEYGQDSKSISAH 79 (81)
T ss_pred EeEeeCCCcEEEEECCEECcCCCceeEEEEeecccccccEEEEEECCCCcccCeEEEEEEEeCCCCeeeEEEee
Confidence 589999999999999999987765433222 2356899999999999999999999999988877664
No 78
>cd05848 Ig1_Contactin-5 First Ig domain of contactin-5. Ig1_Contactin-5: First Ig domain of the neural cell adhesion molecule contactin-5. Contactins are comprised of six Ig domains followed by four fibronectin type III (FnIII) domains, anchored to the membrane by glycosylphosphatidylinositol. The different contactins show different expression patterns in the central nervous system. In rats, a lack of contactin-5 (NB-2) results in an impairment of the neuronal activity in the auditory system. Contactin-5 is expressed specifically in the postnatal nervous system, peaking at about 3 weeks postnatal. Contactin-5 is highly expressed in the adult human brain in the occipital lobe and in the amygdala; lower levels of expression have been detected in the corpus callosum, caudate nucleus, and spinal cord.
Probab=99.33 E-value=1.2e-11 Score=115.26 Aligned_cols=83 Identities=28% Similarity=0.491 Sum_probs=66.2
Q ss_pred CCeeeecCCceeec---CCCeEEEEEEEeeCCCCCcEEEEeeCCEEccCCCcEEEEeeCCeEEEEEccCC-CCCCeEEEE
Q psy2148 916 APEFLTTPTDLTLA---ESTLAHFECRLTPTNDPSMTVEWFHNGKALSAGSRIKTINDFGFVILEINDVY-LRDSGLYTC 991 (1884)
Q Consensus 916 ~p~~~~~~~~~~v~---~G~~v~l~C~v~~~~~P~~~v~W~~~g~~i~~~~~~~~~~~~~~~~L~I~~~~-~~D~G~Y~C 991 (1884)
.|.|+..+.++.+. +|+.++|.|.+. |.|.|.|+|+|||.+|.....+.....++ .|.|.++. .+|+|.|+|
T Consensus 1 ~P~f~~~p~~~~~~~~~~g~~v~l~C~~~--G~P~P~i~W~k~g~~l~~~~~~~~~~~~g--~L~i~~~~~~~D~G~Y~C 76 (94)
T cd05848 1 GPVFVQEPDDAIFPTDSDEKKVILNCEAR--GNPVPTYRWLRNGTEIDTESDYRYSLIDG--NLIISNPSEVKDSGRYQC 76 (94)
T ss_pred CCeeEECCCcEEccCCCCCCEEEEEEEee--ecCCCEEEEEECCeECccCCCceEEeeCC--eEEEccCCccCcCEEEEE
Confidence 37888888887765 478999999998 77999999999999997554333322233 58898875 699999999
Q ss_pred EEEcCCeeEEE
Q psy2148 992 KATNKHGEATT 1002 (1884)
Q Consensus 992 ~a~N~~G~~~~ 1002 (1884)
.|+|.+|+..+
T Consensus 77 ~A~N~~G~~~S 87 (94)
T cd05848 77 LATNSIGSILS 87 (94)
T ss_pred EEEcCCCeEEe
Confidence 99999998743
No 79
>cd05854 Ig6_Contactin-2 Sixth Ig domain of contactin-2. Ig6_Contactin-2: Sixth Ig domain of the neural cell adhesion molecule contactin-2-like. Contactins are comprised of six Ig domains followed by four fibronectin type III (FnIII) domains anchored to the membrane by glycosylphosphatidylinositol. Contactin-2 (TAG-1, axonin-1) facilitates cell adhesion by homophilic binding between molecules in apposed membranes. It may play a part in the neuronal processes of neurite outgrowth, axon guidance and fasciculation, and neuronal migration. The first four Ig domains form the intermolecular binding fragment, which arranges as a compact U-shaped module by contacts between IG domains 1 and 4, and domains 2 and 3. The different contactins show different expression patterns in the central nervous system. During development and in adulthood, contactin-2 is transiently expressed in subsets of central and peripheral neurons. Contactin-2 is also expressed in retinal amacrine cells in the developing c
Probab=99.33 E-value=1.2e-11 Score=112.64 Aligned_cols=78 Identities=22% Similarity=0.339 Sum_probs=64.6
Q ss_pred ceEEEEEEEecCCCc--EEEEEeCCEecCCC---CCeEE-eecCCeEEEEEccCCCCCCEEEEEEEEeCCeeEEEEEEEE
Q psy2148 1758 QLARFDAKISATKPL--DVYWLKNGKKIIPD---IRYKT-LEEDNLFTLLIIEAVVEDSGAYECVAMNNAGEARCEAELV 1831 (1884)
Q Consensus 1758 ~~~~l~C~~~g~p~p--~v~W~k~~~~l~~~---~~~~~-~~~~~~~~L~i~~~~~~d~G~Y~C~a~N~~G~~~~~~~l~ 1831 (1884)
++++|.|.+.|.|.| .++|+|||..+... .++.. ........|.|.+++..|+|.|+|.|.|.+|..++++.|.
T Consensus 1 ~~~~L~C~a~g~P~p~~~v~W~~~g~~i~~~~~~~~~~~~~~~~~~~~L~I~~v~~~D~G~YtC~A~n~~g~~~~~~~L~ 80 (85)
T cd05854 1 ENLTLQCHASHDPTMDLTFTWSLDDFPIDLDKPNGHYRRMEVKETIGDLVIVNAQLSHAGTYTCTAQTVVDSASASATLV 80 (85)
T ss_pred CcEEEEEEEecCCCCCeEEEEEECCeEccccCCCCcEEEEEecceEeEEEEccCChhhCeEEEEEEecCCCCEEEEEEEE
Confidence 468999999999987 58999999998643 24422 2222345899999999999999999999999999999999
Q ss_pred EEec
Q psy2148 1832 VQSK 1835 (1884)
Q Consensus 1832 V~~~ 1835 (1884)
|.++
T Consensus 81 V~~~ 84 (85)
T cd05854 81 VRGP 84 (85)
T ss_pred EECC
Confidence 9873
No 80
>cd05857 Ig2_FGFR Second immunoglobulin (Ig)-like domain of fibroblast growth factor (FGF) receptor. Ig2_FGFR: second immunoglobulin (Ig)-like domain of fibroblast growth factor (FGF) receptor. FGF receptors bind FGF signaling polypeptides. FGFs participate in multiple processes such as morphogenesis, development, and angiogenesis. FGFs bind to four FGF receptor tyrosine kinases (FGFR1, -2, -3, -4). Receptor diversity is controlled by alternative splicing producing splice variants with different ligand binding characteristics and different expression patterns. FGFRs have an extracellular region comprised of three IG-like domains, a single transmembrane helix, and an intracellular tyrosine kinase domain. Ligand binding and specificity reside in the Ig-like domains 2 and 3, and the linker region that connects these two. FGFR activation and signaling depend on FGF-induced dimerization, a process involving cell surface heparin or heparin sulfate proteoglycans.
Probab=99.32 E-value=1.2e-11 Score=114.03 Aligned_cols=82 Identities=26% Similarity=0.428 Sum_probs=68.1
Q ss_pred ceeecCCCeEEEEEEEeeCCCCCcEEEEeeCCEEccCCCcEEE-EeeCCeEEEEEccCCCCCCeEEEEEEEcCCeeEEEE
Q psy2148 925 DLTLAESTLAHFECRLTPTNDPSMTVEWFHNGKALSAGSRIKT-INDFGFVILEINDVYLRDSGLYTCKATNKHGEATTS 1003 (1884)
Q Consensus 925 ~~~v~~G~~v~l~C~v~~~~~P~~~v~W~~~g~~i~~~~~~~~-~~~~~~~~L~I~~~~~~D~G~Y~C~a~N~~G~~~~~ 1003 (1884)
.+.+.+|+.+.|.|.+. |.|.|.|+|+|+|..+..+.+... ........|.|.++..+|+|.|+|.|.|.+|+.+.+
T Consensus 3 ~~~v~~G~~~~L~C~~~--g~P~p~i~W~k~g~~l~~~~~~~~~~~~~~~~~l~i~~~~~~D~G~Y~C~a~N~~G~~~~~ 80 (85)
T cd05857 3 LHAVPAANTVKFRCPAA--GNPTPTMRWLKNGKEFKQEHRIGGYKVRNQHWSLIMESVVPSDKGNYTCVVENEYGSINHT 80 (85)
T ss_pred cEEcCCCCEEEEEEEcC--CCCCCEEEEEECCEECCCCCceeeeEEeCCceEEEEccCCcccCEEEEEEEEeCCCEEEEE
Confidence 35688999999999998 678999999999999987655321 112234479999999999999999999999999999
Q ss_pred EEEEE
Q psy2148 1004 CKLTV 1008 (1884)
Q Consensus 1004 ~~l~V 1008 (1884)
+.|.|
T Consensus 81 ~~l~v 85 (85)
T cd05857 81 YHLDV 85 (85)
T ss_pred EEEEC
Confidence 98876
No 81
>cd05867 Ig4_L1-CAM_like Fourth immunoglobulin (Ig)-like domain of the L1 cell adhesion molecule (CAM). Ig4_L1-CAM_like: fourth immunoglobulin (Ig)-like domain of the L1 cell adhesion molecule (CAM). L1 is comprised of an extracellular region having six Ig-like domains and five fibronectin type III domains, a transmembrane region and an intracellular domain. L1 is primarily expressed in the nervous system and is involved in its development and function. L1 is associated with an X-linked recessive disorder, X-linked hydrocephalus, MASA syndrome, or spastic paraplegia type 1, that involves abnormalities of axonal growth. This group also contains the chicken neuron-glia cell adhesion molecule, Ng-CAM.
Probab=99.32 E-value=1.1e-11 Score=110.83 Aligned_cols=72 Identities=26% Similarity=0.564 Sum_probs=61.7
Q ss_pred CCeEEEEEEEeeCCCCCcEEEEeeCCEEccCCC---cEEEEeeCCeEEEEEccCCCCCCeEEEEEEEcCCeeEEEEEEEE
Q psy2148 931 STLAHFECRLTPTNDPSMTVEWFHNGKALSAGS---RIKTINDFGFVILEINDVYLRDSGLYTCKATNKHGEATTSCKLT 1007 (1884)
Q Consensus 931 G~~v~l~C~v~~~~~P~~~v~W~~~g~~i~~~~---~~~~~~~~~~~~L~I~~~~~~D~G~Y~C~a~N~~G~~~~~~~l~ 1007 (1884)
|+++.|.|.+. |.|.|.|+|+|+|.++.... ++.. ..+ .|.|.+++.+|+|.|+|.|.|.+|...+.+.|.
T Consensus 1 G~~v~l~C~~~--G~P~p~i~W~k~g~~i~~~~~~~~~~~--~~~--~L~I~~~~~~D~G~Y~C~a~N~~G~~~~~~~l~ 74 (76)
T cd05867 1 GETARLDCQVE--GIPTPNITWSINGAPIEGTDPDPRRHV--SSG--ALILTDVQPSDTAVYQCEARNRHGNLLANAHVH 74 (76)
T ss_pred CCeEEEEEEee--EeCCCeEEEEECCEECCCCCCCceEEe--eCC--EEEECCCChhhCEEEEEEEECCCCeEEEEEEEE
Confidence 78999999998 67888999999999986543 3332 222 699999999999999999999999999999988
Q ss_pred E
Q psy2148 1008 V 1008 (1884)
Q Consensus 1008 V 1008 (1884)
|
T Consensus 75 V 75 (76)
T cd05867 75 V 75 (76)
T ss_pred E
Confidence 7
No 82
>cd05868 Ig4_NrCAM Fourth immunoglobulin (Ig)-like domain of NrCAM (NgCAM-related cell adhesion molecule). Ig4_ NrCAM: fourth immunoglobulin (Ig)-like domain of NrCAM (NgCAM-related cell adhesion molecule). NrCAM belongs to the L1 subfamily of cell adhesion molecules (CAMs) and is comprised of an extracellular region having six IG-like domains and five fibronectin type III domains, a transmembrane region and an intracellular domain. NrCAM is primarily expressed in the nervous system.
Probab=99.32 E-value=7.9e-12 Score=111.32 Aligned_cols=74 Identities=22% Similarity=0.390 Sum_probs=61.8
Q ss_pred CCeEEEEEEEeeCCCCCcEEEEeeCCEEccCCCcE-EEEeeCCeEEEEEccCCCCCCeEEEEEEEcCCeeEEEEEEEEE
Q psy2148 931 STLAHFECRLTPTNDPSMTVEWFHNGKALSAGSRI-KTINDFGFVILEINDVYLRDSGLYTCKATNKHGEATTSCKLTV 1008 (1884)
Q Consensus 931 G~~v~l~C~v~~~~~P~~~v~W~~~g~~i~~~~~~-~~~~~~~~~~L~I~~~~~~D~G~Y~C~a~N~~G~~~~~~~l~V 1008 (1884)
|+.++|.|.+. |.|.|+|+|+|+|++|...... ....+++ .|.|.+++.+|+|.|+|.|+|.+|...+++.|.|
T Consensus 1 g~~~~l~C~a~--G~P~P~i~W~k~g~~i~~~~~~~~~~~~~~--~l~i~~v~~~D~G~Y~C~A~N~~G~~~~~~~l~v 75 (76)
T cd05868 1 GEDGTLICRAN--GNPKPSISWLTNGVPIEIAPTDPSRKVDGD--TIIFSKVQERSSAVYQCNASNEYGYLLANAFVNV 75 (76)
T ss_pred CCCEEEEEEee--EeCCCeEEEEECCEEccccCCCceEEecCC--EEEECCCCHhhCEEEEEEEEcCCCEEEEEEEEEe
Confidence 78899999998 7799999999999999643221 1122333 6899999999999999999999999999999987
No 83
>cd07693 Ig1_Robo First immunoglobulin (Ig)-like domain in Robo (roundabout) receptors and similar proteins. Ig1_Robo: domain similar to the first immunoglobulin (Ig)-like domain in Robo (roundabout) receptors. Robo receptors play a role in the development of the central nervous system (CNS), and are receptors of Slit protein. Slit is a repellant secreted by the neural cells in the midline. Slit acts through Robo to prevent most neurons from crossing the midline from either side. Three mammalian Robo homologs (robo1, -2, and -3), and three mammalian Slit homologs (Slit-1,-2, -3), have been identified. Commissural axons, which cross the midline, express low levels of Robo; longitudinal axons, which avoid the midline, express high levels of Robo. robo1, -2, and -3 are expressed by commissural neurons in the vertebrate spinal cord and Slits 1, -2, -3 are expressed at the ventral midline. Robo-3 is a divergent member of the Robo family which instead of being a positive regulator of slit res
Probab=99.32 E-value=1.3e-11 Score=118.70 Aligned_cols=91 Identities=26% Similarity=0.550 Sum_probs=72.1
Q ss_pred CCeeeecCCceeecCCCeEEEEEEEeeCCCCCcEEEEeeCCEEccCC-----CcEEEEeeCCeEEEEE--ccCCCCCCeE
Q psy2148 916 APEFLTTPTDLTLAESTLAHFECRLTPTNDPSMTVEWFHNGKALSAG-----SRIKTINDFGFVILEI--NDVYLRDSGL 988 (1884)
Q Consensus 916 ~p~~~~~~~~~~v~~G~~v~l~C~v~~~~~P~~~v~W~~~g~~i~~~-----~~~~~~~~~~~~~L~I--~~~~~~D~G~ 988 (1884)
||.|+..+.+..+.+|+.+.|.|.+. |.|.|.|+|+|+|..+... .+.....++....+.| .++..+|+|.
T Consensus 1 ~P~i~~~p~~~~v~~G~~~~l~C~~~--g~P~p~i~W~k~g~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~D~G~ 78 (100)
T cd07693 1 PPRIVEHPSDLIVSKGDPATLNCKAE--GRPTPTIQWLKNGQPLETDKDDPRSHRIVLPSGSLFFLRVVHGRKGRSDEGV 78 (100)
T ss_pred CCeEEecCceeEEcCCCeEEEEeeCC--cCCCCEEEEEECCEECccccCCCCcceEEecCCcEEEEEeeccCCCcCcCEE
Confidence 68999999999999999999999998 7788999999999998761 2222333333334443 3447899999
Q ss_pred EEEEEEcCCee-EEEEEEEEE
Q psy2148 989 YTCKATNKHGE-ATTSCKLTV 1008 (1884)
Q Consensus 989 Y~C~a~N~~G~-~~~~~~l~V 1008 (1884)
|+|.|+|.+|. .+..+.|.|
T Consensus 79 Y~C~a~N~~G~~~s~~~~l~v 99 (100)
T cd07693 79 YVCVAHNSLGEAVSRNASLEV 99 (100)
T ss_pred EEEEEEccccceecceEEEEe
Confidence 99999999999 777888876
No 84
>cd05868 Ig4_NrCAM Fourth immunoglobulin (Ig)-like domain of NrCAM (NgCAM-related cell adhesion molecule). Ig4_ NrCAM: fourth immunoglobulin (Ig)-like domain of NrCAM (NgCAM-related cell adhesion molecule). NrCAM belongs to the L1 subfamily of cell adhesion molecules (CAMs) and is comprised of an extracellular region having six IG-like domains and five fibronectin type III domains, a transmembrane region and an intracellular domain. NrCAM is primarily expressed in the nervous system.
Probab=99.32 E-value=8.6e-12 Score=111.09 Aligned_cols=75 Identities=20% Similarity=0.260 Sum_probs=63.2
Q ss_pred CceEEEEEEEecCCCcEEEEEeCCEecCCCCC-eEEeecCCeEEEEEccCCCCCCEEEEEEEEeCCeeEEEEEEEEEE
Q psy2148 1757 GQLARFDAKISATKPLDVYWLKNGKKIIPDIR-YKTLEEDNLFTLLIIEAVVEDSGAYECVAMNNAGEARCEAELVVQ 1833 (1884)
Q Consensus 1757 G~~~~l~C~~~g~p~p~v~W~k~~~~l~~~~~-~~~~~~~~~~~L~i~~~~~~d~G~Y~C~a~N~~G~~~~~~~l~V~ 1833 (1884)
|+.++|.|.+.|.|.|+|+|+|+|+++..... .....++. .|.|.+++..|+|.|+|.|.|.+|...+++.|.|+
T Consensus 1 g~~~~l~C~a~G~P~P~i~W~k~g~~i~~~~~~~~~~~~~~--~l~i~~v~~~D~G~Y~C~A~N~~G~~~~~~~l~v~ 76 (76)
T cd05868 1 GEDGTLICRANGNPKPSISWLTNGVPIEIAPTDPSRKVDGD--TIIFSKVQERSSAVYQCNASNEYGYLLANAFVNVL 76 (76)
T ss_pred CCCEEEEEEeeEeCCCeEEEEECCEEccccCCCceEEecCC--EEEECCCCHhhCEEEEEEEEcCCCEEEEEEEEEeC
Confidence 78899999999999999999999999864322 11122332 79999999999999999999999999999999884
No 85
>cd05746 Ig4_Peroxidasin Fourth immunoglobulin (Ig)-like domain of peroxidasin. Ig4_Peroxidasin: the fourth immunoglobulin (Ig)-like domain in peroxidasin. Peroxidasin has a peroxidase domain and interacting extracellular motifs containing four Ig-like domains. It has been suggested that peroxidasin is secreted, and has functions related to the stabilization of the extracellular matrix. It may play a part in various other important processes such as removal and destruction of cells, which have undergone programmed cell death, and protection of the organism against non-self.
Probab=99.32 E-value=5.4e-12 Score=110.21 Aligned_cols=69 Identities=26% Similarity=0.405 Sum_probs=62.4
Q ss_pred EEEEEEEecCCCcEEEEEeCCEecCCCCCeEEeecCCeEEEEEccCCCCCCEEEEEEEEeCCeeEEEEEEEE
Q psy2148 1760 ARFDAKISATKPLDVYWLKNGKKIIPDIRYKTLEEDNLFTLLIIEAVVEDSGAYECVAMNNAGEARCEAELV 1831 (1884)
Q Consensus 1760 ~~l~C~~~g~p~p~v~W~k~~~~l~~~~~~~~~~~~~~~~L~i~~~~~~d~G~Y~C~a~N~~G~~~~~~~l~ 1831 (1884)
++|.|.+.|.|.|.|+|+|+|..+..+.++.+..++ .|.|.++..+|+|.|+|.|.|..|.++.++.|+
T Consensus 1 v~L~C~~~g~P~p~i~W~k~g~~~~~~~~~~~~~~~---~L~I~~~~~~D~G~Y~C~a~N~~G~~~~~~~Lt 69 (69)
T cd05746 1 VQIPCSAQGDPEPTITWNKDGVQVTESGKFHISPEG---YLAIRDVGVADQGRYECVARNTIGYASVSMVLS 69 (69)
T ss_pred CEeEecceEeCCCEEEEEECCEECCCCCCEEECCCC---EEEECcCChhhCEEEEEEEECCCCcEEEEEEeC
Confidence 579999999999999999999999888888765544 899999999999999999999999999988874
No 86
>cd04969 Ig5_Contactin_like Fifth Ig domain of contactin. Ig5_Contactin_like: Fifth Ig domain of contactins. Contactins are neural cell adhesion molecules and are comprised of six Ig domains followed by four fibronectin type III(FnIII) domains anchored to the membrane by glycosylphosphatidylinositol. The first four Ig domains form the intermolecular binding fragment, which arranges as a compact U-shaped module via contacts between Ig domains 1 and 4, and between Ig domains 2 and 3. Contactin-2 (TAG-1, axonin-1) may play a part in the neuronal processes of neurite outgrowth, axon guidance and fasciculation, and neuronal migration. This group also includes contactin-1 and contactin-5. The different contactins show different expression patterns in the central nervous system. During development and in adulthood, contactin-2 is transiently expressed in subsets of central and peripheral neurons. Contactin-5 is expressed specifically in the rat postnatal nervous system, peaking at about 3 week
Probab=99.32 E-value=8.1e-12 Score=110.82 Aligned_cols=73 Identities=34% Similarity=0.462 Sum_probs=65.2
Q ss_pred CCeEEEEEEEeeCCCCCcEEEEeeCCEEccCCCcEEEEeeCCeEEEEEccCCCCCCeEEEEEEEcCCeeEEEEEEEEE
Q psy2148 931 STLAHFECRLTPTNDPSMTVEWFHNGKALSAGSRIKTINDFGFVILEINDVYLRDSGLYTCKATNKHGEATTSCKLTV 1008 (1884)
Q Consensus 931 G~~v~l~C~v~~~~~P~~~v~W~~~g~~i~~~~~~~~~~~~~~~~L~I~~~~~~D~G~Y~C~a~N~~G~~~~~~~l~V 1008 (1884)
|+.+.|.|.+. |.|.|.++|+|++..+....++.+...+ .|.|.+++.+|+|.|+|.|.|.+|..+.++.|.|
T Consensus 1 G~~v~L~C~~~--g~P~p~v~W~k~~~~~~~~~~~~~~~~~---~L~i~~v~~~D~G~Y~C~a~N~~G~~~~~~~l~V 73 (73)
T cd04969 1 GGDVIIECKPK--AAPKPTISWSKGTELLTNSSRICIWPDG---SLEILNVTKSDEGKYTCFAENFFGKANSTGSLSV 73 (73)
T ss_pred CCeEEEEEeee--EcCCCEEEEEECCEEcccCCCEEECCCC---eEEEccCChhHCEEEEEEEECCCCceEEEEEEEC
Confidence 78899999998 6788999999999999888888765433 6999999999999999999999999999998876
No 87
>cd07693 Ig1_Robo First immunoglobulin (Ig)-like domain in Robo (roundabout) receptors and similar proteins. Ig1_Robo: domain similar to the first immunoglobulin (Ig)-like domain in Robo (roundabout) receptors. Robo receptors play a role in the development of the central nervous system (CNS), and are receptors of Slit protein. Slit is a repellant secreted by the neural cells in the midline. Slit acts through Robo to prevent most neurons from crossing the midline from either side. Three mammalian Robo homologs (robo1, -2, and -3), and three mammalian Slit homologs (Slit-1,-2, -3), have been identified. Commissural axons, which cross the midline, express low levels of Robo; longitudinal axons, which avoid the midline, express high levels of Robo. robo1, -2, and -3 are expressed by commissural neurons in the vertebrate spinal cord and Slits 1, -2, -3 are expressed at the ventral midline. Robo-3 is a divergent member of the Robo family which instead of being a positive regulator of slit res
Probab=99.31 E-value=1.7e-11 Score=117.95 Aligned_cols=91 Identities=31% Similarity=0.507 Sum_probs=73.1
Q ss_pred CCeEEeccCceEEcCCceEEEEEEEecCCCcEEEEEeCCEecCCC-----CCeEEeecCCeEEEEEc--cCCCCCCEEEE
Q psy2148 1742 PPSFLTTISSAVINVGQLARFDAKISATKPLDVYWLKNGKKIIPD-----IRYKTLEEDNLFTLLII--EAVVEDSGAYE 1814 (1884)
Q Consensus 1742 ~P~~~~~~~~~~~~~G~~~~l~C~~~g~p~p~v~W~k~~~~l~~~-----~~~~~~~~~~~~~L~i~--~~~~~d~G~Y~ 1814 (1884)
||.|...+.+..+.+|+.+.|.|.+.|.|.|.|+|+|+|..+... .+..+..++....+.|. .+..+|+|.|+
T Consensus 1 ~P~i~~~p~~~~v~~G~~~~l~C~~~g~P~p~i~W~k~g~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~D~G~Y~ 80 (100)
T cd07693 1 PPRIVEHPSDLIVSKGDPATLNCKAEGRPTPTIQWLKNGQPLETDKDDPRSHRIVLPSGSLFFLRVVHGRKGRSDEGVYV 80 (100)
T ss_pred CCeEEecCceeEEcCCCeEEEEeeCCcCCCCEEEEEECCEECccccCCCCcceEEecCCcEEEEEeeccCCCcCcCEEEE
Confidence 588999999999999999999999999999999999999998762 22333334443444443 34689999999
Q ss_pred EEEEeCCee-EEEEEEEEE
Q psy2148 1815 CVAMNNAGE-ARCEAELVV 1832 (1884)
Q Consensus 1815 C~a~N~~G~-~~~~~~l~V 1832 (1884)
|.|.|..|. .++.+.|.|
T Consensus 81 C~a~N~~G~~~s~~~~l~v 99 (100)
T cd07693 81 CVAHNSLGEAVSRNASLEV 99 (100)
T ss_pred EEEEccccceecceEEEEe
Confidence 999999998 667788876
No 88
>cd05848 Ig1_Contactin-5 First Ig domain of contactin-5. Ig1_Contactin-5: First Ig domain of the neural cell adhesion molecule contactin-5. Contactins are comprised of six Ig domains followed by four fibronectin type III (FnIII) domains, anchored to the membrane by glycosylphosphatidylinositol. The different contactins show different expression patterns in the central nervous system. In rats, a lack of contactin-5 (NB-2) results in an impairment of the neuronal activity in the auditory system. Contactin-5 is expressed specifically in the postnatal nervous system, peaking at about 3 weeks postnatal. Contactin-5 is highly expressed in the adult human brain in the occipital lobe and in the amygdala; lower levels of expression have been detected in the corpus callosum, caudate nucleus, and spinal cord.
Probab=99.31 E-value=2e-11 Score=113.88 Aligned_cols=82 Identities=26% Similarity=0.449 Sum_probs=65.8
Q ss_pred CeEEeccCceEEc---CCceEEEEEEEecCCCcEEEEEeCCEecCCCCCeEEeecCCeEEEEEccCC-CCCCEEEEEEEE
Q psy2148 1743 PSFLTTISSAVIN---VGQLARFDAKISATKPLDVYWLKNGKKIIPDIRYKTLEEDNLFTLLIIEAV-VEDSGAYECVAM 1818 (1884)
Q Consensus 1743 P~~~~~~~~~~~~---~G~~~~l~C~~~g~p~p~v~W~k~~~~l~~~~~~~~~~~~~~~~L~i~~~~-~~d~G~Y~C~a~ 1818 (1884)
|.|+..|.+..+. +|+.++|.|.+.|.|.|.|+|+|+|..+.....+.+...++ .|.|.++. .+|+|.|+|.|.
T Consensus 2 P~f~~~p~~~~~~~~~~g~~v~l~C~~~G~P~P~i~W~k~g~~l~~~~~~~~~~~~g--~L~i~~~~~~~D~G~Y~C~A~ 79 (94)
T cd05848 2 PVFVQEPDDAIFPTDSDEKKVILNCEARGNPVPTYRWLRNGTEIDTESDYRYSLIDG--NLIISNPSEVKDSGRYQCLAT 79 (94)
T ss_pred CeeEECCCcEEccCCCCCCEEEEEEEeeecCCCEEEEEECCeECccCCCceEEeeCC--eEEEccCCccCcCEEEEEEEE
Confidence 6788888877654 47899999999999999999999999997554333332222 78999875 699999999999
Q ss_pred eCCeeEEE
Q psy2148 1819 NNAGEARC 1826 (1884)
Q Consensus 1819 N~~G~~~~ 1826 (1884)
|.+|+...
T Consensus 80 N~~G~~~S 87 (94)
T cd05848 80 NSIGSILS 87 (94)
T ss_pred cCCCeEEe
Confidence 99998753
No 89
>cd05855 Ig_TrkB_d5 Fifth domain (immunoglobulin-like) of Trk receptor TrkB. TrkB_d5: the fifth domain of Trk receptor TrkB, this is an immunoglobulin (Ig)-like domain which binds to neurotrophin. The Trk family of receptors are tyrosine kinase receptors, which mediate the trophic effects of the neurotrophin Nerve growth factor (NGF) family. The Trks are activated by dimerization, leading to autophosphorylation of intracellular tyrosine residues, and triggering the signal transduction pathway. TrkB shares significant sequence homology and domain organization with TrkA, and TrkC. The first three domains are leucine-rich domains. The fourth and fifth domains are Ig-like domains playing a part in ligand binding. TrKB is recognized by brain-derived neurotrophic factor (BDNF) and neurotrophin (NT)-4. In some cell systems NT-3 can activate TrkA and TrkB receptors. TrKB transcripts are found throughout multiple structures of the central and peripheral nervous systems.
Probab=99.31 E-value=9.2e-12 Score=109.35 Aligned_cols=70 Identities=26% Similarity=0.405 Sum_probs=57.9
Q ss_pred EEEEEeeCCCCCcEEEEeeCCEEccCCCcEEE--E---eeCCeEEEEEccCCCCCCeEEEEEEEcCCeeEEEEEEEE
Q psy2148 936 FECRLTPTNDPSMTVEWFHNGKALSAGSRIKT--I---NDFGFVILEINDVYLRDSGLYTCKATNKHGEATTSCKLT 1007 (1884)
Q Consensus 936 l~C~v~~~~~P~~~v~W~~~g~~i~~~~~~~~--~---~~~~~~~L~I~~~~~~D~G~Y~C~a~N~~G~~~~~~~l~ 1007 (1884)
|.|.+. |.|.|+|+|||||++|..+.++.. . .......|.|.++..+|+|.|+|.|+|.+|+++.++.+.
T Consensus 3 i~~~v~--G~P~Pti~W~kng~~l~~~~~~~~~~~~~~~~~~~~~L~i~~~~~~D~G~YtC~A~N~~G~~~~~~~~~ 77 (79)
T cd05855 3 IPFTVK--GNPKPTLQWFHEGAILNESEYICTKIHVINNTEYHGCLQLDNPTHLNNGIYTLVAKNEYGEDEKNVSAH 77 (79)
T ss_pred EEEEEe--EeCCCceEEEECCEECCCCcceeeeeEeecccceEEEEEECCCCcccCEEEEEEEEcCCcccceEEEee
Confidence 789998 789999999999999987765422 1 112345899999999999999999999999988887764
No 90
>cd05857 Ig2_FGFR Second immunoglobulin (Ig)-like domain of fibroblast growth factor (FGF) receptor. Ig2_FGFR: second immunoglobulin (Ig)-like domain of fibroblast growth factor (FGF) receptor. FGF receptors bind FGF signaling polypeptides. FGFs participate in multiple processes such as morphogenesis, development, and angiogenesis. FGFs bind to four FGF receptor tyrosine kinases (FGFR1, -2, -3, -4). Receptor diversity is controlled by alternative splicing producing splice variants with different ligand binding characteristics and different expression patterns. FGFRs have an extracellular region comprised of three IG-like domains, a single transmembrane helix, and an intracellular tyrosine kinase domain. Ligand binding and specificity reside in the Ig-like domains 2 and 3, and the linker region that connects these two. FGFR activation and signaling depend on FGF-induced dimerization, a process involving cell surface heparin or heparin sulfate proteoglycans.
Probab=99.30 E-value=1.8e-11 Score=113.03 Aligned_cols=81 Identities=23% Similarity=0.407 Sum_probs=68.7
Q ss_pred eEEcCCceEEEEEEEecCCCcEEEEEeCCEecCCCCCeE-EeecCCeEEEEEccCCCCCCEEEEEEEEeCCeeEEEEEEE
Q psy2148 1752 AVINVGQLARFDAKISATKPLDVYWLKNGKKIIPDIRYK-TLEEDNLFTLLIIEAVVEDSGAYECVAMNNAGEARCEAEL 1830 (1884)
Q Consensus 1752 ~~~~~G~~~~l~C~~~g~p~p~v~W~k~~~~l~~~~~~~-~~~~~~~~~L~i~~~~~~d~G~Y~C~a~N~~G~~~~~~~l 1830 (1884)
..+.+|+.+.|.|.+.|.|.|.|+|+|+|..+..+.+.. +........|.|.++..+|+|.|+|.|.|..|+...++.|
T Consensus 4 ~~v~~G~~~~L~C~~~g~P~p~i~W~k~g~~l~~~~~~~~~~~~~~~~~l~i~~~~~~D~G~Y~C~a~N~~G~~~~~~~l 83 (85)
T cd05857 4 HAVPAANTVKFRCPAAGNPTPTMRWLKNGKEFKQEHRIGGYKVRNQHWSLIMESVVPSDKGNYTCVVENEYGSINHTYHL 83 (85)
T ss_pred EEcCCCCEEEEEEEcCCCCCCEEEEEECCEECCCCCceeeeEEeCCceEEEEccCCcccCEEEEEEEEeCCCEEEEEEEE
Confidence 457789999999999999999999999999997765432 1122334589999999999999999999999999999998
Q ss_pred EE
Q psy2148 1831 VV 1832 (1884)
Q Consensus 1831 ~V 1832 (1884)
.|
T Consensus 84 ~v 85 (85)
T cd05857 84 DV 85 (85)
T ss_pred EC
Confidence 76
No 91
>cd05773 Ig8_hNephrin_like Eighth immunoglobulin-like domain of nephrin. Ig8_hNephrin_like: domain similar to the eighth immunoglobulin-like domain in human nephrin. Nephrin is an integral component of the slit diaphragm, and is a central component of the glomerular ultrafilter. Nephrin plays a structural role, and has a role in signaling. Nephrin is a transmembrane protein having a short intracellular portion, and an extracellular portion comprised of eight Ig-like domains, and one fibronectin type III-like domain. The extracellular portions of nephrin, from neighboring foot processes of separate podocyte cells, may interact with each other, and in association with other components of the slit diaphragm, form a porous molecular sieve within the slit pore. The intracellular portion of nephrin is associated with linker proteins, which connect nephrin to the actin cytoskeleton. The intracellular portion is tyrosine phosphorylated, and mediates signaling from the slit diaphragm into the p
Probab=99.30 E-value=2e-11 Score=117.25 Aligned_cols=96 Identities=27% Similarity=0.394 Sum_probs=75.1
Q ss_pred CCCeeeecCCceee----cCCCeEEEEEEEeeCCCCCcEEEEeeCCEEccC-CCcEEEEe--eC--CeEEEEEccCC-CC
Q psy2148 915 KAPEFLTTPTDLTL----AESTLAHFECRLTPTNDPSMTVEWFHNGKALSA-GSRIKTIN--DF--GFVILEINDVY-LR 984 (1884)
Q Consensus 915 ~~p~~~~~~~~~~v----~~G~~v~l~C~v~~~~~P~~~v~W~~~g~~i~~-~~~~~~~~--~~--~~~~L~I~~~~-~~ 984 (1884)
.+|.|...+....+ ..|..+.|.|.+. |.|.+.++|+|||..|.. +.++.+.. .+ ...+|.|.++. .+
T Consensus 3 ~~P~~~~~~~~~~~~~~~~~g~~v~L~C~a~--G~P~p~i~W~k~g~~l~~~~~r~~~~~~~~~~~~~s~L~I~~v~~~~ 80 (109)
T cd05773 3 FAPDLQKGPQLRKVASRGDGSSDANLVCQAQ--GVPRVQFRWAKNGVPLDLGNPRYEETTEHTGTVHTSILTIINVSAAL 80 (109)
T ss_pred cccccccCCceEEEEEecCCCCEEEEEEECc--ccCCCEEEEEECCEECCCCCCeEEEEeeccCccceeEEEECcCCccC
Confidence 56777766653222 2468999999998 788899999999999964 34554331 11 13579999997 59
Q ss_pred CCeEEEEEEEcCCeeEEEEEEEEEEeec
Q psy2148 985 DSGLYTCKATNKHGEATTSCKLTVKGRQ 1012 (1884)
Q Consensus 985 D~G~Y~C~a~N~~G~~~~~~~l~V~~~~ 1012 (1884)
|.|.|+|.|.|.+|.++.++.|.|.++|
T Consensus 81 D~G~Y~C~A~N~~G~~~~~i~L~~~~~p 108 (109)
T cd05773 81 DYALFTCTAHNSLGEDSLDIQLVSTSRP 108 (109)
T ss_pred CCEEEEEEEEeCCccCcEEEEEEecCCC
Confidence 9999999999999999999999998765
No 92
>cd05853 Ig6_Contactin-4 Sixth Ig domain of contactin-4. Ig6_Contactin-4: sixth Ig domain of the neural cell adhesion molecule contactin-4. Contactins are neural cell adhesion molecules, and are comprised of six Ig domains followed by four fibronectin type III (FnIII) domains anchored to the membrane by glycosylphosphatidylinositol. The different contactins show different expression patterns in the central nervous system. Highest expresson of contactin-4 is in testes, thyroid, small intestine, uterus and brain. Contactin-4 plays a role in the response of neuroblastoma cells to differentiating agents, such as retinoids. The contactin 4 gene is associated with cerebellar degeneration in spinocerebellar ataxia type 16.
Probab=99.29 E-value=1e-11 Score=110.85 Aligned_cols=81 Identities=17% Similarity=0.316 Sum_probs=67.2
Q ss_pred CcEEEEEEEeecCCCCCeEEEeeCCccCCC---CCCeEEEee-CCEEEEEEcccCcCCCeEEEEEEEecCceEEEEEEEE
Q psy2148 723 ENAHFEARLTPTDDPKLKVEWFWNGKPMKT---GSRFRTFCD-FGFVILEISPVYPEDCGQYSCRAYNDYGEAVTSASMK 798 (1884)
Q Consensus 723 ~~~~l~C~~~~~g~p~~~v~W~k~g~~l~~---~~~~~~~~~-~~~~~L~i~~~~~~d~G~Y~C~a~N~~g~~~~~~~l~ 798 (1884)
+++.|.|.+.+.+.+++.|.|+|||++|.. +.++.+... .....|.|.+++..|+|.|+|.|+|..+..+.++.|.
T Consensus 1 ~~~~l~C~v~~d~~l~~~~~W~~dg~~i~~~~~~~~~~~~~~~~~~~~L~I~nv~~~dsG~YtC~a~n~~~~~~a~a~L~ 80 (85)
T cd05853 1 ESIVLPCQVSHDHSLDIVFTWSFNGHLIDFQKDGDHFERVGGQDSAGDLMIRSIQLKHAGKYVCMVQTSVDKLSAAADLI 80 (85)
T ss_pred CcEEEEEEeccCCCCCcEEEEEECCEECcccCCCccEEEeccCCCCCcEEEecCCHHHCEEEEEEEEcccCceEEEEEEE
Confidence 468999999876788899999999999962 224444321 2234799999999999999999999999999999999
Q ss_pred Eecce
Q psy2148 799 VQGKR 803 (1884)
Q Consensus 799 V~~~p 803 (1884)
|+++|
T Consensus 81 V~~pP 85 (85)
T cd05853 81 VRGPP 85 (85)
T ss_pred EecCC
Confidence 99876
No 93
>cd05855 Ig_TrkB_d5 Fifth domain (immunoglobulin-like) of Trk receptor TrkB. TrkB_d5: the fifth domain of Trk receptor TrkB, this is an immunoglobulin (Ig)-like domain which binds to neurotrophin. The Trk family of receptors are tyrosine kinase receptors, which mediate the trophic effects of the neurotrophin Nerve growth factor (NGF) family. The Trks are activated by dimerization, leading to autophosphorylation of intracellular tyrosine residues, and triggering the signal transduction pathway. TrkB shares significant sequence homology and domain organization with TrkA, and TrkC. The first three domains are leucine-rich domains. The fourth and fifth domains are Ig-like domains playing a part in ligand binding. TrKB is recognized by brain-derived neurotrophic factor (BDNF) and neurotrophin (NT)-4. In some cell systems NT-3 can activate TrkA and TrkB receptors. TrKB transcripts are found throughout multiple structures of the central and peripheral nervous systems.
Probab=99.29 E-value=1.4e-11 Score=108.20 Aligned_cols=71 Identities=15% Similarity=0.134 Sum_probs=59.2
Q ss_pred EEEEEEecCCCcEEEEEeCCEecCCCCCeEE--ee---cCCeEEEEEccCCCCCCEEEEEEEEeCCeeEEEEEEEE
Q psy2148 1761 RFDAKISATKPLDVYWLKNGKKIIPDIRYKT--LE---EDNLFTLLIIEAVVEDSGAYECVAMNNAGEARCEAELV 1831 (1884)
Q Consensus 1761 ~l~C~~~g~p~p~v~W~k~~~~l~~~~~~~~--~~---~~~~~~L~i~~~~~~d~G~Y~C~a~N~~G~~~~~~~l~ 1831 (1884)
.|.|.+.|+|.|+|+|+|||++|..+.+... .. ......|.|.++..+|+|.|+|.|+|.+|++++++.+.
T Consensus 2 ~i~~~v~G~P~Pti~W~kng~~l~~~~~~~~~~~~~~~~~~~~~L~i~~~~~~D~G~YtC~A~N~~G~~~~~~~~~ 77 (79)
T cd05855 2 CIPFTVKGNPKPTLQWFHEGAILNESEYICTKIHVINNTEYHGCLQLDNPTHLNNGIYTLVAKNEYGEDEKNVSAH 77 (79)
T ss_pred eEEEEEeEeCCCceEEEECCEECCCCcceeeeeEeecccceEEEEEECCCCcccCEEEEEEEEcCCcccceEEEee
Confidence 3789999999999999999999987765422 11 12345899999999999999999999999988887765
No 94
>cd04973 Ig1_FGFR First immunoglobulin (Ig)-like domain of fibroblast growth factor receptor (FGFR). Ig1_FGFR: The first immunoglobulin (Ig)-like domain of fibroblast growth factor receptor (FGFR). Fibroblast growth factors (FGFs) participate in morphogenesis, development, angiogenesis, and wound healing. These FGF-stimulated processes are mediated by four FGFR tyrosine kinases (FGRF1-4). FGFRs are comprised of an extracellular portion consisting of three Ig-like domains, a transmembrane helix, and a cytoplasmic portion having protein tyrosine kinase activity. The highly conserved Ig-like domains 2 and 3, and the linker region between D2 and D3 define a general binding site for all FGFs.
Probab=99.29 E-value=1.5e-11 Score=110.61 Aligned_cols=79 Identities=28% Similarity=0.547 Sum_probs=67.6
Q ss_pred CCceeecCCCeEEEEEEEeeCCCCCcEEEEeeCCEEccCCCcEEEEeeCCeEEEEEccCCCCCCeEEEEEEEcCCeeEEE
Q psy2148 923 PTDLTLAESTLAHFECRLTPTNDPSMTVEWFHNGKALSAGSRIKTINDFGFVILEINDVYLRDSGLYTCKATNKHGEATT 1002 (1884)
Q Consensus 923 ~~~~~v~~G~~v~l~C~v~~~~~P~~~v~W~~~g~~i~~~~~~~~~~~~~~~~L~I~~~~~~D~G~Y~C~a~N~~G~~~~ 1002 (1884)
|++..+.+|+.+.|.|.+. +. .+.|.|+|||.+|..+.++.+.. + .|.|.+++.+|+|.|+|.|.|..|..+.
T Consensus 1 ~~~~~~~~G~~v~l~C~~~--~~-~~~v~W~k~g~~l~~~~~~~~~~--~--~L~I~~~~~~DsG~Y~C~a~n~~g~~~~ 73 (79)
T cd04973 1 VESYSAHPGDLLQLRCRLR--DD-VQSINWTKDGVQLGENNRTRITG--E--EVQIKDAVPRDSGLYACVTSSPSGSDTT 73 (79)
T ss_pred CCcEEecCCCCEEEEEEec--CC-CceEEEeeCCcCCCCCceEEEeC--C--EEEECCCChhhCEEEEEEEeCCCCcccE
Confidence 3567889999999999998 43 45899999999998877776642 2 6999999999999999999999999888
Q ss_pred EEEEEE
Q psy2148 1003 SCKLTV 1008 (1884)
Q Consensus 1003 ~~~l~V 1008 (1884)
.+.|.|
T Consensus 74 ~~~v~V 79 (79)
T cd04973 74 YFSVNV 79 (79)
T ss_pred EEEEeC
Confidence 887765
No 95
>cd04978 Ig4_L1-NrCAM_like Fourth immunoglobulin (Ig)-like domain of L1, Ng-CAM (Neuron-glia CAM cell adhesion molecule), and NrCAM (Ng-CAM-related). Ig4_L1-NrCAM_like: fourth immunoglobulin (Ig)-like domain of L1, Ng-CAM (Neuron-glia CAM cell adhesion molecule), and NrCAM (Ng-CAM-related). These proteins belong to the L1 subfamily of cell adhesion molecules (CAMs) and are comprised of an extracellular region having six Ig-like domains and five fibronectin type III domains, a transmembrane region and an intracellular domain. These molecules are primarily expressed in the nervous system. L1 is associated with an X-linked recessive disorder, X-linked hydrocephalus, MASA syndrome, or spastic paraplegia type 1, that involves abnormalities of axonal growth.
Probab=99.28 E-value=1.5e-11 Score=110.63 Aligned_cols=75 Identities=23% Similarity=0.272 Sum_probs=64.2
Q ss_pred CceEEEEEEEecCCCcEEEEEeCCEecCCCCCe-EEeecCCeEEEEEccCCCCCCEEEEEEEEeCCeeEEEEEEEEEE
Q psy2148 1757 GQLARFDAKISATKPLDVYWLKNGKKIIPDIRY-KTLEEDNLFTLLIIEAVVEDSGAYECVAMNNAGEARCEAELVVQ 1833 (1884)
Q Consensus 1757 G~~~~l~C~~~g~p~p~v~W~k~~~~l~~~~~~-~~~~~~~~~~L~i~~~~~~d~G~Y~C~a~N~~G~~~~~~~l~V~ 1833 (1884)
|+.++|.|.+.|.|.|.|.|+++|..+...... .....+ ..|.|.++..+|+|.|+|.|.|..|...+++.|.|.
T Consensus 1 G~~~~l~C~~~g~P~p~i~W~~~g~~~~~~~~~~~~~~~~--~~L~i~~v~~~D~G~Y~C~A~N~~G~~~~~~~l~V~ 76 (76)
T cd04978 1 GETGRLDCEAEGIPQPTITWRLNGVPIEELPPDPRRRVDG--GTLILSNVQPNDTAVYQCNASNVHGYLLANAFVHVV 76 (76)
T ss_pred CCeEEEEEEceeeCCCEEEEEECCEECCCCCCcceEEccC--CEEEECCCChhhCEEEEEEEEccCCeEEEeEEEEEC
Confidence 788999999999999999999999998765432 222222 389999999999999999999999999999999884
No 96
>cd05746 Ig4_Peroxidasin Fourth immunoglobulin (Ig)-like domain of peroxidasin. Ig4_Peroxidasin: the fourth immunoglobulin (Ig)-like domain in peroxidasin. Peroxidasin has a peroxidase domain and interacting extracellular motifs containing four Ig-like domains. It has been suggested that peroxidasin is secreted, and has functions related to the stabilization of the extracellular matrix. It may play a part in various other important processes such as removal and destruction of cells, which have undergone programmed cell death, and protection of the organism against non-self.
Probab=99.28 E-value=1e-11 Score=108.41 Aligned_cols=69 Identities=29% Similarity=0.511 Sum_probs=60.6
Q ss_pred EEEEEEEeeCCCCCcEEEEeeCCEEccCCCcEEEEeeCCeEEEEEccCCCCCCeEEEEEEEcCCeeEEEEEEEE
Q psy2148 934 AHFECRLTPTNDPSMTVEWFHNGKALSAGSRIKTINDFGFVILEINDVYLRDSGLYTCKATNKHGEATTSCKLT 1007 (1884)
Q Consensus 934 v~l~C~v~~~~~P~~~v~W~~~g~~i~~~~~~~~~~~~~~~~L~I~~~~~~D~G~Y~C~a~N~~G~~~~~~~l~ 1007 (1884)
|.|.|.+. |.|.|.|+|+|+|..+..+.++.+...+ +|.|.+++.+|+|.|+|.|.|.+|..+.++.|+
T Consensus 1 v~L~C~~~--g~P~p~i~W~k~g~~~~~~~~~~~~~~~---~L~I~~~~~~D~G~Y~C~a~N~~G~~~~~~~Lt 69 (69)
T cd05746 1 VQIPCSAQ--GDPEPTITWNKDGVQVTESGKFHISPEG---YLAIRDVGVADQGRYECVARNTIGYASVSMVLS 69 (69)
T ss_pred CEeEecce--EeCCCEEEEEECCEECCCCCCEEECCCC---EEEECcCChhhCEEEEEEEECCCCcEEEEEEeC
Confidence 57999998 7788999999999999888887765432 799999999999999999999999999888774
No 97
>cd05773 Ig8_hNephrin_like Eighth immunoglobulin-like domain of nephrin. Ig8_hNephrin_like: domain similar to the eighth immunoglobulin-like domain in human nephrin. Nephrin is an integral component of the slit diaphragm, and is a central component of the glomerular ultrafilter. Nephrin plays a structural role, and has a role in signaling. Nephrin is a transmembrane protein having a short intracellular portion, and an extracellular portion comprised of eight Ig-like domains, and one fibronectin type III-like domain. The extracellular portions of nephrin, from neighboring foot processes of separate podocyte cells, may interact with each other, and in association with other components of the slit diaphragm, form a porous molecular sieve within the slit pore. The intracellular portion of nephrin is associated with linker proteins, which connect nephrin to the actin cytoskeleton. The intracellular portion is tyrosine phosphorylated, and mediates signaling from the slit diaphragm into the p
Probab=99.28 E-value=3.2e-11 Score=115.79 Aligned_cols=96 Identities=21% Similarity=0.293 Sum_probs=75.2
Q ss_pred CCCeEEeccCceEE----cCCceEEEEEEEecCCCcEEEEEeCCEecCCC-CCeEEee--cC--CeEEEEEccCC-CCCC
Q psy2148 1741 VPPSFLTTISSAVI----NVGQLARFDAKISATKPLDVYWLKNGKKIIPD-IRYKTLE--ED--NLFTLLIIEAV-VEDS 1810 (1884)
Q Consensus 1741 ~~P~~~~~~~~~~~----~~G~~~~l~C~~~g~p~p~v~W~k~~~~l~~~-~~~~~~~--~~--~~~~L~i~~~~-~~d~ 1810 (1884)
.+|.|...+....+ ..|..++|.|.+.|.|.|.+.|+|||..|... .++.+.. .+ ....|+|.++. .+|.
T Consensus 3 ~~P~~~~~~~~~~~~~~~~~g~~v~L~C~a~G~P~p~i~W~k~g~~l~~~~~r~~~~~~~~~~~~~s~L~I~~v~~~~D~ 82 (109)
T cd05773 3 FAPDLQKGPQLRKVASRGDGSSDANLVCQAQGVPRVQFRWAKNGVPLDLGNPRYEETTEHTGTVHTSILTIINVSAALDY 82 (109)
T ss_pred cccccccCCceEEEEEecCCCCEEEEEEECcccCCCEEEEEECCEECCCCCCeEEEEeeccCccceeEEEECcCCccCCC
Confidence 46777655553332 24689999999999999999999999998643 4564332 11 23589999997 5999
Q ss_pred EEEEEEEEeCCeeEEEEEEEEEEecC
Q psy2148 1811 GAYECVAMNNAGEARCEAELVVQSKK 1836 (1884)
Q Consensus 1811 G~Y~C~a~N~~G~~~~~~~l~V~~~~ 1836 (1884)
|.|+|.|.|..|.+..++.|.|.++|
T Consensus 83 G~Y~C~A~N~~G~~~~~i~L~~~~~p 108 (109)
T cd05773 83 ALFTCTAHNSLGEDSLDIQLVSTSRP 108 (109)
T ss_pred EEEEEEEEeCCccCcEEEEEEecCCC
Confidence 99999999999999999999998753
No 98
>cd05864 Ig2_VEGFR-2 Second immunoglobulin (Ig)-like domain of vascular endothelial growth factor receptor 2 (VEGFR-2). Ig2_VEGF-2: Second immunoglobulin (Ig)-like domain of vascular endothelial growth factor receptor 2 (VEGFR-2). The VEGFRs have an extracellular component with seven Ig-like domains, a transmembrane segment, and an intracellular tyrosine kinase domain interrupted by a kinase-insert domain. VEGFRs bind VEGFs with high affinity at the Ig-like domains. VEGFR-2 (KDR/Flk-1) is a major mediator of the mitogenic, angiogenic and microvascular permeability-enhancing effects of VEGF-A; VEGF-A is important to the growth and maintenance of vascular endothelial cells and to the development of new blood- and lymphatic-vessels in physiological and pathological states. VEGF-A also interacts with VEGFR-1, which it binds more strongly than VEGFR-2. VEGFR-2 and -1 may mediate a chemotactic and a survival signal in hematopoietic stem cells or leukemia cells.
Probab=99.27 E-value=1.2e-11 Score=106.72 Aligned_cols=69 Identities=23% Similarity=0.351 Sum_probs=57.3
Q ss_pred EEEEEEEeeCCCCCcEEEEeeCCEEccCCCcEEEEeeCCeEEEEEccCCCCCCeEEEEEEEcCCeeEEEEEEEEEE
Q psy2148 934 AHFECRLTPTNDPSMTVEWFHNGKALSAGSRIKTINDFGFVILEINDVYLRDSGLYTCKATNKHGEATTSCKLTVK 1009 (1884)
Q Consensus 934 v~l~C~v~~~~~P~~~v~W~~~g~~i~~~~~~~~~~~~~~~~L~I~~~~~~D~G~Y~C~a~N~~G~~~~~~~l~V~ 1009 (1884)
++|.|.+. |.|.|.++|+|||++|..+.++. .+ ..|.|.++..+|+|.|+|.|.|.+|..+...++++.
T Consensus 1 ~~~~c~v~--G~P~P~v~W~k~g~~l~~~~~~~---~~--~~L~I~~v~~~D~G~YtC~a~N~~G~~~~~~t~~l~ 69 (70)
T cd05864 1 VKIPVKYY--GYPPPEVKWYKNGQLIVLNHTFK---RG--VHLTIYEVTEKDAGNYTVVLTNPITKEEQRHTFQLV 69 (70)
T ss_pred CEEEeEEE--EeCCCEEEEEECCEECCCCCEEc---cC--CEEEECcCCHHHCEEEEEEEEECCCceeeEEEEEEE
Confidence 47999999 78999999999999997764432 22 369999999999999999999999988777666653
No 99
>cd04971 Ig_TrKABC_d5 Fifth domain (immunoglobulin-like) of Trk receptors TrkA, TrkB and TrkC. TrkABC_d5: the fifth domain of Trk receptors TrkA, TrkB and TrkC, this is an immunoglobulin (Ig)-like domain which binds to neurotrophin. The Trk family of receptors are tyrosine kinase receptors. They are activated by dimerization, leading to autophosphorylation of intracellular tyrosine residues, and triggering the signal transduction pathway. TrkA, TrkB, and TrkC share significant sequence homology and domain organization. The first three domains are leucine-rich domains. The fourth and fifth domains are Ig-like domains playing a part in ligand binding. TrkA, Band C mediate the trophic effects of the neurotrophin Nerve growth factor (NGF) family. TrkA is recognized by NGF. TrkB is recognized by brain-derived neurotrophic factor (BDNF) and neurotrophin (NT)-4. TrkC is recognized by NT-3. NT-3 is promiscuous as in some cell systems it activates TrkA and TrkB receptors. TrkA is a receptor foun
Probab=99.27 E-value=2.4e-11 Score=108.81 Aligned_cols=71 Identities=15% Similarity=0.129 Sum_probs=59.7
Q ss_pred EEEEEEecCCCcEEEEEeCCEecCCCCCeEEee-------cCCeEEEEEccCCCCCCEEEEEEEEeCCeeEEEEEEEE
Q psy2148 1761 RFDAKISATKPLDVYWLKNGKKIIPDIRYKTLE-------EDNLFTLLIIEAVVEDSGAYECVAMNNAGEARCEAELV 1831 (1884)
Q Consensus 1761 ~l~C~~~g~p~p~v~W~k~~~~l~~~~~~~~~~-------~~~~~~L~i~~~~~~d~G~Y~C~a~N~~G~~~~~~~l~ 1831 (1884)
.|.|.+.|.|.|.|+|+|||++|..+.++.... ......|.|.++..+|+|.|+|.|+|.+|.+++++.|+
T Consensus 2 ~i~~~v~G~P~P~v~W~k~g~~i~~~~~~~~~~~~~~~~~~~~~~~L~I~~~~~~D~G~YtC~A~N~~G~~~~~~~~~ 79 (81)
T cd04971 2 CIPFTVRGNPKPTLTWYHNGAVLNESDYIRTEIHYEVTTPTEYHGCLQFDNPTHVNNGNYTLVASNEYGQDSKSISAH 79 (81)
T ss_pred eEEEEeEeeCCCcEEEEECCEECcCCCceeEEEEeecccccccEEEEEECCCCcccCeEEEEEEEeCCCCeeeEEEee
Confidence 378999999999999999999998776543221 12345799999999999999999999999999888775
No 100
>cd05876 Ig3_L1-CAM Third immunoglobulin (Ig)-like domain of the L1 cell adhesion molecule (CAM). Ig3_L1-CAM: third immunoglobulin (Ig)-like domain of the L1 cell adhesion molecule (CAM). L1 belongs to the L1 subfamily of cell adhesion molecules (CAMs) and is comprised of an extracellular region having six Ig-like domains, five fibronectin type III domains, a transmembrane region and an intracellular domain. L1 is primarily expressed in the nervous system and is involved in its development and function. L1 is associated with an X-linked recessive disorder, X-linked hydrocephalus, MASA syndrome, or spastic paraplegia type 1, that involves abnormalities of axonal growth. This group also contains the chicken neuron-glia cell adhesion molecule, Ng-CAM.
Probab=99.27 E-value=1.6e-11 Score=107.80 Aligned_cols=70 Identities=24% Similarity=0.355 Sum_probs=59.4
Q ss_pred EEEEEEEecCCCcEEEEEeCCEecCCCCCeEEeecCCeEEEEEccCCCCCCEEEEEEEEeCCeeEEEEEEEEE
Q psy2148 1760 ARFDAKISATKPLDVYWLKNGKKIIPDIRYKTLEEDNLFTLLIIEAVVEDSGAYECVAMNNAGEARCEAELVV 1832 (1884)
Q Consensus 1760 ~~l~C~~~g~p~p~v~W~k~~~~l~~~~~~~~~~~~~~~~L~i~~~~~~d~G~Y~C~a~N~~G~~~~~~~l~V 1832 (1884)
+.|.|.+.|.|.|.|.|+|++..+..+.. ..... ...|.|.++..+|+|.|+|.|.|..|.++.++.|.|
T Consensus 1 ~~L~C~~~G~P~P~v~W~k~~~~~~~~~~-~~~~~--~~~L~I~~v~~~D~G~Y~C~a~N~~G~~~~~~~l~V 70 (71)
T cd05876 1 LVLECIAEGLPTPEVHWDRIDGPLSPNRT-KKLNN--NKTLQLDNVLESDDGEYVCTAENSEGSARHHYTVTV 70 (71)
T ss_pred CEEEEEeeEecCCeEEEEECCcCCCCCce-eEEcC--CCEEEEcccCHHhCEEEEEEEEcCCCeEEEEEEEEE
Confidence 47999999999999999999988765432 22222 238999999999999999999999999999999987
No 101
>cd05864 Ig2_VEGFR-2 Second immunoglobulin (Ig)-like domain of vascular endothelial growth factor receptor 2 (VEGFR-2). Ig2_VEGF-2: Second immunoglobulin (Ig)-like domain of vascular endothelial growth factor receptor 2 (VEGFR-2). The VEGFRs have an extracellular component with seven Ig-like domains, a transmembrane segment, and an intracellular tyrosine kinase domain interrupted by a kinase-insert domain. VEGFRs bind VEGFs with high affinity at the Ig-like domains. VEGFR-2 (KDR/Flk-1) is a major mediator of the mitogenic, angiogenic and microvascular permeability-enhancing effects of VEGF-A; VEGF-A is important to the growth and maintenance of vascular endothelial cells and to the development of new blood- and lymphatic-vessels in physiological and pathological states. VEGF-A also interacts with VEGFR-1, which it binds more strongly than VEGFR-2. VEGFR-2 and -1 may mediate a chemotactic and a survival signal in hematopoietic stem cells or leukemia cells.
Probab=99.27 E-value=1.5e-11 Score=106.22 Aligned_cols=69 Identities=23% Similarity=0.374 Sum_probs=58.3
Q ss_pred EEEEEEEecCCCcEEEEEeCCEecCCCCCeEEeecCCeEEEEEccCCCCCCEEEEEEEEeCCeeEEEEEEEEEE
Q psy2148 1760 ARFDAKISATKPLDVYWLKNGKKIIPDIRYKTLEEDNLFTLLIIEAVVEDSGAYECVAMNNAGEARCEAELVVQ 1833 (1884)
Q Consensus 1760 ~~l~C~~~g~p~p~v~W~k~~~~l~~~~~~~~~~~~~~~~L~i~~~~~~d~G~Y~C~a~N~~G~~~~~~~l~V~ 1833 (1884)
++|.|.+.|.|.|.++|+|||++|..+.++ . .+ ..|.|.++..+|+|.|+|.|.|..|..+...+++|.
T Consensus 1 ~~~~c~v~G~P~P~v~W~k~g~~l~~~~~~--~-~~--~~L~I~~v~~~D~G~YtC~a~N~~G~~~~~~t~~l~ 69 (70)
T cd05864 1 VKIPVKYYGYPPPEVKWYKNGQLIVLNHTF--K-RG--VHLTIYEVTEKDAGNYTVVLTNPITKEEQRHTFQLV 69 (70)
T ss_pred CEEEeEEEEeCCCEEEEEECCEECCCCCEE--c-cC--CEEEECcCCHHHCEEEEEEEEECCCceeeEEEEEEE
Confidence 479999999999999999999999765433 2 22 379999999999999999999999988777777664
No 102
>cd05849 Ig1_Contactin-1 First Ig domain of contactin-1. Ig1_Contactin-1: First Ig domain of the neural cell adhesion molecule contactin-1. Contactins are comprised of six Ig domains followed by four fibronectin type III (FnIII) domains anchored to the membrane by glycosylphosphatidylinositol. Contactin-1 is differentially expressed in tumor tissues and may, through a RhoA mechanism, facilitate invasion and metastasis of human lung adenocarcinoma.
Probab=99.27 E-value=4.8e-11 Score=110.55 Aligned_cols=86 Identities=24% Similarity=0.296 Sum_probs=67.8
Q ss_pred CCeEEeccCceEEcCC---ceEEEEEEEecCCCcEEEEEeCCEecCC-CCCeEEeecCCeEEEEEccCC-CCCCEEEEEE
Q psy2148 1742 PPSFLTTISSAVINVG---QLARFDAKISATKPLDVYWLKNGKKIIP-DIRYKTLEEDNLFTLLIIEAV-VEDSGAYECV 1816 (1884)
Q Consensus 1742 ~P~~~~~~~~~~~~~G---~~~~l~C~~~g~p~p~v~W~k~~~~l~~-~~~~~~~~~~~~~~L~i~~~~-~~d~G~Y~C~ 1816 (1884)
.|.|...|.+..+.++ +.+.|.|.+.|.|.|.|+|+|++..+.. ..++.+ .++ .|.|.++. .+|+|.|+|.
T Consensus 1 ~P~f~~~P~~~~~~~~~~~~~v~l~C~a~G~P~P~i~W~k~~~~i~~~~~~~~~-~~g---~L~I~~~~~~~D~G~Y~C~ 76 (93)
T cd05849 1 GPVFEEQPIDTIYPEESTEGKVSVNCRARANPFPIYKWRKNNLDIDLTNDRYSM-VGG---NLVINNPDKYKDAGRYVCI 76 (93)
T ss_pred CCEEEECCCCEEecCCccCCeEEEeCcCccCCCCEEEEEECCEEccCCCCeEEE-ECC---EEEECcCCcCCCCEEEEEE
Confidence 3778888877766554 4899999999999999999999998864 345543 233 79999985 6899999999
Q ss_pred EEeCCeeEEE-EEEEE
Q psy2148 1817 AMNNAGEARC-EAELV 1831 (1884)
Q Consensus 1817 a~N~~G~~~~-~~~l~ 1831 (1884)
|+|..|.... .++|.
T Consensus 77 A~N~~G~~~s~~a~l~ 92 (93)
T cd05849 77 VSNIYGKVRSREATLS 92 (93)
T ss_pred EEeCcceEEEccEEEe
Confidence 9999998754 45553
No 103
>cd05739 Ig3_RPTP_IIa_LAR_like Third immunoglobulin (Ig)-like domain of the receptor protein tyrosine phosphatase (RPTP)-F, also known as LAR. Ig3_RPTP_IIa_LAR_like: domain similar to the third immunoglobulin (Ig)-like domain found in the receptor protein tyrosine phosphatase (RPTP)-F, also known as LAR. LAR belongs to the RPTP type IIa subfamily. Members of this subfamily are cell adhesion molecule-like proteins involved in central nervous system (CNS) development. They have large extracellular portions, comprised of multiple IG-like domains and two to nine fibronectin type III (FNIII) domains, and a cytoplasmic portion having two tandem phosphatase domains. Included in this group is Drosophila LAR (DLAR).
Probab=99.27 E-value=2.7e-11 Score=104.95 Aligned_cols=69 Identities=19% Similarity=0.325 Sum_probs=58.4
Q ss_pred CceEEEEEEEecCCCcEEEEEeCCEecCCCCCeEEeecCCeEEEEEccCCCCCCEEEEEEEEeCCeeEEEEEEEE
Q psy2148 1757 GQLARFDAKISATKPLDVYWLKNGKKIIPDIRYKTLEEDNLFTLLIIEAVVEDSGAYECVAMNNAGEARCEAELV 1831 (1884)
Q Consensus 1757 G~~~~l~C~~~g~p~p~v~W~k~~~~l~~~~~~~~~~~~~~~~L~i~~~~~~d~G~Y~C~a~N~~G~~~~~~~l~ 1831 (1884)
|++++|.|.+.|.|.|.|+|+|++.++....++.. . ...|+|.++. |+|.|+|.|.|..|..+.+++|+
T Consensus 1 G~~v~L~C~a~G~P~P~v~W~k~g~~l~~~~~~~~--~--~~~L~i~~~~--d~G~Y~C~A~N~~G~~~~~a~l~ 69 (69)
T cd05739 1 GGSVNLTCVAVGAPMPYVKWMKGGEELTKEDEMPV--G--RNVLELTNIY--ESANYTCVAISSLGMIEATAQVT 69 (69)
T ss_pred CCeEEEEEEeeecCCCEEEEEECCEECCCccceec--C--ccEEEEeccc--cCeeEEEEEEeCCCEEEEEEEEC
Confidence 68899999999999999999999999876655432 1 2379999874 78999999999999999888874
No 104
>cd05740 Ig_CEACAM_D4 Fourth immunoglobulin (Ig)-like domain of carcinoembryonic antigen (CEA) related cell adhesion molecule (CEACAM). Ig_CEACAM_D4: immunoglobulin (Ig)-like domain 4 in carcinoembryonic antigen (CEA) related cell adhesion molecule (CEACAM) protein subfamily. The CEA family is a group of anchored or secreted glycoproteins, expressed by epithelial cells, leukocytes, endothelial cells and placenta. The CEA family is divided into the CEACAM and pregnancy-specific glycoprotein (PSG) subfamilies. This group represents the CEACAM subfamily. CEACAM1 has many important cellular functions, it is a cell adhesion molecule, and a signaling molecule that regulates the growth of tumor cells, it is an angiogenic factor, and is a receptor for bacterial and viral pathogens, including mouse hepatitis virus (MHV). In mice, four isoforms of CEACAM1 generated by alternative splicing have either two [D1, D4] or four [D1-D4] Ig-like domains on the cell surface. This family corresponds to the
Probab=99.27 E-value=4.1e-11 Score=110.50 Aligned_cols=86 Identities=24% Similarity=0.419 Sum_probs=68.8
Q ss_pred Ceeee--cCCceeecCCCeEEEEEEEeeCCCCCcEEEEeeCCEEccCCCcEEEEeeCCeEEEEEccCCCCCCeEEEEEEE
Q psy2148 917 PEFLT--TPTDLTLAESTLAHFECRLTPTNDPSMTVEWFHNGKALSAGSRIKTINDFGFVILEINDVYLRDSGLYTCKAT 994 (1884)
Q Consensus 917 p~~~~--~~~~~~v~~G~~v~l~C~v~~~~~P~~~v~W~~~g~~i~~~~~~~~~~~~~~~~L~I~~~~~~D~G~Y~C~a~ 994 (1884)
|.|.. ..+++++.+|++++|.|.+. |. .|.|.|+|+|..+... ++.+..+++ .|.|.+++.+|+|.|+|.|.
T Consensus 2 p~~~~~~~~~~~~v~~g~~v~l~C~a~--g~-~p~i~W~kng~~l~~~-~~~~~~~~~--~L~I~~v~~~D~G~Y~C~a~ 75 (91)
T cd05740 2 PVINSNNSVGNQPPEDNQPVTLTCEAE--GQ-ATYIWWVNNGSLLVPP-RLQLSNDNR--TLTFNNVTRSDTGHYQCEAS 75 (91)
T ss_pred CEeecccccCccccccCCcEEEEEEeC--CC-CCEEEEEECCEECCCC-CEEEeCCCC--EEEECcCChhhCEEEEEEEE
Confidence 55543 34578999999999999999 55 7899999999998654 454443333 69999999999999999999
Q ss_pred cCCeeEE-EEEEEEE
Q psy2148 995 NKHGEAT-TSCKLTV 1008 (1884)
Q Consensus 995 N~~G~~~-~~~~l~V 1008 (1884)
|.+|... ..+.|.|
T Consensus 76 N~~G~~~S~~~~L~V 90 (91)
T cd05740 76 NEVSNMTSDPYILNV 90 (91)
T ss_pred cCCCCEEeeeEEEEe
Confidence 9999754 4667776
No 105
>cd04970 Ig6_Contactin_like Sixth Ig domain of contactin. Ig6_Contactin_like: Sixth Ig domain of contactins. Contactins are neural cell adhesion molecules and are comprised of six Ig domains followed by four fibronectin type III(FnIII) domains anchored to the membrane by glycosylphosphatidylinositol. The first four Ig domains form the intermolecular binding fragment, which arranges as a compact U-shaped module via contacts between Ig domains 1 and 4, and between Ig domains 2 and 3. Contactin-2 (TAG-1, axonin-1) may play a part in the neuronal processes of neurite outgrowth, axon guidance and fasciculation, and neuronal migration. This group also includes contactin-1 and contactin-5. The different contactins show different expression patterns in the central nervous system. During development and in adulthood, contactin-2 is transiently expressed in subsets of central and peripheral neurons. Contactin-5 is expressed specifically in the rat postnatal nervous system, peaking at about 3 week
Probab=99.27 E-value=2.7e-11 Score=111.29 Aligned_cols=81 Identities=21% Similarity=0.334 Sum_probs=62.6
Q ss_pred CeEEEEEEEeeCCCCCcEEEEeeCCEEccCC---CcEEE-EeeCCeEEEEEccCCCCCCeEEEEEEEcCCeeEEEEEEEE
Q psy2148 932 TLAHFECRLTPTNDPSMTVEWFHNGKALSAG---SRIKT-INDFGFVILEINDVYLRDSGLYTCKATNKHGEATTSCKLT 1007 (1884)
Q Consensus 932 ~~v~l~C~v~~~~~P~~~v~W~~~g~~i~~~---~~~~~-~~~~~~~~L~I~~~~~~D~G~Y~C~a~N~~G~~~~~~~l~ 1007 (1884)
+++.|.|.+.+.+.|...+.|+|+|..|... .++.. ........|.|.+++.+|+|.|+|.|.|.+|..+.++.|.
T Consensus 1 e~~~L~C~~~g~P~p~i~~~W~~~g~~i~~~~~~~~~~~~~~~~~~~~L~I~~v~~~D~G~Y~C~a~n~~g~~~~~~~l~ 80 (85)
T cd04970 1 ESITLQCHASHDPTLDLTFTWSFNGVPIDFDKDGGHYRRVGGKDSNGDLMIRNAQLKHAGKYTCTAQTVVDSLSASADLI 80 (85)
T ss_pred CcEEEEEEEecCCCCCeEEEEEECCeEeeccCCCccEEEEecccccceEEEccCCHHhCeeeEEEEecCCCcEEEEEEEE
Confidence 4689999999443334478999999998643 23321 1122334799999999999999999999999999999999
Q ss_pred EEeec
Q psy2148 1008 VKGRQ 1012 (1884)
Q Consensus 1008 V~~~~ 1012 (1884)
|.++|
T Consensus 81 V~~pP 85 (85)
T cd04970 81 VRGPP 85 (85)
T ss_pred EECCC
Confidence 98764
No 106
>cd04976 Ig2_VEGFR Second immunoglobulin (Ig)-like domain of vascular endothelial growth factor receptor (VEGFR). Ig2_VEGFR: Second immunoglobulin (Ig)-like domain of vascular endothelial growth factor receptor (VEGFR). The VEGFRs have an extracellular component with seven Ig-like domains, a transmembrane segment, and an intracellular tyrosine kinase domain interrupted by a kinase-insert domain. The VEGFR family consists of three members, VEGFR-1 (Flt-1), VEGFR-2 (KDR/Flk-1) and VEGFR-3 (Flt-4). VEGFRs bind VEGFs with high affinity at the Ig-like domains. VEGF-A is important to the growth and maintenance of vascular endothelial cells and to the development of new blood- and lymphatic-vessels in physiological and pathological states. VEGFR-2 is a major mediator of the mitogenic, angiogenic and microvascular permeability-enhancing effects of VEGF-A. VEGFR-1 may play an inhibitory part in these processes by binding VEGF and interfering with its interaction with VEGFR-2. VEGFR-1 has a signa
Probab=99.26 E-value=2e-11 Score=106.85 Aligned_cols=70 Identities=29% Similarity=0.441 Sum_probs=60.3
Q ss_pred EEEEEEEecCCCcEEEEEeCCEecCCCCCeEEeecCCeEEEEEccCCCCCCEEEEEEEEeCCeeEEEEEEEEEE
Q psy2148 1760 ARFDAKISATKPLDVYWLKNGKKIIPDIRYKTLEEDNLFTLLIIEAVVEDSGAYECVAMNNAGEARCEAELVVQ 1833 (1884)
Q Consensus 1760 ~~l~C~~~g~p~p~v~W~k~~~~l~~~~~~~~~~~~~~~~L~i~~~~~~d~G~Y~C~a~N~~G~~~~~~~l~V~ 1833 (1884)
++|.|.+.|.|.|.+.|+|+|.++..+.++.. .+ ..|.|.++..+|+|.|+|.|.|..|..+.++.+.|.
T Consensus 1 ~~l~c~v~g~P~p~v~W~k~g~~l~~~~~~~~--~~--~~L~I~~v~~~D~G~YtC~a~N~~g~~~~~~~~~~~ 70 (71)
T cd04976 1 VRLPVKVKAYPPPEIQWYKNGKLISEKNRTKK--SG--HSLTIKDVTEEDAGNYTVVLTNKQAKLEKRLTFTLV 70 (71)
T ss_pred CEEEeEEEEeCCCEEEEEECCEECCCCCEEEc--CC--CEEEECcCCHHHCEEEEEEEEcCCccEEEEEEEEEE
Confidence 47999999999999999999999987755432 22 389999999999999999999999998888887764
No 107
>cd04978 Ig4_L1-NrCAM_like Fourth immunoglobulin (Ig)-like domain of L1, Ng-CAM (Neuron-glia CAM cell adhesion molecule), and NrCAM (Ng-CAM-related). Ig4_L1-NrCAM_like: fourth immunoglobulin (Ig)-like domain of L1, Ng-CAM (Neuron-glia CAM cell adhesion molecule), and NrCAM (Ng-CAM-related). These proteins belong to the L1 subfamily of cell adhesion molecules (CAMs) and are comprised of an extracellular region having six Ig-like domains and five fibronectin type III domains, a transmembrane region and an intracellular domain. These molecules are primarily expressed in the nervous system. L1 is associated with an X-linked recessive disorder, X-linked hydrocephalus, MASA syndrome, or spastic paraplegia type 1, that involves abnormalities of axonal growth.
Probab=99.26 E-value=2.2e-11 Score=109.54 Aligned_cols=74 Identities=23% Similarity=0.367 Sum_probs=62.7
Q ss_pred CCeEEEEEEEeeCCCCCcEEEEeeCCEEccCCCcE-EEEeeCCeEEEEEccCCCCCCeEEEEEEEcCCeeEEEEEEEEE
Q psy2148 931 STLAHFECRLTPTNDPSMTVEWFHNGKALSAGSRI-KTINDFGFVILEINDVYLRDSGLYTCKATNKHGEATTSCKLTV 1008 (1884)
Q Consensus 931 G~~v~l~C~v~~~~~P~~~v~W~~~g~~i~~~~~~-~~~~~~~~~~L~I~~~~~~D~G~Y~C~a~N~~G~~~~~~~l~V 1008 (1884)
|+.++|.|.+. |.|.|.|.|+++|..+....+. .....+ ..|.|.+++.+|+|.|+|.|.|..|...+++.|.|
T Consensus 1 G~~~~l~C~~~--g~P~p~i~W~~~g~~~~~~~~~~~~~~~~--~~L~i~~v~~~D~G~Y~C~A~N~~G~~~~~~~l~V 75 (76)
T cd04978 1 GETGRLDCEAE--GIPQPTITWRLNGVPIEELPPDPRRRVDG--GTLILSNVQPNDTAVYQCNASNVHGYLLANAFVHV 75 (76)
T ss_pred CCeEEEEEEce--eeCCCEEEEEECCEECCCCCCcceEEccC--CEEEECCCChhhCEEEEEEEEccCCeEEEeEEEEE
Confidence 78999999998 7889999999999999765433 122222 37999999999999999999999999999999987
No 108
>cd05739 Ig3_RPTP_IIa_LAR_like Third immunoglobulin (Ig)-like domain of the receptor protein tyrosine phosphatase (RPTP)-F, also known as LAR. Ig3_RPTP_IIa_LAR_like: domain similar to the third immunoglobulin (Ig)-like domain found in the receptor protein tyrosine phosphatase (RPTP)-F, also known as LAR. LAR belongs to the RPTP type IIa subfamily. Members of this subfamily are cell adhesion molecule-like proteins involved in central nervous system (CNS) development. They have large extracellular portions, comprised of multiple IG-like domains and two to nine fibronectin type III (FNIII) domains, and a cytoplasmic portion having two tandem phosphatase domains. Included in this group is Drosophila LAR (DLAR).
Probab=99.26 E-value=2.9e-11 Score=104.81 Aligned_cols=69 Identities=23% Similarity=0.490 Sum_probs=57.8
Q ss_pred CCeEEEEEEEeeCCCCCcEEEEeeCCEEccCCCcEEEEeeCCeEEEEEccCCCCCCeEEEEEEEcCCeeEEEEEEEE
Q psy2148 931 STLAHFECRLTPTNDPSMTVEWFHNGKALSAGSRIKTINDFGFVILEINDVYLRDSGLYTCKATNKHGEATTSCKLT 1007 (1884)
Q Consensus 931 G~~v~l~C~v~~~~~P~~~v~W~~~g~~i~~~~~~~~~~~~~~~~L~I~~~~~~D~G~Y~C~a~N~~G~~~~~~~l~ 1007 (1884)
|++++|.|.+. |.|.|.|+|+|+|.++....++.. +...|.|.++ .|+|.|+|.|.|.+|..++++.|+
T Consensus 1 G~~v~L~C~a~--G~P~P~v~W~k~g~~l~~~~~~~~----~~~~L~i~~~--~d~G~Y~C~A~N~~G~~~~~a~l~ 69 (69)
T cd05739 1 GGSVNLTCVAV--GAPMPYVKWMKGGEELTKEDEMPV----GRNVLELTNI--YESANYTCVAISSLGMIEATAQVT 69 (69)
T ss_pred CCeEEEEEEee--ecCCCEEEEEECCEECCCccceec----CccEEEEecc--ccCeeEEEEEEeCCCEEEEEEEEC
Confidence 68899999999 789999999999999877655432 2236999997 489999999999999998888764
No 109
>cd05850 Ig1_Contactin-2 First Ig domain of contactin-2. Ig1_Contactin-2: First Ig domain of the neural cell adhesion molecule contactin-2-like. Contactins are comprised of six Ig domains followed by four fibronectin type III (FnIII) domains anchored to the membrane by glycosylphosphatidylinositol. Contactin-2 (TAG-1, axonin-1) facilitates cell adhesion by homophilic binding between molecules in apposed membranes. It may play a part in the neuronal processes of neurite outgrowth, axon guidance and fasciculation, and neuronal migration. The first four Ig domains form the intermolecular binding fragment, which arranges as a compact U-shaped module by contacts between IG domains 1 and 4, and domains 2 and 3. The different contactins show different expression patterns in the central nervous system. During development and in adulthood, contactin-2 is transiently expressed in subsets of central and peripheral neurons. Contactin-2 is also expressed in retinal amacrine cells in the developing c
Probab=99.26 E-value=7.4e-11 Score=110.16 Aligned_cols=84 Identities=30% Similarity=0.513 Sum_probs=67.4
Q ss_pred CeEEeccCceEEcCC---ceEEEEEEEecCCCcEEEEEeCCEecCCC--CCeEEeecCCeEEEEEccCC-CCCCEEEEEE
Q psy2148 1743 PSFLTTISSAVINVG---QLARFDAKISATKPLDVYWLKNGKKIIPD--IRYKTLEEDNLFTLLIIEAV-VEDSGAYECV 1816 (1884)
Q Consensus 1743 P~~~~~~~~~~~~~G---~~~~l~C~~~g~p~p~v~W~k~~~~l~~~--~~~~~~~~~~~~~L~i~~~~-~~d~G~Y~C~ 1816 (1884)
|.|...|.+..+.+| ++++|.|.+.|.|.|.|+|+|+|..+... .++.+. .+ .|.|.++. ..|.|.|.|.
T Consensus 2 P~f~~~P~~~~~~~~~~g~~v~l~C~a~g~P~p~i~W~~~g~~l~~~~~~~~~~~-~g---~L~I~~~~~~~D~G~Y~C~ 77 (94)
T cd05850 2 PVFEEQPSSLLFPEGSPEEKVTLGCRARASPPATYRWKMNGTEIKFAPESRYTLV-AG---NLVINNPQKARDAGSYQCL 77 (94)
T ss_pred CeeEECCCCEEecCCCCCCeEEEEeEceeCCCCEEEEEECCEECccCCCceEEEE-CC---eEEEccCCccCcCEEEEEE
Confidence 678888888877665 58999999999999999999999998643 344443 23 79998865 5999999999
Q ss_pred EEeCCeeEEE-EEEE
Q psy2148 1817 AMNNAGEARC-EAEL 1830 (1884)
Q Consensus 1817 a~N~~G~~~~-~~~l 1830 (1884)
|.|..|.... .+.|
T Consensus 78 A~N~~G~~~s~~a~l 92 (94)
T cd05850 78 AINRCGTVVSREANL 92 (94)
T ss_pred EEcCcCcEEEEEEEE
Confidence 9999998754 5555
No 110
>cd04973 Ig1_FGFR First immunoglobulin (Ig)-like domain of fibroblast growth factor receptor (FGFR). Ig1_FGFR: The first immunoglobulin (Ig)-like domain of fibroblast growth factor receptor (FGFR). Fibroblast growth factors (FGFs) participate in morphogenesis, development, angiogenesis, and wound healing. These FGF-stimulated processes are mediated by four FGFR tyrosine kinases (FGRF1-4). FGFRs are comprised of an extracellular portion consisting of three Ig-like domains, a transmembrane helix, and a cytoplasmic portion having protein tyrosine kinase activity. The highly conserved Ig-like domains 2 and 3, and the linker region between D2 and D3 define a general binding site for all FGFs.
Probab=99.26 E-value=2.9e-11 Score=108.79 Aligned_cols=79 Identities=23% Similarity=0.400 Sum_probs=68.8
Q ss_pred cCceEEcCCceEEEEEEEecCCCcEEEEEeCCEecCCCCCeEEeecCCeEEEEEccCCCCCCEEEEEEEEeCCeeEEEEE
Q psy2148 1749 ISSAVINVGQLARFDAKISATKPLDVYWLKNGKKIIPDIRYKTLEEDNLFTLLIIEAVVEDSGAYECVAMNNAGEARCEA 1828 (1884)
Q Consensus 1749 ~~~~~~~~G~~~~l~C~~~g~p~p~v~W~k~~~~l~~~~~~~~~~~~~~~~L~i~~~~~~d~G~Y~C~a~N~~G~~~~~~ 1828 (1884)
|.+..+.+|+.++|.|.+.|. .+.|.|+|||.+|..+.++.+.. + .|.|.++..+|+|.|+|.|.|..|.....+
T Consensus 1 ~~~~~~~~G~~v~l~C~~~~~-~~~v~W~k~g~~l~~~~~~~~~~-~---~L~I~~~~~~DsG~Y~C~a~n~~g~~~~~~ 75 (79)
T cd04973 1 VESYSAHPGDLLQLRCRLRDD-VQSINWTKDGVQLGENNRTRITG-E---EVQIKDAVPRDSGLYACVTSSPSGSDTTYF 75 (79)
T ss_pred CCcEEecCCCCEEEEEEecCC-CceEEEeeCCcCCCCCceEEEeC-C---EEEECCCChhhCEEEEEEEeCCCCcccEEE
Confidence 356778899999999999996 57899999999998877776642 2 799999999999999999999999988888
Q ss_pred EEEE
Q psy2148 1829 ELVV 1832 (1884)
Q Consensus 1829 ~l~V 1832 (1884)
.|+|
T Consensus 76 ~v~V 79 (79)
T cd04973 76 SVNV 79 (79)
T ss_pred EEeC
Confidence 8775
No 111
>cd04976 Ig2_VEGFR Second immunoglobulin (Ig)-like domain of vascular endothelial growth factor receptor (VEGFR). Ig2_VEGFR: Second immunoglobulin (Ig)-like domain of vascular endothelial growth factor receptor (VEGFR). The VEGFRs have an extracellular component with seven Ig-like domains, a transmembrane segment, and an intracellular tyrosine kinase domain interrupted by a kinase-insert domain. The VEGFR family consists of three members, VEGFR-1 (Flt-1), VEGFR-2 (KDR/Flk-1) and VEGFR-3 (Flt-4). VEGFRs bind VEGFs with high affinity at the Ig-like domains. VEGF-A is important to the growth and maintenance of vascular endothelial cells and to the development of new blood- and lymphatic-vessels in physiological and pathological states. VEGFR-2 is a major mediator of the mitogenic, angiogenic and microvascular permeability-enhancing effects of VEGF-A. VEGFR-1 may play an inhibitory part in these processes by binding VEGF and interfering with its interaction with VEGFR-2. VEGFR-1 has a signa
Probab=99.25 E-value=2.1e-11 Score=106.74 Aligned_cols=70 Identities=29% Similarity=0.446 Sum_probs=59.2
Q ss_pred EEEEEEEeeCCCCCcEEEEeeCCEEccCCCcEEEEeeCCeEEEEEccCCCCCCeEEEEEEEcCCeeEEEEEEEEEE
Q psy2148 934 AHFECRLTPTNDPSMTVEWFHNGKALSAGSRIKTINDFGFVILEINDVYLRDSGLYTCKATNKHGEATTSCKLTVK 1009 (1884)
Q Consensus 934 v~l~C~v~~~~~P~~~v~W~~~g~~i~~~~~~~~~~~~~~~~L~I~~~~~~D~G~Y~C~a~N~~G~~~~~~~l~V~ 1009 (1884)
++|.|.+. |.|+|.++|+|||.+|..+.++.. . ..+|.|.++..+|+|.|+|.|.|.+|..+.++.+.|.
T Consensus 1 ~~l~c~v~--g~P~p~v~W~k~g~~l~~~~~~~~--~--~~~L~I~~v~~~D~G~YtC~a~N~~g~~~~~~~~~~~ 70 (71)
T cd04976 1 VRLPVKVK--AYPPPEIQWYKNGKLISEKNRTKK--S--GHSLTIKDVTEEDAGNYTVVLTNKQAKLEKRLTFTLV 70 (71)
T ss_pred CEEEeEEE--EeCCCEEEEEECCEECCCCCEEEc--C--CCEEEECcCCHHHCEEEEEEEEcCCccEEEEEEEEEE
Confidence 47999998 778999999999999988755432 2 2379999999999999999999999988887777763
No 112
>cd05849 Ig1_Contactin-1 First Ig domain of contactin-1. Ig1_Contactin-1: First Ig domain of the neural cell adhesion molecule contactin-1. Contactins are comprised of six Ig domains followed by four fibronectin type III (FnIII) domains anchored to the membrane by glycosylphosphatidylinositol. Contactin-1 is differentially expressed in tumor tissues and may, through a RhoA mechanism, facilitate invasion and metastasis of human lung adenocarcinoma.
Probab=99.25 E-value=6e-11 Score=109.96 Aligned_cols=85 Identities=26% Similarity=0.461 Sum_probs=67.4
Q ss_pred CCeeeecCCceeecCCC---eEEEEEEEeeCCCCCcEEEEeeCCEEccC-CCcEEEEeeCCeEEEEEccCC-CCCCeEEE
Q psy2148 916 APEFLTTPTDLTLAEST---LAHFECRLTPTNDPSMTVEWFHNGKALSA-GSRIKTINDFGFVILEINDVY-LRDSGLYT 990 (1884)
Q Consensus 916 ~p~~~~~~~~~~v~~G~---~v~l~C~v~~~~~P~~~v~W~~~g~~i~~-~~~~~~~~~~~~~~L~I~~~~-~~D~G~Y~ 990 (1884)
+|.|...|.+..+.++. .+.|.|.+. |.|.|.|+|+|++..+.. ..++.+. ++ .|.|.++. .+|+|.|+
T Consensus 1 ~P~f~~~P~~~~~~~~~~~~~v~l~C~a~--G~P~P~i~W~k~~~~i~~~~~~~~~~--~g--~L~I~~~~~~~D~G~Y~ 74 (93)
T cd05849 1 GPVFEEQPIDTIYPEESTEGKVSVNCRAR--ANPFPIYKWRKNNLDIDLTNDRYSMV--GG--NLVINNPDKYKDAGRYV 74 (93)
T ss_pred CCEEEECCCCEEecCCccCCeEEEeCcCc--cCCCCEEEEEECCEEccCCCCeEEEE--CC--EEEECcCCcCCCCEEEE
Confidence 47888888887766544 899999998 789999999999999854 3455432 23 69999985 69999999
Q ss_pred EEEEcCCeeEEE-EEEE
Q psy2148 991 CKATNKHGEATT-SCKL 1006 (1884)
Q Consensus 991 C~a~N~~G~~~~-~~~l 1006 (1884)
|.|+|.+|...+ .+.|
T Consensus 75 C~A~N~~G~~~s~~a~l 91 (93)
T cd05849 75 CIVSNIYGKVRSREATL 91 (93)
T ss_pred EEEEeCcceEEEccEEE
Confidence 999999998744 5554
No 113
>cd05740 Ig_CEACAM_D4 Fourth immunoglobulin (Ig)-like domain of carcinoembryonic antigen (CEA) related cell adhesion molecule (CEACAM). Ig_CEACAM_D4: immunoglobulin (Ig)-like domain 4 in carcinoembryonic antigen (CEA) related cell adhesion molecule (CEACAM) protein subfamily. The CEA family is a group of anchored or secreted glycoproteins, expressed by epithelial cells, leukocytes, endothelial cells and placenta. The CEA family is divided into the CEACAM and pregnancy-specific glycoprotein (PSG) subfamilies. This group represents the CEACAM subfamily. CEACAM1 has many important cellular functions, it is a cell adhesion molecule, and a signaling molecule that regulates the growth of tumor cells, it is an angiogenic factor, and is a receptor for bacterial and viral pathogens, including mouse hepatitis virus (MHV). In mice, four isoforms of CEACAM1 generated by alternative splicing have either two [D1, D4] or four [D1-D4] Ig-like domains on the cell surface. This family corresponds to the
Probab=99.25 E-value=4.7e-11 Score=110.09 Aligned_cols=87 Identities=20% Similarity=0.374 Sum_probs=70.1
Q ss_pred CeEEe--ccCceEEcCCceEEEEEEEecCCCcEEEEEeCCEecCCCCCeEEeecCCeEEEEEccCCCCCCEEEEEEEEeC
Q psy2148 1743 PSFLT--TISSAVINVGQLARFDAKISATKPLDVYWLKNGKKIIPDIRYKTLEEDNLFTLLIIEAVVEDSGAYECVAMNN 1820 (1884)
Q Consensus 1743 P~~~~--~~~~~~~~~G~~~~l~C~~~g~p~p~v~W~k~~~~l~~~~~~~~~~~~~~~~L~i~~~~~~d~G~Y~C~a~N~ 1820 (1884)
|.+.. .+.++.+.+|++++|.|.+.|. .|.|.|+|++..+... ++.+..++. .|.|.++.++|+|.|.|.|.|.
T Consensus 2 p~~~~~~~~~~~~v~~g~~v~l~C~a~g~-~p~i~W~kng~~l~~~-~~~~~~~~~--~L~I~~v~~~D~G~Y~C~a~N~ 77 (91)
T cd05740 2 PVINSNNSVGNQPPEDNQPVTLTCEAEGQ-ATYIWWVNNGSLLVPP-RLQLSNDNR--TLTFNNVTRSDTGHYQCEASNE 77 (91)
T ss_pred CEeecccccCccccccCCcEEEEEEeCCC-CCEEEEEECCEECCCC-CEEEeCCCC--EEEECcCChhhCEEEEEEEEcC
Confidence 45542 3456788999999999999999 9999999999988653 455443333 8999999999999999999999
Q ss_pred CeeEE-EEEEEEEE
Q psy2148 1821 AGEAR-CEAELVVQ 1833 (1884)
Q Consensus 1821 ~G~~~-~~~~l~V~ 1833 (1884)
+|... ..+.|.|.
T Consensus 78 ~G~~~S~~~~L~V~ 91 (91)
T cd05740 78 VSNMTSDPYILNVN 91 (91)
T ss_pred CCCEEeeeEEEEeC
Confidence 99754 46778773
No 114
>cd05726 Ig4_Robo Fhird immunoglobulin (Ig)-like domain in Robo (roundabout) receptors. Ig4_Robo: domain similar to the fhird immunoglobulin (Ig)-like domain in Robo (roundabout) receptors. Robo receptors play a role in the development of the central nervous system (CNS), and are receptors of Slit protein. Slit is a repellant secreted by the neural cells in the midline. Slit acts through Robo to prevent most neurons from crossing the midline from either side. Three mammalian Robo homologs (robo1, -2, and -3), and three mammalian Slit homologs (Slit-1,-2, -3), have been identified. Commissural axons, which cross the midline, express low levels of Robo; longitudinal axons, which avoid the midline, express high levels of Robo. robo1, -2, and -3 are expressed by commissural neurons in the vertebrate spinal cord and Slits 1, -2, -3 are expressed at the ventral midline. Robo-3 is a divergent member of the Robo family which instead of being a positive regulator of slit responsiveness, antagoni
Probab=99.25 E-value=3.3e-11 Score=112.00 Aligned_cols=76 Identities=24% Similarity=0.416 Sum_probs=65.6
Q ss_pred CceEEEEEEEecCCCcEEEEEeCCEec--------CCCCCeEEeecCCeEEEEEccCCCCCCEEEEEEEEeCCeeEEEEE
Q psy2148 1757 GQLARFDAKISATKPLDVYWLKNGKKI--------IPDIRYKTLEEDNLFTLLIIEAVVEDSGAYECVAMNNAGEARCEA 1828 (1884)
Q Consensus 1757 G~~~~l~C~~~g~p~p~v~W~k~~~~l--------~~~~~~~~~~~~~~~~L~i~~~~~~d~G~Y~C~a~N~~G~~~~~~ 1828 (1884)
|++++|.|.+.|.|.|.|.|+|+|..+ ....++.+..++ .|+|.++..+|+|.|+|.|.|..|....++
T Consensus 1 G~~v~L~C~~~g~P~p~v~W~k~g~~~~~~~~~~~~~~~r~~v~~~~---~L~I~~v~~~D~G~Y~C~a~N~~G~~~~~~ 77 (90)
T cd05726 1 GRTVTFQCEATGNPQPAIFWQKEGSQNLLFSYQPPQSSSRFSVSQTG---DLTITNVQRSDVGYYICQTLNVAGSILTKA 77 (90)
T ss_pred CCEEEEEEECCccCCCEEEEEeCCCcceeecccCCCCCCeEEECCCC---eEEEeeCChhhCEEEEEEEEcCCCceEEEE
Confidence 789999999999999999999998753 234456554333 799999999999999999999999999999
Q ss_pred EEEEEec
Q psy2148 1829 ELVVQSK 1835 (1884)
Q Consensus 1829 ~l~V~~~ 1835 (1884)
.|.|.+.
T Consensus 78 ~l~V~~~ 84 (90)
T cd05726 78 YLEVTDV 84 (90)
T ss_pred EEEEeec
Confidence 9999974
No 115
>cd05850 Ig1_Contactin-2 First Ig domain of contactin-2. Ig1_Contactin-2: First Ig domain of the neural cell adhesion molecule contactin-2-like. Contactins are comprised of six Ig domains followed by four fibronectin type III (FnIII) domains anchored to the membrane by glycosylphosphatidylinositol. Contactin-2 (TAG-1, axonin-1) facilitates cell adhesion by homophilic binding between molecules in apposed membranes. It may play a part in the neuronal processes of neurite outgrowth, axon guidance and fasciculation, and neuronal migration. The first four Ig domains form the intermolecular binding fragment, which arranges as a compact U-shaped module by contacts between IG domains 1 and 4, and domains 2 and 3. The different contactins show different expression patterns in the central nervous system. During development and in adulthood, contactin-2 is transiently expressed in subsets of central and peripheral neurons. Contactin-2 is also expressed in retinal amacrine cells in the developing c
Probab=99.25 E-value=8e-11 Score=109.93 Aligned_cols=85 Identities=32% Similarity=0.561 Sum_probs=67.1
Q ss_pred CCeeeecCCceeecCC---CeEEEEEEEeeCCCCCcEEEEeeCCEEccCC--CcEEEEeeCCeEEEEEccCC-CCCCeEE
Q psy2148 916 APEFLTTPTDLTLAES---TLAHFECRLTPTNDPSMTVEWFHNGKALSAG--SRIKTINDFGFVILEINDVY-LRDSGLY 989 (1884)
Q Consensus 916 ~p~~~~~~~~~~v~~G---~~v~l~C~v~~~~~P~~~v~W~~~g~~i~~~--~~~~~~~~~~~~~L~I~~~~-~~D~G~Y 989 (1884)
.|.|...|.++.+.+| ++++|.|.+. |.|.|.|+|++||..|... .++.+. ++ .|.|.++. .+|+|.|
T Consensus 1 ~P~f~~~P~~~~~~~~~~g~~v~l~C~a~--g~P~p~i~W~~~g~~l~~~~~~~~~~~--~g--~L~I~~~~~~~D~G~Y 74 (94)
T cd05850 1 GPVFEEQPSSLLFPEGSPEEKVTLGCRAR--ASPPATYRWKMNGTEIKFAPESRYTLV--AG--NLVINNPQKARDAGSY 74 (94)
T ss_pred CCeeEECCCCEEecCCCCCCeEEEEeEce--eCCCCEEEEEECCEECccCCCceEEEE--CC--eEEEccCCccCcCEEE
Confidence 3788888888887666 5899999998 7788999999999999643 344443 23 58898865 5999999
Q ss_pred EEEEEcCCeeEEE-EEEE
Q psy2148 990 TCKATNKHGEATT-SCKL 1006 (1884)
Q Consensus 990 ~C~a~N~~G~~~~-~~~l 1006 (1884)
+|.|+|.+|...+ .+.|
T Consensus 75 ~C~A~N~~G~~~s~~a~l 92 (94)
T cd05850 75 QCLAINRCGTVVSREANL 92 (94)
T ss_pred EEEEEcCcCcEEEEEEEE
Confidence 9999999998754 4444
No 116
>cd05876 Ig3_L1-CAM Third immunoglobulin (Ig)-like domain of the L1 cell adhesion molecule (CAM). Ig3_L1-CAM: third immunoglobulin (Ig)-like domain of the L1 cell adhesion molecule (CAM). L1 belongs to the L1 subfamily of cell adhesion molecules (CAMs) and is comprised of an extracellular region having six Ig-like domains, five fibronectin type III domains, a transmembrane region and an intracellular domain. L1 is primarily expressed in the nervous system and is involved in its development and function. L1 is associated with an X-linked recessive disorder, X-linked hydrocephalus, MASA syndrome, or spastic paraplegia type 1, that involves abnormalities of axonal growth. This group also contains the chicken neuron-glia cell adhesion molecule, Ng-CAM.
Probab=99.25 E-value=2.3e-11 Score=106.91 Aligned_cols=71 Identities=30% Similarity=0.479 Sum_probs=59.0
Q ss_pred EEEEEEEeeCCCCCcEEEEeeCCEEccCCCcEEEEeeCCeEEEEEccCCCCCCeEEEEEEEcCCeeEEEEEEEEEE
Q psy2148 934 AHFECRLTPTNDPSMTVEWFHNGKALSAGSRIKTINDFGFVILEINDVYLRDSGLYTCKATNKHGEATTSCKLTVK 1009 (1884)
Q Consensus 934 v~l~C~v~~~~~P~~~v~W~~~g~~i~~~~~~~~~~~~~~~~L~I~~~~~~D~G~Y~C~a~N~~G~~~~~~~l~V~ 1009 (1884)
+.|+|.+. |.|.|.|.|+|++..+..+. ......+ .+|.|.+++.+|+|.|+|.|+|..|..+.++.|.|+
T Consensus 1 ~~L~C~~~--G~P~P~v~W~k~~~~~~~~~-~~~~~~~--~~L~I~~v~~~D~G~Y~C~a~N~~G~~~~~~~l~Ve 71 (71)
T cd05876 1 LVLECIAE--GLPTPEVHWDRIDGPLSPNR-TKKLNNN--KTLQLDNVLESDDGEYVCTAENSEGSARHHYTVTVE 71 (71)
T ss_pred CEEEEEee--EecCCeEEEEECCcCCCCCc-eeEEcCC--CEEEEcccCHHhCEEEEEEEEcCCCeEEEEEEEEEC
Confidence 47999998 78999999999998886543 2222222 379999999999999999999999999999998873
No 117
>cd05758 Ig5_KIRREL3-like Fifth immunoglobulin (Ig)-like domain of Kirrel (kin of irregular chiasm-like) 3 (also known as Neph2) and similar proteins. Ig5_KIRREL3-like: domain similar to the fifth immunoglobulin (Ig)-like domain of Kirrel (kin of irregular chiasm-like) 3 (also known as Neph2). This protein has five Ig-like domains, one transmembrane domain, and a cytoplasmic tail. Included in this group is mammalian Kirrel (Neph1), Kirrel2 (Neph3), and Drosophila RST (irregular chiasm C-roughest) protein. These proteins contain multiple Ig domains, have properties of cell adhesion molecules, and are important in organ development.
Probab=99.24 E-value=7e-11 Score=111.84 Aligned_cols=88 Identities=20% Similarity=0.280 Sum_probs=71.6
Q ss_pred CCeeeecCCceeecCCCeEEEEEEEeeCCCCCc-EEEEeeCCEEccCC--CcEEEEee----CCeEEEEEccCCCC-CCe
Q psy2148 916 APEFLTTPTDLTLAESTLAHFECRLTPTNDPSM-TVEWFHNGKALSAG--SRIKTIND----FGFVILEINDVYLR-DSG 987 (1884)
Q Consensus 916 ~p~~~~~~~~~~v~~G~~v~l~C~v~~~~~P~~-~v~W~~~g~~i~~~--~~~~~~~~----~~~~~L~I~~~~~~-D~G 987 (1884)
||.|. .+....+.+|+++.|.|.+. |.|.| .|.|++++..|... .++.+... +..++|.|.++..+ |.|
T Consensus 2 pp~i~-~~~~~~~~~G~~v~L~C~~~--g~P~P~~v~W~~~~~~i~~~~~~r~~i~~~~~~~~~~s~L~I~~v~~~d~~G 78 (98)
T cd05758 2 PPIIT-SEATQYAILGDKGRVECFIF--STPPPDRIVWTWKENELESGSSGRYTVETDPSPGGVLSTLTISNTQESDFQT 78 (98)
T ss_pred CCeEc-CCCcEEEeCCCcEEEEEEEc--ccCCCCEeEEEECCEEccCCCCCCEEEEEecCCCceEEEEEECCccccccce
Confidence 45554 46678899999999999998 77888 69999999998754 56766543 23458999999994 499
Q ss_pred EEEEEEEcCCeeEEEEEEE
Q psy2148 988 LYTCKATNKHGEATTSCKL 1006 (1884)
Q Consensus 988 ~Y~C~a~N~~G~~~~~~~l 1006 (1884)
.|+|.|.|..|.++..+.|
T Consensus 79 ~Y~C~A~N~~G~~~~~~~L 97 (98)
T cd05758 79 SYNCTAWNSFGSGTAIISL 97 (98)
T ss_pred eEEEEEEcCCCcccEEEEe
Confidence 9999999999998888766
No 118
>cd05763 Ig_1 Subgroup of the immunoglobulin (Ig) superfamily. Ig_1: subgroup of the immunoglobulin (Ig) domain found in the Ig superfamily. The Ig superfamily is a heterogenous group of proteins, built on a common fold comprised of a sandwich of two beta sheets. Members of the Ig superfamily are components of immunoglobulin, neuroglia, cell surface glycoproteins, such as T-cell receptors, CD2, CD4, CD8, and membrane glycoproteins, such as butyrophilin and chondroitin sulfate proteoglycan core protein. A predominant feature of most Ig domains is a disulfide bridge connecting the two beta-sheets with a tryptophan residue packed against the disulfide bond.
Probab=99.23 E-value=3.5e-11 Score=107.53 Aligned_cols=72 Identities=31% Similarity=0.617 Sum_probs=59.6
Q ss_pred EEEEEEEecCCCcEEEEEeCCEecCC---CCCeEEeecCCeEEEEEccCCCCCCEEEEEEEEeCCeeEEEEEEEEEE
Q psy2148 1760 ARFDAKISATKPLDVYWLKNGKKIIP---DIRYKTLEEDNLFTLLIIEAVVEDSGAYECVAMNNAGEARCEAELVVQ 1833 (1884)
Q Consensus 1760 ~~l~C~~~g~p~p~v~W~k~~~~l~~---~~~~~~~~~~~~~~L~i~~~~~~d~G~Y~C~a~N~~G~~~~~~~l~V~ 1833 (1884)
++|.|.+.|.|.|.|+|+|+|....+ ..++.+...+. .|.|.++..+|+|.|+|.|.|..|....++.|.|+
T Consensus 1 a~l~C~~~G~P~P~v~W~k~~~~~~~~~~~~~~~~~~~~~--~L~I~~~~~~D~G~Y~C~A~N~~G~~~~~~~l~V~ 75 (75)
T cd05763 1 ARLECAATGHPTPQIAWQKDGGTDFPAARERRMHVMPEDD--VFFIVDVKIEDTGVYSCTAQNTAGSISANATLTVL 75 (75)
T ss_pred CEeEeecccccCCEEEEEeCCCccCCcccccceEEecCCC--EEEEeeCCcccCEEEEEEEEcCCCEEEeeEEEEEC
Confidence 47999999999999999999874322 23454443333 89999999999999999999999999999999884
No 119
>cd05764 Ig_2 Subgroup of the immunoglobulin (Ig) superfamily. Ig_2: subgroup of the immunoglobulin (Ig) domain found in the Ig superfamily. The Ig superfamily is a heterogenous group of proteins, built on a common fold comprised of a sandwich of two beta sheets. Members of the Ig superfamily are components of immunoglobulin, neuroglia, cell surface glycoproteins, such as T-cell receptors, CD2, CD4, CD8, and membrane glycoproteins, such as butyrophilin and chondroitin sulfate proteoglycan core protein. A predominant feature of most Ig domains is a disulfide bridge connecting the two beta-sheets with a tryptophan residue packed against the disulfide bond.
Probab=99.23 E-value=4.7e-11 Score=106.50 Aligned_cols=73 Identities=33% Similarity=0.533 Sum_probs=63.3
Q ss_pred CceEEEEEEEecCCCcEEEEEe-CCEecCCCCCeEEeecCCeEEEEEccCCCCCCEEEEEEEEeCCeeEEEEEEEEE
Q psy2148 1757 GQLARFDAKISATKPLDVYWLK-NGKKIIPDIRYKTLEEDNLFTLLIIEAVVEDSGAYECVAMNNAGEARCEAELVV 1832 (1884)
Q Consensus 1757 G~~~~l~C~~~g~p~p~v~W~k-~~~~l~~~~~~~~~~~~~~~~L~i~~~~~~d~G~Y~C~a~N~~G~~~~~~~l~V 1832 (1884)
|+.+.|.|.+.|.|.|.+.|++ ++..+....++.+..++ .|.|.++..+|.|.|+|.|.|..|.++.++.|.|
T Consensus 1 G~~~~l~C~~~g~P~p~v~W~~~~~~~~~~~~~~~~~~~~---~L~i~~~~~~D~G~Y~C~a~N~~G~~~~~~~l~v 74 (74)
T cd05764 1 GQRATLRCKARGDPEPAIHWISPDGKLISNSSRTLVYDNG---TLDILITTVKDTGSFTCIASNAAGEATATVELHI 74 (74)
T ss_pred CCeEEEEEEccCcCCCEEEEEeCCCEEecCCCeEEEecCC---EEEEEECChhhCEEEEEEEECCCCeEEEEEEEEC
Confidence 7889999999999999999997 67777666666554444 7999999999999999999999999999988875
No 120
>cd05760 Ig2_PTK7 Second immunoglobulin (Ig)-like domain of protein tyrosine kinase (PTK) 7, also known as CCK4. Ig2_PTK7: domain similar to the second immunoglobulin (Ig)-like domain in protein tyrosine kinase (PTK) 7, also known as CCK4. PTK7 is a subfamily of the receptor protein tyrosine kinase family, and is referred to as an RPTK-like molecule. RPTKs transduce extracellular signals across the cell membrane, and play important roles in regulating cell proliferation, migration, and differentiation. PTK7 is organized as an extracellular portion having seven Ig-like domains, a single transmembrane region, and a cytoplasmic tyrosine kinase-like domain. PTK7 is considered a pseudokinase as it has several unusual residues in some of the highly conserved tyrosine kinase (TK) motifs; it is predicted to lack TK activity. PTK7 may function as a cell-adhesion molecule. PTK7 mRNA is expressed at high levels in placenta, melanocytes, liver, lung, pancreas, and kidney. PTK7 is overexpressed in s
Probab=99.23 E-value=5.5e-11 Score=106.37 Aligned_cols=72 Identities=22% Similarity=0.359 Sum_probs=58.5
Q ss_pred EEEEEEEecCCCcEEEEEeCCEecCCCC-CeEEeecCCeEEEEEccCCCCCCEEEEEEEEeCCeeEEEE--EEEEEE
Q psy2148 1760 ARFDAKISATKPLDVYWLKNGKKIIPDI-RYKTLEEDNLFTLLIIEAVVEDSGAYECVAMNNAGEARCE--AELVVQ 1833 (1884)
Q Consensus 1760 ~~l~C~~~g~p~p~v~W~k~~~~l~~~~-~~~~~~~~~~~~L~i~~~~~~d~G~Y~C~a~N~~G~~~~~--~~l~V~ 1833 (1884)
++|.|.+.|.|.|.|+|+|+|.++..+. ++.+.... ..|.|.++..+|+|.|.|.|.|.+|....+ ++|.|.
T Consensus 1 v~L~C~~~g~P~p~v~W~k~g~~l~~~~~~~~~~~~~--~~L~I~~~~~~D~G~Y~C~a~N~~G~~~s~~~~~l~v~ 75 (77)
T cd05760 1 VTLRCHIDGHPRPTYQWFRDGTPLSDGQGNYSVSSKE--RTLTLRSAGPDDSGLYYCCAHNAFGSVCSSQNFTLSII 75 (77)
T ss_pred CEEEEEeeecCCCcEEEEECCEECCCCCccEEEeCCC--CEEEEeeCCcccCEEEEEEEEeCCCeEeeCceEEEEEe
Confidence 5799999999999999999999987654 44443332 389999999999999999999999987554 555544
No 121
>cd05758 Ig5_KIRREL3-like Fifth immunoglobulin (Ig)-like domain of Kirrel (kin of irregular chiasm-like) 3 (also known as Neph2) and similar proteins. Ig5_KIRREL3-like: domain similar to the fifth immunoglobulin (Ig)-like domain of Kirrel (kin of irregular chiasm-like) 3 (also known as Neph2). This protein has five Ig-like domains, one transmembrane domain, and a cytoplasmic tail. Included in this group is mammalian Kirrel (Neph1), Kirrel2 (Neph3), and Drosophila RST (irregular chiasm C-roughest) protein. These proteins contain multiple Ig domains, have properties of cell adhesion molecules, and are important in organ development.
Probab=99.23 E-value=8.8e-11 Score=111.15 Aligned_cols=88 Identities=23% Similarity=0.336 Sum_probs=73.4
Q ss_pred CCeEEeccCceEEcCCceEEEEEEEecCCCc-EEEEEeCCEecCCC--CCeEEeec----CCeEEEEEccCCC-CCCEEE
Q psy2148 1742 PPSFLTTISSAVINVGQLARFDAKISATKPL-DVYWLKNGKKIIPD--IRYKTLEE----DNLFTLLIIEAVV-EDSGAY 1813 (1884)
Q Consensus 1742 ~P~~~~~~~~~~~~~G~~~~l~C~~~g~p~p-~v~W~k~~~~l~~~--~~~~~~~~----~~~~~L~i~~~~~-~d~G~Y 1813 (1884)
||.+.. +....+..|+.+.|.|.+.|.|.| .|.|++++..+... .++.+... +..+.|.|.++.. +|.|.|
T Consensus 2 pp~i~~-~~~~~~~~G~~v~L~C~~~g~P~P~~v~W~~~~~~i~~~~~~r~~i~~~~~~~~~~s~L~I~~v~~~d~~G~Y 80 (98)
T cd05758 2 PPIITS-EATQYAILGDKGRVECFIFSTPPPDRIVWTWKENELESGSSGRYTVETDPSPGGVLSTLTISNTQESDFQTSY 80 (98)
T ss_pred CCeEcC-CCcEEEeCCCcEEEEEEEcccCCCCEeEEEECCEEccCCCCCCEEEEEecCCCceEEEEEECCccccccceeE
Confidence 566644 567788999999999999999999 69999999988754 57776553 2346899999998 459999
Q ss_pred EEEEEeCCeeEEEEEEE
Q psy2148 1814 ECVAMNNAGEARCEAEL 1830 (1884)
Q Consensus 1814 ~C~a~N~~G~~~~~~~l 1830 (1884)
+|.|.|..|.++..++|
T Consensus 81 ~C~A~N~~G~~~~~~~L 97 (98)
T cd05758 81 NCTAWNSFGSGTAIISL 97 (98)
T ss_pred EEEEEcCCCcccEEEEe
Confidence 99999999999988877
No 122
>cd05760 Ig2_PTK7 Second immunoglobulin (Ig)-like domain of protein tyrosine kinase (PTK) 7, also known as CCK4. Ig2_PTK7: domain similar to the second immunoglobulin (Ig)-like domain in protein tyrosine kinase (PTK) 7, also known as CCK4. PTK7 is a subfamily of the receptor protein tyrosine kinase family, and is referred to as an RPTK-like molecule. RPTKs transduce extracellular signals across the cell membrane, and play important roles in regulating cell proliferation, migration, and differentiation. PTK7 is organized as an extracellular portion having seven Ig-like domains, a single transmembrane region, and a cytoplasmic tyrosine kinase-like domain. PTK7 is considered a pseudokinase as it has several unusual residues in some of the highly conserved tyrosine kinase (TK) motifs; it is predicted to lack TK activity. PTK7 may function as a cell-adhesion molecule. PTK7 mRNA is expressed at high levels in placenta, melanocytes, liver, lung, pancreas, and kidney. PTK7 is overexpressed in s
Probab=99.23 E-value=5e-11 Score=106.64 Aligned_cols=71 Identities=30% Similarity=0.544 Sum_probs=57.0
Q ss_pred EEEEEEEeeCCCCCcEEEEeeCCEEccCCC-cEEEEeeCCeEEEEEccCCCCCCeEEEEEEEcCCeeEEEEEEEEE
Q psy2148 934 AHFECRLTPTNDPSMTVEWFHNGKALSAGS-RIKTINDFGFVILEINDVYLRDSGLYTCKATNKHGEATTSCKLTV 1008 (1884)
Q Consensus 934 v~l~C~v~~~~~P~~~v~W~~~g~~i~~~~-~~~~~~~~~~~~L~I~~~~~~D~G~Y~C~a~N~~G~~~~~~~l~V 1008 (1884)
++|.|.+. |.|.|.|+|+|+|.+|.... ++.+...+ ..|.|.++..+|+|.|+|.|.|.+|...++..++|
T Consensus 1 v~L~C~~~--g~P~p~v~W~k~g~~l~~~~~~~~~~~~~--~~L~I~~~~~~D~G~Y~C~a~N~~G~~~s~~~~~l 72 (77)
T cd05760 1 VTLRCHID--GHPRPTYQWFRDGTPLSDGQGNYSVSSKE--RTLTLRSAGPDDSGLYYCCAHNAFGSVCSSQNFTL 72 (77)
T ss_pred CEEEEEee--ecCCCcEEEEECCEECCCCCccEEEeCCC--CEEEEeeCCcccCEEEEEEEEeCCCeEeeCceEEE
Confidence 57999998 77889999999999997654 44443332 37999999999999999999999999865544444
No 123
>cd05725 Ig3_Robo Third immunoglobulin (Ig)-like domain in Robo (roundabout) receptors. Ig3_Robo: domain similar to the third immunoglobulin (Ig)-like domain in Robo (roundabout) receptors. Robo receptors play a role in the development of the central nervous system (CNS), and are receptors of Slit protein. Slit is a repellant secreted by the neural cells in the midline. Slit acts through Robo to prevent most neurons from crossing the midline from either side. Three mammalian Robo homologs (robo1, -2, and -3), and three mammalian Slit homologs (Slit-1,-2, -3), have been identified. Commissural axons, which cross the midline, express low levels of Robo; longitudinal axons, which avoid the midline, express high levels of Robo. robo1, -2, and -3 are expressed by commissural neurons in the vertebrate spinal cord and Slits 1, -2, -3 are expressed at the ventral midline. Robo-3 is a divergent member of the Robo family which instead of being a positive regulator of slit responsiveness, antagoni
Probab=99.22 E-value=4.2e-11 Score=104.94 Aligned_cols=69 Identities=26% Similarity=0.448 Sum_probs=59.8
Q ss_pred EEEEEEEecCCCcEEEEEeCCEecCCCCCeEEeecCCeEEEEEccCCCCCCEEEEEEEEeCCeeEEEEEEEEE
Q psy2148 1760 ARFDAKISATKPLDVYWLKNGKKIIPDIRYKTLEEDNLFTLLIIEAVVEDSGAYECVAMNNAGEARCEAELVV 1832 (1884)
Q Consensus 1760 ~~l~C~~~g~p~p~v~W~k~~~~l~~~~~~~~~~~~~~~~L~i~~~~~~d~G~Y~C~a~N~~G~~~~~~~l~V 1832 (1884)
++|.|.+.|.|.|.+.|+|++..+.. .++.+..++ .|.|.++..+|+|.|+|.|.|..|....++.|.|
T Consensus 1 v~l~C~~~g~P~p~v~W~k~~~~~~~-~~~~~~~~~---~L~I~~v~~~D~G~Y~C~a~N~~G~~~~~~~l~V 69 (69)
T cd05725 1 VEFQCEVGGDPVPTVLWRKEDGELPK-GRAEILDDK---SLKIRNVTAGDEGSYTCEAENMVGKIEASASLTV 69 (69)
T ss_pred CEEEEECccCCCCEEEEEECCccCCC-CcEEEeeCC---EEEECcCChhHCEEEEEEEEcCCCcEEEEEEEEC
Confidence 47999999999999999999887743 455555333 7999999999999999999999999999998876
No 124
>cd05736 Ig2_Follistatin_like Second immunoglobulin (Ig)-like domain of a follistatin-like molecule encoded by the Mahya gene and similar proteins. Ig2_Follistatin_like: domain similar to the second immunoglobulin (Ig)-like domain found in a follistatin-like molecule encoded by the CNS-related Mahya gene. Mahya genes have been retained in certain Bilaterian branches during evolution. They are conserved in Hymenoptera and Deuterostomes, but are absent from other metazoan species such as fruit fly and nematode. Mahya proteins are secretory, with a follistatin-like domain (Kazal-type serine/threonine protease inhibitor domain and EF-hand calcium-binding domain), two Ig-like domains, and a novel C-terminal domain. Mahya may be involved in learning and memory and in processing of sensory information in Hymenoptera and vertebrates. Follistatin is a secreted, multidomain protein that binds activins with high affinity and antagonizes their signaling.
Probab=99.22 E-value=5.2e-11 Score=106.84 Aligned_cols=75 Identities=31% Similarity=0.412 Sum_probs=63.6
Q ss_pred EEEEEEEecCCCcEEEEEeCCEecCCCCCeEEeecCCeEEEEEccCCCCCCEEEEEEEEeCCeeEEEEEEEEEEe
Q psy2148 1760 ARFDAKISATKPLDVYWLKNGKKIIPDIRYKTLEEDNLFTLLIIEAVVEDSGAYECVAMNNAGEARCEAELVVQS 1834 (1884)
Q Consensus 1760 ~~l~C~~~g~p~p~v~W~k~~~~l~~~~~~~~~~~~~~~~L~i~~~~~~d~G~Y~C~a~N~~G~~~~~~~l~V~~ 1834 (1884)
+.|.|.+.|.|.|.|.|+|++..+..+.+..+...+....|.|.++..+|.|.|+|.|.|..|.++.+++|.|.+
T Consensus 1 ~~L~C~v~g~P~p~v~W~k~~~~l~~~~~~~~~~~~~~~~l~I~~~~~~D~G~Y~C~a~N~~G~~~~~~~l~V~~ 75 (76)
T cd05736 1 ASLRCHAEGIPLPRLTWLKNGMDITPKLSKQLTLIANGSELHISNVRYEDTGAYTCIAKNEAGVDEDISSLFVED 75 (76)
T ss_pred CEeEeEeeecCCCEEEEEECCEECCCCCCccEEEeCCCCEEEECcCCcccCEEEEEEEEcCCCCcceEEEEEEEc
Confidence 469999999999999999999998766443333333344899999999999999999999999999999999864
No 125
>cd05738 Ig2_RPTP_IIa_LAR_like Second immunoglobulin (Ig)-like domain of the receptor protein tyrosine phosphatase (RPTP)-F, also known as LAR. Ig2_RPTP_IIa_LAR_like: domain similar to the second immunoglobulin (Ig)-like domain found in the receptor protein tyrosine phosphatase (RPTP)-F, also known as LAR. LAR belongs to the RPTP type IIa subfamily. Members of this subfamily are cell adhesion molecule-like proteins involved in central nervous system (CNS) development. They have large extracellular portions, comprised of multiple Ig-like domains and two to nine fibronectin type III (FNIII) domains, and a cytoplasmic portion having two tandem phosphatase domains.
Probab=99.21 E-value=5.1e-11 Score=105.68 Aligned_cols=70 Identities=31% Similarity=0.429 Sum_probs=59.7
Q ss_pred EEEEEEEecCCCcEEEEEeCCEecC--CCCCeEEeecCCeEEEEEccCCCCCCEEEEEEEEeCCeeE-EEEEEEEE
Q psy2148 1760 ARFDAKISATKPLDVYWLKNGKKII--PDIRYKTLEEDNLFTLLIIEAVVEDSGAYECVAMNNAGEA-RCEAELVV 1832 (1884)
Q Consensus 1760 ~~l~C~~~g~p~p~v~W~k~~~~l~--~~~~~~~~~~~~~~~L~i~~~~~~d~G~Y~C~a~N~~G~~-~~~~~l~V 1832 (1884)
++|.|.+.|.|.|.|+|+|++..+. ...++....++ .|.|.++..+|+|.|+|.|.|..|.. +.++.|.|
T Consensus 1 a~l~C~~~G~P~p~v~W~k~~~~~~~~~~~~~~~~~~g---~L~i~~~~~~D~G~Y~C~a~N~~G~~~s~~a~l~v 73 (74)
T cd05738 1 ATMLCAASGNPDPEITWFKDFLPVDTTSNGRIKQLRSG---ALQIENSEESDQGKYECVATNSAGTRYSAPANLYV 73 (74)
T ss_pred CEEEEEEeEecCCEEEEEECCEECccCCCCCEEEcCCc---EEEECCCChhhCEEEEEEEECCCCceEcccEEEEE
Confidence 4799999999999999999999987 44566554333 69999999999999999999999984 67788877
No 126
>cd05764 Ig_2 Subgroup of the immunoglobulin (Ig) superfamily. Ig_2: subgroup of the immunoglobulin (Ig) domain found in the Ig superfamily. The Ig superfamily is a heterogenous group of proteins, built on a common fold comprised of a sandwich of two beta sheets. Members of the Ig superfamily are components of immunoglobulin, neuroglia, cell surface glycoproteins, such as T-cell receptors, CD2, CD4, CD8, and membrane glycoproteins, such as butyrophilin and chondroitin sulfate proteoglycan core protein. A predominant feature of most Ig domains is a disulfide bridge connecting the two beta-sheets with a tryptophan residue packed against the disulfide bond.
Probab=99.21 E-value=7.7e-11 Score=105.16 Aligned_cols=73 Identities=33% Similarity=0.643 Sum_probs=61.9
Q ss_pred CCeEEEEEEEeeCCCCCcEEEEee-CCEEccCCCcEEEEeeCCeEEEEEccCCCCCCeEEEEEEEcCCeeEEEEEEEEE
Q psy2148 931 STLAHFECRLTPTNDPSMTVEWFH-NGKALSAGSRIKTINDFGFVILEINDVYLRDSGLYTCKATNKHGEATTSCKLTV 1008 (1884)
Q Consensus 931 G~~v~l~C~v~~~~~P~~~v~W~~-~g~~i~~~~~~~~~~~~~~~~L~I~~~~~~D~G~Y~C~a~N~~G~~~~~~~l~V 1008 (1884)
|+.+.|.|.+. |.|.|.+.|++ ++..+....++..... + +|.|.++..+|+|.|+|.|.|..|..+..+.|.|
T Consensus 1 G~~~~l~C~~~--g~P~p~v~W~~~~~~~~~~~~~~~~~~~-~--~L~i~~~~~~D~G~Y~C~a~N~~G~~~~~~~l~v 74 (74)
T cd05764 1 GQRATLRCKAR--GDPEPAIHWISPDGKLISNSSRTLVYDN-G--TLDILITTVKDTGSFTCIASNAAGEATATVELHI 74 (74)
T ss_pred CCeEEEEEEcc--CcCCCEEEEEeCCCEEecCCCeEEEecC-C--EEEEEECChhhCEEEEEEEECCCCeEEEEEEEEC
Confidence 78999999998 77999999997 6777776666555443 2 6999999999999999999999999988888875
No 127
>cd05763 Ig_1 Subgroup of the immunoglobulin (Ig) superfamily. Ig_1: subgroup of the immunoglobulin (Ig) domain found in the Ig superfamily. The Ig superfamily is a heterogenous group of proteins, built on a common fold comprised of a sandwich of two beta sheets. Members of the Ig superfamily are components of immunoglobulin, neuroglia, cell surface glycoproteins, such as T-cell receptors, CD2, CD4, CD8, and membrane glycoproteins, such as butyrophilin and chondroitin sulfate proteoglycan core protein. A predominant feature of most Ig domains is a disulfide bridge connecting the two beta-sheets with a tryptophan residue packed against the disulfide bond.
Probab=99.21 E-value=5.9e-11 Score=106.03 Aligned_cols=71 Identities=30% Similarity=0.582 Sum_probs=58.2
Q ss_pred EEEEEEEeeCCCCCcEEEEeeCCEEcc---CCCcEEEEeeCCeEEEEEccCCCCCCeEEEEEEEcCCeeEEEEEEEEE
Q psy2148 934 AHFECRLTPTNDPSMTVEWFHNGKALS---AGSRIKTINDFGFVILEINDVYLRDSGLYTCKATNKHGEATTSCKLTV 1008 (1884)
Q Consensus 934 v~l~C~v~~~~~P~~~v~W~~~g~~i~---~~~~~~~~~~~~~~~L~I~~~~~~D~G~Y~C~a~N~~G~~~~~~~l~V 1008 (1884)
++|.|.+. |.|.|.|+|+|+|..+. ...++.+...++ .|.|.+++.+|+|.|+|.|.|..|..+..+.|.|
T Consensus 1 a~l~C~~~--G~P~P~v~W~k~~~~~~~~~~~~~~~~~~~~~--~L~I~~~~~~D~G~Y~C~A~N~~G~~~~~~~l~V 74 (75)
T cd05763 1 ARLECAAT--GHPTPQIAWQKDGGTDFPAARERRMHVMPEDD--VFFIVDVKIEDTGVYSCTAQNTAGSISANATLTV 74 (75)
T ss_pred CEeEeecc--cccCCEEEEEeCCCccCCcccccceEEecCCC--EEEEeeCCcccCEEEEEEEEcCCCEEEeeEEEEE
Confidence 47999998 78999999999986432 233454433333 6999999999999999999999999999999987
No 128
>cd04977 Ig1_NCAM-1_like First immunoglobulin (Ig)-like domain of neural cell adhesion molecule NCAM-1 and similar proteins. Ig1_NCAM-1 like: first immunoglobulin (Ig)-like domain of neural cell adhesion molecule NCAM-1. NCAM-1 plays important roles in the development and regeneration of the central nervous system, in synaptogenesis and neural migration. NCAM mediates cell-cell and cell-substratum recognition and adhesion via homophilic (NCAM-NCAM), and heterophilic (NCAM-nonNCAM), interactions. NCAM is expressed as three major isoforms having different intracellular extensions. The extracellular portion of NCAM has five N-terminal Ig-like domains and two fibronectin type III domains. The double zipper adhesion complex model for NCAM homophilic binding involves the Ig1, Ig2, and Ig3 domains. By this model, Ig1 and Ig2 mediate dimerization of NCAM molecules situated on the same cell surface (cis interactions), and Ig3 domains mediate interactions between NCAM molecules expressed on the s
Probab=99.20 E-value=1.2e-10 Score=108.24 Aligned_cols=86 Identities=26% Similarity=0.550 Sum_probs=67.5
Q ss_pred eecCCceeecCCCeEEEEEEEeeCCCCCcEEEEee-CCEEccCCCcEEEEe-eCCeEEEEEccCCCCCCeEEEEEEEcCC
Q psy2148 920 LTTPTDLTLAESTLAHFECRLTPTNDPSMTVEWFH-NGKALSAGSRIKTIN-DFGFVILEINDVYLRDSGLYTCKATNKH 997 (1884)
Q Consensus 920 ~~~~~~~~v~~G~~v~l~C~v~~~~~P~~~v~W~~-~g~~i~~~~~~~~~~-~~~~~~L~I~~~~~~D~G~Y~C~a~N~~ 997 (1884)
...|.+..+..|+++.|.|.+. |.|+ .++|++ +|..+....++.+.. ....++|+|.+++.+|+|.|+|.|.|..
T Consensus 4 ~v~p~~~~v~~G~~~~l~C~~~--G~p~-~i~W~~~~~~~~~~~~~~~~~~~~~~~~~L~I~~v~~~D~G~Y~C~A~N~~ 80 (92)
T cd04977 4 DIVPSQGEISVGESKFFLCQVI--GEPK-DISWFSPNGEKLVTQQQISVVQNDDVRSTLTIYNANIEDAGIYKCVATDAK 80 (92)
T ss_pred EEecCcEEECCCCeEEEEEEeE--eeCC-eEEEECCCCCEeccCCCEEEEeCCCCEEEEEEecCCcccCEEEEEEEEcCC
Confidence 3456778999999999999999 4564 999998 677776655655443 3456789999999999999999999996
Q ss_pred e-eEEEEEEEEE
Q psy2148 998 G-EATTSCKLTV 1008 (1884)
Q Consensus 998 G-~~~~~~~l~V 1008 (1884)
| ..+.++.|.|
T Consensus 81 g~~~~~sv~l~~ 92 (92)
T cd04977 81 GTESEATVNLKI 92 (92)
T ss_pred CCcceeEEEEEC
Confidence 5 4566666654
No 129
>cd05722 Ig1_Neogenin First immunoglobulin (Ig)-like domain in neogenin and similar proteins. Ig1_Neogenin: first immunoglobulin (Ig)-like domain in neogenin and related proteins. Neogenin is a cell surface protein which is expressed in the developing nervous system of vertebrate embryos in the growing nerve cells. It is also expressed in other embryonic tissues, and may play a general role in developmental processes such as cell migration, cell-cell recognition, and tissue growth regulation. Included in this group is the tumor suppressor protein DCC, which is deleted in colorectal carcinoma . DCC and neogenin each have four Ig-like domains followed by six fibronectin type III domains, a transmembrane domain, and an intracellular domain.
Probab=99.20 E-value=9.3e-11 Score=110.46 Aligned_cols=85 Identities=28% Similarity=0.398 Sum_probs=68.7
Q ss_pred EEeccCceEEcCCceEEEEEEEecCCCcEEEEEeCCEecCCCCC--eEEeecCCeEEEEEccC-----CCCCCEEEEEEE
Q psy2148 1745 FLTTISSAVINVGQLARFDAKISATKPLDVYWLKNGKKIIPDIR--YKTLEEDNLFTLLIIEA-----VVEDSGAYECVA 1817 (1884)
Q Consensus 1745 ~~~~~~~~~~~~G~~~~l~C~~~g~p~p~v~W~k~~~~l~~~~~--~~~~~~~~~~~L~i~~~-----~~~d~G~Y~C~a 1817 (1884)
|...|.+..+.+|+++.|.|.+.|.|.|.|+|+|||..+....+ +.+..++ .|.|.++ .++|.|.|+|.|
T Consensus 2 f~~~P~~~~~~~g~~v~l~C~v~g~P~p~i~W~k~g~~l~~~~~~~~~~~~~~---~l~i~~v~~~~~~~~D~G~Y~C~a 78 (95)
T cd05722 2 FLSEPSDIVAVRGGPVVLNCSAEGEPPPKIEWKKDGVLLNLVSDERRQQLPNG---SLLITSVVHSKHNKPDEGFYQCVA 78 (95)
T ss_pred cEECCCCeEEcCCCCEEEeeecccCCCCEEEEEECCeECccccCcceEEccCC---eEEEeeeeccCCCCCcCEEEEEEE
Confidence 45667788889999999999999999999999999999976543 4443333 4666665 589999999999
Q ss_pred EeC-CeeE-EEEEEEEE
Q psy2148 1818 MNN-AGEA-RCEAELVV 1832 (1884)
Q Consensus 1818 ~N~-~G~~-~~~~~l~V 1832 (1884)
.|. .|.. ++.++|+|
T Consensus 79 ~N~~~G~~~s~~~~l~v 95 (95)
T cd05722 79 QNDSLGSIVSRTARLTV 95 (95)
T ss_pred ECCccCcEEEeeeEEeC
Confidence 999 9987 56777765
No 130
>cd05724 Ig2_Robo Second immunoglobulin (Ig)-like domain in Robo (roundabout) receptors. Ig2_Robo: domain similar to the second immunoglobulin (Ig)-like domain in Robo (roundabout) receptors. Robo receptors play a role in the development of the central nervous system (CNS), and are receptors of Slit protein. Slit is a repellant secreted by the neural cells in the midline. Slit acts through Robo to prevent most neurons from crossing the midline from either side. Three mammalian Robo homologs (robo1, -2, and -3), and three mammalian Slit homologs (Slit-1,-2, -3), have been identified. Commissural axons, which cross the midline, express low levels of Robo; longitudinal axons, which avoid the midline, express high levels of Robo. robo1, -2, and -3 are expressed by commissural neurons in the vertebrate spinal cord and Slits 1, -2, -3 are expressed at the ventral midline. Robo-3 is a divergent member of the Robo family which instead of being a positive regulator of slit responsiveness, antago
Probab=99.20 E-value=8.3e-11 Score=108.99 Aligned_cols=81 Identities=33% Similarity=0.602 Sum_probs=66.4
Q ss_pred CCceeecCCCeEEEEEEE-eeCCCCCcEEEEeeCCEEccC-CCcEEEEeeCCeEEEEEccCCCCCCeEEEEEEEcCCeeE
Q psy2148 923 PTDLTLAESTLAHFECRL-TPTNDPSMTVEWFHNGKALSA-GSRIKTINDFGFVILEINDVYLRDSGLYTCKATNKHGEA 1000 (1884)
Q Consensus 923 ~~~~~v~~G~~v~l~C~v-~~~~~P~~~v~W~~~g~~i~~-~~~~~~~~~~~~~~L~I~~~~~~D~G~Y~C~a~N~~G~~ 1000 (1884)
|.+..+.+|+++.|.|.+ . +.|.|.|.|+|+|..+.. ..++.+.. ++ .|.|.+++.+|+|.|+|.|.|..|..
T Consensus 3 p~~~~~~~G~~v~l~C~~~~--g~p~p~i~W~k~g~~~~~~~~~~~~~~-~~--~L~I~~~~~~D~G~Y~C~a~N~~G~~ 77 (86)
T cd05724 3 PSDTQVAVGEMAVLECSPPR--GHPEPTVSWRKDGQPLNLDNERVRIVD-DG--NLLIAEARKSDEGTYKCVATNMVGER 77 (86)
T ss_pred CccEEEeCCCCEEEEEECCC--CCCCCEEEEEECCEECCCCCCCEEEcc-CC--EEEEeECCcccCEEEEEEEEeccCce
Confidence 567889999999999998 5 778899999999999876 44555543 22 69999999999999999999999986
Q ss_pred E-EEEEEEE
Q psy2148 1001 T-TSCKLTV 1008 (1884)
Q Consensus 1001 ~-~~~~l~V 1008 (1884)
. ..+.|.|
T Consensus 78 ~s~~~~l~V 86 (86)
T cd05724 78 ESAAARLSV 86 (86)
T ss_pred eeeeEEEEC
Confidence 4 4556554
No 131
>cd05749 Ig2_Tyro3_like Second immunoglobulin (Ig)-like domain of Axl/Tyro3 receptor tyrosine kinases (RTKs). Ig2_Tyro3_like: the second immunoglobulin (Ig)-like domain in the Axl/Tyro3 family of receptor tyrosine kinases (RTKs). This family includes Axl (also known as Ark, Ufo, and Tyro7), Tyro3 (also known as Sky, Rse, Brt, Dtk, and Tif), and Mer (also known as Nyk, c-Eyk, and Tyro12). Axl/Tyro3 family receptors have an extracellular portion with two Ig-like domains followed by two fibronectin-types III (FNIII) domains, a membrane-spanning single helix, and a cytoplasmic tyrosine kinase domain. Axl, Tyro3 and Mer are widely expressed in adult tissues, though they show higher expression in the brain, in the lymphatic and vascular systems, and in the testis. Axl, Tyro3, and Mer bind the vitamin K dependent protein Gas6 with high affinity, and in doing so activate their tyrosine kinase activity. Axl/Gas6 signaling may play a part in cell adhesion processes, prevention of apoptosis, and c
Probab=99.20 E-value=7e-11 Score=105.41 Aligned_cols=78 Identities=21% Similarity=0.502 Sum_probs=61.6
Q ss_pred eeecCCceeecCCCeEEEEEEEeeCCCCCc-EEEEeeCCEEccCCCcEEEEeeCCeEEEEEccCCCCCCeEEEEEEEcCC
Q psy2148 919 FLTTPTDLTLAESTLAHFECRLTPTNDPSM-TVEWFHNGKALSAGSRIKTINDFGFVILEINDVYLRDSGLYTCKATNKH 997 (1884)
Q Consensus 919 ~~~~~~~~~v~~G~~v~l~C~v~~~~~P~~-~v~W~~~g~~i~~~~~~~~~~~~~~~~L~I~~~~~~D~G~Y~C~a~N~~ 997 (1884)
|+..|+++.+.+|+++.|.|.+. |.|.| +|+|+|||.+|... ... ..+.|.|.++ .|+|.|.|.|+|.+
T Consensus 1 f~~~P~~~~v~~G~~v~l~C~a~--G~P~P~~I~W~k~g~~l~~~--~~~----~~s~L~i~~~--~d~g~Y~C~A~N~~ 70 (81)
T cd05749 1 FTVEPEDLSVTANTPFNLTCQAV--GPPEPVEILWWQGGSPLGDP--PAP----SPSVLNVPGL--NETSKFSCEAHNAK 70 (81)
T ss_pred CcCCCCceEEcCCCCEEEEEEee--eecCCeEEEEEECCEECCCC--CCC----CCCEEEEccc--cCCeEEEEEEEecc
Confidence 45567889999999999999998 78989 79999999998641 111 1236999886 48899999999999
Q ss_pred eeEEE-EEEE
Q psy2148 998 GEATT-SCKL 1006 (1884)
Q Consensus 998 G~~~~-~~~l 1006 (1884)
|...+ .+.|
T Consensus 71 G~~~s~~a~~ 80 (81)
T cd05749 71 GVTTSRTGTV 80 (81)
T ss_pred CcEEeeeEEe
Confidence 97654 4444
No 132
>cd05736 Ig2_Follistatin_like Second immunoglobulin (Ig)-like domain of a follistatin-like molecule encoded by the Mahya gene and similar proteins. Ig2_Follistatin_like: domain similar to the second immunoglobulin (Ig)-like domain found in a follistatin-like molecule encoded by the CNS-related Mahya gene. Mahya genes have been retained in certain Bilaterian branches during evolution. They are conserved in Hymenoptera and Deuterostomes, but are absent from other metazoan species such as fruit fly and nematode. Mahya proteins are secretory, with a follistatin-like domain (Kazal-type serine/threonine protease inhibitor domain and EF-hand calcium-binding domain), two Ig-like domains, and a novel C-terminal domain. Mahya may be involved in learning and memory and in processing of sensory information in Hymenoptera and vertebrates. Follistatin is a secreted, multidomain protein that binds activins with high affinity and antagonizes their signaling.
Probab=99.20 E-value=7.4e-11 Score=105.83 Aligned_cols=75 Identities=25% Similarity=0.374 Sum_probs=62.1
Q ss_pred EEEEEEEeeCCCCCcEEEEeeCCEEccCCCcEEEEeeCCeEEEEEccCCCCCCeEEEEEEEcCCeeEEEEEEEEEEe
Q psy2148 934 AHFECRLTPTNDPSMTVEWFHNGKALSAGSRIKTINDFGFVILEINDVYLRDSGLYTCKATNKHGEATTSCKLTVKG 1010 (1884)
Q Consensus 934 v~l~C~v~~~~~P~~~v~W~~~g~~i~~~~~~~~~~~~~~~~L~I~~~~~~D~G~Y~C~a~N~~G~~~~~~~l~V~~ 1010 (1884)
+.|.|.+. |.|+|.|.|+|++..|..+.+.++...+....|.|.+++.+|+|.|+|.|.|..|..+..+.|.|.+
T Consensus 1 ~~L~C~v~--g~P~p~v~W~k~~~~l~~~~~~~~~~~~~~~~l~I~~~~~~D~G~Y~C~a~N~~G~~~~~~~l~V~~ 75 (76)
T cd05736 1 ASLRCHAE--GIPLPRLTWLKNGMDITPKLSKQLTLIANGSELHISNVRYEDTGAYTCIAKNEAGVDEDISSLFVED 75 (76)
T ss_pred CEeEeEee--ecCCCEEEEEECCEECCCCCCccEEEeCCCCEEEECcCCcccCEEEEEEEEcCCCCcceEEEEEEEc
Confidence 47999998 7788999999999998765433332233334799999999999999999999999999999999863
No 133
>cd05749 Ig2_Tyro3_like Second immunoglobulin (Ig)-like domain of Axl/Tyro3 receptor tyrosine kinases (RTKs). Ig2_Tyro3_like: the second immunoglobulin (Ig)-like domain in the Axl/Tyro3 family of receptor tyrosine kinases (RTKs). This family includes Axl (also known as Ark, Ufo, and Tyro7), Tyro3 (also known as Sky, Rse, Brt, Dtk, and Tif), and Mer (also known as Nyk, c-Eyk, and Tyro12). Axl/Tyro3 family receptors have an extracellular portion with two Ig-like domains followed by two fibronectin-types III (FNIII) domains, a membrane-spanning single helix, and a cytoplasmic tyrosine kinase domain. Axl, Tyro3 and Mer are widely expressed in adult tissues, though they show higher expression in the brain, in the lymphatic and vascular systems, and in the testis. Axl, Tyro3, and Mer bind the vitamin K dependent protein Gas6 with high affinity, and in doing so activate their tyrosine kinase activity. Axl/Gas6 signaling may play a part in cell adhesion processes, prevention of apoptosis, and c
Probab=99.19 E-value=8.2e-11 Score=104.96 Aligned_cols=77 Identities=9% Similarity=0.176 Sum_probs=61.5
Q ss_pred EeccCceEEcCCceEEEEEEEecCCCc-EEEEEeCCEecCCCCCeEEeecCCeEEEEEccCCCCCCEEEEEEEEeCCeeE
Q psy2148 1746 LTTISSAVINVGQLARFDAKISATKPL-DVYWLKNGKKIIPDIRYKTLEEDNLFTLLIIEAVVEDSGAYECVAMNNAGEA 1824 (1884)
Q Consensus 1746 ~~~~~~~~~~~G~~~~l~C~~~g~p~p-~v~W~k~~~~l~~~~~~~~~~~~~~~~L~i~~~~~~d~G~Y~C~a~N~~G~~ 1824 (1884)
...|.+..+.+|+++.|.|.+.|.|.| .|.|+|||.++.. ++. .....|.|..+ .|.|.|.|.|+|.+|..
T Consensus 2 ~~~P~~~~v~~G~~v~l~C~a~G~P~P~~I~W~k~g~~l~~--~~~----~~~s~L~i~~~--~d~g~Y~C~A~N~~G~~ 73 (81)
T cd05749 2 TVEPEDLSVTANTPFNLTCQAVGPPEPVEILWWQGGSPLGD--PPA----PSPSVLNVPGL--NETSKFSCEAHNAKGVT 73 (81)
T ss_pred cCCCCceEEcCCCCEEEEEEeeeecCCeEEEEEECCEECCC--CCC----CCCCEEEEccc--cCCeEEEEEEEeccCcE
Confidence 445678899999999999999999999 7999999999864 111 11237999887 47899999999999976
Q ss_pred EE-EEEE
Q psy2148 1825 RC-EAEL 1830 (1884)
Q Consensus 1825 ~~-~~~l 1830 (1884)
.. .+.|
T Consensus 74 ~s~~a~~ 80 (81)
T cd05749 74 TSRTGTV 80 (81)
T ss_pred EeeeEEe
Confidence 54 4444
No 134
>cd05725 Ig3_Robo Third immunoglobulin (Ig)-like domain in Robo (roundabout) receptors. Ig3_Robo: domain similar to the third immunoglobulin (Ig)-like domain in Robo (roundabout) receptors. Robo receptors play a role in the development of the central nervous system (CNS), and are receptors of Slit protein. Slit is a repellant secreted by the neural cells in the midline. Slit acts through Robo to prevent most neurons from crossing the midline from either side. Three mammalian Robo homologs (robo1, -2, and -3), and three mammalian Slit homologs (Slit-1,-2, -3), have been identified. Commissural axons, which cross the midline, express low levels of Robo; longitudinal axons, which avoid the midline, express high levels of Robo. robo1, -2, and -3 are expressed by commissural neurons in the vertebrate spinal cord and Slits 1, -2, -3 are expressed at the ventral midline. Robo-3 is a divergent member of the Robo family which instead of being a positive regulator of slit responsiveness, antagoni
Probab=99.19 E-value=6.6e-11 Score=103.65 Aligned_cols=69 Identities=36% Similarity=0.617 Sum_probs=58.3
Q ss_pred EEEEEEEeeCCCCCcEEEEeeCCEEccCCCcEEEEeeCCeEEEEEccCCCCCCeEEEEEEEcCCeeEEEEEEEEE
Q psy2148 934 AHFECRLTPTNDPSMTVEWFHNGKALSAGSRIKTINDFGFVILEINDVYLRDSGLYTCKATNKHGEATTSCKLTV 1008 (1884)
Q Consensus 934 v~l~C~v~~~~~P~~~v~W~~~g~~i~~~~~~~~~~~~~~~~L~I~~~~~~D~G~Y~C~a~N~~G~~~~~~~l~V 1008 (1884)
++|.|.+. |.|+|.+.|+|++..+.. .++..... + .|.|.+++.+|+|.|+|.|.|..|..+.++.|.|
T Consensus 1 v~l~C~~~--g~P~p~v~W~k~~~~~~~-~~~~~~~~-~--~L~I~~v~~~D~G~Y~C~a~N~~G~~~~~~~l~V 69 (69)
T cd05725 1 VEFQCEVG--GDPVPTVLWRKEDGELPK-GRAEILDD-K--SLKIRNVTAGDEGSYTCEAENMVGKIEASASLTV 69 (69)
T ss_pred CEEEEECc--cCCCCEEEEEECCccCCC-CcEEEeeC-C--EEEECcCChhHCEEEEEEEEcCCCcEEEEEEEEC
Confidence 57999998 789999999999887754 35555422 2 6999999999999999999999999999988875
No 135
>cd05738 Ig2_RPTP_IIa_LAR_like Second immunoglobulin (Ig)-like domain of the receptor protein tyrosine phosphatase (RPTP)-F, also known as LAR. Ig2_RPTP_IIa_LAR_like: domain similar to the second immunoglobulin (Ig)-like domain found in the receptor protein tyrosine phosphatase (RPTP)-F, also known as LAR. LAR belongs to the RPTP type IIa subfamily. Members of this subfamily are cell adhesion molecule-like proteins involved in central nervous system (CNS) development. They have large extracellular portions, comprised of multiple Ig-like domains and two to nine fibronectin type III (FNIII) domains, and a cytoplasmic portion having two tandem phosphatase domains.
Probab=99.19 E-value=6.6e-11 Score=104.99 Aligned_cols=70 Identities=30% Similarity=0.566 Sum_probs=58.7
Q ss_pred EEEEEEEeeCCCCCcEEEEeeCCEEcc--CCCcEEEEeeCCeEEEEEccCCCCCCeEEEEEEEcCCeeE-EEEEEEEE
Q psy2148 934 AHFECRLTPTNDPSMTVEWFHNGKALS--AGSRIKTINDFGFVILEINDVYLRDSGLYTCKATNKHGEA-TTSCKLTV 1008 (1884)
Q Consensus 934 v~l~C~v~~~~~P~~~v~W~~~g~~i~--~~~~~~~~~~~~~~~L~I~~~~~~D~G~Y~C~a~N~~G~~-~~~~~l~V 1008 (1884)
++|.|.+. |.|.|.|+|+|++.++. .+.++.... .+ .|.|.+++.+|+|.|+|.|.|..|.. +..+.|.|
T Consensus 1 a~l~C~~~--G~P~p~v~W~k~~~~~~~~~~~~~~~~~-~g--~L~i~~~~~~D~G~Y~C~a~N~~G~~~s~~a~l~v 73 (74)
T cd05738 1 ATMLCAAS--GNPDPEITWFKDFLPVDTTSNGRIKQLR-SG--ALQIENSEESDQGKYECVATNSAGTRYSAPANLYV 73 (74)
T ss_pred CEEEEEEe--EecCCEEEEEECCEECccCCCCCEEEcC-Cc--EEEECCCChhhCEEEEEEEECCCCceEcccEEEEE
Confidence 47999998 78999999999999987 455665533 23 59999999999999999999999984 67788877
No 136
>cd05722 Ig1_Neogenin First immunoglobulin (Ig)-like domain in neogenin and similar proteins. Ig1_Neogenin: first immunoglobulin (Ig)-like domain in neogenin and related proteins. Neogenin is a cell surface protein which is expressed in the developing nervous system of vertebrate embryos in the growing nerve cells. It is also expressed in other embryonic tissues, and may play a general role in developmental processes such as cell migration, cell-cell recognition, and tissue growth regulation. Included in this group is the tumor suppressor protein DCC, which is deleted in colorectal carcinoma . DCC and neogenin each have four Ig-like domains followed by six fibronectin type III domains, a transmembrane domain, and an intracellular domain.
Probab=99.19 E-value=1.1e-10 Score=109.92 Aligned_cols=85 Identities=28% Similarity=0.513 Sum_probs=67.4
Q ss_pred eeecCCceeecCCCeEEEEEEEeeCCCCCcEEEEeeCCEEccCCCc--EEEEeeCCeEEEEEccC-----CCCCCeEEEE
Q psy2148 919 FLTTPTDLTLAESTLAHFECRLTPTNDPSMTVEWFHNGKALSAGSR--IKTINDFGFVILEINDV-----YLRDSGLYTC 991 (1884)
Q Consensus 919 ~~~~~~~~~v~~G~~v~l~C~v~~~~~P~~~v~W~~~g~~i~~~~~--~~~~~~~~~~~L~I~~~-----~~~D~G~Y~C 991 (1884)
|...|.+..+.+|+++.|.|.+. +.|.|.|+|+|||..|..... +.+..++ .|.|.++ ..+|+|.|+|
T Consensus 2 f~~~P~~~~~~~g~~v~l~C~v~--g~P~p~i~W~k~g~~l~~~~~~~~~~~~~~---~l~i~~v~~~~~~~~D~G~Y~C 76 (95)
T cd05722 2 FLSEPSDIVAVRGGPVVLNCSAE--GEPPPKIEWKKDGVLLNLVSDERRQQLPNG---SLLITSVVHSKHNKPDEGFYQC 76 (95)
T ss_pred cEECCCCeEEcCCCCEEEeeecc--cCCCCEEEEEECCeECccccCcceEEccCC---eEEEeeeeccCCCCCcCEEEEE
Confidence 45677888999999999999998 778999999999999976543 4443333 3556655 6899999999
Q ss_pred EEEcC-CeeE-EEEEEEEE
Q psy2148 992 KATNK-HGEA-TTSCKLTV 1008 (1884)
Q Consensus 992 ~a~N~-~G~~-~~~~~l~V 1008 (1884)
.|.|. .|.. +..+.|+|
T Consensus 77 ~a~N~~~G~~~s~~~~l~v 95 (95)
T cd05722 77 VAQNDSLGSIVSRTARLTV 95 (95)
T ss_pred EEECCccCcEEEeeeEEeC
Confidence 99999 9986 55677764
No 137
>cd05726 Ig4_Robo Fhird immunoglobulin (Ig)-like domain in Robo (roundabout) receptors. Ig4_Robo: domain similar to the fhird immunoglobulin (Ig)-like domain in Robo (roundabout) receptors. Robo receptors play a role in the development of the central nervous system (CNS), and are receptors of Slit protein. Slit is a repellant secreted by the neural cells in the midline. Slit acts through Robo to prevent most neurons from crossing the midline from either side. Three mammalian Robo homologs (robo1, -2, and -3), and three mammalian Slit homologs (Slit-1,-2, -3), have been identified. Commissural axons, which cross the midline, express low levels of Robo; longitudinal axons, which avoid the midline, express high levels of Robo. robo1, -2, and -3 are expressed by commissural neurons in the vertebrate spinal cord and Slits 1, -2, -3 are expressed at the ventral midline. Robo-3 is a divergent member of the Robo family which instead of being a positive regulator of slit responsiveness, antagoni
Probab=99.19 E-value=8.2e-11 Score=109.38 Aligned_cols=76 Identities=28% Similarity=0.477 Sum_probs=63.8
Q ss_pred CCeEEEEEEEeeCCCCCcEEEEeeCCEEc--------cCCCcEEEEeeCCeEEEEEccCCCCCCeEEEEEEEcCCeeEEE
Q psy2148 931 STLAHFECRLTPTNDPSMTVEWFHNGKAL--------SAGSRIKTINDFGFVILEINDVYLRDSGLYTCKATNKHGEATT 1002 (1884)
Q Consensus 931 G~~v~l~C~v~~~~~P~~~v~W~~~g~~i--------~~~~~~~~~~~~~~~~L~I~~~~~~D~G~Y~C~a~N~~G~~~~ 1002 (1884)
|+.++|.|.+. +.|.|.|.|+|+|..+ ....++.+... + .|.|.+++.+|+|.|+|.|.|.+|....
T Consensus 1 G~~v~L~C~~~--g~P~p~v~W~k~g~~~~~~~~~~~~~~~r~~v~~~-~--~L~I~~v~~~D~G~Y~C~a~N~~G~~~~ 75 (90)
T cd05726 1 GRTVTFQCEAT--GNPQPAIFWQKEGSQNLLFSYQPPQSSSRFSVSQT-G--DLTITNVQRSDVGYYICQTLNVAGSILT 75 (90)
T ss_pred CCEEEEEEECC--ccCCCEEEEEeCCCcceeecccCCCCCCeEEECCC-C--eEEEeeCChhhCEEEEEEEEcCCCceEE
Confidence 78999999998 7788999999998753 23445555332 2 6999999999999999999999999999
Q ss_pred EEEEEEEee
Q psy2148 1003 SCKLTVKGR 1011 (1884)
Q Consensus 1003 ~~~l~V~~~ 1011 (1884)
.+.|.|.+.
T Consensus 76 ~~~l~V~~~ 84 (90)
T cd05726 76 KAYLEVTDV 84 (90)
T ss_pred EEEEEEeec
Confidence 999999864
No 138
>cd04970 Ig6_Contactin_like Sixth Ig domain of contactin. Ig6_Contactin_like: Sixth Ig domain of contactins. Contactins are neural cell adhesion molecules and are comprised of six Ig domains followed by four fibronectin type III(FnIII) domains anchored to the membrane by glycosylphosphatidylinositol. The first four Ig domains form the intermolecular binding fragment, which arranges as a compact U-shaped module via contacts between Ig domains 1 and 4, and between Ig domains 2 and 3. Contactin-2 (TAG-1, axonin-1) may play a part in the neuronal processes of neurite outgrowth, axon guidance and fasciculation, and neuronal migration. This group also includes contactin-1 and contactin-5. The different contactins show different expression patterns in the central nervous system. During development and in adulthood, contactin-2 is transiently expressed in subsets of central and peripheral neurons. Contactin-5 is expressed specifically in the rat postnatal nervous system, peaking at about 3 week
Probab=99.19 E-value=1.1e-10 Score=107.13 Aligned_cols=78 Identities=24% Similarity=0.350 Sum_probs=63.2
Q ss_pred ceEEEEEEEecCCCc--EEEEEeCCEecCCCC---CeE-EeecCCeEEEEEccCCCCCCEEEEEEEEeCCeeEEEEEEEE
Q psy2148 1758 QLARFDAKISATKPL--DVYWLKNGKKIIPDI---RYK-TLEEDNLFTLLIIEAVVEDSGAYECVAMNNAGEARCEAELV 1831 (1884)
Q Consensus 1758 ~~~~l~C~~~g~p~p--~v~W~k~~~~l~~~~---~~~-~~~~~~~~~L~i~~~~~~d~G~Y~C~a~N~~G~~~~~~~l~ 1831 (1884)
+++.|.|.+.|.|.| .+.|+|+|..+..+. ++. .........|.|.+++..|+|.|+|.|.|.+|..+.++.|.
T Consensus 1 e~~~L~C~~~g~P~p~i~~~W~~~g~~i~~~~~~~~~~~~~~~~~~~~L~I~~v~~~D~G~Y~C~a~n~~g~~~~~~~l~ 80 (85)
T cd04970 1 ESITLQCHASHDPTLDLTFTWSFNGVPIDFDKDGGHYRRVGGKDSNGDLMIRNAQLKHAGKYTCTAQTVVDSLSASADLI 80 (85)
T ss_pred CcEEEEEEEecCCCCCeEEEEEECCeEeeccCCCccEEEEecccccceEEEccCCHHhCeeeEEEEecCCCcEEEEEEEE
Confidence 468999999999988 679999999886432 222 11122234899999999999999999999999999999999
Q ss_pred EEec
Q psy2148 1832 VQSK 1835 (1884)
Q Consensus 1832 V~~~ 1835 (1884)
|.++
T Consensus 81 V~~p 84 (85)
T cd04970 81 VRGP 84 (85)
T ss_pred EECC
Confidence 9873
No 139
>cd04977 Ig1_NCAM-1_like First immunoglobulin (Ig)-like domain of neural cell adhesion molecule NCAM-1 and similar proteins. Ig1_NCAM-1 like: first immunoglobulin (Ig)-like domain of neural cell adhesion molecule NCAM-1. NCAM-1 plays important roles in the development and regeneration of the central nervous system, in synaptogenesis and neural migration. NCAM mediates cell-cell and cell-substratum recognition and adhesion via homophilic (NCAM-NCAM), and heterophilic (NCAM-nonNCAM), interactions. NCAM is expressed as three major isoforms having different intracellular extensions. The extracellular portion of NCAM has five N-terminal Ig-like domains and two fibronectin type III domains. The double zipper adhesion complex model for NCAM homophilic binding involves the Ig1, Ig2, and Ig3 domains. By this model, Ig1 and Ig2 mediate dimerization of NCAM molecules situated on the same cell surface (cis interactions), and Ig3 domains mediate interactions between NCAM molecules expressed on the s
Probab=99.18 E-value=2.1e-10 Score=106.53 Aligned_cols=85 Identities=29% Similarity=0.522 Sum_probs=68.4
Q ss_pred eccCceEEcCCceEEEEEEEecCCCcEEEEEe-CCEecCCCCCeEEee-cCCeEEEEEccCCCCCCEEEEEEEEeCCe-e
Q psy2148 1747 TTISSAVINVGQLARFDAKISATKPLDVYWLK-NGKKIIPDIRYKTLE-EDNLFTLLIIEAVVEDSGAYECVAMNNAG-E 1823 (1884)
Q Consensus 1747 ~~~~~~~~~~G~~~~l~C~~~g~p~p~v~W~k-~~~~l~~~~~~~~~~-~~~~~~L~i~~~~~~d~G~Y~C~a~N~~G-~ 1823 (1884)
..|.+..+..|+++.|.|.+.|.| +.++|++ ++..+....++.+.. ......|+|.++..+|+|.|+|.|.|..| .
T Consensus 5 v~p~~~~v~~G~~~~l~C~~~G~p-~~i~W~~~~~~~~~~~~~~~~~~~~~~~~~L~I~~v~~~D~G~Y~C~A~N~~g~~ 83 (92)
T cd04977 5 IVPSQGEISVGESKFFLCQVIGEP-KDISWFSPNGEKLVTQQQISVVQNDDVRSTLTIYNANIEDAGIYKCVATDAKGTE 83 (92)
T ss_pred EecCcEEECCCCeEEEEEEeEeeC-CeEEEECCCCCEeccCCCEEEEeCCCCEEEEEEecCCcccCEEEEEEEEcCCCCc
Confidence 345678899999999999999997 4999998 676666655655444 34567999999999999999999999965 5
Q ss_pred EEEEEEEEE
Q psy2148 1824 ARCEAELVV 1832 (1884)
Q Consensus 1824 ~~~~~~l~V 1832 (1884)
...++.|.|
T Consensus 84 ~~~sv~l~~ 92 (92)
T cd04977 84 SEATVNLKI 92 (92)
T ss_pred ceeEEEEEC
Confidence 677777764
No 140
>cd05724 Ig2_Robo Second immunoglobulin (Ig)-like domain in Robo (roundabout) receptors. Ig2_Robo: domain similar to the second immunoglobulin (Ig)-like domain in Robo (roundabout) receptors. Robo receptors play a role in the development of the central nervous system (CNS), and are receptors of Slit protein. Slit is a repellant secreted by the neural cells in the midline. Slit acts through Robo to prevent most neurons from crossing the midline from either side. Three mammalian Robo homologs (robo1, -2, and -3), and three mammalian Slit homologs (Slit-1,-2, -3), have been identified. Commissural axons, which cross the midline, express low levels of Robo; longitudinal axons, which avoid the midline, express high levels of Robo. robo1, -2, and -3 are expressed by commissural neurons in the vertebrate spinal cord and Slits 1, -2, -3 are expressed at the ventral midline. Robo-3 is a divergent member of the Robo family which instead of being a positive regulator of slit responsiveness, antago
Probab=99.18 E-value=1.5e-10 Score=107.27 Aligned_cols=81 Identities=32% Similarity=0.520 Sum_probs=67.5
Q ss_pred cCceEEcCCceEEEEEEE-ecCCCcEEEEEeCCEecCC-CCCeEEeecCCeEEEEEccCCCCCCEEEEEEEEeCCeeEE-
Q psy2148 1749 ISSAVINVGQLARFDAKI-SATKPLDVYWLKNGKKIIP-DIRYKTLEEDNLFTLLIIEAVVEDSGAYECVAMNNAGEAR- 1825 (1884)
Q Consensus 1749 ~~~~~~~~G~~~~l~C~~-~g~p~p~v~W~k~~~~l~~-~~~~~~~~~~~~~~L~i~~~~~~d~G~Y~C~a~N~~G~~~- 1825 (1884)
|.+..+.+|+++.|.|.+ .|.|.|.+.|+|+|..+.. ..++.+..++ .|.|.++..+|+|.|+|.|.|..|...
T Consensus 3 p~~~~~~~G~~v~l~C~~~~g~p~p~i~W~k~g~~~~~~~~~~~~~~~~---~L~I~~~~~~D~G~Y~C~a~N~~G~~~s 79 (86)
T cd05724 3 PSDTQVAVGEMAVLECSPPRGHPEPTVSWRKDGQPLNLDNERVRIVDDG---NLLIAEARKSDEGTYKCVATNMVGERES 79 (86)
T ss_pred CccEEEeCCCCEEEEEECCCCCCCCEEEEEECCEECCCCCCCEEEccCC---EEEEeECCcccCEEEEEEEEeccCceee
Confidence 457788899999999998 7999999999999999876 4455554433 899999999999999999999999764
Q ss_pred EEEEEEE
Q psy2148 1826 CEAELVV 1832 (1884)
Q Consensus 1826 ~~~~l~V 1832 (1884)
..+.|.|
T Consensus 80 ~~~~l~V 86 (86)
T cd05724 80 AAARLSV 86 (86)
T ss_pred eeEEEEC
Confidence 4566654
No 141
>cd04974 Ig3_FGFR Third immunoglobulin (Ig)-like domain of fibroblast growth factor receptor (FGFR). Ig3_FGFR: third immunoglobulin (Ig)-like domain of fibroblast growth factor receptor (FGFR). Fibroblast growth factors (FGFs) participate in morphogenesis, development, angiogenesis, and wound healing. These FGF-stimulated processes are mediated by four FGFR tyrosine kinases (FGRF1-4). FGFRs are comprised of an extracellular portion consisting of three Ig-like domains, a transmembrane helix, and a cytoplasmic portion having protein tyrosine kinase activity. The highly conserved Ig-like domains 2 and 3, and the linker region between D2 and D3 define a general binding site for FGFs.
Probab=99.18 E-value=5.8e-11 Score=110.04 Aligned_cols=77 Identities=27% Similarity=0.421 Sum_probs=60.2
Q ss_pred CceEEEEEEEecCCCcEEEEEeCC----EecCCCC--CeEEee-------cCCeEEEEEccCCCCCCEEEEEEEEeCCee
Q psy2148 1757 GQLARFDAKISATKPLDVYWLKNG----KKIIPDI--RYKTLE-------EDNLFTLLIIEAVVEDSGAYECVAMNNAGE 1823 (1884)
Q Consensus 1757 G~~~~l~C~~~g~p~p~v~W~k~~----~~l~~~~--~~~~~~-------~~~~~~L~i~~~~~~d~G~Y~C~a~N~~G~ 1823 (1884)
|+.++|.|.+.|.|.|.|+|+|++ ..+.... ...... .+....|.|.+++.+|+|.|+|.|.|.+|.
T Consensus 1 G~~v~l~C~v~g~P~P~i~W~k~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~I~~v~~~D~G~Y~C~A~N~~G~ 80 (90)
T cd04974 1 GSDVEFHCKVYSDAQPHIQWLKHVEVNGSKYGPDGLPYVTVLKVAGINTTDNESEVLYLRNVSFDDAGEYTCLAGNSIGP 80 (90)
T ss_pred CCcEEEEEEEeCCCCCeEEEEEecccCCceeCCCCCceEEEEEecCCcccccccceEEEeccccccCcEEEEEeecccCc
Confidence 678999999999999999999964 3332211 111111 123348999999999999999999999999
Q ss_pred EEEEEEEEEE
Q psy2148 1824 ARCEAELVVQ 1833 (1884)
Q Consensus 1824 ~~~~~~l~V~ 1833 (1884)
..+++.|+|.
T Consensus 81 ~~~sa~L~V~ 90 (90)
T cd04974 81 SHHSAWLTVL 90 (90)
T ss_pred ccCCEEEEeC
Confidence 9999999984
No 142
>cd04974 Ig3_FGFR Third immunoglobulin (Ig)-like domain of fibroblast growth factor receptor (FGFR). Ig3_FGFR: third immunoglobulin (Ig)-like domain of fibroblast growth factor receptor (FGFR). Fibroblast growth factors (FGFs) participate in morphogenesis, development, angiogenesis, and wound healing. These FGF-stimulated processes are mediated by four FGFR tyrosine kinases (FGRF1-4). FGFRs are comprised of an extracellular portion consisting of three Ig-like domains, a transmembrane helix, and a cytoplasmic portion having protein tyrosine kinase activity. The highly conserved Ig-like domains 2 and 3, and the linker region between D2 and D3 define a general binding site for FGFs.
Probab=99.17 E-value=5.9e-11 Score=110.02 Aligned_cols=76 Identities=26% Similarity=0.495 Sum_probs=58.9
Q ss_pred CCeEEEEEEEeeCCCCCcEEEEeeC----CEEccCCC-cE-EEEe-------eCCeEEEEEccCCCCCCeEEEEEEEcCC
Q psy2148 931 STLAHFECRLTPTNDPSMTVEWFHN----GKALSAGS-RI-KTIN-------DFGFVILEINDVYLRDSGLYTCKATNKH 997 (1884)
Q Consensus 931 G~~v~l~C~v~~~~~P~~~v~W~~~----g~~i~~~~-~~-~~~~-------~~~~~~L~I~~~~~~D~G~Y~C~a~N~~ 997 (1884)
|+.++|+|.+. |.|.|.|+|+|+ |..+.... .+ .... .+....|.|.+++.+|+|.|+|.|.|.+
T Consensus 1 G~~v~l~C~v~--g~P~P~i~W~k~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~I~~v~~~D~G~Y~C~A~N~~ 78 (90)
T cd04974 1 GSDVEFHCKVY--SDAQPHIQWLKHVEVNGSKYGPDGLPYVTVLKVAGINTTDNESEVLYLRNVSFDDAGEYTCLAGNSI 78 (90)
T ss_pred CCcEEEEEEEe--CCCCCeEEEEEecccCCceeCCCCCceEEEEEecCCcccccccceEEEeccccccCcEEEEEeeccc
Confidence 78899999998 789999999996 34432221 11 1111 1223479999999999999999999999
Q ss_pred eeEEEEEEEEE
Q psy2148 998 GEATTSCKLTV 1008 (1884)
Q Consensus 998 G~~~~~~~l~V 1008 (1884)
|..++++.|+|
T Consensus 79 G~~~~sa~L~V 89 (90)
T cd04974 79 GPSHHSAWLTV 89 (90)
T ss_pred CcccCCEEEEe
Confidence 99999999988
No 143
>cd05856 Ig2_FGFRL1-like Second immunoglobulin (Ig)-like domain of fibroblast growth factor (FGF) receptor_like-1(FGFRL1). Ig2_FGFRL1-like: second immunoglobulin (Ig)-like domain of fibroblast growth factor (FGF) receptor_like-1(FGFRL1). FGFRL1 is comprised of a signal peptide, three extracellular Ig-like modules, a transmembrane segment, and a short intracellular domain. FGFRL1 is expressed preferentially in skeletal tissues. Similar to FGF receptors, the expressed protein interacts specifically with heparin and with FGF2. FGFRL1 does not have a protein tyrosine kinase domain at its C terminus; neither does its cytoplasmic domain appear to interact with a signaling partner. It has been suggested that FGFRL1 may not have any direct signaling function, but instead acts as a decoy receptor trapping FGFs and preventing them from binding other receptors.
Probab=99.17 E-value=9.2e-11 Score=107.73 Aligned_cols=79 Identities=29% Similarity=0.422 Sum_probs=66.4
Q ss_pred eEEcCCceEEEEEEEecCCCcEEEEEeCCEecCCCCCeEEeecCCeEEEEEccCCCCCCEEEEEEEEeCCeeEEEEEEEE
Q psy2148 1752 AVINVGQLARFDAKISATKPLDVYWLKNGKKIIPDIRYKTLEEDNLFTLLIIEAVVEDSGAYECVAMNNAGEARCEAELV 1831 (1884)
Q Consensus 1752 ~~~~~G~~~~l~C~~~g~p~p~v~W~k~~~~l~~~~~~~~~~~~~~~~L~i~~~~~~d~G~Y~C~a~N~~G~~~~~~~l~ 1831 (1884)
.....|+.++|.|.+.|.|.|.+.|+|++..+........ ......|.|.++..+|+|.|+|.|.|..|..++++.|.
T Consensus 4 ~~~~~G~~v~L~C~~~g~p~p~i~W~k~~~~~~~~~~~~~--~~~~~~L~i~~v~~~D~G~Y~C~a~N~~G~~~~~~~v~ 81 (82)
T cd05856 4 IARPVGSSVRLKCVASGNPRPDITWLKDNKPLTPTEIGES--RKKKWTLSLKNLKPEDSGKYTCHVSNRAGEINATYKVD 81 (82)
T ss_pred eeccCCCeEEEEEEeeEeCCCcEEEEECCcCCcCCcccee--cCceEEEEEccCChhhCEEEEEEEEcCCccEEEEEEEe
Confidence 3456799999999999999999999999998865543322 23346899999999999999999999999998888887
Q ss_pred E
Q psy2148 1832 V 1832 (1884)
Q Consensus 1832 V 1832 (1884)
|
T Consensus 82 v 82 (82)
T cd05856 82 V 82 (82)
T ss_pred C
Confidence 5
No 144
>cd05858 Ig3_FGFR-2 Third immunoglobulin (Ig)-like domain of fibroblast growth factor receptor 2 (FGFR2). Ig3_FGFR-2-like; domain similar to the third immunoglobulin (Ig)-like domain of human fibroblast growth factor receptor 2 (FGFR2). Fibroblast growth factors (FGFs) participate in morphogenesis, development, angiogenesis, and wound healing. These FGF-stimulated processes are mediated by four FGFR tyrosine kinases (FGRF1-4). FGFRs are comprised of an extracellular portion consisting of three Ig-like domains, a transmembrane helix, and a cytoplasmic portion having protein tyrosine kinase activity. The highly conserved Ig-like domains 2 and 3, and the linker region between D2 and D3 define a general binding site for FGFs. FGFR2 is required for male sex determination.
Probab=99.17 E-value=1.2e-10 Score=108.20 Aligned_cols=77 Identities=30% Similarity=0.460 Sum_probs=61.3
Q ss_pred CceEEEEEEEecCCCcEEEEEeC----CEecCCCCC--eEEeec-------CCeEEEEEccCCCCCCEEEEEEEEeCCee
Q psy2148 1757 GQLARFDAKISATKPLDVYWLKN----GKKIIPDIR--YKTLEE-------DNLFTLLIIEAVVEDSGAYECVAMNNAGE 1823 (1884)
Q Consensus 1757 G~~~~l~C~~~g~p~p~v~W~k~----~~~l~~~~~--~~~~~~-------~~~~~L~i~~~~~~d~G~Y~C~a~N~~G~ 1823 (1884)
|++++|.|.+.|.|.|.|+|+|+ |..+....+ ..+... .....|.|.+++.+|+|.|+|.|.|..|.
T Consensus 1 G~~v~L~C~~~g~P~P~i~W~k~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~I~~v~~~D~G~Y~C~A~N~~G~ 80 (90)
T cd05858 1 GSTVEFVCKVYSDAQPHIQWLKHVEKNGSKYGPDGLPYVTVLKTAGVNTTDKEMEVLYLRNVTFEDAGEYTCLAGNSIGI 80 (90)
T ss_pred CCeEEEEEEEecCCCCEEEEEEecccCCcEeCCCCCeeEEEeccCCceecCCceeEEEEccCCHHHCEEEEEEEEeCCCc
Confidence 78899999999999999999984 455543322 222111 12358999999999999999999999999
Q ss_pred EEEEEEEEEE
Q psy2148 1824 ARCEAELVVQ 1833 (1884)
Q Consensus 1824 ~~~~~~l~V~ 1833 (1884)
+..++.|.|+
T Consensus 81 ~~~~a~L~V~ 90 (90)
T cd05858 81 SHHSAWLTVL 90 (90)
T ss_pred ccceEEEEEC
Confidence 9999999983
No 145
>cd05731 Ig3_L1-CAM_like Third immunoglobulin (Ig)-like domain of the L1 cell adhesion molecule (CAM). Ig3_L1-CAM_like: domain similar to the third immunoglobulin (Ig)-like domain of the L1 cell adhesion molecule (CAM). L1 belongs to the L1 subfamily of cell adhesion molecules (CAMs) and is comprised of an extracellular region having six Ig-like domains and five fibronectin type III domains, a transmembrane region and an intracellular domain. L1 is primarily expressed in the nervous system and is involved in its development and function. L1 is associated with an X-linked recessive disorder, X-linked hydrocephalus, MASA syndrome, or spastic paraplegia type 1, that involves abnormalities of axonal growth. This group also contains the chicken neuron-glia cell adhesion molecule, Ng-CAM and human neurofascin.
Probab=99.17 E-value=9.9e-11 Score=103.74 Aligned_cols=71 Identities=28% Similarity=0.388 Sum_probs=59.5
Q ss_pred EEEEEEEecCCCcEEEEEeCCEecCCCCCeEEeecCCeEEEEEccCCCCCCEEEEEEEEeCCeeEEEEEEEEEE
Q psy2148 1760 ARFDAKISATKPLDVYWLKNGKKIIPDIRYKTLEEDNLFTLLIIEAVVEDSGAYECVAMNNAGEARCEAELVVQ 1833 (1884)
Q Consensus 1760 ~~l~C~~~g~p~p~v~W~k~~~~l~~~~~~~~~~~~~~~~L~i~~~~~~d~G~Y~C~a~N~~G~~~~~~~l~V~ 1833 (1884)
++|.|.+.|.|.|.+.|+|++..+... +..... ....|.|.++..+|+|.|+|.|.|..|..+.++.|.|.
T Consensus 1 v~l~C~~~g~P~p~v~W~k~~~~~~~~-~~~~~~--~~~~L~i~~v~~~D~G~Y~C~a~N~~G~~~~~~~l~V~ 71 (71)
T cd05731 1 LLLECIAEGLPTPEISWIKIGGELPAD-RTKFEN--FNKTLKIDNVSEEDDGEYRCTASNSLGSARHTISVTVE 71 (71)
T ss_pred CEEEEEeeEecCCeEEEEECCeECCCC-ceeEec--CCCEEEECCCCHHHCEEEEEEEEeCCceEEEEEEEEEC
Confidence 479999999999999999999887543 222222 23489999999999999999999999999999999873
No 146
>cd05856 Ig2_FGFRL1-like Second immunoglobulin (Ig)-like domain of fibroblast growth factor (FGF) receptor_like-1(FGFRL1). Ig2_FGFRL1-like: second immunoglobulin (Ig)-like domain of fibroblast growth factor (FGF) receptor_like-1(FGFRL1). FGFRL1 is comprised of a signal peptide, three extracellular Ig-like modules, a transmembrane segment, and a short intracellular domain. FGFRL1 is expressed preferentially in skeletal tissues. Similar to FGF receptors, the expressed protein interacts specifically with heparin and with FGF2. FGFRL1 does not have a protein tyrosine kinase domain at its C terminus; neither does its cytoplasmic domain appear to interact with a signaling partner. It has been suggested that FGFRL1 may not have any direct signaling function, but instead acts as a decoy receptor trapping FGFs and preventing them from binding other receptors.
Probab=99.17 E-value=9.1e-11 Score=107.74 Aligned_cols=79 Identities=22% Similarity=0.435 Sum_probs=65.1
Q ss_pred eeecCCCeEEEEEEEeeCCCCCcEEEEeeCCEEccCCCcEEEEeeCCeEEEEEccCCCCCCeEEEEEEEcCCeeEEEEEE
Q psy2148 926 LTLAESTLAHFECRLTPTNDPSMTVEWFHNGKALSAGSRIKTINDFGFVILEINDVYLRDSGLYTCKATNKHGEATTSCK 1005 (1884)
Q Consensus 926 ~~v~~G~~v~l~C~v~~~~~P~~~v~W~~~g~~i~~~~~~~~~~~~~~~~L~I~~~~~~D~G~Y~C~a~N~~G~~~~~~~ 1005 (1884)
+.+..|+++.|.|.+. +.|.|.++|+|+|..+......... .....|.|.+++.+|+|.|+|.|.|..|..+..+.
T Consensus 4 ~~~~~G~~v~L~C~~~--g~p~p~i~W~k~~~~~~~~~~~~~~--~~~~~L~i~~v~~~D~G~Y~C~a~N~~G~~~~~~~ 79 (82)
T cd05856 4 IARPVGSSVRLKCVAS--GNPRPDITWLKDNKPLTPTEIGESR--KKKWTLSLKNLKPEDSGKYTCHVSNRAGEINATYK 79 (82)
T ss_pred eeccCCCeEEEEEEee--EeCCCcEEEEECCcCCcCCccceec--CceEEEEEccCChhhCEEEEEEEEcCCccEEEEEE
Confidence 4566799999999998 6788899999999988665443222 23457999999999999999999999999888888
Q ss_pred EEE
Q psy2148 1006 LTV 1008 (1884)
Q Consensus 1006 l~V 1008 (1884)
|.|
T Consensus 80 v~v 82 (82)
T cd05856 80 VDV 82 (82)
T ss_pred EeC
Confidence 765
No 147
>cd05898 Ig5_KIRREL3 Fifth immunoglobulin (Ig)-like domain of Kirrel (kin of irregular chiasm-like) 3 protein (also known as Neph2). Ig5_KIRREL3: the fifth immunoglobulin (Ig)-like domain of Kirrel (kin of irregular chiasm-like) 3 protein (also known as Neph2). This protein has five Ig-like domains, one transmembrane domain, and a cytoplasmic tail. Included in this group is mammalian Kirrel (Neph1). These proteins contain multiple Ig domains, have properties of cell adhesion molecules, and are important in organ development. Neph1 and 2 may mediate axonal guidance and synapse formation in certain areas of the CNS. In the kidney, they participate in the formation of the slit diaphragm.
Probab=99.16 E-value=2.9e-10 Score=104.46 Aligned_cols=88 Identities=23% Similarity=0.330 Sum_probs=74.7
Q ss_pred CCeEEeccCceEEcCCceEEEEEEEecCCCc-EEEEEeCCEecCCC--CCeEEeec----CCeEEEEEccCCCCC-CEEE
Q psy2148 1742 PPSFLTTISSAVINVGQLARFDAKISATKPL-DVYWLKNGKKIIPD--IRYKTLEE----DNLFTLLIIEAVVED-SGAY 1813 (1884)
Q Consensus 1742 ~P~~~~~~~~~~~~~G~~~~l~C~~~g~p~p-~v~W~k~~~~l~~~--~~~~~~~~----~~~~~L~i~~~~~~d-~G~Y 1813 (1884)
||.+ .......+.+|++++|.|.+.+.|+| .|.|.+++..|..+ .+|.+... +..+.|+|.++.+.| .|.|
T Consensus 2 pP~i-~~~~s~~~~~G~~~~L~C~~~s~P~P~~i~W~w~~~~i~~~~~~r~~I~~~~~~~g~~S~L~I~~~~~~d~~g~Y 80 (98)
T cd05898 2 PPII-SSEQVQYAVRGERGKVKCFIGSTPPPDRIAWAWKENVLESGTSERYTVERTSTGSGVLSTLTINNIMEADFQTHY 80 (98)
T ss_pred CCEE-ecCceEEEeCCCcEEEEEEEccCCCCcEEEEEEccccccCCCCCCEEEEEEccCCCcEEEEEECCCccccCCcEE
Confidence 6766 56678899999999999999888887 48999998887654 57877654 478899999998866 8999
Q ss_pred EEEEEeCCeeEEEEEEE
Q psy2148 1814 ECVAMNNAGEARCEAEL 1830 (1884)
Q Consensus 1814 ~C~a~N~~G~~~~~~~l 1830 (1884)
.|.|.|.+|+....++|
T Consensus 81 ~C~a~N~~G~d~~~i~L 97 (98)
T cd05898 81 NCTAWNSFGSGTAIIQL 97 (98)
T ss_pred EEEEEeCCccceEEEEe
Confidence 99999999999988887
No 148
>cd05858 Ig3_FGFR-2 Third immunoglobulin (Ig)-like domain of fibroblast growth factor receptor 2 (FGFR2). Ig3_FGFR-2-like; domain similar to the third immunoglobulin (Ig)-like domain of human fibroblast growth factor receptor 2 (FGFR2). Fibroblast growth factors (FGFs) participate in morphogenesis, development, angiogenesis, and wound healing. These FGF-stimulated processes are mediated by four FGFR tyrosine kinases (FGRF1-4). FGFRs are comprised of an extracellular portion consisting of three Ig-like domains, a transmembrane helix, and a cytoplasmic portion having protein tyrosine kinase activity. The highly conserved Ig-like domains 2 and 3, and the linker region between D2 and D3 define a general binding site for FGFs. FGFR2 is required for male sex determination.
Probab=99.16 E-value=1.5e-10 Score=107.56 Aligned_cols=76 Identities=26% Similarity=0.510 Sum_probs=60.2
Q ss_pred CCeEEEEEEEeeCCCCCcEEEEee----CCEEccCCCc--EEEEee-------CCeEEEEEccCCCCCCeEEEEEEEcCC
Q psy2148 931 STLAHFECRLTPTNDPSMTVEWFH----NGKALSAGSR--IKTIND-------FGFVILEINDVYLRDSGLYTCKATNKH 997 (1884)
Q Consensus 931 G~~v~l~C~v~~~~~P~~~v~W~~----~g~~i~~~~~--~~~~~~-------~~~~~L~I~~~~~~D~G~Y~C~a~N~~ 997 (1884)
|+.++|.|.+. +.|.|.|+|+| +|..+..+.+ ...... .....|.|.+++.+|+|.|+|.|.|.+
T Consensus 1 G~~v~L~C~~~--g~P~P~i~W~k~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~I~~v~~~D~G~Y~C~A~N~~ 78 (90)
T cd05858 1 GSTVEFVCKVY--SDAQPHIQWLKHVEKNGSKYGPDGLPYVTVLKTAGVNTTDKEMEVLYLRNVTFEDAGEYTCLAGNSI 78 (90)
T ss_pred CCeEEEEEEEe--cCCCCEEEEEEecccCCcEeCCCCCeeEEEeccCCceecCCceeEEEEccCCHHHCEEEEEEEEeCC
Confidence 78999999998 77999999999 4555543322 121111 123579999999999999999999999
Q ss_pred eeEEEEEEEEE
Q psy2148 998 GEATTSCKLTV 1008 (1884)
Q Consensus 998 G~~~~~~~l~V 1008 (1884)
|..+.++.|.|
T Consensus 79 G~~~~~a~L~V 89 (90)
T cd05858 79 GISHHSAWLTV 89 (90)
T ss_pred CcccceEEEEE
Confidence 99999999988
No 149
>cd05750 Ig_Pro_neuregulin Immunoglobulin (Ig)-like domain in neuregulins (NRGs). Ig_Pro_neuregulin: immunoglobulin (Ig)-like domain in neuregulins (NRGs). NRGs are signaling molecules, which participate in cell-cell interactions in the nervous system, breast, heart, and other organ systems, and are implicated in the pathology of diseases including schizophrenia, multiple sclerosis, and breast cancer. There are four members of the neuregulin gene family (NRG1, -2, -3, and -4). The NRG-1 protein, binds to and activates the tyrosine kinases receptors ErbB3 and ErbB4, initiating signaling cascades. The other NRGs proteins bind one or the other or both of these ErbBs. NRG-1 has multiple functions; for example, in the brain it regulates various processes such as radial glia formation and neuronal migration, dendritic development, and expression of neurotransmitters receptors; in the peripheral nervous system NRG-1 regulates processes such as target cell differentiation, and Schwann cell surv
Probab=99.14 E-value=1.6e-10 Score=103.68 Aligned_cols=71 Identities=32% Similarity=0.539 Sum_probs=58.3
Q ss_pred EEEEEEEeeCCCCCcEEEEeeCCEEccCCCcEE---EEeeCCeEEEEEccCCCCCCeEEEEEEEcCCeeEEEEEE
Q psy2148 934 AHFECRLTPTNDPSMTVEWFHNGKALSAGSRIK---TINDFGFVILEINDVYLRDSGLYTCKATNKHGEATTSCK 1005 (1884)
Q Consensus 934 v~l~C~v~~~~~P~~~v~W~~~g~~i~~~~~~~---~~~~~~~~~L~I~~~~~~D~G~Y~C~a~N~~G~~~~~~~ 1005 (1884)
+.|.|.+.+ +.|.|.++|+|+|.++....+.. +........|.|.+++.+|+|.|+|.|.|.+|.++.++.
T Consensus 1 ~~l~C~~~g-~~P~p~~~W~k~g~~l~~~~~~~~~~~~~~~~~~~L~I~~~~~~D~G~Y~C~a~N~~G~~~~~~~ 74 (75)
T cd05750 1 LVLKCEATS-EYPSLRFKWFKDGKELNRKNKPRNIKIRNKKKNSELQINKAKLADSGEYTCVVENILGNDTVTAN 74 (75)
T ss_pred CEEEEEccC-CCCCceEEEEcCCeeccccCCcceEEEEecCceEEEEEccCCcccCeEEEEEEEEcCCceeEEEe
Confidence 469999983 28889999999999997665432 334445678999999999999999999999999887764
No 150
>cd07702 Ig2_VEGFR-1 Second immunoglobulin (Ig)-like domain of vascular endothelial growth factor receptor 1 (VEGFR-1). Ig2_VEGFR-1: Second immunoglobulin (Ig)-like domain of vascular endothelial growth factor receptor 1 (VEGFR-1). VEGFRs have an extracellular component with seven Ig-like domains, a transmembrane segment, and an intracellular tyrosine kinase domain interrupted by a kinase-insert domain. VEGFRs bind VEGFs with high affinity at the Ig-like domains. VEGFR-1 binds VEGF-A strongly; VEGF-A is important to the growth and maintenance of vascular endothelial cells and to the development of new blood- and lymphatic-vessels in physiological and pathological states. VEGFR-1 may play an inhibitory rolet in the function of VEGFR-2 by binding VEGF-A and interfering with its interaction with VEGFR-2. VEGFR-1 has a signaling role in mediating monocyte chemotaxis and may mediate a chemotactic and a survival signal in hematopoietic stem cells or leukemia cells.
Probab=99.14 E-value=2.3e-10 Score=98.76 Aligned_cols=69 Identities=23% Similarity=0.356 Sum_probs=56.2
Q ss_pred EEEEEEEecCCCcEEEEEeCCEecCCC-CCeEEeecCCeEEEEEccCCCCCCEEEEEEEEeCCeeEEEEEEEEE
Q psy2148 1760 ARFDAKISATKPLDVYWLKNGKKIIPD-IRYKTLEEDNLFTLLIIEAVVEDSGAYECVAMNNAGEARCEAELVV 1832 (1884)
Q Consensus 1760 ~~l~C~~~g~p~p~v~W~k~~~~l~~~-~~~~~~~~~~~~~L~i~~~~~~d~G~Y~C~a~N~~G~~~~~~~l~V 1832 (1884)
++|.|.+.|.|.|.+.|+|+|.++..+ .++.. .+. +|.|.++..+|+|.|+|.|+|..........+++
T Consensus 1 ~~l~c~v~g~P~P~v~W~kdg~~l~~~~~~~~~--~~~--~L~I~~v~~~D~G~YtC~a~~~~~~~~~~~~i~~ 70 (72)
T cd07702 1 YRLTPKVKAFPAPEVIWLKDGLPAAEKCSRYHV--DGY--SLVIKDVTEEDAGIYTILLGIKQYNLFKNLTITL 70 (72)
T ss_pred CeEEeeEEEcCCCeEEEEECCEECCCCCcEEEe--CCC--EEEECcCCHHHCEEEEEEEEccccceEeeEEEEE
Confidence 479999999999999999999998765 34432 332 7999999999999999999999776666655544
No 151
>cd05731 Ig3_L1-CAM_like Third immunoglobulin (Ig)-like domain of the L1 cell adhesion molecule (CAM). Ig3_L1-CAM_like: domain similar to the third immunoglobulin (Ig)-like domain of the L1 cell adhesion molecule (CAM). L1 belongs to the L1 subfamily of cell adhesion molecules (CAMs) and is comprised of an extracellular region having six Ig-like domains and five fibronectin type III domains, a transmembrane region and an intracellular domain. L1 is primarily expressed in the nervous system and is involved in its development and function. L1 is associated with an X-linked recessive disorder, X-linked hydrocephalus, MASA syndrome, or spastic paraplegia type 1, that involves abnormalities of axonal growth. This group also contains the chicken neuron-glia cell adhesion molecule, Ng-CAM and human neurofascin.
Probab=99.12 E-value=1.9e-10 Score=101.91 Aligned_cols=70 Identities=33% Similarity=0.483 Sum_probs=57.9
Q ss_pred EEEEEEEeeCCCCCcEEEEeeCCEEccCCCcEEEEeeCCeEEEEEccCCCCCCeEEEEEEEcCCeeEEEEEEEEE
Q psy2148 934 AHFECRLTPTNDPSMTVEWFHNGKALSAGSRIKTINDFGFVILEINDVYLRDSGLYTCKATNKHGEATTSCKLTV 1008 (1884)
Q Consensus 934 v~l~C~v~~~~~P~~~v~W~~~g~~i~~~~~~~~~~~~~~~~L~I~~~~~~D~G~Y~C~a~N~~G~~~~~~~l~V 1008 (1884)
+.|.|.+. |.|.|.+.|+|++..+..+ +..... ....|.|.+++.+|+|.|+|.|.|..|..+.++.|.|
T Consensus 1 v~l~C~~~--g~P~p~v~W~k~~~~~~~~-~~~~~~--~~~~L~i~~v~~~D~G~Y~C~a~N~~G~~~~~~~l~V 70 (71)
T cd05731 1 LLLECIAE--GLPTPEISWIKIGGELPAD-RTKFEN--FNKTLKIDNVSEEDDGEYRCTASNSLGSARHTISVTV 70 (71)
T ss_pred CEEEEEee--EecCCeEEEEECCeECCCC-ceeEec--CCCEEEECCCCHHHCEEEEEEEEeCCceEEEEEEEEE
Confidence 47999998 6788899999999887654 222222 2337999999999999999999999999999998887
No 152
>cd05771 IgC_Tapasin_R Tapasin-R immunoglobulin-like domain. IgC_Tapasin_R: Immunoglobulin-like domain on Tapasin-R. Tapasin is a V-C1 (variable-constant) immunoglobulin superfamily molecule present in the endoplasmic reticulum (ER), where it links MHC class I molecules to the transporter associated with antigen processing (TAP). Tapasin-R is a tapasin-related protein that contains similar structural motifs to Tapasin, with some marked differences, especially in the V domain, transmembrane and cytoplasmic regions. The majority of Tapasin-R is located within the ER; however, there may be some expression of Tapasin-R at the cell surface. Tapasin-R lacks an obvious ER retention signal.
Probab=99.11 E-value=1.2e-09 Score=111.26 Aligned_cols=117 Identities=14% Similarity=0.186 Sum_probs=86.5
Q ss_pred EEEEcccccCCCeEEEEEEEeCCceEEEEEEEEEEecccCCCCCCCCCeEEeccCceEEcCCceEEEEEEEecC-CC-cE
Q psy2148 1696 ILIMRQVFMEDSGVFAVIAENRGGKAKCSANLVVEEKRQGGRGGVVPPSFLTTISSAVINVGQLARFDAKISAT-KP-LD 1773 (1884)
Q Consensus 1696 ~L~i~~v~~~DsG~Y~C~a~n~~g~~~~~~~l~V~~~~~~~~~~~~~P~~~~~~~~~~~~~G~~~~l~C~~~g~-p~-p~ 1773 (1884)
+|.|.+++.+|+|.|.|.+.+..|.....+.|.|. .+|.+...+.......|+.++|.|.+.|. |. +.
T Consensus 2 sL~i~~v~~~D~G~Y~C~~~~~~~~~~~~~~l~v~----------~~P~v~~~~~~~~~~~~~~~~L~C~a~g~~P~~~~ 71 (139)
T cd05771 2 SLTLPGLTVHDEGTYICSVSTPPHQAQQIIQLSVS----------EPPRVRLSLEKLVSMIEEPQTLICHIAGYYPLDVQ 71 (139)
T ss_pred eEEECCCCHHHCEEEEEEEEccCcceeeEEEEEEe----------cCCceEEeCCCceeecCCcEEEEEEECCCCCCCeE
Confidence 59999999999999999999988999999999998 47888776666555589999999999994 64 48
Q ss_pred EEEEeCCEecCC----CCC-----eEEeecCC---eEEEEEccCCCCCCEEEEEEEEeCCe
Q psy2148 1774 VYWLKNGKKIIP----DIR-----YKTLEEDN---LFTLLIIEAVVEDSGAYECVAMNNAG 1822 (1884)
Q Consensus 1774 v~W~k~~~~l~~----~~~-----~~~~~~~~---~~~L~i~~~~~~d~G~Y~C~a~N~~G 1822 (1884)
|+|+|+|..... ... .....++. .+.|.|.....++.+.|+|.+.+..-
T Consensus 72 i~W~~~g~~~~~~~~~~~~~~~~~~~~~~dgt~~~~s~L~v~~~~~~~g~~ytC~V~H~~l 132 (139)
T cd05771 72 VEWTREPPGDSPPPVSLSNVSFSSHRQHQDGTYSLSSHLTLEPGTEDAGATYTCRVSHVSL 132 (139)
T ss_pred EEEEECCCCCccceeccCCeEecceEeCCCCCEEEEEEEEecCCccCCCCEEEEEEEcCCC
Confidence 999999864221 011 11111222 23677765555567799999987643
No 153
>cd05756 Ig1_IL1R_like First immunoglobulin (Ig)-like domain of interleukin-1 receptor (IL1R) and similar proteins. Ig1_IL1R_like: domain similar to the first immunoglobulin (Ig)-like domain of interleukin-1 receptor (IL1R). IL-1 alpha and IL-1 beta are cytokines which participate in the regulation of inflammation, immune responses, and hematopoiesis. These cytokines bind to the IL-1 receptor type 1 (IL1R1), which is activated on additional association with an accessory protein, IL1RAP. IL-1 also binds a second receptor designated type II (IL1R2). Mature IL1R1 consists of three Ig-like domains, a transmembrane domain, and a large cytoplasmic domain. Mature IL1R2 is organized similarly except that it has a short cytoplasmic domain. The latter does not initiate signal transduction. A naturally occurring cytokine IL-1RA (IL-1 receptor antagonist) is widely expressed and binds to IL-1 receptors, inhibiting the binding of IL-1 alpha and IL-1 beta.
Probab=99.11 E-value=1.8e-10 Score=106.71 Aligned_cols=81 Identities=20% Similarity=0.309 Sum_probs=66.1
Q ss_pred CceeecCCCeEEEEEEEec-----cCCCeEEEEeCCeecCCC--CCeEEEEeCceeEEEEcccccCCCeEEEEEEEeCCc
Q psy2148 1647 QPCRAFEQDQARFEVEFDG-----DPLPTIKWFREDFPITSS--PDFQIHTFSTKSILIMRQVFMEDSGVFAVIAENRGG 1719 (1884)
Q Consensus 1647 ~~~~v~~G~~~~l~C~~~g-----~p~~~i~W~~~~~~~~~~--~~~~~~~~~~~~~L~i~~v~~~DsG~Y~C~a~n~~g 1719 (1884)
+...+.+|+.+.|.|.+.| .|.+.|.|+|++..+... ...++.. .+..|.|.++..+|+|.|.|.+.|..|
T Consensus 7 ~~~~v~~G~~~~L~C~~~g~~~~~~p~~~v~Wyk~~~~~~~~~~~~~r~~~--~~~~L~I~~~~~~DsG~Y~C~~~N~~g 84 (94)
T cd05756 7 KKSYVLEGEPVVIKCPLFYSYIAQSPGLNLTWYKSDGKTPIPTEERSRMHQ--QKDLLWFLPAALEDSGLYTCVVRNSTY 84 (94)
T ss_pred eEEEEecCCCeEEECCCCCcccccCCCceEEEEEcCCCCcccccccceeee--cCCeEEEccCCcccCeEEEEEEcCCCc
Confidence 4567889999999999999 689999999999764321 1222222 346799999999999999999999999
Q ss_pred eEEEEEEEEE
Q psy2148 1720 KAKCSANLVV 1729 (1884)
Q Consensus 1720 ~~~~~~~l~V 1729 (1884)
....+++|+|
T Consensus 85 ~~~~~~~L~v 94 (94)
T cd05756 85 CMKVSISLTV 94 (94)
T ss_pred cEEEEEEEEC
Confidence 9999988875
No 154
>cd05750 Ig_Pro_neuregulin Immunoglobulin (Ig)-like domain in neuregulins (NRGs). Ig_Pro_neuregulin: immunoglobulin (Ig)-like domain in neuregulins (NRGs). NRGs are signaling molecules, which participate in cell-cell interactions in the nervous system, breast, heart, and other organ systems, and are implicated in the pathology of diseases including schizophrenia, multiple sclerosis, and breast cancer. There are four members of the neuregulin gene family (NRG1, -2, -3, and -4). The NRG-1 protein, binds to and activates the tyrosine kinases receptors ErbB3 and ErbB4, initiating signaling cascades. The other NRGs proteins bind one or the other or both of these ErbBs. NRG-1 has multiple functions; for example, in the brain it regulates various processes such as radial glia formation and neuronal migration, dendritic development, and expression of neurotransmitters receptors; in the peripheral nervous system NRG-1 regulates processes such as target cell differentiation, and Schwann cell surv
Probab=99.11 E-value=2.8e-10 Score=102.17 Aligned_cols=70 Identities=24% Similarity=0.384 Sum_probs=59.3
Q ss_pred EEEEEEEec-CCCcEEEEEeCCEecCCCCCeE---EeecCCeEEEEEccCCCCCCEEEEEEEEeCCeeEEEEEE
Q psy2148 1760 ARFDAKISA-TKPLDVYWLKNGKKIIPDIRYK---TLEEDNLFTLLIIEAVVEDSGAYECVAMNNAGEARCEAE 1829 (1884)
Q Consensus 1760 ~~l~C~~~g-~p~p~v~W~k~~~~l~~~~~~~---~~~~~~~~~L~i~~~~~~d~G~Y~C~a~N~~G~~~~~~~ 1829 (1884)
+.|.|.+.| .|.|.+.|+|+|.++..+.+.. +........|.|.++..+|+|.|+|.|.|..|.+..++.
T Consensus 1 ~~l~C~~~g~~P~p~~~W~k~g~~l~~~~~~~~~~~~~~~~~~~L~I~~~~~~D~G~Y~C~a~N~~G~~~~~~~ 74 (75)
T cd05750 1 LVLKCEATSEYPSLRFKWFKDGKELNRKNKPRNIKIRNKKKNSELQINKAKLADSGEYTCVVENILGNDTVTAN 74 (75)
T ss_pred CEEEEEccCCCCCceEEEEcCCeeccccCCcceEEEEecCceEEEEEccCCcccCeEEEEEEEEcCCceeEEEe
Confidence 369999999 9999999999999997665432 334445679999999999999999999999999887765
No 155
>cd05898 Ig5_KIRREL3 Fifth immunoglobulin (Ig)-like domain of Kirrel (kin of irregular chiasm-like) 3 protein (also known as Neph2). Ig5_KIRREL3: the fifth immunoglobulin (Ig)-like domain of Kirrel (kin of irregular chiasm-like) 3 protein (also known as Neph2). This protein has five Ig-like domains, one transmembrane domain, and a cytoplasmic tail. Included in this group is mammalian Kirrel (Neph1). These proteins contain multiple Ig domains, have properties of cell adhesion molecules, and are important in organ development. Neph1 and 2 may mediate axonal guidance and synapse formation in certain areas of the CNS. In the kidney, they participate in the formation of the slit diaphragm.
Probab=99.11 E-value=7.7e-10 Score=101.74 Aligned_cols=89 Identities=20% Similarity=0.334 Sum_probs=71.6
Q ss_pred CCeeeecCCceeecCCCeEEEEEEEeeCCCCCcEEEEeeCCEEccCC--CcEEEEee----CCeEEEEEccCCCCC-CeE
Q psy2148 916 APEFLTTPTDLTLAESTLAHFECRLTPTNDPSMTVEWFHNGKALSAG--SRIKTIND----FGFVILEINDVYLRD-SGL 988 (1884)
Q Consensus 916 ~p~~~~~~~~~~v~~G~~v~l~C~v~~~~~P~~~v~W~~~g~~i~~~--~~~~~~~~----~~~~~L~I~~~~~~D-~G~ 988 (1884)
||.| ...+...+.+|++++|.|.+.+ ..|+..|.|..++..|..+ .+|.+... +..+.|.|.++...| .|.
T Consensus 2 pP~i-~~~~s~~~~~G~~~~L~C~~~s-~P~P~~i~W~w~~~~i~~~~~~r~~I~~~~~~~g~~S~L~I~~~~~~d~~g~ 79 (98)
T cd05898 2 PPII-SSEQVQYAVRGERGKVKCFIGS-TPPPDRIAWAWKENVLESGTSERYTVERTSTGSGVLSTLTINNIMEADFQTH 79 (98)
T ss_pred CCEE-ecCceEEEeCCCcEEEEEEEcc-CCCCcEEEEEEccccccCCCCCCEEEEEEccCCCcEEEEEECCCccccCCcE
Confidence 4555 6667788999999999999973 3334468999988888653 68877654 467899999998877 799
Q ss_pred EEEEEEcCCeeEEEEEEE
Q psy2148 989 YTCKATNKHGEATTSCKL 1006 (1884)
Q Consensus 989 Y~C~a~N~~G~~~~~~~l 1006 (1884)
|.|.|.|..|+++..+.|
T Consensus 80 Y~C~a~N~~G~d~~~i~L 97 (98)
T cd05898 80 YNCTAWNSFGSGTAIIQL 97 (98)
T ss_pred EEEEEEeCCccceEEEEe
Confidence 999999999999888776
No 156
>cd07702 Ig2_VEGFR-1 Second immunoglobulin (Ig)-like domain of vascular endothelial growth factor receptor 1 (VEGFR-1). Ig2_VEGFR-1: Second immunoglobulin (Ig)-like domain of vascular endothelial growth factor receptor 1 (VEGFR-1). VEGFRs have an extracellular component with seven Ig-like domains, a transmembrane segment, and an intracellular tyrosine kinase domain interrupted by a kinase-insert domain. VEGFRs bind VEGFs with high affinity at the Ig-like domains. VEGFR-1 binds VEGF-A strongly; VEGF-A is important to the growth and maintenance of vascular endothelial cells and to the development of new blood- and lymphatic-vessels in physiological and pathological states. VEGFR-1 may play an inhibitory rolet in the function of VEGFR-2 by binding VEGF-A and interfering with its interaction with VEGFR-2. VEGFR-1 has a signaling role in mediating monocyte chemotaxis and may mediate a chemotactic and a survival signal in hematopoietic stem cells or leukemia cells.
Probab=99.11 E-value=3.2e-10 Score=97.93 Aligned_cols=68 Identities=25% Similarity=0.284 Sum_probs=54.3
Q ss_pred EEEEEEEeeCCCCCcEEEEeeCCEEccCC-CcEEEEeeCCeEEEEEccCCCCCCeEEEEEEEcCCeeEEEEEEEE
Q psy2148 934 AHFECRLTPTNDPSMTVEWFHNGKALSAG-SRIKTINDFGFVILEINDVYLRDSGLYTCKATNKHGEATTSCKLT 1007 (1884)
Q Consensus 934 v~l~C~v~~~~~P~~~v~W~~~g~~i~~~-~~~~~~~~~~~~~L~I~~~~~~D~G~Y~C~a~N~~G~~~~~~~l~ 1007 (1884)
++|.|.+. |.|+|+++|+|+|.++..+ .++.. .++ .|.|.+++.+|+|.|+|.|+|..........++
T Consensus 1 ~~l~c~v~--g~P~P~v~W~kdg~~l~~~~~~~~~--~~~--~L~I~~v~~~D~G~YtC~a~~~~~~~~~~~~i~ 69 (72)
T cd07702 1 YRLTPKVK--AFPAPEVIWLKDGLPAAEKCSRYHV--DGY--SLVIKDVTEEDAGIYTILLGIKQYNLFKNLTIT 69 (72)
T ss_pred CeEEeeEE--EcCCCeEEEEECCEECCCCCcEEEe--CCC--EEEECcCCHHHCEEEEEEEEccccceEeeEEEE
Confidence 47999999 7899999999999998765 33332 222 699999999999999999999876665555444
No 157
>cd05756 Ig1_IL1R_like First immunoglobulin (Ig)-like domain of interleukin-1 receptor (IL1R) and similar proteins. Ig1_IL1R_like: domain similar to the first immunoglobulin (Ig)-like domain of interleukin-1 receptor (IL1R). IL-1 alpha and IL-1 beta are cytokines which participate in the regulation of inflammation, immune responses, and hematopoiesis. These cytokines bind to the IL-1 receptor type 1 (IL1R1), which is activated on additional association with an accessory protein, IL1RAP. IL-1 also binds a second receptor designated type II (IL1R2). Mature IL1R1 consists of three Ig-like domains, a transmembrane domain, and a large cytoplasmic domain. Mature IL1R2 is organized similarly except that it has a short cytoplasmic domain. The latter does not initiate signal transduction. A naturally occurring cytokine IL-1RA (IL-1 receptor antagonist) is widely expressed and binds to IL-1 receptors, inhibiting the binding of IL-1 alpha and IL-1 beta.
Probab=99.10 E-value=2.5e-10 Score=105.76 Aligned_cols=81 Identities=22% Similarity=0.308 Sum_probs=66.1
Q ss_pred CceEEcCCceEEEEEEEec-----CCCcEEEEEeCCEecCCC--CCeEEeecCCeEEEEEccCCCCCCEEEEEEEEeCCe
Q psy2148 1750 SSAVINVGQLARFDAKISA-----TKPLDVYWLKNGKKIIPD--IRYKTLEEDNLFTLLIIEAVVEDSGAYECVAMNNAG 1822 (1884)
Q Consensus 1750 ~~~~~~~G~~~~l~C~~~g-----~p~p~v~W~k~~~~l~~~--~~~~~~~~~~~~~L~i~~~~~~d~G~Y~C~a~N~~G 1822 (1884)
+...+.+|+.+.|.|.+.| .|.|.|.|+|++..+... ....+...+ ..|.|.++..+|+|.|+|.|.|..|
T Consensus 7 ~~~~v~~G~~~~L~C~~~g~~~~~~p~~~v~Wyk~~~~~~~~~~~~~r~~~~~--~~L~I~~~~~~DsG~Y~C~~~N~~g 84 (94)
T cd05756 7 KKSYVLEGEPVVIKCPLFYSYIAQSPGLNLTWYKSDGKTPIPTEERSRMHQQK--DLLWFLPAALEDSGLYTCVVRNSTY 84 (94)
T ss_pred eEEEEecCCCeEEECCCCCcccccCCCceEEEEEcCCCCcccccccceeeecC--CeEEEccCCcccCeEEEEEEcCCCc
Confidence 4567789999999999999 689999999999765321 122222223 2899999999999999999999999
Q ss_pred eEEEEEEEEE
Q psy2148 1823 EARCEAELVV 1832 (1884)
Q Consensus 1823 ~~~~~~~l~V 1832 (1884)
..+.++.|+|
T Consensus 85 ~~~~~~~L~v 94 (94)
T cd05756 85 CMKVSISLTV 94 (94)
T ss_pred cEEEEEEEEC
Confidence 9999999876
No 158
>cd05765 Ig_3 Subgroup of the immunoglobulin (Ig) superfamily. Ig_3: subgroup of the immunoglobulin (Ig) domain found in the Ig superfamily. The Ig superfamily is a heterogenous group of proteins, built on a common fold comprised of a sandwich of two beta sheets. Members of the Ig superfamily are components of immunoglobulin, neuroglia, cell surface glycoproteins, such as T-cell receptors, CD2, CD4, CD8, and membrane glycoproteins, such as butyrophilin and chondroitin sulfate proteoglycan core protein. A predominant feature of most Ig domains is a disulfide bridge connecting the two beta-sheets with a tryptophan residue packed against the disulfide bond.
Probab=99.10 E-value=2.6e-10 Score=104.22 Aligned_cols=73 Identities=29% Similarity=0.499 Sum_probs=58.2
Q ss_pred CceEEEEEEEecCCCcEEEEEeCCE---e--cCCCC---CeEEeecCCeEEEEEccCCCCCCEEEEEEEEeCCeeEEEEE
Q psy2148 1757 GQLARFDAKISATKPLDVYWLKNGK---K--IIPDI---RYKTLEEDNLFTLLIIEAVVEDSGAYECVAMNNAGEARCEA 1828 (1884)
Q Consensus 1757 G~~~~l~C~~~g~p~p~v~W~k~~~---~--l~~~~---~~~~~~~~~~~~L~i~~~~~~d~G~Y~C~a~N~~G~~~~~~ 1828 (1884)
|+.++|.|.+.|.|.|.|+|+|++. . +.... ++... ....|.|.++..+|+|.|+|.|.|..|....++
T Consensus 1 G~~v~l~C~~~g~P~p~v~W~k~~~~~~~~~~~~~~~~~~~~~~---~~~~L~I~~~~~~D~G~Y~C~a~N~~G~~~~~~ 77 (81)
T cd05765 1 GETASFHCDVTGRPPPEITWEKQVHGKENLIMRPNHVRGNVVVT---NIGQLVIYNAQPQDAGLYTCTARNSGGLLRANF 77 (81)
T ss_pred CCcEEEEeeccccCCCcEEEEecCCCCcceeecCCcccCCEEEc---cccEEEEccCCcccCEEEEEEEecCCceEEEEE
Confidence 7889999999999999999999842 1 11111 11111 224899999999999999999999999999999
Q ss_pred EEEE
Q psy2148 1829 ELVV 1832 (1884)
Q Consensus 1829 ~l~V 1832 (1884)
+|.|
T Consensus 78 ~l~v 81 (81)
T cd05765 78 PLSV 81 (81)
T ss_pred EEeC
Confidence 9986
No 159
>cd05895 Ig_Pro_neuregulin-1 Immunoglobulin (Ig)-like domain found in neuregulin (NRG)-1. Ig_Pro_neuregulin-1: immunoglobulin (Ig)-like domain found in neuregulin (NRG)-1. There are many NRG-1 isoforms which arise from the alternative splicing of mRNA. NRG-1 belongs to the neuregulin gene family, which is comprised of four genes. This group represents NRG-1. NRGs are signaling molecules, which participate in cell-cell interactions in the nervous system, breast, and heart, and other organ systems, and are implicated in the pathology of diseases including schizophrenia, multiple sclerosis, and breast cancer. The NRG-1 protein binds to and activates the tyrosine kinases receptors ErbB3 and ErbB4, initiating signaling cascades. NRG-1 has multiple functions; for example, in the brain it regulates various processes such as radial glia formation and neuronal migration, dendritic development, and expression of neurotransmitters receptors; in the peripheral nervous system NRG-1 regulates process
Probab=99.09 E-value=4.5e-10 Score=100.66 Aligned_cols=71 Identities=28% Similarity=0.543 Sum_probs=56.9
Q ss_pred EEEEEEEeeCCCCCcEEEEeeCCEEccCC----CcEEEEeeCCeEEEEEccCCCCCCeEEEEEEEcCCeeEEEEEE
Q psy2148 934 AHFECRLTPTNDPSMTVEWFHNGKALSAG----SRIKTINDFGFVILEINDVYLRDSGLYTCKATNKHGEATTSCK 1005 (1884)
Q Consensus 934 v~l~C~v~~~~~P~~~v~W~~~g~~i~~~----~~~~~~~~~~~~~L~I~~~~~~D~G~Y~C~a~N~~G~~~~~~~ 1005 (1884)
+.|.|.+.+ +.|.+.++|+|+|++|... .++.+........|.|.++..+|+|.|+|.|+|..|..+.++.
T Consensus 1 ~~L~C~a~~-~~p~~~~~W~~~g~~i~~~~~~~~~~~~~~~~~~~~L~I~~~~~~DsG~Y~C~a~N~~g~~~~~~~ 75 (76)
T cd05895 1 LVLRCETVS-EYPSLRFKWFKNGKEIGAKNKPDNKIKIRKKKKSSELQISKASLADNGEYKCMVSSKLGNDSVTAN 75 (76)
T ss_pred CEEEEeccc-CCCCCceEEEECCcccccCCCCCceEEEEeCCcEEEEEECcCCcccCEEEEEEEEeCCCceeEEEe
Confidence 479999873 4688899999999998643 2344444445568999999999999999999999999887765
No 160
>cd04967 Ig1_Contactin First Ig domain of contactin. Ig1_Contactin: First Ig domain of contactins. Contactins are neural cell adhesion molecules and are comprised of six Ig domains followed by four fibronectin type III(FnIII) domains anchored to the membrane by glycosylphosphatidylinositol. The first four Ig domains form the intermolecular binding fragment, which arranges as a compact U-shaped module via contacts between Ig domains 1 and 4, and between Ig domains 2 and 3. Contactin-2 (TAG-1, axonin-1) may play a part in the neuronal processes of neurite outgrowth, axon guidance and fasciculation, and neuronal migration. This group also includes contactin-1 and contactin-5. The different contactins show different expression patterns in the central nervous system. During development and in adulthood, contactin-2 is transiently expressed in subsets of central and peripheral neurons. Contactin-5 is expressed specifically in the rat postnatal nervous system, peaking at about 3 weeks postnata
Probab=99.08 E-value=7.4e-10 Score=103.22 Aligned_cols=80 Identities=30% Similarity=0.510 Sum_probs=62.9
Q ss_pred CeeeecCCceeecC---CCeEEEEEEEeeCCCCCcEEEEeeCCEEccC--CCcEEEEeeCCeEEEEEccCCC-CCCeEEE
Q psy2148 917 PEFLTTPTDLTLAE---STLAHFECRLTPTNDPSMTVEWFHNGKALSA--GSRIKTINDFGFVILEINDVYL-RDSGLYT 990 (1884)
Q Consensus 917 p~~~~~~~~~~v~~---G~~v~l~C~v~~~~~P~~~v~W~~~g~~i~~--~~~~~~~~~~~~~~L~I~~~~~-~D~G~Y~ 990 (1884)
|.|+..+.+..+.+ |+.+.|.|.+. |.|.|+|+|+|++..+.. ..++.. .++ .|.|.++.. +|+|.|+
T Consensus 2 P~f~~~p~~~~~~~~~~~~~~~l~C~~~--g~p~p~i~W~k~~~~l~~~~~~~~~~--~~~--~L~i~~~~~~~d~G~Y~ 75 (91)
T cd04967 2 PVFEEQPDDTIFPEESDEGKVSLNCRAR--GSPPPTYRWLMNGTEIDDEPDSRYSL--VGG--NLVISNPSKAKDAGRYQ 75 (91)
T ss_pred CeeEeCCCCEEccCCCCCCEEEEEEeee--EcCCCEEEEEECCEECCCCCCCCEEE--ECC--EEEEecCCccCCCEEEE
Confidence 77888888876654 46799999998 678899999999999843 334433 223 588988874 9999999
Q ss_pred EEEEcCCeeEEE
Q psy2148 991 CKATNKHGEATT 1002 (1884)
Q Consensus 991 C~a~N~~G~~~~ 1002 (1884)
|.|+|.+|...+
T Consensus 76 C~a~N~~G~~~S 87 (91)
T cd04967 76 CLASNIVGTVLS 87 (91)
T ss_pred EEEEcCCCEEEe
Confidence 999999997654
No 161
>cd05765 Ig_3 Subgroup of the immunoglobulin (Ig) superfamily. Ig_3: subgroup of the immunoglobulin (Ig) domain found in the Ig superfamily. The Ig superfamily is a heterogenous group of proteins, built on a common fold comprised of a sandwich of two beta sheets. Members of the Ig superfamily are components of immunoglobulin, neuroglia, cell surface glycoproteins, such as T-cell receptors, CD2, CD4, CD8, and membrane glycoproteins, such as butyrophilin and chondroitin sulfate proteoglycan core protein. A predominant feature of most Ig domains is a disulfide bridge connecting the two beta-sheets with a tryptophan residue packed against the disulfide bond.
Probab=99.08 E-value=4.1e-10 Score=102.92 Aligned_cols=76 Identities=25% Similarity=0.397 Sum_probs=57.0
Q ss_pred CCeEEEEEEEeeCCCCCcEEEEeeCCE---E--ccCCCcEEEEeeCCeEEEEEccCCCCCCeEEEEEEEcCCeeEEEEEE
Q psy2148 931 STLAHFECRLTPTNDPSMTVEWFHNGK---A--LSAGSRIKTINDFGFVILEINDVYLRDSGLYTCKATNKHGEATTSCK 1005 (1884)
Q Consensus 931 G~~v~l~C~v~~~~~P~~~v~W~~~g~---~--i~~~~~~~~~~~~~~~~L~I~~~~~~D~G~Y~C~a~N~~G~~~~~~~ 1005 (1884)
|+.++|.|.+. |.|.|.|+|+|++. . +................|.|.+++.+|+|.|+|.|.|.+|..+.++.
T Consensus 1 G~~v~l~C~~~--g~P~p~v~W~k~~~~~~~~~~~~~~~~~~~~~~~~~~L~I~~~~~~D~G~Y~C~a~N~~G~~~~~~~ 78 (81)
T cd05765 1 GETASFHCDVT--GRPPPEITWEKQVHGKENLIMRPNHVRGNVVVTNIGQLVIYNAQPQDAGLYTCTARNSGGLLRANFP 78 (81)
T ss_pred CCcEEEEeecc--ccCCCcEEEEecCCCCcceeecCCcccCCEEEccccEEEEccCCcccCEEEEEEEecCCceEEEEEE
Confidence 78999999998 78889999999742 1 11111000001112347999999999999999999999999999999
Q ss_pred EEE
Q psy2148 1006 LTV 1008 (1884)
Q Consensus 1006 l~V 1008 (1884)
|+|
T Consensus 79 l~v 81 (81)
T cd05765 79 LSV 81 (81)
T ss_pred EeC
Confidence 876
No 162
>cd04967 Ig1_Contactin First Ig domain of contactin. Ig1_Contactin: First Ig domain of contactins. Contactins are neural cell adhesion molecules and are comprised of six Ig domains followed by four fibronectin type III(FnIII) domains anchored to the membrane by glycosylphosphatidylinositol. The first four Ig domains form the intermolecular binding fragment, which arranges as a compact U-shaped module via contacts between Ig domains 1 and 4, and between Ig domains 2 and 3. Contactin-2 (TAG-1, axonin-1) may play a part in the neuronal processes of neurite outgrowth, axon guidance and fasciculation, and neuronal migration. This group also includes contactin-1 and contactin-5. The different contactins show different expression patterns in the central nervous system. During development and in adulthood, contactin-2 is transiently expressed in subsets of central and peripheral neurons. Contactin-5 is expressed specifically in the rat postnatal nervous system, peaking at about 3 weeks postnata
Probab=99.08 E-value=9.5e-10 Score=102.51 Aligned_cols=80 Identities=24% Similarity=0.451 Sum_probs=63.5
Q ss_pred CeEEeccCceEEcC---CceEEEEEEEecCCCcEEEEEeCCEecCCC--CCeEEeecCCeEEEEEccCCC-CCCEEEEEE
Q psy2148 1743 PSFLTTISSAVINV---GQLARFDAKISATKPLDVYWLKNGKKIIPD--IRYKTLEEDNLFTLLIIEAVV-EDSGAYECV 1816 (1884)
Q Consensus 1743 P~~~~~~~~~~~~~---G~~~~l~C~~~g~p~p~v~W~k~~~~l~~~--~~~~~~~~~~~~~L~i~~~~~-~d~G~Y~C~ 1816 (1884)
|.|...|.+..+.+ |+.+.|.|.+.|.|.|.|+|+|++..+... .++... ++ .|.|.++.. +|+|.|+|.
T Consensus 2 P~f~~~p~~~~~~~~~~~~~~~l~C~~~g~p~p~i~W~k~~~~l~~~~~~~~~~~-~~---~L~i~~~~~~~d~G~Y~C~ 77 (91)
T cd04967 2 PVFEEQPDDTIFPEESDEGKVSLNCRARGSPPPTYRWLMNGTEIDDEPDSRYSLV-GG---NLVISNPSKAKDAGRYQCL 77 (91)
T ss_pred CeeEeCCCCEEccCCCCCCEEEEEEeeeEcCCCEEEEEECCEECCCCCCCCEEEE-CC---EEEEecCCccCCCEEEEEE
Confidence 67888787776654 467999999999999999999999998543 344332 22 789988874 899999999
Q ss_pred EEeCCeeEEE
Q psy2148 1817 AMNNAGEARC 1826 (1884)
Q Consensus 1817 a~N~~G~~~~ 1826 (1884)
|+|..|.+..
T Consensus 78 a~N~~G~~~S 87 (91)
T cd04967 78 ASNIVGTVLS 87 (91)
T ss_pred EEcCCCEEEe
Confidence 9999997653
No 163
>cd05733 Ig6_L1-CAM_like Sixth immunoglobulin (Ig)-like domain of the L1 cell adhesion molecule (CAM) and similar proteins. Ig6_L1-CAM_like: domain similar to the sixth immunoglobulin (Ig)-like domain of the L1 cell adhesion molecule (CAM). L1 belongs to the L1 subfamily of cell adhesion molecules (CAMs) and is comprised of an extracellular region having six Ig-like domains and five fibronectin type III domains, a transmembrane region and an intracellular domain. L1 is primarily expressed in the nervous system and is involved in its development and function. L1 is associated with an X-linked recessive disorder, X-linked hydrocephalus, MASA syndrome, or spastic paraplegia type 1, that involves abnormalities of axonal growth. This group also contains NrCAM [Ng(neuronglia)CAM-related cell adhesion molecule], which is primarily expressed in the nervous system, and human neurofascin.
Probab=99.05 E-value=5.3e-10 Score=100.01 Aligned_cols=65 Identities=25% Similarity=0.386 Sum_probs=51.4
Q ss_pred EEEEEEEecCCCcEEEEEeCCEecCCCC--CeEEeecCCeEEEEEccCCC----CCCEEEEEEEEeCCeeEEE
Q psy2148 1760 ARFDAKISATKPLDVYWLKNGKKIIPDI--RYKTLEEDNLFTLLIIEAVV----EDSGAYECVAMNNAGEARC 1826 (1884)
Q Consensus 1760 ~~l~C~~~g~p~p~v~W~k~~~~l~~~~--~~~~~~~~~~~~L~i~~~~~----~d~G~Y~C~a~N~~G~~~~ 1826 (1884)
++|.|.+.|.|.|.|+|+|+|..+.... ++.+.... ..|.|.++.. +|+|.|+|.|.|..|.+..
T Consensus 1 i~l~C~~~G~P~P~v~W~k~g~~l~~~~~~~~~~~~~~--g~L~i~~~~~~~~~~d~G~Y~C~A~N~~G~~~s 71 (77)
T cd05733 1 IVIKCEAKGNPPPTFSWTRNGTHFDPEKDPRVTMKPDS--GTLVIDNMNGGRAEDYEGEYQCYASNELGTAIS 71 (77)
T ss_pred CEEEeeCcccCCCeEEEEECCeECCCCCCCCEEEeCCC--CEEEEeccCCCCCcCCCEEEEEEEEcCCCcEEc
Confidence 4799999999999999999999986543 34333322 3788888753 7899999999999997654
No 164
>cd05752 Ig1_FcgammaR_like Frst immunoglobulin (Ig)-like domain of Fcgamma-receptors (FcgammaRs) and similar proteins. Ig1_FcgammaR_like: domain similar to the first immunoglobulin (Ig)-like domain of Fcgamma-receptors (FcgammaRs). Interactions between IgG and FcgammaR are important to the initiation of cellular and humoral response. IgG binding to FcgammaR leads to a cascade of signals and ultimately to functions such as antibody-dependent-cellular-cytotoxicity (ADCC), endocytosis, phagocytosis, release of inflammatory mediators, etc. FcgammaR has two Ig-like domains. This group also contains FcepsilonRI, which binds IgE with high affinity.
Probab=99.04 E-value=4.7e-10 Score=99.57 Aligned_cols=77 Identities=25% Similarity=0.423 Sum_probs=59.6
Q ss_pred CeeeecCCceeecCCCeEEEEEEEeeCCCCC-cEEEEeeCCEEccCCCcEEEEeeCCeEEEEEccCCCCCCeEEEEEEEc
Q psy2148 917 PEFLTTPTDLTLAESTLAHFECRLTPTNDPS-MTVEWFHNGKALSAGSRIKTINDFGFVILEINDVYLRDSGLYTCKATN 995 (1884)
Q Consensus 917 p~~~~~~~~~~v~~G~~v~l~C~v~~~~~P~-~~v~W~~~g~~i~~~~~~~~~~~~~~~~L~I~~~~~~D~G~Y~C~a~N 995 (1884)
|.+...|+...+.+|++++|.|.+. +.|. ..+.|+|||..|... + ..|.|.++ .+|+|.|+|.|.|
T Consensus 1 ~vv~~~P~~~~v~~G~~V~L~C~~~--~~p~~~~~~W~kng~~l~~~--------~--~~l~i~~~-~~dsG~Y~C~a~~ 67 (78)
T cd05752 1 AVVSLDPPWTTIFQGEKVTLTCNGF--NSPEQNSTQWYHNGKLLETT--------T--NSYRIRAA-NNDSGEYRCQTQG 67 (78)
T ss_pred CeEEeCCCCeEeeCCCCEEEEEeCC--CCCCCccEEEEECCEEeecc--------C--CeEEEeec-ccCCEEeEEECCC
Confidence 4567778889999999999999998 5454 469999999988321 1 26899999 9999999999998
Q ss_pred CCeeEEEEEEEEE
Q psy2148 996 KHGEATTSCKLTV 1008 (1884)
Q Consensus 996 ~~G~~~~~~~l~V 1008 (1884)
. ..+..+.|+|
T Consensus 68 ~--~~S~~v~l~V 78 (78)
T cd05752 68 S--SLSDPVHLEV 78 (78)
T ss_pred C--cCCCCEEEeC
Confidence 5 3444445443
No 165
>cd05874 Ig6_NrCAM Sixth immunoglobulin (Ig)-like domain of NrCAM (Ng (neuronglia) CAM-related cell adhesion molecule). Ig6_NrCAM: sixth immunoglobulin (Ig)-like domain of NrCAM (Ng (neuronglia) CAM-related cell adhesion molecule). NrCAM belongs to the L1 subfamily of cell adhesion molecules (CAMs) and is comprised of an extracellular region having six Ig-like domains and five fibronectin type III domains, a transmembrane region, and an intracellular domain. NrCAM is primarily expressed in the nervous system.
Probab=99.04 E-value=7.7e-10 Score=98.52 Aligned_cols=65 Identities=23% Similarity=0.334 Sum_probs=50.3
Q ss_pred EEEEEEEecCCCcEEEEEeCCEecCCC--CCeEEeecCCeEEEEEccCCC----CCCEEEEEEEEeCCeeEEE
Q psy2148 1760 ARFDAKISATKPLDVYWLKNGKKIIPD--IRYKTLEEDNLFTLLIIEAVV----EDSGAYECVAMNNAGEARC 1826 (1884)
Q Consensus 1760 ~~l~C~~~g~p~p~v~W~k~~~~l~~~--~~~~~~~~~~~~~L~i~~~~~----~d~G~Y~C~a~N~~G~~~~ 1826 (1884)
+.|.|.+.|.|.|+|+|+|+|.++... .++.+...++ +|.|..+.. .|.|.|+|.|.|.+|.+.+
T Consensus 1 ~~l~C~a~G~P~P~i~W~k~g~~l~~~~~~~~~~~~~~g--~l~i~~~~~~~~~~d~G~Y~C~A~N~~G~~~s 71 (77)
T cd05874 1 IVIQCEAKGKPPPSFSWTRNGTHFDIDKDPKVTMKPNTG--TLVINIMNGEKAEAYEGVYQCTARNERGAAVS 71 (77)
T ss_pred CEEEeeCcccCCCeEEEEECCeECCCcCCCCEEEeCCCc--eEEEeccccCCCCCCCEEEEEEEEcCCCeEEe
Confidence 479999999999999999999987533 3344333333 677776654 3789999999999998665
No 166
>cd05733 Ig6_L1-CAM_like Sixth immunoglobulin (Ig)-like domain of the L1 cell adhesion molecule (CAM) and similar proteins. Ig6_L1-CAM_like: domain similar to the sixth immunoglobulin (Ig)-like domain of the L1 cell adhesion molecule (CAM). L1 belongs to the L1 subfamily of cell adhesion molecules (CAMs) and is comprised of an extracellular region having six Ig-like domains and five fibronectin type III domains, a transmembrane region and an intracellular domain. L1 is primarily expressed in the nervous system and is involved in its development and function. L1 is associated with an X-linked recessive disorder, X-linked hydrocephalus, MASA syndrome, or spastic paraplegia type 1, that involves abnormalities of axonal growth. This group also contains NrCAM [Ng(neuronglia)CAM-related cell adhesion molecule], which is primarily expressed in the nervous system, and human neurofascin.
Probab=99.04 E-value=6e-10 Score=99.67 Aligned_cols=65 Identities=28% Similarity=0.510 Sum_probs=50.7
Q ss_pred EEEEEEEeeCCCCCcEEEEeeCCEEccCC--CcEEEEeeCCeEEEEEccCCC----CCCeEEEEEEEcCCeeEEE
Q psy2148 934 AHFECRLTPTNDPSMTVEWFHNGKALSAG--SRIKTINDFGFVILEINDVYL----RDSGLYTCKATNKHGEATT 1002 (1884)
Q Consensus 934 v~l~C~v~~~~~P~~~v~W~~~g~~i~~~--~~~~~~~~~~~~~L~I~~~~~----~D~G~Y~C~a~N~~G~~~~ 1002 (1884)
+.|.|.+. |.|.|.|+|+|||..+... .++.+....+ .|.|.++.. +|+|.|+|.|+|.+|...+
T Consensus 1 i~l~C~~~--G~P~P~v~W~k~g~~l~~~~~~~~~~~~~~g--~L~i~~~~~~~~~~d~G~Y~C~A~N~~G~~~s 71 (77)
T cd05733 1 IVIKCEAK--GNPPPTFSWTRNGTHFDPEKDPRVTMKPDSG--TLVIDNMNGGRAEDYEGEYQCYASNELGTAIS 71 (77)
T ss_pred CEEEeeCc--ccCCCeEEEEECCeECCCCCCCCEEEeCCCC--EEEEeccCCCCCcCCCEEEEEEEEcCCCcEEc
Confidence 47999998 7899999999999998643 3444433334 678877753 7899999999999998654
No 167
>cd05742 Ig1_VEGFR_like First immunoglobulin (Ig)-like domain of vascular endothelial growth factor (VEGF) receptor (R) and similar proteins. Ig1_VEGFR_like: first immunoglobulin (Ig)-like domain of vascular endothelial growth factor (VEGF) receptor(R) related proteins. The VEGFRs have an extracellular component with seven Ig-like domains, a transmembrane segment, and an intracellular tyrosine kinase domain interrupted by a kinase-insert domain. The VEGFR family consists of three members, VEGFR-1 (Flt-1), VEGFR-2 (KDR/Flk-1) and VEGFR-3 (Flt-4). VEGF-A interacts with both VEGFR-1 and VEGFR-2. VEGFR-1 binds strongest to VEGF, VEGF-2 binds more weakly. VEGFR-3 appears not to bind VEGF, but binds other members of the VEGF family (VEGF-C and -D). VEGFRs bind VEGFs with high affinity with the IG-like domains. VEGF-A is important to the growth and maintenance of vascular endothelial cells and to the development of new blood- and lymphatic-vessels in physiological and pathological states. VEGF
Probab=99.03 E-value=8.2e-10 Score=101.17 Aligned_cols=79 Identities=22% Similarity=0.359 Sum_probs=61.3
Q ss_pred CCeEEEEEEEeeCCCCCcEEEEeeCCEEccCCCcE----E-EEeeCCeEEEEEccCCCCCCeEEEEEEEcCCeeEEEEEE
Q psy2148 931 STLAHFECRLTPTNDPSMTVEWFHNGKALSAGSRI----K-TINDFGFVILEINDVYLRDSGLYTCKATNKHGEATTSCK 1005 (1884)
Q Consensus 931 G~~v~l~C~v~~~~~P~~~v~W~~~g~~i~~~~~~----~-~~~~~~~~~L~I~~~~~~D~G~Y~C~a~N~~G~~~~~~~ 1005 (1884)
|+++.|.|.+.+...|.+.|+|++++..+...... . .......+.|.|.+++.+|+|.|+|.|+|..|..+.++.
T Consensus 1 Ge~~~L~C~~~g~~~~~~~i~W~~~~~~~~~~~~~~~~~~~~~~~~~~s~L~I~~v~~~DsG~Y~C~a~n~~~~~~~s~~ 80 (84)
T cd05742 1 GETLVLNCTVLTELNEGVDFQWTYPGKKRGRGKSMVTRQSLSEATELSSTLTIPNATLKDSGTYTCAASSGTMDQKESTK 80 (84)
T ss_pred CCeEEEEEEEEeCCCccEEEEEecCCcccCCceEeecccccccceEEEEEEEECCCChhhCEEEEEEEccCCCceEEEEE
Confidence 78999999999533388999999988766432111 1 111223568999999999999999999999999999998
Q ss_pred EEEE
Q psy2148 1006 LTVK 1009 (1884)
Q Consensus 1006 l~V~ 1009 (1884)
|.|+
T Consensus 81 v~v~ 84 (84)
T cd05742 81 VNIH 84 (84)
T ss_pred EEEC
Confidence 8873
No 168
>cd05873 Ig_Sema4D_like Immunoglobulin (Ig)-like domain of the class IV semaphorin Sema4D. Ig_Sema4D_like; Immunoglobulin (Ig)-like domain of Sema4D. Sema4D is a Class IV semaphorin. Semaphorins are classified based on structural features additional to the Sema domain. Sema4D has extracellular Sema and Ig domains, a transmembrane domain, and a short cytoplasmic domain. Sema4D plays a part in the development of GABAergic synapses. Sema4D in addition is an immune semaphorin. It is abundant on resting T cells; its expression is weak on resting B cells and antigen presenting cells (APCs), but is upregulated by various stimuli. The receptor used by Sema4D in the immune system is CD72. Sem4D enhances the activation of B cells and DCs through binding CD72, perhaps by reducing CD72s inhibitory signals. The receptor used by Sema4D in the non-lymphatic tissues is plexin-B1. Sem4D is anchored to the cell surface but its extracellular domain can be released from the cell surface by a metalloproteas
Probab=99.02 E-value=1.9e-09 Score=96.74 Aligned_cols=68 Identities=24% Similarity=0.333 Sum_probs=56.9
Q ss_pred CCceeecCCCeEEEEEEEeeCCCCCcEEEEeeCCEEccCC-CcEEEEeeCCeEEEEEccCCCCCCeEEEEEEEcCC
Q psy2148 923 PTDLTLAESTLAHFECRLTPTNDPSMTVEWFHNGKALSAG-SRIKTINDFGFVILEINDVYLRDSGLYTCKATNKH 997 (1884)
Q Consensus 923 ~~~~~v~~G~~v~l~C~v~~~~~P~~~v~W~~~g~~i~~~-~~~~~~~~~~~~~L~I~~~~~~D~G~Y~C~a~N~~ 997 (1884)
|++.++.+|+++.|.|.+. .|.+.|+|+|||.+|..+ .++.+. ++ .|.|.+++.+|+|.|+|.|.+..
T Consensus 3 P~~~~v~~G~~v~L~C~~~---~~~~~i~W~~ng~~i~~~~~r~~~~-~~---~L~I~nv~~~DsG~Y~C~a~e~~ 71 (87)
T cd05873 3 PRQRTFKLGNNAELKCSPK---SNLARVVWKFDGKVLTPESAKYLLY-RD---GLLIFNASEADAGRYQCLSVEKS 71 (87)
T ss_pred cceEEEECCCCEEEEEECC---CCCCeEEEEECCEECCCCCceEEEE-CC---cEEEeCCCHHHCEEEEEEEEecc
Confidence 5678999999999999985 366799999999999776 455443 33 49999999999999999999864
No 169
>cd05874 Ig6_NrCAM Sixth immunoglobulin (Ig)-like domain of NrCAM (Ng (neuronglia) CAM-related cell adhesion molecule). Ig6_NrCAM: sixth immunoglobulin (Ig)-like domain of NrCAM (Ng (neuronglia) CAM-related cell adhesion molecule). NrCAM belongs to the L1 subfamily of cell adhesion molecules (CAMs) and is comprised of an extracellular region having six Ig-like domains and five fibronectin type III domains, a transmembrane region, and an intracellular domain. NrCAM is primarily expressed in the nervous system.
Probab=99.01 E-value=1.3e-09 Score=97.01 Aligned_cols=65 Identities=25% Similarity=0.496 Sum_probs=49.3
Q ss_pred EEEEEEEeeCCCCCcEEEEeeCCEEccCC--CcEEEEeeCCeEEEEEccCCC----CCCeEEEEEEEcCCeeEEE
Q psy2148 934 AHFECRLTPTNDPSMTVEWFHNGKALSAG--SRIKTINDFGFVILEINDVYL----RDSGLYTCKATNKHGEATT 1002 (1884)
Q Consensus 934 v~l~C~v~~~~~P~~~v~W~~~g~~i~~~--~~~~~~~~~~~~~L~I~~~~~----~D~G~Y~C~a~N~~G~~~~ 1002 (1884)
+.|.|.+. |.|.|+|+|+|+|.++... .++.+...++ +|.|..+.. .|.|.|+|.|+|.+|...+
T Consensus 1 ~~l~C~a~--G~P~P~i~W~k~g~~l~~~~~~~~~~~~~~g--~l~i~~~~~~~~~~d~G~Y~C~A~N~~G~~~s 71 (77)
T cd05874 1 IVIQCEAK--GKPPPSFSWTRNGTHFDIDKDPKVTMKPNTG--TLVINIMNGEKAEAYEGVYQCTARNERGAAVS 71 (77)
T ss_pred CEEEeeCc--ccCCCeEEEEECCeECCCcCCCCEEEeCCCc--eEEEeccccCCCCCCCEEEEEEEEcCCCeEEe
Confidence 47999998 7899999999999987433 3444433344 566766654 4789999999999998665
No 170
>cd05734 Ig7_DSCAM Seventh immunoglobulin (Ig)-like domain of Down Syndrome Cell Adhesion molecule (DSCAM). Ig7_DSCAM: the seventh immunoglobulin (Ig)-like domain of Down Syndrome Cell Adhesion molecule (DSCAM). DSCAM is a cell adhesion molecule expressed largely in the developing nervous system. The gene encoding DSCAM is located at human chromosome 21q22, the locus associated with the mental retardation phenotype of Down Syndrome. DSCAM is predicted to be the largest member of the IG superfamily. It has been demonstrated that DSCAM can mediate cation-independent homophilic intercellular adhesion.
Probab=99.00 E-value=1.1e-09 Score=98.88 Aligned_cols=70 Identities=24% Similarity=0.352 Sum_probs=54.9
Q ss_pred EEEEEEEecCCCcEEEEEeCCEecC--------CCCCeEEeecCCeEEEEEccCCCCCCEEEEEEEEeCCeeE-EEEEEE
Q psy2148 1760 ARFDAKISATKPLDVYWLKNGKKII--------PDIRYKTLEEDNLFTLLIIEAVVEDSGAYECVAMNNAGEA-RCEAEL 1830 (1884)
Q Consensus 1760 ~~l~C~~~g~p~p~v~W~k~~~~l~--------~~~~~~~~~~~~~~~L~i~~~~~~d~G~Y~C~a~N~~G~~-~~~~~l 1830 (1884)
++|.|.+.|.|.|.|.|+|++.... ...++.+..++ +|.|.++..+|+|.|+|.|.|..|.+ +.++.|
T Consensus 1 v~l~C~~~G~P~P~v~W~~~~~~~~~~~~~~~~~~~r~~~~~~~---~L~I~~v~~~D~G~Y~C~a~N~~G~~~s~~~~l 77 (79)
T cd05734 1 VTLNCSAEGYPPPTIVWKHSKGRGHPQHTHTCCLAGRIQLLSNG---SLLIKHVLEEDSGYYLCKVSNDVGADASKSMVL 77 (79)
T ss_pred CEeEeeCeEeCCCEEEEEECCCccccccccccccCCCEEEecCC---eEEECcCCcccCEEEEEEEEeCCCCCCceEEEE
Confidence 5799999999999999999754321 23455443333 89999999999999999999999976 566676
Q ss_pred EE
Q psy2148 1831 VV 1832 (1884)
Q Consensus 1831 ~V 1832 (1884)
+|
T Consensus 78 ~~ 79 (79)
T cd05734 78 TV 79 (79)
T ss_pred eC
Confidence 64
No 171
>cd05895 Ig_Pro_neuregulin-1 Immunoglobulin (Ig)-like domain found in neuregulin (NRG)-1. Ig_Pro_neuregulin-1: immunoglobulin (Ig)-like domain found in neuregulin (NRG)-1. There are many NRG-1 isoforms which arise from the alternative splicing of mRNA. NRG-1 belongs to the neuregulin gene family, which is comprised of four genes. This group represents NRG-1. NRGs are signaling molecules, which participate in cell-cell interactions in the nervous system, breast, and heart, and other organ systems, and are implicated in the pathology of diseases including schizophrenia, multiple sclerosis, and breast cancer. The NRG-1 protein binds to and activates the tyrosine kinases receptors ErbB3 and ErbB4, initiating signaling cascades. NRG-1 has multiple functions; for example, in the brain it regulates various processes such as radial glia formation and neuronal migration, dendritic development, and expression of neurotransmitters receptors; in the peripheral nervous system NRG-1 regulates process
Probab=99.00 E-value=1.6e-09 Score=97.10 Aligned_cols=71 Identities=24% Similarity=0.408 Sum_probs=57.8
Q ss_pred EEEEEEEec-CCCcEEEEEeCCEecCCC----CCeEEeecCCeEEEEEccCCCCCCEEEEEEEEeCCeeEEEEEEE
Q psy2148 1760 ARFDAKISA-TKPLDVYWLKNGKKIIPD----IRYKTLEEDNLFTLLIIEAVVEDSGAYECVAMNNAGEARCEAEL 1830 (1884)
Q Consensus 1760 ~~l~C~~~g-~p~p~v~W~k~~~~l~~~----~~~~~~~~~~~~~L~i~~~~~~d~G~Y~C~a~N~~G~~~~~~~l 1830 (1884)
+.|.|.+.+ .|.+.++|+|+|+.+... .++.+........|.|.++..+|+|.|+|.|.|..|..+.++++
T Consensus 1 ~~L~C~a~~~~p~~~~~W~~~g~~i~~~~~~~~~~~~~~~~~~~~L~I~~~~~~DsG~Y~C~a~N~~g~~~~~~~~ 76 (76)
T cd05895 1 LVLRCETVSEYPSLRFKWFKNGKEIGAKNKPDNKIKIRKKKKSSELQISKASLADNGEYKCMVSSKLGNDSVTANV 76 (76)
T ss_pred CEEEEecccCCCCCceEEEECCcccccCCCCCceEEEEeCCcEEEEEECcCCcccCEEEEEEEEeCCCceeEEEeC
Confidence 479999875 688999999999998643 23444444556789999999999999999999999998887753
No 172
>cd05875 Ig6_hNeurofascin_like Sixth immunoglobulin (Ig)-like domain of human neurofascin (NF). Ig6_hNeurofascin_like: the sixth immunoglobulin (Ig)-like domain of human neurofascin (NF). NF belongs to the L1 subfamily of cell adhesion molecules (CAMs) and is comprised of an extracellular region having six Ig-like domains and five fibronectin type III domains, a transmembrane region, and a cytoplasmic domain. NF has many alternatively spliced isoforms having different temporal expression patterns during development. NF participates in axon subcellular targeting and synapse formation, however little is known of the functions of the different isoforms.
Probab=99.00 E-value=1.5e-09 Score=96.65 Aligned_cols=66 Identities=26% Similarity=0.314 Sum_probs=51.3
Q ss_pred EEEEEEEecCCCcEEEEEeCCEecC--CCCCeEEeecCCeEEEEEccCC----CCCCEEEEEEEEeCCeeEEEE
Q psy2148 1760 ARFDAKISATKPLDVYWLKNGKKII--PDIRYKTLEEDNLFTLLIIEAV----VEDSGAYECVAMNNAGEARCE 1827 (1884)
Q Consensus 1760 ~~l~C~~~g~p~p~v~W~k~~~~l~--~~~~~~~~~~~~~~~L~i~~~~----~~d~G~Y~C~a~N~~G~~~~~ 1827 (1884)
+.|.|.+.|.|.|.|+|+|+|..+. .+.++.+...+ .+|.|.++. .+|+|.|+|.|.|..|.+...
T Consensus 1 ~~l~C~~~G~P~P~v~W~k~g~~~~~~~~~~~~~~~~~--~~L~i~~~~~~~~~~d~G~Y~C~A~N~~G~~~s~ 72 (77)
T cd05875 1 IIIECEAKGNPVPTFQWTRNGKFFNVAKDPRVSMRRRS--GTLVIDFSGGGRPEDYEGEYQCFARNNLGTALSN 72 (77)
T ss_pred CEEEEeccccCCCEEEEEECCEEccCcCCCcEEEeCCC--ceEEEeccCCCCCCCCCEEEEEEEEeccceEEEE
Confidence 4799999999999999999999764 34455543333 378888764 247999999999999976544
No 173
>cd05742 Ig1_VEGFR_like First immunoglobulin (Ig)-like domain of vascular endothelial growth factor (VEGF) receptor (R) and similar proteins. Ig1_VEGFR_like: first immunoglobulin (Ig)-like domain of vascular endothelial growth factor (VEGF) receptor(R) related proteins. The VEGFRs have an extracellular component with seven Ig-like domains, a transmembrane segment, and an intracellular tyrosine kinase domain interrupted by a kinase-insert domain. The VEGFR family consists of three members, VEGFR-1 (Flt-1), VEGFR-2 (KDR/Flk-1) and VEGFR-3 (Flt-4). VEGF-A interacts with both VEGFR-1 and VEGFR-2. VEGFR-1 binds strongest to VEGF, VEGF-2 binds more weakly. VEGFR-3 appears not to bind VEGF, but binds other members of the VEGF family (VEGF-C and -D). VEGFRs bind VEGFs with high affinity with the IG-like domains. VEGF-A is important to the growth and maintenance of vascular endothelial cells and to the development of new blood- and lymphatic-vessels in physiological and pathological states. VEGF
Probab=99.00 E-value=1.4e-09 Score=99.67 Aligned_cols=76 Identities=22% Similarity=0.338 Sum_probs=61.2
Q ss_pred CceEEEEEEEecC--CCcEEEEEeCCEecCCCC----CeE-EeecCCeEEEEEccCCCCCCEEEEEEEEeCCeeEEEEEE
Q psy2148 1757 GQLARFDAKISAT--KPLDVYWLKNGKKIIPDI----RYK-TLEEDNLFTLLIIEAVVEDSGAYECVAMNNAGEARCEAE 1829 (1884)
Q Consensus 1757 G~~~~l~C~~~g~--p~p~v~W~k~~~~l~~~~----~~~-~~~~~~~~~L~i~~~~~~d~G~Y~C~a~N~~G~~~~~~~ 1829 (1884)
|+.++|.|.+.|. |.|.|+|++++..+.... +.. .......+.|+|.+++.+|+|.|+|.|.|..|..+.++.
T Consensus 1 Ge~~~L~C~~~g~~~~~~~i~W~~~~~~~~~~~~~~~~~~~~~~~~~~s~L~I~~v~~~DsG~Y~C~a~n~~~~~~~s~~ 80 (84)
T cd05742 1 GETLVLNCTVLTELNEGVDFQWTYPGKKRGRGKSMVTRQSLSEATELSSTLTIPNATLKDSGTYTCAASSGTMDQKESTK 80 (84)
T ss_pred CCeEEEEEEEEeCCCccEEEEEecCCcccCCceEeecccccccceEEEEEEEECCCChhhCEEEEEEEccCCCceEEEEE
Confidence 7899999999999 889999999887654321 111 111223569999999999999999999999999999999
Q ss_pred EEE
Q psy2148 1830 LVV 1832 (1884)
Q Consensus 1830 l~V 1832 (1884)
|.|
T Consensus 81 v~v 83 (84)
T cd05742 81 VNI 83 (84)
T ss_pred EEE
Confidence 887
No 174
>cd05861 Ig1_PDGFR-alphabeta Frst immunoglobulin (Ig)-like domain of platelet-derived growth factor (PDGF) receptors (R), alpha (CD140a), and beta (CD140b). Ig1_PDGFR-alphabeta: The first immunoglobulin (Ig)-like domain of platelet-derived growth factor (PDGF) receptors (R), alpha (CD140a), and beta (CD140b). PDGF is a potent mitogen for connective tissue cells. PDGF-stimulated processes are mediated by three different PDGFs (PDGF-A,-B, and C). PDGFRalpha binds to all three PDGFs, whereas the PDGFRbeta binds only to PDGF-B. PDGFRs alpha and beta have similar organization: an extracellular component with five Ig-like domains, a transmembrane segment, and a cytoplasmic portion having protein tyrosine kinase activity. In mice, PDGFRalpha and PDGFRbeta are essential for normal development.
Probab=99.00 E-value=2.3e-09 Score=97.54 Aligned_cols=77 Identities=29% Similarity=0.393 Sum_probs=60.4
Q ss_pred CceEEEEEEEecCCCcEEEEEeCCEecCCCC----CeEEeecCCeEEEEEccCCCCCCEEEEEEEEeCCe--eEEEEEEE
Q psy2148 1757 GQLARFDAKISATKPLDVYWLKNGKKIIPDI----RYKTLEEDNLFTLLIIEAVVEDSGAYECVAMNNAG--EARCEAEL 1830 (1884)
Q Consensus 1757 G~~~~l~C~~~g~p~p~v~W~k~~~~l~~~~----~~~~~~~~~~~~L~i~~~~~~d~G~Y~C~a~N~~G--~~~~~~~l 1830 (1884)
|++++|.|.+.|.|.|.+.|++.++...... +..+......+.|.|.+++.+|+|.|+|.|.|..+ ....++.|
T Consensus 1 Ge~~~l~C~~~~~~~~~~~W~~~~~~~~~~~~~~~~~~~~~~~~~s~L~I~~~~~~DsG~Y~C~a~n~~~~~~~~~sv~i 80 (84)
T cd05861 1 GETITVNCIVQGNEVVDFSWTYPGKDIGKGIPEVEEVKVPATTLRSTLTFPHATVEDSGTYECAAHESTQDQKAFKKVNI 80 (84)
T ss_pred CCcEEEEEEEECCCccEEEEEECCccCCCCceEEEEEecCCcEEEEEEEECCCCcCCCEEEEEEEEECccCcceeEEEEE
Confidence 7899999999999999999999876532211 11111222356999999999999999999999887 77888888
Q ss_pred EEE
Q psy2148 1831 VVQ 1833 (1884)
Q Consensus 1831 ~V~ 1833 (1884)
+|.
T Consensus 81 ~V~ 83 (84)
T cd05861 81 TVH 83 (84)
T ss_pred EEe
Confidence 885
No 175
>cd05771 IgC_Tapasin_R Tapasin-R immunoglobulin-like domain. IgC_Tapasin_R: Immunoglobulin-like domain on Tapasin-R. Tapasin is a V-C1 (variable-constant) immunoglobulin superfamily molecule present in the endoplasmic reticulum (ER), where it links MHC class I molecules to the transporter associated with antigen processing (TAP). Tapasin-R is a tapasin-related protein that contains similar structural motifs to Tapasin, with some marked differences, especially in the V domain, transmembrane and cytoplasmic regions. The majority of Tapasin-R is located within the ER; however, there may be some expression of Tapasin-R at the cell surface. Tapasin-R lacks an obvious ER retention signal.
Probab=99.00 E-value=7e-09 Score=105.76 Aligned_cols=118 Identities=19% Similarity=0.320 Sum_probs=82.9
Q ss_pred EEEEcCCCCCCCEEEEEEEEcCCeeeEEEEEEEEeecCCCCCCceEeccCCccCccCCCeEEEEEEEeeCCCCC-CeEEE
Q psy2148 367 VLEILGTKIEDTGVYTCRATNKWGQAEISVNLECVDKSKGQPPKFTSHIKSLEGLKDGDSAHFECTLTPVNDPE-LKVEW 445 (1884)
Q Consensus 367 ~L~I~~~~~~D~G~Y~C~a~n~~g~~~~~~~l~V~~~~~~~~p~~~~~~~~~~~v~~G~~v~L~C~~~~~~~p~-~~i~W 445 (1884)
+|.|.+++.+|+|.|+|.+.+..+..+..+.|.|. .+|.+...+.... ..+|+.++|.|.+.++ +|. ++|+|
T Consensus 2 sL~i~~v~~~D~G~Y~C~~~~~~~~~~~~~~l~v~-----~~P~v~~~~~~~~-~~~~~~~~L~C~a~g~-~P~~~~i~W 74 (139)
T cd05771 2 SLTLPGLTVHDEGTYICSVSTPPHQAQQIIQLSVS-----EPPRVRLSLEKLV-SMIEEPQTLICHIAGY-YPLDVQVEW 74 (139)
T ss_pred eEEECCCCHHHCEEEEEEEEccCcceeeEEEEEEe-----cCCceEEeCCCce-eecCCcEEEEEEECCC-CCCCeEEEE
Confidence 58999999999999999999988888888888886 6777765554432 3378999999999853 454 69999
Q ss_pred eeCCEEccc-----cC----cEEEEecCCE---EEEEEcccCCCCcEEEEEEEEeCce
Q psy2148 446 FHNGKPIFH-----KN----RVKMVSDFGF---VVMDIAYVQSHDSGEYVCRAWNNFI 491 (1884)
Q Consensus 446 ~k~g~~l~~-----~~----~~~~~~~~~~---~~L~i~~v~~~d~G~Y~C~a~n~~~ 491 (1884)
+++|..... .. ......++.+ +.|.|..-..++.+.|+|.+.+...
T Consensus 75 ~~~g~~~~~~~~~~~~~~~~~~~~~~dgt~~~~s~L~v~~~~~~~g~~ytC~V~H~~l 132 (139)
T cd05771 75 TREPPGDSPPPVSLSNVSFSSHRQHQDGTYSLSSHLTLEPGTEDAGATYTCRVSHVSL 132 (139)
T ss_pred EECCCCCccceeccCCeEecceEeCCCCCEEEEEEEEecCCccCCCCEEEEEEEcCCC
Confidence 999854211 11 1111222222 3566654444456699999987643
No 176
>cd05752 Ig1_FcgammaR_like Frst immunoglobulin (Ig)-like domain of Fcgamma-receptors (FcgammaRs) and similar proteins. Ig1_FcgammaR_like: domain similar to the first immunoglobulin (Ig)-like domain of Fcgamma-receptors (FcgammaRs). Interactions between IgG and FcgammaR are important to the initiation of cellular and humoral response. IgG binding to FcgammaR leads to a cascade of signals and ultimately to functions such as antibody-dependent-cellular-cytotoxicity (ADCC), endocytosis, phagocytosis, release of inflammatory mediators, etc. FcgammaR has two Ig-like domains. This group also contains FcepsilonRI, which binds IgE with high affinity.
Probab=98.99 E-value=9.9e-10 Score=97.49 Aligned_cols=76 Identities=18% Similarity=0.195 Sum_probs=59.8
Q ss_pred CeEEeccCceEEcCCceEEEEEEEecCCC-cEEEEEeCCEecCCCCCeEEeecCCeEEEEEccCCCCCCEEEEEEEEeCC
Q psy2148 1743 PSFLTTISSAVINVGQLARFDAKISATKP-LDVYWLKNGKKIIPDIRYKTLEEDNLFTLLIIEAVVEDSGAYECVAMNNA 1821 (1884)
Q Consensus 1743 P~~~~~~~~~~~~~G~~~~l~C~~~g~p~-p~v~W~k~~~~l~~~~~~~~~~~~~~~~L~i~~~~~~d~G~Y~C~a~N~~ 1821 (1884)
|.+...|....+.+|++++|+|.+.+.|. +.+.|+|||..+.. .+ ..|.|.++ .+|+|.|+|.|.|.
T Consensus 1 ~vv~~~P~~~~v~~G~~V~L~C~~~~~p~~~~~~W~kng~~l~~--------~~--~~l~i~~~-~~dsG~Y~C~a~~~- 68 (78)
T cd05752 1 AVVSLDPPWTTIFQGEKVTLTCNGFNSPEQNSTQWYHNGKLLET--------TT--NSYRIRAA-NNDSGEYRCQTQGS- 68 (78)
T ss_pred CeEEeCCCCeEeeCCCCEEEEEeCCCCCCCccEEEEECCEEeec--------cC--CeEEEeec-ccCCEEeEEECCCC-
Confidence 45666678889999999999999999886 46999999998732 11 27999999 99999999999885
Q ss_pred eeEEEEEEEE
Q psy2148 1822 GEARCEAELV 1831 (1884)
Q Consensus 1822 G~~~~~~~l~ 1831 (1884)
..+..++|+
T Consensus 69 -~~S~~v~l~ 77 (78)
T cd05752 69 -SLSDPVHLE 77 (78)
T ss_pred -cCCCCEEEe
Confidence 333444444
No 177
>cd05861 Ig1_PDGFR-alphabeta Frst immunoglobulin (Ig)-like domain of platelet-derived growth factor (PDGF) receptors (R), alpha (CD140a), and beta (CD140b). Ig1_PDGFR-alphabeta: The first immunoglobulin (Ig)-like domain of platelet-derived growth factor (PDGF) receptors (R), alpha (CD140a), and beta (CD140b). PDGF is a potent mitogen for connective tissue cells. PDGF-stimulated processes are mediated by three different PDGFs (PDGF-A,-B, and C). PDGFRalpha binds to all three PDGFs, whereas the PDGFRbeta binds only to PDGF-B. PDGFRs alpha and beta have similar organization: an extracellular component with five Ig-like domains, a transmembrane segment, and a cytoplasmic portion having protein tyrosine kinase activity. In mice, PDGFRalpha and PDGFRbeta are essential for normal development.
Probab=98.98 E-value=3e-09 Score=96.73 Aligned_cols=77 Identities=21% Similarity=0.350 Sum_probs=58.9
Q ss_pred CCeEEEEEEEeeCCCCCcEEEEeeCCEEccCCC----cEEEEeeCCeEEEEEccCCCCCCeEEEEEEEcCCe--eEEEEE
Q psy2148 931 STLAHFECRLTPTNDPSMTVEWFHNGKALSAGS----RIKTINDFGFVILEINDVYLRDSGLYTCKATNKHG--EATTSC 1004 (1884)
Q Consensus 931 G~~v~l~C~v~~~~~P~~~v~W~~~g~~i~~~~----~~~~~~~~~~~~L~I~~~~~~D~G~Y~C~a~N~~G--~~~~~~ 1004 (1884)
|++++|.|.+. +.|.+.+.|++.++.+.... +..+......++|.|.+++.+|+|.|+|.|+|..+ ..+.++
T Consensus 1 Ge~~~l~C~~~--~~~~~~~~W~~~~~~~~~~~~~~~~~~~~~~~~~s~L~I~~~~~~DsG~Y~C~a~n~~~~~~~~~sv 78 (84)
T cd05861 1 GETITVNCIVQ--GNEVVDFSWTYPGKDIGKGIPEVEEVKVPATTLRSTLTFPHATVEDSGTYECAAHESTQDQKAFKKV 78 (84)
T ss_pred CCcEEEEEEEE--CCCccEEEEEECCccCCCCceEEEEEecCCcEEEEEEEECCCCcCCCEEEEEEEEECccCcceeEEE
Confidence 78999999998 67888999999876542211 11222222356899999999999999999999877 677788
Q ss_pred EEEEE
Q psy2148 1005 KLTVK 1009 (1884)
Q Consensus 1005 ~l~V~ 1009 (1884)
.|+|.
T Consensus 79 ~i~V~ 83 (84)
T cd05861 79 NITVH 83 (84)
T ss_pred EEEEe
Confidence 88875
No 178
>cd07701 Ig1_Necl-3 First (N-terminal) immunoglobulin (Ig)-like domain of nectin-like molecule-3 (Necl-3, also known as cell adhesion molecule 2 (CADM2)). Ig1_Necl-3: domain similar to the N-terminal immunoglobulin (Ig)-like domain of nectin-like molecule-3, Necl-3 (also known as cell adhesion molecule 2 (CADM2), SynCAM2, IGSF4D). Nectin-like molecules have similar domain structures to those of nectins. At least five nectin-like molecules have been identified (Necl-1 - Necl-5). They all have an extracellular region containing three Ig-like domains, a transmembrane region, and a cytoplasmic region. The N-terminal Ig-like domain of the extracellular region, belongs to the V-type subfamily of Ig domains, is essential to cell-cell adhesion, and plays a part in the interaction with the envelope glycoprotein D of various viruses. Necl-3 accumulates in central and peripheral nervous system tissue, and has been shown to selectively interact with oligodendrocytes.
Probab=98.98 E-value=3.6e-09 Score=98.60 Aligned_cols=83 Identities=18% Similarity=0.323 Sum_probs=65.7
Q ss_pred cCceEEcCCceEEEEEEEecCCCcEEEEEeC--------CEecCCCCCeEEeec-CCeEEEEEccCCCCCCEEEEEEEEe
Q psy2148 1749 ISSAVINVGQLARFDAKISATKPLDVYWLKN--------GKKIIPDIRYKTLEE-DNLFTLLIIEAVVEDSGAYECVAMN 1819 (1884)
Q Consensus 1749 ~~~~~~~~G~~~~l~C~~~g~p~p~v~W~k~--------~~~l~~~~~~~~~~~-~~~~~L~i~~~~~~d~G~Y~C~a~N 1819 (1884)
+++..+.+|++++|.|.+.+.|.|.|.|++. +.....+.|+..... ....+|+|.+++.+|+|.|+|.+.+
T Consensus 4 ~~~v~v~eG~~v~L~C~~~~~p~~~v~W~~~~~~~l~~~~~~~~~~~r~~~~~~~~~~~sL~I~~v~~~DsG~Y~C~~~t 83 (95)
T cd07701 4 TQNVTVVEGGTANLTCRVDQNDNTSLQWSNPAQQTLYFDDKKALRDNRIELVRASWHELSISISDVSLSDEGQYTCSLFT 83 (95)
T ss_pred cceEEEecCCcEEEEEEEecCCceEEEEeCCCCeEEEEcCcccccCCCEEEEECCCCcEEEEECcCCcccCEEEEEEeEe
Confidence 4678899999999999999999999999863 333334567765433 4557999999999999999999998
Q ss_pred CCeeEEEEEEEEE
Q psy2148 1820 NAGEARCEAELVV 1832 (1884)
Q Consensus 1820 ~~G~~~~~~~l~V 1832 (1884)
.. ....++.|+|
T Consensus 84 ~~-~~~~~~~l~v 95 (95)
T cd07701 84 MP-VKTSKAYLTV 95 (95)
T ss_pred ec-CccEEEEEEC
Confidence 54 4477778775
No 179
>cd07701 Ig1_Necl-3 First (N-terminal) immunoglobulin (Ig)-like domain of nectin-like molecule-3 (Necl-3, also known as cell adhesion molecule 2 (CADM2)). Ig1_Necl-3: domain similar to the N-terminal immunoglobulin (Ig)-like domain of nectin-like molecule-3, Necl-3 (also known as cell adhesion molecule 2 (CADM2), SynCAM2, IGSF4D). Nectin-like molecules have similar domain structures to those of nectins. At least five nectin-like molecules have been identified (Necl-1 - Necl-5). They all have an extracellular region containing three Ig-like domains, a transmembrane region, and a cytoplasmic region. The N-terminal Ig-like domain of the extracellular region, belongs to the V-type subfamily of Ig domains, is essential to cell-cell adhesion, and plays a part in the interaction with the envelope glycoprotein D of various viruses. Necl-3 accumulates in central and peripheral nervous system tissue, and has been shown to selectively interact with oligodendrocytes.
Probab=98.97 E-value=3.1e-09 Score=98.96 Aligned_cols=83 Identities=27% Similarity=0.466 Sum_probs=64.3
Q ss_pred CCceeecCCCeEEEEEEEeeCCCCCcEEEEeeC--------CEEccCCCcEEEEee-CCeEEEEEccCCCCCCeEEEEEE
Q psy2148 923 PTDLTLAESTLAHFECRLTPTNDPSMTVEWFHN--------GKALSAGSRIKTIND-FGFVILEINDVYLRDSGLYTCKA 993 (1884)
Q Consensus 923 ~~~~~v~~G~~v~l~C~v~~~~~P~~~v~W~~~--------g~~i~~~~~~~~~~~-~~~~~L~I~~~~~~D~G~Y~C~a 993 (1884)
++++++.+|+++.|+|.++ +.|.+.|.|++. +.....+.|+..... .+..+|.|.+++.+|+|.|+|.+
T Consensus 4 ~~~v~v~eG~~v~L~C~~~--~~p~~~v~W~~~~~~~l~~~~~~~~~~~r~~~~~~~~~~~sL~I~~v~~~DsG~Y~C~~ 81 (95)
T cd07701 4 TQNVTVVEGGTANLTCRVD--QNDNTSLQWSNPAQQTLYFDDKKALRDNRIELVRASWHELSISISDVSLSDEGQYTCSL 81 (95)
T ss_pred cceEEEecCCcEEEEEEEe--cCCceEEEEeCCCCeEEEEcCcccccCCCEEEEECCCCcEEEEECcCCcccCEEEEEEe
Confidence 4678999999999999998 678889999863 333334567765333 35568999999999999999999
Q ss_pred EcCCeeEEEEEEEEE
Q psy2148 994 TNKHGEATTSCKLTV 1008 (1884)
Q Consensus 994 ~N~~G~~~~~~~l~V 1008 (1884)
.+..+ .+..+.|+|
T Consensus 82 ~t~~~-~~~~~~l~v 95 (95)
T cd07701 82 FTMPV-KTSKAYLTV 95 (95)
T ss_pred EeecC-ccEEEEEEC
Confidence 98543 477777765
No 180
>cd05729 Ig2_FGFR_like Second immunoglobulin (Ig)-like domain of fibroblast growth factor (FGF) receptor and similar proteins. Ig2_FGFR_like: domain similar to the second immunoglobulin (Ig)-like domain of fibroblast growth factor (FGF) receptor. FGF receptors bind FGF signaling polypeptides. FGFs participate in multiple processes such as morphogenesis, development, and angiogenesis. FGFs bind to four FGF receptor tyrosine kinases (FGFR1, -2, -3, -4). Receptor diversity is controlled by alternative splicing producing splice variants with different ligand binding characteristics and different expression patterns. FGFRs have an extracellular region comprised of three Ig-like domains, a single transmembrane helix, and an intracellular tyrosine kinase domain. Ligand binding and specificity reside in the Ig-like domains 2 and 3, and the linker region that connects these two. FGFR activation and signaling depend on FGF-induced dimerization, a process involving cell surface heparin or heparin
Probab=98.96 E-value=6e-09 Score=96.51 Aligned_cols=81 Identities=26% Similarity=0.459 Sum_probs=66.9
Q ss_pred eeecCCCeEEEEEEEeeCCCCCcEEEEeeCCEEccCCCcEEEEe-eCCeEEEEEccCCCCCCeEEEEEEEcCCeeEEEEE
Q psy2148 926 LTLAESTLAHFECRLTPTNDPSMTVEWFHNGKALSAGSRIKTIN-DFGFVILEINDVYLRDSGLYTCKATNKHGEATTSC 1004 (1884)
Q Consensus 926 ~~v~~G~~v~l~C~v~~~~~P~~~v~W~~~g~~i~~~~~~~~~~-~~~~~~L~I~~~~~~D~G~Y~C~a~N~~G~~~~~~ 1004 (1884)
+.+..|+.+.|.|.+. +.|.+.+.|+|++..+.......... ....+.|.|.++..+|+|.|.|.|.|..|..+.++
T Consensus 4 ~~~~~G~~~~l~C~~~--~~p~~~v~W~k~~~~~~~~~~~~~~~~~~~~~~l~i~~~~~~d~g~Y~C~~~n~~g~~~~~~ 81 (85)
T cd05729 4 HAVPAGSTVRLKCPAS--GNPRPTITWLKDGKPFKKEHRIGGYKVRKKKWTLILESVVPSDSGKYTCIVENKYGSINHTY 81 (85)
T ss_pred eEecCCCcEEEEEEcC--CCCCCeEEEEECCEECcccCceeEEEccCcEEEEEEeECCcccCEEEEEEEEECCceEEEEE
Confidence 4677899999999998 67888999999999987665443322 23345799999999999999999999999988888
Q ss_pred EEEE
Q psy2148 1005 KLTV 1008 (1884)
Q Consensus 1005 ~l~V 1008 (1884)
.|.|
T Consensus 82 ~l~v 85 (85)
T cd05729 82 KVDV 85 (85)
T ss_pred EEeC
Confidence 8764
No 181
>cd05754 Ig3_Perlecan_like Third immunoglobulin (Ig)-like domain found in Perlecan and similar proteins. Ig3_Perlecan_like: domain similar to the third immunoglobulin (Ig)-like domain found in Perlecan. Perlecan is a large multi-domain heparin sulfate proteoglycan, important in tissue development and organogenesis. Perlecan can be represented as 5 major portions; its fourth major portion (domain IV) is a tandem repeat of immunoglobulin-like domains (Ig2-Ig15), which can vary in size due to alternative splicing. Perlecan binds many cellular and extracellular ligands. Its domain IV region has many binding sites. Some of these have been mapped at the level of individual Ig-like domains, including a site restricted to the Ig5 domain for heparin/sulfatide, a site restricted to the Ig3 domain for nidogen-1 and nidogen-2, a site restricted to Ig4-5 for fibronectin, and sites restricted to Ig2 and to Ig13-15 for fibulin-2.
Probab=98.96 E-value=3.3e-09 Score=97.53 Aligned_cols=80 Identities=25% Similarity=0.469 Sum_probs=65.3
Q ss_pred eecCCceeecCCCeEEEEEEEeeCCCCCcEEEEeeCCEEccCCCcEEEEeeCCeEEEEEccCCCCCCeEEEEEEEcCCee
Q psy2148 920 LTTPTDLTLAESTLAHFECRLTPTNDPSMTVEWFHNGKALSAGSRIKTINDFGFVILEINDVYLRDSGLYTCKATNKHGE 999 (1884)
Q Consensus 920 ~~~~~~~~v~~G~~v~l~C~v~~~~~P~~~v~W~~~g~~i~~~~~~~~~~~~~~~~L~I~~~~~~D~G~Y~C~a~N~~G~ 999 (1884)
+..++...+.+|++++|.|.+.+ +.|.+.+.|++++..+.... ...+ ..|.|.+++.+|+|.|+|.|.|..|.
T Consensus 5 ~~~p~~~~v~~G~~v~L~C~~~~-~~~~~~i~W~~~~~~~~~~~----~~~~--~~L~I~~v~~~DsG~Y~C~a~n~~g~ 77 (85)
T cd05754 5 VEEPRSQEVRPGADVSFICRAKS-KSPAYTLVWTRVGGGLPSRA----MDFN--GILTIRNVQLSDAGTYVCTGSNMLDT 77 (85)
T ss_pred ecCCCceEEcCCCCEEEEEEcCC-CCCCcEEEEEECCCcCCCcc----cccC--CEEEECCCCHHHCEEEEEEEeccCCe
Confidence 35567789999999999999973 46888999999997764321 1112 26999999999999999999999999
Q ss_pred EEEEEEE
Q psy2148 1000 ATTSCKL 1006 (1884)
Q Consensus 1000 ~~~~~~l 1006 (1884)
.++++.|
T Consensus 78 ~~~~~~l 84 (85)
T cd05754 78 DEATATL 84 (85)
T ss_pred EeEEEEE
Confidence 9988876
No 182
>cd05729 Ig2_FGFR_like Second immunoglobulin (Ig)-like domain of fibroblast growth factor (FGF) receptor and similar proteins. Ig2_FGFR_like: domain similar to the second immunoglobulin (Ig)-like domain of fibroblast growth factor (FGF) receptor. FGF receptors bind FGF signaling polypeptides. FGFs participate in multiple processes such as morphogenesis, development, and angiogenesis. FGFs bind to four FGF receptor tyrosine kinases (FGFR1, -2, -3, -4). Receptor diversity is controlled by alternative splicing producing splice variants with different ligand binding characteristics and different expression patterns. FGFRs have an extracellular region comprised of three Ig-like domains, a single transmembrane helix, and an intracellular tyrosine kinase domain. Ligand binding and specificity reside in the Ig-like domains 2 and 3, and the linker region that connects these two. FGFR activation and signaling depend on FGF-induced dimerization, a process involving cell surface heparin or heparin
Probab=98.95 E-value=7.2e-09 Score=95.97 Aligned_cols=81 Identities=25% Similarity=0.423 Sum_probs=67.8
Q ss_pred eEEcCCceEEEEEEEecCCCcEEEEEeCCEecCCCCCeEEe-ecCCeEEEEEccCCCCCCEEEEEEEEeCCeeEEEEEEE
Q psy2148 1752 AVINVGQLARFDAKISATKPLDVYWLKNGKKIIPDIRYKTL-EEDNLFTLLIIEAVVEDSGAYECVAMNNAGEARCEAEL 1830 (1884)
Q Consensus 1752 ~~~~~G~~~~l~C~~~g~p~p~v~W~k~~~~l~~~~~~~~~-~~~~~~~L~i~~~~~~d~G~Y~C~a~N~~G~~~~~~~l 1830 (1884)
..+..|+.++|.|.+.+.|.|.+.|+|++..+......... .......|.|.++..+|.|.|+|.|.|..|..+.++.|
T Consensus 4 ~~~~~G~~~~l~C~~~~~p~~~v~W~k~~~~~~~~~~~~~~~~~~~~~~l~i~~~~~~d~g~Y~C~~~n~~g~~~~~~~l 83 (85)
T cd05729 4 HAVPAGSTVRLKCPASGNPRPTITWLKDGKPFKKEHRIGGYKVRKKKWTLILESVVPSDSGKYTCIVENKYGSINHTYKV 83 (85)
T ss_pred eEecCCCcEEEEEEcCCCCCCeEEEEECCEECcccCceeEEEccCcEEEEEEeECCcccCEEEEEEEEECCceEEEEEEE
Confidence 45668999999999999999999999999988755444322 23345689999999999999999999999999988888
Q ss_pred EE
Q psy2148 1831 VV 1832 (1884)
Q Consensus 1831 ~V 1832 (1884)
.|
T Consensus 84 ~v 85 (85)
T cd05729 84 DV 85 (85)
T ss_pred eC
Confidence 75
No 183
>cd05875 Ig6_hNeurofascin_like Sixth immunoglobulin (Ig)-like domain of human neurofascin (NF). Ig6_hNeurofascin_like: the sixth immunoglobulin (Ig)-like domain of human neurofascin (NF). NF belongs to the L1 subfamily of cell adhesion molecules (CAMs) and is comprised of an extracellular region having six Ig-like domains and five fibronectin type III domains, a transmembrane region, and a cytoplasmic domain. NF has many alternatively spliced isoforms having different temporal expression patterns during development. NF participates in axon subcellular targeting and synapse formation, however little is known of the functions of the different isoforms.
Probab=98.95 E-value=3.5e-09 Score=94.26 Aligned_cols=68 Identities=22% Similarity=0.326 Sum_probs=52.4
Q ss_pred EEEEEEEeccCCCeEEEEeCCeecCCCCCeEEEEeCceeEEEEcccc----cCCCeEEEEEEEeCCceEEEE
Q psy2148 1657 ARFEVEFDGDPLPTIKWFREDFPITSSPDFQIHTFSTKSILIMRQVF----MEDSGVFAVIAENRGGKAKCS 1724 (1884)
Q Consensus 1657 ~~l~C~~~g~p~~~i~W~~~~~~~~~~~~~~~~~~~~~~~L~i~~v~----~~DsG~Y~C~a~n~~g~~~~~ 1724 (1884)
+.|.|.+.|.|.|.|+|+|+|..+.......+......++|.|.++. .+|+|.|.|.|.|..|.....
T Consensus 1 ~~l~C~~~G~P~P~v~W~k~g~~~~~~~~~~~~~~~~~~~L~i~~~~~~~~~~d~G~Y~C~A~N~~G~~~s~ 72 (77)
T cd05875 1 IIIECEAKGNPVPTFQWTRNGKFFNVAKDPRVSMRRRSGTLVIDFSGGGRPEDYEGEYQCFARNNLGTALSN 72 (77)
T ss_pred CEEEEeccccCCCEEEEEECCEEccCcCCCcEEEeCCCceEEEeccCCCCCCCCCEEEEEEEEeccceEEEE
Confidence 47999999999999999999997643333333344456789998864 247999999999999976543
No 184
>cd05873 Ig_Sema4D_like Immunoglobulin (Ig)-like domain of the class IV semaphorin Sema4D. Ig_Sema4D_like; Immunoglobulin (Ig)-like domain of Sema4D. Sema4D is a Class IV semaphorin. Semaphorins are classified based on structural features additional to the Sema domain. Sema4D has extracellular Sema and Ig domains, a transmembrane domain, and a short cytoplasmic domain. Sema4D plays a part in the development of GABAergic synapses. Sema4D in addition is an immune semaphorin. It is abundant on resting T cells; its expression is weak on resting B cells and antigen presenting cells (APCs), but is upregulated by various stimuli. The receptor used by Sema4D in the immune system is CD72. Sem4D enhances the activation of B cells and DCs through binding CD72, perhaps by reducing CD72s inhibitory signals. The receptor used by Sema4D in the non-lymphatic tissues is plexin-B1. Sem4D is anchored to the cell surface but its extracellular domain can be released from the cell surface by a metalloproteas
Probab=98.94 E-value=6.7e-09 Score=93.27 Aligned_cols=68 Identities=25% Similarity=0.497 Sum_probs=57.7
Q ss_pred cCceEEcCCceEEEEEEEecCCCcEEEEEeCCEecCCC-CCeEEeecCCeEEEEEccCCCCCCEEEEEEEEeCC
Q psy2148 1749 ISSAVINVGQLARFDAKISATKPLDVYWLKNGKKIIPD-IRYKTLEEDNLFTLLIIEAVVEDSGAYECVAMNNA 1821 (1884)
Q Consensus 1749 ~~~~~~~~G~~~~l~C~~~g~p~p~v~W~k~~~~l~~~-~~~~~~~~~~~~~L~i~~~~~~d~G~Y~C~a~N~~ 1821 (1884)
|.+..+..|+++.|.|.+.+ |.|.|.|+|||.+|..+ .++.+ .++ .|.|.+++.+|+|.|+|.|.+..
T Consensus 3 P~~~~v~~G~~v~L~C~~~~-~~~~i~W~~ng~~i~~~~~r~~~-~~~---~L~I~nv~~~DsG~Y~C~a~e~~ 71 (87)
T cd05873 3 PRQRTFKLGNNAELKCSPKS-NLARVVWKFDGKVLTPESAKYLL-YRD---GLLIFNASEADAGRYQCLSVEKS 71 (87)
T ss_pred cceEEEECCCCEEEEEECCC-CCCeEEEEECCEECCCCCceEEE-ECC---cEEEeCCCHHHCEEEEEEEEecc
Confidence 56788899999999999864 67899999999999876 45554 333 69999999999999999999874
No 185
>cd05882 Ig1_Necl-1 First (N-terminal) immunoglobulin (Ig)-like domain of nectin-like molcule-1 (Necl-1, also known as cell adhesion molecule3 (CADM3)). Ig1_Necl-1: domain similar to the N-terminal immunoglobulin (Ig)-like domain of nectin-like molecule-1, Necl-1 (also known as celll adhesion molecule 3 (CADM3), SynCAM2, IGSF4). Nectin-like molecules have similar domain structures to those of nectins. At least five nectin-like molecules have been identified (Necl-1 - Necl-5). They all have an extracellular region containing three Ig-like domains, a transmembrane region, and a cytoplasmic region. The N-terminal Ig-like domain of the extracellular region belongs to the V-type subfamily of Ig domains, is essential to cell-cell adhesion, and plays a part in the interaction with the envelope glycoprotein D of various viruses. Necl-1 has Ca(2+)-independent homophilic and heterophilic cell-cell adhesion activity. Necl-1 is specifically expressed in neural tissue, and is important to the format
Probab=98.94 E-value=7.4e-09 Score=95.84 Aligned_cols=82 Identities=23% Similarity=0.396 Sum_probs=62.5
Q ss_pred CceeecCCCeEEEEEEEeeCCCCCcEEEEeeCCEEc--------cCCCcEEEEee-CCeEEEEEccCCCCCCeEEEEEEE
Q psy2148 924 TDLTLAESTLAHFECRLTPTNDPSMTVEWFHNGKAL--------SAGSRIKTIND-FGFVILEINDVYLRDSGLYTCKAT 994 (1884)
Q Consensus 924 ~~~~v~~G~~v~l~C~v~~~~~P~~~v~W~~~g~~i--------~~~~~~~~~~~-~~~~~L~I~~~~~~D~G~Y~C~a~ 994 (1884)
+++++.+|+++.|.|.+. +.|.+.|.|+|++..+ ..+.|+.+... .+...|.|.+++.+|+|.|+|.|.
T Consensus 5 ~~~tv~~G~tv~L~C~v~--g~~~~~v~W~k~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~L~I~nV~~~D~G~YtC~~~ 82 (95)
T cd05882 5 QDETVAVGGTVTLKCGVK--EHDNSSLQWSNTAQQTLYFGEKRALRDNRIQLVKSTPTELIISISNVQLSDEGEYTCSIF 82 (95)
T ss_pred ccEEEecCCcEEEEEEEe--CCCCCeEEEeccCccEEEeCCeEEEeCCeEEEEeCCCceEEEEECCCCcccCEEEEEEEE
Confidence 678999999999999998 6788899999977643 23455554333 245689999999999999999998
Q ss_pred cCCeeEEEEEEEEE
Q psy2148 995 NKHGEATTSCKLTV 1008 (1884)
Q Consensus 995 N~~G~~~~~~~l~V 1008 (1884)
. .-..++.+.|+|
T Consensus 83 t-~~~~~~~~~~~v 95 (95)
T cd05882 83 T-MPVRTAKATVTV 95 (95)
T ss_pred e-eccccEEEEEEC
Confidence 7 234455555554
No 186
>cd05734 Ig7_DSCAM Seventh immunoglobulin (Ig)-like domain of Down Syndrome Cell Adhesion molecule (DSCAM). Ig7_DSCAM: the seventh immunoglobulin (Ig)-like domain of Down Syndrome Cell Adhesion molecule (DSCAM). DSCAM is a cell adhesion molecule expressed largely in the developing nervous system. The gene encoding DSCAM is located at human chromosome 21q22, the locus associated with the mental retardation phenotype of Down Syndrome. DSCAM is predicted to be the largest member of the IG superfamily. It has been demonstrated that DSCAM can mediate cation-independent homophilic intercellular adhesion.
Probab=98.92 E-value=3.1e-09 Score=96.03 Aligned_cols=70 Identities=31% Similarity=0.490 Sum_probs=52.9
Q ss_pred EEEEEEEeeCCCCCcEEEEeeCCEEcc--------CCCcEEEEeeCCeEEEEEccCCCCCCeEEEEEEEcCCeeE-EEEE
Q psy2148 934 AHFECRLTPTNDPSMTVEWFHNGKALS--------AGSRIKTINDFGFVILEINDVYLRDSGLYTCKATNKHGEA-TTSC 1004 (1884)
Q Consensus 934 v~l~C~v~~~~~P~~~v~W~~~g~~i~--------~~~~~~~~~~~~~~~L~I~~~~~~D~G~Y~C~a~N~~G~~-~~~~ 1004 (1884)
|+|.|.+. |.|.|.|+|+|++.... ...++..... .+|.|.++..+|+|.|+|.|.|..|.+ +..+
T Consensus 1 v~l~C~~~--G~P~P~v~W~~~~~~~~~~~~~~~~~~~r~~~~~~---~~L~I~~v~~~D~G~Y~C~a~N~~G~~~s~~~ 75 (79)
T cd05734 1 VTLNCSAE--GYPPPTIVWKHSKGRGHPQHTHTCCLAGRIQLLSN---GSLLIKHVLEEDSGYYLCKVSNDVGADASKSM 75 (79)
T ss_pred CEeEeeCe--EeCCCEEEEEECCCccccccccccccCCCEEEecC---CeEEECcCCcccCEEEEEEEEeCCCCCCceEE
Confidence 57999998 77889999999643221 2345544332 269999999999999999999999976 5566
Q ss_pred EEEE
Q psy2148 1005 KLTV 1008 (1884)
Q Consensus 1005 ~l~V 1008 (1884)
.|+|
T Consensus 76 ~l~~ 79 (79)
T cd05734 76 VLTV 79 (79)
T ss_pred EEeC
Confidence 6654
No 187
>cd05757 Ig2_IL1R_like Second immunoglobulin (Ig)-like domain of interleukin-1 receptor (IL1R) and similar proteins. Ig2_IL1R_like: domain similar to the second immunoglobulin (Ig)-like domain of interleukin-1 receptor (IL1R). IL-1 alpha and IL-1 beta are cytokines which participate in the regulation of inflammation, immune responses, and hematopoiesis. These cytokines bind to the IL-1 receptor type 1 (IL1R1), which is activated on additional association with an accessory protein, IL1RAP. IL-1 also binds a second receptor designated type II (IL1R2). Mature IL1R1 consists of three IG-like domains, a transmembrane domain, and a large cytoplasmic domain. Mature IL1R2 is organized similarly except that it has a short cytoplasmic domain. The latter does not initiate signal transduction. A naturally occurring cytokine IL-1RA (IL-1 receptor antagonist) is widely expressed and binds to IL-1 receptors, inhibiting the binding of IL-1 alpha and IL-1 beta. This group also contains ILIR-like 1 (IL1
Probab=98.91 E-value=4.1e-09 Score=96.86 Aligned_cols=80 Identities=23% Similarity=0.290 Sum_probs=62.9
Q ss_pred eeecCCCeEEEEEEEeeC---CCCCcEEEEeeCCEEccCCCcEEEEeeCCeEEEEEccCCCCCCeEEEEEEEcCCeeEEE
Q psy2148 926 LTLAESTLAHFECRLTPT---NDPSMTVEWFHNGKALSAGSRIKTINDFGFVILEINDVYLRDSGLYTCKATNKHGEATT 1002 (1884)
Q Consensus 926 ~~v~~G~~v~l~C~v~~~---~~P~~~v~W~~~g~~i~~~~~~~~~~~~~~~~L~I~~~~~~D~G~Y~C~a~N~~G~~~~ 1002 (1884)
+.+.+|+++.|.|...+. ..|.|.|.|||||++|....+... .+ ..|.|.++..+|+|.|+|.|.|.+|....
T Consensus 5 ~~~~~g~~~~l~Cp~~~~~~~~~~~p~i~Wyk~~~~i~~~~~~~~--~~--~~L~I~~v~~~DsG~YtC~~~n~~~~~~~ 80 (92)
T cd05757 5 QILFSTKGGKIVCPDLDDFKNENTLPPVQWYKDCKLLEGDRKRFV--KG--SKLLIQNVTEEDAGNYTCKLTFTHNGKQY 80 (92)
T ss_pred EEEeeccCCEEECCChHHccCCCCCCcEEEeECCEECCCCccEEe--cC--CEEEEeeCChhhCEEEEEEEEecCCCEEE
Confidence 567889999999987531 126789999999999986654332 22 37999999999999999999999988776
Q ss_pred EEEEEEE
Q psy2148 1003 SCKLTVK 1009 (1884)
Q Consensus 1003 ~~~l~V~ 1009 (1884)
.+..++.
T Consensus 81 ~~t~t~~ 87 (92)
T cd05757 81 NVTRTIS 87 (92)
T ss_pred EEEEEEE
Confidence 6655554
No 188
>cd05882 Ig1_Necl-1 First (N-terminal) immunoglobulin (Ig)-like domain of nectin-like molcule-1 (Necl-1, also known as cell adhesion molecule3 (CADM3)). Ig1_Necl-1: domain similar to the N-terminal immunoglobulin (Ig)-like domain of nectin-like molecule-1, Necl-1 (also known as celll adhesion molecule 3 (CADM3), SynCAM2, IGSF4). Nectin-like molecules have similar domain structures to those of nectins. At least five nectin-like molecules have been identified (Necl-1 - Necl-5). They all have an extracellular region containing three Ig-like domains, a transmembrane region, and a cytoplasmic region. The N-terminal Ig-like domain of the extracellular region belongs to the V-type subfamily of Ig domains, is essential to cell-cell adhesion, and plays a part in the interaction with the envelope glycoprotein D of various viruses. Necl-1 has Ca(2+)-independent homophilic and heterophilic cell-cell adhesion activity. Necl-1 is specifically expressed in neural tissue, and is important to the format
Probab=98.91 E-value=1.2e-08 Score=94.42 Aligned_cols=82 Identities=15% Similarity=0.325 Sum_probs=63.7
Q ss_pred CceEEcCCceEEEEEEEecCCCcEEEEEeCCEec--------CCCCCeEEeec-CCeEEEEEccCCCCCCEEEEEEEEeC
Q psy2148 1750 SSAVINVGQLARFDAKISATKPLDVYWLKNGKKI--------IPDIRYKTLEE-DNLFTLLIIEAVVEDSGAYECVAMNN 1820 (1884)
Q Consensus 1750 ~~~~~~~G~~~~l~C~~~g~p~p~v~W~k~~~~l--------~~~~~~~~~~~-~~~~~L~i~~~~~~d~G~Y~C~a~N~ 1820 (1884)
.+..+.+|+++.|.|.+.|.|.|.|.|+|++..+ ..+.|+.+... .....|.|.++..+|+|.|+|.|..
T Consensus 5 ~~~tv~~G~tv~L~C~v~g~~~~~v~W~k~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~L~I~nV~~~D~G~YtC~~~t- 83 (95)
T cd05882 5 QDETVAVGGTVTLKCGVKEHDNSSLQWSNTAQQTLYFGEKRALRDNRIQLVKSTPTELIISISNVQLSDEGEYTCSIFT- 83 (95)
T ss_pred ccEEEecCCcEEEEEEEeCCCCCeEEEeccCccEEEeCCeEEEeCCeEEEEeCCCceEEEEECCCCcccCEEEEEEEEe-
Confidence 5788999999999999999999999999887643 23355554332 3467999999999999999999987
Q ss_pred CeeEEEEEEEEE
Q psy2148 1821 AGEARCEAELVV 1832 (1884)
Q Consensus 1821 ~G~~~~~~~l~V 1832 (1884)
.-..++.++|+|
T Consensus 84 ~~~~~~~~~~~v 95 (95)
T cd05882 84 MPVRTAKATVTV 95 (95)
T ss_pred eccccEEEEEEC
Confidence 334555566654
No 189
>cd05754 Ig3_Perlecan_like Third immunoglobulin (Ig)-like domain found in Perlecan and similar proteins. Ig3_Perlecan_like: domain similar to the third immunoglobulin (Ig)-like domain found in Perlecan. Perlecan is a large multi-domain heparin sulfate proteoglycan, important in tissue development and organogenesis. Perlecan can be represented as 5 major portions; its fourth major portion (domain IV) is a tandem repeat of immunoglobulin-like domains (Ig2-Ig15), which can vary in size due to alternative splicing. Perlecan binds many cellular and extracellular ligands. Its domain IV region has many binding sites. Some of these have been mapped at the level of individual Ig-like domains, including a site restricted to the Ig5 domain for heparin/sulfatide, a site restricted to the Ig3 domain for nidogen-1 and nidogen-2, a site restricted to Ig4-5 for fibronectin, and sites restricted to Ig2 and to Ig13-15 for fibulin-2.
Probab=98.90 E-value=6.3e-09 Score=95.67 Aligned_cols=77 Identities=18% Similarity=0.294 Sum_probs=63.8
Q ss_pred ccCceEEcCCceEEEEEEEec-CCCcEEEEEeCCEecCCCCCeEEeecCCeEEEEEccCCCCCCEEEEEEEEeCCeeEEE
Q psy2148 1748 TISSAVINVGQLARFDAKISA-TKPLDVYWLKNGKKIIPDIRYKTLEEDNLFTLLIIEAVVEDSGAYECVAMNNAGEARC 1826 (1884)
Q Consensus 1748 ~~~~~~~~~G~~~~l~C~~~g-~p~p~v~W~k~~~~l~~~~~~~~~~~~~~~~L~i~~~~~~d~G~Y~C~a~N~~G~~~~ 1826 (1884)
.|....+.+|++++|.|.+.+ .|.+.|.|++++..+.... ...+ ..|.|.++..+|+|.|+|.|.|..|...+
T Consensus 7 ~p~~~~v~~G~~v~L~C~~~~~~~~~~i~W~~~~~~~~~~~----~~~~--~~L~I~~v~~~DsG~Y~C~a~n~~g~~~~ 80 (85)
T cd05754 7 EPRSQEVRPGADVSFICRAKSKSPAYTLVWTRVGGGLPSRA----MDFN--GILTIRNVQLSDAGTYVCTGSNMLDTDEA 80 (85)
T ss_pred CCCceEEcCCCCEEEEEEcCCCCCCcEEEEEECCCcCCCcc----cccC--CEEEECCCCHHHCEEEEEEEeccCCeEeE
Confidence 456778899999999999975 7889999999997754321 1112 28999999999999999999999999999
Q ss_pred EEEE
Q psy2148 1827 EAEL 1830 (1884)
Q Consensus 1827 ~~~l 1830 (1884)
++.|
T Consensus 81 ~~~l 84 (85)
T cd05754 81 TATL 84 (85)
T ss_pred EEEE
Confidence 8876
No 190
>cd05757 Ig2_IL1R_like Second immunoglobulin (Ig)-like domain of interleukin-1 receptor (IL1R) and similar proteins. Ig2_IL1R_like: domain similar to the second immunoglobulin (Ig)-like domain of interleukin-1 receptor (IL1R). IL-1 alpha and IL-1 beta are cytokines which participate in the regulation of inflammation, immune responses, and hematopoiesis. These cytokines bind to the IL-1 receptor type 1 (IL1R1), which is activated on additional association with an accessory protein, IL1RAP. IL-1 also binds a second receptor designated type II (IL1R2). Mature IL1R1 consists of three IG-like domains, a transmembrane domain, and a large cytoplasmic domain. Mature IL1R2 is organized similarly except that it has a short cytoplasmic domain. The latter does not initiate signal transduction. A naturally occurring cytokine IL-1RA (IL-1 receptor antagonist) is widely expressed and binds to IL-1 receptors, inhibiting the binding of IL-1 alpha and IL-1 beta. This group also contains ILIR-like 1 (IL1
Probab=98.86 E-value=9.9e-09 Score=94.33 Aligned_cols=79 Identities=16% Similarity=0.199 Sum_probs=62.9
Q ss_pred ceEEcCCceEEEEEEEec-----CCCcEEEEEeCCEecCCCCCeEEeecCCeEEEEEccCCCCCCEEEEEEEEeCCeeEE
Q psy2148 1751 SAVINVGQLARFDAKISA-----TKPLDVYWLKNGKKIIPDIRYKTLEEDNLFTLLIIEAVVEDSGAYECVAMNNAGEAR 1825 (1884)
Q Consensus 1751 ~~~~~~G~~~~l~C~~~g-----~p~p~v~W~k~~~~l~~~~~~~~~~~~~~~~L~i~~~~~~d~G~Y~C~a~N~~G~~~ 1825 (1884)
.+.+.+|.++.|.|...+ +|.|.+.|+||++++....+.. . .+ ..|.|.++..+|+|.|+|.|.|..|...
T Consensus 4 ~~~~~~g~~~~l~Cp~~~~~~~~~~~p~i~Wyk~~~~i~~~~~~~-~-~~--~~L~I~~v~~~DsG~YtC~~~n~~~~~~ 79 (92)
T cd05757 4 KQILFSTKGGKIVCPDLDDFKNENTLPPVQWYKDCKLLEGDRKRF-V-KG--SKLLIQNVTEEDAGNYTCKLTFTHNGKQ 79 (92)
T ss_pred eEEEeeccCCEEECCChHHccCCCCCCcEEEeECCEECCCCccEE-e-cC--CEEEEeeCChhhCEEEEEEEEecCCCEE
Confidence 356778999999999765 2578999999999997655433 2 22 3899999999999999999999998777
Q ss_pred EEEEEEEE
Q psy2148 1826 CEAELVVQ 1833 (1884)
Q Consensus 1826 ~~~~l~V~ 1833 (1884)
..+.+++.
T Consensus 80 ~~~t~t~~ 87 (92)
T cd05757 80 YNVTRTIS 87 (92)
T ss_pred EEEEEEEE
Confidence 66655554
No 191
>cd04979 Ig_Semaphorin_C Immunoglobulin (Ig)-like domain of semaphorin. Ig_Semaphorin_C; Immunoglobulin (Ig)-like domain in semaphorins. Semaphorins are transmembrane protein that have important roles in a variety of tissues. Functionally, semaphorins were initially characterized for their importance in the development of the nervous system and in axonal guidance. Later they have been found to be important for the formation and functioning of the cardiovascular, endocrine, gastrointestinal, hepatic, immune, musculoskeletal, renal, reproductive, and respiratory systems. Semaphorins function through binding to their receptors and transmembrane semaphorins also serves as receptors themselves. Although molecular mechanism of semaphorins is poorly understood, the Ig-like domains may involve in ligand binding or dimerization.
Probab=98.84 E-value=1.4e-08 Score=94.29 Aligned_cols=80 Identities=24% Similarity=0.388 Sum_probs=62.8
Q ss_pred CCceeecCCCeEEEEEEEeeCCCCCcEEEEeeCCEEccCCC----cEEEEeeCCeEEEEEccCCCCCCeEEEEEEEcCC-
Q psy2148 923 PTDLTLAESTLAHFECRLTPTNDPSMTVEWFHNGKALSAGS----RIKTINDFGFVILEINDVYLRDSGLYTCKATNKH- 997 (1884)
Q Consensus 923 ~~~~~v~~G~~v~l~C~v~~~~~P~~~v~W~~~g~~i~~~~----~~~~~~~~~~~~L~I~~~~~~D~G~Y~C~a~N~~- 997 (1884)
++.+.+.+|+++.|+|.+. + |.+.+.|+|++..+.... ++.... + .|.|.+++.+|+|.|+|.|.|..
T Consensus 3 ~~~~~v~~g~~v~L~C~~~--~-p~~~i~W~k~~~~~~~~~~~~~~~~~~~-~---~L~I~~~~~~D~G~Y~C~a~~~~~ 75 (89)
T cd04979 3 EKVVTVVEGNSVFLECSPK--S-NLASVVWLFQGGPLQRKEEPEERLLVTE-D---GLLIRSVSPADAGVYTCQSVEHGF 75 (89)
T ss_pred ceEEEEECCCcEEEEEeCC--C-CCceEEEEECCcccccccCcCceEEEcC-C---CEEEccCCHHHCEEEEEEEecCcc
Confidence 4567889999999999986 4 778999999998886642 333322 2 49999999999999999999764
Q ss_pred eeEEEEEEEEEE
Q psy2148 998 GEATTSCKLTVK 1009 (1884)
Q Consensus 998 G~~~~~~~l~V~ 1009 (1884)
+....+..|.|.
T Consensus 76 ~~~~~~~~l~V~ 87 (89)
T cd04979 76 KQTLATYSLNVL 87 (89)
T ss_pred ceeEeEEEEEEe
Confidence 556667777775
No 192
>cd04979 Ig_Semaphorin_C Immunoglobulin (Ig)-like domain of semaphorin. Ig_Semaphorin_C; Immunoglobulin (Ig)-like domain in semaphorins. Semaphorins are transmembrane protein that have important roles in a variety of tissues. Functionally, semaphorins were initially characterized for their importance in the development of the nervous system and in axonal guidance. Later they have been found to be important for the formation and functioning of the cardiovascular, endocrine, gastrointestinal, hepatic, immune, musculoskeletal, renal, reproductive, and respiratory systems. Semaphorins function through binding to their receptors and transmembrane semaphorins also serves as receptors themselves. Although molecular mechanism of semaphorins is poorly understood, the Ig-like domains may involve in ligand binding or dimerization.
Probab=98.81 E-value=2.1e-08 Score=93.04 Aligned_cols=80 Identities=21% Similarity=0.314 Sum_probs=63.8
Q ss_pred CceEEcCCceEEEEEEEecCCCcEEEEEeCCEecCCCC----CeEEeecCCeEEEEEccCCCCCCEEEEEEEEeCC-eeE
Q psy2148 1750 SSAVINVGQLARFDAKISATKPLDVYWLKNGKKIIPDI----RYKTLEEDNLFTLLIIEAVVEDSGAYECVAMNNA-GEA 1824 (1884)
Q Consensus 1750 ~~~~~~~G~~~~l~C~~~g~p~p~v~W~k~~~~l~~~~----~~~~~~~~~~~~L~i~~~~~~d~G~Y~C~a~N~~-G~~ 1824 (1884)
....+.+|+.+.|.|.+.+ |.+.+.|+|++..+.... ++... .+ .|.|.++..+|+|.|+|.|.|.. +..
T Consensus 4 ~~~~v~~g~~v~L~C~~~~-p~~~i~W~k~~~~~~~~~~~~~~~~~~-~~---~L~I~~~~~~D~G~Y~C~a~~~~~~~~ 78 (89)
T cd04979 4 KVVTVVEGNSVFLECSPKS-NLASVVWLFQGGPLQRKEEPEERLLVT-ED---GLLIRSVSPADAGVYTCQSVEHGFKQT 78 (89)
T ss_pred eEEEEECCCcEEEEEeCCC-CCceEEEEECCcccccccCcCceEEEc-CC---CEEEccCCHHHCEEEEEEEecCcccee
Confidence 4567889999999999987 888999999998876542 33322 22 59999999999999999998765 566
Q ss_pred EEEEEEEEEe
Q psy2148 1825 RCEAELVVQS 1834 (1884)
Q Consensus 1825 ~~~~~l~V~~ 1834 (1884)
..+.+|.|.+
T Consensus 79 ~~~~~l~V~~ 88 (89)
T cd04979 79 LATYSLNVLE 88 (89)
T ss_pred EeEEEEEEec
Confidence 6778888864
No 193
>cd05862 Ig1_VEGFR First immunoglobulin (Ig)-like domain of vascular endothelial growth factor (VEGF) receptor(R). IG1_VEGFR: first immunoglobulin (Ig)-like domain of vascular endothelial growth factor (VEGF) receptor(R). The VEGFRs have an extracellular component with seven Ig-like domains, a transmembrane segment, and an intracellular tyrosine kinase domain interrupted by a kinase-insert domain. The VEGFR family consists of three members, VEGFR-1 (Flt-1), VEGFR-2 (KDR/Flk-1) and VEGFR-3 (Flt-4). VEGF_A interacts with both VEGFR-1 and VEGFR-2. VEGFR-1 binds strongest to VEGF, VEGF-2 binds more weakly. VEGFR-3 appears not to bind VEGF, but binds other members of the VEGF family (VEGF-C and -D). VEGFRs bind VEGFs with high affinity with the IG-like domains. VEGF-A is important to the growth and maintenance of vascular endothelial cells and to the development of new blood- and lymphatic-vessels in physiological and pathological states. VEGFR-2 is a major mediator of the mitogenic, angioge
Probab=98.80 E-value=2.1e-08 Score=91.46 Aligned_cols=79 Identities=24% Similarity=0.272 Sum_probs=60.3
Q ss_pred CCeEEEEEEEeeCCCCCcEEEEeeCCEEccCC---C--cEEE-EeeCCeEEEEEccCCCCCCeEEEEEEEcCCeeEEEEE
Q psy2148 931 STLAHFECRLTPTNDPSMTVEWFHNGKALSAG---S--RIKT-INDFGFVILEINDVYLRDSGLYTCKATNKHGEATTSC 1004 (1884)
Q Consensus 931 G~~v~l~C~v~~~~~P~~~v~W~~~g~~i~~~---~--~~~~-~~~~~~~~L~I~~~~~~D~G~Y~C~a~N~~G~~~~~~ 1004 (1884)
|+++.|.|.+.+...+...+.|.+.+..+... . +... ......++|.|.+++.+|+|.|+|.|+|..|....+.
T Consensus 1 Ge~~~L~C~~~~~~~~~~~~~W~~p~~~~~~~~~~~~~~~~~~~~~~~~s~L~I~~~~~~DsG~Y~C~a~n~~~~~~~~t 80 (86)
T cd05862 1 GEKLVLNCTARTELNVGIDFQWDYPGKKEQRAKSVSENRRSLQEHTELSSTLTIENVTLSDLGRYTCTASSGQMIAKNST 80 (86)
T ss_pred CCcEEEEEEEEeCCCCcEEEEEEcCCcccccceecccccccccccceeeeEEEEecCCcccCEEEEEEEeecceEecccE
Confidence 78999999998544566788999987654211 1 1111 1122356899999999999999999999999999999
Q ss_pred EEEEE
Q psy2148 1005 KLTVK 1009 (1884)
Q Consensus 1005 ~l~V~ 1009 (1884)
.|.|+
T Consensus 81 ~~~V~ 85 (86)
T cd05862 81 IVIVH 85 (86)
T ss_pred EEEEe
Confidence 99986
No 194
>cd05727 Ig2_Contactin-2-like Second Ig domain of the neural cell adhesion molecule contactin-2 and similar proteins. Ig2_Contactin-2-like: second Ig domain of the neural cell adhesion molecule contactin-2. Contactins are comprised of six Ig domains followed by four fibronectin type III (FnIII) domains anchored to the membrane by glycosylphosphatidylinositol. Contactin-2 (aliases TAG-1, axonin-1) facilitates cell adhesion by homophilic binding between molecules in apposed membranes. The first four Ig domains form the intermolecular binding fragment which arranges as a compact U-shaped module by contacts between Ig domains 1 and 4, and domains 2 and 3. It has been proposed that a linear zipper-like array forms, from contactin-2 molecules alternatively provided by the two apposed membranes.
Probab=98.76 E-value=1.5e-08 Score=92.22 Aligned_cols=74 Identities=19% Similarity=0.273 Sum_probs=58.9
Q ss_pred CceeecCCCeEEEEEEEeeCCCCCcEEEEeeCCEEc--cCCCcEEEEeeCCeEEEEEccCCCCCCeEEEEEEEcCCeeE
Q psy2148 924 TDLTLAESTLAHFECRLTPTNDPSMTVEWFHNGKAL--SAGSRIKTINDFGFVILEINDVYLRDSGLYTCKATNKHGEA 1000 (1884)
Q Consensus 924 ~~~~v~~G~~v~l~C~v~~~~~P~~~v~W~~~g~~i--~~~~~~~~~~~~~~~~L~I~~~~~~D~G~Y~C~a~N~~G~~ 1000 (1884)
....+.+|+.+.|.|..- .+.|++.+.|++++.++ ..+.|..+....| .|.|.+++.+|+|.|+|.|+|..+..
T Consensus 11 ~~~~v~eG~~~~L~C~pP-~g~P~p~~~W~k~~~~~~~~~d~r~~~~~~~G--~L~fs~v~~~D~g~Y~C~A~n~~~~~ 86 (96)
T cd05727 11 DEVKVKEGWGVVLFCDPP-PHYPDLSYRWLLNEFPNFIPEDGRRFVSQTNG--NLYIAKVEASDRGNYSCFVSSPSSTK 86 (96)
T ss_pred CceeeeeCCcEEEeeCCC-CCCCCCEEEEEECCcccccccCCCeEEeCCCC--cEEEeecCHhhCceeEEEEEecccCC
Confidence 456789999999999875 48899999999999865 3344444444344 59999999999999999999986544
No 195
>cd05860 Ig4_SCFR Fourth immunoglobulin (Ig)-like domain of stem cell factor receptor (SCFR). Ig4_SCFR: The fourth Immunoglobulin (Ig)-like domain in stem cell factor receptor (SCFR). SCFR is organized as an extracellular component having five IG-like domains, a transmembrane segment, and a cytoplasmic portion having protein tyrosine kinase activity. SCFR and its ligand SCF are critical for normal hematopoiesis, mast cell development, melanocytes and gametogenesis. SCF binds to the second and third Ig-like domains of SCFR. This fourth Ig-like domain participates in SCFR dimerization, which follows ligand binding. Deletion of this fourth domain abolishes the ligand-induced dimerization of SCFR and completely inhibits signal transduction.
Probab=98.76 E-value=8.1e-08 Score=87.15 Aligned_cols=84 Identities=12% Similarity=0.171 Sum_probs=69.8
Q ss_pred CceEEcCCceEEEEEEEecCCCcE-EEEEeCCEecCCCCCeEEeec--C---CeEEEEEccCCCCCCEEEEEEEEeCCee
Q psy2148 1750 SSAVINVGQLARFDAKISATKPLD-VYWLKNGKKIIPDIRYKTLEE--D---NLFTLLIIEAVVEDSGAYECVAMNNAGE 1823 (1884)
Q Consensus 1750 ~~~~~~~G~~~~l~C~~~g~p~p~-v~W~k~~~~l~~~~~~~~~~~--~---~~~~L~i~~~~~~d~G~Y~C~a~N~~G~ 1823 (1884)
....+.+|+.+.|.|.+.++|+|+ +.|.+++..+.......+... + ..+.|.|.++..+|+|.|+|.|.|..+.
T Consensus 11 ~~~~v~~gE~~~L~V~ieAYP~p~~~~W~~~~~~l~~~~~~~~~~~~~~~~rY~S~L~L~Rlk~~E~G~YTf~a~N~~~~ 90 (101)
T cd05860 11 TTIFVNAGENLDLIVEYEAYPKPEHQQWIYMNRTLTNTSDHYVKSRNESNNRYVSELHLTRLKGTEGGTYTFLVSNSDAS 90 (101)
T ss_pred ceEEEECCCCEEEEEEEEeCCCCeeeEEEcCCcccCccccceeEEeccCceEEEEEEEEeecChhhCcEEEEEEECCCCe
Confidence 457789999999999999999998 999999987754433112221 1 3469999999999999999999999999
Q ss_pred EEEEEEEEEE
Q psy2148 1824 ARCEAELVVQ 1833 (1884)
Q Consensus 1824 ~~~~~~l~V~ 1833 (1884)
++.+++|.|+
T Consensus 91 ~s~tF~l~v~ 100 (101)
T cd05860 91 ASVTFNVYVN 100 (101)
T ss_pred EEEEEEEEEe
Confidence 9999999886
No 196
>cd05753 Ig2_FcgammaR_like Second immunoglobulin (Ig)-like domain of Fcgamma-receptors (FcgammaRs) and similar proteins. Ig2_FcgammaR_like: domain similar to the second immunoglobulin (Ig)-like domain of Fcgamma-receptors (FcgammaRs). Interactions between IgG and FcgammaR are important to the initiation of cellular and humoral response. IgG binding to FcgammaR leads to a cascade of signals and ultimately to functions such as antibody-dependent-cellular-cytotoxicity (ADCC), endocytosis, phagocytosis, release of inflammatory mediators, etc. FcgammaR has two Ig-like domains. This group also contains FcepsilonRI, which binds IgE with high affinity.
Probab=98.75 E-value=2.3e-08 Score=90.57 Aligned_cols=67 Identities=24% Similarity=0.315 Sum_probs=54.5
Q ss_pred ceeecCCCeEEEEEEEeeCCCCCcEEEEeeCCEEccCCCcEEEEeeCCeEEEEEccCCCCCCeEEEEEEEcCCeeE
Q psy2148 925 DLTLAESTLAHFECRLTPTNDPSMTVEWFHNGKALSAGSRIKTINDFGFVILEINDVYLRDSGLYTCKATNKHGEA 1000 (1884)
Q Consensus 925 ~~~v~~G~~v~l~C~v~~~~~P~~~v~W~~~g~~i~~~~~~~~~~~~~~~~L~I~~~~~~D~G~Y~C~a~N~~G~~ 1000 (1884)
...|.+|++++|.|.+.. +.|.+.+.|+|+|..+.... ....|.|.+++.+|+|.|+|.|.|..|..
T Consensus 8 ~~~V~~G~~vtL~C~~~~-~~~~~~~~w~k~g~~~~~~~--------~~~~l~I~~~~~~dsG~Y~C~~~~~~~~~ 74 (83)
T cd05753 8 SRVVFEGEPLVLRCHGWK-NKPVYKVTYYRDGKAKKYSH--------SNSNLSIPQATLSDSGSYHCSGIIGSYDY 74 (83)
T ss_pred cceecCCCCEEEEeeCCC-CCcceEEEEEECCeEccccC--------CCceEEECccCHHHCEEEEEEEEeCCcee
Confidence 347899999999999852 56677899999998774321 12369999999999999999999999854
No 197
>cd07690 Ig1_CD4 First immunoglobulin (Ig) domain of CD4. Ig1_CD4; first immunoglobulin (Ig) domain of CD4. CD4 and CD8 are the two primary co-receptor proteins found on the surface of T cells, and the presence of either CD4 or CD8 determines the function of the T cell. CD4 is found on helper T cells, where it is required for the binding of MHC (major histocompatibility complex) class II molecules, while CD8 is found on cytotoxic T cells, where it is required for the binding of MHC class I molecules. CD4 contains four immunoglobulin domains, with the first three included in this hierarchy. The fourth domain has a general Ig architecture, but has slight topological changes in the arrangement of beta strands relative to the other structures in this family and is not specifically included in the hierarchy.
Probab=98.70 E-value=5.5e-08 Score=89.18 Aligned_cols=73 Identities=22% Similarity=0.352 Sum_probs=56.8
Q ss_pred EEcCCceEEEEEEEecCCCcEEEEEeCCEecC--------------CCCCeEEee---cCCeEEEEEccCCCCCCEEEEE
Q psy2148 1753 VINVGQLARFDAKISATKPLDVYWLKNGKKII--------------PDIRYKTLE---EDNLFTLLIIEAVVEDSGAYEC 1815 (1884)
Q Consensus 1753 ~~~~G~~~~l~C~~~g~p~p~v~W~k~~~~l~--------------~~~~~~~~~---~~~~~~L~i~~~~~~d~G~Y~C 1815 (1884)
.+.+|++|+|.|.+.+.+.+.|.|++++.... ...|+.... ..+.+.|+|.++..+|+|+|+|
T Consensus 3 ~~~~G~~VtL~C~~s~~~~~~i~W~~~~~k~~~g~~~~l~~~~~~~~~~r~~~~~~~~~~g~~~L~I~~l~~sDsgtY~C 82 (94)
T cd07690 3 LGKKGDTAELPCTASQKKSIQFHWKNSNQIKILGNQGSFLTKGPSKLNDRADSRRNLWDQGSFPLIIKNLKIEDSDTYIC 82 (94)
T ss_pred EeeCCCCEEEEEEeCCCCCcEEEEEECCcEEccCcCCEEEEecccccCCCCceecccCCCCeEEEEECCCCHHHCEEEEE
Confidence 46789999999999999999999998773321 112333222 4456789999999999999999
Q ss_pred EEEeCCeeEE
Q psy2148 1816 VAMNNAGEAR 1825 (1884)
Q Consensus 1816 ~a~N~~G~~~ 1825 (1884)
.|.|..++.+
T Consensus 83 ~v~~~~~~~~ 92 (94)
T cd07690 83 EVEDKKEEVE 92 (94)
T ss_pred EECCccceEE
Confidence 9999887643
No 198
>cd07690 Ig1_CD4 First immunoglobulin (Ig) domain of CD4. Ig1_CD4; first immunoglobulin (Ig) domain of CD4. CD4 and CD8 are the two primary co-receptor proteins found on the surface of T cells, and the presence of either CD4 or CD8 determines the function of the T cell. CD4 is found on helper T cells, where it is required for the binding of MHC (major histocompatibility complex) class II molecules, while CD8 is found on cytotoxic T cells, where it is required for the binding of MHC class I molecules. CD4 contains four immunoglobulin domains, with the first three included in this hierarchy. The fourth domain has a general Ig architecture, but has slight topological changes in the arrangement of beta strands relative to the other structures in this family and is not specifically included in the hierarchy.
Probab=98.70 E-value=5.4e-08 Score=89.24 Aligned_cols=73 Identities=21% Similarity=0.369 Sum_probs=56.2
Q ss_pred eeecCCCeEEEEEEEeeCCCCCcEEEEeeCCEEcc--------------CCCcEEEEe---eCCeEEEEEccCCCCCCeE
Q psy2148 926 LTLAESTLAHFECRLTPTNDPSMTVEWFHNGKALS--------------AGSRIKTIN---DFGFVILEINDVYLRDSGL 988 (1884)
Q Consensus 926 ~~v~~G~~v~l~C~v~~~~~P~~~v~W~~~g~~i~--------------~~~~~~~~~---~~~~~~L~I~~~~~~D~G~ 988 (1884)
+.+.+|++|+|.|.++ +.|.+.+.|++++.... ...|+.... +.+.+.|+|.+++.+|+|+
T Consensus 2 v~~~~G~~VtL~C~~s--~~~~~~i~W~~~~~k~~~g~~~~l~~~~~~~~~~r~~~~~~~~~~g~~~L~I~~l~~sDsgt 79 (94)
T cd07690 2 VLGKKGDTAELPCTAS--QKKSIQFHWKNSNQIKILGNQGSFLTKGPSKLNDRADSRRNLWDQGSFPLIIKNLKIEDSDT 79 (94)
T ss_pred eEeeCCCCEEEEEEeC--CCCCcEEEEEECCcEEccCcCCEEEEecccccCCCCceecccCCCCeEEEEECCCCHHHCEE
Confidence 4578999999999998 67888999998773321 123333333 4456789999999999999
Q ss_pred EEEEEEcCCeeE
Q psy2148 989 YTCKATNKHGEA 1000 (1884)
Q Consensus 989 Y~C~a~N~~G~~ 1000 (1884)
|.|.+.|..++.
T Consensus 80 Y~C~v~~~~~~~ 91 (94)
T cd07690 80 YICEVEDKKEEV 91 (94)
T ss_pred EEEEECCccceE
Confidence 999999987764
No 199
>cd05717 Ig1_Necl-1-3_like First (N-terminal) immunoglobulin (Ig)-like domain of the nectin-like molecules Necl-1 - Necl-3 (also known as cell adhesion molecules CADM3, CADM1, and CADM2 respectively). Ig1_Necl-1-3_like: N-terminal immunoglobulin (Ig)-like domain of the nectin-like molecules Necl-1 (also known as cell adhesion molecule 3 (CADM3)), Necl-2 (CADM1), and Necl-3 (CADM2). At least five nectin-like molecules have been identified (Necl-1 - Necl-5). They all have an extracellular region containing three Ig-like domains, a transmembrane region, and a cytoplasmic region. The N-terminal Ig-like domain of the extracellular region belongs to the V-type subfamily of Ig domains, is essential to cell-cell adhesion, and plays a part in the interaction with the envelope glycoprotein D of various viruses. Necl-1, Necl-2, and Necl-3 have Ca(2+)-independent homophilic and heterophilic cell-cell adhesion activity. Necl-1 is specifically expressed in neural tissue, and is important to the form
Probab=98.70 E-value=1e-07 Score=89.76 Aligned_cols=83 Identities=27% Similarity=0.468 Sum_probs=61.2
Q ss_pred CCceeecCCCeEEEEEEEeeCCCCCcEEEEeeCCEEc--------cCCCcEEEEe-eCCeEEEEEccCCCCCCeEEEEEE
Q psy2148 923 PTDLTLAESTLAHFECRLTPTNDPSMTVEWFHNGKAL--------SAGSRIKTIN-DFGFVILEINDVYLRDSGLYTCKA 993 (1884)
Q Consensus 923 ~~~~~v~~G~~v~l~C~v~~~~~P~~~v~W~~~g~~i--------~~~~~~~~~~-~~~~~~L~I~~~~~~D~G~Y~C~a 993 (1884)
.+++.+.+|++++|.|.+. +.|.+.+.|++.+..+ ..+.|+.+.. .+....|.|.+++.+|+|.|+|.+
T Consensus 4 ~~~~~v~~G~~v~L~C~~~--~~~~~~v~W~~p~~~~~~~~~~~~~~~~r~~~~~~~~~~~~L~I~~v~~~DsG~Y~C~~ 81 (95)
T cd05717 4 TQDVTVVEGGTATLKCRVK--NNDNSSLQWSNPNQQTLYFNDKRALRDNRIQLVNFSANELSISISNVSLSDEGRYTCSL 81 (95)
T ss_pred CCcEEEcCCCCEEEEEEEC--CCCCceEEEeCCCCcEEEeccccccccCcEEEEcCCCCeeEEEEccCCcccCEEEEEEE
Confidence 4678899999999999998 5677899998632211 1235666532 234568999999999999999999
Q ss_pred EcCCeeEEEEEEEEE
Q psy2148 994 TNKHGEATTSCKLTV 1008 (1884)
Q Consensus 994 ~N~~G~~~~~~~l~V 1008 (1884)
.+... .+.++.|+|
T Consensus 82 ~~~~~-~~~~~~~~v 95 (95)
T cd05717 82 YTMPV-QTAKATVTV 95 (95)
T ss_pred ecCCC-ceEEEEEEC
Confidence 98753 466666665
No 200
>cd05727 Ig2_Contactin-2-like Second Ig domain of the neural cell adhesion molecule contactin-2 and similar proteins. Ig2_Contactin-2-like: second Ig domain of the neural cell adhesion molecule contactin-2. Contactins are comprised of six Ig domains followed by four fibronectin type III (FnIII) domains anchored to the membrane by glycosylphosphatidylinositol. Contactin-2 (aliases TAG-1, axonin-1) facilitates cell adhesion by homophilic binding between molecules in apposed membranes. The first four Ig domains form the intermolecular binding fragment which arranges as a compact U-shaped module by contacts between Ig domains 1 and 4, and domains 2 and 3. It has been proposed that a linear zipper-like array forms, from contactin-2 molecules alternatively provided by the two apposed membranes.
Probab=98.69 E-value=3.2e-08 Score=90.15 Aligned_cols=73 Identities=21% Similarity=0.300 Sum_probs=57.3
Q ss_pred CccccccccceEEEEEEeeCCCCCCeEEEeecCeec--CCCCCceeeeeCceEEEEEeeeccCCCeEEEEEEEecCcc
Q psy2148 1433 TQDQLVEMQSTKFECQLAPVGDPNMKVEWFLNGKPL--PHKNRFNPIYDFGYVAMNFGWVYPEDSGEYLCRATNLYGM 1508 (1884)
Q Consensus 1433 ~~~~v~~g~~~~l~C~~~~~g~p~~~i~W~~~~~~l--~~~~~~~~~~~~~~~~L~i~~~~~~d~G~Y~c~a~n~~G~ 1508 (1884)
+...+.+|+.+.|.|... .|.|.+.+.|++++.++ ..+.+..+...+| .|.|.+++.+|+|.|+|.|+|.+..
T Consensus 11 ~~~~v~eG~~~~L~C~pP-~g~P~p~~~W~k~~~~~~~~~d~r~~~~~~~G--~L~fs~v~~~D~g~Y~C~A~n~~~~ 85 (96)
T cd05727 11 DEVKVKEGWGVVLFCDPP-PHYPDLSYRWLLNEFPNFIPEDGRRFVSQTNG--NLYIAKVEASDRGNYSCFVSSPSST 85 (96)
T ss_pred CceeeeeCCcEEEeeCCC-CCCCCCEEEEEECCcccccccCCCeEEeCCCC--cEEEeecCHhhCceeEEEEEecccC
Confidence 334588999999999874 79999999999998764 2233333333344 6999999999999999999998643
No 201
>cd05897 Ig2_IL1R2_like Second immunoglobulin (Ig)-like domain of interleukin-1 receptor-2 (IL1R2). Ig2_IL1R2_like: domain similar to the second immunoglobulin (Ig)-like domain of interleukin-1 receptor-2 (IL1R2). IL-1 alpha and IL-1 beta are cytokines which participate in the regulation of inflammation, immune responses, and hematopoiesis. These cytokines bind to the IL-1 receptor type 1 (IL1R1), which is activated on additional association with an accessory protein, IL1RAP. IL-1 also binds the type II (IL1R2) represented in this group. Mature IL1R2 consists of three IG-like domains, a transmembrane domain, and a short cytoplasmic domain. It lacks the large cytoplasmic domain of Mature IL1R1, and does not initiate signal transduction. A naturally occurring cytokine IL-1RA (IL-1 receptor antagonist) is widely expressed and binds to IL-1 receptors, inhibiting the binding of IL-1 alpha and IL-1 beta.
Probab=98.69 E-value=5e-08 Score=89.08 Aligned_cols=74 Identities=28% Similarity=0.477 Sum_probs=55.7
Q ss_pred eeecCCCeEEEEEE-EeeC--CCCCcEEEEeeCCEEccCCCc-EEEEeeCCeEEEEEccCCCCCCeEEEEEEEcCCeeEE
Q psy2148 926 LTLAESTLAHFECR-LTPT--NDPSMTVEWFHNGKALSAGSR-IKTINDFGFVILEINDVYLRDSGLYTCKATNKHGEAT 1001 (1884)
Q Consensus 926 ~~v~~G~~v~l~C~-v~~~--~~P~~~v~W~~~g~~i~~~~~-~~~~~~~~~~~L~I~~~~~~D~G~Y~C~a~N~~G~~~ 1001 (1884)
+.+..|.+..|.|. +.+. ..+.++|+||||+.+|....+ +....+ ...|.|.++..+|+|.|+|.|.|.+|...
T Consensus 5 ~~~~~~~~~~l~Cp~~~~f~~~~~~~~v~WYKd~~~l~~~~~~~~~~~~--~~~L~I~~v~~~D~G~YtC~~~~~~~g~~ 82 (95)
T cd05897 5 QILFTSTSGKLVCPDLSDFTINRTDVELQWYKDSVLLDKDNEKFYSLKG--STYLHIIDVSLNDSGYYTCKLQFTHEGKK 82 (95)
T ss_pred eEeccccCcEEECCCHHHcccCCCCCcEEEccCCEECcCCCcceEecCC--CCEEEEEEcChhhCEEEEEEEEEeeCCEE
Confidence 45678999999996 2322 457779999999999976543 332222 22699999999999999999999987543
No 202
>cd05897 Ig2_IL1R2_like Second immunoglobulin (Ig)-like domain of interleukin-1 receptor-2 (IL1R2). Ig2_IL1R2_like: domain similar to the second immunoglobulin (Ig)-like domain of interleukin-1 receptor-2 (IL1R2). IL-1 alpha and IL-1 beta are cytokines which participate in the regulation of inflammation, immune responses, and hematopoiesis. These cytokines bind to the IL-1 receptor type 1 (IL1R1), which is activated on additional association with an accessory protein, IL1RAP. IL-1 also binds the type II (IL1R2) represented in this group. Mature IL1R2 consists of three IG-like domains, a transmembrane domain, and a short cytoplasmic domain. It lacks the large cytoplasmic domain of Mature IL1R1, and does not initiate signal transduction. A naturally occurring cytokine IL-1RA (IL-1 receptor antagonist) is widely expressed and binds to IL-1 receptors, inhibiting the binding of IL-1 alpha and IL-1 beta.
Probab=98.69 E-value=6e-08 Score=88.58 Aligned_cols=80 Identities=18% Similarity=0.269 Sum_probs=59.6
Q ss_pred eEEcCCceEEEEEEE-ec----CCCcEEEEEeCCEecCCCC-CeEEeecCCeEEEEEccCCCCCCEEEEEEEEeCCeeE-
Q psy2148 1752 AVINVGQLARFDAKI-SA----TKPLDVYWLKNGKKIIPDI-RYKTLEEDNLFTLLIIEAVVEDSGAYECVAMNNAGEA- 1824 (1884)
Q Consensus 1752 ~~~~~G~~~~l~C~~-~g----~p~p~v~W~k~~~~l~~~~-~~~~~~~~~~~~L~i~~~~~~d~G~Y~C~a~N~~G~~- 1824 (1884)
+.+..|.+..|.|.- .+ .+.|+|+||||++++.... ++....++ ..|.|.++..+|+|.|+|.|.|..|..
T Consensus 5 ~~~~~~~~~~l~Cp~~~~f~~~~~~~~v~WYKd~~~l~~~~~~~~~~~~~--~~L~I~~v~~~D~G~YtC~~~~~~~g~~ 82 (95)
T cd05897 5 QILFTSTSGKLVCPDLSDFTINRTDVELQWYKDSVLLDKDNEKFYSLKGS--TYLHIIDVSLNDSGYYTCKLQFTHEGKK 82 (95)
T ss_pred eEeccccCcEEECCCHHHcccCCCCCcEEEccCCEECcCCCcceEecCCC--CEEEEEEcChhhCEEEEEEEEEeeCCEE
Confidence 456678899999973 33 4678999999999987554 33332332 279999999999999999999998643
Q ss_pred ---EEEEEEEEE
Q psy2148 1825 ---RCEAELVVQ 1833 (1884)
Q Consensus 1825 ---~~~~~l~V~ 1833 (1884)
++.+.|.|.
T Consensus 83 y~vtr~~~l~v~ 94 (95)
T cd05897 83 YNITRIIKLRIV 94 (95)
T ss_pred EEEEEEEEEEEc
Confidence 455566553
No 203
>cd05717 Ig1_Necl-1-3_like First (N-terminal) immunoglobulin (Ig)-like domain of the nectin-like molecules Necl-1 - Necl-3 (also known as cell adhesion molecules CADM3, CADM1, and CADM2 respectively). Ig1_Necl-1-3_like: N-terminal immunoglobulin (Ig)-like domain of the nectin-like molecules Necl-1 (also known as cell adhesion molecule 3 (CADM3)), Necl-2 (CADM1), and Necl-3 (CADM2). At least five nectin-like molecules have been identified (Necl-1 - Necl-5). They all have an extracellular region containing three Ig-like domains, a transmembrane region, and a cytoplasmic region. The N-terminal Ig-like domain of the extracellular region belongs to the V-type subfamily of Ig domains, is essential to cell-cell adhesion, and plays a part in the interaction with the envelope glycoprotein D of various viruses. Necl-1, Necl-2, and Necl-3 have Ca(2+)-independent homophilic and heterophilic cell-cell adhesion activity. Necl-1 is specifically expressed in neural tissue, and is important to the form
Probab=98.68 E-value=1.3e-07 Score=89.11 Aligned_cols=82 Identities=16% Similarity=0.327 Sum_probs=62.6
Q ss_pred CceEEcCCceEEEEEEEecCCCcEEEEEeCCEec--------CCCCCeEEee-cCCeEEEEEccCCCCCCEEEEEEEEeC
Q psy2148 1750 SSAVINVGQLARFDAKISATKPLDVYWLKNGKKI--------IPDIRYKTLE-EDNLFTLLIIEAVVEDSGAYECVAMNN 1820 (1884)
Q Consensus 1750 ~~~~~~~G~~~~l~C~~~g~p~p~v~W~k~~~~l--------~~~~~~~~~~-~~~~~~L~i~~~~~~d~G~Y~C~a~N~ 1820 (1884)
++..+.+|++++|.|.+.+.|.+.+.|++.+..+ ....|+.+.. .+..+.|+|.+++.+|+|.|+|.+.+.
T Consensus 5 ~~~~v~~G~~v~L~C~~~~~~~~~v~W~~p~~~~~~~~~~~~~~~~r~~~~~~~~~~~~L~I~~v~~~DsG~Y~C~~~~~ 84 (95)
T cd05717 5 QDVTVVEGGTATLKCRVKNNDNSSLQWSNPNQQTLYFNDKRALRDNRIQLVNFSANELSISISNVSLSDEGRYTCSLYTM 84 (95)
T ss_pred CcEEEcCCCCEEEEEEECCCCCceEEEeCCCCcEEEeccccccccCcEEEEcCCCCeeEEEEccCCcccCEEEEEEEecC
Confidence 5678899999999999999889999998633211 1235666533 234568999999999999999999987
Q ss_pred CeeEEEEEEEEE
Q psy2148 1821 AGEARCEAELVV 1832 (1884)
Q Consensus 1821 ~G~~~~~~~l~V 1832 (1884)
.. .+.++.|+|
T Consensus 85 ~~-~~~~~~~~v 95 (95)
T cd05717 85 PV-QTAKATVTV 95 (95)
T ss_pred CC-ceEEEEEEC
Confidence 53 466777765
No 204
>cd05871 Ig_Semaphorin_classIII Immunoglobulin (Ig)-like domain of class III semaphorin. Ig_Semaphorin_class III; Immunoglobulin (Ig)-like domain of class III semaphorins. Semaphorins are classified into various classes on the basis of structural features additional to the Sema domain. Class III semaphorins are a vertebrate class having a Sema domain, an Ig domain, a short basic domain, and are secreted. They have been shown to be axonal guidance cues and have a part in the regulation of the cardiovascular, immune and respiratory systems. Sema3A, the prototype member of this class III subfamily, induces growth cone collapse and is an inhibitor of axonal sprouting. In perinatal rat cortex as a chemoattractant, it functions to direct, for pyramidal neurons, the orientated extension of apical dendrites. It may play a role, prior to the development of apical dendrites, in signaling the radial migration of newborn cortical neurons towards the upper layers. Sema3A selectively inhibits vascula
Probab=98.68 E-value=1.2e-07 Score=87.22 Aligned_cols=79 Identities=18% Similarity=0.176 Sum_probs=60.9
Q ss_pred ceEEcCCceEEEEEEEecCCCcEEEEEeCCE--ec----CCCCCeEEeecCCeEEEEEccCCCCCCEEEEEEEE-eCCee
Q psy2148 1751 SAVINVGQLARFDAKISATKPLDVYWLKNGK--KI----IPDIRYKTLEEDNLFTLLIIEAVVEDSGAYECVAM-NNAGE 1823 (1884)
Q Consensus 1751 ~~~~~~G~~~~l~C~~~g~p~p~v~W~k~~~--~l----~~~~~~~~~~~~~~~~L~i~~~~~~d~G~Y~C~a~-N~~G~ 1823 (1884)
...+.+|+++.|.|.. +.|.|.+.|+|.+. .+ ....++... . ..|.|.++.++|+|.|+|.|. |..|.
T Consensus 5 ~~~~~eG~~v~L~C~~-~~p~p~v~Wykq~~g~~~~~~~~~~~r~~~~-~---~~L~I~~~~~~DsG~Y~C~a~~~~~~~ 79 (91)
T cd05871 5 VVYGVENNSTFLECLP-KSPQASVKWLFQRGGDQRKEEVKTEERLIHT-E---RGLLLRSLQRSDAGVYTCTAVEHSFSQ 79 (91)
T ss_pred EEEEecCCcEEEEEEC-CCCCceEEEEEECCCCCccccccccccEEEe-c---CeEEEeeCChhHCEEEEEEEEccCCeE
Confidence 3567789999999996 58999999998432 21 123444432 2 269999999999999999997 67888
Q ss_pred EEEEEEEEEEe
Q psy2148 1824 ARCEAELVVQS 1834 (1884)
Q Consensus 1824 ~~~~~~l~V~~ 1834 (1884)
....++|+|..
T Consensus 80 ~~~~~~l~v~~ 90 (91)
T cd05871 80 TLAKYTLHVIE 90 (91)
T ss_pred EEEEEEEEEec
Confidence 88899999874
No 205
>cd05862 Ig1_VEGFR First immunoglobulin (Ig)-like domain of vascular endothelial growth factor (VEGF) receptor(R). IG1_VEGFR: first immunoglobulin (Ig)-like domain of vascular endothelial growth factor (VEGF) receptor(R). The VEGFRs have an extracellular component with seven Ig-like domains, a transmembrane segment, and an intracellular tyrosine kinase domain interrupted by a kinase-insert domain. The VEGFR family consists of three members, VEGFR-1 (Flt-1), VEGFR-2 (KDR/Flk-1) and VEGFR-3 (Flt-4). VEGF_A interacts with both VEGFR-1 and VEGFR-2. VEGFR-1 binds strongest to VEGF, VEGF-2 binds more weakly. VEGFR-3 appears not to bind VEGF, but binds other members of the VEGF family (VEGF-C and -D). VEGFRs bind VEGFs with high affinity with the IG-like domains. VEGF-A is important to the growth and maintenance of vascular endothelial cells and to the development of new blood- and lymphatic-vessels in physiological and pathological states. VEGFR-2 is a major mediator of the mitogenic, angioge
Probab=98.68 E-value=8.9e-08 Score=87.38 Aligned_cols=80 Identities=23% Similarity=0.218 Sum_probs=60.3
Q ss_pred CCcEEEEEEEeecCCCCCeEEEeeCCccCCC---CCCeEE---EeeCCEEEEEEcccCcCCCeEEEEEEEecCceEEEEE
Q psy2148 722 GENAHFEARLTPTDDPKLKVEWFWNGKPMKT---GSRFRT---FCDFGFVILEISPVYPEDCGQYSCRAYNDYGEAVTSA 795 (1884)
Q Consensus 722 G~~~~l~C~~~~~g~p~~~v~W~k~g~~l~~---~~~~~~---~~~~~~~~L~i~~~~~~d~G~Y~C~a~N~~g~~~~~~ 795 (1884)
|+++.|.|.+.+...+...+.|.+.+..+.. ....+. ......+.|.|.+++.+|+|.|+|.|+|..|....+.
T Consensus 1 Ge~~~L~C~~~~~~~~~~~~~W~~p~~~~~~~~~~~~~~~~~~~~~~~~s~L~I~~~~~~DsG~Y~C~a~n~~~~~~~~t 80 (86)
T cd05862 1 GEKLVLNCTARTELNVGIDFQWDYPGKKEQRAKSVSENRRSLQEHTELSSTLTIENVTLSDLGRYTCTASSGQMIAKNST 80 (86)
T ss_pred CCcEEEEEEEEeCCCCcEEEEEEcCCcccccceecccccccccccceeeeEEEEecCCcccCEEEEEEEeecceEecccE
Confidence 7899999999865556678899987764321 111111 1122456899999999999999999999999999999
Q ss_pred EEEEec
Q psy2148 796 SMKVQG 801 (1884)
Q Consensus 796 ~l~V~~ 801 (1884)
.|.|++
T Consensus 81 ~~~V~~ 86 (86)
T cd05862 81 IVIVHE 86 (86)
T ss_pred EEEEeC
Confidence 998864
No 206
>cd05871 Ig_Semaphorin_classIII Immunoglobulin (Ig)-like domain of class III semaphorin. Ig_Semaphorin_class III; Immunoglobulin (Ig)-like domain of class III semaphorins. Semaphorins are classified into various classes on the basis of structural features additional to the Sema domain. Class III semaphorins are a vertebrate class having a Sema domain, an Ig domain, a short basic domain, and are secreted. They have been shown to be axonal guidance cues and have a part in the regulation of the cardiovascular, immune and respiratory systems. Sema3A, the prototype member of this class III subfamily, induces growth cone collapse and is an inhibitor of axonal sprouting. In perinatal rat cortex as a chemoattractant, it functions to direct, for pyramidal neurons, the orientated extension of apical dendrites. It may play a role, prior to the development of apical dendrites, in signaling the radial migration of newborn cortical neurons towards the upper layers. Sema3A selectively inhibits vascula
Probab=98.67 E-value=1.2e-07 Score=87.22 Aligned_cols=78 Identities=22% Similarity=0.418 Sum_probs=59.0
Q ss_pred ceeecCCCeEEEEEEEeeCCCCCcEEEEeeC--CEE----ccCCCcEEEEeeCCeEEEEEccCCCCCCeEEEEEEE-cCC
Q psy2148 925 DLTLAESTLAHFECRLTPTNDPSMTVEWFHN--GKA----LSAGSRIKTINDFGFVILEINDVYLRDSGLYTCKAT-NKH 997 (1884)
Q Consensus 925 ~~~v~~G~~v~l~C~v~~~~~P~~~v~W~~~--g~~----i~~~~~~~~~~~~~~~~L~I~~~~~~D~G~Y~C~a~-N~~ 997 (1884)
.+.+.+|+++.|.|.. +.|.|.+.|||. +.. +....++.... + .|.|.+++.+|+|.|+|.|. |..
T Consensus 5 ~~~~~eG~~v~L~C~~---~~p~p~v~Wykq~~g~~~~~~~~~~~r~~~~~--~--~L~I~~~~~~DsG~Y~C~a~~~~~ 77 (91)
T cd05871 5 VVYGVENNSTFLECLP---KSPQASVKWLFQRGGDQRKEEVKTEERLIHTE--R--GLLLRSLQRSDAGVYTCTAVEHSF 77 (91)
T ss_pred EEEEecCCcEEEEEEC---CCCCceEEEEEECCCCCccccccccccEEEec--C--eEEEeeCChhHCEEEEEEEEccCC
Confidence 3567899999999995 467889999983 322 22334544322 2 49999999999999999998 577
Q ss_pred eeEEEEEEEEEE
Q psy2148 998 GEATTSCKLTVK 1009 (1884)
Q Consensus 998 G~~~~~~~l~V~ 1009 (1884)
|.....+.|+|.
T Consensus 78 ~~~~~~~~l~v~ 89 (91)
T cd05871 78 SQTLAKYTLHVI 89 (91)
T ss_pred eEEEEEEEEEEe
Confidence 877888888886
No 207
>cd05845 Ig2_L1-CAM_like Second immunoglobulin (Ig)-like domain of the L1 cell adhesion molecule (CAM) and similar proteins. Ig2_L1-CAM_like: domain similar to the second immunoglobulin (Ig)-like domain of the L1 cell adhesion molecule (CAM). L1 belongs to the L1 subfamily of cell adhesion molecules (CAMs) and is comprised of an extracellular region having six Ig-like domains, five fibronectin type III domains, a transmembrane region and an intracellular domain. L1 is primarily expressed in the nervous system and is involved in its development and function. L1 is associated with an X-linked recessive disorder, X-linked hydrocephalus, MASA syndrome, or spastic paraplegia type 1, that involves abnormalities of axonal growth.
Probab=98.67 E-value=3.8e-08 Score=89.44 Aligned_cols=72 Identities=21% Similarity=0.319 Sum_probs=60.7
Q ss_pred cCceEEcCCceEEEEEE-EecCCCcEEEEEeCCEe-cCCCCCeEEeecCCeEEEEEccCCCCCCE-EEEEEEEeCCee
Q psy2148 1749 ISSAVINVGQLARFDAK-ISATKPLDVYWLKNGKK-IIPDIRYKTLEEDNLFTLLIIEAVVEDSG-AYECVAMNNAGE 1823 (1884)
Q Consensus 1749 ~~~~~~~~G~~~~l~C~-~~g~p~p~v~W~k~~~~-l~~~~~~~~~~~~~~~~L~i~~~~~~d~G-~Y~C~a~N~~G~ 1823 (1884)
.+...+.+|+.+.|.|. ..|.|.|.|.|++++.. +..+.|+.+..+| .|.|.++..+|+| .|.|.|+|....
T Consensus 10 ~~~v~V~eG~~~~L~C~pP~g~P~P~i~W~~~~~~~i~~~~Ri~~~~~G---nL~fs~v~~~D~g~~Y~C~a~~~~~~ 84 (95)
T cd05845 10 IRPVEVEEGDSVVLPCNPPKSAVPLRIYWMNSDLLHITQDERVSMGQNG---NLYFANVEEQDSHPDYICHAHFPGLR 84 (95)
T ss_pred cceeEEecCCCEEEEecCCCCCCCCEEEEECCCCccccccccEEECCCc---eEEEEEEehhhCCCCeEEEEEccccc
Confidence 46788999999999997 69999999999988755 4445677666565 8999999999999 899999998754
No 208
>cd05845 Ig2_L1-CAM_like Second immunoglobulin (Ig)-like domain of the L1 cell adhesion molecule (CAM) and similar proteins. Ig2_L1-CAM_like: domain similar to the second immunoglobulin (Ig)-like domain of the L1 cell adhesion molecule (CAM). L1 belongs to the L1 subfamily of cell adhesion molecules (CAMs) and is comprised of an extracellular region having six Ig-like domains, five fibronectin type III domains, a transmembrane region and an intracellular domain. L1 is primarily expressed in the nervous system and is involved in its development and function. L1 is associated with an X-linked recessive disorder, X-linked hydrocephalus, MASA syndrome, or spastic paraplegia type 1, that involves abnormalities of axonal growth.
Probab=98.66 E-value=4.3e-08 Score=89.07 Aligned_cols=78 Identities=15% Similarity=0.248 Sum_probs=61.6
Q ss_pred Ceee-ecCCceeecCCCeEEEEEEE-eeCCCCCcEEEEeeCCEE-ccCCCcEEEEeeCCeEEEEEccCCCCCCe-EEEEE
Q psy2148 917 PEFL-TTPTDLTLAESTLAHFECRL-TPTNDPSMTVEWFHNGKA-LSAGSRIKTINDFGFVILEINDVYLRDSG-LYTCK 992 (1884)
Q Consensus 917 p~~~-~~~~~~~v~~G~~v~l~C~v-~~~~~P~~~v~W~~~g~~-i~~~~~~~~~~~~~~~~L~I~~~~~~D~G-~Y~C~ 992 (1884)
|.|. ...+.+.|.+|+.+.|.|.. . |.|.|.|.|++++.. +..+.|+.+..+| .|.|.+++.+|+| .|.|.
T Consensus 3 ~~~~~~~~~~v~V~eG~~~~L~C~pP~--g~P~P~i~W~~~~~~~i~~~~Ri~~~~~G---nL~fs~v~~~D~g~~Y~C~ 77 (95)
T cd05845 3 PKWPKEKIRPVEVEEGDSVVLPCNPPK--SAVPLRIYWMNSDLLHITQDERVSMGQNG---NLYFANVEEQDSHPDYICH 77 (95)
T ss_pred CcCCccccceeEEecCCCEEEEecCCC--CCCCCEEEEECCCCccccccccEEECCCc---eEEEEEEehhhCCCCeEEE
Confidence 3444 33577899999999999974 5 889999999998755 4556676655543 5999999999999 89999
Q ss_pred EEcCCee
Q psy2148 993 ATNKHGE 999 (1884)
Q Consensus 993 a~N~~G~ 999 (1884)
|+|....
T Consensus 78 a~~~~~~ 84 (95)
T cd05845 78 AHFPGLR 84 (95)
T ss_pred EEccccc
Confidence 9998643
No 209
>smart00409 IG Immunoglobulin.
Probab=98.66 E-value=3.2e-07 Score=85.26 Aligned_cols=83 Identities=33% Similarity=0.569 Sum_probs=70.8
Q ss_pred CceeecCCCeEEEEEEEeeCCCCCcEEEEeeC-CEEccCCCcEEEEeeCCeEEEEEccCCCCCCeEEEEEEEcCCeeEEE
Q psy2148 924 TDLTLAESTLAHFECRLTPTNDPSMTVEWFHN-GKALSAGSRIKTINDFGFVILEINDVYLRDSGLYTCKATNKHGEATT 1002 (1884)
Q Consensus 924 ~~~~v~~G~~v~l~C~v~~~~~P~~~v~W~~~-g~~i~~~~~~~~~~~~~~~~L~I~~~~~~D~G~Y~C~a~N~~G~~~~ 1002 (1884)
....+..|+++.|.|.+. +.+.+.+.|+++ +..+....++..........|.|.++..+|+|.|+|.+.|..|....
T Consensus 2 ~~~~~~~g~~~~l~C~~~--~~~~~~~~W~~~~~~~v~~~~~~~~~~~~~~~~l~i~~~~~~d~G~Y~C~v~~~~~~~~~ 79 (86)
T smart00409 2 PSVTVKEGESVTLSCEVS--GSPPPEVTWYKQGGKLLAESGRFSVSRSGSNSTLTISNVTPEDSGTYTCAATNSSGSASS 79 (86)
T ss_pred CcEEEeCCCeEEEEEEEc--cCCCCeEEEEECCCEEcCCCCcEEEEEcCCeeEEEEEeeccccCeEEEEEEEcCCCeEEE
Confidence 456788999999999998 447889999998 98888677777766655678999999999999999999999988887
Q ss_pred EEEEEE
Q psy2148 1003 SCKLTV 1008 (1884)
Q Consensus 1003 ~~~l~V 1008 (1884)
.+.|.|
T Consensus 80 ~~~l~V 85 (86)
T smart00409 80 TTTLTV 85 (86)
T ss_pred EEEEEE
Confidence 777766
No 210
>smart00410 IG_like Immunoglobulin like. IG domains that cannot be classified into one of IGv1, IGc1, IGc2, IG.
Probab=98.66 E-value=3.2e-07 Score=85.26 Aligned_cols=83 Identities=33% Similarity=0.569 Sum_probs=70.8
Q ss_pred CceeecCCCeEEEEEEEeeCCCCCcEEEEeeC-CEEccCCCcEEEEeeCCeEEEEEccCCCCCCeEEEEEEEcCCeeEEE
Q psy2148 924 TDLTLAESTLAHFECRLTPTNDPSMTVEWFHN-GKALSAGSRIKTINDFGFVILEINDVYLRDSGLYTCKATNKHGEATT 1002 (1884)
Q Consensus 924 ~~~~v~~G~~v~l~C~v~~~~~P~~~v~W~~~-g~~i~~~~~~~~~~~~~~~~L~I~~~~~~D~G~Y~C~a~N~~G~~~~ 1002 (1884)
....+..|+++.|.|.+. +.+.+.+.|+++ +..+....++..........|.|.++..+|+|.|+|.+.|..|....
T Consensus 2 ~~~~~~~g~~~~l~C~~~--~~~~~~~~W~~~~~~~v~~~~~~~~~~~~~~~~l~i~~~~~~d~G~Y~C~v~~~~~~~~~ 79 (86)
T smart00410 2 PSVTVKEGESVTLSCEVS--GSPPPEVTWYKQGGKLLAESGRFSVSRSGSNSTLTISNVTPEDSGTYTCAATNSSGSASS 79 (86)
T ss_pred CcEEEeCCCeEEEEEEEc--cCCCCeEEEEECCCEEcCCCCcEEEEEcCCeeEEEEEeeccccCeEEEEEEEcCCCeEEE
Confidence 456788999999999998 447889999998 98888677777766655678999999999999999999999988887
Q ss_pred EEEEEE
Q psy2148 1003 SCKLTV 1008 (1884)
Q Consensus 1003 ~~~l~V 1008 (1884)
.+.|.|
T Consensus 80 ~~~l~V 85 (86)
T smart00410 80 TTTLTV 85 (86)
T ss_pred EEEEEE
Confidence 777766
No 211
>cd05753 Ig2_FcgammaR_like Second immunoglobulin (Ig)-like domain of Fcgamma-receptors (FcgammaRs) and similar proteins. Ig2_FcgammaR_like: domain similar to the second immunoglobulin (Ig)-like domain of Fcgamma-receptors (FcgammaRs). Interactions between IgG and FcgammaR are important to the initiation of cellular and humoral response. IgG binding to FcgammaR leads to a cascade of signals and ultimately to functions such as antibody-dependent-cellular-cytotoxicity (ADCC), endocytosis, phagocytosis, release of inflammatory mediators, etc. FcgammaR has two Ig-like domains. This group also contains FcepsilonRI, which binds IgE with high affinity.
Probab=98.66 E-value=7.4e-08 Score=87.22 Aligned_cols=73 Identities=19% Similarity=0.221 Sum_probs=56.8
Q ss_pred ceEEcCCceEEEEEEEec-CCCcEEEEEeCCEecCCCCCeEEeecCCeEEEEEccCCCCCCEEEEEEEEeCCeeEE-EEE
Q psy2148 1751 SAVINVGQLARFDAKISA-TKPLDVYWLKNGKKIIPDIRYKTLEEDNLFTLLIIEAVVEDSGAYECVAMNNAGEAR-CEA 1828 (1884)
Q Consensus 1751 ~~~~~~G~~~~l~C~~~g-~p~p~v~W~k~~~~l~~~~~~~~~~~~~~~~L~i~~~~~~d~G~Y~C~a~N~~G~~~-~~~ 1828 (1884)
...+.+|++++|.|.+.+ .+.+.+.|+|+|+.+... .....|.|.+++.+|+|.|+|.|.|..|... ..+
T Consensus 8 ~~~V~~G~~vtL~C~~~~~~~~~~~~w~k~g~~~~~~--------~~~~~l~I~~~~~~dsG~Y~C~~~~~~~~~~s~~~ 79 (83)
T cd05753 8 SRVVFEGEPLVLRCHGWKNKPVYKVTYYRDGKAKKYS--------HSNSNLSIPQATLSDSGSYHCSGIIGSYDYSSEPV 79 (83)
T ss_pred cceecCCCCEEEEeeCCCCCcceEEEEEECCeEcccc--------CCCceEEECccCHHHCEEEEEEEEeCCceecCCCE
Confidence 346889999999999854 667789999999876421 1224899999999999999999999998533 334
Q ss_pred EEE
Q psy2148 1829 ELV 1831 (1884)
Q Consensus 1829 ~l~ 1831 (1884)
+|+
T Consensus 80 ~i~ 82 (83)
T cd05753 80 SIT 82 (83)
T ss_pred EEE
Confidence 444
No 212
>PF13895 Ig_2: Immunoglobulin domain; PDB: 2V5R_B 2V5M_A 2V5S_B 2GI7_A 3LAF_A 4DEP_C 3O4O_B 2EC8_A 2E9W_A 1J87_A ....
Probab=98.66 E-value=1.4e-07 Score=86.12 Aligned_cols=78 Identities=32% Similarity=0.643 Sum_probs=60.5
Q ss_pred CeeeecCCceeecCCCeEEEEEEEeeCCCCCcEEEEeeCCEEccCCCcEEEEeeCCeEEEEEccCCCCCCeEEEEEEEcC
Q psy2148 917 PEFLTTPTDLTLAESTLAHFECRLTPTNDPSMTVEWFHNGKALSAGSRIKTINDFGFVILEINDVYLRDSGLYTCKATNK 996 (1884)
Q Consensus 917 p~~~~~~~~~~v~~G~~v~l~C~v~~~~~P~~~v~W~~~g~~i~~~~~~~~~~~~~~~~L~I~~~~~~D~G~Y~C~a~N~ 996 (1884)
|.+...+ ..+.+|+.+.|.|.+. +.|.+.+.|++++..+..+.. .|.|.++..+|+|.|+|.|.|.
T Consensus 2 P~l~~~~--~~v~~g~~~~l~C~~~--~~p~~~~~w~~~~~~~~~~~~----------~~~~~~~~~~~~g~y~C~~~~~ 67 (80)
T PF13895_consen 2 PVLSSSP--QSVEEGDSVTLTCSVS--GNPPPQVQWYKNGSPINSSQN----------GLFIPNVSPEDSGNYTCRASNG 67 (80)
T ss_dssp -EEEEES--SEEETTSEEEEEEEEE--SSSSSEEEEEETTEEEEEESS----------EEEESSEEGGGTEEEEEEEEET
T ss_pred cEEEccc--eEEeCCCcEEEEEEEE--cccceeeeeeeeeeeeeeeee----------eeeeeeeccccCEEEEEEEEeC
Confidence 4555444 5688999999999998 777889999999988763321 1777889999999999999996
Q ss_pred Ce-eEEEEEEEEE
Q psy2148 997 HG-EATTSCKLTV 1008 (1884)
Q Consensus 997 ~G-~~~~~~~l~V 1008 (1884)
.| ..+..+.|+|
T Consensus 68 ~~~~~s~~~~v~V 80 (80)
T PF13895_consen 68 SGSNTSTSVNVTV 80 (80)
T ss_dssp TEEEEEEEEEEEE
T ss_pred CCCeEeeeEEeeC
Confidence 54 5566777765
No 213
>cd05860 Ig4_SCFR Fourth immunoglobulin (Ig)-like domain of stem cell factor receptor (SCFR). Ig4_SCFR: The fourth Immunoglobulin (Ig)-like domain in stem cell factor receptor (SCFR). SCFR is organized as an extracellular component having five IG-like domains, a transmembrane segment, and a cytoplasmic portion having protein tyrosine kinase activity. SCFR and its ligand SCF are critical for normal hematopoiesis, mast cell development, melanocytes and gametogenesis. SCF binds to the second and third Ig-like domains of SCFR. This fourth Ig-like domain participates in SCFR dimerization, which follows ligand binding. Deletion of this fourth domain abolishes the ligand-induced dimerization of SCFR and completely inhibits signal transduction.
Probab=98.65 E-value=2.2e-07 Score=84.32 Aligned_cols=83 Identities=13% Similarity=0.158 Sum_probs=67.8
Q ss_pred ceeecCCCeEEEEEEEeeCCCCCcE-EEEeeCCEEccCCCcEEEEee-----CCeEEEEEccCCCCCCeEEEEEEEcCCe
Q psy2148 925 DLTLAESTLAHFECRLTPTNDPSMT-VEWFHNGKALSAGSRIKTIND-----FGFVILEINDVYLRDSGLYTCKATNKHG 998 (1884)
Q Consensus 925 ~~~v~~G~~v~l~C~v~~~~~P~~~-v~W~~~g~~i~~~~~~~~~~~-----~~~~~L~I~~~~~~D~G~Y~C~a~N~~G 998 (1884)
.+.|.+|+.+.|.|.+. +.|+|. +.|.+++..+.......+... .-.+.|.+.++..+|+|.|+|.|.|..+
T Consensus 12 ~~~v~~gE~~~L~V~ie--AYP~p~~~~W~~~~~~l~~~~~~~~~~~~~~~~rY~S~L~L~Rlk~~E~G~YTf~a~N~~~ 89 (101)
T cd05860 12 TIFVNAGENLDLIVEYE--AYPKPEHQQWIYMNRTLTNTSDHYVKSRNESNNRYVSELHLTRLKGTEGGTYTFLVSNSDA 89 (101)
T ss_pred eEEEECCCCEEEEEEEE--eCCCCeeeEEEcCCcccCccccceeEEeccCceEEEEEEEEeecChhhCcEEEEEEECCCC
Confidence 47899999999999999 678887 999999887754433112211 1346899999999999999999999999
Q ss_pred eEEEEEEEEEE
Q psy2148 999 EATTSCKLTVK 1009 (1884)
Q Consensus 999 ~~~~~~~l~V~ 1009 (1884)
..+..+.|.|.
T Consensus 90 ~~s~tF~l~v~ 100 (101)
T cd05860 90 SASVTFNVYVN 100 (101)
T ss_pred eEEEEEEEEEe
Confidence 99999999875
No 214
>smart00409 IG Immunoglobulin.
Probab=98.65 E-value=3.6e-07 Score=84.83 Aligned_cols=83 Identities=30% Similarity=0.508 Sum_probs=72.5
Q ss_pred CceEEcCCceEEEEEEEecCCCcEEEEEeC-CEecCCCCCeEEeecCCeEEEEEccCCCCCCEEEEEEEEeCCeeEEEEE
Q psy2148 1750 SSAVINVGQLARFDAKISATKPLDVYWLKN-GKKIIPDIRYKTLEEDNLFTLLIIEAVVEDSGAYECVAMNNAGEARCEA 1828 (1884)
Q Consensus 1750 ~~~~~~~G~~~~l~C~~~g~p~p~v~W~k~-~~~l~~~~~~~~~~~~~~~~L~i~~~~~~d~G~Y~C~a~N~~G~~~~~~ 1828 (1884)
....+..|+++.|.|.+.+.+.+.+.|+++ +..+....++..........|.|.++...|+|.|+|.+.|..|.....+
T Consensus 2 ~~~~~~~g~~~~l~C~~~~~~~~~~~W~~~~~~~v~~~~~~~~~~~~~~~~l~i~~~~~~d~G~Y~C~v~~~~~~~~~~~ 81 (86)
T smart00409 2 PSVTVKEGESVTLSCEVSGSPPPEVTWYKQGGKLLAESGRFSVSRSGSNSTLTISNVTPEDSGTYTCAATNSSGSASSTT 81 (86)
T ss_pred CcEEEeCCCeEEEEEEEccCCCCeEEEEECCCEEcCCCCcEEEEEcCCeeEEEEEeeccccCeEEEEEEEcCCCeEEEEE
Confidence 356678899999999999988899999998 8888767777777766567999999999999999999999999888888
Q ss_pred EEEE
Q psy2148 1829 ELVV 1832 (1884)
Q Consensus 1829 ~l~V 1832 (1884)
.|.|
T Consensus 82 ~l~V 85 (86)
T smart00409 82 TLTV 85 (86)
T ss_pred EEEE
Confidence 8776
No 215
>smart00410 IG_like Immunoglobulin like. IG domains that cannot be classified into one of IGv1, IGc1, IGc2, IG.
Probab=98.65 E-value=3.6e-07 Score=84.83 Aligned_cols=83 Identities=30% Similarity=0.508 Sum_probs=72.5
Q ss_pred CceEEcCCceEEEEEEEecCCCcEEEEEeC-CEecCCCCCeEEeecCCeEEEEEccCCCCCCEEEEEEEEeCCeeEEEEE
Q psy2148 1750 SSAVINVGQLARFDAKISATKPLDVYWLKN-GKKIIPDIRYKTLEEDNLFTLLIIEAVVEDSGAYECVAMNNAGEARCEA 1828 (1884)
Q Consensus 1750 ~~~~~~~G~~~~l~C~~~g~p~p~v~W~k~-~~~l~~~~~~~~~~~~~~~~L~i~~~~~~d~G~Y~C~a~N~~G~~~~~~ 1828 (1884)
....+..|+++.|.|.+.+.+.+.+.|+++ +..+....++..........|.|.++...|+|.|+|.+.|..|.....+
T Consensus 2 ~~~~~~~g~~~~l~C~~~~~~~~~~~W~~~~~~~v~~~~~~~~~~~~~~~~l~i~~~~~~d~G~Y~C~v~~~~~~~~~~~ 81 (86)
T smart00410 2 PSVTVKEGESVTLSCEVSGSPPPEVTWYKQGGKLLAESGRFSVSRSGSNSTLTISNVTPEDSGTYTCAATNSSGSASSTT 81 (86)
T ss_pred CcEEEeCCCeEEEEEEEccCCCCeEEEEECCCEEcCCCCcEEEEEcCCeeEEEEEeeccccCeEEEEEEEcCCCeEEEEE
Confidence 356678899999999999988899999998 8888767777777766567999999999999999999999999888888
Q ss_pred EEEE
Q psy2148 1829 ELVV 1832 (1884)
Q Consensus 1829 ~l~V 1832 (1884)
.|.|
T Consensus 82 ~l~V 85 (86)
T smart00410 82 TLTV 85 (86)
T ss_pred EEEE
Confidence 8776
No 216
>PF13895 Ig_2: Immunoglobulin domain; PDB: 2V5R_B 2V5M_A 2V5S_B 2GI7_A 3LAF_A 4DEP_C 3O4O_B 2EC8_A 2E9W_A 1J87_A ....
Probab=98.65 E-value=1.4e-07 Score=86.04 Aligned_cols=78 Identities=28% Similarity=0.503 Sum_probs=61.5
Q ss_pred CeEEeccCceEEcCCceEEEEEEEecCCCcEEEEEeCCEecCCCCCeEEeecCCeEEEEEccCCCCCCEEEEEEEEeCCe
Q psy2148 1743 PSFLTTISSAVINVGQLARFDAKISATKPLDVYWLKNGKKIIPDIRYKTLEEDNLFTLLIIEAVVEDSGAYECVAMNNAG 1822 (1884)
Q Consensus 1743 P~~~~~~~~~~~~~G~~~~l~C~~~g~p~p~v~W~k~~~~l~~~~~~~~~~~~~~~~L~i~~~~~~d~G~Y~C~a~N~~G 1822 (1884)
|.+...+ ..+.+|+.++|.|.+.+.|.+.+.|++++..+..+. + .|.|.++..+|.|.|+|.|.|..|
T Consensus 2 P~l~~~~--~~v~~g~~~~l~C~~~~~p~~~~~w~~~~~~~~~~~-------~---~~~~~~~~~~~~g~y~C~~~~~~~ 69 (80)
T PF13895_consen 2 PVLSSSP--QSVEEGDSVTLTCSVSGNPPPQVQWYKNGSPINSSQ-------N---GLFIPNVSPEDSGNYTCRASNGSG 69 (80)
T ss_dssp -EEEEES--SEEETTSEEEEEEEEESSSSSEEEEEETTEEEEEES-------S---EEEESSEEGGGTEEEEEEEEETTE
T ss_pred cEEEccc--eEEeCCCcEEEEEEEEcccceeeeeeeeeeeeeeee-------e---eeeeeeeccccCEEEEEEEEeCCC
Confidence 5555444 668899999999999999999999999998775221 1 277788999999999999999664
Q ss_pred -eEEEEEEEEE
Q psy2148 1823 -EARCEAELVV 1832 (1884)
Q Consensus 1823 -~~~~~~~l~V 1832 (1884)
..+.+++|+|
T Consensus 70 ~~~s~~~~v~V 80 (80)
T PF13895_consen 70 SNTSTSVNVTV 80 (80)
T ss_dssp EEEEEEEEEEE
T ss_pred CeEeeeEEeeC
Confidence 5667777776
No 217
>smart00408 IGc2 Immunoglobulin C-2 Type.
Probab=98.60 E-value=1.7e-07 Score=80.90 Aligned_cols=63 Identities=33% Similarity=0.567 Sum_probs=50.9
Q ss_pred CCCeEEEEEEEeeCCCCCcEEEEeeCCEEccCCCcEEEEeeCCeEEEEEccCCCCCCeEEEEEEEcCCe
Q psy2148 930 ESTLAHFECRLTPTNDPSMTVEWFHNGKALSAGSRIKTINDFGFVILEINDVYLRDSGLYTCKATNKHG 998 (1884)
Q Consensus 930 ~G~~v~l~C~v~~~~~P~~~v~W~~~g~~i~~~~~~~~~~~~~~~~L~I~~~~~~D~G~Y~C~a~N~~G 998 (1884)
+|++++|.|.+. +.|.+.+.|++++..+.. ...... ....|.|.+++.+|+|.|+|.|.|..|
T Consensus 1 ~g~~~~l~C~~~--~~~~~~v~W~~~~~~~~~--~~~~~~--~~~~L~i~~~~~~d~G~Y~C~~~n~~g 63 (63)
T smart00408 1 EGQSVTLTCPAE--GDPVPNITWLKDGKPLPE--SNRLSA--SGSTLTIKSVSLEDSGEYTCVAENSAG 63 (63)
T ss_pred CCceEEEEeeCc--cCCCCeEEEEECCEECCC--CCEEec--CCcEEEEeeCCcccCEEEEEEEecCCC
Confidence 588999999986 678889999999998872 222222 233799999999999999999999865
No 218
>smart00408 IGc2 Immunoglobulin C-2 Type.
Probab=98.60 E-value=1.9e-07 Score=80.55 Aligned_cols=63 Identities=33% Similarity=0.474 Sum_probs=52.1
Q ss_pred CCceEEEEEEEecCCCcEEEEEeCCEecCCCCCeEEeecCCeEEEEEccCCCCCCEEEEEEEEeCCe
Q psy2148 1756 VGQLARFDAKISATKPLDVYWLKNGKKIIPDIRYKTLEEDNLFTLLIIEAVVEDSGAYECVAMNNAG 1822 (1884)
Q Consensus 1756 ~G~~~~l~C~~~g~p~p~v~W~k~~~~l~~~~~~~~~~~~~~~~L~i~~~~~~d~G~Y~C~a~N~~G 1822 (1884)
+|++++|.|.+.+.|.+.+.|++++..+. ....... ....|.|.++..+|+|.|+|.|.|..|
T Consensus 1 ~g~~~~l~C~~~~~~~~~v~W~~~~~~~~--~~~~~~~--~~~~L~i~~~~~~d~G~Y~C~~~n~~g 63 (63)
T smart00408 1 EGQSVTLTCPAEGDPVPNITWLKDGKPLP--ESNRLSA--SGSTLTIKSVSLEDSGEYTCVAENSAG 63 (63)
T ss_pred CCceEEEEeeCccCCCCeEEEEECCEECC--CCCEEec--CCcEEEEeeCCcccCEEEEEEEecCCC
Confidence 48899999999999999999999999887 2222222 234899999999999999999999875
No 219
>cd05885 Ig2_Necl-4 Second immunoglobulin (Ig)-like domain of nectin-like molecule-4 (Necl-4, also known as cell adhesion molecule 4 (CADM4)). Ig2_Necl-4: second immunoglobulin (Ig)-like domain of nectin-like molecule-4 (Necl-4, also known as cell adhesion molecule 4 (CADM4)). Nectin-like molecules have similar domain structures to those of nectins. At least five nectin-like molecules have been identified (Necl-1-Necl-5). These have an extracellular region containing three Ig-like domains, one transmembrane region, and one cytoplasmic region. Ig domains are likely to participate in ligand binding and recognition. Necl-4 is expressed on Schwann cells, and plays a key part in initiating peripheral nervous system (PNS) myelination. In injured peripheral nerve cells, the mRNA signal for both Necl-4 and Necl-5 was observed to be elevated. Necl-4 participates in cell-cell adhesion and is proposed to play a role in tumor suppression.
Probab=98.57 E-value=1.8e-07 Score=81.85 Aligned_cols=65 Identities=15% Similarity=0.268 Sum_probs=50.2
Q ss_pred EEEEEEEeeCCCCCcEEEEeeCCEEccCCCcEEEEee---CCeEEEEEccCCCCCCeEEEEEEEcCCeeE
Q psy2148 934 AHFECRLTPTNDPSMTVEWFHNGKALSAGSRIKTIND---FGFVILEINDVYLRDSGLYTCKATNKHGEA 1000 (1884)
Q Consensus 934 v~l~C~v~~~~~P~~~v~W~~~g~~i~~~~~~~~~~~---~~~~~L~I~~~~~~D~G~Y~C~a~N~~G~~ 1000 (1884)
+.|.|...+ +.|++.|+|||||++|..... ..... ....+|.+.....+|.+.|+|.|.|.++..
T Consensus 2 ~~L~C~s~~-skP~a~i~W~k~~~~l~~~~~-~~~~~~~~t~~s~L~~~~~~~Ddg~~~~C~A~n~a~~~ 69 (80)
T cd05885 2 VELTCLSPR-SKPAATLRWYRDRKELKGVIS-QQENGKTVSVSNTIRFPVDRKDDGAILSCEASHPALVS 69 (80)
T ss_pred EEEEEeCCC-ccCCCeEEEEECCEECCCCcc-cccCCceEEEEEEEEEEeeeccCCcEEEEEEEChhhCC
Confidence 789999986 899999999999999965321 11111 013369999999999999999999998753
No 220
>cd05872 Ig_Sema4B_like Immunoglobulin (Ig)-like domain of the class IV semaphorin Sema4B. Ig_Sema4B_like; Immunoglobulin (Ig)-like domain of Sema4B_like. Sema4B is a Class IV semaphorin. Semaphorins are classified based on structural features additional to the Sema domain. Sema4B has extracellular Sema and Ig domains, a transmembrane domain and a short cytoplasmic domain. Sema4B has been shown to preferentially regulate the development of the postsynaptic specialization at the glutamatergic synapses. This cytoplasmic domain includes a PDZ-binding motif upon which the synaptic localization of Sem4B is dependent. Sema4B is a ligand of CLCP1, CLCP1 was identified in an expression profiling analysis, which compared a highly metastic lung cancer subline with its low metastic parental line. Sema4B was shown to promote CLCP1 endocytosis, and their interaction is a potential target for therapeutic intervention of metastasis.
Probab=98.56 E-value=3e-07 Score=81.89 Aligned_cols=78 Identities=22% Similarity=0.300 Sum_probs=62.0
Q ss_pred CceeecCCCeEEEEEEEeeCCCCCcEEEEeeCCEEccCCCcEEEEeeCCeEEEEEccCCCCCCeEEEEEEEcCCeeEEEE
Q psy2148 924 TDLTLAESTLAHFECRLTPTNDPSMTVEWFHNGKALSAGSRIKTINDFGFVILEINDVYLRDSGLYTCKATNKHGEATTS 1003 (1884)
Q Consensus 924 ~~~~v~~G~~v~l~C~v~~~~~P~~~v~W~~~g~~i~~~~~~~~~~~~~~~~L~I~~~~~~D~G~Y~C~a~N~~G~~~~~ 1003 (1884)
++.++.+|+++.|.|... .+.+.+.|+++|..|..+.++.....+ |.|.+++.+|+|.|.|.+. ..|-...-
T Consensus 4 ~~~tv~~g~~v~L~C~~~---s~~A~v~W~~ng~~l~~~~r~~~~~~G----LlI~~~~~~dsG~Y~C~s~-E~gf~~~~ 75 (85)
T cd05872 4 KNRTVAPGADVVLPCQLR---SNLASPVWLFNGTPLNAQFSYRVGTDG----LLILVTSPEHSGTYRCYSE-EEGFQQLV 75 (85)
T ss_pred eEEEEecCCCEEEECCCC---CCCccEEEEECCcccCCCcceEEeCCC----CEEEECCHhhCEEEEEEEe-cCCCeEEE
Confidence 567899999999999996 346699999999999888777665554 8899999999999999987 44655554
Q ss_pred EEEEEE
Q psy2148 1004 CKLTVK 1009 (1884)
Q Consensus 1004 ~~l~V~ 1009 (1884)
+.+.+.
T Consensus 76 ~~y~l~ 81 (85)
T cd05872 76 ASYSLN 81 (85)
T ss_pred EEEEEE
Confidence 444443
No 221
>cd05885 Ig2_Necl-4 Second immunoglobulin (Ig)-like domain of nectin-like molecule-4 (Necl-4, also known as cell adhesion molecule 4 (CADM4)). Ig2_Necl-4: second immunoglobulin (Ig)-like domain of nectin-like molecule-4 (Necl-4, also known as cell adhesion molecule 4 (CADM4)). Nectin-like molecules have similar domain structures to those of nectins. At least five nectin-like molecules have been identified (Necl-1-Necl-5). These have an extracellular region containing three Ig-like domains, one transmembrane region, and one cytoplasmic region. Ig domains are likely to participate in ligand binding and recognition. Necl-4 is expressed on Schwann cells, and plays a key part in initiating peripheral nervous system (PNS) myelination. In injured peripheral nerve cells, the mRNA signal for both Necl-4 and Necl-5 was observed to be elevated. Necl-4 participates in cell-cell adhesion and is proposed to play a role in tumor suppression.
Probab=98.52 E-value=3.4e-07 Score=80.20 Aligned_cols=65 Identities=12% Similarity=0.111 Sum_probs=50.5
Q ss_pred EEEEEEEeecCCCCCeEEEeeCCccCCCCCCeEEEeeC---CEEEEEEcccCcCCCeEEEEEEEecCceE
Q psy2148 725 AHFEARLTPTDDPKLKVEWFWNGKPMKTGSRFRTFCDF---GFVILEISPVYPEDCGQYSCRAYNDYGEA 791 (1884)
Q Consensus 725 ~~l~C~~~~~g~p~~~v~W~k~g~~l~~~~~~~~~~~~---~~~~L~i~~~~~~d~G~Y~C~a~N~~g~~ 791 (1884)
++|+|...+ +.|+++++|||||++|..... ....+. ...+|.|.....+|.+.|+|+|.|.++..
T Consensus 2 ~~L~C~s~~-skP~a~i~W~k~~~~l~~~~~-~~~~~~~~t~~s~L~~~~~~~Ddg~~~~C~A~n~a~~~ 69 (80)
T cd05885 2 VELTCLSPR-SKPAATLRWYRDRKELKGVIS-QQENGKTVSVSNTIRFPVDRKDDGAILSCEASHPALVS 69 (80)
T ss_pred EEEEEeCCC-ccCCCeEEEEECCEECCCCcc-cccCCceEEEEEEEEEEeeeccCCcEEEEEEEChhhCC
Confidence 689999875 799999999999999965321 111110 23469999999999999999999998864
No 222
>cd05881 Ig1_Necl-2 First (N-terminal) immunoglobulin (Ig)-like domain of nectin-like molecule 2 (also known as cell adhesion molecule 1 (CADM1)). Ig1_Necl-2: domain similar to the N-terminal immunoglobulin (Ig)-like domain of nectin-like molecule-2, Necl-2 (also known as cell adhesion molecule 1 (CADM1), SynCAM1, IGSF4A, Tslc1, sgIGSF, and RA175). Nectin-like molecules have similar domain structures to those of nectins. At least five nectin-like molecules have been identified (Necl-1 - Necl-5). They all have an extracellular region containing three Ig-like domains, a transmembrane region, and a cytoplasmic region. The N-terminal Ig-like domain of the extracellular region, belongs to the V-type subfamily of Ig domains, is essential to cell-cell adhesion, and plays a part in the interaction with the envelope glycoprotein D of various viruses. Necl-2 has Ca(2+)-independent homophilic and heterophilic cell-cell adhesion activity. Necl-2 is expressed in a wide variety of tissues, and is a
Probab=98.52 E-value=1e-06 Score=80.80 Aligned_cols=70 Identities=23% Similarity=0.444 Sum_probs=56.0
Q ss_pred CceeecCCCeEEEEEEEeeCCCCCcEEEEeeCCEEc--------cCCCcEEEEe-eCCeEEEEEccCCCCCCeEEEEEEE
Q psy2148 924 TDLTLAESTLAHFECRLTPTNDPSMTVEWFHNGKAL--------SAGSRIKTIN-DFGFVILEINDVYLRDSGLYTCKAT 994 (1884)
Q Consensus 924 ~~~~v~~G~~v~l~C~v~~~~~P~~~v~W~~~g~~i--------~~~~~~~~~~-~~~~~~L~I~~~~~~D~G~Y~C~a~ 994 (1884)
+++++.+|++++|+|.++ +.....+.|++-+..+ ..+.|+.... .+...+|.|.+++.+|+|.|.|.+.
T Consensus 5 ~nvtv~~G~ta~L~C~v~--~~~~~~v~w~~~~~~~i~~~~~~~~~d~Rf~~~~~~~~~~tL~I~~vq~~D~G~Y~Cqv~ 82 (95)
T cd05881 5 EDVTVVEGEVAIISCRVK--NNDDSVIQLLNPNRQTIYFRDVRPLKDSRFQLVNFSSNELRVSLSNVSLSDEGRYFCQLY 82 (95)
T ss_pred CceEEcCCCcEEEEEEEc--cCCccEEEEEecCCcEEEecCccccCCcCEEEEeCCCCEEEEEECcCCcccCEEEEEEEE
Confidence 678999999999999998 4444568888765432 3567887665 4567789999999999999999996
Q ss_pred c
Q psy2148 995 N 995 (1884)
Q Consensus 995 N 995 (1884)
.
T Consensus 83 t 83 (95)
T cd05881 83 T 83 (95)
T ss_pred c
Confidence 5
No 223
>cd05896 Ig1_IL1RAPL-1_like First immunoglobulin (Ig)-like domain of X-linked interleukin-1 receptor accessory protein-like 1 (IL1RAPL-1). Ig1_ IL1RAPL-1_like: domain similar to the first immunoglobulin (Ig)-like domain of X-linked interleukin-1 receptor accessory protein-like 1 (IL1RAPL-1). IL-1 alpha and IL-1 beta are cytokines which participates in the regulation of inflammation, immune responses, and hematopoiesis. These cytokines bind to the IL-1 receptor type 1 (IL1R1), which is activated on additional association with an accessory protein, IL1RAP. IL-1 also binds a second receptor designated type II (IL1R2). Mature IL1R1 consists of three Ig-like domains, a transmembrane domain, and a large cytoplasmic domain. Mature IL1R2 is organized similarly except that it has a short cytoplasmic domain. The latter does not initiate signal transduction. A naturally occurring cytokine IL-1RA (IL-1 receptor antagonist) is widely expressed and binds to IL-1 receptors, inhibiting the binding of
Probab=98.51 E-value=4.9e-07 Score=82.30 Aligned_cols=82 Identities=20% Similarity=0.315 Sum_probs=60.1
Q ss_pred ceeecCCCeEEEEEEEee---------CCCCCcEEEEeeCCEEccCCCc-----EEEEeeCCeEEEEEccCCCCCCeEEE
Q psy2148 925 DLTLAESTLAHFECRLTP---------TNDPSMTVEWFHNGKALSAGSR-----IKTINDFGFVILEINDVYLRDSGLYT 990 (1884)
Q Consensus 925 ~~~v~~G~~v~l~C~v~~---------~~~P~~~v~W~~~g~~i~~~~~-----~~~~~~~~~~~L~I~~~~~~D~G~Y~ 990 (1884)
...+.+|+++.|.|..-. ...+...|+|+|++..+..... .++...+. .|.|.++..+|+|.|+
T Consensus 9 ~~~~~~GE~v~l~C~~~~~~~~~~~~~~~~~~~~v~WyK~~~~~~~~~~~~~~~~Ri~~~~~--~Lwf~Pa~~eDSG~Y~ 86 (104)
T cd05896 9 KYMVLAGEPVRIKCALFYGYIRTNYSMAQSAGLSLMWYKSSGDGEEPIEIIFDGVRMSKEED--SIWFRPAELQDSGLYT 86 (104)
T ss_pred eEEEcCCCeEEEECCCccccccccccccccCCceEEEEECCCCCCCCCcccccceeEEEeCC--EEEEEeCChhhCeEEE
Confidence 467899999999999710 0122347999999866654331 23333333 6999999999999999
Q ss_pred EEEEcCCeeEEEEEEEEE
Q psy2148 991 CKATNKHGEATTSCKLTV 1008 (1884)
Q Consensus 991 C~a~N~~G~~~~~~~l~V 1008 (1884)
|++.|.......++.|+|
T Consensus 87 C~~rN~t~C~~~~i~l~V 104 (104)
T cd05896 87 CVLRNSTYCMKVSMSLTV 104 (104)
T ss_pred EEECCCCcceEEEEEEEC
Confidence 999999877777777765
No 224
>cd05896 Ig1_IL1RAPL-1_like First immunoglobulin (Ig)-like domain of X-linked interleukin-1 receptor accessory protein-like 1 (IL1RAPL-1). Ig1_ IL1RAPL-1_like: domain similar to the first immunoglobulin (Ig)-like domain of X-linked interleukin-1 receptor accessory protein-like 1 (IL1RAPL-1). IL-1 alpha and IL-1 beta are cytokines which participates in the regulation of inflammation, immune responses, and hematopoiesis. These cytokines bind to the IL-1 receptor type 1 (IL1R1), which is activated on additional association with an accessory protein, IL1RAP. IL-1 also binds a second receptor designated type II (IL1R2). Mature IL1R1 consists of three Ig-like domains, a transmembrane domain, and a large cytoplasmic domain. Mature IL1R2 is organized similarly except that it has a short cytoplasmic domain. The latter does not initiate signal transduction. A naturally occurring cytokine IL-1RA (IL-1 receptor antagonist) is widely expressed and binds to IL-1 receptors, inhibiting the binding of
Probab=98.51 E-value=3.6e-07 Score=83.15 Aligned_cols=81 Identities=14% Similarity=0.243 Sum_probs=60.9
Q ss_pred CceeecCCCeEEEEEEEe-----------ccCCCeEEEEeCCeecCCCCC-----eEEEEeCceeEEEEcccccCCCeEE
Q psy2148 1647 QPCRAFEQDQARFEVEFD-----------GDPLPTIKWFREDFPITSSPD-----FQIHTFSTKSILIMRQVFMEDSGVF 1710 (1884)
Q Consensus 1647 ~~~~v~~G~~~~l~C~~~-----------g~p~~~i~W~~~~~~~~~~~~-----~~~~~~~~~~~L~i~~v~~~DsG~Y 1710 (1884)
....+.+|+++.|.|... ......+.|+|++..+..... .++. ..+..|.|.++..+|+|.|
T Consensus 8 ~~~~~~~GE~v~l~C~~~~~~~~~~~~~~~~~~~~v~WyK~~~~~~~~~~~~~~~~Ri~--~~~~~Lwf~Pa~~eDSG~Y 85 (104)
T cd05896 8 KKYMVLAGEPVRIKCALFYGYIRTNYSMAQSAGLSLMWYKSSGDGEEPIEIIFDGVRMS--KEEDSIWFRPAELQDSGLY 85 (104)
T ss_pred eeEEEcCCCeEEEECCCccccccccccccccCCceEEEEECCCCCCCCCcccccceeEE--EeCCEEEEEeCChhhCeEE
Confidence 346788999999999862 223458999999855443321 1222 2345699999999999999
Q ss_pred EEEEEeCCceEEEEEEEEE
Q psy2148 1711 AVIAENRGGKAKCSANLVV 1729 (1884)
Q Consensus 1711 ~C~a~n~~g~~~~~~~l~V 1729 (1884)
+|++.|.......++.|+|
T Consensus 86 ~C~~rN~t~C~~~~i~l~V 104 (104)
T cd05896 86 TCVLRNSTYCMKVSMSLTV 104 (104)
T ss_pred EEEECCCCcceEEEEEEEC
Confidence 9999999888888887765
No 225
>PHA03376 BARF1; Provisional
Probab=98.51 E-value=1e-06 Score=86.65 Aligned_cols=125 Identities=15% Similarity=0.190 Sum_probs=83.2
Q ss_pred CceeecCCCeEEEEEEEe---ccCCCeEEEEeCC----ee-c------------CCCCCeEEEEeCceeEEEEcccccCC
Q psy2148 1647 QPCRAFEQDQARFEVEFD---GDPLPTIKWFRED----FP-I------------TSSPDFQIHTFSTKSILIMRQVFMED 1706 (1884)
Q Consensus 1647 ~~~~v~~G~~~~l~C~~~---g~p~~~i~W~~~~----~~-~------------~~~~~~~~~~~~~~~~L~i~~v~~~D 1706 (1884)
..+.+..|+.+.|.|... ..+...|.|+|.+ .. + ....++.+....++.+|.|.+++.+|
T Consensus 19 ~pVta~VGEda~LsC~lnp~ssa~~MrIrWqKs~p~~~~VvL~~~ggdVv~~QmEyRGrtD~~~~~gnvsLvI~~l~lSD 98 (221)
T PHA03376 19 QAVTAFLGERVTLTSYWRRVSLGPEIEVSWFKLGPGEEQVLIGRMHHDVIFIEWPFRGFFDIHRSANTFFLVVTAANISH 98 (221)
T ss_pred cchhheeCCcEEEEecccCccCCCceEEEEEecCCCCCCEEEEEcCCeeeeeeeccccEEEEEecCCeEEEEEEeeeecC
Confidence 467788999999999775 2356789999942 11 1 11123344444677899999999999
Q ss_pred CeEEEEEEEeCCceEEEEEEEEEEecccCCCCCCCCCeEEeccCceEEcCCceEEEEEEEecCCCcEEEEEeCCE
Q psy2148 1707 SGVFAVIAENRGGKAKCSANLVVEEKRQGGRGGVVPPSFLTTISSAVINVGQLARFDAKISATKPLDVYWLKNGK 1781 (1884)
Q Consensus 1707 sG~Y~C~a~n~~g~~~~~~~l~V~~~~~~~~~~~~~P~~~~~~~~~~~~~G~~~~l~C~~~g~p~p~v~W~k~~~ 1781 (1884)
.|.|+|............-.|++.. |-.+...........-+..++.|.+.|.|.|.++|.-+..
T Consensus 99 dGtY~C~fQkge~~~~k~ehLt~V~----------~~~Lsv~a~~~dFp~~~~~~i~C~sggfP~P~~~Wle~~~ 163 (221)
T PHA03376 99 DGNYLCRMKLGETEVTKQEHLSVVK----------PLTLSVHSERSQFPDFSVLTVTCTVNAFPHPHVQWLMPEG 163 (221)
T ss_pred CceEEEEEEcCCCceeeeeeeeeee----------cceEEEEeccccCCCCCeeEEEEecCCcCCchheeccccC
Confidence 9999999987665555555555542 1111111111111114557899998889999999987754
No 226
>cd05881 Ig1_Necl-2 First (N-terminal) immunoglobulin (Ig)-like domain of nectin-like molecule 2 (also known as cell adhesion molecule 1 (CADM1)). Ig1_Necl-2: domain similar to the N-terminal immunoglobulin (Ig)-like domain of nectin-like molecule-2, Necl-2 (also known as cell adhesion molecule 1 (CADM1), SynCAM1, IGSF4A, Tslc1, sgIGSF, and RA175). Nectin-like molecules have similar domain structures to those of nectins. At least five nectin-like molecules have been identified (Necl-1 - Necl-5). They all have an extracellular region containing three Ig-like domains, a transmembrane region, and a cytoplasmic region. The N-terminal Ig-like domain of the extracellular region, belongs to the V-type subfamily of Ig domains, is essential to cell-cell adhesion, and plays a part in the interaction with the envelope glycoprotein D of various viruses. Necl-2 has Ca(2+)-independent homophilic and heterophilic cell-cell adhesion activity. Necl-2 is expressed in a wide variety of tissues, and is a
Probab=98.50 E-value=1.1e-06 Score=80.57 Aligned_cols=71 Identities=13% Similarity=0.145 Sum_probs=57.6
Q ss_pred CCceeecCCCeEEEEEEEeccCCCeEEEEeCCeec--------CCCCCeEEEE-eCceeEEEEcccccCCCeEEEEEEEe
Q psy2148 1646 IQPCRAFEQDQARFEVEFDGDPLPTIKWFREDFPI--------TSSPDFQIHT-FSTKSILIMRQVFMEDSGVFAVIAEN 1716 (1884)
Q Consensus 1646 ~~~~~v~~G~~~~l~C~~~g~p~~~i~W~~~~~~~--------~~~~~~~~~~-~~~~~~L~i~~v~~~DsG~Y~C~a~n 1716 (1884)
.+++.+.+|+++.|.|.+.+.....+.|++.+..+ ..++||.... .+...+|.|.+++.+|+|.|.|.+..
T Consensus 4 ~~nvtv~~G~ta~L~C~v~~~~~~~v~w~~~~~~~i~~~~~~~~~d~Rf~~~~~~~~~~tL~I~~vq~~D~G~Y~Cqv~t 83 (95)
T cd05881 4 TEDVTVVEGEVAIISCRVKNNDDSVIQLLNPNRQTIYFRDVRPLKDSRFQLVNFSSNELRVSLSNVSLSDEGRYFCQLYT 83 (95)
T ss_pred cCceEEcCCCcEEEEEEEccCCccEEEEEecCCcEEEecCccccCCcCEEEEeCCCCEEEEEECcCCcccCEEEEEEEEc
Confidence 35688999999999999999877778888766432 3566777665 35567899999999999999999865
No 227
>PHA03376 BARF1; Provisional
Probab=98.49 E-value=4.9e-06 Score=82.08 Aligned_cols=123 Identities=17% Similarity=0.209 Sum_probs=80.4
Q ss_pred ccCCCceEEEEEEEEEc-CCCceEEEEeeCCE----e-------------eccccceEEEeeCCeEEEEEcCCCCCCCEE
Q psy2148 319 NLSEGEIAHFEASLIPV-GDQTMTVEFLYNGK----P-------------IEASHRIRTVHAFGMVVLEILGTKIEDTGV 380 (1884)
Q Consensus 319 ~v~~g~~~~l~c~~~~~-g~p~~~i~W~k~g~----~-------------i~~~~~~~~~~~~~~~~L~I~~~~~~D~G~ 380 (1884)
....||.+.|.|...+. ..+...|.|+|.+. . .....++.+..+.++.+|.|.+++.+|.|.
T Consensus 22 ta~VGEda~LsC~lnp~ssa~~MrIrWqKs~p~~~~VvL~~~ggdVv~~QmEyRGrtD~~~~~gnvsLvI~~l~lSDdGt 101 (221)
T PHA03376 22 TAFLGERVTLTSYWRRVSLGPEIEVSWFKLGPGEEQVLIGRMHHDVIFIEWPFRGFFDIHRSANTFFLVVTAANISHDGN 101 (221)
T ss_pred hheeCCcEEEEecccCccCCCceEEEEEecCCCCCCEEEEEcCCeeeeeeeccccEEEEEecCCeEEEEEEeeeecCCce
Confidence 46789999999987532 34778999999421 1 122344556666789999999999999999
Q ss_pred EEEEEEcCCeeeEEEEEEEEeecCCCCCCceEeccCCccCccCCCeEEEEEEEeeCCCCCCeEEEeeCC
Q psy2148 381 YTCRATNKWGQAEISVNLECVDKSKGQPPKFTSHIKSLEGLKDGDSAHFECTLTPVNDPELKVEWFHNG 449 (1884)
Q Consensus 381 Y~C~a~n~~g~~~~~~~l~V~~~~~~~~p~~~~~~~~~~~v~~G~~v~L~C~~~~~~~p~~~i~W~k~g 449 (1884)
|+|............-.|++. .|-.+....... ....-+..++.|.+. +.|.|.++|.-+.
T Consensus 102 Y~C~fQkge~~~~k~ehLt~V-----~~~~Lsv~a~~~-dFp~~~~~~i~C~sg--gfP~P~~~Wle~~ 162 (221)
T PHA03376 102 YLCRMKLGETEVTKQEHLSVV-----KPLTLSVHSERS-QFPDFSVLTVTCTVN--AFPHPHVQWLMPE 162 (221)
T ss_pred EEEEEEcCCCceeeeeeeeee-----ecceEEEEeccc-cCCCCCeeEEEEecC--CcCCchheecccc
Confidence 999998765444333333332 111122111000 011245678999943 8999999998763
No 228
>PF00047 ig: Immunoglobulin domain The Prosite family only concerns antibodies and MHCs.; InterPro: IPR013151 Members of the immunoglobulin superfamily are found in hundreds of proteins of different functions. Examples include antibodies, the giant muscle kinase titin and receptor tyrosine kinases. Immunoglobulin-like domains may be involved in protein-protein and protein-ligand interactions. The Pfam alignments do not include the first and last strand of the immunoglobulin-like domain.; PDB: 1B6U_A 3O4O_C 3VH8_H 1BIH_A 2C9A_A 2V5Y_A 1BQH_K 2ATP_A 3B9K_A 1NEZ_H ....
Probab=98.49 E-value=3.3e-07 Score=79.05 Aligned_cols=62 Identities=31% Similarity=0.539 Sum_probs=48.2
Q ss_pred CCeEEEEEEEeeCCCCCcEEEEeeCCEEccCCCcEEEEeeCCe--EEEEEccCCCCCCeEEEEEE
Q psy2148 931 STLAHFECRLTPTNDPSMTVEWFHNGKALSAGSRIKTINDFGF--VILEINDVYLRDSGLYTCKA 993 (1884)
Q Consensus 931 G~~v~l~C~v~~~~~P~~~v~W~~~g~~i~~~~~~~~~~~~~~--~~L~I~~~~~~D~G~Y~C~a 993 (1884)
|++++|.|.+. .+.|...+.|+|++..+.............. ..|.|.+++.+|+|.|+|.|
T Consensus 1 G~~v~L~C~~~-~~~~~~~~~W~~~~~~~~~~~~~~~~~~~~~~~~~L~i~~v~~~d~G~Y~C~v 64 (64)
T PF00047_consen 1 GSSVTLTCSVS-SGPPPTTVTWSKNGQSLPEGSTTNRSTNSVSSTSRLTISNVTPEDSGTYTCVV 64 (64)
T ss_dssp TSEEEEEEEEE-ESSSTSEEEEEETTTTTSEEEEEEEEETTTEEEEEEEESSCTGGGTEEEEEEE
T ss_pred CCeEEEEeecC-CCCCCcEEEEEECCccccCcceeEeecccceeeeEEEEccCCHHHCEEEEEEC
Confidence 78999999992 2778889999999987766554444333221 13999999999999999987
No 229
>PF00047 ig: Immunoglobulin domain The Prosite family only concerns antibodies and MHCs.; InterPro: IPR013151 Members of the immunoglobulin superfamily are found in hundreds of proteins of different functions. Examples include antibodies, the giant muscle kinase titin and receptor tyrosine kinases. Immunoglobulin-like domains may be involved in protein-protein and protein-ligand interactions. The Pfam alignments do not include the first and last strand of the immunoglobulin-like domain.; PDB: 1B6U_A 3O4O_C 3VH8_H 1BIH_A 2C9A_A 2V5Y_A 1BQH_K 2ATP_A 3B9K_A 1NEZ_H ....
Probab=98.43 E-value=5.1e-07 Score=77.80 Aligned_cols=61 Identities=28% Similarity=0.441 Sum_probs=48.7
Q ss_pred CceEEEEEEE-ecCCCcEEEEEeCCEecCCCCCeEEeecCCeE--EEEEccCCCCCCEEEEEEE
Q psy2148 1757 GQLARFDAKI-SATKPLDVYWLKNGKKIIPDIRYKTLEEDNLF--TLLIIEAVVEDSGAYECVA 1817 (1884)
Q Consensus 1757 G~~~~l~C~~-~g~p~p~v~W~k~~~~l~~~~~~~~~~~~~~~--~L~i~~~~~~d~G~Y~C~a 1817 (1884)
|++++|.|.+ .+.+.+.+.|+|++..+............... .|.|.+++.+|+|.|+|.|
T Consensus 1 G~~v~L~C~~~~~~~~~~~~W~~~~~~~~~~~~~~~~~~~~~~~~~L~i~~v~~~d~G~Y~C~v 64 (64)
T PF00047_consen 1 GSSVTLTCSVSSGPPPTTVTWSKNGQSLPEGSTTNRSTNSVSSTSRLTISNVTPEDSGTYTCVV 64 (64)
T ss_dssp TSEEEEEEEEEESSSTSEEEEEETTTTTSEEEEEEEEETTTEEEEEEEESSCTGGGTEEEEEEE
T ss_pred CCeEEEEeecCCCCCCcEEEEEECCccccCcceeEeecccceeeeEEEEccCCHHHCEEEEEEC
Confidence 7899999999 77888999999999877655544443333211 3999999999999999986
No 230
>cd05872 Ig_Sema4B_like Immunoglobulin (Ig)-like domain of the class IV semaphorin Sema4B. Ig_Sema4B_like; Immunoglobulin (Ig)-like domain of Sema4B_like. Sema4B is a Class IV semaphorin. Semaphorins are classified based on structural features additional to the Sema domain. Sema4B has extracellular Sema and Ig domains, a transmembrane domain and a short cytoplasmic domain. Sema4B has been shown to preferentially regulate the development of the postsynaptic specialization at the glutamatergic synapses. This cytoplasmic domain includes a PDZ-binding motif upon which the synaptic localization of Sem4B is dependent. Sema4B is a ligand of CLCP1, CLCP1 was identified in an expression profiling analysis, which compared a highly metastic lung cancer subline with its low metastic parental line. Sema4B was shown to promote CLCP1 endocytosis, and their interaction is a potential target for therapeutic intervention of metastasis.
Probab=98.40 E-value=1.2e-06 Score=78.13 Aligned_cols=78 Identities=22% Similarity=0.378 Sum_probs=62.1
Q ss_pred CceEEcCCceEEEEEEEecCCCcEEEEEeCCEecCCCCCeEEeecCCeEEEEEccCCCCCCEEEEEEEEeCCeeEE--EE
Q psy2148 1750 SSAVINVGQLARFDAKISATKPLDVYWLKNGKKIIPDIRYKTLEEDNLFTLLIIEAVVEDSGAYECVAMNNAGEAR--CE 1827 (1884)
Q Consensus 1750 ~~~~~~~G~~~~l~C~~~g~p~p~v~W~k~~~~l~~~~~~~~~~~~~~~~L~i~~~~~~d~G~Y~C~a~N~~G~~~--~~ 1827 (1884)
...++..|+.+.|.|...+. .+.+.|+++|..+..+.++.....+ |.|.+++.+|+|.|.|.+. +.|-.. .+
T Consensus 4 ~~~tv~~g~~v~L~C~~~s~-~A~v~W~~ng~~l~~~~r~~~~~~G----LlI~~~~~~dsG~Y~C~s~-E~gf~~~~~~ 77 (85)
T cd05872 4 KNRTVAPGADVVLPCQLRSN-LASPVWLFNGTPLNAQFSYRVGTDG----LLILVTSPEHSGTYRCYSE-EEGFQQLVAS 77 (85)
T ss_pred eEEEEecCCCEEEECCCCCC-CccEEEEECCcccCCCcceEEeCCC----CEEEECCHhhCEEEEEEEe-cCCCeEEEEE
Confidence 45678899999999999886 5699999999999887777766554 7899999999999999985 445444 44
Q ss_pred EEEEEE
Q psy2148 1828 AELVVQ 1833 (1884)
Q Consensus 1828 ~~l~V~ 1833 (1884)
..|.|.
T Consensus 78 y~l~v~ 83 (85)
T cd05872 78 YSLNVV 83 (85)
T ss_pred EEEEEe
Confidence 455543
No 231
>cd05759 Ig2_KIRREL3-like Second immunoglobulin (Ig)-like domain of Kirrel (kin of irregular chiasm-like) 3 (also known as Neph2). Ig2_KIRREL3-like: domain similar to the second immunoglobulin (Ig)-like domain of Kirrel (kin of irregular chiasm-like) 3 (also known as Neph2). This protein has five Ig-like domains, one transmembrane domain, and a cytoplasmic tail. Included in this group is mammalian Kirrel (Neph1), Kirrel2 (Neph3), and Drosophila RST (irregular chiasm C-roughest) protein. These proteins contain multiple Ig domains, have properties of cell adhesion molecules, and are important in organ development.
Probab=98.37 E-value=1.6e-06 Score=79.01 Aligned_cols=72 Identities=21% Similarity=0.378 Sum_probs=51.0
Q ss_pred eEEEEEEEeeCCCCCcEEEEeeCCEEccCCCcEEE-EeeCC----eEEEEEccCCCCCCeEEEEEEEcCCeeEEEEEE
Q psy2148 933 LAHFECRLTPTNDPSMTVEWFHNGKALSAGSRIKT-INDFG----FVILEINDVYLRDSGLYTCKATNKHGEATTSCK 1005 (1884)
Q Consensus 933 ~v~l~C~v~~~~~P~~~v~W~~~g~~i~~~~~~~~-~~~~~----~~~L~I~~~~~~D~G~Y~C~a~N~~G~~~~~~~ 1005 (1884)
.+.|.|.+.+ +.|.+.|+|+|+|+.+........ ..+++ .+.|.|.....+|.|.|+|.|.|..........
T Consensus 1 ~~~L~C~v~g-~~P~~~v~W~~~g~~l~~~~~~~~~~~~~~~~~~~s~L~i~~~~~~~~~~y~C~a~n~~l~~~~~~s 77 (82)
T cd05759 1 PYNLTCRARG-AKPAAEIIWFRDGEVLDGATYSKELLKDGKRETTVSTLPITPSDHDTGRTFTCRARNEALPTGKETS 77 (82)
T ss_pred CEEEEEEEeC-ccCCCEEEEEECCEEccCceeeeeEecCCCeEEEEEEEEEeCceecCCCEEEEEEcCccCCCCcEEE
Confidence 3689999985 478889999999999865432111 12222 346888888888999999999998654433333
No 232
>cd04983 IgV_TCR_alpha_like Immunoglobulin (Ig) variable (V) domain of T-cell receptor (TCR) alpha chain and similar proteins. IgV_TCR_alpha: immunoglobulin (Ig) variable domain of the alpha chain of alpha/beta T-cell antigen receptors (TCRs). TCRs mediate antigen recognition by T lymphocytes, and are composed of alpha and beta, or gamma and delta, polypeptide chains with variable (V) and constant (C) regions. This group represents the variable domain of the alpha chain of TCRs and also includes the variable domain of delta chains of TCRs. Alpha/beta TCRs recognize antigen as peptide fragments presented by major histocompatibility complex (MHC) molecules. The variable domain of TCRs is responsible for antigen recognition, and is located at the N-terminus of the receptor. Gamma/delta TCRs recognize intact protein antigens; they recognize proteins antigens directly and without antigen processing, and MHC independently of the bound peptide.
Probab=98.29 E-value=4.1e-06 Score=81.62 Aligned_cols=76 Identities=20% Similarity=0.365 Sum_probs=58.2
Q ss_pred ecCCceeecCCCeEEEEEEEeeCCCCCcEEEEeeCCE---Ec-----------cCCCcEEEEee--CCeEEEEEccCCCC
Q psy2148 921 TTPTDLTLAESTLAHFECRLTPTNDPSMTVEWFHNGK---AL-----------SAGSRIKTIND--FGFVILEINDVYLR 984 (1884)
Q Consensus 921 ~~~~~~~v~~G~~v~l~C~v~~~~~P~~~v~W~~~g~---~i-----------~~~~~~~~~~~--~~~~~L~I~~~~~~ 984 (1884)
..++.+.+.+|++|+|.|.+. +.+...+.|||... +. ....|+.+... .+.+.|+|.+++.+
T Consensus 3 q~~~~v~~~~G~~v~L~C~~~--~~~~~~v~W~k~~~~~~~~~l~~~~~~~~~~~~~r~~~~~~~~~~~~~L~I~~~~~~ 80 (109)
T cd04983 3 QSPQSLSVQEGENVTLNCNYS--TSTFYYLFWYRQYPGQGPQFLIYISSNGEEKEKGRFSATLDKSRKSSSLHISAAQLS 80 (109)
T ss_pred ecCCceEEcCCCCEEEEEEEC--CCCccEEEEEEECCCCCeEEEEEEecCCCcccCCcEEEEEcccCCEEEEEECCCCHH
Confidence 456778999999999999998 44677999998431 10 13456655433 36789999999999
Q ss_pred CCeEEEEEEEcCCe
Q psy2148 985 DSGLYTCKATNKHG 998 (1884)
Q Consensus 985 D~G~Y~C~a~N~~G 998 (1884)
|+|.|.|.+.+..+
T Consensus 81 DsG~Y~C~~~~~~~ 94 (109)
T cd04983 81 DSAVYFCALSESGG 94 (109)
T ss_pred HCEEEEEEEecCCC
Confidence 99999999997643
No 233
>cd05759 Ig2_KIRREL3-like Second immunoglobulin (Ig)-like domain of Kirrel (kin of irregular chiasm-like) 3 (also known as Neph2). Ig2_KIRREL3-like: domain similar to the second immunoglobulin (Ig)-like domain of Kirrel (kin of irregular chiasm-like) 3 (also known as Neph2). This protein has five Ig-like domains, one transmembrane domain, and a cytoplasmic tail. Included in this group is mammalian Kirrel (Neph1), Kirrel2 (Neph3), and Drosophila RST (irregular chiasm C-roughest) protein. These proteins contain multiple Ig domains, have properties of cell adhesion molecules, and are important in organ development.
Probab=98.25 E-value=4e-06 Score=76.31 Aligned_cols=72 Identities=17% Similarity=0.281 Sum_probs=51.6
Q ss_pred EEEEEEEec-CCCcEEEEEeCCEecCCCCCeE-EeecCC----eEEEEEccCCCCCCEEEEEEEEeCCee--EEEEEEEE
Q psy2148 1760 ARFDAKISA-TKPLDVYWLKNGKKIIPDIRYK-TLEEDN----LFTLLIIEAVVEDSGAYECVAMNNAGE--ARCEAELV 1831 (1884)
Q Consensus 1760 ~~l~C~~~g-~p~p~v~W~k~~~~l~~~~~~~-~~~~~~----~~~L~i~~~~~~d~G~Y~C~a~N~~G~--~~~~~~l~ 1831 (1884)
+.|.|.+.| .|.+.|+|+|+|+.+....... ...++. ...|.|.....+|.|.|+|.|.|.... ...+++|.
T Consensus 2 ~~L~C~v~g~~P~~~v~W~~~g~~l~~~~~~~~~~~~~~~~~~~s~L~i~~~~~~~~~~y~C~a~n~~l~~~~~~s~~l~ 81 (82)
T cd05759 2 YNLTCRARGAKPAAEIIWFRDGEVLDGATYSKELLKDGKRETTVSTLPITPSDHDTGRTFTCRARNEALPTGKETSVTLD 81 (82)
T ss_pred EEEEEEEeCccCCCEEEEEECCEEccCceeeeeEecCCCeEEEEEEEEEeCceecCCCEEEEEEcCccCCCCcEEEEEEc
Confidence 689999987 6989999999999886542211 112222 247888887788899999999998754 44445544
No 234
>cd04983 IgV_TCR_alpha_like Immunoglobulin (Ig) variable (V) domain of T-cell receptor (TCR) alpha chain and similar proteins. IgV_TCR_alpha: immunoglobulin (Ig) variable domain of the alpha chain of alpha/beta T-cell antigen receptors (TCRs). TCRs mediate antigen recognition by T lymphocytes, and are composed of alpha and beta, or gamma and delta, polypeptide chains with variable (V) and constant (C) regions. This group represents the variable domain of the alpha chain of TCRs and also includes the variable domain of delta chains of TCRs. Alpha/beta TCRs recognize antigen as peptide fragments presented by major histocompatibility complex (MHC) molecules. The variable domain of TCRs is responsible for antigen recognition, and is located at the N-terminus of the receptor. Gamma/delta TCRs recognize intact protein antigens; they recognize proteins antigens directly and without antigen processing, and MHC independently of the bound peptide.
Probab=98.15 E-value=8.5e-06 Score=79.36 Aligned_cols=75 Identities=17% Similarity=0.273 Sum_probs=58.5
Q ss_pred ccCceEEcCCceEEEEEEEecCCCcEEEEEeCCEe--c------------CCCCCeEEeec--CCeEEEEEccCCCCCCE
Q psy2148 1748 TISSAVINVGQLARFDAKISATKPLDVYWLKNGKK--I------------IPDIRYKTLEE--DNLFTLLIIEAVVEDSG 1811 (1884)
Q Consensus 1748 ~~~~~~~~~G~~~~l~C~~~g~p~p~v~W~k~~~~--l------------~~~~~~~~~~~--~~~~~L~i~~~~~~d~G 1811 (1884)
.+....+.+|++++|.|.+.+.+.+.+.|+|.... . ....|+.+... .+.+.|.|.+++.+|+|
T Consensus 4 ~~~~v~~~~G~~v~L~C~~~~~~~~~v~W~k~~~~~~~~~l~~~~~~~~~~~~~r~~~~~~~~~~~~~L~I~~~~~~DsG 83 (109)
T cd04983 4 SPQSLSVQEGENVTLNCNYSTSTFYYLFWYRQYPGQGPQFLIYISSNGEEKEKGRFSATLDKSRKSSSLHISAAQLSDSA 83 (109)
T ss_pred cCCceEEcCCCCEEEEEEECCCCccEEEEEEECCCCCeEEEEEEecCCCcccCCcEEEEEcccCCEEEEEECCCCHHHCE
Confidence 34567889999999999999888889999986421 0 12356665443 46889999999999999
Q ss_pred EEEEEEEeCCe
Q psy2148 1812 AYECVAMNNAG 1822 (1884)
Q Consensus 1812 ~Y~C~a~N~~G 1822 (1884)
.|.|.+.+..+
T Consensus 84 ~Y~C~~~~~~~ 94 (109)
T cd04983 84 VYFCALSESGG 94 (109)
T ss_pred EEEEEEecCCC
Confidence 99999987653
No 235
>cd05713 Ig_MOG_like Immunoglobulin (Ig)-like domain of myelin oligodendrocyte glycoprotein (MOG). Ig_MOG_like: immunoglobulin (Ig)-like domain of myelin oligodendrocyte glycoprotein (MOG). MOG, a minor component of the myelin sheath, is an important CNS-specific autoantigen, linked to the pathogenesis of multiple sclerosis (MS) and experimental autoimmune encephalomyelitis (EAE). It is a transmembrane protein having an extracellular Ig domain. MOG is expressed in the CNS on the outermost lamellae of the myelin sheath, and on the surface of oligodendrocytes, and may participate in the completion, compaction, and/or maintenance of myelin. This group also includes butyrophilin (BTN). BTN is the most abundant protein in bovine milk-fat globule membrane (MFGM).
Probab=98.14 E-value=1.5e-05 Score=76.05 Aligned_cols=78 Identities=28% Similarity=0.427 Sum_probs=53.6
Q ss_pred CCeEEEEEEEeeCCC-CCcEEEEeeCCE-----------Ecc------CCCcEEEEe---eCCeEEEEEccCCCCCCeEE
Q psy2148 931 STLAHFECRLTPTND-PSMTVEWFHNGK-----------ALS------AGSRIKTIN---DFGFVILEINDVYLRDSGLY 989 (1884)
Q Consensus 931 G~~v~l~C~v~~~~~-P~~~v~W~~~g~-----------~i~------~~~~~~~~~---~~~~~~L~I~~~~~~D~G~Y 989 (1884)
|++|+|.|...+... -...|.|+|... ... -..|+.+.. ..+...|.|.+++.+|+|.|
T Consensus 1 G~~v~L~C~~~~~~~~~~~~v~W~k~~~~~~v~~~~~~~~~~~~~~~~~~~R~~~~~~~~~~~~~sL~I~~v~~~D~G~Y 80 (100)
T cd05713 1 GEDAELPCHLSPKMSAEHMEVRWFRSQFSPAVHLYRDGQDQYGEQMPEYRGRTELLKDAIAEGSVALRIHNVRASDEGLY 80 (100)
T ss_pred CCcEEEEeEEcCCCCCCeeEEEEEECCCceeEEEEcCCcccccccCccccceEEeecccccCCcEEEEEEcCChhhCEEE
Confidence 789999999862111 123688888541 111 012444322 13557899999999999999
Q ss_pred EEEEEcCCeeEEEEEEEEE
Q psy2148 990 TCKATNKHGEATTSCKLTV 1008 (1884)
Q Consensus 990 ~C~a~N~~G~~~~~~~l~V 1008 (1884)
+|.+.|..+..+..+.|.|
T Consensus 81 ~C~v~~~~~~~~~~i~l~v 99 (100)
T cd05713 81 TCFFQSDGFYEEATVELKV 99 (100)
T ss_pred EEEEecCCcEEEEEEEEEE
Confidence 9999998888887777776
No 236
>cd05877 Ig_LP_like Immunoglobulin (Ig)-like domain of human cartilage link protein (LP). Ig_LP_like: immunoglobulin (Ig)-like domain similar to that that found in human cartilage link protein (LP). In cartilage, chondroitin-keratan sulfate proteoglycan (CSPG), aggrecan, forms cartilage link protein stabilized aggregates with hyaluronan (HA). These aggregates contribute to the tissue's load bearing properties. Aggregates having other CSPGs substituting for aggrecan may contribute to the structural integrity of many different tissues. Members of the vertebrate HPLN (hyaluronan/HA and proteoglycan binding link) protein family are physically linked adjacent to CSPG genes.
Probab=98.13 E-value=1.5e-05 Score=76.94 Aligned_cols=81 Identities=19% Similarity=0.290 Sum_probs=58.5
Q ss_pred CCCeEEEEEEEeeCC----CCCcEEEEeeCCE----E----ccC----------CCcEEEEee-CCeEEEEEccCCCCCC
Q psy2148 930 ESTLAHFECRLTPTN----DPSMTVEWFHNGK----A----LSA----------GSRIKTIND-FGFVILEINDVYLRDS 986 (1884)
Q Consensus 930 ~G~~v~l~C~v~~~~----~P~~~v~W~~~g~----~----i~~----------~~~~~~~~~-~~~~~L~I~~~~~~D~ 986 (1884)
+|++|+|.|.....+ .....|.|+|... . +.. ..|+..... .+...|.|.+++.+|+
T Consensus 1 ~G~~vtL~C~~~~~~~~~~~~~~~v~W~k~~~~~~~~~~~~~~~~~~~~~~~~~~~R~~~~~~~~~~~sL~I~~v~~~Ds 80 (106)
T cd05877 1 RGGNVTLPCRYHYEPELSAPRKIRVKWTKLESDYLKEEDVLVAIGTRHKSYGSYQGRVFLRRAHDLDASLVITDLRLEDY 80 (106)
T ss_pred CCCcEEEEeEeECCCcCCCCccceEEEEEecCCCCeeEEEEEEcCcEEEeccCccCcEEecCCCCCcEEEEEccCChHHC
Confidence 489999999987321 2345799999531 1 111 134443221 3456899999999999
Q ss_pred eEEEEEEEcCCeeEEEEEEEEEEe
Q psy2148 987 GLYTCKATNKHGEATTSCKLTVKG 1010 (1884)
Q Consensus 987 G~Y~C~a~N~~G~~~~~~~l~V~~ 1010 (1884)
|.|.|.+.|..|..+..+.|.|.+
T Consensus 81 G~Y~C~v~~~~~~~~~~~~l~v~~ 104 (106)
T cd05877 81 GRYRCEVIDGLEDESVVVALRLRG 104 (106)
T ss_pred EEEEEEEEecccceEEEEEEEEEE
Confidence 999999999999998889998875
No 237
>cd05877 Ig_LP_like Immunoglobulin (Ig)-like domain of human cartilage link protein (LP). Ig_LP_like: immunoglobulin (Ig)-like domain similar to that that found in human cartilage link protein (LP). In cartilage, chondroitin-keratan sulfate proteoglycan (CSPG), aggrecan, forms cartilage link protein stabilized aggregates with hyaluronan (HA). These aggregates contribute to the tissue's load bearing properties. Aggregates having other CSPGs substituting for aggrecan may contribute to the structural integrity of many different tissues. Members of the vertebrate HPLN (hyaluronan/HA and proteoglycan binding link) protein family are physically linked adjacent to CSPG genes.
Probab=98.12 E-value=1.7e-05 Score=76.64 Aligned_cols=79 Identities=18% Similarity=0.244 Sum_probs=59.8
Q ss_pred CCceEEEEEEEecCC------CcEEEEEeCCEe-------c-C----------CCCCeEEee-cCCeEEEEEccCCCCCC
Q psy2148 1756 VGQLARFDAKISATK------PLDVYWLKNGKK-------I-I----------PDIRYKTLE-EDNLFTLLIIEAVVEDS 1810 (1884)
Q Consensus 1756 ~G~~~~l~C~~~g~p------~p~v~W~k~~~~-------l-~----------~~~~~~~~~-~~~~~~L~i~~~~~~d~ 1810 (1884)
.|++|+|.|.....| ...|.|+|.... + . -..|+.+.. ..+.++|.|.+++.+|+
T Consensus 1 ~G~~vtL~C~~~~~~~~~~~~~~~v~W~k~~~~~~~~~~~~~~~~~~~~~~~~~~~R~~~~~~~~~~~sL~I~~v~~~Ds 80 (106)
T cd05877 1 RGGNVTLPCRYHYEPELSAPRKIRVKWTKLESDYLKEEDVLVAIGTRHKSYGSYQGRVFLRRAHDLDASLVITDLRLEDY 80 (106)
T ss_pred CCCcEEEEeEeECCCcCCCCccceEEEEEecCCCCeeEEEEEEcCcEEEeccCccCcEEecCCCCCcEEEEEccCChHHC
Confidence 489999999987663 357999986411 1 0 013444422 23456899999999999
Q ss_pred EEEEEEEEeCCeeEEEEEEEEEEe
Q psy2148 1811 GAYECVAMNNAGEARCEAELVVQS 1834 (1884)
Q Consensus 1811 G~Y~C~a~N~~G~~~~~~~l~V~~ 1834 (1884)
|.|.|.+.|..|..+..++|.|.+
T Consensus 81 G~Y~C~v~~~~~~~~~~~~l~v~~ 104 (106)
T cd05877 81 GRYRCEVIDGLEDESVVVALRLRG 104 (106)
T ss_pred EEEEEEEEecccceEEEEEEEEEE
Confidence 999999999999999999999875
No 238
>cd05900 Ig_Aggrecan Immunoglobulin (Ig)-like domain of the chondroitin sulfate proteoglycan core protein (CSPG), aggrecan. Ig_Aggrecan: immunoglobulin (Ig)-like domain of the chondroitin sulfate proteoglycan core protein (CSPG), aggrecan. These aggregates contribute to the tissue's load bearing properties. In CSPGs, the Ig-like domain is followed by hyaluronan (HA)-binding tandem repeats, and a C-terminal region with epidermal growth factor-like, lectin-like, and complement regulatory protein-like domains. Separating these N- and C-terminal regions is a nonhomologous glycosaminoglycan attachment region. In cartilage, aggrecan forms cartilage link protein stabilized aggregates with HA. These aggregates contribute to the tissue's load bearing properties. Aggrecan has a wide distribution in connective tissue and extracellular matrices. Members of the vertebrate HPLN (hyaluronan/HA and proteoglycan binding link) protein family are physically linked adjacent to CSPG genes.
Probab=98.12 E-value=1.6e-05 Score=75.91 Aligned_cols=79 Identities=20% Similarity=0.192 Sum_probs=59.4
Q ss_pred CCceEEEEEEEecCC------------CcEEEEEeCCE--e---c---------CC--CCCeEEee---cCCeEEEEEcc
Q psy2148 1756 VGQLARFDAKISATK------------PLDVYWLKNGK--K---I---------IP--DIRYKTLE---EDNLFTLLIIE 1804 (1884)
Q Consensus 1756 ~G~~~~l~C~~~g~p------------~p~v~W~k~~~--~---l---------~~--~~~~~~~~---~~~~~~L~i~~ 1804 (1884)
.|++++|.|...... .+.|.|+|... . + .. ..|+.+.. ..+.++|+|.+
T Consensus 1 ~G~~VtLpC~~~~~~~~~~~~~~~~~~~~~I~W~k~~~g~~~~ii~~~~~~~~~~~~f~~R~sl~~~~~~~~~asL~I~n 80 (112)
T cd05900 1 LGSSLLIPCYFQDPIAKDPGAPTVAPLSPRIKWSFISKEKESVLLVATEGKVRVNTEYLDRVSLPNYPAIPSDATLEITE 80 (112)
T ss_pred CCCcEEEeeEEeCCcCccccccccCCCCCEEEEEEecCCCccEEEEEECCeEEECccccCeEEecccCCCCCCcEEEEee
Confidence 489999999997643 46899998521 1 1 00 12555543 33567999999
Q ss_pred CCCCCCEEEEEEEEeCCeeEEEEEEEEEEe
Q psy2148 1805 AVVEDSGAYECVAMNNAGEARCEAELVVQS 1834 (1884)
Q Consensus 1805 ~~~~d~G~Y~C~a~N~~G~~~~~~~l~V~~ 1834 (1884)
++.+|+|+|+|.+.+........+.|.|.+
T Consensus 81 l~~sDsG~Y~C~V~~g~~~~~~~v~l~v~g 110 (112)
T cd05900 81 LRSNDSGTYRCEVMHGIEDNYDTVEVQVKG 110 (112)
T ss_pred cccccCEEEEEEEecCCCCceeEEEEEEEe
Confidence 999999999999998888888888888875
No 239
>PF13927 Ig_3: Immunoglobulin domain; PDB: 2D3V_A 1G0X_A 1VDG_A 1P7Q_D 3D2U_H 1UFU_A 1UGN_A 3VH8_H 3OQ3_B 4DKD_C ....
Probab=98.12 E-value=4.5e-06 Score=74.93 Aligned_cols=75 Identities=20% Similarity=0.423 Sum_probs=50.8
Q ss_pred CCeeeecCCceeecCCCeEEEEEEEeeCCCCCcEEEEeeCCEEccCCCcEEEEeeCCeEEEEEccCCCCCCeEEEEEEEc
Q psy2148 916 APEFLTTPTDLTLAESTLAHFECRLTPTNDPSMTVEWFHNGKALSAGSRIKTINDFGFVILEINDVYLRDSGLYTCKATN 995 (1884)
Q Consensus 916 ~p~~~~~~~~~~v~~G~~v~l~C~v~~~~~P~~~v~W~~~g~~i~~~~~~~~~~~~~~~~L~I~~~~~~D~G~Y~C~a~N 995 (1884)
+|.|...+.......+. ++|.|.+.+ +.|.+.++|+ +........ .........+|.|.++..+|.|.|+|.|+|
T Consensus 1 kP~I~~~~~~~~~~~~~-~~l~C~~~~-~~~~~~~~W~-~~~~~~~~~--~~~~~~~~~~L~i~~v~~~~~g~y~C~a~N 75 (75)
T PF13927_consen 1 KPQISVPPPPVVTSGGS-VTLTCSAEG-GPPPPSISWY-DSNPSFNSN--SRGSSSSNSTLTISNVTRSDNGTYTCIASN 75 (75)
T ss_dssp ESEEEEESTSEEETTEE-EEEEEEESS-EESSEEEEEE-TEEEEEEEE--EEEEEEEEEEEEESSCCGGGTEEEEEEEEE
T ss_pred CCEEEEcCCCcEeecee-EEEEEEEcc-ccCCeEEEEE-ecCCceeee--eeeccceeeEEEEccCCHHhCcEEEEEEEC
Confidence 36777666666655555 999999984 3338899999 111111111 111222345799999999999999999987
No 240
>cd05713 Ig_MOG_like Immunoglobulin (Ig)-like domain of myelin oligodendrocyte glycoprotein (MOG). Ig_MOG_like: immunoglobulin (Ig)-like domain of myelin oligodendrocyte glycoprotein (MOG). MOG, a minor component of the myelin sheath, is an important CNS-specific autoantigen, linked to the pathogenesis of multiple sclerosis (MS) and experimental autoimmune encephalomyelitis (EAE). It is a transmembrane protein having an extracellular Ig domain. MOG is expressed in the CNS on the outermost lamellae of the myelin sheath, and on the surface of oligodendrocytes, and may participate in the completion, compaction, and/or maintenance of myelin. This group also includes butyrophilin (BTN). BTN is the most abundant protein in bovine milk-fat globule membrane (MFGM).
Probab=98.12 E-value=1.7e-05 Score=75.69 Aligned_cols=76 Identities=21% Similarity=0.307 Sum_probs=54.5
Q ss_pred CceEEEEEEEecCC---CcEEEEEeCCE-----------ecC------CCCCeEEee---cCCeEEEEEccCCCCCCEEE
Q psy2148 1757 GQLARFDAKISATK---PLDVYWLKNGK-----------KII------PDIRYKTLE---EDNLFTLLIIEAVVEDSGAY 1813 (1884)
Q Consensus 1757 G~~~~l~C~~~g~p---~p~v~W~k~~~-----------~l~------~~~~~~~~~---~~~~~~L~i~~~~~~d~G~Y 1813 (1884)
|++|+|.|...... ...|.|+|... ... -..|+.+.. ..+..+|+|.+++.+|+|.|
T Consensus 1 G~~v~L~C~~~~~~~~~~~~v~W~k~~~~~~v~~~~~~~~~~~~~~~~~~~R~~~~~~~~~~~~~sL~I~~v~~~D~G~Y 80 (100)
T cd05713 1 GEDAELPCHLSPKMSAEHMEVRWFRSQFSPAVHLYRDGQDQYGEQMPEYRGRTELLKDAIAEGSVALRIHNVRASDEGLY 80 (100)
T ss_pred CCcEEEEeEEcCCCCCCeeEEEEEECCCceeEEEEcCCcccccccCccccceEEeecccccCCcEEEEEEcCChhhCEEE
Confidence 78899999986322 23588877652 111 012444322 23467999999999999999
Q ss_pred EEEEEeCCeeEEEEEEEEE
Q psy2148 1814 ECVAMNNAGEARCEAELVV 1832 (1884)
Q Consensus 1814 ~C~a~N~~G~~~~~~~l~V 1832 (1884)
+|.+.|..+..+..++|.|
T Consensus 81 ~C~v~~~~~~~~~~i~l~v 99 (100)
T cd05713 81 TCFFQSDGFYEEATVELKV 99 (100)
T ss_pred EEEEecCCcEEEEEEEEEE
Confidence 9999999888888888887
No 241
>cd05774 Ig_CEACAM_D1 First immunoglobulin (Ig)-like domain of carcinoembryonic antigen (CEA) related cell adhesion molecule (CEACAM). IG_CEACAM_D1: immunoglobulin (Ig)-like domain 1 in carcinoembryonic antigen (CEA) related cell adhesion molecule (CEACAM) protein subfamily. The CEA family is a group of anchored or secreted glycoproteins, expressed by epithelial cells, leukocytes, endothelial cells and placenta. The CEA family is divided into the CEACAM and pregnancy-specific glycoprotein (PSG) subfamilies. This group represents the CEACAM subfamily. CEACAM1 has many important cellular functions, it is a cell adhesion molecule, and a signaling molecule that regulates the growth of tumor cells, it is an angiogenic factor, and is a receptor for bacterial and viral pathogens, including mouse hepatitis virus (MHV). In mice, four isoforms of CEACAM1 generated by alternative splicing have either two [D1, D4] or four [D1-D4] Ig-like domains on the cell surface. This family corresponds to the D
Probab=98.12 E-value=1.3e-05 Score=75.38 Aligned_cols=81 Identities=16% Similarity=0.217 Sum_probs=56.3
Q ss_pred CCceeecCCCeEEEEEEEeeCCCCCcEEEEeeCCE-----Ec----c----------CCCcEEEEeeCCeEEEEEccCCC
Q psy2148 923 PTDLTLAESTLAHFECRLTPTNDPSMTVEWFHNGK-----AL----S----------AGSRIKTINDFGFVILEINDVYL 983 (1884)
Q Consensus 923 ~~~~~v~~G~~v~l~C~v~~~~~P~~~v~W~~~g~-----~i----~----------~~~~~~~~~~~~~~~L~I~~~~~ 983 (1884)
+.+..+.+|++|.|.|.-. +.+...++|||+.. .| . ...|..+..++ +|.|.+++.
T Consensus 5 ~~p~~~~~G~~V~L~v~~~--p~~~~~~~W~kg~~~~~~~~I~~y~~~~~~~~~gp~~~gR~~~~~ng---SL~I~~v~~ 79 (105)
T cd05774 5 LVPPQVAEGENVLLLVHNL--PENLLAYAWYKGKTVSPNFLIASYIISTNSSTPGPAYSGRETIYPNG---SLLIQNVTQ 79 (105)
T ss_pred ccCCcccCCCCEEEEecCC--CCCceEEEEEcCCCCCCCEEEEEEECCCcccccCcccCCcEEEeCCC---cEEEecCCc
Confidence 3445678999999999764 44455899999632 22 0 12344444433 699999999
Q ss_pred CCCeEEEEEEEcCC-eeEEEEEEEEE
Q psy2148 984 RDSGLYTCKATNKH-GEATTSCKLTV 1008 (1884)
Q Consensus 984 ~D~G~Y~C~a~N~~-G~~~~~~~l~V 1008 (1884)
+|+|.|+|.+.|.. ........|.|
T Consensus 80 ~D~G~Y~~~v~~~~~~~~~~~v~l~V 105 (105)
T cd05774 80 KDTGFYTLQTITTNFQVEQATVHLQV 105 (105)
T ss_pred ccCEEEEEEEEeCCccEEEEEEEEEC
Confidence 99999999999976 45555555543
No 242
>cd05714 Ig_CSPGs_LP Immunoglobulin (Ig)-like domain of chondroitin sulfate proteoglycans (CSPGs), human cartilage link protein (LP) and similar proteins. Ig_CSPGs_LP: immunoglobulin (Ig)-like domain similar to that found in chondroitin sulfate proteoglycans (CSPGs) and human cartilage link protein (LP). Included in this group are the CSPGs aggrecan, versican, and neurocan. In CSPGs this Ig-like domain is followed by hyaluronan (HA)-binding tandem repeats, and a C-terminal region with epidermal growth factor-like, lectin-like, and complement regulatory protein-like domains. Separating these N- and C-terminal regions is a nonhomologous glycosaminoglycan attachment region. In cartilage, aggrecan forms cartilage link protein stabilized aggregates with hyaluronan (HA). These aggregates contribute to the tissue's load bearing properties. Aggrecan and versican have a wide distribution in connective tissue and extracellular matrices. Neurocan is localized almost exclusively in nervous tissue.
Probab=98.11 E-value=2e-05 Score=76.07 Aligned_cols=79 Identities=19% Similarity=0.312 Sum_probs=58.8
Q ss_pred CCceEEEEEEEecCC------CcEEEEEeCC-----E-ec--CCCC----------CeEEe-ecCCeEEEEEccCCCCCC
Q psy2148 1756 VGQLARFDAKISATK------PLDVYWLKNG-----K-KI--IPDI----------RYKTL-EEDNLFTLLIIEAVVEDS 1810 (1884)
Q Consensus 1756 ~G~~~~l~C~~~g~p------~p~v~W~k~~-----~-~l--~~~~----------~~~~~-~~~~~~~L~i~~~~~~d~ 1810 (1884)
.|++|+|.|.....+ .+.|.|+|.. . .+ ..+. |.... ...+..+|+|.+++.+|+
T Consensus 1 ~G~~V~L~C~~~~~~~~~~~~~~~i~W~k~~~~~~~~~~v~~~~~~~~~~~~~~~~r~~~~~~~~~~~sL~I~~v~~sD~ 80 (106)
T cd05714 1 LGGNVTLPCRFHLEPALSAPHGPRIKWTKLESDGAKEVDVLVAIGGRVKVYGSGRVRVPLYPADPGDASLVITDLRLEDS 80 (106)
T ss_pred CCCCEEEeEEeECCcccCCCCCcEEEEEEeCCCCCceEEEEEEcCCEEEEcCCCceEEEeeCCCCCcceEEECCCCHHHC
Confidence 389999999998754 4689999973 1 01 0111 11111 123567999999999999
Q ss_pred EEEEEEEEeCCeeEEEEEEEEEEe
Q psy2148 1811 GAYECVAMNNAGEARCEAELVVQS 1834 (1884)
Q Consensus 1811 G~Y~C~a~N~~G~~~~~~~l~V~~ 1834 (1884)
|.|+|.+.|..+..+..++|.|.+
T Consensus 81 G~Y~C~v~~~~~~~~~~v~L~V~~ 104 (106)
T cd05714 81 GRYRCEVIDGIEDEQDTVELEVRG 104 (106)
T ss_pred EEEEEEEEcCCCceEEEEEEEEEE
Confidence 999999999988889999999976
No 243
>cd05899 IgV_TCR_beta Immunoglobulin (Ig) variable (V) domain of T-cell receptor (TCR) bet a chain. IgV_TCR_beta: immunoglobulin (Ig) variable domain of the beta chain of alpha/beta T-cell antigen receptors (TCRs). TCRs mediate antigen recognition by T lymphocytes, and are composed of alpha and beta, or gamma and delta, polypeptide chains with variable (V) and constant (C) regions. This group includes the variable domain of the alpha chain of alpha/beta TCRs. Alpha/beta TCRs recognize antigen as peptide fragments presented by major histocompatibility complex (MHC) molecules. The variable domain of TCRs is responsible for antigen recognition, and is located at the N-terminus of the receptor. Gamma/delta TCRs recognize intact protein antigens; they recognize proteins antigens directly and without antigen processing, and MHC independently of the bound peptide.
Probab=98.10 E-value=1.3e-05 Score=77.81 Aligned_cols=75 Identities=20% Similarity=0.332 Sum_probs=56.2
Q ss_pred ecCCceeecCCCeEEEEEEEeeCCCCCcEEEEeeCC--EEcc----------------CCCcEEEEeeC-CeEEEEEccC
Q psy2148 921 TTPTDLTLAESTLAHFECRLTPTNDPSMTVEWFHNG--KALS----------------AGSRIKTINDF-GFVILEINDV 981 (1884)
Q Consensus 921 ~~~~~~~v~~G~~v~l~C~v~~~~~P~~~v~W~~~g--~~i~----------------~~~~~~~~~~~-~~~~L~I~~~ 981 (1884)
..+..+.+.+|++|+|.|.+. + +...+.|||.. ..+. ...|+...... +.+.|.|.++
T Consensus 3 Q~p~~~~v~~G~~v~l~C~~~--~-~~~~v~Wykq~~g~~~~~l~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~L~I~~~ 79 (110)
T cd05899 3 QSPRYLIKGRGQSVTLRCSQT--S-GHDNMYWYRQDPGKGLQLLFYSNGGSLNEEEGDPKDRFSASRPSLTRSSLTIKSA 79 (110)
T ss_pred ECCCceEEcCCCcEEEEEEEC--C-CCCEEEEEEECCCCCcEEEEEEcCCCceEecCccCCceEEECcCCCccEEEECCC
Confidence 456778999999999999997 4 56789999943 1110 12455544332 5678999999
Q ss_pred CCCCCeEEEEEEEcCCe
Q psy2148 982 YLRDSGLYTCKATNKHG 998 (1884)
Q Consensus 982 ~~~D~G~Y~C~a~N~~G 998 (1884)
+.+|+|.|.|.+.+..|
T Consensus 80 ~~~Dsg~Y~Ca~~~~~~ 96 (110)
T cd05899 80 EPEDSAVYLCASSLGGG 96 (110)
T ss_pred ChhhCEEEEEEeeCCCC
Confidence 99999999999987543
No 244
>cd05900 Ig_Aggrecan Immunoglobulin (Ig)-like domain of the chondroitin sulfate proteoglycan core protein (CSPG), aggrecan. Ig_Aggrecan: immunoglobulin (Ig)-like domain of the chondroitin sulfate proteoglycan core protein (CSPG), aggrecan. These aggregates contribute to the tissue's load bearing properties. In CSPGs, the Ig-like domain is followed by hyaluronan (HA)-binding tandem repeats, and a C-terminal region with epidermal growth factor-like, lectin-like, and complement regulatory protein-like domains. Separating these N- and C-terminal regions is a nonhomologous glycosaminoglycan attachment region. In cartilage, aggrecan forms cartilage link protein stabilized aggregates with HA. These aggregates contribute to the tissue's load bearing properties. Aggrecan has a wide distribution in connective tissue and extracellular matrices. Members of the vertebrate HPLN (hyaluronan/HA and proteoglycan binding link) protein family are physically linked adjacent to CSPG genes.
Probab=98.10 E-value=1.8e-05 Score=75.57 Aligned_cols=81 Identities=22% Similarity=0.287 Sum_probs=58.5
Q ss_pred CCCeEEEEEEEeeCCCC----------CcEEEEeeC--CEE---cc-----------CCCcEEEEe---eCCeEEEEEcc
Q psy2148 930 ESTLAHFECRLTPTNDP----------SMTVEWFHN--GKA---LS-----------AGSRIKTIN---DFGFVILEIND 980 (1884)
Q Consensus 930 ~G~~v~l~C~v~~~~~P----------~~~v~W~~~--g~~---i~-----------~~~~~~~~~---~~~~~~L~I~~ 980 (1884)
.|++|+|.|.......+ .+.|.|+|- |.+ +. -..|+.+.. ..+...|+|.+
T Consensus 1 ~G~~VtLpC~~~~~~~~~~~~~~~~~~~~~I~W~k~~~g~~~~ii~~~~~~~~~~~~f~~R~sl~~~~~~~~~asL~I~n 80 (112)
T cd05900 1 LGSSLLIPCYFQDPIAKDPGAPTVAPLSPRIKWSFISKEKESVLLVATEGKVRVNTEYLDRVSLPNYPAIPSDATLEITE 80 (112)
T ss_pred CCCcEEEeeEEeCCcCccccccccCCCCCEEEEEEecCCCccEEEEEECCeEEECccccCeEEecccCCCCCCcEEEEee
Confidence 48999999999732211 468999994 211 10 112555543 33567899999
Q ss_pred CCCCCCeEEEEEEEcCCeeEEEEEEEEEEe
Q psy2148 981 VYLRDSGLYTCKATNKHGEATTSCKLTVKG 1010 (1884)
Q Consensus 981 ~~~~D~G~Y~C~a~N~~G~~~~~~~l~V~~ 1010 (1884)
++.+|+|.|.|.+.++....+....|.|.+
T Consensus 81 l~~sDsG~Y~C~V~~g~~~~~~~v~l~v~g 110 (112)
T cd05900 81 LRSNDSGTYRCEVMHGIEDNYDTVEVQVKG 110 (112)
T ss_pred cccccCEEEEEEEecCCCCceeEEEEEEEe
Confidence 999999999999998888888888888865
No 245
>cd05714 Ig_CSPGs_LP Immunoglobulin (Ig)-like domain of chondroitin sulfate proteoglycans (CSPGs), human cartilage link protein (LP) and similar proteins. Ig_CSPGs_LP: immunoglobulin (Ig)-like domain similar to that found in chondroitin sulfate proteoglycans (CSPGs) and human cartilage link protein (LP). Included in this group are the CSPGs aggrecan, versican, and neurocan. In CSPGs this Ig-like domain is followed by hyaluronan (HA)-binding tandem repeats, and a C-terminal region with epidermal growth factor-like, lectin-like, and complement regulatory protein-like domains. Separating these N- and C-terminal regions is a nonhomologous glycosaminoglycan attachment region. In cartilage, aggrecan forms cartilage link protein stabilized aggregates with hyaluronan (HA). These aggregates contribute to the tissue's load bearing properties. Aggrecan and versican have a wide distribution in connective tissue and extracellular matrices. Neurocan is localized almost exclusively in nervous tissue.
Probab=98.10 E-value=2.2e-05 Score=75.69 Aligned_cols=81 Identities=23% Similarity=0.430 Sum_probs=58.0
Q ss_pred CCCeEEEEEEEeeCC----CCCcEEEEeeCC-----E-Ec--cCCCcE--------EEE---eeCCeEEEEEccCCCCCC
Q psy2148 930 ESTLAHFECRLTPTN----DPSMTVEWFHNG-----K-AL--SAGSRI--------KTI---NDFGFVILEINDVYLRDS 986 (1884)
Q Consensus 930 ~G~~v~l~C~v~~~~----~P~~~v~W~~~g-----~-~i--~~~~~~--------~~~---~~~~~~~L~I~~~~~~D~ 986 (1884)
.|++|+|.|...... ...+.|.|+|.. . .+ ..+.+. +.. ...+...|+|.+++.+|+
T Consensus 1 ~G~~V~L~C~~~~~~~~~~~~~~~i~W~k~~~~~~~~~~v~~~~~~~~~~~~~~~~r~~~~~~~~~~~sL~I~~v~~sD~ 80 (106)
T cd05714 1 LGGNVTLPCRFHLEPALSAPHGPRIKWTKLESDGAKEVDVLVAIGGRVKVYGSGRVRVPLYPADPGDASLVITDLRLEDS 80 (106)
T ss_pred CCCCEEEeEEeECCcccCCCCCcEEEEEEeCCCCCceEEEEEEcCCEEEEcCCCceEEEeeCCCCCcceEEECCCCHHHC
Confidence 489999999998421 125689999962 1 11 111111 111 123567899999999999
Q ss_pred eEEEEEEEcCCeeEEEEEEEEEEe
Q psy2148 987 GLYTCKATNKHGEATTSCKLTVKG 1010 (1884)
Q Consensus 987 G~Y~C~a~N~~G~~~~~~~l~V~~ 1010 (1884)
|.|.|.+.|..+..+..+.|.|.+
T Consensus 81 G~Y~C~v~~~~~~~~~~v~L~V~~ 104 (106)
T cd05714 81 GRYRCEVIDGIEDEQDTVELEVRG 104 (106)
T ss_pred EEEEEEEEcCCCceEEEEEEEEEE
Confidence 999999999988888889999875
No 246
>cd05883 Ig2_Necl-2 Second immunoglobulin (Ig)-like domain of nectin-like molecule 2 (also known as cell adhesion molecule 1 (CADM1)). Ig2_Necl-2: second immunoglobulin (Ig)-like domain of nectin-like molecule 2 (also known as cell adhesion molecule 1 (CADM1)). Nectin-like molecules (Necls) have similar domain structures to those of nectins. At least five nectin-like molecules have been identified (Necl-1 - Necl-5). These have an extracellular region containing three Ig-like domains, one transmembrane region, and one cytoplasmic region. Necl-2 has Ca(2+)-independent homophilic and heterophilic cell-cell adhesion activity. Necl-1 is expressed in a wide variety of tissues, and is a putative tumour suppressor gene, which is downregulated in aggressive neuroblastoma. Ig domains are likely to participate in ligand binding and recognition.
Probab=98.09 E-value=2.7e-05 Score=68.58 Aligned_cols=75 Identities=19% Similarity=0.265 Sum_probs=53.5
Q ss_pred EEEEEEEeeCCCCCcEEEEeeCCEEccCCCcEEEEeeC---CeEEEEEccCCCCCCeEEEEEEEcCCe-eEEEEEEEEEE
Q psy2148 934 AHFECRLTPTNDPSMTVEWFHNGKALSAGSRIKTINDF---GFVILEINDVYLRDSGLYTCKATNKHG-EATTSCKLTVK 1009 (1884)
Q Consensus 934 v~l~C~v~~~~~P~~~v~W~~~g~~i~~~~~~~~~~~~---~~~~L~I~~~~~~D~G~Y~C~a~N~~G-~~~~~~~l~V~ 1009 (1884)
+.|.|.+.| +.|++.|+|||+|+++...........+ ..++|.+..-..+|...|+|+|.|.+- ..+....|.|.
T Consensus 2 ~~L~C~s~g-SkP~A~I~W~k~~~~l~~~~~~~~~~~~~~t~~S~L~~~p~~eDdG~~~~C~a~~~~l~~~~~~~~L~V~ 80 (82)
T cd05883 2 IELNCTAMA-SKPAATIRWFKGNKELTGKSTVEETWSRMFTVTSQLMLKVTKEDDGVPVICLVDHPAVKDLQTQRYLEVQ 80 (82)
T ss_pred EEEEEEecC-CCCCCEEEEEECCEECcCcccceeccCCCcEEEEEEEEECchhhCCCEEEEEEcCcccCCceeeEEEEEE
Confidence 689999996 7899999999999999765332112222 245788877667778899999999653 24455566654
No 247
>cd05774 Ig_CEACAM_D1 First immunoglobulin (Ig)-like domain of carcinoembryonic antigen (CEA) related cell adhesion molecule (CEACAM). IG_CEACAM_D1: immunoglobulin (Ig)-like domain 1 in carcinoembryonic antigen (CEA) related cell adhesion molecule (CEACAM) protein subfamily. The CEA family is a group of anchored or secreted glycoproteins, expressed by epithelial cells, leukocytes, endothelial cells and placenta. The CEA family is divided into the CEACAM and pregnancy-specific glycoprotein (PSG) subfamilies. This group represents the CEACAM subfamily. CEACAM1 has many important cellular functions, it is a cell adhesion molecule, and a signaling molecule that regulates the growth of tumor cells, it is an angiogenic factor, and is a receptor for bacterial and viral pathogens, including mouse hepatitis virus (MHV). In mice, four isoforms of CEACAM1 generated by alternative splicing have either two [D1, D4] or four [D1-D4] Ig-like domains on the cell surface. This family corresponds to the D
Probab=98.08 E-value=1.7e-05 Score=74.77 Aligned_cols=80 Identities=19% Similarity=0.210 Sum_probs=56.6
Q ss_pred CceEEcCCceEEEEEEEecCCCcEEEEEeCCEe-----c----C----------CCCCeEEeecCCeEEEEEccCCCCCC
Q psy2148 1750 SSAVINVGQLARFDAKISATKPLDVYWLKNGKK-----I----I----------PDIRYKTLEEDNLFTLLIIEAVVEDS 1810 (1884)
Q Consensus 1750 ~~~~~~~G~~~~l~C~~~g~p~p~v~W~k~~~~-----l----~----------~~~~~~~~~~~~~~~L~i~~~~~~d~ 1810 (1884)
.+..+.+|+++.|.|.....+...+.|+|+... + . -+.|..+..++ +|.|.+++..|+
T Consensus 6 ~p~~~~~G~~V~L~v~~~p~~~~~~~W~kg~~~~~~~~I~~y~~~~~~~~~gp~~~gR~~~~~ng---SL~I~~v~~~D~ 82 (105)
T cd05774 6 VPPQVAEGENVLLLVHNLPENLLAYAWYKGKTVSPNFLIASYIISTNSSTPGPAYSGRETIYPNG---SLLIQNVTQKDT 82 (105)
T ss_pred cCCcccCCCCEEEEecCCCCCceEEEEEcCCCCCCCEEEEEEECCCcccccCcccCCcEEEeCCC---cEEEecCCcccC
Confidence 345677899999998654333348999997321 1 0 12344444444 899999999999
Q ss_pred EEEEEEEEeCC-eeEEEEEEEEE
Q psy2148 1811 GAYECVAMNNA-GEARCEAELVV 1832 (1884)
Q Consensus 1811 G~Y~C~a~N~~-G~~~~~~~l~V 1832 (1884)
|.|+|.+.|.. ......++|.|
T Consensus 83 G~Y~~~v~~~~~~~~~~~v~l~V 105 (105)
T cd05774 83 GFYTLQTITTNFQVEQATVHLQV 105 (105)
T ss_pred EEEEEEEEeCCccEEEEEEEEEC
Confidence 99999999987 45666666654
No 248
>cd05899 IgV_TCR_beta Immunoglobulin (Ig) variable (V) domain of T-cell receptor (TCR) bet a chain. IgV_TCR_beta: immunoglobulin (Ig) variable domain of the beta chain of alpha/beta T-cell antigen receptors (TCRs). TCRs mediate antigen recognition by T lymphocytes, and are composed of alpha and beta, or gamma and delta, polypeptide chains with variable (V) and constant (C) regions. This group includes the variable domain of the alpha chain of alpha/beta TCRs. Alpha/beta TCRs recognize antigen as peptide fragments presented by major histocompatibility complex (MHC) molecules. The variable domain of TCRs is responsible for antigen recognition, and is located at the N-terminus of the receptor. Gamma/delta TCRs recognize intact protein antigens; they recognize proteins antigens directly and without antigen processing, and MHC independently of the bound peptide.
Probab=98.08 E-value=1.2e-05 Score=78.05 Aligned_cols=74 Identities=20% Similarity=0.330 Sum_probs=56.5
Q ss_pred ccCceEEcCCceEEEEEEEecCCCcEEEEEeCCE--ecC----------------CCCCeEEeecC-CeEEEEEccCCCC
Q psy2148 1748 TISSAVINVGQLARFDAKISATKPLDVYWLKNGK--KII----------------PDIRYKTLEED-NLFTLLIIEAVVE 1808 (1884)
Q Consensus 1748 ~~~~~~~~~G~~~~l~C~~~g~p~p~v~W~k~~~--~l~----------------~~~~~~~~~~~-~~~~L~i~~~~~~ 1808 (1884)
.|....+.+|++++|.|.+.+ +.+.+.|||... .+. ...|+.+.... ..+.|.|.+++.+
T Consensus 4 ~p~~~~v~~G~~v~l~C~~~~-~~~~v~Wykq~~g~~~~~l~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~L~I~~~~~~ 82 (110)
T cd05899 4 SPRYLIKGRGQSVTLRCSQTS-GHDNMYWYRQDPGKGLQLLFYSNGGSLNEEEGDPKDRFSASRPSLTRSSLTIKSAEPE 82 (110)
T ss_pred CCCceEEcCCCcEEEEEEECC-CCCEEEEEEECCCCCcEEEEEEcCCCceEecCccCCceEEECcCCCccEEEECCCChh
Confidence 456778899999999999988 778999998742 110 12455554432 5679999999999
Q ss_pred CCEEEEEEEEeCCe
Q psy2148 1809 DSGAYECVAMNNAG 1822 (1884)
Q Consensus 1809 d~G~Y~C~a~N~~G 1822 (1884)
|+|.|.|.+.+..|
T Consensus 83 Dsg~Y~Ca~~~~~~ 96 (110)
T cd05899 83 DSAVYLCASSLGGG 96 (110)
T ss_pred hCEEEEEEeeCCCC
Confidence 99999999987543
No 249
>cd05751 Ig1_LILRB1_like First immunoglobulin (Ig)-like domain found in Leukocyte Ig-like receptors (LILR)B1 (also known as LIR-1) and similar proteins. Ig1_LILRB1_like: domain similar to the first immunoglobulin (Ig)-like domain found in Leukocyte Ig-like receptors (LILR)B1 (also known as LIR-1). This group includes, LILRA5 (LIR9), an activating natural cytotoxicity receptor NKp46, and the immune-type receptor glycoprotein VI (GPVI). LILRs are a family of immunoreceptors expressed on expressed on T and B cells, on monocytes, dendritic cells, and subgroups of natural killer (NK) cells. The human LILR family contains nine proteins (LILRA1-3,and 5, and LILRB1-5). From functional assays, and as the cytoplasmic domains of various LILRs, for example LILRB1 (LIR-1), LILRB2 (LIR-2), and LILRB3 (LIR-3) contain immunoreceptor tyrosine-based inhibitory motifs (ITIMs) it is thought that LIR proteins are inhibitory receptors. Of the eight LIR family proteins, only LIR-1(LILRB1), and LIR-2 (LILRB2),
Probab=98.07 E-value=9.1e-06 Score=75.39 Aligned_cols=73 Identities=12% Similarity=0.135 Sum_probs=54.0
Q ss_pred CeeeecCCCccccCCCCcEEEEEEEeecCCCCCeEEEeeCCccCCCCCCeEEEeeCCEEEEEEcccCcCCCeEEEEEEEe
Q psy2148 707 PVFTVPLSNIDDLREGENAHFEARLTPTDDPKLKVEWFWNGKPMKTGSRFRTFCDFGFVILEISPVYPEDCGQYSCRAYN 786 (1884)
Q Consensus 707 p~~~~~~~~~~~v~~G~~~~l~C~~~~~g~p~~~v~W~k~g~~l~~~~~~~~~~~~~~~~L~i~~~~~~d~G~Y~C~a~N 786 (1884)
|.+...+.. .|.+|++++|+|... .+...+.|+|+|....... ....+....|.|.+++.+|+|.|+|.+.|
T Consensus 3 P~L~a~p~~--vV~~G~~VtL~C~~~---~~~~~f~l~k~g~~~~~~~---~~~~~~~~~f~i~~v~~~~~G~Y~C~~~~ 74 (91)
T cd05751 3 PSLWAEPSS--VVPLGKPVTLRCQGP---YGAVEYRLYREGSTFAVKK---PPEPQNKAKFFIPSMKREHAGRYRCYYRS 74 (91)
T ss_pred CEEEecCCC--ccCCCCcEEEEEecC---CCCCEEEEEECCCCccccc---cCCCceeEEEEccCCChhHCEEEEEEEEC
Confidence 444444332 689999999999864 6778999999988644211 11223456799999999999999999998
Q ss_pred c
Q psy2148 787 D 787 (1884)
Q Consensus 787 ~ 787 (1884)
.
T Consensus 75 ~ 75 (91)
T cd05751 75 G 75 (91)
T ss_pred C
Confidence 6
No 250
>PF13927 Ig_3: Immunoglobulin domain; PDB: 2D3V_A 1G0X_A 1VDG_A 1P7Q_D 3D2U_H 1UFU_A 1UGN_A 3VH8_H 3OQ3_B 4DKD_C ....
Probab=98.07 E-value=5.4e-06 Score=74.40 Aligned_cols=74 Identities=19% Similarity=0.325 Sum_probs=51.5
Q ss_pred CCeEEeccCceEEcCCceEEEEEEEecCC-CcEEEEEeCCEecCCCCCeEEeecCCeEEEEEccCCCCCCEEEEEEEEe
Q psy2148 1742 PPSFLTTISSAVINVGQLARFDAKISATK-PLDVYWLKNGKKIIPDIRYKTLEEDNLFTLLIIEAVVEDSGAYECVAMN 1819 (1884)
Q Consensus 1742 ~P~~~~~~~~~~~~~G~~~~l~C~~~g~p-~p~v~W~k~~~~l~~~~~~~~~~~~~~~~L~i~~~~~~d~G~Y~C~a~N 1819 (1884)
+|.+...+.......+. ++|.|.+.+.| .+.++|+ +....... ...........|.|.++..+|.|.|+|.|.|
T Consensus 1 kP~I~~~~~~~~~~~~~-~~l~C~~~~~~~~~~~~W~-~~~~~~~~--~~~~~~~~~~~L~i~~v~~~~~g~y~C~a~N 75 (75)
T PF13927_consen 1 KPQISVPPPPVVTSGGS-VTLTCSAEGGPPPPSISWY-DSNPSFNS--NSRGSSSSNSTLTISNVTRSDNGTYTCIASN 75 (75)
T ss_dssp ESEEEEESTSEEETTEE-EEEEEEESSEESSEEEEEE-TEEEEEEE--EEEEEEEEEEEEEESSCCGGGTEEEEEEEEE
T ss_pred CCEEEEcCCCcEeecee-EEEEEEEccccCCeEEEEE-ecCCceee--eeeeccceeeEEEEccCCHHhCcEEEEEEEC
Confidence 36677666666665555 99999999987 8899999 11111000 0111223345899999999999999999998
No 251
>cd05751 Ig1_LILRB1_like First immunoglobulin (Ig)-like domain found in Leukocyte Ig-like receptors (LILR)B1 (also known as LIR-1) and similar proteins. Ig1_LILRB1_like: domain similar to the first immunoglobulin (Ig)-like domain found in Leukocyte Ig-like receptors (LILR)B1 (also known as LIR-1). This group includes, LILRA5 (LIR9), an activating natural cytotoxicity receptor NKp46, and the immune-type receptor glycoprotein VI (GPVI). LILRs are a family of immunoreceptors expressed on expressed on T and B cells, on monocytes, dendritic cells, and subgroups of natural killer (NK) cells. The human LILR family contains nine proteins (LILRA1-3,and 5, and LILRB1-5). From functional assays, and as the cytoplasmic domains of various LILRs, for example LILRB1 (LIR-1), LILRB2 (LIR-2), and LILRB3 (LIR-3) contain immunoreceptor tyrosine-based inhibitory motifs (ITIMs) it is thought that LIR proteins are inhibitory receptors. Of the eight LIR family proteins, only LIR-1(LILRB1), and LIR-2 (LILRB2),
Probab=98.06 E-value=1.1e-05 Score=74.73 Aligned_cols=67 Identities=13% Similarity=0.130 Sum_probs=51.1
Q ss_pred cccccCCCceEEEEEEEEEcCCCceEEEEeeCCEeeccccceEEEeeCCeEEEEEcCCCCCCCEEEEEEEEcC
Q psy2148 316 HLSNLSEGEIAHFEASLIPVGDQTMTVEFLYNGKPIEASHRIRTVHAFGMVVLEILGTKIEDTGVYTCRATNK 388 (1884)
Q Consensus 316 ~~~~v~~g~~~~l~c~~~~~g~p~~~i~W~k~g~~i~~~~~~~~~~~~~~~~L~I~~~~~~D~G~Y~C~a~n~ 388 (1884)
+...+.+|++++|.|.. ..+...+.|+|+|...... . .........|.|.+++.+|+|.|+|.+.+.
T Consensus 9 p~~vV~~G~~VtL~C~~---~~~~~~f~l~k~g~~~~~~-~--~~~~~~~~~f~i~~v~~~~~G~Y~C~~~~~ 75 (91)
T cd05751 9 PSSVVPLGKPVTLRCQG---PYGAVEYRLYREGSTFAVK-K--PPEPQNKAKFFIPSMKREHAGRYRCYYRSG 75 (91)
T ss_pred CCCccCCCCcEEEEEec---CCCCCEEEEEECCCCcccc-c--cCCCceeEEEEccCCChhHCEEEEEEEECC
Confidence 34468999999999974 4677889999998764321 1 111234567999999999999999999986
No 252
>cd05879 Ig_P0 Immunoglobulin (Ig)-like domain of Protein zero (P0). Ig_P0ex: immunoglobulin (Ig) domain of Protein zero (P0). P0 accounts for over 50% of the total protein in peripheral nervous system (PNS) myelin. P0 is a single-pass transmembrane glycoprotein with a highly basic intracellular domain and an Ig domain. The extracellular domain of P0 (P0-ED) is similar to the Ig variable domain, carrying one acceptor sequence for N-linked glycosylation. P0 plays a role in membrane adhesion in the spiral wraps of the myelin sheath. The intracellular domain is thought to mediate membrane apposition of the cytoplasmic faces and may, through electrostatic interactions, interact directly with lipid headgroups. It is thought that homophilic interactions of the P0 extracellular domain mediate membrane juxtaposition in the extracellular space of PNS myelin.
Probab=98.04 E-value=3.9e-05 Score=73.96 Aligned_cols=86 Identities=15% Similarity=0.285 Sum_probs=58.5
Q ss_pred cCCceeecCCCeEEEEEEEeeCC--CCCcEEEEe---------------eCCEEccC-C----CcEEEEee--CCeEEEE
Q psy2148 922 TPTDLTLAESTLAHFECRLTPTN--DPSMTVEWF---------------HNGKALSA-G----SRIKTIND--FGFVILE 977 (1884)
Q Consensus 922 ~~~~~~v~~G~~v~l~C~v~~~~--~P~~~v~W~---------------~~g~~i~~-~----~~~~~~~~--~~~~~L~ 977 (1884)
.+.++.+..|+.++|.|...... .+...|+|. ++|..... . .|+....+ .+...|.
T Consensus 4 ~~~ev~a~~G~~v~L~C~f~~~~~~~~~~~v~W~~~~~~~~~~~~v~~y~~g~~~~~~~~~f~~Rv~f~g~~~~~daSI~ 83 (116)
T cd05879 4 TDREVYGTVGSDVTLSCSFWSSEWISDDISFTWHYQPDGSRDAISIFHYGKGQPYIDDVGPFKERIEWVGNPSRKDGSIV 83 (116)
T ss_pred ccceEEEEcCCcEEEEEEEecCCCCCCcEEEEEEEcCCCCCccEEEEEeCCCceecccccCccCceEEeCCCCcCeeEEE
Confidence 35667889999999999998422 245689993 34444321 1 24443322 3456899
Q ss_pred EccCCCCCCeEEEEEEEcCCeeE--EEEEEEE
Q psy2148 978 INDVYLRDSGLYTCKATNKHGEA--TTSCKLT 1007 (1884)
Q Consensus 978 I~~~~~~D~G~Y~C~a~N~~G~~--~~~~~l~ 1007 (1884)
|++++.+|.|.|+|.+.|.-+.. ...+.|.
T Consensus 84 I~nv~~sD~G~Y~C~v~n~p~~~~~~~~~~l~ 115 (116)
T cd05879 84 IHNLDYTDNGTFTCDVKNPPDIVGKSSQVTLY 115 (116)
T ss_pred EccCCcccCEEEEEEEEcCCCcCCceeEEEEE
Confidence 99999999999999999975532 2444443
No 253
>cd00099 IgV Immunoglobulin variable domain (IgV). IgV: Immunoglobulin variable domain (IgV). Members of the IgV family are components of immunoglobulin (Ig) and T cell receptors. The basic structure of Ig molecules is a tetramer of two light chains and two heavy chains linked by disulfide bonds. In Ig, each chain is composed of one variable domain (IgV) and one or more constant domains (IgC); these names reflect the fact that the variability in sequences is higher in the variable domain than in the constant domain. Within the variable domain, there are regions of even more variability called the hypervariable or complementarity-determining regions (CDRs) which are responsible for antigen binding. A predominant feature of most Ig domains is the disulfide bridge connecting 2 beta-sheets with a tryptophan residue packed against the disulfide bond.
Probab=98.04 E-value=1.5e-05 Score=77.08 Aligned_cols=72 Identities=21% Similarity=0.384 Sum_probs=53.8
Q ss_pred eeecCCCeEEEEEEEeeCCCCCcEEEEeeCCE-----Ec------------cCCCcEEEEeeC--CeEEEEEccCCCCCC
Q psy2148 926 LTLAESTLAHFECRLTPTNDPSMTVEWFHNGK-----AL------------SAGSRIKTINDF--GFVILEINDVYLRDS 986 (1884)
Q Consensus 926 ~~v~~G~~v~l~C~v~~~~~P~~~v~W~~~g~-----~i------------~~~~~~~~~~~~--~~~~L~I~~~~~~D~ 986 (1884)
+++.+|++|+|.|.+... .+...+.|+|... .+ ....|+.+..+. +.+.|+|.+++.+|+
T Consensus 1 ~~v~~G~~v~L~C~~~~~-~~~~~v~W~k~~~~~~~~~i~~~~~~~~~~~~~~~~r~~~~~~~~~~~~sL~I~~v~~~D~ 79 (105)
T cd00099 1 LSVSEGESVTLSCTYSGS-FSSYYIFWYRQKPGKGPELLIYISSNGSQYAGGVKGRFSGTRDSSKSSFTLTISSLQPEDS 79 (105)
T ss_pred CeecCCCCEEEEEEEeCC-cCcceEEEEEECCCCCCEEEEEEeCCCCccCccCCCcEEEEEeccCCEEEEEECCCCHHHC
Confidence 357899999999999832 2667899999432 11 123455554443 677999999999999
Q ss_pred eEEEEEEEcCCe
Q psy2148 987 GLYTCKATNKHG 998 (1884)
Q Consensus 987 G~Y~C~a~N~~G 998 (1884)
|.|.|.+.+..+
T Consensus 80 G~Y~C~v~~~~~ 91 (105)
T cd00099 80 AVYYCAVSLSGG 91 (105)
T ss_pred EEEEEEEecCCC
Confidence 999999998765
No 254
>cd04980 IgV_L_kappa Immunoglobulin (Ig) light chain, kappa type, variable (V) domain. IgV_L_kappa: Immunoglobulin (Ig) light chain, kappa type, variable (V) domain. The basic structure of Ig molecules is a tetramer of two light chains and two heavy chains linked by disulfide bonds. In Ig, each chain is composed of one variable domain (IgV) and one or more constant domains (IgC); these names reflect the fact that the variability in sequences is higher in the variable domain than in the constant domain. There are five types of heavy chains (alpha, gamma, delta, epsilon, and mu), which determine the type of immunoglobulin: IgA, IgG, IgD, IgE, and IgM, respectively. In higher vertebrates, there are two types of light chain, designated kappa and lambda, which seem to be functionally identical, and can associate with any of the heavy chains.
Probab=98.03 E-value=2.1e-05 Score=75.83 Aligned_cols=75 Identities=19% Similarity=0.272 Sum_probs=56.4
Q ss_pred EeccCceEEcCCceEEEEEEEecCC-CcEEEEEeCC--Ee---c---------CCCCCeEEeecCCeEEEEEccCCCCCC
Q psy2148 1746 LTTISSAVINVGQLARFDAKISATK-PLDVYWLKNG--KK---I---------IPDIRYKTLEEDNLFTLLIIEAVVEDS 1810 (1884)
Q Consensus 1746 ~~~~~~~~~~~G~~~~l~C~~~g~p-~p~v~W~k~~--~~---l---------~~~~~~~~~~~~~~~~L~i~~~~~~d~ 1810 (1884)
...|....+.+|++++|.|.+.+.. ...+.|||.. +. | ....|+.....+..+.|.|.+++.+|+
T Consensus 4 ~Q~p~~~~v~~G~~v~L~C~~~~~~~~~~~~Wyrq~~g~~~~~l~~~~~~~~~~~~~r~~~~~~~~~~~L~I~~~~~~Ds 83 (106)
T cd04980 4 TQSPATLSVSPGESATISCKASQSVSSNYLAWYQQKPGQAPKLLIYGASTLASGTPSRFSGSGSGTDFTLTISRVEPEDA 83 (106)
T ss_pred EECCCcEEECCCCCEEEEEEECCCCCCCcEEEEEECCCCCcEEEEECccccCCCCCCCEEEeccCCEEEEEECCCChHHC
Confidence 3445677889999999999998765 5689999763 11 1 012356655555677999999999999
Q ss_pred EEEEEEEEeC
Q psy2148 1811 GAYECVAMNN 1820 (1884)
Q Consensus 1811 G~Y~C~a~N~ 1820 (1884)
|.|.|.+.|.
T Consensus 84 g~Y~Ca~~~~ 93 (106)
T cd04980 84 AVYYCQQYGT 93 (106)
T ss_pred EEEEEEEeCC
Confidence 9999998754
No 255
>cd04980 IgV_L_kappa Immunoglobulin (Ig) light chain, kappa type, variable (V) domain. IgV_L_kappa: Immunoglobulin (Ig) light chain, kappa type, variable (V) domain. The basic structure of Ig molecules is a tetramer of two light chains and two heavy chains linked by disulfide bonds. In Ig, each chain is composed of one variable domain (IgV) and one or more constant domains (IgC); these names reflect the fact that the variability in sequences is higher in the variable domain than in the constant domain. There are five types of heavy chains (alpha, gamma, delta, epsilon, and mu), which determine the type of immunoglobulin: IgA, IgG, IgD, IgE, and IgM, respectively. In higher vertebrates, there are two types of light chain, designated kappa and lambda, which seem to be functionally identical, and can associate with any of the heavy chains.
Probab=98.02 E-value=2.2e-05 Score=75.68 Aligned_cols=76 Identities=20% Similarity=0.369 Sum_probs=55.9
Q ss_pred eeecCCceeecCCCeEEEEEEEeeCCCC-CcEEEEeeCC--E---Ec---------cCCCcEEEEeeCCeEEEEEccCCC
Q psy2148 919 FLTTPTDLTLAESTLAHFECRLTPTNDP-SMTVEWFHNG--K---AL---------SAGSRIKTINDFGFVILEINDVYL 983 (1884)
Q Consensus 919 ~~~~~~~~~v~~G~~v~l~C~v~~~~~P-~~~v~W~~~g--~---~i---------~~~~~~~~~~~~~~~~L~I~~~~~ 983 (1884)
+...+..+.+.+|++|+|.|.+.+ .. ...+.|||.. . .| ....++........+.|.|.+++.
T Consensus 3 v~Q~p~~~~v~~G~~v~L~C~~~~--~~~~~~~~Wyrq~~g~~~~~l~~~~~~~~~~~~~r~~~~~~~~~~~L~I~~~~~ 80 (106)
T cd04980 3 LTQSPATLSVSPGESATISCKASQ--SVSSNYLAWYQQKPGQAPKLLIYGASTLASGTPSRFSGSGSGTDFTLTISRVEP 80 (106)
T ss_pred EEECCCcEEECCCCCEEEEEEECC--CCCCCcEEEEEECCCCCcEEEEECccccCCCCCCCEEEeccCCEEEEEECCCCh
Confidence 345677789999999999999973 33 4579999842 1 11 012356654455667899999999
Q ss_pred CCCeEEEEEEEcC
Q psy2148 984 RDSGLYTCKATNK 996 (1884)
Q Consensus 984 ~D~G~Y~C~a~N~ 996 (1884)
+|+|.|.|.+.+.
T Consensus 81 ~Dsg~Y~Ca~~~~ 93 (106)
T cd04980 81 EDAAVYYCQQYGT 93 (106)
T ss_pred HHCEEEEEEEeCC
Confidence 9999999999764
No 256
>cd05718 Ig1_PVR_like First immunoglobulin (Ig) domain of poliovirus receptor (PVR, also known as CD155) and similar proteins. Ig1_PVR_like: domain similar to the first immunoglobulin (Ig) domain of poliovirus receptor (PVR, also known as CD155). Poliovirus (PV) binds to its cellular receptor (PVR/CD155) to initiate infection. CD155 is a membrane-anchored, single-span glycoprotein; its extracellular region has three Ig-like domains. There are four different isotypes of CD155 (referred to as alpha, beta, gamma, and delta), that result from alternate splicing of the CD155 mRNA, and have identical extracellular domains. CD155-beta and - gamma, are secreted, CD155-alpha and delta are membrane-bound and function as PV receptors. The virus recognition site is contained in the amino-terminal domain, D1. Having the virus attachment site on the receptor distal from the plasma membrane, may be important for successful initiation of infection of cells by the virus. CD155 binds in the poliovirus "c
Probab=97.98 E-value=4.1e-05 Score=72.78 Aligned_cols=76 Identities=22% Similarity=0.298 Sum_probs=55.0
Q ss_pred ceEEEEEEEecCC---CcEEEEEeCCEe---------------cCC--CCCeEEeecC-CeEEEEEccCCCCCCEEEEEE
Q psy2148 1758 QLARFDAKISATK---PLDVYWLKNGKK---------------IIP--DIRYKTLEED-NLFTLLIIEAVVEDSGAYECV 1816 (1884)
Q Consensus 1758 ~~~~l~C~~~g~p---~p~v~W~k~~~~---------------l~~--~~~~~~~~~~-~~~~L~i~~~~~~d~G~Y~C~ 1816 (1884)
++|+|.|.....+ ...|.|+|.... ..+ ..|..+.... +..+|+|.+++.+|+|.|.|.
T Consensus 1 ~~v~L~C~~~~~~~~~~~~v~W~k~~~~~~~~i~~~~~~~~~~~~~~~~~R~~~~~~~~~~~sL~I~~v~~~D~G~Y~C~ 80 (98)
T cd05718 1 ESVTLECSFPVPGPVQITQVTWMKITGGSKQNIAVFHPQYGISIPPSYEGRVSFLNSSLEDATISISNLRLEDEGNYICE 80 (98)
T ss_pred CCEEEEeEeeCCCCceEEEEEEeeECCCCCEEEEEEecCCCcccCcCcCceEEEeCCCCCceEEEEccCCcccCEEEEEE
Confidence 4689999998754 347999997531 011 1222222211 456999999999999999999
Q ss_pred EEe-CCeeEEEEEEEEEE
Q psy2148 1817 AMN-NAGEARCEAELVVQ 1833 (1884)
Q Consensus 1817 a~N-~~G~~~~~~~l~V~ 1833 (1884)
+.+ ..|..+..+.|+|+
T Consensus 81 v~~~~~g~~~~~~~l~V~ 98 (98)
T cd05718 81 FATFPQGNRQKVTTLTVL 98 (98)
T ss_pred EEeCCCCcEEEEEEEEeC
Confidence 975 77999999999884
No 257
>cd05883 Ig2_Necl-2 Second immunoglobulin (Ig)-like domain of nectin-like molecule 2 (also known as cell adhesion molecule 1 (CADM1)). Ig2_Necl-2: second immunoglobulin (Ig)-like domain of nectin-like molecule 2 (also known as cell adhesion molecule 1 (CADM1)). Nectin-like molecules (Necls) have similar domain structures to those of nectins. At least five nectin-like molecules have been identified (Necl-1 - Necl-5). These have an extracellular region containing three Ig-like domains, one transmembrane region, and one cytoplasmic region. Necl-2 has Ca(2+)-independent homophilic and heterophilic cell-cell adhesion activity. Necl-1 is expressed in a wide variety of tissues, and is a putative tumour suppressor gene, which is downregulated in aggressive neuroblastoma. Ig domains are likely to participate in ligand binding and recognition.
Probab=97.96 E-value=4.4e-05 Score=67.26 Aligned_cols=74 Identities=14% Similarity=0.133 Sum_probs=52.0
Q ss_pred EEEEEEEeecCCCCCeEEEeeCCccCCCCCCeEEEeeC---CEEEEEEcccCcCCCeEEEEEEEecCce-EEEEEEEEE
Q psy2148 725 AHFEARLTPTDDPKLKVEWFWNGKPMKTGSRFRTFCDF---GFVILEISPVYPEDCGQYSCRAYNDYGE-AVTSASMKV 799 (1884)
Q Consensus 725 ~~l~C~~~~~g~p~~~v~W~k~g~~l~~~~~~~~~~~~---~~~~L~i~~~~~~d~G~Y~C~a~N~~g~-~~~~~~l~V 799 (1884)
+.|.|.+.+ +.|++.|+|+|+|.++............ ..++|.|..-..+|...|+|+|.|+.-. ...+..|.|
T Consensus 2 ~~L~C~s~g-SkP~A~I~W~k~~~~l~~~~~~~~~~~~~~t~~S~L~~~p~~eDdG~~~~C~a~~~~l~~~~~~~~L~V 79 (82)
T cd05883 2 IELNCTAMA-SKPAATIRWFKGNKELTGKSTVEETWSRMFTVTSQLMLKVTKEDDGVPVICLVDHPAVKDLQTQRYLEV 79 (82)
T ss_pred EEEEEEecC-CCCCCEEEEEECCEECcCcccceeccCCCcEEEEEEEEECchhhCCCEEEEEEcCcccCCceeeEEEEE
Confidence 689999986 6999999999999999654322212212 2356888777666777999999997643 344455555
No 258
>cd00099 IgV Immunoglobulin variable domain (IgV). IgV: Immunoglobulin variable domain (IgV). Members of the IgV family are components of immunoglobulin (Ig) and T cell receptors. The basic structure of Ig molecules is a tetramer of two light chains and two heavy chains linked by disulfide bonds. In Ig, each chain is composed of one variable domain (IgV) and one or more constant domains (IgC); these names reflect the fact that the variability in sequences is higher in the variable domain than in the constant domain. Within the variable domain, there are regions of even more variability called the hypervariable or complementarity-determining regions (CDRs) which are responsible for antigen binding. A predominant feature of most Ig domains is the disulfide bridge connecting 2 beta-sheets with a tryptophan residue packed against the disulfide bond.
Probab=97.96 E-value=2.5e-05 Score=75.54 Aligned_cols=70 Identities=20% Similarity=0.375 Sum_probs=54.6
Q ss_pred EEcCCceEEEEEEEecC-CCcEEEEEeCCEe-----c------------CCCCCeEEeecC--CeEEEEEccCCCCCCEE
Q psy2148 1753 VINVGQLARFDAKISAT-KPLDVYWLKNGKK-----I------------IPDIRYKTLEED--NLFTLLIIEAVVEDSGA 1812 (1884)
Q Consensus 1753 ~~~~G~~~~l~C~~~g~-p~p~v~W~k~~~~-----l------------~~~~~~~~~~~~--~~~~L~i~~~~~~d~G~ 1812 (1884)
.+.+|++++|.|.+.+. +...+.|+|.... + ....|+.+.... +.++|+|.+++.+|+|.
T Consensus 2 ~v~~G~~v~L~C~~~~~~~~~~v~W~k~~~~~~~~~i~~~~~~~~~~~~~~~~r~~~~~~~~~~~~sL~I~~v~~~D~G~ 81 (105)
T cd00099 2 SVSEGESVTLSCTYSGSFSSYYIFWYRQKPGKGPELLIYISSNGSQYAGGVKGRFSGTRDSSKSSFTLTISSLQPEDSAV 81 (105)
T ss_pred eecCCCCEEEEEEEeCCcCcceEEEEEECCCCCCEEEEEEeCCCCccCccCCCcEEEEEeccCCEEEEEECCCCHHHCEE
Confidence 46789999999999986 6778999986431 1 112455554443 67899999999999999
Q ss_pred EEEEEEeCCe
Q psy2148 1813 YECVAMNNAG 1822 (1884)
Q Consensus 1813 Y~C~a~N~~G 1822 (1884)
|.|.+.+..+
T Consensus 82 Y~C~v~~~~~ 91 (105)
T cd00099 82 YYCAVSLSGG 91 (105)
T ss_pred EEEEEecCCC
Confidence 9999998775
No 259
>cd05755 Ig2_ICAM-1_like Second immunoglobulin (Ig)-like domain of intercellular cell adhesion molecule-1 (ICAM-1, CD54) and similar proteins. Ig2_ ICAM-1_like: domain similar to the second immunoglobulin (Ig)-like domain of intercellular cell adhesion molecule-1 (ICAM-1, CD54). During the inflammation process, these molecules recruit leukocytes onto the vascular endothelium before extravasation to the injured tissues. ICAM-1 may be involved in organ targeted tumor metastasis. The interaction of ICAM-1 with leukocyte function-associated antigen-1 (LFA-1) plays a part in leukocyte-endothelial cell recognition. This group also contains ICAM-2, which also interacts with LFA-1. Transmigration of immature dendritic cells across resting endothelium is dependent on the interaction of ICAM-2 with, yet unidentified, ligand(s) on the dendritic cells. ICAM-1 has five Ig-like domains and ICAM-2 has two. ICAM-1 may also act as host receptor for viruses and parasites.
Probab=97.96 E-value=3.4e-05 Score=71.11 Aligned_cols=77 Identities=10% Similarity=0.060 Sum_probs=52.8
Q ss_pred cCCceeecCCCeEEEEEEEeeCCCCCcE--EEEeeCCEEccCCCcEEE--EeeCCeEEEEEccCCCCCCeEEEEEEEcCC
Q psy2148 922 TPTDLTLAESTLAHFECRLTPTNDPSMT--VEWFHNGKALSAGSRIKT--INDFGFVILEINDVYLRDSGLYTCKATNKH 997 (1884)
Q Consensus 922 ~~~~~~v~~G~~v~l~C~v~~~~~P~~~--v~W~~~g~~i~~~~~~~~--~~~~~~~~L~I~~~~~~D~G~Y~C~a~N~~ 997 (1884)
.+....+.+|+.++|.|.+.+ +.|.+. |+|||++.+|........ .......+|.+.--..+|.-.|+|+|.+.+
T Consensus 7 ~~~p~~~~eG~~~tL~C~v~g-~~P~a~L~i~W~rG~~~l~~~~~~~~~~~~~~~~stlt~~~~r~D~g~~~sC~A~l~l 85 (100)
T cd05755 7 SPLPSWQPVGKNYTLQCDVPG-VAPRQNLTVVLLRGNETLSRQPFGDNTKSPVNAPATITITVDREDHGANFSCETELDL 85 (100)
T ss_pred ecCCCcccCCCcEEEEEEEcC-cCCCCcEEEEEeeCCEEcccceeccccCCCceeEEEEEEecchhhCCcEEEEEEEecc
Confidence 344455789999999999996 778886 799999999965321110 011234567776444444449999999876
Q ss_pred ee
Q psy2148 998 GE 999 (1884)
Q Consensus 998 G~ 999 (1884)
+.
T Consensus 86 ~~ 87 (100)
T cd05755 86 RP 87 (100)
T ss_pred Cc
Confidence 54
No 260
>cd05878 Ig_Aggrecan_like Immunoglobulin (Ig)-like domain of the aggrecan-like chondroitin sulfate proteoglycan core protein (CSPG). Ig_Aggrecan_like: immunoglobulin (Ig)-like domain of the aggrecan-like chondroitin sulfate proteoglycan core protein (CSPG)s. Included in this group are the Ig domains of other CSPGs: versican, and neurocan. In CSPGs this Ig-like domain is followed by hyaluronan (HA)-binding tandem repeats, and a C-terminal region with epidermal growth factor-like, lectin-like, and complement regulatory protein-like domains. Separating these N- and C-terminal regions is a nonhomologous glycosaminoglycan attachment region. In cartilage, aggrecan forms cartilage link protein stabilized aggregates with hyaluronan (HA). These aggregates contribute to the tissue's load bearing properties. Aggrecan and versican have a wide distribution in connective tissue and extracellular matrices. Neurocan is localized almost exclusively in nervous tissue. Aggregates having other CSPGs substi
Probab=97.95 E-value=5.5e-05 Score=72.80 Aligned_cols=80 Identities=25% Similarity=0.388 Sum_probs=57.3
Q ss_pred CCeEEEEEEEeeCCCC--------CcEEEEeeC--CEEcc--------------CCCcEEEEe---eCCeEEEEEccCCC
Q psy2148 931 STLAHFECRLTPTNDP--------SMTVEWFHN--GKALS--------------AGSRIKTIN---DFGFVILEINDVYL 983 (1884)
Q Consensus 931 G~~v~l~C~v~~~~~P--------~~~v~W~~~--g~~i~--------------~~~~~~~~~---~~~~~~L~I~~~~~ 983 (1884)
|++|+|.|.......+ ...|.|+|. ++.+. -..|+.+.. ..+...|+|.+++.
T Consensus 2 G~~V~LpC~~~~~~~~~~~~~~~~~~~i~W~k~~~~~~~~v~~~~~~~~~~~~~f~gR~~~~~~~~~~~~asL~I~~l~~ 81 (110)
T cd05878 2 SSSVLLPCYFTLPPALPPPSNAPESPRIKWTKLSGQKEVTVLVAQDGVVKVGQEYQGRVSLPNYPENRGDASLEISRLRS 81 (110)
T ss_pred CCCEEEeeEeeCCccccccccCCCCCEEEEEEecCCCcEEEEEEECCEEEecccccCeEEeccCCCCCCcEEEEECCCCh
Confidence 8999999999742221 367999995 22210 012444422 23567899999999
Q ss_pred CCCeEEEEEEEcCCeeEEEEEEEEEEe
Q psy2148 984 RDSGLYTCKATNKHGEATTSCKLTVKG 1010 (1884)
Q Consensus 984 ~D~G~Y~C~a~N~~G~~~~~~~l~V~~ 1010 (1884)
+|+|.|.|.+....+..+..+.|.|.+
T Consensus 82 sD~G~Y~C~v~~~~~~~~~~v~l~V~g 108 (110)
T cd05878 82 SDSGVYRCEVMHGIEDEQDTVPLEVTG 108 (110)
T ss_pred hhCEEEEEEEEeCCCcceEEEEEEEEE
Confidence 999999999998777778888888875
No 261
>cd05718 Ig1_PVR_like First immunoglobulin (Ig) domain of poliovirus receptor (PVR, also known as CD155) and similar proteins. Ig1_PVR_like: domain similar to the first immunoglobulin (Ig) domain of poliovirus receptor (PVR, also known as CD155). Poliovirus (PV) binds to its cellular receptor (PVR/CD155) to initiate infection. CD155 is a membrane-anchored, single-span glycoprotein; its extracellular region has three Ig-like domains. There are four different isotypes of CD155 (referred to as alpha, beta, gamma, and delta), that result from alternate splicing of the CD155 mRNA, and have identical extracellular domains. CD155-beta and - gamma, are secreted, CD155-alpha and delta are membrane-bound and function as PV receptors. The virus recognition site is contained in the amino-terminal domain, D1. Having the virus attachment site on the receptor distal from the plasma membrane, may be important for successful initiation of infection of cells by the virus. CD155 binds in the poliovirus "c
Probab=97.94 E-value=5.5e-05 Score=71.90 Aligned_cols=75 Identities=15% Similarity=0.271 Sum_probs=54.0
Q ss_pred CeEEEEEEEeccC---CCeEEEEeCCee---------------cCCCCCeEEEEeC---ceeEEEEcccccCCCeEEEEE
Q psy2148 1655 DQARFEVEFDGDP---LPTIKWFREDFP---------------ITSSPDFQIHTFS---TKSILIMRQVFMEDSGVFAVI 1713 (1884)
Q Consensus 1655 ~~~~l~C~~~g~p---~~~i~W~~~~~~---------------~~~~~~~~~~~~~---~~~~L~i~~v~~~DsG~Y~C~ 1713 (1884)
++|+|.|.....+ ...|.|+|.... +....+.++.... ...+|.|.+++.+|+|.|.|.
T Consensus 1 ~~v~L~C~~~~~~~~~~~~v~W~k~~~~~~~~i~~~~~~~~~~~~~~~~~R~~~~~~~~~~~sL~I~~v~~~D~G~Y~C~ 80 (98)
T cd05718 1 ESVTLECSFPVPGPVQITQVTWMKITGGSKQNIAVFHPQYGISIPPSYEGRVSFLNSSLEDATISISNLRLEDEGNYICE 80 (98)
T ss_pred CCEEEEeEeeCCCCceEEEEEEeeECCCCCEEEEEEecCCCcccCcCcCceEEEeCCCCCceEEEEccCCcccCEEEEEE
Confidence 5789999998754 457999996521 0111122333322 457899999999999999999
Q ss_pred EEe-CCceEEEEEEEEE
Q psy2148 1714 AEN-RGGKAKCSANLVV 1729 (1884)
Q Consensus 1714 a~n-~~g~~~~~~~l~V 1729 (1884)
+.+ ..|.......|.|
T Consensus 81 v~~~~~g~~~~~~~l~V 97 (98)
T cd05718 81 FATFPQGNRQKVTTLTV 97 (98)
T ss_pred EEeCCCCcEEEEEEEEe
Confidence 875 6788888888877
No 262
>KOG0613|consensus
Probab=97.94 E-value=3.3e-05 Score=99.35 Aligned_cols=299 Identities=15% Similarity=0.102 Sum_probs=185.2
Q ss_pred cEEEEEEEeecCCCCCeEEEeeCCccCCCCCCeEEEeeCCEEEEEEcccCcCCCeEEEEEEEecCceEEEEEEEEEecce
Q psy2148 724 NAHFEARLTPTDDPKLKVEWFWNGKPMKTGSRFRTFCDFGFVILEISPVYPEDCGQYSCRAYNDYGEAVTSASMKVQGKR 803 (1884)
Q Consensus 724 ~~~l~C~~~~~g~p~~~v~W~k~g~~l~~~~~~~~~~~~~~~~L~i~~~~~~d~G~Y~C~a~N~~g~~~~~~~l~V~~~p 803 (1884)
.+.+.|.+ |.|.+..+|+.+|..+..++..++........+.|..+-+.+.|.|.-.+-|..|...... +
T Consensus 207 ~v~~v~s~---gqp~~~~~~~~~g~~i~~~~~~~~s~t~e~s~~~i~~~l~~~~G~~~~~~~~~l~e~~~~~-------~ 276 (1205)
T KOG0613|consen 207 RVRAVVSA---GQPEPLERWEILGELIAPGSAPSMSVTLEASDRKIQLTLRAPRGPYSAHILGYLIEQRKHK-------G 276 (1205)
T ss_pred eEEEEEec---CCCccchhhhhcccccCCCCccccccccchhheeeeEEeecCCCchHHHHhcchhhhcccC-------C
Confidence 34555655 5888999999999999988887776554555677777778888988877776666554410 0
Q ss_pred eeEEeccCCCCceEEEEEeeecCCCcCCCceeEEEEEccccceeEEEEEEEecccceEEeecCCCCcccccceeeecccC
Q psy2148 804 SIILESQLPKGMEVFISFHEISPVYPEDCGQYSCRAYNDYGEAVTSASMKVQGKRSIILESQLPKGMEGTIDKIAELEGY 883 (1884)
Q Consensus 804 ~~~~~~~~~~g~~~~~~~~~i~~~~~~d~g~y~c~a~n~~g~~~~s~~l~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 883 (1884)
. ....|.+..+.+.+.|+|...+..|.........+...+.. +.+..
T Consensus 277 ~---------------~t~~i~~~~~~~~~s~t~~~~~~~~q~~~~v~~~~~i~~~~----~~p~~-------------- 323 (1205)
T KOG0613|consen 277 G---------------NTKTIQNDGPEPELSWTVADKRQGCQDRFKVTEEAPIGKGK----PGPES-------------- 323 (1205)
T ss_pred C---------------ccccccccCCccccceeeecccCCcccceeeeEEeeccccc----cCchh--------------
Confidence 0 11234566677888888888888777765544333211110 00000
Q ss_pred CcccccchhhhhhhhccCCCCcccccccccC---CCCeeeecCCceeecCCCeEEEEEEEeeCCCCCcE-EEEeeCCEEc
Q psy2148 884 GHEREDRTIDKIAELEGYGHEREDRIEEDLG---KAPEFLTTPTDLTLAESTLAHFECRLTPTNDPSMT-VEWFHNGKAL 959 (1884)
Q Consensus 884 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~p~~~~~~~~~~v~~G~~v~l~C~v~~~~~P~~~-v~W~~~g~~i 959 (1884)
...-.. ..|.+.....++.+..+..+++.|... +.+.+. +.|++++...
T Consensus 324 -------------------------~~~aaa~~~~~~v~~~~~~~v~a~d~~~v~m~~~~~--~~~~p~~~~~~~~~~~~ 376 (1205)
T KOG0613|consen 324 -------------------------LQAAAARPPEVPVGLVRNLSVTARDNTLVEMPTALS--GTQKPDEAQGYHGEEVS 376 (1205)
T ss_pred -------------------------hhhhccCCccccccccccceeccccCcceeeccccc--CCcCCchheeecccccc
Confidence 000000 123333344567788899999999998 556665 9999998877
Q ss_pred cCCC--cEEEEeeCCeEEEEEccCCCCCCeEEEEEEEcCCeeEEEEEEEEEEeecccccccchhHhHhcchhhHHHHHHh
Q psy2148 960 SAGS--RIKTINDFGFVILEINDVYLRDSGLYTCKATNKHGEATTSCKLTVKGRQGIDVEPQVSAIFANATKNIQKLEEA 1037 (1884)
Q Consensus 960 ~~~~--~~~~~~~~~~~~L~I~~~~~~D~G~Y~C~a~N~~G~~~~~~~l~V~~~~~~~~~p~~~~~~~~~~~~~~~~~~~ 1037 (1884)
..+. .+........+.+.|..+...+.+.|.|.|.|..|........+|...+.-
T Consensus 377 ~~~~~~~~~~~~~~ts~~~~~~~~~~~e~~~~~~~a~n~~g~~~~~~~~~vs~~~~g----------------------- 433 (1205)
T KOG0613|consen 377 SESLGALPCPVGTVTSHTYTIKDAGPGEGYFTRVPAVNKGGTEQTIAESTVSEEMPG----------------------- 433 (1205)
T ss_pred cccccccccccccccCcchhhhhcCcccccccccceeccCCcccccchhhcccccCC-----------------------
Confidence 6554 333344445567899999999999999999999998776665555432110
Q ss_pred hcccCcCCCCCCCCCCCceeeecCCCcCcCCC--CcEEEEEEEeeCCCCCcEEEEEECCEeccCCCceEEEeeCcEEEEE
Q psy2148 1038 LYRKDELIPDEEKPNPPVFTSQLQDNLDVPEA--GKVHFDCRLEPKSDPTMRIDWFFNGRPFATGSRVKTVYDFGFISLD 1115 (1884)
Q Consensus 1038 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~v~~g--~~~~l~C~v~~~~~p~~~v~W~k~~~~l~~~~~~~~~~~~~~~~l~ 1115 (1884)
..++.+..... .....+ +.+.+.|.+.....|...++|++++-+... +......+...+|.
T Consensus 434 -------------t~~~~~kk~~~--~t~~L~~~~~i~~~~~~~s~~~~~~~~tt~~~~~~~s~--~s~~l~r~~~tslL 496 (1205)
T KOG0613|consen 434 -------------TQPPKFKKDVS--TTDLLTVKDEITVRTPDSSTSMPMTTVTTIKDGLPLSD--RSVTLTRDVLTSLL 496 (1205)
T ss_pred -------------CCCcccccccc--ccccccCCcccccccCCCCccccceeEeeccCCccccc--ccccccccchhhhe
Confidence 01222221111 222223 678888888733444455677777655432 22222334445677
Q ss_pred EcccCcCCcEEEEEEEE
Q psy2148 1116 MDYVYARDSGEYICRAT 1132 (1884)
Q Consensus 1116 i~~~~~~d~G~Y~C~a~ 1132 (1884)
+.-....|+|.|.-...
T Consensus 497 lk~~~~~~~A~~~~a~~ 513 (1205)
T KOG0613|consen 497 LKVASLSDGAQYTRALR 513 (1205)
T ss_pred eeccCCCccchhhhhhh
Confidence 88888889999944443
No 263
>cd05761 Ig2_Necl-1-4_like Second immunoglobulin (Ig)-like domain of the nectin-like molecules Necl-1 - Necl-4 (also known as cell adhesion molecules CADM3, CADM1, CADM2, and CADM4, respectively). Ig2_Necl-1-4_like: domain similar to the second immunoglobulin (Ig)-like domain of the nectin-like molecules Necl-1 (also known as cell adhesion molecule 3 (CADM3)), Necl-2 (CADM1), Necl-3 (CADM2) and Necl-4 (CADM4). These nectin-like molecules have similar domain structures to those of nectins. At least five nectin-like molecules have been identified (Necl-1 - Necl-5). These have an extracellular region containing three Ig-like domains, one transmembrane region, and one cytoplasmic region. The N-terminal Ig-like domain of the extracellular region belongs to the V-type subfamily of Ig domains, is essential to cell-cell adhesion, and plays a part in the interaction with the envelope glycoprotein D of various viruses. Necl-1 and Necl-2 have Ca(2+)-independent homophilic and heterophilic cell-cel
Probab=97.92 E-value=5.3e-05 Score=68.56 Aligned_cols=65 Identities=15% Similarity=0.242 Sum_probs=45.8
Q ss_pred EEEEEEEeeCCCCCcEEEEeeCCEEccCCCcEEEEeeCC----eEEEEEccCCCCCCeEEEEEEEcCCee
Q psy2148 934 AHFECRLTPTNDPSMTVEWFHNGKALSAGSRIKTINDFG----FVILEINDVYLRDSGLYTCKATNKHGE 999 (1884)
Q Consensus 934 v~l~C~v~~~~~P~~~v~W~~~g~~i~~~~~~~~~~~~~----~~~L~I~~~~~~D~G~Y~C~a~N~~G~ 999 (1884)
+.|.|.+.+ +.|++.|+|+++|++|...........++ .+.|.+.....+|.+.|+|+|.|....
T Consensus 2 ~~L~C~~~~-~~P~~~v~W~~~~~~l~~~~~~~~~~~~~~~~~~s~l~~~~~~~d~g~~~~C~v~h~~l~ 70 (82)
T cd05761 2 VELTCTSSG-SKPAATIRWFKGDKELKGVKLKEEDENGKTFTVTSSLRFQVDREDDGAPIICRVDHPALK 70 (82)
T ss_pred EEEEEEecC-cCcCCeEEEEECCEEccCceeeEecCCCCEEEEEEEEEEEcchhhCCCEEEEEEeChhcC
Confidence 689999985 67889999999999996543222222222 234666555566678999999998654
No 264
>cd05879 Ig_P0 Immunoglobulin (Ig)-like domain of Protein zero (P0). Ig_P0ex: immunoglobulin (Ig) domain of Protein zero (P0). P0 accounts for over 50% of the total protein in peripheral nervous system (PNS) myelin. P0 is a single-pass transmembrane glycoprotein with a highly basic intracellular domain and an Ig domain. The extracellular domain of P0 (P0-ED) is similar to the Ig variable domain, carrying one acceptor sequence for N-linked glycosylation. P0 plays a role in membrane adhesion in the spiral wraps of the myelin sheath. The intracellular domain is thought to mediate membrane apposition of the cytoplasmic faces and may, through electrostatic interactions, interact directly with lipid headgroups. It is thought that homophilic interactions of the P0 extracellular domain mediate membrane juxtaposition in the extracellular space of PNS myelin.
Probab=97.91 E-value=9.8e-05 Score=71.22 Aligned_cols=82 Identities=15% Similarity=0.211 Sum_probs=57.1
Q ss_pred CceEEcCCceEEEEEEEecC----CCcEEEE---------------EeCCEecCC-C----CCeEEee--cCCeEEEEEc
Q psy2148 1750 SSAVINVGQLARFDAKISAT----KPLDVYW---------------LKNGKKIIP-D----IRYKTLE--EDNLFTLLII 1803 (1884)
Q Consensus 1750 ~~~~~~~G~~~~l~C~~~g~----p~p~v~W---------------~k~~~~l~~-~----~~~~~~~--~~~~~~L~i~ 1803 (1884)
....+..|+.++|.|..... +...|.| |++|..... . .|..+.. ..+..+|.|.
T Consensus 6 ~ev~a~~G~~v~L~C~f~~~~~~~~~~~v~W~~~~~~~~~~~~v~~y~~g~~~~~~~~~f~~Rv~f~g~~~~~daSI~I~ 85 (116)
T cd05879 6 REVYGTVGSDVTLSCSFWSSEWISDDISFTWHYQPDGSRDAISIFHYGKGQPYIDDVGPFKERIEWVGNPSRKDGSIVIH 85 (116)
T ss_pred ceEEEEcCCcEEEEEEEecCCCCCCcEEEEEEEcCCCCCccEEEEEeCCCceecccccCccCceEEeCCCCcCeeEEEEc
Confidence 45678899999999999764 3468999 334444321 1 2554432 2355699999
Q ss_pred cCCCCCCEEEEEEEEeCCeeEE--EEEEEE
Q psy2148 1804 EAVVEDSGAYECVAMNNAGEAR--CEAELV 1831 (1884)
Q Consensus 1804 ~~~~~d~G~Y~C~a~N~~G~~~--~~~~l~ 1831 (1884)
+++.+|.|+|+|.+.|.-+... ..+.|.
T Consensus 86 nv~~sD~G~Y~C~v~n~p~~~~~~~~~~l~ 115 (116)
T cd05879 86 NLDYTDNGTFTCDVKNPPDIVGKSSQVTLY 115 (116)
T ss_pred cCCcccCEEEEEEEEcCCCcCCceeEEEEE
Confidence 9999999999999999876333 344444
No 265
>cd05880 Ig_EVA1 Immunoglobulin (Ig)-like domain of epithelial V-like antigen 1 (EVA). Ig_EVA: immunoglobulin (Ig) domain of epithelial V-like antigen 1 (EVA). EVA is also known as myelin protein zero-like 2. EVA is an adhesion molecule, which may play a role in structural organization of the thymus and early lymphocyte development.
Probab=97.87 E-value=8.5e-05 Score=72.29 Aligned_cols=84 Identities=23% Similarity=0.256 Sum_probs=55.5
Q ss_pred cCceEEcCCceEEEEEEEecCC----CcEEEEEeC----CEe--c----C-----CC----CCeEEee--cCCeEEEEEc
Q psy2148 1749 ISSAVINVGQLARFDAKISATK----PLDVYWLKN----GKK--I----I-----PD----IRYKTLE--EDNLFTLLII 1803 (1884)
Q Consensus 1749 ~~~~~~~~G~~~~l~C~~~g~p----~p~v~W~k~----~~~--l----~-----~~----~~~~~~~--~~~~~~L~i~ 1803 (1884)
+....+.+|++++|.|.....+ ...|.|++. +.+ + . .. .|+.+.. ..+..+|+|.
T Consensus 5 ~~~v~~~~G~~v~L~C~~s~~~~~~~~~~i~W~~~~~~~~~~~~v~~~~~~~~~~~~~~f~~R~~~~~~~~~~~~sL~I~ 84 (115)
T cd05880 5 SKEVEAVNGTDVRLKCTFSSSAPIGDTLVITWNFRPLDGGREESVFYYHKRPYPPPDGRFKGRVVWDGNIMRRDASILIW 84 (115)
T ss_pred CceEEEEcCCCEEEEEEEEeCCCCCCcEEEEEEEECCCCCceeEEEEECCCccccCcccccCeEEEecCCcCCceEEEEe
Confidence 4567788999999999987543 246999752 211 1 0 11 1222221 2345689999
Q ss_pred cCCCCCCEEEEEEEEeCCeeE--EEEEEEEE
Q psy2148 1804 EAVVEDSGAYECVAMNNAGEA--RCEAELVV 1832 (1884)
Q Consensus 1804 ~~~~~d~G~Y~C~a~N~~G~~--~~~~~l~V 1832 (1884)
+++.+|+|.|+|.+.|..+.. ...++|+|
T Consensus 85 ~v~~~D~G~Y~C~v~~~~~~~~~~~~~~~~~ 115 (115)
T cd05880 85 QLQPTDNGTYTCQVKNPPDVHGPIGEIRLRV 115 (115)
T ss_pred eCChhhCEEEEEEEEeCCCCCCCccEEEEeC
Confidence 999999999999999987642 34445543
No 266
>cd05775 Ig_SLAM-CD84_like_N N-terminal immunoglobulin (Ig)-like domain of the signaling lymphocyte activation molecule (SLAM) family, CD84_like. Ig_SLAM-CD84_like_N: The N-terminal immunoglobulin (Ig)-like domain of the signaling lymphocyte activation molecule (SLAM) family, CD84_like. The SLAM family is a group of immune-cell specific receptors that can regulate both adaptive and innate immune responses. Members of this group include proteins such as CD84, SLAM (CD150), Ly-9 (CD229), NTB-A (ly-108, SLAM6), 19A (CRACC), and SLAMF9. The genes coding for the SLAM family are nested on chromosome 1, in humans at 1q23, and in mice at 1H2. The SLAM family is a subset of the CD2 family, which also includes CD2 and CD58 located on chromosome 1 at 1p13 in humans. In mice, CD2 is located on chromosome 3, and there is no CD58 homolog. The SLAM family proteins are organized as an extracellular domain with either two or four Ig-like domains, a single transmembrane segment, and a cytoplasmic region
Probab=97.86 E-value=3.8e-05 Score=72.14 Aligned_cols=78 Identities=13% Similarity=0.255 Sum_probs=55.1
Q ss_pred cCCCeEEEEEEEec-cCCCeEEEEeCCeecC--C-----------CCCe--EEEEeCceeEEEEcccccCCCeEEEEEEE
Q psy2148 1652 FEQDQARFEVEFDG-DPLPTIKWFREDFPIT--S-----------SPDF--QIHTFSTKSILIMRQVFMEDSGVFAVIAE 1715 (1884)
Q Consensus 1652 ~~G~~~~l~C~~~g-~p~~~i~W~~~~~~~~--~-----------~~~~--~~~~~~~~~~L~i~~v~~~DsG~Y~C~a~ 1715 (1884)
..|++|+|.|.... .....+.|+|....+. . .+++ ++.....+.+|+|.+++.+|+|.|.|.+.
T Consensus 2 ~~G~sVtL~c~~~~~~~~~~v~W~~~~~~~i~~~~~~~~~~~~~~~~~f~~R~~~~~~~~sL~I~~~~~~DsG~Y~c~v~ 81 (97)
T cd05775 2 ILGGSVTLPLNIPDGTEIESITWSFNTSLAIITPGEETAPEIIVTDPSYKERVNFSQNDYSLQISNLKMEDAGSYRAEIN 81 (97)
T ss_pred ccCCeEEEeCCCCCCcEEEEEEEecCCEeEEEecCCCCCCccEEeCCCceeeEEecCCceeEEECCCchHHCEEEEEEEE
Confidence 47999999998865 5567899998753211 0 1122 23333456889999999999999999999
Q ss_pred eCCceE-EEEEEEEE
Q psy2148 1716 NRGGKA-KCSANLVV 1729 (1884)
Q Consensus 1716 n~~g~~-~~~~~l~V 1729 (1884)
+..|.. ...+.|.|
T Consensus 82 ~~~~~~~~~~f~L~v 96 (97)
T cd05775 82 TKNGVTITKEFTLHI 96 (97)
T ss_pred cCCCCeEEEEEEEEe
Confidence 887653 45555555
No 267
>cd04982 IgV_TCR_gamma Immunoglobulin (Ig) variable (V) domain of T-cell receptor (TCR) gamma chain. IgV_TCR_gamma: immunoglobulin (Ig) variable (V) domain of the gamma chain of gamma/delta T-cell receptors (TCRs). TCRs mediate antigen recognition by T lymphocytes, and are heterodimers consisting of alpha and beta chains or gamma and delta chains. Each chain contains a variable (V) and a constant (C) region. The majority of T cells contain alpha/beta TCRs but a small subset contain gamma/delta TCRs. Alpha/beta TCRs recognize antigen as peptide fragments presented by major histocompatibility complex (MHC) molecules. Gamma/delta TCRs recognize intact protein antigens; they recognize protein antigens directly and without antigen processing, and MHC independently of the bound peptide. Gamma/delta T cells can also be stimulated by non-peptide antigens such as small phosphate- or amine-containing compounds. The variable domain of gamma/delta TCRs is responsible for antigen recognition and is
Probab=97.86 E-value=5.1e-05 Score=74.69 Aligned_cols=74 Identities=20% Similarity=0.409 Sum_probs=55.7
Q ss_pred cCCceeecCCCeEEEEEEEeeCCCCCcEEEEeeC--CEEc-----------------cCCCcEEEEeeC--CeEEEEEcc
Q psy2148 922 TPTDLTLAESTLAHFECRLTPTNDPSMTVEWFHN--GKAL-----------------SAGSRIKTINDF--GFVILEIND 980 (1884)
Q Consensus 922 ~~~~~~v~~G~~v~l~C~v~~~~~P~~~v~W~~~--g~~i-----------------~~~~~~~~~~~~--~~~~L~I~~ 980 (1884)
.+..+.+.+|++|+|.|.+.+...+.+.+.|||. |..+ ....|+.+..+. ..+.|+|.+
T Consensus 4 ~p~~~~~~~G~~v~l~C~~~~~~~~~~~v~Wyrq~~g~~~~~l~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~L~I~~ 83 (116)
T cd04982 4 PQLSITREESKSVTISCKVSGIDFSTTYIHWYRQKPGQALERLLYVSSTSTQRKLSGGTKNKFEARKDVGKSTSTLTIQN 83 (116)
T ss_pred cCCeEEeCCCCCEEEEEEEeCCCccccEEEEEEECCCCCCEEEEEEecCCCcEEeCcccCCCEEEEEECCCCEEEEEEEE
Confidence 4566789999999999999732256778999994 2211 013566665554 578999999
Q ss_pred CCCCCCeEEEEEEEc
Q psy2148 981 VYLRDSGLYTCKATN 995 (1884)
Q Consensus 981 ~~~~D~G~Y~C~a~N 995 (1884)
++.+|+|.|.|.+..
T Consensus 84 ~~~~Dsg~Y~C~~~~ 98 (116)
T cd04982 84 LEKEDSATYYCAYWE 98 (116)
T ss_pred CCHHHCEEEEEEEec
Confidence 999999999999864
No 268
>cd04982 IgV_TCR_gamma Immunoglobulin (Ig) variable (V) domain of T-cell receptor (TCR) gamma chain. IgV_TCR_gamma: immunoglobulin (Ig) variable (V) domain of the gamma chain of gamma/delta T-cell receptors (TCRs). TCRs mediate antigen recognition by T lymphocytes, and are heterodimers consisting of alpha and beta chains or gamma and delta chains. Each chain contains a variable (V) and a constant (C) region. The majority of T cells contain alpha/beta TCRs but a small subset contain gamma/delta TCRs. Alpha/beta TCRs recognize antigen as peptide fragments presented by major histocompatibility complex (MHC) molecules. Gamma/delta TCRs recognize intact protein antigens; they recognize protein antigens directly and without antigen processing, and MHC independently of the bound peptide. Gamma/delta T cells can also be stimulated by non-peptide antigens such as small phosphate- or amine-containing compounds. The variable domain of gamma/delta TCRs is responsible for antigen recognition and is
Probab=97.85 E-value=5.2e-05 Score=74.65 Aligned_cols=71 Identities=17% Similarity=0.226 Sum_probs=55.0
Q ss_pred cCceEEcCCceEEEEEEEec--CCCcEEEEEeCC--Eec-----------------CCCCCeEEeecC--CeEEEEEccC
Q psy2148 1749 ISSAVINVGQLARFDAKISA--TKPLDVYWLKNG--KKI-----------------IPDIRYKTLEED--NLFTLLIIEA 1805 (1884)
Q Consensus 1749 ~~~~~~~~G~~~~l~C~~~g--~p~p~v~W~k~~--~~l-----------------~~~~~~~~~~~~--~~~~L~i~~~ 1805 (1884)
+....+.+|++++|.|.+.+ .+.+.+.|+|.. ... ....|+.+.... ..+.|+|.++
T Consensus 5 p~~~~~~~G~~v~l~C~~~~~~~~~~~v~Wyrq~~g~~~~~l~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~L~I~~~ 84 (116)
T cd04982 5 QLSITREESKSVTISCKVSGIDFSTTYIHWYRQKPGQALERLLYVSSTSTQRKLSGGTKNKFEARKDVGKSTSTLTIQNL 84 (116)
T ss_pred CCeEEeCCCCCEEEEEEEeCCCccccEEEEEEECCCCCCEEEEEEecCCCcEEeCcccCCCEEEEEECCCCEEEEEEEEC
Confidence 34567889999999999988 678899999852 211 013466665554 6789999999
Q ss_pred CCCCCEEEEEEEEe
Q psy2148 1806 VVEDSGAYECVAMN 1819 (1884)
Q Consensus 1806 ~~~d~G~Y~C~a~N 1819 (1884)
+.+|+|.|.|.+..
T Consensus 85 ~~~Dsg~Y~C~~~~ 98 (116)
T cd04982 85 EKEDSATYYCAYWE 98 (116)
T ss_pred CHHHCEEEEEEEec
Confidence 99999999999864
No 269
>cd05878 Ig_Aggrecan_like Immunoglobulin (Ig)-like domain of the aggrecan-like chondroitin sulfate proteoglycan core protein (CSPG). Ig_Aggrecan_like: immunoglobulin (Ig)-like domain of the aggrecan-like chondroitin sulfate proteoglycan core protein (CSPG)s. Included in this group are the Ig domains of other CSPGs: versican, and neurocan. In CSPGs this Ig-like domain is followed by hyaluronan (HA)-binding tandem repeats, and a C-terminal region with epidermal growth factor-like, lectin-like, and complement regulatory protein-like domains. Separating these N- and C-terminal regions is a nonhomologous glycosaminoglycan attachment region. In cartilage, aggrecan forms cartilage link protein stabilized aggregates with hyaluronan (HA). These aggregates contribute to the tissue's load bearing properties. Aggrecan and versican have a wide distribution in connective tissue and extracellular matrices. Neurocan is localized almost exclusively in nervous tissue. Aggregates having other CSPGs substi
Probab=97.83 E-value=0.0001 Score=70.95 Aligned_cols=96 Identities=11% Similarity=0.057 Sum_probs=56.6
Q ss_pred CCcEEEEEEEeecCCC--------cceEEEecccccccccccccceEE--EeeccceeeeeeeeeeeeceEEEEEeeecc
Q psy2148 1279 AEPVRFETRVEPRVDP--------RLRVECSLSTAFFFPFINISTAFL--IFNFCLHAVIFSHPIFDLGFVSLDIDYVYP 1348 (1884)
Q Consensus 1279 g~~v~l~c~v~~~~~p--------~~~~~W~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~L~I~~~~~ 1348 (1884)
|+.++|.|.+.....+ ...+.|+|....-....-.+.... ....-..|..........+.+.|+|.+++.
T Consensus 2 G~~V~LpC~~~~~~~~~~~~~~~~~~~i~W~k~~~~~~~~v~~~~~~~~~~~~~f~gR~~~~~~~~~~~~asL~I~~l~~ 81 (110)
T cd05878 2 SSSVLLPCYFTLPPALPPPSNAPESPRIKWTKLSGQKEVTVLVAQDGVVKVGQEYQGRVSLPNYPENRGDASLEISRLRS 81 (110)
T ss_pred CCCEEEeeEeeCCccccccccCCCCCEEEEEEecCCCcEEEEEEECCEEEecccccCeEEeccCCCCCCcEEEEECCCCh
Confidence 8999999998753222 478999996321111100000000 000001121111111345778899999999
Q ss_pred cCceEEEEEEEccccceeeeEEEEEe
Q psy2148 1349 EDQGEYVCRAYNDHGEAFTKATISCK 1374 (1884)
Q Consensus 1349 ~d~G~Y~C~a~n~~g~~~~~~~l~v~ 1374 (1884)
+|+|.|.|.+.......+..+.|.|.
T Consensus 82 sD~G~Y~C~v~~~~~~~~~~v~l~V~ 107 (110)
T cd05878 82 SDSGVYRCEVMHGIEDEQDTVPLEVT 107 (110)
T ss_pred hhCEEEEEEEEeCCCcceEEEEEEEE
Confidence 99999999998755556666777765
No 270
>cd05880 Ig_EVA1 Immunoglobulin (Ig)-like domain of epithelial V-like antigen 1 (EVA). Ig_EVA: immunoglobulin (Ig) domain of epithelial V-like antigen 1 (EVA). EVA is also known as myelin protein zero-like 2. EVA is an adhesion molecule, which may play a role in structural organization of the thymus and early lymphocyte development.
Probab=97.82 E-value=9.5e-05 Score=71.94 Aligned_cols=75 Identities=13% Similarity=0.261 Sum_probs=51.2
Q ss_pred cCCceeecCCCeEEEEEEEeccC----CCeEEEEeC----Cee--c---C------CCCCe--EEEE----eCceeEEEE
Q psy2148 1645 KIQPCRAFEQDQARFEVEFDGDP----LPTIKWFRE----DFP--I---T------SSPDF--QIHT----FSTKSILIM 1699 (1884)
Q Consensus 1645 ~~~~~~v~~G~~~~l~C~~~g~p----~~~i~W~~~----~~~--~---~------~~~~~--~~~~----~~~~~~L~i 1699 (1884)
.++.+.+.+|+++.|.|.....+ ...|.|++. +.+ + . ...++ +... ..++.+|.|
T Consensus 4 ~~~~v~~~~G~~v~L~C~~s~~~~~~~~~~i~W~~~~~~~~~~~~v~~~~~~~~~~~~~~f~~R~~~~~~~~~~~~sL~I 83 (115)
T cd05880 4 TSKEVEAVNGTDVRLKCTFSSSAPIGDTLVITWNFRPLDGGREESVFYYHKRPYPPPDGRFKGRVVWDGNIMRRDASILI 83 (115)
T ss_pred cCceEEEEcCCCEEEEEEEEeCCCCCCcEEEEEEEECCCCCceeEEEEECCCccccCcccccCeEEEecCCcCCceEEEE
Confidence 35667899999999999987543 246999852 111 1 0 11122 1211 134568999
Q ss_pred cccccCCCeEEEEEEEeCCc
Q psy2148 1700 RQVFMEDSGVFAVIAENRGG 1719 (1884)
Q Consensus 1700 ~~v~~~DsG~Y~C~a~n~~g 1719 (1884)
.+++.+|+|.|.|.+.|..+
T Consensus 84 ~~v~~~D~G~Y~C~v~~~~~ 103 (115)
T cd05880 84 WQLQPTDNGTYTCQVKNPPD 103 (115)
T ss_pred eeCChhhCEEEEEEEEeCCC
Confidence 99999999999999998754
No 271
>cd07705 Ig2_Necl-1 Second immunoglobulin (Ig)-like domain of nectin-like molcule-1 (Necl-1, also known as cell adhesion molecule3 (CADM3)). Ig2_Necl-1: second immunoglobulin (Ig)-like domain of nectin-like molcule-1 (Necl-1, also known as cell adhesion molecule3 (CADM3)). These nectin-like molecules have similar domain structures to those of nectins. At least five nectin-like molecules have been identified (Necl-1 - Necl-5). These have an extracellular region containing three Ig-like domains, one transmembrane region, and one cytoplasmic region. The N-terminal Ig-like domain of the extracellular region belongs to the V-type subfamily of Ig domains, is essential to cell-cell adhesion, and plays a part in the interaction with the envelope glycoprotein D of various viruses. Necl-1 and Necl-2 have Ca(2+)-independent homophilic and heterophilic cell-cell adhesion activity. Necl-1 is specifically expressed in neural tissue and is important to the formation of synapses, axon bundles, and myel
Probab=97.82 E-value=0.00013 Score=65.91 Aligned_cols=65 Identities=14% Similarity=0.235 Sum_probs=46.5
Q ss_pred EEEEEEEeeCCCCCcEEEEeeCCEEccCCCcEEEEeeC-C----eEEEEEccCCCCCCeEEEEEEEcCCee
Q psy2148 934 AHFECRLTPTNDPSMTVEWFHNGKALSAGSRIKTINDF-G----FVILEINDVYLRDSGLYTCKATNKHGE 999 (1884)
Q Consensus 934 v~l~C~v~~~~~P~~~v~W~~~g~~i~~~~~~~~~~~~-~----~~~L~I~~~~~~D~G~Y~C~a~N~~G~ 999 (1884)
+.|.|.+.+ +.|++.|+|++||++|............ + .+.|.|.....+|...|+|+|.+....
T Consensus 2 ~~LtC~a~g-~~P~~~ItW~k~g~~l~~~~~~~~~~~~~~t~~~~s~l~~~~~~~d~g~~~tC~v~h~~l~ 71 (83)
T cd07705 2 AKLRCTSSG-SKPAANIKWRKGDQELEGAPTSVLEDGNGKTFTVSSSVEFQVTREDDGAEITCSVGHESLH 71 (83)
T ss_pred EEEEEEecC-ccCCCEeEEEECCEECCCcceeEEECCCCCEEEEEEEEEEEecchhCCCEEEEEEECcccC
Confidence 689999985 6788999999999998765432222222 2 235666555667789999999998643
No 272
>cd05741 Ig_CEACAM_D1_like First immunoglobulin (Ig)-like domain of carcinoembryonic antigen (CEA) related cell adhesion molecule (CEACAM) and similar proteins. Ig_CEACAM_D1_like : immunoglobulin (IG)-like domain 1 in carcinoembryonic antigen (CEA) related cell adhesion molecule (CEACAM) protein subfamily-like. The CEA family is a group of anchored or secreted glycoproteins, expressed by epithelial cells, leukocytes, endothelial cells and placenta. The CEA family is divided into the CEACAM and pregnancy-specific glycoprotein (PSG) subfamilies. This group represents the CEACAM subfamily. CEACAM1 has many important cellular functions, it is a cell adhesion molecule, and a signaling molecule that regulates the growth of tumor cells, it is an angiogenic factor, and is a receptor for bacterial and viral pathogens, including mouse hepatitis virus (MHV). In mice, four isoforms of CEACAM1 generated by alternative splicing have either two [D1, D4] or four [D1-D4] Ig-like domains on the cell surf
Probab=97.82 E-value=6.9e-05 Score=70.24 Aligned_cols=73 Identities=22% Similarity=0.276 Sum_probs=52.8
Q ss_pred CceEEEEEEEecCCCcEEEEEeCCEecCC------------------CCCeEEeecCCeEEEEEccCCCCCCEEEEEEEE
Q psy2148 1757 GQLARFDAKISATKPLDVYWLKNGKKIIP------------------DIRYKTLEEDNLFTLLIIEAVVEDSGAYECVAM 1818 (1884)
Q Consensus 1757 G~~~~l~C~~~g~p~p~v~W~k~~~~l~~------------------~~~~~~~~~~~~~~L~i~~~~~~d~G~Y~C~a~ 1818 (1884)
|++|+|.|.....+...|.|+|+...... ..|+.+..+ .+|.|.+++.+|+|.|+|.+.
T Consensus 1 G~~VtL~c~~~~~~~~~i~W~~~~~~~~~~~i~~~~~~~~~~~~~~~~~R~~~~~~---~sL~I~~l~~~DsG~Y~c~v~ 77 (92)
T cd05741 1 GESVTLPVSNLPENLQEITWYKGKDKSVEAEIASYIATNSTVFGPAYSGRETIYPN---GSLLIQNLTKEDSGTYTLQII 77 (92)
T ss_pred CCcEEEEcccCCCCCEEEEEECCCCCCcceEEEEEecCCceeECCCcCCeEEEcCC---ceEEEccCCchhcEEEEEEEE
Confidence 78999999998766678999998744311 123333322 589999999999999999998
Q ss_pred eCCe-eEEEEEEEEE
Q psy2148 1819 NNAG-EARCEAELVV 1832 (1884)
Q Consensus 1819 N~~G-~~~~~~~l~V 1832 (1884)
+..| .....+.|.|
T Consensus 78 ~~~~~~~~~~~~l~v 92 (92)
T cd05741 78 STNGVTENAKFFLRV 92 (92)
T ss_pred cCCCcEEEEEEEEEC
Confidence 8764 3445555543
No 273
>cd05775 Ig_SLAM-CD84_like_N N-terminal immunoglobulin (Ig)-like domain of the signaling lymphocyte activation molecule (SLAM) family, CD84_like. Ig_SLAM-CD84_like_N: The N-terminal immunoglobulin (Ig)-like domain of the signaling lymphocyte activation molecule (SLAM) family, CD84_like. The SLAM family is a group of immune-cell specific receptors that can regulate both adaptive and innate immune responses. Members of this group include proteins such as CD84, SLAM (CD150), Ly-9 (CD229), NTB-A (ly-108, SLAM6), 19A (CRACC), and SLAMF9. The genes coding for the SLAM family are nested on chromosome 1, in humans at 1q23, and in mice at 1H2. The SLAM family is a subset of the CD2 family, which also includes CD2 and CD58 located on chromosome 1 at 1p13 in humans. In mice, CD2 is located on chromosome 3, and there is no CD58 homolog. The SLAM family proteins are organized as an extracellular domain with either two or four Ig-like domains, a single transmembrane segment, and a cytoplasmic region
Probab=97.80 E-value=5.8e-05 Score=70.89 Aligned_cols=78 Identities=23% Similarity=0.301 Sum_probs=55.0
Q ss_pred cCCceEEEEEEEec-CCCcEEEEEeCCEecC--C-----C------CCe--EEeecCCeEEEEEccCCCCCCEEEEEEEE
Q psy2148 1755 NVGQLARFDAKISA-TKPLDVYWLKNGKKII--P-----D------IRY--KTLEEDNLFTLLIIEAVVEDSGAYECVAM 1818 (1884)
Q Consensus 1755 ~~G~~~~l~C~~~g-~p~p~v~W~k~~~~l~--~-----~------~~~--~~~~~~~~~~L~i~~~~~~d~G~Y~C~a~ 1818 (1884)
..|++|+|.|.... .....|.|+|+...+. . . .++ ++.-.....+|+|.+++.+|+|.|.|.+.
T Consensus 2 ~~G~sVtL~c~~~~~~~~~~v~W~~~~~~~i~~~~~~~~~~~~~~~~~f~~R~~~~~~~~sL~I~~~~~~DsG~Y~c~v~ 81 (97)
T cd05775 2 ILGGSVTLPLNIPDGTEIESITWSFNTSLAIITPGEETAPEIIVTDPSYKERVNFSQNDYSLQISNLKMEDAGSYRAEIN 81 (97)
T ss_pred ccCCeEEEeCCCCCCcEEEEEEEecCCEeEEEecCCCCCCccEEeCCCceeeEEecCCceeEEECCCchHHCEEEEEEEE
Confidence 46999999998865 4455799998754321 0 0 111 12223445699999999999999999999
Q ss_pred eCCeeE-EEEEEEEE
Q psy2148 1819 NNAGEA-RCEAELVV 1832 (1884)
Q Consensus 1819 N~~G~~-~~~~~l~V 1832 (1884)
+..|.. ...++|.|
T Consensus 82 ~~~~~~~~~~f~L~v 96 (97)
T cd05775 82 TKNGVTITKEFTLHI 96 (97)
T ss_pred cCCCCeEEEEEEEEe
Confidence 988754 56677766
No 274
>cd05761 Ig2_Necl-1-4_like Second immunoglobulin (Ig)-like domain of the nectin-like molecules Necl-1 - Necl-4 (also known as cell adhesion molecules CADM3, CADM1, CADM2, and CADM4, respectively). Ig2_Necl-1-4_like: domain similar to the second immunoglobulin (Ig)-like domain of the nectin-like molecules Necl-1 (also known as cell adhesion molecule 3 (CADM3)), Necl-2 (CADM1), Necl-3 (CADM2) and Necl-4 (CADM4). These nectin-like molecules have similar domain structures to those of nectins. At least five nectin-like molecules have been identified (Necl-1 - Necl-5). These have an extracellular region containing three Ig-like domains, one transmembrane region, and one cytoplasmic region. The N-terminal Ig-like domain of the extracellular region belongs to the V-type subfamily of Ig domains, is essential to cell-cell adhesion, and plays a part in the interaction with the envelope glycoprotein D of various viruses. Necl-1 and Necl-2 have Ca(2+)-independent homophilic and heterophilic cell-cel
Probab=97.80 E-value=8.4e-05 Score=67.29 Aligned_cols=66 Identities=14% Similarity=0.120 Sum_probs=46.0
Q ss_pred EEEEEEEeecCCCCCeEEEeeCCccCCCCCCeEEEeeCC----EEEEEEcccCcCCCeEEEEEEEecCceE
Q psy2148 725 AHFEARLTPTDDPKLKVEWFWNGKPMKTGSRFRTFCDFG----FVILEISPVYPEDCGQYSCRAYNDYGEA 791 (1884)
Q Consensus 725 ~~l~C~~~~~g~p~~~v~W~k~g~~l~~~~~~~~~~~~~----~~~L~i~~~~~~d~G~Y~C~a~N~~g~~ 791 (1884)
+.|.|.+.+ +.|.+.++|+++|++|..........+++ ...|.+.....++.+.|+|+|.|.....
T Consensus 2 ~~L~C~~~~-~~P~~~v~W~~~~~~l~~~~~~~~~~~~~~~~~~s~l~~~~~~~d~g~~~~C~v~h~~l~~ 71 (82)
T cd05761 2 VELTCTSSG-SKPAATIRWFKGDKELKGVKLKEEDENGKTFTVTSSLRFQVDREDDGAPIICRVDHPALKS 71 (82)
T ss_pred EEEEEEecC-cCcCCeEEEEECCEEccCceeeEecCCCCEEEEEEEEEEEcchhhCCCEEEEEEeChhcCC
Confidence 689999985 67989999999999986433111111222 2346666656666779999999987653
No 275
>cd05755 Ig2_ICAM-1_like Second immunoglobulin (Ig)-like domain of intercellular cell adhesion molecule-1 (ICAM-1, CD54) and similar proteins. Ig2_ ICAM-1_like: domain similar to the second immunoglobulin (Ig)-like domain of intercellular cell adhesion molecule-1 (ICAM-1, CD54). During the inflammation process, these molecules recruit leukocytes onto the vascular endothelium before extravasation to the injured tissues. ICAM-1 may be involved in organ targeted tumor metastasis. The interaction of ICAM-1 with leukocyte function-associated antigen-1 (LFA-1) plays a part in leukocyte-endothelial cell recognition. This group also contains ICAM-2, which also interacts with LFA-1. Transmigration of immature dendritic cells across resting endothelium is dependent on the interaction of ICAM-2 with, yet unidentified, ligand(s) on the dendritic cells. ICAM-1 has five Ig-like domains and ICAM-2 has two. ICAM-1 may also act as host receptor for viruses and parasites.
Probab=97.78 E-value=0.0001 Score=68.02 Aligned_cols=77 Identities=9% Similarity=0.070 Sum_probs=52.5
Q ss_pred eccCceEEcCCceEEEEEEEec-CCCcE--EEEEeCCEecCCCCCeEE--eecCCeEEEEEccCCCCCCEEEEEEEEeCC
Q psy2148 1747 TTISSAVINVGQLARFDAKISA-TKPLD--VYWLKNGKKIIPDIRYKT--LEEDNLFTLLIIEAVVEDSGAYECVAMNNA 1821 (1884)
Q Consensus 1747 ~~~~~~~~~~G~~~~l~C~~~g-~p~p~--v~W~k~~~~l~~~~~~~~--~~~~~~~~L~i~~~~~~d~G~Y~C~a~N~~ 1821 (1884)
..+....+.+|+.++|+|.+.| .|.+. |.|||+++++........ .......+|++.....+|.-.|+|.|.+.+
T Consensus 6 l~~~p~~~~eG~~~tL~C~v~g~~P~a~L~i~W~rG~~~l~~~~~~~~~~~~~~~~stlt~~~~r~D~g~~~sC~A~l~l 85 (100)
T cd05755 6 LSPLPSWQPVGKNYTLQCDVPGVAPRQNLTVVLLRGNETLSRQPFGDNTKSPVNAPATITITVDREDHGANFSCETELDL 85 (100)
T ss_pred EecCCCcccCCCcEEEEEEEcCcCCCCcEEEEEeeCCEEcccceeccccCCCceeEEEEEEecchhhCCcEEEEEEEecc
Confidence 3445556789999999999987 67776 799999999965321110 112234477776444444449999999987
Q ss_pred ee
Q psy2148 1822 GE 1823 (1884)
Q Consensus 1822 G~ 1823 (1884)
+.
T Consensus 86 ~~ 87 (100)
T cd05755 86 RP 87 (100)
T ss_pred Cc
Confidence 64
No 276
>cd05715 Ig_P0-like Immunoglobulin (Ig)-like domain of Protein zero (P0) and similar proteins. Ig_P0ex-like: domain similar to the immunoglobulin (Ig) domain of Protein zero (P0). P0 accounts for over 50% of the total protein in peripheral nervous system (PNS) myelin. P0 is a single-pass transmembrane glycoprotein with a highly basic intracellular domain and an extracellular Ig domain. The extracellular domain of P0 (P0-ED) is similar to the Ig variable domain, carrying one acceptor sequence for N-linked glycosylation. P0 plays a role in membrane adhesion in the spiral wraps of the myelin sheath. The intracellular domain is thought to mediate membrane apposition of the cytoplasmic faces and may, through electrostatic interactions, interact directly with lipid headgroups. It is thought that homophilic interactions of the P0 extracellular domain mediate membrane juxtaposition in the extracellular space of PNS myelin. This group also contains the Ig domain of Sodium channel subunit beta-2
Probab=97.77 E-value=0.00013 Score=71.50 Aligned_cols=83 Identities=19% Similarity=0.233 Sum_probs=55.0
Q ss_pred cCceEEcCCceEEEEEEEecCC----CcEEEEEeCCE------ec---------C-CC----CCeEEee--cCCeEEEEE
Q psy2148 1749 ISSAVINVGQLARFDAKISATK----PLDVYWLKNGK------KI---------I-PD----IRYKTLE--EDNLFTLLI 1802 (1884)
Q Consensus 1749 ~~~~~~~~G~~~~l~C~~~g~p----~p~v~W~k~~~------~l---------~-~~----~~~~~~~--~~~~~~L~i 1802 (1884)
|....+.+|++++|.|...... ...|.|++... .+ . .. .|+.+.. ..+.++|+|
T Consensus 5 p~~v~v~~G~~vtL~C~~s~~~~~~~~~~v~W~~~~~~~~~~~~v~~~~~~~~~~~~~~~~~~R~~~~~~~~~~~~sL~I 84 (116)
T cd05715 5 PREVYAVNGSDVRLKCTFSSSEPISDDISVTWSFQPEGSGDTESIFHYHKGPYYPLKDGRFKDRVEWVGNPSRKDASIVI 84 (116)
T ss_pred CCeEEEEcCCCeEEEeEEeCCCCcCCceEEEEEEecCCCCCcEEEEEEcCCccccccCccccCcEEEecCCcCCeeEEEE
Confidence 4566788999999999987532 25699986421 10 0 11 1222222 234578999
Q ss_pred ccCCCCCCEEEEEEEEeCCeeE--EEEEEEE
Q psy2148 1803 IEAVVEDSGAYECVAMNNAGEA--RCEAELV 1831 (1884)
Q Consensus 1803 ~~~~~~d~G~Y~C~a~N~~G~~--~~~~~l~ 1831 (1884)
.+++.+|+|.|.|.+.|.-+.. ...+.|.
T Consensus 85 ~~v~~~D~G~Y~C~v~~~~~~~~~~~~~~~~ 115 (116)
T cd05715 85 HNLQFTDNGTYTCDVKNPPDIVGKPGEIRLR 115 (116)
T ss_pred eeCCcccCEEEEEEEEeCCCCCCCccEEEEe
Confidence 9999999999999999886642 2345554
No 277
>cd07705 Ig2_Necl-1 Second immunoglobulin (Ig)-like domain of nectin-like molcule-1 (Necl-1, also known as cell adhesion molecule3 (CADM3)). Ig2_Necl-1: second immunoglobulin (Ig)-like domain of nectin-like molcule-1 (Necl-1, also known as cell adhesion molecule3 (CADM3)). These nectin-like molecules have similar domain structures to those of nectins. At least five nectin-like molecules have been identified (Necl-1 - Necl-5). These have an extracellular region containing three Ig-like domains, one transmembrane region, and one cytoplasmic region. The N-terminal Ig-like domain of the extracellular region belongs to the V-type subfamily of Ig domains, is essential to cell-cell adhesion, and plays a part in the interaction with the envelope glycoprotein D of various viruses. Necl-1 and Necl-2 have Ca(2+)-independent homophilic and heterophilic cell-cell adhesion activity. Necl-1 is specifically expressed in neural tissue and is important to the formation of synapses, axon bundles, and myel
Probab=97.77 E-value=0.00013 Score=65.91 Aligned_cols=66 Identities=9% Similarity=0.113 Sum_probs=46.4
Q ss_pred EEEEEEEeecCCCCCeEEEeeCCccCCCCCCeEEEeeC-CE----EEEEEcccCcCCCeEEEEEEEecCceE
Q psy2148 725 AHFEARLTPTDDPKLKVEWFWNGKPMKTGSRFRTFCDF-GF----VILEISPVYPEDCGQYSCRAYNDYGEA 791 (1884)
Q Consensus 725 ~~l~C~~~~~g~p~~~v~W~k~g~~l~~~~~~~~~~~~-~~----~~L~i~~~~~~d~G~Y~C~a~N~~g~~ 791 (1884)
++|.|.+.+ +.|++.|+|++||++|...........+ +. ..|.|.....+|...|+|+|.|.....
T Consensus 2 ~~LtC~a~g-~~P~~~ItW~k~g~~l~~~~~~~~~~~~~~t~~~~s~l~~~~~~~d~g~~~tC~v~h~~l~~ 72 (83)
T cd07705 2 AKLRCTSSG-SKPAANIKWRKGDQELEGAPTSVLEDGNGKTFTVSSSVEFQVTREDDGAEITCSVGHESLHD 72 (83)
T ss_pred EEEEEEecC-ccCCCEeEEEECCEECCCcceeEEECCCCCEEEEEEEEEEEecchhCCCEEEEEEECcccCC
Confidence 689999986 5799999999999998654332222212 22 346665666667789999999987543
No 278
>cd04984 IgV_L_lambda Immunoglobulin (Ig) lambda light chain variable (V) domain. IgV_L_lambda: Immunoglobulin (Ig) light chain, lambda type, variable (V) domain. The basic structure of Ig molecules is a tetramer of two light chains and two heavy chains linked by disulfide bonds. In Ig, each chain is composed of one variable domain (IgV) and one or more constant domains (IgC); these names reflect the fact that the variability in sequences is higher in the variable domain than in the constant domain. There are five types of heavy chains (alpha, gamma, delta, epsilon, and mu), which determine the type of immunoglobulin: IgA, IgG, IgD, IgE, and IgM, respectively. In higher vertebrates, there are two types of light chain, designated kappa and lambda, which seem to be functionally identical, and can associate with any of the heavy chains.
Probab=97.76 E-value=9.8e-05 Score=69.95 Aligned_cols=70 Identities=16% Similarity=0.250 Sum_probs=51.5
Q ss_pred eecCCCeEEEEEEEeeCCCCCcEEEEeeCC--EEc------------cCCCcEEEEeeCCeEEEEEccCCCCCCeEEEEE
Q psy2148 927 TLAESTLAHFECRLTPTNDPSMTVEWFHNG--KAL------------SAGSRIKTINDFGFVILEINDVYLRDSGLYTCK 992 (1884)
Q Consensus 927 ~v~~G~~v~l~C~v~~~~~P~~~v~W~~~g--~~i------------~~~~~~~~~~~~~~~~L~I~~~~~~D~G~Y~C~ 992 (1884)
.+.+|++|+|.|.+.........+.|||.. ... ....|+....+++.+.|+|.+++.+|+|.|.|.
T Consensus 2 ~v~~G~~v~l~C~~~~~~~~~~~i~Wy~q~~g~~~~~l~~~~~~~~~~~~~rf~~~~~~~~~~L~I~~~~~~Dsg~Y~C~ 81 (98)
T cd04984 2 SVSPGETVTITCTGSSGNISGNYVNWYQQKPGSAPRYLIYEDSDRPSGIPDRFSGSKSGNTASLTISGAQTEDEADYYCQ 81 (98)
T ss_pred ccCCCCCEEEEEEEcCCCcCCCCEEEEEECCCCCccEEEEeccccCCCCCCCEEEEccCCEEEEEECCCChhhCEEEEEE
Confidence 578999999999987321144579999832 111 113467766666778899999999999999999
Q ss_pred EEcC
Q psy2148 993 ATNK 996 (1884)
Q Consensus 993 a~N~ 996 (1884)
+.+.
T Consensus 82 ~~~~ 85 (98)
T cd04984 82 VWDS 85 (98)
T ss_pred EccC
Confidence 8753
No 279
>cd05741 Ig_CEACAM_D1_like First immunoglobulin (Ig)-like domain of carcinoembryonic antigen (CEA) related cell adhesion molecule (CEACAM) and similar proteins. Ig_CEACAM_D1_like : immunoglobulin (IG)-like domain 1 in carcinoembryonic antigen (CEA) related cell adhesion molecule (CEACAM) protein subfamily-like. The CEA family is a group of anchored or secreted glycoproteins, expressed by epithelial cells, leukocytes, endothelial cells and placenta. The CEA family is divided into the CEACAM and pregnancy-specific glycoprotein (PSG) subfamilies. This group represents the CEACAM subfamily. CEACAM1 has many important cellular functions, it is a cell adhesion molecule, and a signaling molecule that regulates the growth of tumor cells, it is an angiogenic factor, and is a receptor for bacterial and viral pathogens, including mouse hepatitis virus (MHV). In mice, four isoforms of CEACAM1 generated by alternative splicing have either two [D1, D4] or four [D1-D4] Ig-like domains on the cell surf
Probab=97.75 E-value=9e-05 Score=69.49 Aligned_cols=74 Identities=16% Similarity=0.290 Sum_probs=51.3
Q ss_pred CCeEEEEEEEeccCCCeEEEEeCCeecCC--------------CCCe--EEEEeCceeEEEEcccccCCCeEEEEEEEeC
Q psy2148 1654 QDQARFEVEFDGDPLPTIKWFREDFPITS--------------SPDF--QIHTFSTKSILIMRQVFMEDSGVFAVIAENR 1717 (1884)
Q Consensus 1654 G~~~~l~C~~~g~p~~~i~W~~~~~~~~~--------------~~~~--~~~~~~~~~~L~i~~v~~~DsG~Y~C~a~n~ 1717 (1884)
|++|+|.|.....+...|.|+|+...... ..++ +... ..+.+|.|.+++.+|+|.|.|.+...
T Consensus 1 G~~VtL~c~~~~~~~~~i~W~~~~~~~~~~~i~~~~~~~~~~~~~~~~~R~~~-~~~~sL~I~~l~~~DsG~Y~c~v~~~ 79 (92)
T cd05741 1 GESVTLPVSNLPENLQEITWYKGKDKSVEAEIASYIATNSTVFGPAYSGRETI-YPNGSLLIQNLTKEDSGTYTLQIIST 79 (92)
T ss_pred CCcEEEEcccCCCCCEEEEEECCCCCCcceEEEEEecCCceeECCCcCCeEEE-cCCceEEEccCCchhcEEEEEEEEcC
Confidence 78999999998777789999997643211 0011 1112 23378999999999999999999887
Q ss_pred Cce-EEEEEEEE
Q psy2148 1718 GGK-AKCSANLV 1728 (1884)
Q Consensus 1718 ~g~-~~~~~~l~ 1728 (1884)
.|. ......|.
T Consensus 80 ~~~~~~~~~~l~ 91 (92)
T cd05741 80 NGVTENAKFFLR 91 (92)
T ss_pred CCcEEEEEEEEE
Confidence 543 33444443
No 280
>cd04984 IgV_L_lambda Immunoglobulin (Ig) lambda light chain variable (V) domain. IgV_L_lambda: Immunoglobulin (Ig) light chain, lambda type, variable (V) domain. The basic structure of Ig molecules is a tetramer of two light chains and two heavy chains linked by disulfide bonds. In Ig, each chain is composed of one variable domain (IgV) and one or more constant domains (IgC); these names reflect the fact that the variability in sequences is higher in the variable domain than in the constant domain. There are five types of heavy chains (alpha, gamma, delta, epsilon, and mu), which determine the type of immunoglobulin: IgA, IgG, IgD, IgE, and IgM, respectively. In higher vertebrates, there are two types of light chain, designated kappa and lambda, which seem to be functionally identical, and can associate with any of the heavy chains.
Probab=97.74 E-value=9.2e-05 Score=70.12 Aligned_cols=68 Identities=19% Similarity=0.223 Sum_probs=52.5
Q ss_pred EEcCCceEEEEEEEecC--CCcEEEEEeCCE--ecC------------CCCCeEEeecCCeEEEEEccCCCCCCEEEEEE
Q psy2148 1753 VINVGQLARFDAKISAT--KPLDVYWLKNGK--KII------------PDIRYKTLEEDNLFTLLIIEAVVEDSGAYECV 1816 (1884)
Q Consensus 1753 ~~~~G~~~~l~C~~~g~--p~p~v~W~k~~~--~l~------------~~~~~~~~~~~~~~~L~i~~~~~~d~G~Y~C~ 1816 (1884)
.+.+|++++|.|...+. ....+.|||... .+. ...|+....++..+.|+|.+++.+|+|.|.|.
T Consensus 2 ~v~~G~~v~l~C~~~~~~~~~~~i~Wy~q~~g~~~~~l~~~~~~~~~~~~~rf~~~~~~~~~~L~I~~~~~~Dsg~Y~C~ 81 (98)
T cd04984 2 SVSPGETVTITCTGSSGNISGNYVNWYQQKPGSAPRYLIYEDSDRPSGIPDRFSGSKSGNTASLTISGAQTEDEADYYCQ 81 (98)
T ss_pred ccCCCCCEEEEEEEcCCCcCCCCEEEEEECCCCCccEEEEeccccCCCCCCCEEEEccCCEEEEEECCCChhhCEEEEEE
Confidence 46789999999999775 556799997643 110 12466666666778999999999999999999
Q ss_pred EEeC
Q psy2148 1817 AMNN 1820 (1884)
Q Consensus 1817 a~N~ 1820 (1884)
+.+.
T Consensus 82 ~~~~ 85 (98)
T cd04984 82 VWDS 85 (98)
T ss_pred EccC
Confidence 8753
No 281
>cd05715 Ig_P0-like Immunoglobulin (Ig)-like domain of Protein zero (P0) and similar proteins. Ig_P0ex-like: domain similar to the immunoglobulin (Ig) domain of Protein zero (P0). P0 accounts for over 50% of the total protein in peripheral nervous system (PNS) myelin. P0 is a single-pass transmembrane glycoprotein with a highly basic intracellular domain and an extracellular Ig domain. The extracellular domain of P0 (P0-ED) is similar to the Ig variable domain, carrying one acceptor sequence for N-linked glycosylation. P0 plays a role in membrane adhesion in the spiral wraps of the myelin sheath. The intracellular domain is thought to mediate membrane apposition of the cytoplasmic faces and may, through electrostatic interactions, interact directly with lipid headgroups. It is thought that homophilic interactions of the P0 extracellular domain mediate membrane juxtaposition in the extracellular space of PNS myelin. This group also contains the Ig domain of Sodium channel subunit beta-2
Probab=97.73 E-value=0.00016 Score=70.98 Aligned_cols=77 Identities=17% Similarity=0.437 Sum_probs=51.5
Q ss_pred cCCceeecCCCeEEEEEEEeeCCC--CCcEEEEeeCCE------Ec---------c-CCC----cEEEEee--CCeEEEE
Q psy2148 922 TPTDLTLAESTLAHFECRLTPTND--PSMTVEWFHNGK------AL---------S-AGS----RIKTIND--FGFVILE 977 (1884)
Q Consensus 922 ~~~~~~v~~G~~v~l~C~v~~~~~--P~~~v~W~~~g~------~i---------~-~~~----~~~~~~~--~~~~~L~ 977 (1884)
.++.+.+.+|++|+|.|....... ....|.|++... .+ . ... |+.+..+ .+.+.|+
T Consensus 4 ~p~~v~v~~G~~vtL~C~~s~~~~~~~~~~v~W~~~~~~~~~~~~v~~~~~~~~~~~~~~~~~~R~~~~~~~~~~~~sL~ 83 (116)
T cd05715 4 TPREVYAVNGSDVRLKCTFSSSEPISDDISVTWSFQPEGSGDTESIFHYHKGPYYPLKDGRFKDRVEWVGNPSRKDASIV 83 (116)
T ss_pred cCCeEEEEcCCCeEEEeEEeCCCCcCCceEEEEEEecCCCCCcEEEEEEcCCccccccCccccCcEEEecCCcCCeeEEE
Confidence 356778899999999999873221 225699987321 11 0 111 2222211 2346899
Q ss_pred EccCCCCCCeEEEEEEEcCCe
Q psy2148 978 INDVYLRDSGLYTCKATNKHG 998 (1884)
Q Consensus 978 I~~~~~~D~G~Y~C~a~N~~G 998 (1884)
|.+++.+|+|.|.|.+.|.-+
T Consensus 84 I~~v~~~D~G~Y~C~v~~~~~ 104 (116)
T cd05715 84 IHNLQFTDNGTYTCDVKNPPD 104 (116)
T ss_pred EeeCCcccCEEEEEEEEeCCC
Confidence 999999999999999998754
No 282
>cd05902 Ig_Neurocan Immunoglobulin (Ig)-like domain of the chondroitin sulfate proteoglycan core protein (CSPG), neurocan. Ig_Neurocan: immunoglobulin (Ig)-like domain of the chondroitin sulfate proteoglycan core protein (CSPG), neurocan. In CSPGs, the Ig-like domain is followed by hyaluronan (HA)-binding tandem repeats, and a C-terminal region with epidermal growth factor-like, lectin-like, and complement regulatory protein-like domains. Separating these N- and C-terminal regions is a nonhomologous glycosaminoglycan attachment region. In cartilage, the CSPG aggrecan (not included in this group) forms cartilage link protein stabilized aggregates with HA. These aggregates contribute to the tissue's load bearing properties. Unlike aggrecan which is widely distributed in connective tissue and extracellular matrices, neurocan is localized almost exclusively in nervous tissue. Aggregates having other CSPGs substituting for aggrecan may contribute to the structural integrity of many differen
Probab=97.69 E-value=0.00028 Score=67.19 Aligned_cols=80 Identities=19% Similarity=0.263 Sum_probs=56.7
Q ss_pred CCeEEEEEEEeeCCC-----CCcEEEEeeC-----CEEc----cC----------CCcEEEEee---CCeEEEEEccCCC
Q psy2148 931 STLAHFECRLTPTND-----PSMTVEWFHN-----GKAL----SA----------GSRIKTIND---FGFVILEINDVYL 983 (1884)
Q Consensus 931 G~~v~l~C~v~~~~~-----P~~~v~W~~~-----g~~i----~~----------~~~~~~~~~---~~~~~L~I~~~~~ 983 (1884)
|++|+|.|...-.+. ..+.|.|.|. ...+ .. ..|..+..+ .+..+|.|++++.
T Consensus 2 ~~~v~LpC~~~~~p~~~~~~~~~~I~W~k~~~~~~~~~~~v~v~~~~~~~~~~~y~gRvsl~~~~~~~~~asL~i~nv~~ 81 (110)
T cd05902 2 SSSVLLPCVFTLPPSASSPPEGPRIKWTKLRPASGQKQRPVLVARDNVVRVAKAFQGRVSLPGYPKNRYNASLVLSRLRY 81 (110)
T ss_pred CCcEEEeeEEEcCccccCCCCCCEEEEEEeCCCCCceEEEEEECCCCcEEEchhcccEEEeecCCCCCceEEEEECCCCH
Confidence 789999999762111 2468999984 1211 01 124444432 2567899999999
Q ss_pred CCCeEEEEEEEcCCeeEEEEEEEEEEe
Q psy2148 984 RDSGLYTCKATNKHGEATTSCKLTVKG 1010 (1884)
Q Consensus 984 ~D~G~Y~C~a~N~~G~~~~~~~l~V~~ 1010 (1884)
+|+|.|.|.+.......+..+.|.|.+
T Consensus 82 ~D~G~Y~C~v~~g~~~~~~~v~L~V~g 108 (110)
T cd05902 82 SDSGTYRCEVVLGINDEQDTVPLEVTG 108 (110)
T ss_pred HHCEEEEEEEEECCcccEEEEEEEEEE
Confidence 999999999999777778888888864
No 283
>cd05902 Ig_Neurocan Immunoglobulin (Ig)-like domain of the chondroitin sulfate proteoglycan core protein (CSPG), neurocan. Ig_Neurocan: immunoglobulin (Ig)-like domain of the chondroitin sulfate proteoglycan core protein (CSPG), neurocan. In CSPGs, the Ig-like domain is followed by hyaluronan (HA)-binding tandem repeats, and a C-terminal region with epidermal growth factor-like, lectin-like, and complement regulatory protein-like domains. Separating these N- and C-terminal regions is a nonhomologous glycosaminoglycan attachment region. In cartilage, the CSPG aggrecan (not included in this group) forms cartilage link protein stabilized aggregates with HA. These aggregates contribute to the tissue's load bearing properties. Unlike aggrecan which is widely distributed in connective tissue and extracellular matrices, neurocan is localized almost exclusively in nervous tissue. Aggregates having other CSPGs substituting for aggrecan may contribute to the structural integrity of many differen
Probab=97.69 E-value=0.00029 Score=67.08 Aligned_cols=78 Identities=15% Similarity=0.225 Sum_probs=54.6
Q ss_pred CCeEEEEEEEeccC-------CCeEEEEeCC-----ee----cCC--------C--CCeEEEEe---CceeEEEEccccc
Q psy2148 1654 QDQARFEVEFDGDP-------LPTIKWFRED-----FP----ITS--------S--PDFQIHTF---STKSILIMRQVFM 1704 (1884)
Q Consensus 1654 G~~~~l~C~~~g~p-------~~~i~W~~~~-----~~----~~~--------~--~~~~~~~~---~~~~~L~i~~v~~ 1704 (1884)
|+.+.|.|...-.| .+.|.|.|.. .. +.. . .|..+... .++.+|.|.+++.
T Consensus 2 ~~~v~LpC~~~~~p~~~~~~~~~~I~W~k~~~~~~~~~~~v~v~~~~~~~~~~~y~gRvsl~~~~~~~~~asL~i~nv~~ 81 (110)
T cd05902 2 SSSVLLPCVFTLPPSASSPPEGPRIKWTKLRPASGQKQRPVLVARDNVVRVAKAFQGRVSLPGYPKNRYNASLVLSRLRY 81 (110)
T ss_pred CCcEEEeeEEEcCccccCCCCCCEEEEEEeCCCCCceEEEEEECCCCcEEEchhcccEEEeecCCCCCceEEEEECCCCH
Confidence 78999999976433 3789999851 11 001 1 12222211 2457899999999
Q ss_pred CCCeEEEEEEEeCCceEEEEEEEEEEe
Q psy2148 1705 EDSGVFAVIAENRGGKAKCSANLVVEE 1731 (1884)
Q Consensus 1705 ~DsG~Y~C~a~n~~g~~~~~~~l~V~~ 1731 (1884)
+|+|.|.|.+..........+.|.|.+
T Consensus 82 ~D~G~Y~C~v~~g~~~~~~~v~L~V~g 108 (110)
T cd05902 82 SDSGTYRCEVVLGINDEQDTVPLEVTG 108 (110)
T ss_pred HHCEEEEEEEEECCcccEEEEEEEEEE
Confidence 999999999998766677888888874
No 284
>cd00098 IgC Immunoglobulin Constant domain. IgC: Immunoglobulin constant domain (IgC). Members of the IgC family are components of immunoglobulin, T-cell receptors, CD1 cell surface glycoproteins, secretory glycoproteins A/C, and Major Histocompatibility Complex (MHC) class I/II molecules. In immunoglobulins, each chain is composed of one variable domain (IgV) and one or more IgC domains. These names reflect the fact that the variability in sequences is higher in the variable domain than in the constant domain. The IgV domain is responsible for antigen binding, and the IgC domain is involved in oligomerization and molecular interactions.
Probab=97.68 E-value=9.6e-05 Score=69.79 Aligned_cols=71 Identities=25% Similarity=0.368 Sum_probs=50.8
Q ss_pred cCCCeEEEEEEEeeCCCCCcEEEEeeCCEEccCCCc-EE-EEeeCC----eEEEEEccCCCCCCeEEEEEEEcCCee
Q psy2148 929 AESTLAHFECRLTPTNDPSMTVEWFHNGKALSAGSR-IK-TINDFG----FVILEINDVYLRDSGLYTCKATNKHGE 999 (1884)
Q Consensus 929 ~~G~~v~l~C~v~~~~~P~~~v~W~~~g~~i~~~~~-~~-~~~~~~----~~~L~I~~~~~~D~G~Y~C~a~N~~G~ 999 (1884)
..|+.++|.|.+.+...+.+.|+|++||..+..... .. ....++ .+.|.|......|.|.|+|+|.|....
T Consensus 11 ~~~~~~~L~C~a~g~~P~~~~i~W~~~g~~~~~~~~~~~~~~~~~gt~~~~s~l~v~~~~~~~~~~y~C~v~h~~~~ 87 (95)
T cd00098 11 LLGGSVTLTCLATGFYPPDITVTWLKNGKELTSGVTTTPPVPNSDGTYSVSSQLTVSPSDWNSGDTYTCVVTHESLP 87 (95)
T ss_pred HcCCCeEEEEEEeeEECCCcEEEEEECCEECCCceeccccccCCCCCEEEEEEEEECHHHhCCCCCEEEEEEeCCCC
Confidence 468999999999953223578999999999976653 11 122222 235777766667999999999997653
No 285
>KOG0613|consensus
Probab=97.68 E-value=0.00015 Score=93.42 Aligned_cols=214 Identities=14% Similarity=0.069 Sum_probs=151.7
Q ss_pred CCceEEEEEEecCCCCeEEEEEcCEEeeeeeEEEEeeccceeeeecceeeEEEEecCCCCCCCCeeeecCCceeecCCCe
Q psy2148 1577 GEPARFCTRVTGYPRPRVMWLINGHTIVNEIVRKITATETTEMEHKGKIQERVVDASEKPAKPPVFTKKIQPCRAFEQDQ 1656 (1884)
Q Consensus 1577 g~~~~l~C~~~g~p~~~v~W~~~g~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~v~~G~~ 1656 (1884)
++...+.....|.|.+.++|+.+|..+.. ...++.....++..
T Consensus 204 ~e~~v~~v~s~gqp~~~~~~~~~g~~i~~-------------------------------------~~~~~~s~t~e~s~ 246 (1205)
T KOG0613|consen 204 YESRVRAVVSAGQPEPLERWEILGELIAP-------------------------------------GSAPSMSVTLEASD 246 (1205)
T ss_pred cceeEEEEEecCCCccchhhhhcccccCC-------------------------------------CCccccccccchhh
Confidence 45555555567899999999999987632 22334445667888
Q ss_pred EEEEEEEeccCCCeEEEEeCCeecCCCCCeEEEEeCceeEEEEcccccCCCeEEEEEEEeCCceEEEEEEEEEEecccCC
Q psy2148 1657 ARFEVEFDGDPLPTIKWFREDFPITSSPDFQIHTFSTKSILIMRQVFMEDSGVFAVIAENRGGKAKCSANLVVEEKRQGG 1736 (1884)
Q Consensus 1657 ~~l~C~~~g~p~~~i~W~~~~~~~~~~~~~~~~~~~~~~~L~i~~v~~~DsG~Y~C~a~n~~g~~~~~~~l~V~~~~~~~ 1736 (1884)
..+.|.+.+.+.+.+.|+.+....... .....++.|.+-...+.+.|+|...+..|.....+...+.......
T Consensus 247 ~~i~~~l~~~~G~~~~~~~~~l~e~~~-------~~~~~t~~i~~~~~~~~~s~t~~~~~~~~q~~~~v~~~~~i~~~~~ 319 (1205)
T KOG0613|consen 247 RKIQLTLRAPRGPYSAHILGYLIEQRK-------HKGGNTKTIQNDGPEPELSWTVADKRQGCQDRFKVTEEAPIGKGKP 319 (1205)
T ss_pred eeeeEEeecCCCchHHHHhcchhhhcc-------cCCCccccccccCCccccceeeecccCCcccceeeeEEeecccccc
Confidence 999999999999999998887543322 1233457788888889999999998887776665544443211111
Q ss_pred C------CCCCC---CeEEeccCceEEcCCceEEEEEEEecCCCcE-EEEEeCCEecCCCCC--eEEeecCCeEEEEEcc
Q psy2148 1737 R------GGVVP---PSFLTTISSAVINVGQLARFDAKISATKPLD-VYWLKNGKKIIPDIR--YKTLEEDNLFTLLIIE 1804 (1884)
Q Consensus 1737 ~------~~~~~---P~~~~~~~~~~~~~G~~~~l~C~~~g~p~p~-v~W~k~~~~l~~~~~--~~~~~~~~~~~L~i~~ 1804 (1884)
. ....+ |.+........+..+..+++.|...+.+.|. ++|++++.....+.. ...........+.|..
T Consensus 320 ~p~~~~~aaa~~~~~~v~~~~~~~v~a~d~~~v~m~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ts~~~~~~~ 399 (1205)
T KOG0613|consen 320 GPESLQAAAARPPEVPVGLVRNLSVTARDNTLVEMPTALSGTQKPDEAQGYHGEEVSSESLGALPCPVGTVTSHTYTIKD 399 (1205)
T ss_pred CchhhhhhccCCccccccccccceeccccCcceeecccccCCcCCchheeecccccccccccccccccccccCcchhhhh
Confidence 0 00112 2223333455667788999999999999987 999999887766552 3333445566899999
Q ss_pred CCCCCCEEEEEEEEeCCeeEEEEEEEEEEe
Q psy2148 1805 AVVEDSGAYECVAMNNAGEARCEAELVVQS 1834 (1884)
Q Consensus 1805 ~~~~d~G~Y~C~a~N~~G~~~~~~~l~V~~ 1834 (1884)
+...+.+.|.|.|.|..|........+|..
T Consensus 400 ~~~~e~~~~~~~a~n~~g~~~~~~~~~vs~ 429 (1205)
T KOG0613|consen 400 AGPGEGYFTRVPAVNKGGTEQTIAESTVSE 429 (1205)
T ss_pred cCcccccccccceeccCCcccccchhhccc
Confidence 999999999999999999888777777664
No 286
>cd07694 Ig2_CD4 Second immunoglobulin (Ig) domain of CD4. Ig2_CD4; second immunoglobulin (Ig) domain of CD4. CD4 and CD8 are the two primary co-receptor proteins found on the surface of T cells, and the presence of either CD4 or CD8 determines the function of the T cell. CD4 is found on helper T cells, where it is required for the binding of MHC (major histocompatibility complex) class II molecules, while CD8 is found on cytotoxic T cells, where it is required for the binding of MHC class I molecules. CD4 contains four immunoglobulin domains, with the first three included in this hierarchy. The fourth domain has a general Ig architecture, but has slight topological changes in the arrangement of beta strands relative to the other structures in this family and is not specifically included in the hierarchy.
Probab=97.67 E-value=0.00032 Score=61.38 Aligned_cols=78 Identities=21% Similarity=0.280 Sum_probs=56.1
Q ss_pred ceEEcCCceEEEEEEEecCC--CcEEEEEeCCEecCCCCCeEEeecCCeEEEEEccCCCCCCEEEEEEEEeCCeeEEEEE
Q psy2148 1751 SAVINVGQLARFDAKISATK--PLDVYWLKNGKKIIPDIRYKTLEEDNLFTLLIIEAVVEDSGAYECVAMNNAGEARCEA 1828 (1884)
Q Consensus 1751 ~~~~~~G~~~~l~C~~~g~p--~p~v~W~k~~~~l~~~~~~~~~~~~~~~~L~i~~~~~~d~G~Y~C~a~N~~G~~~~~~ 1828 (1884)
+..+..|++++|+|.....+ .+.|+|+-.+...... ...+..+|.+..+...|+|.++|.+.-..-.....+
T Consensus 8 ~~~lL~G~sLtLtl~~~s~s~p~~~i~w~~P~n~~~~~------~~~~~ktL~~~qv~~qdSG~WtC~V~~~~k~~~~~~ 81 (88)
T cd07694 8 SDHVLSGTNLTLTLHGSSNSLPAFKVEWRGPGNKSKQI------LNQDKKTLNLVQLGPNDSGTWDCIVSVNSSEKTLKL 81 (88)
T ss_pred CCeeecCCcEEEEEecCCCCCCCccEEEeCCCCcccee------ccCCccEEEeceeCcccCCEEEEEEEECceEEEEEe
Confidence 45778999999999996644 4599998665543211 112334899999999999999999976555555666
Q ss_pred EEEEEe
Q psy2148 1829 ELVVQS 1834 (1884)
Q Consensus 1829 ~l~V~~ 1834 (1884)
.+.|.+
T Consensus 82 ~V~Vl~ 87 (88)
T cd07694 82 DIKVLA 87 (88)
T ss_pred eEEEEe
Confidence 666653
No 287
>cd05711 Ig_FcalphaRI Immunoglobulin (IG)-like domain of of FcalphaRI. IG_FcalphaRI : immunoglobulin (IG)-like domain of of FcalphaRI. FcalphaRI (CD89) is an IgA-specific receptor that is expressed on monocytes, eosinophils, neutrophils and macrophages. FcalphaRI mediates IgA-induced immune effector responses such as phagocytosis, antibody-dependent cell-mediated cytotoxicity and respiratory burst. Both monomeric and dimeric IgA can bind to FcalphaRI, and monomeric or dimeric IgA immune complexes can activate phagocytosis and other immune responses through the clustering of FcalphaRI. The Fc RI ectodomain is comprised of two Ig-like domains oriented at about 90 degree to each another.
Probab=97.67 E-value=0.00016 Score=67.30 Aligned_cols=75 Identities=12% Similarity=0.145 Sum_probs=49.7
Q ss_pred CceEeccCCccCccCCCeEEEEEEEeeCCCCCCeEEEeeCCEEccccCcEEEEecCCEEEEEEcccCCCCcEEEEEEEEe
Q psy2148 409 PKFTSHIKSLEGLKDGDSAHFECTLTPVNDPELKVEWFHNGKPIFHKNRVKMVSDFGFVVMDIAYVQSHDSGEYVCRAWN 488 (1884)
Q Consensus 409 p~~~~~~~~~~~v~~G~~v~L~C~~~~~~~p~~~i~W~k~g~~l~~~~~~~~~~~~~~~~L~i~~v~~~d~G~Y~C~a~n 488 (1884)
|.+...+.. .|.+|++|+|.|... .+...+.|||+|...................|.|..++.+|+|.|+|....
T Consensus 2 P~l~a~p~~--vV~~G~~VTL~C~~~---~~~~~f~l~k~g~~~~~~~~~~~~~~~~~a~f~I~~~~~~~~G~Y~C~~~~ 76 (94)
T cd05711 2 PFLSAHPSP--VVPSGENVTLQCHSD---IRFDRFILYKEGRSKPVLHLYEKHHGGFQASFPLGPVTPAHAGTYRCYGSY 76 (94)
T ss_pred CEEEecCCC--ccCCCCeEEEEEecC---CCCCEEEEEECCCCCCceecccccCCeEEEEEEecCCCcccCEEEEEEEEC
Confidence 444444433 378999999999875 255689999998653221000001112234689999999999999998753
No 288
>PHA03269 envelope glycoprotein C; Provisional
Probab=97.66 E-value=0.0026 Score=72.79 Aligned_cols=205 Identities=15% Similarity=0.172 Sum_probs=110.8
Q ss_pred EEEEEcCCCCCCCEEEEEEEEcCC-ee--eEEEEEEEEeecCCCCCCceEeccCCccCccCCCeEEEEEEEeeCCCCC--
Q psy2148 366 VVLEILGTKIEDTGVYTCRATNKW-GQ--AEISVNLECVDKSKGQPPKFTSHIKSLEGLKDGDSAHFECTLTPVNDPE-- 440 (1884)
Q Consensus 366 ~~L~I~~~~~~D~G~Y~C~a~n~~-g~--~~~~~~l~V~~~~~~~~p~~~~~~~~~~~v~~G~~v~L~C~~~~~~~p~-- 440 (1884)
..|.|.++...++|.|+=+..+.. +. .+..+.|.+. .+|.+.....+ +.+|+...-.|.+.. -+|+
T Consensus 289 ~pL~I~sltaATeGvY~Wrv~~~~n~t~~~~~~VtV~~y-----r~PsVsV~p~P---VL~Ge~YkAtC~vA~-YYPp~S 359 (566)
T PHA03269 289 FSLHILSLDASTEGTYIWRVIHTANKNVINEHHITVMSY-----KRPNITVIGDP---VLLGNPYAAYCKVNK-YYPPHS 359 (566)
T ss_pred cceEEeecccccCceEEEEEecCCCCceeeeeEEEEEEe-----cCCCccccCCc---cccCCCceEEEEeee-ecCCCc
Confidence 569999999999999987765432 22 3345556555 67777665554 669999999999975 3443
Q ss_pred CeEEEeeCCEEcccc---CcEEEEecCCEE---EEEEcccCCCC--cEEEEEEEEeCceecCCcceEEeecccCCCCCCC
Q psy2148 441 LKVEWFHNGKPIFHK---NRVKMVSDFGFV---VMDIAYVQSHD--SGEYVCRAWNNFIFIPPFPIFIFHQIRLPSPSQD 512 (1884)
Q Consensus 441 ~~i~W~k~g~~l~~~---~~~~~~~~~~~~---~L~i~~v~~~d--~G~Y~C~a~n~~~~~~~~~~~~~~~~~~~~~~~~ 512 (1884)
..+.||+||.++... ..+....++.+. +|++......| --..+|.+....+..+.........+.+...+.-
T Consensus 360 vrlrWf~ng~~V~~~~it~t~~~~~dGlFSrVSTLtlp~~~~~d~~PPsLrCeV~W~RDsVS~tRfnAaatP~VY~~PtI 439 (566)
T PHA03269 360 VIVKWTSNFGNIGKNFITDAIKENADGLFSSVSALHIPAQKNADYPPPAIQCNVLWIRDGVSHMKYSAAVTPDVYPFPNV 439 (566)
T ss_pred eEEEEEeCCcccCccccccceeecCCCceEEEEEEeccCccccCCCCCCceEEEEEccCCchheecccccCCccccCCeE
Confidence 689999999888642 222333344332 33332211122 2366999976544322211111111111111111
Q ss_pred ccccCCCCeEEEEEEEeeCCCCccEEEEeeCCeeecCCCceEE-EeeCceEEEEEcc---ccccc-cEEEEEEEE
Q psy2148 513 NLDVPEAGKVHFDCRLEPKSDPTMRIDWFFNGRPFATGSRVKT-VYDFGFISLDMDY---VYARD-SGEYICRAT 582 (1884)
Q Consensus 513 ~~~v~~g~~~~L~C~~~~~~~p~~~i~W~~~~~~l~~~~~~~~-~~~~~~~~L~i~~---~~~~d-~G~Y~C~a~ 582 (1884)
.+.+..|+ ..|.+.-.++....+.|+.++........... ...+.-...+|.+ ++.+| --+|+|.+.
T Consensus 440 Sm~FedG~---AVCtA~CVP~~~V~l~WlVgD~p~~~~~t~itG~C~ehPGLVNLRS~~pLS~~dgpveYTCrL~ 511 (566)
T PHA03269 440 SIEIIDGH---IVCLAKCVPRGVVHFNWWINDIPIEHENSEILGVCDNNKRFVNLQSSCDTSELDGPITYSCHLD 511 (566)
T ss_pred EEEEeCCE---EEEecccccCCCceEEEEecCCCCCCccceeeccCCCCCCceeecccccccccCCceeEEEEEe
Confidence 22334443 45666543444568999998776433322111 0111112344544 33333 258999874
No 289
>PHA02987 Ig domain OX-2-like protein; Provisional
Probab=97.63 E-value=0.00025 Score=71.57 Aligned_cols=86 Identities=17% Similarity=0.241 Sum_probs=64.0
Q ss_pred CceEEcCCceEEEEEEEe-cCCCcEEEEEeCCEecC----------C--CCCeE-EeecCCeEEEEEccCCCCCCEEEEE
Q psy2148 1750 SSAVINVGQLARFDAKIS-ATKPLDVYWLKNGKKII----------P--DIRYK-TLEEDNLFTLLIIEAVVEDSGAYEC 1815 (1884)
Q Consensus 1750 ~~~~~~~G~~~~l~C~~~-g~p~p~v~W~k~~~~l~----------~--~~~~~-~~~~~~~~~L~i~~~~~~d~G~Y~C 1815 (1884)
....+.+|++++|.|... +...+.|.|+|.++.+. + ..|+. +........|+|.+++.+|+|.|+|
T Consensus 23 ~~v~V~ege~VtLsCs~t~s~~~~qVtWkK~~~~IatY~~~g~~i~~~Fk~Rve~mS~s~~~StItIknVt~sDeGcY~C 102 (189)
T PHA02987 23 VKITVSEHVNVKISCNKTSSFNSILITWKKNNKTIAGYGPCGPVIVDKFKNKIEYLSKSFNESTILIKNVSLKDNGCYTC 102 (189)
T ss_pred EEEEEcCCCCEEEEEecCCCCccceEEEEEcCCCEEEEecCCcEEChhhcCeEEEeccCCCcceEEEEeCChhhCeEEEE
Confidence 345678999999999984 65678899999754321 1 12444 2333455699999999999999999
Q ss_pred EE-EeCCe-eEEEEEEEEEEec
Q psy2148 1816 VA-MNNAG-EARCEAELVVQSK 1835 (1884)
Q Consensus 1816 ~a-~N~~G-~~~~~~~l~V~~~ 1835 (1884)
.. .-+.| ..+..+.|+|...
T Consensus 103 ~F~tfp~G~~~~gt~CLtVt~~ 124 (189)
T PHA02987 103 IFNTLLSKNNEKGVVCLNVTTD 124 (189)
T ss_pred EEEecCCCCCceeEEEEEEEch
Confidence 97 34457 7888899999863
No 290
>cd07694 Ig2_CD4 Second immunoglobulin (Ig) domain of CD4. Ig2_CD4; second immunoglobulin (Ig) domain of CD4. CD4 and CD8 are the two primary co-receptor proteins found on the surface of T cells, and the presence of either CD4 or CD8 determines the function of the T cell. CD4 is found on helper T cells, where it is required for the binding of MHC (major histocompatibility complex) class II molecules, while CD8 is found on cytotoxic T cells, where it is required for the binding of MHC class I molecules. CD4 contains four immunoglobulin domains, with the first three included in this hierarchy. The fourth domain has a general Ig architecture, but has slight topological changes in the arrangement of beta strands relative to the other structures in this family and is not specifically included in the hierarchy.
Probab=97.63 E-value=0.00053 Score=60.03 Aligned_cols=76 Identities=22% Similarity=0.356 Sum_probs=52.9
Q ss_pred ccCCCCcEEEEEEEeecCCCCCeEEEeeCCccCCCCCCeEEEeeCCEEEEEEcccCcCCCeEEEEEEEecCceEEEEEEE
Q psy2148 718 DLREGENAHFEARLTPTDDPKLKVEWFWNGKPMKTGSRFRTFCDFGFVILEISPVYPEDCGQYSCRAYNDYGEAVTSASM 797 (1884)
Q Consensus 718 ~v~~G~~~~l~C~~~~~g~p~~~v~W~k~g~~l~~~~~~~~~~~~~~~~L~i~~~~~~d~G~Y~C~a~N~~g~~~~~~~l 797 (1884)
.+..|++++|+|+....+.|.+.++|+..+.... +.. ..+..+|.+..+...|+|.++|.++-..-.......|
T Consensus 10 ~lL~G~sLtLtl~~~s~s~p~~~i~w~~P~n~~~-----~~~-~~~~ktL~~~qv~~qdSG~WtC~V~~~~k~~~~~~~V 83 (88)
T cd07694 10 HVLSGTNLTLTLHGSSNSLPAFKVEWRGPGNKSK-----QIL-NQDKKTLNLVQLGPNDSGTWDCIVSVNSSEKTLKLDI 83 (88)
T ss_pred eeecCCcEEEEEecCCCCCCCccEEEeCCCCccc-----eec-cCCccEEEeceeCcccCCEEEEEEEECceEEEEEeeE
Confidence 5789999999999864445667999986433221 111 1234689999999999999999997553344444554
Q ss_pred EE
Q psy2148 798 KV 799 (1884)
Q Consensus 798 ~V 799 (1884)
.|
T Consensus 84 ~V 85 (88)
T cd07694 84 KV 85 (88)
T ss_pred EE
Confidence 44
No 291
>cd05901 Ig_Versican Immunoglobulin (Ig)-like domain of the chondroitin sulfate proteoglycan core protein (CSPG), versican. Ig_Versican: immunoglobulin (Ig)-like domain of the chondroitin sulfate proteoglycan core protein (CSPG), versican. In CSPGs, the Ig-like domain is followed by hyaluronan (HA)-binding tandem repeats, and a C-terminal region with epidermal growth factor-like, lectin-like, and complement regulatory protein-like domains. Separating these N- and C-terminal regions is a nonhomologous glycosaminoglycan attachment region. In cartilage, the CSPG aggrecan (not included in this group) forms cartilage link protein stabilized aggregates with HA. These aggregates contribute to the tissue's load bearing properties. Like aggrecan, versican has a wide distribution in connective tissue and extracellular matrices. Aggregates having other CSPGs substituting for aggrecan may contribute to the structural integrity of many different tissues. Members of the vertebrate HPLN (hyaluronan/HA
Probab=97.63 E-value=0.0006 Score=64.80 Aligned_cols=78 Identities=21% Similarity=0.275 Sum_probs=57.5
Q ss_pred CceEEEEEEEecCC-----------CcEEEEEeC-----CE-----ec------------CCCCCeEEeec---CCeEEE
Q psy2148 1757 GQLARFDAKISATK-----------PLDVYWLKN-----GK-----KI------------IPDIRYKTLEE---DNLFTL 1800 (1884)
Q Consensus 1757 G~~~~l~C~~~g~p-----------~p~v~W~k~-----~~-----~l------------~~~~~~~~~~~---~~~~~L 1800 (1884)
|++++|.|...-.| .+.|.|+|- |+ .+ .-..|..+... .+..+|
T Consensus 2 ~g~v~LPC~f~~~p~~p~~~~~~~~~~rIkW~~~~~~~~g~~~~e~~Vlv~~~g~~~~~~~y~gRv~l~~~~~~~g~asL 81 (117)
T cd05901 2 SGSVVLPCRFSTLPTLPPSVITTSEFLRIKWTKIEVDKNGKDHKETTVLVAQNGIIKIGQEYMGRVSVPSHPEDQGDASL 81 (117)
T ss_pred CCCEEEeeEEEecCCCCCcccCCCCCcEEEEEEecccccccCCCccEEEEEECCEEEECCcccCcEEeeccCCcCCceEE
Confidence 67899999998544 237999874 11 11 00124444322 245799
Q ss_pred EEccCCCCCCEEEEEEEEeCCeeEEEEEEEEEEe
Q psy2148 1801 LIIEAVVEDSGAYECVAMNNAGEARCEAELVVQS 1834 (1884)
Q Consensus 1801 ~i~~~~~~d~G~Y~C~a~N~~G~~~~~~~l~V~~ 1834 (1884)
.|.+++.+|+|.|.|.+.+........++|.|.+
T Consensus 82 ~i~~v~~sD~G~Y~C~V~~g~~~~~~~v~L~V~G 115 (117)
T cd05901 82 TIVKLRASDAGVYRCEVMHGIEDTQDTVSLDVSG 115 (117)
T ss_pred EEcccccccCEEEEEEEEECCcccEEEEEEEEEE
Confidence 9999999999999999999999999999999975
No 292
>cd05888 Ig1_Nectin-4_like Frst immunoglobulin (Ig) domain of nectin-4 (also known as poliovirus receptor related protein 4, or as LNIR receptor) and similar proteins. Ig1_Nectin-4_like: domain similar to the first immunoglobulin (Ig) domain of nectin-4 (also known as poliovirus receptor related protein 4, or as LNIR receptor). Nectin-4 belongs to the nectin family, which is comprised of four transmembrane glycoproteins (nectins-1 through -4). Nectins are synaptic cell adhesion molecules (CAMs) which participate in adhesion and signaling at various intracellular junctions. Nectins form homophilic cis-dimers, followed by homophilic and heterophilic trans-dimers involved in cell-cell adhesion. For example nectin-4 trans-interacts with nectin-1. Nectin-4 has also been shown to interact with the actin filament-binding protein, afadin. Unlike the other nectins, which are widely expressed in adult tissues, nectin-4 is mainly expressed during embryogenesis, and is not detected in normal adult
Probab=97.63 E-value=0.00028 Score=66.79 Aligned_cols=74 Identities=23% Similarity=0.359 Sum_probs=53.6
Q ss_pred eEEEEEEEecCC---CcEEEEEeCCEe-----c---C--------C--CCCeEEee--cCCeEEEEEccCCCCCCEEEEE
Q psy2148 1759 LARFDAKISATK---PLDVYWLKNGKK-----I---I--------P--DIRYKTLE--EDNLFTLLIIEAVVEDSGAYEC 1815 (1884)
Q Consensus 1759 ~~~l~C~~~g~p---~p~v~W~k~~~~-----l---~--------~--~~~~~~~~--~~~~~~L~i~~~~~~d~G~Y~C 1815 (1884)
+++|.|.....+ ...|.|+|.... + . . ..|..+.. .....+|+|.+++.+|+|.|.|
T Consensus 2 ~v~L~C~~~~~~~~~~~~v~W~k~~~~~~~~~i~~~~~~~~~~~~~~~~~Rv~f~~~~~~~~~sL~I~nv~~sD~GtY~C 81 (100)
T cd05888 2 DTRLPCRYNVSDGETVVQVLWIRENAGGVEEEIALLHFKYGQTEFHAYEGRVRFETPNPIADGALILRNAVQADEGKYKC 81 (100)
T ss_pred CEEEEeEEecCCCCcEEEEEEEEccCCCCcEEEEEEeccCCcccCCCccCcEEEeCCCCCCceEEEEecCccccceEEEE
Confidence 589999987544 347999984311 1 0 0 02444442 2346689999999999999999
Q ss_pred EEEe-CCeeEEEEEEEEE
Q psy2148 1816 VAMN-NAGEARCEAELVV 1832 (1884)
Q Consensus 1816 ~a~N-~~G~~~~~~~l~V 1832 (1884)
.+.| +.|..+..+.|+|
T Consensus 82 ~v~~~p~g~~~~~~~L~V 99 (100)
T cd05888 82 RVITFPAGNFEAELVLTV 99 (100)
T ss_pred EEEeCCCCCeeeEEEEEe
Confidence 9998 7888888888887
No 293
>cd05884 Ig2_Necl-3 Second immunoglobulin (Ig)-like domain of nectin-like molecule-3 (Necl-3, also known as cell adhesion molecule 2 (CADM2)). Ig2_Necl-3: second immunoglobulin (Ig)-like domain of nectin-like molecule-3 (Necl-3, also known as cell adhesion molecule 2 (CADM2)). Nectin-like molecules have similar domain structures to those of nectins. At least five nectin-like molecules have been identified (Necl-1 - Necl-5). These have an extracellular region containing three Ig-like domains, one transmembrane region, and one cytoplasmic region. Necl-3 has been shown to accumulate in tissues of the central and peripheral nervous system, where it is expressed in ependymal cells and myelinated axons. It is observed at the interface between the axon shaft and the myelin sheath. Ig domains are likely to participate in ligand binding and recognition.
Probab=97.63 E-value=0.00025 Score=63.88 Aligned_cols=64 Identities=16% Similarity=0.329 Sum_probs=46.0
Q ss_pred EEEEEEEeeCCCCCcEEEEeeCCEEccCCCcEEEEe-eCC----eEEEEEccCCCCCCeEEEEEEEcCCe
Q psy2148 934 AHFECRLTPTNDPSMTVEWFHNGKALSAGSRIKTIN-DFG----FVILEINDVYLRDSGLYTCKATNKHG 998 (1884)
Q Consensus 934 v~l~C~v~~~~~P~~~v~W~~~g~~i~~~~~~~~~~-~~~----~~~L~I~~~~~~D~G~Y~C~a~N~~G 998 (1884)
+.|.|.+.+ +.|++.|+|+|||+++.......... .++ .+.|.|..-..+|...|+|+|.|..-
T Consensus 2 ~~LtC~a~g-f~P~~~itW~kng~~l~~~~~~~~~~~~~~t~~~~s~L~~~~~~~d~g~~ytC~v~h~~l 70 (83)
T cd05884 2 MQLTCKTSG-SKPAADIRWFKNDKEIKDVKYLKEEDANRKTFTVSSTLDFRVDRSDDGVAIICRVDHESL 70 (83)
T ss_pred EEEEEEeCC-ccCCCEEEEEECCEECcCceeeEeeCCCCCEEEEEEEEEEEcccccCCCEEEEEEechhc
Confidence 689999996 67889999999999986543222221 222 33677775556778899999998643
No 294
>cd05901 Ig_Versican Immunoglobulin (Ig)-like domain of the chondroitin sulfate proteoglycan core protein (CSPG), versican. Ig_Versican: immunoglobulin (Ig)-like domain of the chondroitin sulfate proteoglycan core protein (CSPG), versican. In CSPGs, the Ig-like domain is followed by hyaluronan (HA)-binding tandem repeats, and a C-terminal region with epidermal growth factor-like, lectin-like, and complement regulatory protein-like domains. Separating these N- and C-terminal regions is a nonhomologous glycosaminoglycan attachment region. In cartilage, the CSPG aggrecan (not included in this group) forms cartilage link protein stabilized aggregates with HA. These aggregates contribute to the tissue's load bearing properties. Like aggrecan, versican has a wide distribution in connective tissue and extracellular matrices. Aggregates having other CSPGs substituting for aggrecan may contribute to the structural integrity of many different tissues. Members of the vertebrate HPLN (hyaluronan/HA
Probab=97.62 E-value=0.00047 Score=65.53 Aligned_cols=96 Identities=16% Similarity=0.100 Sum_probs=57.1
Q ss_pred CCcEEEEEEEeecC---------CCcceEEEeccc-----cccccc-ccccceE--EEeeccceeeeeeeeeeeeceEEE
Q psy2148 1279 AEPVRFETRVEPRV---------DPRLRVECSLST-----AFFFPF-INISTAF--LIFNFCLHAVIFSHPIFDLGFVSL 1341 (1884)
Q Consensus 1279 g~~v~l~c~v~~~~---------~p~~~~~W~~~~-----~~~~~~-~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~L 1341 (1884)
|++++|.|.+.-.+ ...+.|+|.+-. ...... .-+.... ........|..........+..+|
T Consensus 2 ~g~v~LPC~f~~~p~~p~~~~~~~~~~rIkW~~~~~~~~g~~~~e~~Vlv~~~g~~~~~~~y~gRv~l~~~~~~~g~asL 81 (117)
T cd05901 2 SGSVVLPCRFSTLPTLPPSVITTSEFLRIKWTKIEVDKNGKDHKETTVLVAQNGIIKIGQEYMGRVSVPSHPEDQGDASL 81 (117)
T ss_pred CCCEEEeeEEEecCCCCCcccCCCCCcEEEEEEecccccccCCCccEEEEEECCEEEECCcccCcEEeeccCCcCCceEE
Confidence 67899999998432 124589999752 111100 0000000 000111122222222233467899
Q ss_pred EEeeecccCceEEEEEEEccccceeeeEEEEEe
Q psy2148 1342 DIDYVYPEDQGEYVCRAYNDHGEAFTKATISCK 1374 (1884)
Q Consensus 1342 ~I~~~~~~d~G~Y~C~a~n~~g~~~~~~~l~v~ 1374 (1884)
.|.+++.+|+|.|+|++.+........+.|.|.
T Consensus 82 ~i~~v~~sD~G~Y~C~V~~g~~~~~~~v~L~V~ 114 (117)
T cd05901 82 TIVKLRASDAGVYRCEVMHGIEDTQDTVSLDVS 114 (117)
T ss_pred EEcccccccCEEEEEEEEECCcccEEEEEEEEE
Confidence 999999999999999999877666777777764
No 295
>cd05886 Ig1_Nectin-1_like First immunoglobulin (Ig) domain of nectin-1 (also known as poliovirus receptor related protein 1, or as CD111) and similar proteins. Ig1_Nectin-1_like: domain similar to the first immunoglobulin (Ig) domain of nectin-1 (also known as poliovirus receptor related protein 1, or as CD111). Nectin-1 belongs to the nectin family comprised of four transmembrane glycoproteins (nectins-1 through -4). Nectins are synaptic cell adhesion molecules (CAMs) which facilitate adhesion and signaling at various intracellular junctions. Nectins form homophilic cis-dimers, followed by homophilic and heterophilic trans-dimers involved in cell-cell adhesion. In addition nectins heterophilically trans-interact with other CAMs such as nectin-like molecules (Necls), nectin-1 for example, has been shown to trans-interact with Necl-1. Nectins also interact with various other proteins, including the actin filament (F-actin)-binding protein, afadin. Mutation in the human nectin-1 gene is
Probab=97.60 E-value=0.00027 Score=65.89 Aligned_cols=92 Identities=13% Similarity=0.095 Sum_probs=54.5
Q ss_pred cEEEEEEEeecC--CCcceEEEecccccccccccccce---EEEeeccceeeeeeeeeeeeceEEEEEeeecccCceEEE
Q psy2148 1281 PVRFETRVEPRV--DPRLRVECSLSTAFFFPFINISTA---FLIFNFCLHAVIFSHPIFDLGFVSLDIDYVYPEDQGEYV 1355 (1884)
Q Consensus 1281 ~v~l~c~v~~~~--~p~~~~~W~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~L~I~~~~~~d~G~Y~ 1355 (1884)
.++|.|...... .....++|.+....-.......-. ......-..|..+.. ...+..+|.|.+++.+|+|.|+
T Consensus 2 ~v~L~C~f~~~~~~~~~~~V~W~k~~~~~~~~va~y~~~~g~~~~~~f~~Rv~f~~--~~~~daSi~i~nl~~~D~G~Y~ 79 (99)
T cd05886 2 DVVLHCSFINPLPPVKITQVTWQKLTNGSKQNVAIYNPSMGVSVLPPYRERVTFKN--PSFEDGTISLSRLELEDEGVYI 79 (99)
T ss_pred cEEEEeEeecCCCCCCeEEEEEEECCCCCceEEEEECCcCCcccCccccCcEEEcC--CCCCcceEEEcCCccccCEEEE
Confidence 589999987421 112369998753211111100000 000011122332221 1235678999999999999999
Q ss_pred EEEEc-cccceeeeEEEEEe
Q psy2148 1356 CRAYN-DHGEAFTKATISCK 1374 (1884)
Q Consensus 1356 C~a~n-~~g~~~~~~~l~v~ 1374 (1884)
|.+.| ..|..+..+.|+|+
T Consensus 80 C~v~t~P~g~~~~~~~L~V~ 99 (99)
T cd05886 80 CEFATFPTGNRESQLNLTVY 99 (99)
T ss_pred EEEEeCCCCCeEEEEEEEEC
Confidence 99998 68888888888874
No 296
>PF07686 V-set: Immunoglobulin V-set domain; InterPro: IPR013106 The basic structure of immunoglobulin (Ig) molecules is a tetramer of two light chains and two heavy chains linked by disulphide bonds. There are two types of light chains: kappa and lambda, each composed of a constant domain (CL) and a variable domain (VL). There are five types of heavy chains: alpha, delta, epsilon, gamma and mu, all consisting of a variable domain (VH) and three (in alpha, delta and gamma) or four (in epsilon and mu) constant domains (CH1 to CH4). Ig molecules are highly modular proteins, in which the variable and constant domains have clear, conserved sequence patterns. The domains in Ig and Ig-like molecules are grouped into four types: V-set (variable; IPR013106 from INTERPRO), C1-set (constant-1; IPR003597 from INTERPRO), C2-set (constant-2; IPR008424 from INTERPRO) and I-set (intermediate; IPR013098 from INTERPRO) []. Structural studies have shown that these domains share a common core Greek-key beta-sandwich structure, with the types differing in the number of strands in the beta-sheets as well as in their sequence patterns [, ]. Immunoglobulin-like domains that are related in both sequence and structure can be found in several diverse protein families. Ig-like domains are involved in a variety of functions, including cell-cell recognition, cell-surface receptors, muscle structure and the immune system []. This entry represents the V-set domains, which are Ig-like domains resembling the antibody variable domain. V-set domains are found in diverse protein families, including immunoglobulin light and heavy chains; in several T-cell receptors such as CD2 (Cluster of Differentiation 2), CD4, CD80, and CD86; in myelin membrane adhesion molecules; in junction adhesion molecules (JAM); in tyrosine-protein kinase receptors; and in the programmed cell death protein 1 (PD1).; PDB: 1PY9_A 2NXY_D 1U9K_B 3RNK_A 3BP6_A 3BIK_B 3SBW_A 1NPU_A 3BP5_A 3RNQ_A ....
Probab=97.60 E-value=0.00054 Score=67.49 Aligned_cols=103 Identities=19% Similarity=0.088 Sum_probs=61.1
Q ss_pred eecceeeeecCCcEEEEEEEeecCCCcceEEEecccccccccccc-----cceEEEeeccceeeeeeeeeeeeceEEEEE
Q psy2148 1269 TEIESVTVQEAEPVRFETRVEPRVDPRLRVECSLSTAFFFPFINI-----STAFLIFNFCLHAVIFSHPIFDLGFVSLDI 1343 (1884)
Q Consensus 1269 ~~~~~~~v~~g~~v~l~c~v~~~~~p~~~~~W~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~L~I 1343 (1884)
..+..+.+.+|+++.|.|... .......+.|++........... ............+.. .......+..+|.|
T Consensus 6 ~~~~~v~~~~G~~v~L~C~~~-~~~~~~~v~W~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~r~~-~~~~~~~~~~sL~i 83 (114)
T PF07686_consen 6 QPPSPVTVQEGESVTLPCSYS-SSSNQSSVYWYRQSPGQGPQLIIRYSLSSTNETPTPSYSGRFT-FSGNGSQNNFSLTI 83 (114)
T ss_dssp EEESEEEEETTSEEEEEEEEE-SSSSGSEEEEEEEETTSEEEEEEEEETTEEEEEEETTETTTEE-EEEETTTTEEEEEE
T ss_pred EeCCeEEEecCCCEEEEEEEe-CCCCcceEEEEEECccccceeeeeeccceeeeccccceeeeee-eeecccCCeEEEEE
Confidence 346788999999999999988 24466799999955421111100 000000011111111 11112245678999
Q ss_pred eeecccCceEEEEEEEcc-ccceeeeEEEEE
Q psy2148 1344 DYVYPEDQGEYVCRAYND-HGEAFTKATISC 1373 (1884)
Q Consensus 1344 ~~~~~~d~G~Y~C~a~n~-~g~~~~~~~l~v 1373 (1884)
.+++.+|+|.|.|.+... .+.......|.|
T Consensus 84 ~~l~~~DsG~Y~C~v~~~~~~~~~~~~~L~V 114 (114)
T PF07686_consen 84 KNLQPSDSGTYFCQVSTSNEQSFGNGTKLTV 114 (114)
T ss_dssp SSESGGGEEEEEEEEEESSEEEEEEEEEEEE
T ss_pred CCCCcCcCEEEEEEEEECCCCEECCcEEEEC
Confidence 999999999999999865 334444455544
No 297
>cd05886 Ig1_Nectin-1_like First immunoglobulin (Ig) domain of nectin-1 (also known as poliovirus receptor related protein 1, or as CD111) and similar proteins. Ig1_Nectin-1_like: domain similar to the first immunoglobulin (Ig) domain of nectin-1 (also known as poliovirus receptor related protein 1, or as CD111). Nectin-1 belongs to the nectin family comprised of four transmembrane glycoproteins (nectins-1 through -4). Nectins are synaptic cell adhesion molecules (CAMs) which facilitate adhesion and signaling at various intracellular junctions. Nectins form homophilic cis-dimers, followed by homophilic and heterophilic trans-dimers involved in cell-cell adhesion. In addition nectins heterophilically trans-interact with other CAMs such as nectin-like molecules (Necls), nectin-1 for example, has been shown to trans-interact with Necl-1. Nectins also interact with various other proteins, including the actin filament (F-actin)-binding protein, afadin. Mutation in the human nectin-1 gene is
Probab=97.59 E-value=0.00048 Score=64.30 Aligned_cols=38 Identities=21% Similarity=0.299 Sum_probs=33.9
Q ss_pred ceEEEEEeeeccCCCeEEEEEEEe-cCcceEEEEEEEEe
Q psy2148 1481 GYVAMNFGWVYPEDSGEYLCRATN-LYGMDETRAILKTT 1518 (1884)
Q Consensus 1481 ~~~~L~i~~~~~~d~G~Y~c~a~n-~~G~~~~~~~l~V~ 1518 (1884)
+..+|.|.+++.+|+|.|+|.+.| ..|..+..+.|.|+
T Consensus 61 ~daSi~i~nl~~~D~G~Y~C~v~t~P~g~~~~~~~L~V~ 99 (99)
T cd05886 61 EDGTISLSRLELEDEGVYICEFATFPTGNRESQLNLTVY 99 (99)
T ss_pred CcceEEEcCCccccCEEEEEEEEeCCCCCeEEEEEEEEC
Confidence 347899999999999999999999 68888888999884
No 298
>PF07686 V-set: Immunoglobulin V-set domain; InterPro: IPR013106 The basic structure of immunoglobulin (Ig) molecules is a tetramer of two light chains and two heavy chains linked by disulphide bonds. There are two types of light chains: kappa and lambda, each composed of a constant domain (CL) and a variable domain (VL). There are five types of heavy chains: alpha, delta, epsilon, gamma and mu, all consisting of a variable domain (VH) and three (in alpha, delta and gamma) or four (in epsilon and mu) constant domains (CH1 to CH4). Ig molecules are highly modular proteins, in which the variable and constant domains have clear, conserved sequence patterns. The domains in Ig and Ig-like molecules are grouped into four types: V-set (variable; IPR013106 from INTERPRO), C1-set (constant-1; IPR003597 from INTERPRO), C2-set (constant-2; IPR008424 from INTERPRO) and I-set (intermediate; IPR013098 from INTERPRO) []. Structural studies have shown that these domains share a common core Greek-key beta-sandwich structure, with the types differing in the number of strands in the beta-sheets as well as in their sequence patterns [, ]. Immunoglobulin-like domains that are related in both sequence and structure can be found in several diverse protein families. Ig-like domains are involved in a variety of functions, including cell-cell recognition, cell-surface receptors, muscle structure and the immune system []. This entry represents the V-set domains, which are Ig-like domains resembling the antibody variable domain. V-set domains are found in diverse protein families, including immunoglobulin light and heavy chains; in several T-cell receptors such as CD2 (Cluster of Differentiation 2), CD4, CD80, and CD86; in myelin membrane adhesion molecules; in junction adhesion molecules (JAM); in tyrosine-protein kinase receptors; and in the programmed cell death protein 1 (PD1).; PDB: 1PY9_A 2NXY_D 1U9K_B 3RNK_A 3BP6_A 3BIK_B 3SBW_A 1NPU_A 3BP5_A 3RNQ_A ....
Probab=97.59 E-value=0.00051 Score=67.69 Aligned_cols=85 Identities=24% Similarity=0.348 Sum_probs=61.7
Q ss_pred ccCceEEcCCceEEEEEEEe-cCCCcEEEEEeCCE-----ecC--------------CCCCeEEeec--CCeEEEEEccC
Q psy2148 1748 TISSAVINVGQLARFDAKIS-ATKPLDVYWLKNGK-----KII--------------PDIRYKTLEE--DNLFTLLIIEA 1805 (1884)
Q Consensus 1748 ~~~~~~~~~G~~~~l~C~~~-g~p~p~v~W~k~~~-----~l~--------------~~~~~~~~~~--~~~~~L~i~~~ 1805 (1884)
.+....+.+|+++.|.|... ......+.|++... .+. ...++.+..+ ...++|.|.++
T Consensus 7 ~~~~v~~~~G~~v~L~C~~~~~~~~~~v~W~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~sL~i~~l 86 (114)
T PF07686_consen 7 PPSPVTVQEGESVTLPCSYSSSSNQSSVYWYRQSPGQGPQLIIRYSLSSTNETPTPSYSGRFTFSGNGSQNNFSLTIKNL 86 (114)
T ss_dssp EESEEEEETTSEEEEEEEEESSSSGSEEEEEEEETTSEEEEEEEEETTEEEEEEETTETTTEEEEEETTTTEEEEEESSE
T ss_pred eCCeEEEecCCCEEEEEEEeCCCCcceEEEEEECccccceeeeeeccceeeeccccceeeeeeeeecccCCeEEEEECCC
Confidence 35677889999999999999 55667899998432 111 1123343333 34779999999
Q ss_pred CCCCCEEEEEEEEeC-CeeEEEEEEEEE
Q psy2148 1806 VVEDSGAYECVAMNN-AGEARCEAELVV 1832 (1884)
Q Consensus 1806 ~~~d~G~Y~C~a~N~-~G~~~~~~~l~V 1832 (1884)
+.+|+|.|.|.+... .+.......|+|
T Consensus 87 ~~~DsG~Y~C~v~~~~~~~~~~~~~L~V 114 (114)
T PF07686_consen 87 QPSDSGTYFCQVSTSNEQSFGNGTKLTV 114 (114)
T ss_dssp SGGGEEEEEEEEEESSEEEEEEEEEEEE
T ss_pred CcCcCEEEEEEEEECCCCEECCcEEEEC
Confidence 999999999999887 445556667765
No 299
>cd05711 Ig_FcalphaRI Immunoglobulin (IG)-like domain of of FcalphaRI. IG_FcalphaRI : immunoglobulin (IG)-like domain of of FcalphaRI. FcalphaRI (CD89) is an IgA-specific receptor that is expressed on monocytes, eosinophils, neutrophils and macrophages. FcalphaRI mediates IgA-induced immune effector responses such as phagocytosis, antibody-dependent cell-mediated cytotoxicity and respiratory burst. Both monomeric and dimeric IgA can bind to FcalphaRI, and monomeric or dimeric IgA immune complexes can activate phagocytosis and other immune responses through the clustering of FcalphaRI. The Fc RI ectodomain is comprised of two Ig-like domains oriented at about 90 degree to each another.
Probab=97.59 E-value=0.00024 Score=66.22 Aligned_cols=74 Identities=14% Similarity=0.160 Sum_probs=51.4
Q ss_pred CeEEeccCceEEcCCceEEEEEEEecCCCcEEEEEeCCEecCCCCCeEEeecCCeEEEEEccCCCCCCEEEEEEEE
Q psy2148 1743 PSFLTTISSAVINVGQLARFDAKISATKPLDVYWLKNGKKIIPDIRYKTLEEDNLFTLLIIEAVVEDSGAYECVAM 1818 (1884)
Q Consensus 1743 P~~~~~~~~~~~~~G~~~~l~C~~~g~p~p~v~W~k~~~~l~~~~~~~~~~~~~~~~L~i~~~~~~d~G~Y~C~a~ 1818 (1884)
|.+... ....+..|++|+|.|.... +.-.+.|+|+|...................+.|..++.+|+|.|.|...
T Consensus 2 P~l~a~-p~~vV~~G~~VTL~C~~~~-~~~~f~l~k~g~~~~~~~~~~~~~~~~~a~f~I~~~~~~~~G~Y~C~~~ 75 (94)
T cd05711 2 PFLSAH-PSPVVPSGENVTLQCHSDI-RFDRFILYKEGRSKPVLHLYEKHHGGFQASFPLGPVTPAHAGTYRCYGS 75 (94)
T ss_pred CEEEec-CCCccCCCCeEEEEEecCC-CCCEEEEEECCCCCCceecccccCCeEEEEEEecCCCcccCEEEEEEEE
Confidence 444433 3566789999999998765 4568999999976422110011112345589999999999999999974
No 300
>cd07706 IgV_TCR_delta Immunoglobulin (Ig) variable (V) domain of T-cell receptor (TCR) delta chain. IgV_TCR_delta: immunoglobulin (Ig) variable (V) domain of the delta chain of gamma/delta T-cell receptors (TCRs). TCRs mediate antigen recognition by T lymphocytes, and are heterodimers consisting of alpha and beta chains or gamma and delta chains. Each chain contains a variable (V) and a constant (C) region. The majority of T cells contain alpha/beta TCRs but a small subset contain gamma/delta TCRs. Alpha/beta TCRs recognize antigen as peptide fragments presented by major histocompatibility complex (MHC) molecules. Gamma/delta TCRs recognize intact protein antigens; they recognize protein antigens directly and without antigen processing, and MHC independently of the bound peptide. Gamma/delta T cells can also be stimulated by non-peptide antigens such as small phosphate- or amine-containing compounds. The variable domain of gamma/delta TCRs is responsible for antigen recognition and is
Probab=97.58 E-value=0.00031 Score=69.06 Aligned_cols=76 Identities=17% Similarity=0.302 Sum_probs=55.7
Q ss_pred eecCCceeecCCCeEEEEEEEeeCCCCCcEEEEeeC--CEE---c---------cCCCcEEEEe--eCCeEEEEEccCCC
Q psy2148 920 LTTPTDLTLAESTLAHFECRLTPTNDPSMTVEWFHN--GKA---L---------SAGSRIKTIN--DFGFVILEINDVYL 983 (1884)
Q Consensus 920 ~~~~~~~~v~~G~~v~l~C~v~~~~~P~~~v~W~~~--g~~---i---------~~~~~~~~~~--~~~~~~L~I~~~~~ 983 (1884)
...++.+.+.+|++|+|.|.... ......+.|||. +.. | ....|+.+.. ..+.+.|.|.+++.
T Consensus 3 ~q~~~~v~~~~G~~v~L~C~~~~-~~~~~~v~Wyrq~~~~~~~~l~~~~~~~~~~~~~R~~~~~~~~~~~~sL~I~~~~~ 81 (116)
T cd07706 3 TQAQPDVSVQVGEEVTLNCRYET-SWTNYYIFWYKQLPSGEMTFLIRQKSIYGNATKGRYSVNFQKAQKSISLTISALQL 81 (116)
T ss_pred EEeCCceEEcCCCCEEEEEEEeC-CCCceEEEEEEECCCCceEEEEEecCccCCccCCeEEEEEeccCCEEEEEECCCCH
Confidence 45567788999999999999873 224567999993 211 1 1235676653 34567899999999
Q ss_pred CCCeEEEEEEEcC
Q psy2148 984 RDSGLYTCKATNK 996 (1884)
Q Consensus 984 ~D~G~Y~C~a~N~ 996 (1884)
+|+|.|.|.+.+.
T Consensus 82 ~Dsg~Y~C~~~~~ 94 (116)
T cd07706 82 EDSAKYFCALSTL 94 (116)
T ss_pred HHCEEEEEEEECC
Confidence 9999999999753
No 301
>cd05888 Ig1_Nectin-4_like Frst immunoglobulin (Ig) domain of nectin-4 (also known as poliovirus receptor related protein 4, or as LNIR receptor) and similar proteins. Ig1_Nectin-4_like: domain similar to the first immunoglobulin (Ig) domain of nectin-4 (also known as poliovirus receptor related protein 4, or as LNIR receptor). Nectin-4 belongs to the nectin family, which is comprised of four transmembrane glycoproteins (nectins-1 through -4). Nectins are synaptic cell adhesion molecules (CAMs) which participate in adhesion and signaling at various intracellular junctions. Nectins form homophilic cis-dimers, followed by homophilic and heterophilic trans-dimers involved in cell-cell adhesion. For example nectin-4 trans-interacts with nectin-1. Nectin-4 has also been shown to interact with the actin filament-binding protein, afadin. Unlike the other nectins, which are widely expressed in adult tissues, nectin-4 is mainly expressed during embryogenesis, and is not detected in normal adult
Probab=97.53 E-value=0.00056 Score=64.69 Aligned_cols=74 Identities=19% Similarity=0.340 Sum_probs=51.2
Q ss_pred eEEEEEEEeccC---CCeEEEEeCCe-----ec---C--------CC--CCeEEEE--eCceeEEEEcccccCCCeEEEE
Q psy2148 1656 QARFEVEFDGDP---LPTIKWFREDF-----PI---T--------SS--PDFQIHT--FSTKSILIMRQVFMEDSGVFAV 1712 (1884)
Q Consensus 1656 ~~~l~C~~~g~p---~~~i~W~~~~~-----~~---~--------~~--~~~~~~~--~~~~~~L~i~~v~~~DsG~Y~C 1712 (1884)
+++|.|.....+ ...|.|+|... .+ . .. .|.++.. ...+..|+|.+++.+|+|.|.|
T Consensus 2 ~v~L~C~~~~~~~~~~~~v~W~k~~~~~~~~~i~~~~~~~~~~~~~~~~~Rv~f~~~~~~~~~sL~I~nv~~sD~GtY~C 81 (100)
T cd05888 2 DTRLPCRYNVSDGETVVQVLWIRENAGGVEEEIALLHFKYGQTEFHAYEGRVRFETPNPIADGALILRNAVQADEGKYKC 81 (100)
T ss_pred CEEEEeEEecCCCCcEEEEEEEEccCCCCcEEEEEEeccCCcccCCCccCcEEEeCCCCCCceEEEEecCccccceEEEE
Confidence 689999987544 45899998421 11 0 00 1222221 1235689999999999999999
Q ss_pred EEEe-CCceEEEEEEEEE
Q psy2148 1713 IAEN-RGGKAKCSANLVV 1729 (1884)
Q Consensus 1713 ~a~n-~~g~~~~~~~l~V 1729 (1884)
.+.+ +.|..+..+.|.|
T Consensus 82 ~v~~~p~g~~~~~~~L~V 99 (100)
T cd05888 82 RVITFPAGNFEAELVLTV 99 (100)
T ss_pred EEEeCCCCCeeeEEEEEe
Confidence 9998 6787777777776
No 302
>cd07706 IgV_TCR_delta Immunoglobulin (Ig) variable (V) domain of T-cell receptor (TCR) delta chain. IgV_TCR_delta: immunoglobulin (Ig) variable (V) domain of the delta chain of gamma/delta T-cell receptors (TCRs). TCRs mediate antigen recognition by T lymphocytes, and are heterodimers consisting of alpha and beta chains or gamma and delta chains. Each chain contains a variable (V) and a constant (C) region. The majority of T cells contain alpha/beta TCRs but a small subset contain gamma/delta TCRs. Alpha/beta TCRs recognize antigen as peptide fragments presented by major histocompatibility complex (MHC) molecules. Gamma/delta TCRs recognize intact protein antigens; they recognize protein antigens directly and without antigen processing, and MHC independently of the bound peptide. Gamma/delta T cells can also be stimulated by non-peptide antigens such as small phosphate- or amine-containing compounds. The variable domain of gamma/delta TCRs is responsible for antigen recognition and is
Probab=97.52 E-value=0.00042 Score=68.13 Aligned_cols=73 Identities=18% Similarity=0.333 Sum_probs=54.8
Q ss_pred eccCceEEcCCceEEEEEEEecC-CCcEEEEEeCC--Ee---c---------CCCCCeEEee--cCCeEEEEEccCCCCC
Q psy2148 1747 TTISSAVINVGQLARFDAKISAT-KPLDVYWLKNG--KK---I---------IPDIRYKTLE--EDNLFTLLIIEAVVED 1809 (1884)
Q Consensus 1747 ~~~~~~~~~~G~~~~l~C~~~g~-p~p~v~W~k~~--~~---l---------~~~~~~~~~~--~~~~~~L~i~~~~~~d 1809 (1884)
..+....+..|++++|.|..... ....+.|+|.. .. + ....|+.+.. ..+.++|+|.++..+|
T Consensus 4 q~~~~v~~~~G~~v~L~C~~~~~~~~~~v~Wyrq~~~~~~~~l~~~~~~~~~~~~~R~~~~~~~~~~~~sL~I~~~~~~D 83 (116)
T cd07706 4 QAQPDVSVQVGEEVTLNCRYETSWTNYYIFWYKQLPSGEMTFLIRQKSIYGNATKGRYSVNFQKAQKSISLTISALQLED 83 (116)
T ss_pred EeCCceEEcCCCCEEEEEEEeCCCCceEEEEEEECCCCceEEEEEecCccCCccCCeEEEEEeccCCEEEEEECCCCHHH
Confidence 34567788999999999998764 45679999852 11 1 1135666653 3457899999999999
Q ss_pred CEEEEEEEEe
Q psy2148 1810 SGAYECVAMN 1819 (1884)
Q Consensus 1810 ~G~Y~C~a~N 1819 (1884)
+|.|.|.+.+
T Consensus 84 sg~Y~C~~~~ 93 (116)
T cd07706 84 SAKYFCALST 93 (116)
T ss_pred CEEEEEEEEC
Confidence 9999999975
No 303
>PHA02987 Ig domain OX-2-like protein; Provisional
Probab=97.51 E-value=0.00054 Score=69.26 Aligned_cols=85 Identities=14% Similarity=0.200 Sum_probs=63.2
Q ss_pred CceeecCCCeEEEEEEEe-ccCCCeEEEEeCCeec----------CC--CCCeE-EEEeCceeEEEEcccccCCCeEEEE
Q psy2148 1647 QPCRAFEQDQARFEVEFD-GDPLPTIKWFREDFPI----------TS--SPDFQ-IHTFSTKSILIMRQVFMEDSGVFAV 1712 (1884)
Q Consensus 1647 ~~~~v~~G~~~~l~C~~~-g~p~~~i~W~~~~~~~----------~~--~~~~~-~~~~~~~~~L~i~~v~~~DsG~Y~C 1712 (1884)
..+.|.+|+++.|.|... +...+.++|+|....+ .. ..++. +.......+|+|.+++.+|+|.|.|
T Consensus 23 ~~v~V~ege~VtLsCs~t~s~~~~qVtWkK~~~~IatY~~~g~~i~~~Fk~Rve~mS~s~~~StItIknVt~sDeGcY~C 102 (189)
T PHA02987 23 VKITVSEHVNVKISCNKTSSFNSILITWKKNNKTIAGYGPCGPVIVDKFKNKIEYLSKSFNESTILIKNVSLKDNGCYTC 102 (189)
T ss_pred EEEEEcCCCCEEEEEecCCCCccceEEEEEcCCCEEEEecCCcEEChhhcCeEEEeccCCCcceEEEEeCChhhCeEEEE
Confidence 456789999999999985 6678899999974321 11 11333 2233355789999999999999999
Q ss_pred EEEe-CCc-eEEEEEEEEEEe
Q psy2148 1713 IAEN-RGG-KAKCSANLVVEE 1731 (1884)
Q Consensus 1713 ~a~n-~~g-~~~~~~~l~V~~ 1731 (1884)
.... +.| ..+..+-|+|..
T Consensus 103 ~F~tfp~G~~~~gt~CLtVt~ 123 (189)
T PHA02987 103 IFNTLLSKNNEKGVVCLNVTT 123 (189)
T ss_pred EEEecCCCCCceeEEEEEEEc
Confidence 8754 467 788889999985
No 304
>cd05884 Ig2_Necl-3 Second immunoglobulin (Ig)-like domain of nectin-like molecule-3 (Necl-3, also known as cell adhesion molecule 2 (CADM2)). Ig2_Necl-3: second immunoglobulin (Ig)-like domain of nectin-like molecule-3 (Necl-3, also known as cell adhesion molecule 2 (CADM2)). Nectin-like molecules have similar domain structures to those of nectins. At least five nectin-like molecules have been identified (Necl-1 - Necl-5). These have an extracellular region containing three Ig-like domains, one transmembrane region, and one cytoplasmic region. Necl-3 has been shown to accumulate in tissues of the central and peripheral nervous system, where it is expressed in ependymal cells and myelinated axons. It is observed at the interface between the axon shaft and the myelin sheath. Ig domains are likely to participate in ligand binding and recognition.
Probab=97.50 E-value=0.0003 Score=63.37 Aligned_cols=65 Identities=15% Similarity=0.227 Sum_probs=46.1
Q ss_pred EEEEEEEeecCCCCCeEEEeeCCccCCCCCCeEEEe-eCC----EEEEEEcccCcCCCeEEEEEEEecCce
Q psy2148 725 AHFEARLTPTDDPKLKVEWFWNGKPMKTGSRFRTFC-DFG----FVILEISPVYPEDCGQYSCRAYNDYGE 790 (1884)
Q Consensus 725 ~~l~C~~~~~g~p~~~v~W~k~g~~l~~~~~~~~~~-~~~----~~~L~i~~~~~~d~G~Y~C~a~N~~g~ 790 (1884)
++|.|.+.+ +.|++.++|+|||+++.......... .++ ...|.|.....++...|+|+|.|....
T Consensus 2 ~~LtC~a~g-f~P~~~itW~kng~~l~~~~~~~~~~~~~~t~~~~s~L~~~~~~~d~g~~ytC~v~h~~l~ 71 (83)
T cd05884 2 MQLTCKTSG-SKPAADIRWFKNDKEIKDVKYLKEEDANRKTFTVSSTLDFRVDRSDDGVAIICRVDHESLN 71 (83)
T ss_pred EEEEEEeCC-ccCCCEEEEEECCEECcCceeeEeeCCCCCEEEEEEEEEEEcccccCCCEEEEEEechhcC
Confidence 689999986 68889999999999986543222221 111 235777665566777999999987644
No 305
>cd05846 Ig1_MRC-OX-2_like First immunoglobulin (Ig) domain of rat MRC OX-2 antigen (also known as CD200) and similar proteins. Ig1_ MRC-OX-2_like: domain similar to the first immunoglobulin (Ig) domain of rat MRC OX-2 antigen (also known as CD200). MRC OX-2 is a membrane glycoprotein expressed in a variety of lymphoid and non-lymphoid cells in rats. It has a similar broad distribution pattern in humans. MRC OX-2 may regulate myeloid cell activity. The protein has an extracellular portion containing two Ig-like domains, a transmembrane portion, and a cytoplasmic portion.
Probab=97.50 E-value=0.00034 Score=65.92 Aligned_cols=76 Identities=21% Similarity=0.262 Sum_probs=53.9
Q ss_pred CceEEEEEEEecCCCc-EEEEEeCCEe----c---CC----------CCCeEEe-ecCCeEEEEEccCCCCCCEEEEEEE
Q psy2148 1757 GQLARFDAKISATKPL-DVYWLKNGKK----I---IP----------DIRYKTL-EEDNLFTLLIIEAVVEDSGAYECVA 1817 (1884)
Q Consensus 1757 G~~~~l~C~~~g~p~p-~v~W~k~~~~----l---~~----------~~~~~~~-~~~~~~~L~i~~~~~~d~G~Y~C~a 1817 (1884)
|++++|.|........ .|.|+|.... + .. ..|+.+. .+...++|+|.+++.+|+|.|+|.+
T Consensus 1 G~~vtL~C~~~~~~~~~~v~W~k~~~~~~~~i~~~~~~~~~~~~~~~~~r~~~~~~~~~~~sL~I~nv~~~D~G~Y~C~~ 80 (97)
T cd05846 1 GGNVTLSCNLTLPEEVLQVTWQKIQGSSPENIATYSEKYGVKIQPSYFRRRSITSLGLNSTSITIWNVTLEDEGCYKCIF 80 (97)
T ss_pred CCcEEEEEEeCCCCeeEEEEEEEcCCCCceEEEEEcccCCcccCCCccCeEEEcCCCCCccEEEEeCCceeeeEEEEEEE
Confidence 7899999997654332 6999986421 0 00 1122221 1234569999999999999999998
Q ss_pred E-eCCeeEEEEEEEEE
Q psy2148 1818 M-NNAGEARCEAELVV 1832 (1884)
Q Consensus 1818 ~-N~~G~~~~~~~l~V 1832 (1884)
. .+.|..+..+.|+|
T Consensus 81 ~~~p~g~~~~~~~L~v 96 (97)
T cd05846 81 NTFPDGSKSGTMCLTV 96 (97)
T ss_pred EeCCCCCeeeEEEEEE
Confidence 5 66888888899987
No 306
>cd05846 Ig1_MRC-OX-2_like First immunoglobulin (Ig) domain of rat MRC OX-2 antigen (also known as CD200) and similar proteins. Ig1_ MRC-OX-2_like: domain similar to the first immunoglobulin (Ig) domain of rat MRC OX-2 antigen (also known as CD200). MRC OX-2 is a membrane glycoprotein expressed in a variety of lymphoid and non-lymphoid cells in rats. It has a similar broad distribution pattern in humans. MRC OX-2 may regulate myeloid cell activity. The protein has an extracellular portion containing two Ig-like domains, a transmembrane portion, and a cytoplasmic portion.
Probab=97.49 E-value=0.00039 Score=65.56 Aligned_cols=93 Identities=16% Similarity=0.070 Sum_probs=55.2
Q ss_pred CCcEEEEEEEeecCCCcceEEEeccccccccccccc---ceEEEeeccceeeeeeeeeeeeceEEEEEeeecccCceEEE
Q psy2148 1279 AEPVRFETRVEPRVDPRLRVECSLSTAFFFPFINIS---TAFLIFNFCLHAVIFSHPIFDLGFVSLDIDYVYPEDQGEYV 1355 (1884)
Q Consensus 1279 g~~v~l~c~v~~~~~p~~~~~W~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~L~I~~~~~~d~G~Y~ 1355 (1884)
|++++|.|..... .....+.|+|............ ........-..+.... ....+.++|+|.+++.+|+|.|.
T Consensus 1 G~~vtL~C~~~~~-~~~~~v~W~k~~~~~~~~i~~~~~~~~~~~~~~~~~r~~~~--~~~~~~~sL~I~nv~~~D~G~Y~ 77 (97)
T cd05846 1 GGNVTLSCNLTLP-EEVLQVTWQKIQGSSPENIATYSEKYGVKIQPSYFRRRSIT--SLGLNSTSITIWNVTLEDEGCYK 77 (97)
T ss_pred CCcEEEEEEeCCC-CeeEEEEEEEcCCCCceEEEEEcccCCcccCCCccCeEEEc--CCCCCccEEEEeCCceeeeEEEE
Confidence 7899999987642 2234799998543210000000 0000000111121111 22345688999999999999999
Q ss_pred EEEE-ccccceeeeEEEEEe
Q psy2148 1356 CRAY-NDHGEAFTKATISCK 1374 (1884)
Q Consensus 1356 C~a~-n~~g~~~~~~~l~v~ 1374 (1884)
|.+. ...|..+..+-|+|+
T Consensus 78 C~~~~~p~g~~~~~~~L~v~ 97 (97)
T cd05846 78 CIFNTFPDGSKSGTMCLTVY 97 (97)
T ss_pred EEEEeCCCCCeeeEEEEEEC
Confidence 9987 567887777888773
No 307
>cd05887 Ig1_Nectin-3_like First immunoglobulin (Ig) domain of nectin-3 (also known as poliovirus receptor related protein 3) and similar proteins. Ig1_Nectin-3_like: domain similar to the first immunoglobulin (Ig) domain of nectin-3 (also known as poliovirus receptor related protein 3). Nectin-3 belongs to the nectin family comprised of four transmembrane glycoproteins (nectins-1 through -4). Nectins are synaptic cell adhesion molecules (CAMs) which participate in adhesion and signaling at various intracellular junctions. Nectins form homophilic cis-dimers, followed by homophilic and heterophilic trans-dimers involved in cell-cell adhesion. For example, during spermatid development, the nectin-3,-2 trans-interaction is required for the formation of Sertoli cell-spermatid junctions in testis, and during morphogenesis of the ciliary body, the nectin-3,-1 trans-interaction is important for apex-apex adhesion between the pigment and non-pigment layers of the ciliary epithelia. Nectins also
Probab=97.46 E-value=0.00084 Score=61.93 Aligned_cols=75 Identities=12% Similarity=0.211 Sum_probs=52.0
Q ss_pred CeEEEEEEEeccC-CCeEEEEeCCe----ecC-----------CC--CCeEEE-EeCceeEEEEcccccCCCeEEEEEEE
Q psy2148 1655 DQARFEVEFDGDP-LPTIKWFREDF----PIT-----------SS--PDFQIH-TFSTKSILIMRQVFMEDSGVFAVIAE 1715 (1884)
Q Consensus 1655 ~~~~l~C~~~g~p-~~~i~W~~~~~----~~~-----------~~--~~~~~~-~~~~~~~L~i~~v~~~DsG~Y~C~a~ 1715 (1884)
++++|.|.....+ ...|+|.|... .+. .. .|..+. ....+.+|.|.+++.+|+|.|.|.+.
T Consensus 1 ~~vtL~C~~~~~~~~~qV~W~k~~~~~~~~ia~y~~~~g~~~~~~y~~Rv~~~~~~~~d~sl~i~nv~~~D~G~Y~C~v~ 80 (96)
T cd05887 1 KNVTLKCRIQVNETITQSSWEKIHGKGSVTLAVHHPMYGISIQPDYQGRVSFKNYSLLDATIMLENVGFSDIGVYICKAV 80 (96)
T ss_pred CCEEEEEEecCCCcEEEEEEEEcCCCCcEEEEEEcccCCcccChhhCCcEEEcCCCCCccEEEEeCCCccccEEEEEEEE
Confidence 4689999987433 35899988421 110 00 122221 12345789999999999999999975
Q ss_pred e-CCceEEEEEEEEE
Q psy2148 1716 N-RGGKAKCSANLVV 1729 (1884)
Q Consensus 1716 n-~~g~~~~~~~l~V 1729 (1884)
+ +.|...++..|.|
T Consensus 81 tfP~G~~~~~~~l~~ 95 (96)
T cd05887 81 TFPLGNTQSSTTVTV 95 (96)
T ss_pred eCCCCCeeEEEEEEE
Confidence 4 6899999999887
No 308
>cd05887 Ig1_Nectin-3_like First immunoglobulin (Ig) domain of nectin-3 (also known as poliovirus receptor related protein 3) and similar proteins. Ig1_Nectin-3_like: domain similar to the first immunoglobulin (Ig) domain of nectin-3 (also known as poliovirus receptor related protein 3). Nectin-3 belongs to the nectin family comprised of four transmembrane glycoproteins (nectins-1 through -4). Nectins are synaptic cell adhesion molecules (CAMs) which participate in adhesion and signaling at various intracellular junctions. Nectins form homophilic cis-dimers, followed by homophilic and heterophilic trans-dimers involved in cell-cell adhesion. For example, during spermatid development, the nectin-3,-2 trans-interaction is required for the formation of Sertoli cell-spermatid junctions in testis, and during morphogenesis of the ciliary body, the nectin-3,-1 trans-interaction is important for apex-apex adhesion between the pigment and non-pigment layers of the ciliary epithelia. Nectins also
Probab=97.44 E-value=0.00064 Score=62.70 Aligned_cols=91 Identities=15% Similarity=0.154 Sum_probs=55.8
Q ss_pred CcEEEEEEEeecCCCcceEEEeccccccccccccc---ceEEEeeccceeeeeeeeeeeeceEEEEEeeecccCceEEEE
Q psy2148 1280 EPVRFETRVEPRVDPRLRVECSLSTAFFFPFINIS---TAFLIFNFCLHAVIFSHPIFDLGFVSLDIDYVYPEDQGEYVC 1356 (1884)
Q Consensus 1280 ~~v~l~c~v~~~~~p~~~~~W~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~L~I~~~~~~d~G~Y~C 1356 (1884)
++++|.|.... ......++|.|....-....... ...........|..+.. ...+..+|.|.+++.+|+|.|+|
T Consensus 1 ~~vtL~C~~~~-~~~~~qV~W~k~~~~~~~~ia~y~~~~g~~~~~~y~~Rv~~~~--~~~~d~sl~i~nv~~~D~G~Y~C 77 (96)
T cd05887 1 KNVTLKCRIQV-NETITQSSWEKIHGKGSVTLAVHHPMYGISIQPDYQGRVSFKN--YSLLDATIMLENVGFSDIGVYIC 77 (96)
T ss_pred CCEEEEEEecC-CCcEEEEEEEEcCCCCcEEEEEEcccCCcccChhhCCcEEEcC--CCCCccEEEEeCCCccccEEEEE
Confidence 47899999874 34556899998643110000000 00000011122333321 23456799999999999999999
Q ss_pred EEE-ccccceeeeEEEEE
Q psy2148 1357 RAY-NDHGEAFTKATISC 1373 (1884)
Q Consensus 1357 ~a~-n~~g~~~~~~~l~v 1373 (1884)
.+. ...|...++..|+|
T Consensus 78 ~v~tfP~G~~~~~~~l~~ 95 (96)
T cd05887 78 KAVTFPLGNTQSSTTVTV 95 (96)
T ss_pred EEEeCCCCCeeEEEEEEE
Confidence 986 67888888888887
No 309
>cd05716 Ig_pIgR Immunoglobulin (Ig)-like domain in the polymeric Ig receptor (pIgR). Ig_pIgR: Immunoglobulin (Ig)-like domain in the polymeric Ig receptor (pIgR). pIgR delivers dimeric IgA and pentameric IgM to mucosal secretions. Polymeric immunoglobulin (pIgs) are the first defense against pathogens and toxins. IgA and IgM can form polymers via an 18-residue extension at their c-termini referred to as the tailpiece. pIgR transports pIgs across mucosal epithelia into mucosal secretions. Human pIgR is a glycosylated type I transmembrane protein, comprised of a 620 residue extracellular region, a 23 residue transmembrane region, and a 103 residue cytoplasmic tail. The extracellular region contains five domains that share sequence similarity with Ig variable (v) regions.
Probab=97.39 E-value=0.00064 Score=64.45 Aligned_cols=70 Identities=19% Similarity=0.311 Sum_probs=52.1
Q ss_pred eEEcCCceEEEEEEEec-CCCcEEEEEeCCEec-------------CCCCCeEEee--cCCeEEEEEccCCCCCCEEEEE
Q psy2148 1752 AVINVGQLARFDAKISA-TKPLDVYWLKNGKKI-------------IPDIRYKTLE--EDNLFTLLIIEAVVEDSGAYEC 1815 (1884)
Q Consensus 1752 ~~~~~G~~~~l~C~~~g-~p~p~v~W~k~~~~l-------------~~~~~~~~~~--~~~~~~L~i~~~~~~d~G~Y~C 1815 (1884)
..+.+|++++|.|.... .+...+.|+|....- ....|+.+.. ..+.+.|+|.+++.+|+|.|.|
T Consensus 2 v~~~~G~~vtl~C~~~~~~~~~~~~W~r~~~~~~~~~l~~~~~~~~~~~~r~~~~~~~~~~~~~L~I~~v~~~DsG~Y~C 81 (98)
T cd05716 2 VTGELGGSVTIPCPYPPKNRSYEKYWCKWGSAGCCLIIVSEGSVQSQYEGRVSLTDDPDNGVFTVTLNQLRKEDAGWYWC 81 (98)
T ss_pred EEEEeCCeEEEEeeCCCCCCCcEeEeECCCCCCCCeEEECCCccccccCCCEEEEecCCCCEEEEEEcCCCHHHCEEEEE
Confidence 35678999999999875 356689999875311 1124565542 3467899999999999999999
Q ss_pred EEEeCC
Q psy2148 1816 VAMNNA 1821 (1884)
Q Consensus 1816 ~a~N~~ 1821 (1884)
.+.+..
T Consensus 82 ~~~~~~ 87 (98)
T cd05716 82 GVGDDG 87 (98)
T ss_pred EcccCC
Confidence 987754
No 310
>cd00098 IgC Immunoglobulin Constant domain. IgC: Immunoglobulin constant domain (IgC). Members of the IgC family are components of immunoglobulin, T-cell receptors, CD1 cell surface glycoproteins, secretory glycoproteins A/C, and Major Histocompatibility Complex (MHC) class I/II molecules. In immunoglobulins, each chain is composed of one variable domain (IgV) and one or more IgC domains. These names reflect the fact that the variability in sequences is higher in the variable domain than in the constant domain. The IgV domain is responsible for antigen binding, and the IgC domain is involved in oligomerization and molecular interactions.
Probab=97.39 E-value=0.0004 Score=65.57 Aligned_cols=71 Identities=20% Similarity=0.350 Sum_probs=51.5
Q ss_pred CCCCeEEEEEEEeeCCCCccEEEEeeCCeeecCCCc-eEEE-eeCc-e---EEEEEccccccccEEEEEEEEcCcee
Q psy2148 517 PEAGKVHFDCRLEPKSDPTMRIDWFFNGRPFATGSR-VKTV-YDFG-F---ISLDMDYVYARDSGEYICRATNKWGT 587 (1884)
Q Consensus 517 ~~g~~~~L~C~~~~~~~p~~~i~W~~~~~~l~~~~~-~~~~-~~~~-~---~~L~i~~~~~~d~G~Y~C~a~n~~g~ 587 (1884)
..|+.++|.|.+.++..+.+.++|+++|..+..... .... ..++ . +.|.|.....++.+.|+|.|.+....
T Consensus 11 ~~~~~~~L~C~a~g~~P~~~~i~W~~~g~~~~~~~~~~~~~~~~~gt~~~~s~l~v~~~~~~~~~~y~C~v~h~~~~ 87 (95)
T cd00098 11 LLGGSVTLTCLATGFYPPDITVTWLKNGKELTSGVTTTPPVPNSDGTYSVSSQLTVSPSDWNSGDTYTCVVTHESLP 87 (95)
T ss_pred HcCCCeEEEEEEeeEECCCcEEEEEECCEECCCceeccccccCCCCCEEEEEEEEECHHHhCCCCCEEEEEEeCCCC
Confidence 478999999999875545689999999998876543 1111 1222 1 45777777777999999999987653
No 311
>cd07698 IgC_MHC_I_alpha3 Class I major histocompatibility complex (MHC) alpha chain immunoglobulin domain. IgC_MHC_I_alpha3; Immunoglobulin (Ig) domain of major histocompatibility complex (MHC) class I alpha chain. Class I MHC proteins bind antigenic peptide fragments and present them to CD8+ T lymphocytes. Class I molecules consist of a transmembrane alpha chain and a small chain called the beta2 microglobulin. The alpha chain contains three extracellular domains, two of which fold together to form the peptide-binding cleft (alpha1 and alpha2), and one which has an Ig fold (alpha3). Peptide binding to class I molecules occurs in the endoplasmic reticulum (ER) and involves both chaperones and dedicated factors to assist in peptide loading. Class I MHC molecules are expressed on most nucleated cells.
Probab=97.38 E-value=0.001 Score=62.04 Aligned_cols=79 Identities=18% Similarity=0.292 Sum_probs=46.3
Q ss_pred CCeeeecCCceeecCCCeEEEEEEEeeCCCCCcEEEEeeCCEEccCCC---cEEEEeeCCeEEEEEccCCCCCCeEEEEE
Q psy2148 916 APEFLTTPTDLTLAESTLAHFECRLTPTNDPSMTVEWFHNGKALSAGS---RIKTINDFGFVILEINDVYLRDSGLYTCK 992 (1884)
Q Consensus 916 ~p~~~~~~~~~~v~~G~~v~l~C~v~~~~~P~~~v~W~~~g~~i~~~~---~~~~~~~~~~~~L~I~~~~~~D~G~Y~C~ 992 (1884)
||.+........ |+.++|.|.+.|.-.+...|+|+++|..+..+. ......++.......-.+..+|.+.|+|+
T Consensus 2 pP~v~v~~~~~~---~~~~~L~C~a~gF~P~~i~v~W~~~g~~~~~~~~~~~~~~~~d~ty~~~s~l~v~~~~~~~ytC~ 78 (93)
T cd07698 2 PPEVRVTRKRAP---DGSLTLSCHATGFYPRDIEVTWLRDGEDSVDDVESGEILPNGDGTYQLWVTLEVPPEDKARYSCR 78 (93)
T ss_pred CCEEEEEecCCC---CCcEEEEEEEEEEeCCCcEEEEEECCEECcccccccceEECCCCeEEEEEEEEECCCCCCEEEEE
Confidence 455544333322 778999999996434446999999997543322 22212222222222223334588999999
Q ss_pred EEcCC
Q psy2148 993 ATNKH 997 (1884)
Q Consensus 993 a~N~~ 997 (1884)
+.+..
T Consensus 79 V~H~~ 83 (93)
T cd07698 79 VEHSG 83 (93)
T ss_pred EEeCC
Confidence 98764
No 312
>cd05772 IgC_SIRP Signal-regulatory protein (SIRP) immunoglobulin-like domain. IgC_SIRP: Immunoglobulin-like domain of signal-regulatory proteins (SIRP); the signal-regulatory proteins (SIRP) are Ig-like cell surface receptors detected in hematopoietic and non-hematopoietic cells. While their extracellular domains are similar, SIRP are classified as alpha or beta based on the length of the intracytoplasmic domain. Those having a 110- to 113-amino acid tail are classified as SIRP-alpha, and those having a 5-amino acid tail as SIRP-beta. SIRP-alpha and SIRP-beta molecules are thought to have complementary roles in signal regulation: SIRP-alpha inhibit signalling via their immunoreceptor tyrosine (IT)-based inhibition motifs while SIRP-beta are activating. SIRP-beta lack the cytoplasmic domainof SIRP-alpha, and associate with at least one other transmembrane protein (DAP-12 or KARAP). The IT-based activation motifs within DAP-12's cytoplasmic domain may link SIRP-beta to the activating
Probab=97.36 E-value=0.0013 Score=62.85 Aligned_cols=79 Identities=14% Similarity=0.201 Sum_probs=50.5
Q ss_pred CCCCCCccccCCCCeEEEEEEEeeCCCCccEEEEeeCCeeecCCCceEEEeeCc-----eEEEEEccccccccEEEEEEE
Q psy2148 507 PSPSQDNLDVPEAGKVHFDCRLEPKSDPTMRIDWFFNGRPFATGSRVKTVYDFG-----FISLDMDYVYARDSGEYICRA 581 (1884)
Q Consensus 507 ~~~~~~~~~v~~g~~~~L~C~~~~~~~p~~~i~W~~~~~~l~~~~~~~~~~~~~-----~~~L~i~~~~~~d~G~Y~C~a 581 (1884)
|.+.........|+.++|.|.+.++..+.+.++|++||+.+..+........++ .+.|.+..-..++.-.|+|.+
T Consensus 9 p~i~~~~~~~~~g~~~tL~C~a~gF~P~~i~v~W~kng~~~~~~~~~~~p~~d~~ty~~~S~L~~~~~~~d~~~~ytC~V 88 (111)
T cd05772 9 PVVSGPSGRANPGQSVNFTCSAHGFSPRDITVKWLKNGNELSAEQPNITPEGDSVSYNVTSTVQVKLTEDDVHSQVTCEV 88 (111)
T ss_pred cEeCCchhccCCCCCEEEEEEEeeEeCCCCEEEEEECCEECcccccceeeCCCCCcEEEEEEEEEECccccccCceEEEE
Confidence 333334445667889999999998766678999999999986532211111221 234656653333334599999
Q ss_pred EcCc
Q psy2148 582 TNKW 585 (1884)
Q Consensus 582 ~n~~ 585 (1884)
.+..
T Consensus 89 ~H~~ 92 (111)
T cd05772 89 QHRT 92 (111)
T ss_pred EeCC
Confidence 8864
No 313
>cd07700 IgV_CD8_beta Immunoglobulin (Ig) like domain of CD8 beta chain. IgV_CD8_beta: immunoglobulin (Ig)-like domain in CD8 beta. The CD8 glycoprotein plays an essential role in the control of T-cell selection, maturation and the T-cell receptor (TCR)-mediated response to peptide antigen. CD8 is comprised of alpha and beta subunits and is expressed as either an alpha/alpha or alpha/beta dimer. Both dimeric isoforms can serve as a coreceptor for T cell activation and differentiation, however they have distinct physiological roles, different cellular distributions, unique binding partners etc. Each CD8 subunit is comprised of an extracellular domain containing a V-type Ig-like domain, a single pass transmembrane portion and a short intracellular domain.
Probab=97.35 E-value=0.00065 Score=65.41 Aligned_cols=67 Identities=16% Similarity=0.434 Sum_probs=48.8
Q ss_pred EEcCCceEEEEEEEecC-CCcEEEEEeCCEe-----c------C-----------CCCCeEE--eecCCeEEEEEccCCC
Q psy2148 1753 VINVGQLARFDAKISAT-KPLDVYWLKNGKK-----I------I-----------PDIRYKT--LEEDNLFTLLIIEAVV 1807 (1884)
Q Consensus 1753 ~~~~G~~~~l~C~~~g~-p~p~v~W~k~~~~-----l------~-----------~~~~~~~--~~~~~~~~L~i~~~~~ 1807 (1884)
.+..|++++|.|.+.+. ....+.|||...- + . ...++.+ ....+.+.|+|.++..
T Consensus 2 ~v~~G~~vtL~C~~~~~~~~~~~~Wyrq~~g~~~~~~~~l~~~~~~~~~~~~~~~~~~rf~~~~~~~~~~~~L~I~~~~~ 81 (107)
T cd07700 2 LVQTNNTVKLSCEAKGISENTRIYWLRWRQAPKDSHFEFLALWSPLGGATYGEEVSQEKFSIRVTSDSSRYRLHINRVKP 81 (107)
T ss_pred EEcCCCCEEEEEEEecCCCCCeEEEEEECCCCCCCccEEEEEEcCCCCeEEccccccCcEEEEEECCCCEEEEEECCCCH
Confidence 46789999999999764 3457999976431 0 0 0235544 2344567899999999
Q ss_pred CCCEEEEEEEEe
Q psy2148 1808 EDSGAYECVAMN 1819 (1884)
Q Consensus 1808 ~d~G~Y~C~a~N 1819 (1884)
+|+|.|.|...+
T Consensus 82 ~Dsg~YyCa~~~ 93 (107)
T cd07700 82 EDSGTYFCMTVG 93 (107)
T ss_pred HHCEEEEEeEcC
Confidence 999999999863
No 314
>cd05716 Ig_pIgR Immunoglobulin (Ig)-like domain in the polymeric Ig receptor (pIgR). Ig_pIgR: Immunoglobulin (Ig)-like domain in the polymeric Ig receptor (pIgR). pIgR delivers dimeric IgA and pentameric IgM to mucosal secretions. Polymeric immunoglobulin (pIgs) are the first defense against pathogens and toxins. IgA and IgM can form polymers via an 18-residue extension at their c-termini referred to as the tailpiece. pIgR transports pIgs across mucosal epithelia into mucosal secretions. Human pIgR is a glycosylated type I transmembrane protein, comprised of a 620 residue extracellular region, a 23 residue transmembrane region, and a 103 residue cytoplasmic tail. The extracellular region contains five domains that share sequence similarity with Ig variable (v) regions.
Probab=97.33 E-value=0.00078 Score=63.84 Aligned_cols=71 Identities=21% Similarity=0.389 Sum_probs=51.8
Q ss_pred eeecCCCeEEEEEEEeeCCCCCcEEEEeeCCEE-----c--------cCCCcEEEEe--eCCeEEEEEccCCCCCCeEEE
Q psy2148 926 LTLAESTLAHFECRLTPTNDPSMTVEWFHNGKA-----L--------SAGSRIKTIN--DFGFVILEINDVYLRDSGLYT 990 (1884)
Q Consensus 926 ~~v~~G~~v~l~C~v~~~~~P~~~v~W~~~g~~-----i--------~~~~~~~~~~--~~~~~~L~I~~~~~~D~G~Y~ 990 (1884)
+.+.+|++|+|.|.... ..+...+.|+|.... | ....|+.+.. ..+.+.|+|.+++.+|+|.|.
T Consensus 2 v~~~~G~~vtl~C~~~~-~~~~~~~~W~r~~~~~~~~~l~~~~~~~~~~~~r~~~~~~~~~~~~~L~I~~v~~~DsG~Y~ 80 (98)
T cd05716 2 VTGELGGSVTIPCPYPP-KNRSYEKYWCKWGSAGCCLIIVSEGSVQSQYEGRVSLTDDPDNGVFTVTLNQLRKEDAGWYW 80 (98)
T ss_pred EEEEeCCeEEEEeeCCC-CCCCcEeEeECCCCCCCCeEEECCCccccccCCCEEEEecCCCCEEEEEEcCCCHHHCEEEE
Confidence 46789999999999873 235567999995421 1 1234565542 246779999999999999999
Q ss_pred EEEEcCC
Q psy2148 991 CKATNKH 997 (1884)
Q Consensus 991 C~a~N~~ 997 (1884)
|.+.+..
T Consensus 81 C~~~~~~ 87 (98)
T cd05716 81 CGVGDDG 87 (98)
T ss_pred EEcccCC
Confidence 9998753
No 315
>cd05772 IgC_SIRP Signal-regulatory protein (SIRP) immunoglobulin-like domain. IgC_SIRP: Immunoglobulin-like domain of signal-regulatory proteins (SIRP); the signal-regulatory proteins (SIRP) are Ig-like cell surface receptors detected in hematopoietic and non-hematopoietic cells. While their extracellular domains are similar, SIRP are classified as alpha or beta based on the length of the intracytoplasmic domain. Those having a 110- to 113-amino acid tail are classified as SIRP-alpha, and those having a 5-amino acid tail as SIRP-beta. SIRP-alpha and SIRP-beta molecules are thought to have complementary roles in signal regulation: SIRP-alpha inhibit signalling via their immunoreceptor tyrosine (IT)-based inhibition motifs while SIRP-beta are activating. SIRP-beta lack the cytoplasmic domainof SIRP-alpha, and associate with at least one other transmembrane protein (DAP-12 or KARAP). The IT-based activation motifs within DAP-12's cytoplasmic domain may link SIRP-beta to the activating
Probab=97.32 E-value=0.0018 Score=61.92 Aligned_cols=70 Identities=16% Similarity=0.355 Sum_probs=46.1
Q ss_pred ccCCCeEEEEEEEeeCCCCCCeEEEeeCCEEccccCcEEE-EecCCE----EEEEEcccCCCCcE-EEEEEEEeCce
Q psy2148 421 LKDGDSAHFECTLTPVNDPELKVEWFHNGKPIFHKNRVKM-VSDFGF----VVMDIAYVQSHDSG-EYVCRAWNNFI 491 (1884)
Q Consensus 421 v~~G~~v~L~C~~~~~~~p~~~i~W~k~g~~l~~~~~~~~-~~~~~~----~~L~i~~v~~~d~G-~Y~C~a~n~~~ 491 (1884)
...|+.++|.|.+.++-.+..+++|+|||+.+........ ..+++. +.|.+. ....|.| .|+|.+.+...
T Consensus 18 ~~~g~~~tL~C~a~gF~P~~i~v~W~kng~~~~~~~~~~~p~~d~~ty~~~S~L~~~-~~~~d~~~~ytC~V~H~~l 93 (111)
T cd05772 18 ANPGQSVNFTCSAHGFSPRDITVKWLKNGNELSAEQPNITPEGDSVSYNVTSTVQVK-LTEDDVHSQVTCEVQHRTL 93 (111)
T ss_pred cCCCCCEEEEEEEeeEeCCCCEEEEEECCEECcccccceeeCCCCCcEEEEEEEEEE-CccccccCceEEEEEeCCC
Confidence 5578889999999985444689999999999864322111 122222 335554 3445555 59999998654
No 316
>KOG1480|consensus
Probab=97.30 E-value=8.5e-05 Score=89.14 Aligned_cols=191 Identities=21% Similarity=0.308 Sum_probs=113.0
Q ss_pred CCCeeEeecceeeeecCCcEEEEEEEeecCCCcceEEEecccccccccccccceEEEeeccceeeeeeeeeeeeceEEEE
Q psy2148 1263 EPPRFITEIESVTVQEAEPVRFETRVEPRVDPRLRVECSLSTAFFFPFINISTAFLIFNFCLHAVIFSHPIFDLGFVSLD 1342 (1884)
Q Consensus 1263 ~~p~~~~~~~~~~v~~g~~v~l~c~v~~~~~p~~~~~W~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~ 1342 (1884)
.-|+|+.++++..+..|.++.|.|.+. |.+.+....+...+....+.+........-..+ . ...+.
T Consensus 23 ~l~~~~~~p~~~yii~~~p~~l~c~a~----~a~~i~~kc~~~wv~~~~~~~~~~~d~tsg~~~---~-------~~si~ 88 (909)
T KOG1480|consen 23 DLPHFTTEPKSAYIIKNKPLRLQCKAN----PATQIRFKCNSEWVHQSRHEKLEGTDETSGLGV---R-------EVSID 88 (909)
T ss_pred CcceeeecCCccceecCCCccceecCC----cccccccccChhhhcCccceeeeccCcccceeE---E-------eeeee
Confidence 558999999999999999999999754 667777777777666654433222111100000 0 01233
Q ss_pred EeeecccCce---EE--EEEEEccccceeeeEEEEEeecCceeecccCCcchhhhHHHHHHHHhhhcccccccccCCccC
Q psy2148 1343 IDYVYPEDQG---EY--VCRAYNDHGEAFTKATISCKKIPTIQLQNQVPKGMLKTEALIQMEAAIKKYTSEIYLTEDDLY 1417 (1884)
Q Consensus 1343 I~~~~~~d~G---~Y--~C~a~n~~g~~~~~~~l~v~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1417 (1884)
|..-..++.| .| .|.|....|...+.. ....++ ..+++.
T Consensus 89 Isr~~v~~~~~~~d~~cQc~a~~~~g~~~s~~----------------------a~vr~a---y~rk~f----------- 132 (909)
T KOG1480|consen 89 ISRQQVETSGGPEDYWCQCVAWSDDGTVKSRK----------------------ATVRIA---YLRKHF----------- 132 (909)
T ss_pred eehhhhhcccCccceeeeeeeecCCCcchhhh----------------------HHHHHH---HHHHhh-----------
Confidence 3333333322 34 456666666221110 000011 111111
Q ss_pred CcccCCCCeEEEccCCccccccccceEEEEEEeeCCCCCCeEEEeecCeecCCCCCceeeeeCceEEEEEeeeccCCCeE
Q psy2148 1418 EPEKKQPPRFVTQIKTQDQLVEMQSTKFECQLAPVGDPNMKVEWFLNGKPLPHKNRFNPIYDFGYVAMNFGWVYPEDSGE 1497 (1884)
Q Consensus 1418 ~~~~~~pP~~~~~~~~~~~v~~g~~~~l~C~~~~~g~p~~~i~W~~~~~~l~~~~~~~~~~~~~~~~L~i~~~~~~d~G~ 1497 (1884)
...+.- ..|..+..+.|.|... .|.|...++|++++..+.+..+.. ...+ +.|.|..++..|.|+
T Consensus 133 ----------~~~p~~-q~V~~~s~~~l~cr~p-e~~paae~~w~k~e~~~~pd~n~~-~~~d--~~li~~~arlsd~~n 197 (909)
T KOG1480|consen 133 ----------EQSPVG-QEVQEETTLQLPCRPP-EGDPKAEVEWLKNEVVIDPDANVI-RASD--HNLIISQARLSDSGN 197 (909)
T ss_pred ----------ccChhh-heecccccccccccCc-ccchhhhhhccccCCCCCccccch-hhhc--CCccccchhhhhccc
Confidence 111111 1366778889999985 799999999999998887743332 2222 358889999999999
Q ss_pred EEEEEEecCcceEEE-EEEEEe
Q psy2148 1498 YLCRATNLYGMDETR-AILKTT 1518 (1884)
Q Consensus 1498 Y~c~a~n~~G~~~~~-~~l~V~ 1518 (1884)
|+|.|.|-++..... +.+.|+
T Consensus 198 ytc~a~ni~~~r~~~~~~v~vy 219 (909)
T KOG1480|consen 198 YTCEATNIVAKRKSDPATVQVY 219 (909)
T ss_pred ceeeeehhhccccccceEEEEE
Confidence 999999988765542 444443
No 317
>cd05720 Ig_CD8_alpha Immunoglobulin (Ig) like domain of CD8 alpha chain. Ig_CD8_alpha: immunoglobulin (Ig)-like domain in CD8 alpha. The CD8 glycoprotein plays an essential role in the control of T-cell selection, maturation and the T-cell receptor (TCR)-mediated response to peptide antigen. CD8 is comprised of alpha and beta subunits and is expressed as either an alphaalpha or alphabeta dimer. Both dimeric isoforms can serve as a coreceptor for T cell activation and differentiation, however they have distinct physiological roles, different cellular distributions, unique binding partners etc. Each CD8 subunit is comprised of an extracellular domain containing a v-type Ig-like domain, a single pass transmembrane portion and a short intracellular domain. The Ig domain of CD8 alpha binds to antibodies.
Probab=97.30 E-value=0.00067 Score=64.74 Aligned_cols=67 Identities=19% Similarity=0.314 Sum_probs=49.4
Q ss_pred EEcCCceEEEEEEEecCCCcEEEEEeCCEe----c------CC------------CCCeEEeecCCeEEEEEccCCCCCC
Q psy2148 1753 VINVGQLARFDAKISATKPLDVYWLKNGKK----I------IP------------DIRYKTLEEDNLFTLLIIEAVVEDS 1810 (1884)
Q Consensus 1753 ~~~~G~~~~l~C~~~g~p~p~v~W~k~~~~----l------~~------------~~~~~~~~~~~~~~L~i~~~~~~d~ 1810 (1884)
.+..|++|+|.|.........+.|+|...- + .. ..|+.+......+.|+|.+++.+|+
T Consensus 2 ~v~~G~~vtL~C~~~~~~~~~v~Wyrq~~g~~~~~~~l~~~~~~~~~~~~~~~~~~~rf~~~~~~~~~~L~I~~~~~sDs 81 (104)
T cd05720 2 DAELGQKVELKCEVLNSSPTGCSWLFQPPGSAPQPTFLVYLSGSSKITWDEEELSSKRFSGSRSSNSFVLTLKNFQKENE 81 (104)
T ss_pred cccCCCeEEEEEEecCCCCCcEEEEEeCCCCCCCCEEEEEEeCCCCeeeccccCCCceEEEEecCCEEEEEECCCCHHHC
Confidence 367899999999987654567999977521 1 00 1245444455778999999999999
Q ss_pred EEEEEEEEe
Q psy2148 1811 GAYECVAMN 1819 (1884)
Q Consensus 1811 G~Y~C~a~N 1819 (1884)
|.|.|.+.+
T Consensus 82 gtY~Ca~~~ 90 (104)
T cd05720 82 GYYFCSVAS 90 (104)
T ss_pred EEEEEEEcc
Confidence 999998764
No 318
>PHA03270 envelope glycoprotein C; Provisional
Probab=97.30 E-value=0.061 Score=61.48 Aligned_cols=174 Identities=11% Similarity=0.124 Sum_probs=98.4
Q ss_pred CeEEEEEcCCCCCCCEEEEEEEEcCCeeeE--EEEEEEEeecCCCCCCceEeccCCccCccCCCeEEEEEEEeeCCCCC-
Q psy2148 364 GMVVLEILGTKIEDTGVYTCRATNKWGQAE--ISVNLECVDKSKGQPPKFTSHIKSLEGLKDGDSAHFECTLTPVNDPE- 440 (1884)
Q Consensus 364 ~~~~L~I~~~~~~D~G~Y~C~a~n~~g~~~--~~~~l~V~~~~~~~~p~~~~~~~~~~~v~~G~~v~L~C~~~~~~~p~- 440 (1884)
.+..|.|..++...+|.|+=...+..+... ..++|..+ .+|.+.....+ +.+|+...-.|.+.. -+|+
T Consensus 180 p~~~L~I~slt~aTeGvY~Wr~~~~~~~~~~~~~VtV~~y-----r~Psvsv~~~P---vL~Ge~Y~AtC~va~-YYPp~ 250 (466)
T PHA03270 180 PTQRLVIQELTLATQGMYYWARGPADRPHRYGTWTRVRMF-----RRPSLSIRPHA---VLEGEPFGATCVAAN-YYPGD 250 (466)
T ss_pred CcceEEEEEcccccceEEEEEEecCCCceeeeeEEEEEEe-----cCCcccccCCc---cccCCCceEEEEeee-ecCCC
Confidence 345699999999999999999777655433 44555544 67777665554 569999999999975 3443
Q ss_pred -CeEEEeeCCEEccccCc----EEEEecCC--EEEEEEcccCCCC-cEEEEEEEEeCceecCCcceEEeecccCCCCCCC
Q psy2148 441 -LKVEWFHNGKPIFHKNR----VKMVSDFG--FVVMDIAYVQSHD-SGEYVCRAWNNFIFIPPFPIFIFHQIRLPSPSQD 512 (1884)
Q Consensus 441 -~~i~W~k~g~~l~~~~~----~~~~~~~~--~~~L~i~~v~~~d-~G~Y~C~a~n~~~~~~~~~~~~~~~~~~~~~~~~ 512 (1884)
..+.||+|+.++..... .....++- .++|++....... .-+.+|.+.-.....+.........+.+...+.-
T Consensus 251 Sv~lrWf~ng~~V~~~~~i~~~~~~~~dGfs~vStvtsea~~~~~~PPsLrC~v~W~rd~vS~sR~nAa~~P~VY~~P~I 330 (466)
T PHA03270 251 RAAFRWFEGGDEVFAPERVRTRVDAQRDGFSATSTLTSEARAGLAPPRNLTCEFTWHRDSVSFSRRNATGAPTVLPRPTI 330 (466)
T ss_pred ceEEEEEeCCccccCcceeeeeeEecCCCeeEEEEEeccccccCCCCCCceEEEEEccCCccceeecccccCccccCCeE
Confidence 68999999998853222 11222221 1233332221111 1278999875544322211111111111111111
Q ss_pred ccccCCCCeEEEEEEEeeCCCCccEEEEeeCCeeecCC
Q psy2148 513 NLDVPEAGKVHFDCRLEPKSDPTMRIDWFFNGRPFATG 550 (1884)
Q Consensus 513 ~~~v~~g~~~~L~C~~~~~~~p~~~i~W~~~~~~l~~~ 550 (1884)
.+.+..|. ..|.+.--+. ...+.|+.++......
T Consensus 331 sv~F~dG~---AVCtA~CVPe-gV~l~W~V~D~~~pa~ 364 (466)
T PHA03270 331 EMEFGGDE---AVCTAACVPE-GVTLAWLLGADPAPAE 364 (466)
T ss_pred EEEEeCCE---EEEeccccCC-CCEEEEEecCCCCCCc
Confidence 22333343 3466553333 5689999987766443
No 319
>PHA03273 envelope glycoprotein C; Provisional
Probab=97.28 E-value=0.011 Score=68.00 Aligned_cols=169 Identities=15% Similarity=0.142 Sum_probs=96.0
Q ss_pred EEEEEcCCCCCCCEEEEEEEEcCCeeeEEEEEEEEeecCCCCCCceEeccCCccCccCCCeEEEEEEEeeCCCCC--CeE
Q psy2148 366 VVLEILGTKIEDTGVYTCRATNKWGQAEISVNLECVDKSKGQPPKFTSHIKSLEGLKDGDSAHFECTLTPVNDPE--LKV 443 (1884)
Q Consensus 366 ~~L~I~~~~~~D~G~Y~C~a~n~~g~~~~~~~l~V~~~~~~~~p~~~~~~~~~~~v~~G~~v~L~C~~~~~~~p~--~~i 443 (1884)
..|+|..++..++|.|+=+..+..+.......+.|.. ..+|.+.....+ +.+|+...-.|.+.. -+|+ ..+
T Consensus 198 ~~LtI~sltaaTeGvYtWr~~~~n~t~~~~~~VtV~~---yr~Psvsv~~~P---vL~Ge~y~A~C~aa~-YYPp~Sv~~ 270 (486)
T PHA03273 198 FPLTIKSVDWRTAGVYVWSLYAKNGTLVNSTSVTVST---YNAPLVDLSVHP---SLKGENYRAVCVVAS-YFPHSSVKL 270 (486)
T ss_pred cceEEEecchhhceEEEEEEecCCCceeeeeEEEEEE---ecCCcccccCCc---cccCCCceEEEEeee-ecCCCceEE
Confidence 5699999999999999877666545433333444421 267777665554 669999999999975 3443 689
Q ss_pred EEeeCCEEccc-cC---cEEEEecCC---EEEEEEcccCC-CCcEEEEEEEEeCceecCCcceEEeecccCCCCCCCccc
Q psy2148 444 EWFHNGKPIFH-KN---RVKMVSDFG---FVVMDIAYVQS-HDSGEYVCRAWNNFIFIPPFPIFIFHQIRLPSPSQDNLD 515 (1884)
Q Consensus 444 ~W~k~g~~l~~-~~---~~~~~~~~~---~~~L~i~~v~~-~d~G~Y~C~a~n~~~~~~~~~~~~~~~~~~~~~~~~~~~ 515 (1884)
.||+||.++.. .. ......++. .++|++..... +..-+.+|.+.-.....+.........+.+...+.-.+.
T Consensus 271 rWf~dg~~V~~~~~~~~~~~~~~~gl~T~vStlt~~~~~~~~~PP~lrC~v~W~rd~vS~~RfsAt~~P~Vy~~P~Is~~ 350 (486)
T PHA03273 271 RWYKNAKEVDFTKYVTNASSVWVDGLITRISTLSIPVDPDEEYTPSLRCSIEWYRDEVSFARIAKAGTPSVFVAPTVSVT 350 (486)
T ss_pred EEEeCCeeccccccceeeEEEecCCceEEEEEEeccCcccCCCCCCceEEEEEccCCcceeeccccccCccccCCeEEEE
Confidence 99999999873 21 222233333 23444443222 223388999976544422211110111111111111223
Q ss_pred cCCCCeEEEEEEEeeCCCCccEEEEeeCC
Q psy2148 516 VPEAGKVHFDCRLEPKSDPTMRIDWFFNG 544 (1884)
Q Consensus 516 v~~g~~~~L~C~~~~~~~p~~~i~W~~~~ 544 (1884)
+..|+ ..|.+.-.+.....+.|+.++
T Consensus 351 F~~G~---AVCtA~CVP~egV~l~W~v~D 376 (486)
T PHA03273 351 VEDGD---AVCTAKCVPSTGVFVSWSVND 376 (486)
T ss_pred EeCCE---EEEecccccCCCeeEEEEccC
Confidence 33343 457665333335789999877
No 320
>cd07699 IgC_L Immunoglobulin Constant domain. IgC_L: Immunoglobulin (Ig) light chain constant (C) domain. The basic structure of Ig molecules is a tetramer of two light chains and two heavy chains linked by disulfide bonds. In Ig, each chain is composed of one variable domain (IgV) and one or more constant domains (IgC); these names reflect the fact that the variability in sequences is higher in the variable domain than in the constant domain. There are five types of heavy chains (alpha, gamma, delta, epsilon, and mu), which determine the type of immunoglobulin: IgA, IgG, IgD, IgE, and IgM, respectively. In higher vertebrates, there are two types of light chain, designated kappa and lambda, which seem to be functionally identical, and can associate with any of the heavy chains.
Probab=97.25 E-value=0.001 Score=62.61 Aligned_cols=83 Identities=16% Similarity=0.236 Sum_probs=53.2
Q ss_pred CeeeecCCCccccCCCCcEEEEEEEeecCCC-CCeEEEeeCCccCCCCCCe--EEEe-eCCE---EEEEEcccCcCCCeE
Q psy2148 707 PVFTVPLSNIDDLREGENAHFEARLTPTDDP-KLKVEWFWNGKPMKTGSRF--RTFC-DFGF---VILEISPVYPEDCGQ 779 (1884)
Q Consensus 707 p~~~~~~~~~~~v~~G~~~~l~C~~~~~g~p-~~~v~W~k~g~~l~~~~~~--~~~~-~~~~---~~L~i~~~~~~d~G~ 779 (1884)
|.+.+-++.......++.++|.|.+.+. .| ...++|++||+++..+... ...+ ++.. ..|.+..-...+...
T Consensus 2 P~V~v~~p~~~~~~~~~~~~L~C~~~gf-yP~~i~v~W~~~g~~~~~~~~~~~~~~~~dgty~~~s~L~v~~~~w~~~~~ 80 (100)
T cd07699 2 PSVTIFPPSSEELEKSGKATLVCLINDF-YPGFATVQWKVDGATVSSGVQTSTTEQQSDNTYSLSSYLTLTKSDWNKHKV 80 (100)
T ss_pred CeEEEECCCHHHHccCCCcEEEEEEEeE-ECCCCEEEEEECCEECcccEeccccEECCCCCEEEEEEEEEcHHHhCCCCe
Confidence 4444444444456678889999999975 45 7899999999998543211 1112 2222 236666555555679
Q ss_pred EEEEEEecCce
Q psy2148 780 YSCRAYNDYGE 790 (1884)
Q Consensus 780 Y~C~a~N~~g~ 790 (1884)
|+|.+.+....
T Consensus 81 ~sC~V~H~~l~ 91 (100)
T cd07699 81 YTCEVTHEGLS 91 (100)
T ss_pred EEEEEEecCCC
Confidence 99999987543
No 321
>PF08205 C2-set_2: CD80-like C2-set immunoglobulin domain ; InterPro: IPR013162 The basic structure of immunoglobulin (Ig) molecules is a tetramer of two light chains and two heavy chains linked by disulphide bonds. There are two types of light chains: kappa and lambda, each composed of a constant domain (CL) and a variable domain (VL). There are five types of heavy chains: alpha, delta, epsilon, gamma and mu, all consisting of a variable domain (VH) and three (in alpha, delta and gamma) or four (in epsilon and mu) constant domains (CH1 to CH4). Ig molecules are highly modular proteins, in which the variable and constant domains have clear, conserved sequence patterns. The domains in Ig and Ig-like molecules are grouped into four types: V-set (variable; IPR013106 from INTERPRO), C1-set (constant-1; IPR003597 from INTERPRO), C2-set (constant-2; IPR008424 from INTERPRO) and I-set (intermediate; IPR013098 from INTERPRO) []. Structural studies have shown that these domains share a common core Greek-key beta-sandwich structure, with the types differing in the number of strands in the beta-sheets as well as in their sequence patterns [, ]. Immunoglobulin-like domains that are related in both sequence and structure can be found in several diverse protein families. Ig-like domains are involved in a variety of functions, including cell-cell recognition, cell-surface receptors, muscle structure and the immune system []. This entry represents the C2-set type domains found in the T-cell antigen CD80, as well as in related proteins. CD80 (B7-1) is a glycoprotein expressed on antigen-presenting cells []. The shared ligands on CD80 and CD86 (B7-2) deliver the co-stimulatory signal through CD28 and CTLA-4 on T-cells, where CD28 augments the T-cell response and CTLA-4 attenuates it [].; PDB: 3S58_A 3O3U_N 3CJJ_A 3S59_A 2PF6_B 2PET_A 3ALP_A 3SKU_D 3U83_A 3U82_B ....
Probab=97.25 E-value=0.0012 Score=61.21 Aligned_cols=68 Identities=16% Similarity=0.308 Sum_probs=47.1
Q ss_pred CCeEEEEEEEeeCCCCCcEEEEeeCCEEccCCCcE-EEEeeCC----eEEEEEccCCCCCCeEEEEEEEcCCee
Q psy2148 931 STLAHFECRLTPTNDPSMTVEWFHNGKALSAGSRI-KTINDFG----FVILEINDVYLRDSGLYTCKATNKHGE 999 (1884)
Q Consensus 931 G~~v~l~C~v~~~~~P~~~v~W~~~g~~i~~~~~~-~~~~~~~----~~~L~I~~~~~~D~G~Y~C~a~N~~G~ 999 (1884)
|+.+.|+|.+.+ +.|++.|+|+.++..+...... ....+++ .++|.+..-..++...++|.|.|..-.
T Consensus 14 ~~~~~~~C~s~~-~~P~~~i~W~~~~~~~~~~~~~~~~~~~~~~~~~~S~l~~~~~~~~~~~~~~C~~~~~~~~ 86 (89)
T PF08205_consen 14 GEEVTLTCSSSG-GYPPPQITWYLDGGPVVASNTTQSSSPDNGLFTVSSTLTLTPTREDHGKTLTCRASHPALS 86 (89)
T ss_dssp TEEEEEEEEEEE-EBS-EEEEEEETTCEECEEEEEEEEETTTTTEEEEEEEEEETTGGGTTEEEEEEEEETTCC
T ss_pred ceEEEEEEEeCC-eECCeEEEEEECCCceeeeeeeeeeccCCCcceEEEEEEEEcChHHCCeEEEEEEECCccC
Confidence 789999999886 8999999999999888221111 1112222 246777655566788999999997644
No 322
>cd07700 IgV_CD8_beta Immunoglobulin (Ig) like domain of CD8 beta chain. IgV_CD8_beta: immunoglobulin (Ig)-like domain in CD8 beta. The CD8 glycoprotein plays an essential role in the control of T-cell selection, maturation and the T-cell receptor (TCR)-mediated response to peptide antigen. CD8 is comprised of alpha and beta subunits and is expressed as either an alpha/alpha or alpha/beta dimer. Both dimeric isoforms can serve as a coreceptor for T cell activation and differentiation, however they have distinct physiological roles, different cellular distributions, unique binding partners etc. Each CD8 subunit is comprised of an extracellular domain containing a V-type Ig-like domain, a single pass transmembrane portion and a short intracellular domain.
Probab=97.25 E-value=0.00096 Score=64.23 Aligned_cols=68 Identities=19% Similarity=0.340 Sum_probs=47.4
Q ss_pred eecCCCeEEEEEEEeeCCCCCcEEEEeeC--C---EEc------c-----------CCCcEEE--EeeCCeEEEEEccCC
Q psy2148 927 TLAESTLAHFECRLTPTNDPSMTVEWFHN--G---KAL------S-----------AGSRIKT--INDFGFVILEINDVY 982 (1884)
Q Consensus 927 ~v~~G~~v~l~C~v~~~~~P~~~v~W~~~--g---~~i------~-----------~~~~~~~--~~~~~~~~L~I~~~~ 982 (1884)
.+.+|++|+|+|.+... .....+.|||. | +.+ . ...++.+ ......+.|+|.+++
T Consensus 2 ~v~~G~~vtL~C~~~~~-~~~~~~~Wyrq~~g~~~~~~~~l~~~~~~~~~~~~~~~~~~rf~~~~~~~~~~~~L~I~~~~ 80 (107)
T cd07700 2 LVQTNNTVKLSCEAKGI-SENTRIYWLRWRQAPKDSHFEFLALWSPLGGATYGEEVSQEKFSIRVTSDSSRYRLHINRVK 80 (107)
T ss_pred EEcCCCCEEEEEEEecC-CCCCeEEEEEECCCCCCCccEEEEEEcCCCCeEEccccccCcEEEEEECCCCEEEEEECCCC
Confidence 57899999999998631 23347999983 2 110 0 0234543 233456789999999
Q ss_pred CCCCeEEEEEEEc
Q psy2148 983 LRDSGLYTCKATN 995 (1884)
Q Consensus 983 ~~D~G~Y~C~a~N 995 (1884)
.+|+|.|.|...+
T Consensus 81 ~~Dsg~YyCa~~~ 93 (107)
T cd07700 81 PEDSGTYFCMTVG 93 (107)
T ss_pred HHHCEEEEEeEcC
Confidence 9999999999864
No 323
>cd07698 IgC_MHC_I_alpha3 Class I major histocompatibility complex (MHC) alpha chain immunoglobulin domain. IgC_MHC_I_alpha3; Immunoglobulin (Ig) domain of major histocompatibility complex (MHC) class I alpha chain. Class I MHC proteins bind antigenic peptide fragments and present them to CD8+ T lymphocytes. Class I molecules consist of a transmembrane alpha chain and a small chain called the beta2 microglobulin. The alpha chain contains three extracellular domains, two of which fold together to form the peptide-binding cleft (alpha1 and alpha2), and one which has an Ig fold (alpha3). Peptide binding to class I molecules occurs in the endoplasmic reticulum (ER) and involves both chaperones and dedicated factors to assist in peptide loading. Class I MHC molecules are expressed on most nucleated cells.
Probab=97.23 E-value=0.0022 Score=59.81 Aligned_cols=68 Identities=18% Similarity=0.320 Sum_probs=43.4
Q ss_pred CCeEEEEEEEeeCCCCCCeEEEeeCCEEccccC---cEEEEecCCEEEEEEcccCCCCcEEEEEEEEeCce
Q psy2148 424 GDSAHFECTLTPVNDPELKVEWFHNGKPIFHKN---RVKMVSDFGFVVMDIAYVQSHDSGEYVCRAWNNFI 491 (1884)
Q Consensus 424 G~~v~L~C~~~~~~~p~~~i~W~k~g~~l~~~~---~~~~~~~~~~~~L~i~~v~~~d~G~Y~C~a~n~~~ 491 (1884)
|+.++|.|.+.++-.+...++|+++|..+.... ......++.........+...+.+.|+|++.+...
T Consensus 14 ~~~~~L~C~a~gF~P~~i~v~W~~~g~~~~~~~~~~~~~~~~d~ty~~~s~l~v~~~~~~~ytC~V~H~~~ 84 (93)
T cd07698 14 DGSLTLSCHATGFYPRDIEVTWLRDGEDSVDDVESGEILPNGDGTYQLWVTLEVPPEDKARYSCRVEHSGL 84 (93)
T ss_pred CCcEEEEEEEEEEeCCCcEEEEEECCEECcccccccceEECCCCeEEEEEEEEECCCCCCEEEEEEEeCCC
Confidence 678999999997545557999999996443221 22222222222223334555688899999987653
No 324
>cd05766 IgC_MHC_II_beta Class II major histocompatibility complex (MHC) beta chain immunoglobulin domain. IgC_MHC_II_beta: Immunoglobulin (Ig) domain of major histocompatibility complex (MHC) class II beta chain. MHC class II molecules play a key role in the initiation of the antigen-specific immune reponse. In both humans and in mice these molecules have been shown to be expressed constitutively on the cell surface of professional antigen-presenting cells (APCs), for example on B-lymphocytes, monocytes, and macrophages. The expression of these molecules has been shown to be induced in nonprofessional APCs such as keratinocyctes, and they are expressed on the surface of activated human T cells and on T cells from other species. The MHC II molecules present antigenic peptides to CD4(+) T-lymphocytes. These peptides derive mostly from protelytic processing via the endocytic pathway, of antigens internalized by the APC. These peptides bind to the MHC class II molecules in the endosome be
Probab=97.22 E-value=0.0026 Score=58.94 Aligned_cols=71 Identities=15% Similarity=0.302 Sum_probs=46.0
Q ss_pred ccCCCeEEEEEEEeeCCCCCCeEEEeeCCEEccccC---cEEEEecCCEEEEEEcccCCCCcEEEEEEEEeCce
Q psy2148 421 LKDGDSAHFECTLTPVNDPELKVEWFHNGKPIFHKN---RVKMVSDFGFVVMDIAYVQSHDSGEYVCRAWNNFI 491 (1884)
Q Consensus 421 v~~G~~v~L~C~~~~~~~p~~~i~W~k~g~~l~~~~---~~~~~~~~~~~~L~i~~v~~~d~G~Y~C~a~n~~~ 491 (1884)
+..|+.++|.|.+.++-.+..+++|++||+.+.... ......++.........+...+...|+|.+.....
T Consensus 11 ~~~~~~~~L~C~~~gFyP~~i~v~W~~~g~~~~~~~~~~~~~~~~dgTy~~~s~L~~~~~~~~~ysC~V~H~~l 84 (94)
T cd05766 11 GSLSHPHLLVCHVWGFYPPEITVKWFKNGQEETEGVVSTELIPNGDWTYQILVMLETTPSRGDTYTCVVEHSSL 84 (94)
T ss_pred ccCCCCeEEEEEEeeecCCCCEEEEEECCeecCCCceecceEECCCCcEEEEEEEEEcCCCCCEEEEEEEeCCC
Confidence 446889999999998766677999999999876531 11111222222222223444566699999988654
No 325
>KOG1480|consensus
Probab=97.19 E-value=0.00015 Score=87.08 Aligned_cols=174 Identities=20% Similarity=0.259 Sum_probs=113.5
Q ss_pred CCCeeeecCCceeecCCCeEEEEEEEeccCCCeEEEEeCCeecCCCCCeEEEEeCcee-------EEEEcccccCCCe--
Q psy2148 1638 KPPVFTKKIQPCRAFEQDQARFEVEFDGDPLPTIKWFREDFPITSSPDFQIHTFSTKS-------ILIMRQVFMEDSG-- 1708 (1884)
Q Consensus 1638 ~~p~~~~~~~~~~v~~G~~~~l~C~~~g~p~~~i~W~~~~~~~~~~~~~~~~~~~~~~-------~L~i~~v~~~DsG-- 1708 (1884)
.-|.|+..+.+.++..|.++.|.|.+. |.++|...-++.-+.......+...+..+ .+.|.....++.|
T Consensus 23 ~l~~~~~~p~~~yii~~~p~~l~c~a~--~a~~i~~kc~~~wv~~~~~~~~~~~d~tsg~~~~~~si~Isr~~v~~~~~~ 100 (909)
T KOG1480|consen 23 DLPHFTTEPKSAYIIKNKPLRLQCKAN--PATQIRFKCNSEWVHQSRHEKLEGTDETSGLGVREVSIDISRQQVETSGGP 100 (909)
T ss_pred CcceeeecCCccceecCCCccceecCC--cccccccccChhhhcCccceeeeccCcccceeEEeeeeeeehhhhhcccCc
Confidence 457899999999999999999999876 66666655555544443332222222111 2333333333333
Q ss_pred -EEEE--EEEeCCceEEEEEEEEEEecccCCCCCCCCCeEEeccCceEEcCCceEEEEEEE-ecCCCcEEEEEeCCEecC
Q psy2148 1709 -VFAV--IAENRGGKAKCSANLVVEEKRQGGRGGVVPPSFLTTISSAVINVGQLARFDAKI-SATKPLDVYWLKNGKKII 1784 (1884)
Q Consensus 1709 -~Y~C--~a~n~~g~~~~~~~l~V~~~~~~~~~~~~~P~~~~~~~~~~~~~G~~~~l~C~~-~g~p~p~v~W~k~~~~l~ 1784 (1884)
.|.| .|....|...... -.|. ..+..-.|...+.-..|..+..+++.|.. .+.|...+.|+|++..+.
T Consensus 101 ~d~~cQc~a~~~~g~~~s~~-a~vr-------~ay~rk~f~~~p~~q~V~~~s~~~l~cr~pe~~paae~~w~k~e~~~~ 172 (909)
T KOG1480|consen 101 EDYWCQCVAWSDDGTVKSRK-ATVR-------IAYLRKHFEQSPVGQEVQEETTLQLPCRPPEGDPKAEVEWLKNEVVID 172 (909)
T ss_pred cceeeeeeeecCCCcchhhh-HHHH-------HHHHHHhhccChhhheecccccccccccCcccchhhhhhccccCCCCC
Confidence 2555 4655556221111 0000 00112235556667778888889999886 788999999999999998
Q ss_pred CCCCeEEeecCCeEEEEEccCCCCCCEEEEEEEEeCCeeE
Q psy2148 1785 PDIRYKTLEEDNLFTLLIIEAVVEDSGAYECVAMNNAGEA 1824 (1884)
Q Consensus 1785 ~~~~~~~~~~~~~~~L~i~~~~~~d~G~Y~C~a~N~~G~~ 1824 (1884)
+.......... .|.|..+...|.|+|+|.|.|..+..
T Consensus 173 pd~n~~~~~d~---~li~~~arlsd~~nytc~a~ni~~~r 209 (909)
T KOG1480|consen 173 PDANVIRASDH---NLIISQARLSDSGNYTCEATNIVAKR 209 (909)
T ss_pred ccccchhhhcC---Cccccchhhhhcccceeeeehhhccc
Confidence 86555544444 69999999999999999999998853
No 326
>cd05712 Ig_Siglec_N Immunoglobulin (Ig) domain at the N terminus of Siglec (sialic acid-binding Ig-like lectins). Ig_Siglec_N: immunoglobulin (Ig) domain at the N terminus of Siglec (sialic acid-binding Ig-like lectins). Siglec refers to a structurally related protein family that specifically recognizes sialic acid in oligosaccharide chains of glycoproteins and glycolipids. Siglecs are type I transmembrane proteins, organized as an extracellular module composed of Ig-like domains (an N-terminal variable set of Ig-like carbohydrate recognition domains, and 1 to 16 constant Ig-like domains), followed by transmembrane and short cytoplasmic domains. Human siglecs are classified into two subgroups, one subgroup is comprised of sialoadhesin (Siglec-1), CD22 (Siglec-2), and MAG, the other subgroup is comprised of CD33-related Siglecs which include CD33 (Siglec-3) and human Siglecs 5-11.
Probab=97.17 E-value=0.0018 Score=63.72 Aligned_cols=75 Identities=16% Similarity=0.255 Sum_probs=51.6
Q ss_pred cCCceeecCCCeEEEEEEEeeCC---C-CCcEEEEeeCCE-----E-c---c--------CCCcEEEE--eeCCeEEEEE
Q psy2148 922 TPTDLTLAESTLAHFECRLTPTN---D-PSMTVEWFHNGK-----A-L---S--------AGSRIKTI--NDFGFVILEI 978 (1884)
Q Consensus 922 ~~~~~~v~~G~~v~l~C~v~~~~---~-P~~~v~W~~~g~-----~-i---~--------~~~~~~~~--~~~~~~~L~I 978 (1884)
.|+.+.+.+|+.|+|.|...... . ....+.|||... . + . ...|+... ...+.+.|+|
T Consensus 5 ~P~~v~~~~G~~VtL~C~f~~~~~~~~~~~~~~~Wykq~~g~~~~~~~~~~~~~~~~~~~f~gR~~~~~~~~~~~~sL~I 84 (119)
T cd05712 5 MPKSVSVQEGLCVLIPCSFSYPADWPVSNGVHGIWYKGHPYPKNRPPVATNNRSRLVHESTRGRFRLLGDLGKKNCSLLI 84 (119)
T ss_pred CCCEEEEeccccEEEEEEeeCcccccCCCceEEEEEeCCCCCCCCCcEEEcCCCccccccccccEEEecCCCCCEEEEEE
Confidence 45677899999999999875211 0 124689998421 1 1 0 11355543 2345678999
Q ss_pred ccCCCCCCeEEEEEEEcC
Q psy2148 979 NDVYLRDSGLYTCKATNK 996 (1884)
Q Consensus 979 ~~~~~~D~G~Y~C~a~N~ 996 (1884)
.+++.+|+|.|.|.+...
T Consensus 85 ~~l~~~Dsg~Y~C~~~~~ 102 (119)
T cd05712 85 SDAQPEDSGKYFFRVELG 102 (119)
T ss_pred ccCChhhCeEEEEEEEcC
Confidence 999999999999998764
No 327
>cd05712 Ig_Siglec_N Immunoglobulin (Ig) domain at the N terminus of Siglec (sialic acid-binding Ig-like lectins). Ig_Siglec_N: immunoglobulin (Ig) domain at the N terminus of Siglec (sialic acid-binding Ig-like lectins). Siglec refers to a structurally related protein family that specifically recognizes sialic acid in oligosaccharide chains of glycoproteins and glycolipids. Siglecs are type I transmembrane proteins, organized as an extracellular module composed of Ig-like domains (an N-terminal variable set of Ig-like carbohydrate recognition domains, and 1 to 16 constant Ig-like domains), followed by transmembrane and short cytoplasmic domains. Human siglecs are classified into two subgroups, one subgroup is comprised of sialoadhesin (Siglec-1), CD22 (Siglec-2), and MAG, the other subgroup is comprised of CD33-related Siglecs which include CD33 (Siglec-3) and human Siglecs 5-11.
Probab=97.16 E-value=0.0022 Score=63.10 Aligned_cols=73 Identities=14% Similarity=0.094 Sum_probs=50.2
Q ss_pred cCCceeecCCCeEEEEEEEeccC------CCeEEEEeCCee------c--CC---------CCCeEEE--EeCceeEEEE
Q psy2148 1645 KIQPCRAFEQDQARFEVEFDGDP------LPTIKWFREDFP------I--TS---------SPDFQIH--TFSTKSILIM 1699 (1884)
Q Consensus 1645 ~~~~~~v~~G~~~~l~C~~~g~p------~~~i~W~~~~~~------~--~~---------~~~~~~~--~~~~~~~L~i 1699 (1884)
.++.+.+.+|+.|+|.|.....+ ...+.|+|...- + .. ..|+.+. ......+|+|
T Consensus 5 ~P~~v~~~~G~~VtL~C~f~~~~~~~~~~~~~~~Wykq~~g~~~~~~~~~~~~~~~~~~~f~gR~~~~~~~~~~~~sL~I 84 (119)
T cd05712 5 MPKSVSVQEGLCVLIPCSFSYPADWPVSNGVHGIWYKGHPYPKNRPPVATNNRSRLVHESTRGRFRLLGDLGKKNCSLLI 84 (119)
T ss_pred CCCEEEEeccccEEEEEEeeCcccccCCCceEEEEEeCCCCCCCCCcEEEcCCCccccccccccEEEecCCCCCEEEEEE
Confidence 35667889999999999876322 356899986421 0 00 1233332 2344578999
Q ss_pred cccccCCCeEEEEEEEeC
Q psy2148 1700 RQVFMEDSGVFAVIAENR 1717 (1884)
Q Consensus 1700 ~~v~~~DsG~Y~C~a~n~ 1717 (1884)
.+++.+|+|.|.|.+...
T Consensus 85 ~~l~~~Dsg~Y~C~~~~~ 102 (119)
T cd05712 85 SDAQPEDSGKYFFRVELG 102 (119)
T ss_pred ccCChhhCeEEEEEEEcC
Confidence 999999999999988764
No 328
>cd05720 Ig_CD8_alpha Immunoglobulin (Ig) like domain of CD8 alpha chain. Ig_CD8_alpha: immunoglobulin (Ig)-like domain in CD8 alpha. The CD8 glycoprotein plays an essential role in the control of T-cell selection, maturation and the T-cell receptor (TCR)-mediated response to peptide antigen. CD8 is comprised of alpha and beta subunits and is expressed as either an alphaalpha or alphabeta dimer. Both dimeric isoforms can serve as a coreceptor for T cell activation and differentiation, however they have distinct physiological roles, different cellular distributions, unique binding partners etc. Each CD8 subunit is comprised of an extracellular domain containing a v-type Ig-like domain, a single pass transmembrane portion and a short intracellular domain. The Ig domain of CD8 alpha binds to antibodies.
Probab=97.16 E-value=0.0011 Score=63.24 Aligned_cols=67 Identities=13% Similarity=0.169 Sum_probs=48.1
Q ss_pred eecCCCeEEEEEEEeccCCCeEEEEeCCee-------c---CC------------CCCeEEEEeCceeEEEEcccccCCC
Q psy2148 1650 RAFEQDQARFEVEFDGDPLPTIKWFREDFP-------I---TS------------SPDFQIHTFSTKSILIMRQVFMEDS 1707 (1884)
Q Consensus 1650 ~v~~G~~~~l~C~~~g~p~~~i~W~~~~~~-------~---~~------------~~~~~~~~~~~~~~L~i~~v~~~Ds 1707 (1884)
.+.+|++|+|.|.+.+.....+.|+|...- | .. ..++.+........|+|.+++.+|+
T Consensus 2 ~v~~G~~vtL~C~~~~~~~~~v~Wyrq~~g~~~~~~~l~~~~~~~~~~~~~~~~~~~rf~~~~~~~~~~L~I~~~~~sDs 81 (104)
T cd05720 2 DAELGQKVELKCEVLNSSPTGCSWLFQPPGSAPQPTFLVYLSGSSKITWDEEELSSKRFSGSRSSNSFVLTLKNFQKENE 81 (104)
T ss_pred cccCCCeEEEEEEecCCCCCcEEEEEeCCCCCCCCEEEEEEeCCCCeeeccccCCCceEEEEecCCEEEEEECCCCHHHC
Confidence 367899999999987665667999985421 0 00 1234443445567899999999999
Q ss_pred eEEEEEEEe
Q psy2148 1708 GVFAVIAEN 1716 (1884)
Q Consensus 1708 G~Y~C~a~n 1716 (1884)
|.|.|.+.+
T Consensus 82 gtY~Ca~~~ 90 (104)
T cd05720 82 GYYFCSVAS 90 (104)
T ss_pred EEEEEEEcc
Confidence 999998753
No 329
>cd05766 IgC_MHC_II_beta Class II major histocompatibility complex (MHC) beta chain immunoglobulin domain. IgC_MHC_II_beta: Immunoglobulin (Ig) domain of major histocompatibility complex (MHC) class II beta chain. MHC class II molecules play a key role in the initiation of the antigen-specific immune reponse. In both humans and in mice these molecules have been shown to be expressed constitutively on the cell surface of professional antigen-presenting cells (APCs), for example on B-lymphocytes, monocytes, and macrophages. The expression of these molecules has been shown to be induced in nonprofessional APCs such as keratinocyctes, and they are expressed on the surface of activated human T cells and on T cells from other species. The MHC II molecules present antigenic peptides to CD4(+) T-lymphocytes. These peptides derive mostly from protelytic processing via the endocytic pathway, of antigens internalized by the APC. These peptides bind to the MHC class II molecules in the endosome be
Probab=97.13 E-value=0.0041 Score=57.71 Aligned_cols=72 Identities=18% Similarity=0.274 Sum_probs=45.4
Q ss_pred cCCCCcEEEEEEEeecCCCCCeEEEeeCCccCCCCCC-eEEE-e-eCCEEEEEEcccCcCCCeEEEEEEEecCce
Q psy2148 719 LREGENAHFEARLTPTDDPKLKVEWFWNGKPMKTGSR-FRTF-C-DFGFVILEISPVYPEDCGQYSCRAYNDYGE 790 (1884)
Q Consensus 719 v~~G~~~~l~C~~~~~g~p~~~v~W~k~g~~l~~~~~-~~~~-~-~~~~~~L~i~~~~~~d~G~Y~C~a~N~~g~ 790 (1884)
+.+|+.++|.|.+.+.-.+...++|++||+++..+.. .... + ++.......-.+...+...|+|.+.+....
T Consensus 11 ~~~~~~~~L~C~~~gFyP~~i~v~W~~~g~~~~~~~~~~~~~~~~dgTy~~~s~L~~~~~~~~~ysC~V~H~~l~ 85 (94)
T cd05766 11 GSLSHPHLLVCHVWGFYPPEITVKWFKNGQEETEGVVSTELIPNGDWTYQILVMLETTPSRGDTYTCVVEHSSLQ 85 (94)
T ss_pred ccCCCCeEEEEEEeeecCCCCEEEEEECCeecCCCceecceEECCCCcEEEEEEEEEcCCCCCEEEEEEEeCCCC
Confidence 4578999999999975334459999999998765411 1111 1 222222222223345666999999987644
No 330
>PHA03270 envelope glycoprotein C; Provisional
Probab=97.11 E-value=0.07 Score=61.01 Aligned_cols=173 Identities=15% Similarity=0.104 Sum_probs=98.9
Q ss_pred EEEEEEccCCcCCCeEEEEEEEcCCeeEEEEEEEEEEeeeccccCCCceeeccccccccCCCceEEEEEEEEEcCCC--c
Q psy2148 262 YVALDIVGAYAEDSGIYTVKATNSKGSATTSGTLKCLERLFVNHNYPLFSLQFQHLSNLSEGEIAHFEASLIPVGDQ--T 339 (1884)
Q Consensus 262 ~~~L~I~~~~~~d~G~Y~C~a~n~~g~~~~~~~l~V~~~l~v~~~~p~~~~~~~~~~~v~~g~~~~l~c~~~~~g~p--~ 339 (1884)
+..|+|..++...+|.|+-+..+..+.......+.|.. ..+|.+.+.+.+ +.+|+...-.|.+.. .+| .
T Consensus 181 ~~~L~I~slt~aTeGvY~Wr~~~~~~~~~~~~~VtV~~-----yr~Psvsv~~~P---vL~Ge~Y~AtC~va~-YYPp~S 251 (466)
T PHA03270 181 TQRLVIQELTLATQGMYYWARGPADRPHRYGTWTRVRM-----FRRPSLSIRPHA---VLEGEPFGATCVAAN-YYPGDR 251 (466)
T ss_pred cceEEEEEcccccceEEEEEEecCCCceeeeeEEEEEE-----ecCCcccccCCc---cccCCCceEEEEeee-ecCCCc
Confidence 45799999999999999999887766444444444321 244666555443 568999888998643 334 4
Q ss_pred eEEEEeeCCEeeccccceEE---EeeCC---eEEEEEcCCCCCC-CEEEEEEEEcCCeee-EEEEEEEEeecCCCCCCce
Q psy2148 340 MTVEFLYNGKPIEASHRIRT---VHAFG---MVVLEILGTKIED-TGVYTCRATNKWGQA-EISVNLECVDKSKGQPPKF 411 (1884)
Q Consensus 340 ~~i~W~k~g~~i~~~~~~~~---~~~~~---~~~L~I~~~~~~D-~G~Y~C~a~n~~g~~-~~~~~l~V~~~~~~~~p~~ 411 (1884)
..+.||+||.++......+. ...++ .++|++....... -=..+|.+.-..... ...+.-.+. .....+|.+
T Consensus 252 v~lrWf~ng~~V~~~~~i~~~~~~~~dGfs~vStvtsea~~~~~~PPsLrC~v~W~rd~vS~sR~nAa~~-P~VY~~P~I 330 (466)
T PHA03270 252 AAFRWFEGGDEVFAPERVRTRVDAQRDGFSATSTLTSEARAGLAPPRNLTCEFTWHRDSVSFSRRNATGA-PTVLPRPTI 330 (466)
T ss_pred eEEEEEeCCccccCcceeeeeeEecCCCeeEEEEEeccccccCCCCCCceEEEEEccCCccceeeccccc-CccccCCeE
Confidence 78999999998864222211 11222 2334443332211 236899987554332 212211111 112356666
Q ss_pred EeccCCccCccCCCeEEEEEEEeeCCCCCCeEEEeeCCEEccc
Q psy2148 412 TSHIKSLEGLKDGDSAHFECTLTPVNDPELKVEWFHNGKPIFH 454 (1884)
Q Consensus 412 ~~~~~~~~~v~~G~~v~L~C~~~~~~~p~~~i~W~k~g~~l~~ 454 (1884)
... +..|. ..|.+.-.. ....+.|+-++.+...
T Consensus 331 sv~------F~dG~---AVCtA~CVP-egV~l~W~V~D~~~pa 363 (466)
T PHA03270 331 EME------FGGDE---AVCTAACVP-EGVTLAWLLGADPAPA 363 (466)
T ss_pred EEE------EeCCE---EEEeccccC-CCCEEEEEecCCCCCC
Confidence 543 33343 357766322 2578999887765543
No 331
>cd07699 IgC_L Immunoglobulin Constant domain. IgC_L: Immunoglobulin (Ig) light chain constant (C) domain. The basic structure of Ig molecules is a tetramer of two light chains and two heavy chains linked by disulfide bonds. In Ig, each chain is composed of one variable domain (IgV) and one or more constant domains (IgC); these names reflect the fact that the variability in sequences is higher in the variable domain than in the constant domain. There are five types of heavy chains (alpha, gamma, delta, epsilon, and mu), which determine the type of immunoglobulin: IgA, IgG, IgD, IgE, and IgM, respectively. In higher vertebrates, there are two types of light chain, designated kappa and lambda, which seem to be functionally identical, and can associate with any of the heavy chains.
Probab=97.10 E-value=0.0016 Score=61.27 Aligned_cols=82 Identities=15% Similarity=0.176 Sum_probs=50.7
Q ss_pred CceEeccCCccCccCCCeEEEEEEEeeCCCCCCeEEEeeCCEEccccCc--EEEEecCCE----EEEEEcccCCCCcEEE
Q psy2148 409 PKFTSHIKSLEGLKDGDSAHFECTLTPVNDPELKVEWFHNGKPIFHKNR--VKMVSDFGF----VVMDIAYVQSHDSGEY 482 (1884)
Q Consensus 409 p~~~~~~~~~~~v~~G~~v~L~C~~~~~~~p~~~i~W~k~g~~l~~~~~--~~~~~~~~~----~~L~i~~v~~~d~G~Y 482 (1884)
|.+...+.+...+..++.++|.|.+.++-.+...++|++||..+..+.. ......+++ ..|.+..-..++...|
T Consensus 2 P~V~v~~p~~~~~~~~~~~~L~C~~~gfyP~~i~v~W~~~g~~~~~~~~~~~~~~~~dgty~~~s~L~v~~~~w~~~~~~ 81 (100)
T cd07699 2 PSVTIFPPSSEELEKSGKATLVCLINDFYPGFATVQWKVDGATVSSGVQTSTTEQQSDNTYSLSSYLTLTKSDWNKHKVY 81 (100)
T ss_pred CeEEEECCCHHHHccCCCcEEEEEEEeEECCCCEEEEEECCEECcccEeccccEECCCCCEEEEEEEEEcHHHhCCCCeE
Confidence 3443333333335567889999999986555899999999999853211 011121232 2344544333446699
Q ss_pred EEEEEeCc
Q psy2148 483 VCRAWNNF 490 (1884)
Q Consensus 483 ~C~a~n~~ 490 (1884)
+|.+.+..
T Consensus 82 sC~V~H~~ 89 (100)
T cd07699 82 TCEVTHEG 89 (100)
T ss_pred EEEEEecC
Confidence 99998865
No 332
>smart00407 IGc1 Immunoglobulin C-Type.
Probab=97.08 E-value=0.0028 Score=56.16 Aligned_cols=65 Identities=25% Similarity=0.466 Sum_probs=43.4
Q ss_pred eEEEEEEEeeCCCCCcEEEEeeCCEEccCCCcEE--EEeeCC----eEEEEEccCCCCCCeEEEEEEEcCC
Q psy2148 933 LAHFECRLTPTNDPSMTVEWFHNGKALSAGSRIK--TINDFG----FVILEINDVYLRDSGLYTCKATNKH 997 (1884)
Q Consensus 933 ~v~l~C~v~~~~~P~~~v~W~~~g~~i~~~~~~~--~~~~~~----~~~L~I~~~~~~D~G~Y~C~a~N~~ 997 (1884)
.++|.|.+.+.-.+.+.|+|+|||+++..+.... ..+.++ .+.|.|.....++...|+|++....
T Consensus 1 ~~~L~C~a~gf~P~~i~v~W~k~g~~~~~~~~~~~~~~~~~gt~~~~s~L~v~~~~~~~~~~~tC~V~H~~ 71 (75)
T smart00407 1 KATLVCLVSGFYPPDITVTWLRNGQEVTSGVSTTDPLKNSDGTYFLSSYLTVSASTWESGDTYTCQVTHEG 71 (75)
T ss_pred CeEEEEEEEeEeCCCCEEEEEECCEECCCCEEECceEECCCCCEEEEEEEEEccccCCCCCEEEEEEEEcC
Confidence 3689999997433447999999999864432211 111222 3357776666778899999997653
No 333
>cd05770 IgC_beta2m Class I major histocompatibility complex (MHC) beta2-microglobulin. IgC_beta2m: Immunoglobulin-like domain in beta2-Microglobulin (beta2m). Beta2m is the non-covalently bound light chain of the human class I major histocompatibility complex (MHC-I). Beta2m is structured as a beta-sandwich domain composed of two facing beta-sheets (four stranded and three stranded), that is typical of the C-type immunoglobulin superfamily. This structure is stabilized by an intramolecular disulfide bridge connecting two Cys residues in the facing beta -sheets. In vivo, MHC-I continuously exposes beta2m on the cell surface, where it may be released to plasmatic fluids, transported to the kidneys, degraded and then excreted.
Probab=97.07 E-value=0.0048 Score=56.66 Aligned_cols=69 Identities=22% Similarity=0.480 Sum_probs=46.5
Q ss_pred ccCCCeEEEEEEEeeCCCCCCeEEEeeCCEEccccCc---EEEEecCCEEEEEEcccCCCCcEEEEEEEEeCc
Q psy2148 421 LKDGDSAHFECTLTPVNDPELKVEWFHNGKPIFHKNR---VKMVSDFGFVVMDIAYVQSHDSGEYVCRAWNNF 490 (1884)
Q Consensus 421 v~~G~~v~L~C~~~~~~~p~~~i~W~k~g~~l~~~~~---~~~~~~~~~~~L~i~~v~~~d~G~Y~C~a~n~~ 490 (1884)
+..|+..+|.|.+.++-.+...++|+|||+.+. +.. .....|+.........+...+...|+|.+....
T Consensus 12 ~~~g~~~~L~C~a~gFyP~~i~v~W~~dg~~~~-~~~~~~~~p~~d~tyq~~s~l~~~~~~~~~ysC~V~H~~ 83 (93)
T cd05770 12 AENGKPNVLNCYVTGFHPPDIEIRLLKNGVKIP-KVEQSDLSFSKDWTFYLLKSTEFTPTKGDEYACRVRHNS 83 (93)
T ss_pred CcCCCceEEEEEEEEEeCCCCEEEEEECCEECC-CcEECcEEECCCCCEEEEEEEEECCCCCCeEEEEEEECC
Confidence 446777899999998777789999999999886 322 111222222222223445667779999998753
No 334
>cd05767 IgC_MHC_II_alpha Class II major histocompatibility complex (MHC) alpha chain immunoglobulin domain. IgC_MHC_II_alpha: Immunoglobulin (Ig) domain of major histocompatibility complex (MHC) class II alpha chain. MHC class II molecules play a key role in the initiation of the antigen-specific immune reponse. In both humans and in mice these molecules have been shown to be expressed constitutively on the cell surface of professional antigen-presenting cells (APCs), for example on B-lymphocytes, monocytes, and macrophages. The expression of these molecules has been shown to be induced in nonprofessional APCs such as keratinocyctes, and they are expressed on the surface of activated human T cells and on T cells from other species. The MHC II molecules present antigenic peptides to CD4(+) T-lymphocytes. These peptides derive mostly from protelytic processing via the endocytic pathway, of antigens internalized by the APC. These peptides bind to the MHC class II molecules in the endosom
Probab=97.04 E-value=0.004 Score=57.44 Aligned_cols=66 Identities=20% Similarity=0.369 Sum_probs=43.6
Q ss_pred cCCCeEEEEEEEeeCCCCCCeEEEeeCCEEccccCc---EEEEecCCE---EEEEEcccCCCCcEEEEEEEEeCc
Q psy2148 422 KDGDSAHFECTLTPVNDPELKVEWFHNGKPIFHKNR---VKMVSDFGF---VVMDIAYVQSHDSGEYVCRAWNNF 490 (1884)
Q Consensus 422 ~~G~~v~L~C~~~~~~~p~~~i~W~k~g~~l~~~~~---~~~~~~~~~---~~L~i~~v~~~d~G~Y~C~a~n~~ 490 (1884)
..|+.++|.|.+.++-.+...++|+|||..+..+.. .....|+.. ..|.+ ...+...|+|.+....
T Consensus 13 ~~~~~~tL~C~a~gFyP~~I~v~W~~~g~~~~~~~~~~~~~~~~Dgty~~~s~L~v---~~~~~~~ytC~V~H~~ 84 (94)
T cd05767 13 ELGEPNTLICFVDNFFPPVLNVTWLKNGVPVTDGVSETRYYPRQDLSFQKFSYLNF---TPEEGDIYSCIVEHWG 84 (94)
T ss_pred cCCCCeEEEEEEEEEECCcCEEEEEECCeEccCceEEeeeEeCCCCcEEEEEEEEE---ECCCCCeEEEEEEeCC
Confidence 346778999999987666799999999998764321 111222222 23444 3455669999998754
No 335
>PF08205 C2-set_2: CD80-like C2-set immunoglobulin domain ; InterPro: IPR013162 The basic structure of immunoglobulin (Ig) molecules is a tetramer of two light chains and two heavy chains linked by disulphide bonds. There are two types of light chains: kappa and lambda, each composed of a constant domain (CL) and a variable domain (VL). There are five types of heavy chains: alpha, delta, epsilon, gamma and mu, all consisting of a variable domain (VH) and three (in alpha, delta and gamma) or four (in epsilon and mu) constant domains (CH1 to CH4). Ig molecules are highly modular proteins, in which the variable and constant domains have clear, conserved sequence patterns. The domains in Ig and Ig-like molecules are grouped into four types: V-set (variable; IPR013106 from INTERPRO), C1-set (constant-1; IPR003597 from INTERPRO), C2-set (constant-2; IPR008424 from INTERPRO) and I-set (intermediate; IPR013098 from INTERPRO) []. Structural studies have shown that these domains share a common core Greek-key beta-sandwich structure, with the types differing in the number of strands in the beta-sheets as well as in their sequence patterns [, ]. Immunoglobulin-like domains that are related in both sequence and structure can be found in several diverse protein families. Ig-like domains are involved in a variety of functions, including cell-cell recognition, cell-surface receptors, muscle structure and the immune system []. This entry represents the C2-set type domains found in the T-cell antigen CD80, as well as in related proteins. CD80 (B7-1) is a glycoprotein expressed on antigen-presenting cells []. The shared ligands on CD80 and CD86 (B7-2) deliver the co-stimulatory signal through CD28 and CTLA-4 on T-cells, where CD28 augments the T-cell response and CTLA-4 attenuates it [].; PDB: 3S58_A 3O3U_N 3CJJ_A 3S59_A 2PF6_B 2PET_A 3ALP_A 3SKU_D 3U83_A 3U82_B ....
Probab=97.04 E-value=0.0047 Score=57.26 Aligned_cols=68 Identities=15% Similarity=0.253 Sum_probs=45.1
Q ss_pred CceEEEEEEEe-cCCCcEEEEEeCCEecCCCCCeE-EeecCC----eEEEEEccCCCCCCEEEEEEEEeCCeeE
Q psy2148 1757 GQLARFDAKIS-ATKPLDVYWLKNGKKIIPDIRYK-TLEEDN----LFTLLIIEAVVEDSGAYECVAMNNAGEA 1824 (1884)
Q Consensus 1757 G~~~~l~C~~~-g~p~p~v~W~k~~~~l~~~~~~~-~~~~~~----~~~L~i~~~~~~d~G~Y~C~a~N~~G~~ 1824 (1884)
|+.+.|+|.+. |+|.|.|+|+.++..+....... ....++ .+.|.+.....++...++|.|.|..-..
T Consensus 14 ~~~~~~~C~s~~~~P~~~i~W~~~~~~~~~~~~~~~~~~~~~~~~~~S~l~~~~~~~~~~~~~~C~~~~~~~~~ 87 (89)
T PF08205_consen 14 GEEVTLTCSSSGGYPPPQITWYLDGGPVVASNTTQSSSPDNGLFTVSSTLTLTPTREDHGKTLTCRASHPALSQ 87 (89)
T ss_dssp TEEEEEEEEEEEEBS-EEEEEEETTCEECEEEEEEEEETTTTTEEEEEEEEEETTGGGTTEEEEEEEEETTCCE
T ss_pred ceEEEEEEEeCCeECCeEEEEEECCCceeeeeeeeeeccCCCcceEEEEEEEEcChHHCCeEEEEEEECCccCC
Confidence 78999999774 58999999999998872111111 111111 2367776555566779999999987543
No 336
>PHA03269 envelope glycoprotein C; Provisional
Probab=97.04 E-value=0.057 Score=62.35 Aligned_cols=201 Identities=16% Similarity=0.204 Sum_probs=108.3
Q ss_pred EEEEEEccCCcCCCeEEEEEEEcCC-eeEEEEEEEEEEeeeccccCCCceeeccccccccCCCceEEEEEEEEEcCCC--
Q psy2148 262 YVALDIVGAYAEDSGIYTVKATNSK-GSATTSGTLKCLERLFVNHNYPLFSLQFQHLSNLSEGEIAHFEASLIPVGDQ-- 338 (1884)
Q Consensus 262 ~~~L~I~~~~~~d~G~Y~C~a~n~~-g~~~~~~~l~V~~~l~v~~~~p~~~~~~~~~~~v~~g~~~~l~c~~~~~g~p-- 338 (1884)
...|+|.+++..++|.|.-+..+.. +.......+.|.. ..+|.+.+.+.+ +.+|+...-.|.+.. .+|
T Consensus 288 ~~pL~I~sltaATeGvY~Wrv~~~~n~t~~~~~~VtV~~-----yr~PsVsV~p~P---VL~Ge~YkAtC~vA~-YYPp~ 358 (566)
T PHA03269 288 DFSLHILSLDASTEGTYIWRVIHTANKNVINEHHITVMS-----YKRPNITVIGDP---VLLGNPYAAYCKVNK-YYPPH 358 (566)
T ss_pred ccceEEeecccccCceEEEEEecCCCCceeeeeEEEEEE-----ecCCCccccCCc---cccCCCceEEEEeee-ecCCC
Confidence 3579999999999999998876433 2223333333321 134555554443 668999888998643 333
Q ss_pred ceEEEEeeCCEeeccccceE--EEeeCCe----EEEEEcCCCCCC--CEEEEEEEEcCCeee-E----EEEEEEEeecCC
Q psy2148 339 TMTVEFLYNGKPIEASHRIR--TVHAFGM----VVLEILGTKIED--TGVYTCRATNKWGQA-E----ISVNLECVDKSK 405 (1884)
Q Consensus 339 ~~~i~W~k~g~~i~~~~~~~--~~~~~~~----~~L~I~~~~~~D--~G~Y~C~a~n~~g~~-~----~~~~l~V~~~~~ 405 (1884)
...+.||+||.++....... ....++. ++|++......| -=..+|.+.-..+.. . .++.-.|
T Consensus 359 SvrlrWf~ng~~V~~~~it~t~~~~~dGlFSrVSTLtlp~~~~~d~~PPsLrCeV~W~RDsVS~tRfnAaatP~V----- 433 (566)
T PHA03269 359 SVIVKWTSNFGNIGKNFITDAIKENADGLFSSVSALHIPAQKNADYPPPAIQCNVLWIRDGVSHMKYSAAVTPDV----- 433 (566)
T ss_pred ceEEEEEeCCcccCccccccceeecCCCceEEEEEEeccCccccCCCCCCceEEEEEccCCchheecccccCCcc-----
Confidence 47899999999887522111 1122332 234442222222 235699988554332 1 1222222
Q ss_pred CCCCceEeccCCccCccCCCeEEEEEEEeeCCCCCCeEEEeeCCEEccccCcEEEEe----cCCEEEEEEcc---cCCCC
Q psy2148 406 GQPPKFTSHIKSLEGLKDGDSAHFECTLTPVNDPELKVEWFHNGKPIFHKNRVKMVS----DFGFVVMDIAY---VQSHD 478 (1884)
Q Consensus 406 ~~~p~~~~~~~~~~~v~~G~~v~L~C~~~~~~~p~~~i~W~k~g~~l~~~~~~~~~~----~~~~~~L~i~~---v~~~d 478 (1884)
..+|.+... +..|. ..|.+.-.......+.|+-++.+...... .+.. ..|. ..|.+ +..+|
T Consensus 434 Y~~PtISm~------FedG~---AVCtA~CVP~~~V~l~WlVgD~p~~~~~t-~itG~C~ehPGL--VNLRS~~pLS~~d 501 (566)
T PHA03269 434 YPFPNVSIE------IIDGH---IVCLAKCVPRGVVHFNWWINDIPIEHENS-EILGVCDNNKRF--VNLQSSCDTSELD 501 (566)
T ss_pred ccCCeEEEE------EeCCE---EEEecccccCCCceEEEEecCCCCCCccc-eeeccCCCCCCc--eeecccccccccC
Confidence 256666543 33443 35877622223368999988766433222 1111 1232 22333 44444
Q ss_pred c-EEEEEEEEe
Q psy2148 479 S-GEYVCRAWN 488 (1884)
Q Consensus 479 ~-G~Y~C~a~n 488 (1884)
. -+|+|+...
T Consensus 502 gpveYTCrL~G 512 (566)
T PHA03269 502 GPITYSCHLDG 512 (566)
T ss_pred CceeEEEEEee
Confidence 2 399998764
No 337
>cd05767 IgC_MHC_II_alpha Class II major histocompatibility complex (MHC) alpha chain immunoglobulin domain. IgC_MHC_II_alpha: Immunoglobulin (Ig) domain of major histocompatibility complex (MHC) class II alpha chain. MHC class II molecules play a key role in the initiation of the antigen-specific immune reponse. In both humans and in mice these molecules have been shown to be expressed constitutively on the cell surface of professional antigen-presenting cells (APCs), for example on B-lymphocytes, monocytes, and macrophages. The expression of these molecules has been shown to be induced in nonprofessional APCs such as keratinocyctes, and they are expressed on the surface of activated human T cells and on T cells from other species. The MHC II molecules present antigenic peptides to CD4(+) T-lymphocytes. These peptides derive mostly from protelytic processing via the endocytic pathway, of antigens internalized by the APC. These peptides bind to the MHC class II molecules in the endosom
Probab=97.03 E-value=0.0036 Score=57.73 Aligned_cols=65 Identities=15% Similarity=0.269 Sum_probs=43.6
Q ss_pred cCCCeEEEEEEEeeCCCCCcEEEEeeCCEEccCCCcEE--EEeeCCe----EEEEEccCCCCCCeEEEEEEEcC
Q psy2148 929 AESTLAHFECRLTPTNDPSMTVEWFHNGKALSAGSRIK--TINDFGF----VILEINDVYLRDSGLYTCKATNK 996 (1884)
Q Consensus 929 ~~G~~v~l~C~v~~~~~P~~~v~W~~~g~~i~~~~~~~--~~~~~~~----~~L~I~~~~~~D~G~Y~C~a~N~ 996 (1884)
..|+.++|.|.+.|.-.+...|+|.+||..+..+.... ..+.++. +.|.+. .++...|+|.+...
T Consensus 13 ~~~~~~tL~C~a~gFyP~~I~v~W~~~g~~~~~~~~~~~~~~~~Dgty~~~s~L~v~---~~~~~~ytC~V~H~ 83 (94)
T cd05767 13 ELGEPNTLICFVDNFFPPVLNVTWLKNGVPVTDGVSETRYYPRQDLSFQKFSYLNFT---PEEGDIYSCIVEHW 83 (94)
T ss_pred cCCCCeEEEEEEEEEECCcCEEEEEECCeEccCceEEeeeEeCCCCcEEEEEEEEEE---CCCCCeEEEEEEeC
Confidence 34667899999997655678999999999986542211 1222232 245554 34667999999765
No 338
>cd05770 IgC_beta2m Class I major histocompatibility complex (MHC) beta2-microglobulin. IgC_beta2m: Immunoglobulin-like domain in beta2-Microglobulin (beta2m). Beta2m is the non-covalently bound light chain of the human class I major histocompatibility complex (MHC-I). Beta2m is structured as a beta-sandwich domain composed of two facing beta-sheets (four stranded and three stranded), that is typical of the C-type immunoglobulin superfamily. This structure is stabilized by an intramolecular disulfide bridge connecting two Cys residues in the facing beta -sheets. In vivo, MHC-I continuously exposes beta2m on the cell surface, where it may be released to plasmatic fluids, transported to the kidneys, degraded and then excreted.
Probab=97.02 E-value=0.0046 Score=56.80 Aligned_cols=67 Identities=12% Similarity=0.277 Sum_probs=44.9
Q ss_pred cCCCeEEEEEEEeeCCCCCcEEEEeeCCEEccCCCcEE--EEeeCCeE-EEEEccCCCCCCeEEEEEEEcC
Q psy2148 929 AESTLAHFECRLTPTNDPSMTVEWFHNGKALSAGSRIK--TINDFGFV-ILEINDVYLRDSGLYTCKATNK 996 (1884)
Q Consensus 929 ~~G~~v~l~C~v~~~~~P~~~v~W~~~g~~i~~~~~~~--~~~~~~~~-~L~I~~~~~~D~G~Y~C~a~N~ 996 (1884)
..|...+|.|.+.+.-.+...|+|+|||..+. +.... ..+.++.+ ...-..+...+...|+|.+...
T Consensus 13 ~~g~~~~L~C~a~gFyP~~i~v~W~~dg~~~~-~~~~~~~~p~~d~tyq~~s~l~~~~~~~~~ysC~V~H~ 82 (93)
T cd05770 13 ENGKPNVLNCYVTGFHPPDIEIRLLKNGVKIP-KVEQSDLSFSKDWTFYLLKSTEFTPTKGDEYACRVRHN 82 (93)
T ss_pred cCCCceEEEEEEEEEeCCCCEEEEEECCEECC-CcEECcEEECCCCCEEEEEEEEECCCCCCeEEEEEEEC
Confidence 45777899999998767788999999999987 43211 11223322 2222234466788899999764
No 339
>cd00096 Ig Immunoglobulin domain. Ig: immunoglobulin (Ig) domain found in the Ig superfamily. The Ig superfamily is a heterogenous group of proteins, built on a common fold comprised of a sandwich of two beta sheets. Members of this group are components of immunoglobulin, neuroglia, cell surface glycoproteins, such as, T-cell receptors, CD2, CD4, CD8, and membrane glycoproteins, such as, butyrophilin and chondroitin sulfate proteoglycan core protein. A predominant feature of most Ig domains is a disulfide bridge connecting the two beta-sheets with a tryptophan residue packed against the disulfide bond.
Probab=97.01 E-value=0.0024 Score=56.19 Aligned_cols=63 Identities=35% Similarity=0.527 Sum_probs=48.0
Q ss_pred EEEEEEEecCCCcEEEEEeCCEecCCCCCe----EEeecCCeEEEEEccCCCCCCEEEEEEEEeCCe
Q psy2148 1760 ARFDAKISATKPLDVYWLKNGKKIIPDIRY----KTLEEDNLFTLLIIEAVVEDSGAYECVAMNNAG 1822 (1884)
Q Consensus 1760 ~~l~C~~~g~p~p~v~W~k~~~~l~~~~~~----~~~~~~~~~~L~i~~~~~~d~G~Y~C~a~N~~G 1822 (1884)
+.|.|.+.+.+.+.+.|++++......... ..........|.|.++...|.|.|.|.+.+..+
T Consensus 1 ~~l~C~~~~~~~~~~~W~~~~~~~~~~~~~~~~~~~~~~~~~~~l~i~~~~~~d~g~y~C~~~~~~~ 67 (74)
T cd00096 1 VTLTCLASGPPPPTITWLKNGKPLPSSVLTRVRSSRGTSSGSSTLTISNVTLEDSGTYTCVASNSAG 67 (74)
T ss_pred CEEEEEecCCCCCcEEEEECCEECCCcccEEeccccCcceeEEEEEECccCcccCcEEEEEEecCcC
Confidence 468999999888899999999876544321 111223456899999999999999999988763
No 340
>PHA03273 envelope glycoprotein C; Provisional
Probab=97.00 E-value=0.059 Score=62.30 Aligned_cols=162 Identities=18% Similarity=0.158 Sum_probs=97.4
Q ss_pred EEEEEccCCcCCCeEEEEEEEcCCeeEEEEEEEEEEeeeccccCCCceeeccccccccCCCceEEEEEEEEEcCCC--ce
Q psy2148 263 VALDIVGAYAEDSGIYTVKATNSKGSATTSGTLKCLERLFVNHNYPLFSLQFQHLSNLSEGEIAHFEASLIPVGDQ--TM 340 (1884)
Q Consensus 263 ~~L~I~~~~~~d~G~Y~C~a~n~~g~~~~~~~l~V~~~l~v~~~~p~~~~~~~~~~~v~~g~~~~l~c~~~~~g~p--~~ 340 (1884)
..|+|..++..++|.|+-+..+..+.......+.|.. ..+|.+.+.+.+ +.+|+...-.|.+.. .+| ..
T Consensus 198 ~~LtI~sltaaTeGvYtWr~~~~n~t~~~~~~VtV~~-----yr~Psvsv~~~P---vL~Ge~y~A~C~aa~-YYPp~Sv 268 (486)
T PHA03273 198 FPLTIKSVDWRTAGVYVWSLYAKNGTLVNSTSVTVST-----YNAPLVDLSVHP---SLKGENYRAVCVVAS-YFPHSSV 268 (486)
T ss_pred cceEEEecchhhceEEEEEEecCCCceeeeeEEEEEE-----ecCCcccccCCc---cccCCCceEEEEeee-ecCCCce
Confidence 5699999999999999988766655444445554421 244666555443 668999888998643 334 47
Q ss_pred EEEEeeCCEeeccccc----eEEEeeCC---eEEEEEcCCCCC-CCEEEEEEEEcCCee-eEEE----EEEEEeecCCCC
Q psy2148 341 TVEFLYNGKPIEASHR----IRTVHAFG---MVVLEILGTKIE-DTGVYTCRATNKWGQ-AEIS----VNLECVDKSKGQ 407 (1884)
Q Consensus 341 ~i~W~k~g~~i~~~~~----~~~~~~~~---~~~L~I~~~~~~-D~G~Y~C~a~n~~g~-~~~~----~~l~V~~~~~~~ 407 (1884)
.+.||+||.++..... .....++. .++|++...... .-=..+|.+.-..+. +... +.-.| ..
T Consensus 269 ~~rWf~dg~~V~~~~~~~~~~~~~~~gl~T~vStlt~~~~~~~~~PP~lrC~v~W~rd~vS~~RfsAt~~P~V-----y~ 343 (486)
T PHA03273 269 KLRWYKNAKEVDFTKYVTNASSVWVDGLITRISTLSIPVDPDEEYTPSLRCSIEWYRDEVSFARIAKAGTPSV-----FV 343 (486)
T ss_pred EEEEEeCCeeccccccceeeEEEecCCceEEEEEEeccCcccCCCCCCceEEEEEccCCcceeeccccccCcc-----cc
Confidence 8999999999873221 11111222 234555544332 234789998855433 2211 22222 25
Q ss_pred CCceEeccCCccCccCCCeEEEEEEEeeCCCC--CCeEEEeeCC
Q psy2148 408 PPKFTSHIKSLEGLKDGDSAHFECTLTPVNDP--ELKVEWFHNG 449 (1884)
Q Consensus 408 ~p~~~~~~~~~~~v~~G~~v~L~C~~~~~~~p--~~~i~W~k~g 449 (1884)
+|.+... +..|. ..|.+. .-| ...+.|+-++
T Consensus 344 ~P~Is~~------F~~G~---AVCtA~--CVP~egV~l~W~v~D 376 (486)
T PHA03273 344 APTVSVT------VEDGD---AVCTAK--CVPSTGVFVSWSVND 376 (486)
T ss_pred CCeEEEE------EeCCE---EEEecc--cccCCCeeEEEEccC
Confidence 6666543 33343 358876 444 4889998876
No 341
>cd00096 Ig Immunoglobulin domain. Ig: immunoglobulin (Ig) domain found in the Ig superfamily. The Ig superfamily is a heterogenous group of proteins, built on a common fold comprised of a sandwich of two beta sheets. Members of this group are components of immunoglobulin, neuroglia, cell surface glycoproteins, such as, T-cell receptors, CD2, CD4, CD8, and membrane glycoproteins, such as, butyrophilin and chondroitin sulfate proteoglycan core protein. A predominant feature of most Ig domains is a disulfide bridge connecting the two beta-sheets with a tryptophan residue packed against the disulfide bond.
Probab=96.99 E-value=0.0027 Score=55.90 Aligned_cols=63 Identities=35% Similarity=0.601 Sum_probs=47.1
Q ss_pred EEEEEEEeeCCCCCcEEEEeeCCEEccCCCcE----EEEeeCCeEEEEEccCCCCCCeEEEEEEEcCCe
Q psy2148 934 AHFECRLTPTNDPSMTVEWFHNGKALSAGSRI----KTINDFGFVILEINDVYLRDSGLYTCKATNKHG 998 (1884)
Q Consensus 934 v~l~C~v~~~~~P~~~v~W~~~g~~i~~~~~~----~~~~~~~~~~L~I~~~~~~D~G~Y~C~a~N~~G 998 (1884)
+.|.|.+. +.+...+.|++++......... ..........|.|.++..+|.|.|.|.+.+..+
T Consensus 1 ~~l~C~~~--~~~~~~~~W~~~~~~~~~~~~~~~~~~~~~~~~~~~l~i~~~~~~d~g~y~C~~~~~~~ 67 (74)
T cd00096 1 VTLTCLAS--GPPPPTITWLKNGKPLPSSVLTRVRSSRGTSSGSSTLTISNVTLEDSGTYTCVASNSAG 67 (74)
T ss_pred CEEEEEec--CCCCCcEEEEECCEECCCcccEEeccccCcceeEEEEEECccCcccCcEEEEEEecCcC
Confidence 46899998 4778899999998877554321 111223455799999999999999999988763
No 342
>cd05769 IgC_TCR_beta T cell receptor (TCR) beta chain constant immunoglobulin domain. IgC_TCR_beta: Constant domain of the beta chain of alpha/beta T-cell antigen receptors (TCRs). TCRs mediate antigen recognition by T lymphocytes, and are composed of alpha and beta, or gamma and delta, polypeptide chains with variable (V) and constant (C) regions. This group includes the variable domain of the beta chain. Alpha/beta TCRs recognize antigen as peptide fragments presented by major histocompatibility complex (MHC) molecules. The antigen binding site is formed by the variable domains of the alpha and beta chains, located at the N-terminus of each chain. Alpha/beta TCRs recognize antigens differently from gamma/delta TCRs.
Probab=96.97 E-value=0.0041 Score=59.63 Aligned_cols=85 Identities=16% Similarity=0.172 Sum_probs=53.5
Q ss_pred CeeeecCCCccccCCCCcEEEEEEEeecCCCC-CeEEEeeCCccCCCCCC---eEEEeeCCE----EEEEEcccCcCC-C
Q psy2148 707 PVFTVPLSNIDDLREGENAHFEARLTPTDDPK-LKVEWFWNGKPMKTGSR---FRTFCDFGF----VILEISPVYPED-C 777 (1884)
Q Consensus 707 p~~~~~~~~~~~v~~G~~~~l~C~~~~~g~p~-~~v~W~k~g~~l~~~~~---~~~~~~~~~----~~L~i~~~~~~d-~ 777 (1884)
|.+.+-+++...+.+++.++|.|.+.+. .|. .+|+|+|||+++..+.. .....+++. +.|.|......+ .
T Consensus 3 P~V~v~~ps~~e~~~~~~~tL~Cla~gF-yP~~I~V~W~kng~~l~~g~~~~~~~~~~~~gTYs~~S~L~v~~~~w~~~~ 81 (115)
T cd05769 3 PTVAIFPPSEAEIRNKRKATLVCLATGF-YPDHVSLSWKVNGKEVTDGVATDPQALRENTSTYSISSRLRVSATEWFNPR 81 (115)
T ss_pred CEEEEECcChHHhccCCCcEEEEEEEeE-eCCCcEEEEEECCEECCCCcccccceecCCCCeEEEEEEEEEChHHhccCC
Confidence 4444333443355677889999999975 455 69999999998865432 111111122 246666555444 4
Q ss_pred eEEEEEEEecCceEE
Q psy2148 778 GQYSCRAYNDYGEAV 792 (1884)
Q Consensus 778 G~Y~C~a~N~~g~~~ 792 (1884)
-.|+|.+.+......
T Consensus 82 ~~ytC~V~H~g~~~~ 96 (115)
T cd05769 82 NTFTCIVQFYGGTDT 96 (115)
T ss_pred CeEEEEEEEeCCccc
Confidence 589999998755544
No 343
>cd05847 IgC_CH2_IgE CH2 domain (second constant Ig domain of the heavy chain) in immunoglobulin E (IgE). IgC_CH2_IgE: The second constant domain of the heavy chain of immunoglobulin E (IgE). The basic structure of immunoglobulin (Ig) molecules is a tetramer of two light chains and two heavy chains linked by disulfide bonds. There are two types of light chains: kappa and lambda; each composed of a constant domain and a variable domain. There are five types of heavy chains: alpha, delta, epsilon, gamma, and mu, all consisting of a variable domain (VH) and three (in alpha, delta, and gamma) or four (in epsilon and mu) constant domains (CH1 to CH4). The different classes of antibodies vary in their heavy chains; the IgE class has the epsilon type. This domain (Cepsilon2) of IgE is in place of the flexible hinge region found in IgG.
Probab=96.91 E-value=0.005 Score=56.92 Aligned_cols=70 Identities=17% Similarity=0.291 Sum_probs=45.6
Q ss_pred CCCeEEEEEEEeeCCCCCcEEEEeeCCEEccCCCc---EEEEeeCC---eEEEEEccCCCCCCeEEEEEEEcCCee
Q psy2148 930 ESTLAHFECRLTPTNDPSMTVEWFHNGKALSAGSR---IKTINDFG---FVILEINDVYLRDSGLYTCKATNKHGE 999 (1884)
Q Consensus 930 ~G~~v~l~C~v~~~~~P~~~v~W~~~g~~i~~~~~---~~~~~~~~---~~~L~I~~~~~~D~G~Y~C~a~N~~G~ 999 (1884)
.+..++|.|.+.+.-.+...|+|++||..+..+.. ....+++. .+.|.|......+...|+|++......
T Consensus 13 ~~~~~~L~C~a~gFyP~~I~vtW~~dg~~~~~~~~~s~~~~~~~~Ty~~~S~L~v~~~~w~~~~~ytC~V~H~~~~ 88 (94)
T cd05847 13 TSETIQLLCLISGYTPGTIEVEWLVDGQVATLVAASTAPQKEEGSTFSTTSELNVTQEDWKSGKTYTCKVTHQGTT 88 (94)
T ss_pred CCCCEEEEEEEEeEECCCCEEEEEECCEECcCceeecccEECCCCcEEEEEEEEEchHHhcCCCeEEEEEEECCee
Confidence 45679999999975555689999999998743321 11112221 234666644445678999999886544
No 344
>cd05889 Ig1_DNAM-1_like First immunoglobulin (Ig) domain of DNAX accessory molecule 1 (DNAM-1, also known as CD226) and similar proteins. Ig1_DNAM-1_like: domain similar to the first immunoglobulin (Ig) domain of DNAX accessory molecule 1 (DNAM-1, also known as CD226). DNAM-1 is a transmembrane protein having two Ig-like domains. It is an adhesion molecule which plays a part in tumor-directed cytotoxicity and adhesion in natural killer (NK) cells and T lymphocytes. It has been shown to regulate the NK cell killing of several tumor types, including myeloma cells and ovarian carcinoma cells. DNAM-1 interacts specifically with poliovirus receptor (PVR; CD155) and nectin -2 (CD211), other members of the Ig superfamily. DNAM-1 is expressed in most peripheral T cells, NK cells, monocytes and a subset of B lymphocytes.
Probab=96.90 E-value=0.005 Score=56.96 Aligned_cols=89 Identities=17% Similarity=0.140 Sum_probs=50.8
Q ss_pred CcEEEEEEEeecCCCcceEEEeccccccccccccc---ceEEEeeccceeeeeeeeeeeeceEEEEEeeecccCceEEEE
Q psy2148 1280 EPVRFETRVEPRVDPRLRVECSLSTAFFFPFINIS---TAFLIFNFCLHAVIFSHPIFDLGFVSLDIDYVYPEDQGEYVC 1356 (1884)
Q Consensus 1280 ~~v~l~c~v~~~~~p~~~~~W~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~L~I~~~~~~d~G~Y~C 1356 (1884)
++++|.|.... ......++|.|....-....... ...........|..+... .....+|.|.+++.+|+|.|+|
T Consensus 1 ~~vtL~C~~~~-~~~~~qV~W~k~~~~~~~~iavy~~~~g~~~~~~y~~Rv~f~~~--~~~d~sI~i~nvt~~D~G~Y~C 77 (96)
T cd05889 1 EKMKLECVYPK-TGVLIQVSWTKHNGSHKENIAVYHPIYGMHIEDKYRGRVYFLNS--TREDMSLSFNNATEEDVGLYCC 77 (96)
T ss_pred CCEEEEeEcCC-CCcEEEEEEEEcCCCCCceEEEEECCCCCEECccccCeEEEecC--CCCccEEEEcCCCcccCEEEEE
Confidence 57899999764 34567899998643111110000 001111111233333221 1245789999999999999999
Q ss_pred EEEc-cccceeeeEEE
Q psy2148 1357 RAYN-DHGEAFTKATI 1371 (1884)
Q Consensus 1357 ~a~n-~~g~~~~~~~l 1371 (1884)
.+.+ ..|.....+.|
T Consensus 78 ~~~t~P~g~~~~~i~~ 93 (96)
T cd05889 78 SLVTYPQGSWEKVIEV 93 (96)
T ss_pred EEEeCCCCCeEEEEEE
Confidence 9975 46665554443
No 345
>cd05768 IgC_CH4 CH4 domain (fourth constant Ig domain of the heavy chain) in immunoglobulin. IgC_CH4: The fourth immunoglobulin constant domain (IgC), of immunoglobulin (Ig) heavy chains. This domain is found on the Fc fragment. The basic structure of Ig molecules is a tetramer of two light chains and two heavy chains linked by disulfide bonds. There are two types of light chains: kappa and lambda; each composed of a constant domain and a variable domain. There are five types of heavy chains: alpha, delta, epsilon, gamma and mu, all consisting of a variable domain (VH) and three (in alpha, delta and gamma) or four (in epsilon and mu) constant domains (CH1 to CH4). Ig molecules are modular proteins, in which the variable and constant domains have clear, conserved sequence patterns.
Probab=96.89 E-value=0.0034 Score=59.18 Aligned_cols=73 Identities=15% Similarity=0.236 Sum_probs=46.3
Q ss_pred ccCCCCcEEEEEEEeecCCCCCeEEEeeCCccCCCCCCeE--EEe----eCCE---EEEEEcccCcCCCeEEEEEEEecC
Q psy2148 718 DLREGENAHFEARLTPTDDPKLKVEWFWNGKPMKTGSRFR--TFC----DFGF---VILEISPVYPEDCGQYSCRAYNDY 788 (1884)
Q Consensus 718 ~v~~G~~~~l~C~~~~~g~p~~~v~W~k~g~~l~~~~~~~--~~~----~~~~---~~L~i~~~~~~d~G~Y~C~a~N~~ 788 (1884)
.+..|..++|.|.+.+.-.+...++|+|||+++....... ... ++.. ..|.|..-...+...|+|.+.+..
T Consensus 12 ~~~~~~~~tL~C~a~gFyP~~i~v~W~k~g~~~~~~~~~~~~~~~~~~~dgTy~~~s~L~v~~~~w~~~~~ytC~V~H~~ 91 (102)
T cd05768 12 ELSLQETATLTCLVKGFSPSDIFVKWLQNGQPLSKQKYVTTAPMQEPGGNESYFLYSKLTVSAEDWNAGDVFTCVVGHEA 91 (102)
T ss_pred HhCcCCceEEEEEEeeEeCCCCEEEEEECCEECCcccccccCcccccCCCCeEEEEEEEEEcHHHhcCCCcEEEEeEeCC
Confidence 4556889999999997533446889999999875432111 111 1222 236665444445668999999865
Q ss_pred ce
Q psy2148 789 GE 790 (1884)
Q Consensus 789 g~ 790 (1884)
..
T Consensus 92 l~ 93 (102)
T cd05768 92 LP 93 (102)
T ss_pred CC
Confidence 43
No 346
>cd05889 Ig1_DNAM-1_like First immunoglobulin (Ig) domain of DNAX accessory molecule 1 (DNAM-1, also known as CD226) and similar proteins. Ig1_DNAM-1_like: domain similar to the first immunoglobulin (Ig) domain of DNAX accessory molecule 1 (DNAM-1, also known as CD226). DNAM-1 is a transmembrane protein having two Ig-like domains. It is an adhesion molecule which plays a part in tumor-directed cytotoxicity and adhesion in natural killer (NK) cells and T lymphocytes. It has been shown to regulate the NK cell killing of several tumor types, including myeloma cells and ovarian carcinoma cells. DNAM-1 interacts specifically with poliovirus receptor (PVR; CD155) and nectin -2 (CD211), other members of the Ig superfamily. DNAM-1 is expressed in most peripheral T cells, NK cells, monocytes and a subset of B lymphocytes.
Probab=96.83 E-value=0.0082 Score=55.56 Aligned_cols=73 Identities=12% Similarity=0.182 Sum_probs=46.6
Q ss_pred CeEEEEEEEecc-CCCeEEEEeCCe----ec-----------CCCCCeEEEEe---CceeEEEEcccccCCCeEEEEEEE
Q psy2148 1655 DQARFEVEFDGD-PLPTIKWFREDF----PI-----------TSSPDFQIHTF---STKSILIMRQVFMEDSGVFAVIAE 1715 (1884)
Q Consensus 1655 ~~~~l~C~~~g~-p~~~i~W~~~~~----~~-----------~~~~~~~~~~~---~~~~~L~i~~v~~~DsG~Y~C~a~ 1715 (1884)
+.++|.|..... ....++|.|... .+ ...-..++... ..+.+|.|.+++.+|+|.|.|.+.
T Consensus 1 ~~vtL~C~~~~~~~~~qV~W~k~~~~~~~~iavy~~~~g~~~~~~y~~Rv~f~~~~~~d~sI~i~nvt~~D~G~Y~C~~~ 80 (96)
T cd05889 1 EKMKLECVYPKTGVLIQVSWTKHNGSHKENIAVYHPIYGMHIEDKYRGRVYFLNSTREDMSLSFNNATEEDVGLYCCSLV 80 (96)
T ss_pred CCEEEEeEcCCCCcEEEEEEEEcCCCCCceEEEEECCCCCEECccccCeEEEecCCCCccEEEEcCCCcccCEEEEEEEE
Confidence 468899987632 346788998532 11 01101122222 245789999999999999999986
Q ss_pred eC-CceEEEEEEE
Q psy2148 1716 NR-GGKAKCSANL 1727 (1884)
Q Consensus 1716 n~-~g~~~~~~~l 1727 (1884)
.- .|...+.+.+
T Consensus 81 t~P~g~~~~~i~~ 93 (96)
T cd05889 81 TYPQGSWEKVIEV 93 (96)
T ss_pred eCCCCCeEEEEEE
Confidence 64 6776665544
No 347
>smart00407 IGc1 Immunoglobulin C-Type.
Probab=96.83 E-value=0.0047 Score=54.76 Aligned_cols=65 Identities=18% Similarity=0.386 Sum_probs=44.6
Q ss_pred eEEEEEEEeeCCCCccEEEEeeCCeeecCCCce-EEEe-eCc-e---EEEEEccccccccEEEEEEEEcCc
Q psy2148 521 KVHFDCRLEPKSDPTMRIDWFFNGRPFATGSRV-KTVY-DFG-F---ISLDMDYVYARDSGEYICRATNKW 585 (1884)
Q Consensus 521 ~~~L~C~~~~~~~p~~~i~W~~~~~~l~~~~~~-~~~~-~~~-~---~~L~i~~~~~~d~G~Y~C~a~n~~ 585 (1884)
.++|.|.+.++..+.+.++|+|+|+++..+... .... .++ . +.|.|.....++...|+|.+.+..
T Consensus 1 ~~~L~C~a~gf~P~~i~v~W~k~g~~~~~~~~~~~~~~~~~gt~~~~s~L~v~~~~~~~~~~~tC~V~H~~ 71 (75)
T smart00407 1 KATLVCLVSGFYPPDITVTWLRNGQEVTSGVSTTDPLKNSDGTYFLSSYLTVSASTWESGDTYTCQVTHEG 71 (75)
T ss_pred CeEEEEEEEeEeCCCCEEEEEECCEECCCCEEECceEECCCCCEEEEEEEEEccccCCCCCEEEEEEEEcC
Confidence 368999999876677899999999975443211 1111 122 1 456776667788899999998754
No 348
>PHA03271 envelope glycoprotein C; Provisional
Probab=96.82 E-value=0.067 Score=60.53 Aligned_cols=172 Identities=12% Similarity=0.157 Sum_probs=94.5
Q ss_pred eEEEEEcCCCCCCCEEEEEEEEcCCee--eEEEEEEEEeecCCCCCCceEeccCCccCccCCCeEEEEEEEeeCCCCC--
Q psy2148 365 MVVLEILGTKIEDTGVYTCRATNKWGQ--AEISVNLECVDKSKGQPPKFTSHIKSLEGLKDGDSAHFECTLTPVNDPE-- 440 (1884)
Q Consensus 365 ~~~L~I~~~~~~D~G~Y~C~a~n~~g~--~~~~~~l~V~~~~~~~~p~~~~~~~~~~~v~~G~~v~L~C~~~~~~~p~-- 440 (1884)
...|.|.++...|+|.|.....+.... .+..+.+.+. ..||.+.....+ +.+|+...-.|.+.. -+|+
T Consensus 206 ~m~v~I~svD~~t~Gy~~v~~~d~~N~~i~e~~~~~~v~----~RPPsVsV~a~P---VL~Ge~YkAtC~vAn-YYPP~S 277 (490)
T PHA03271 206 TMGVEIRNVDYADNGYIQVIMRDPFNRPLLDKHIYIRVC----QRPASVDVLAPP---VLSGENYKASCIVRH-FYPPGS 277 (490)
T ss_pred eeeEEEEEeecccceEEEEEecCCCCCccccceEEEEEE----ecCCCccccCCc---cccCCCceEEEEeee-ecCCCc
Confidence 356899999999999776665553333 2334444443 367777666554 568999999999975 3443
Q ss_pred CeEEEeeCCEEccccCcEEEE-----ecCC---EEEEEEcccCCCCcEEEEEEEEeCceecCCcceEEeecccCCCCCCC
Q psy2148 441 LKVEWFHNGKPIFHKNRVKMV-----SDFG---FVVMDIAYVQSHDSGEYVCRAWNNFIFIPPFPIFIFHQIRLPSPSQD 512 (1884)
Q Consensus 441 ~~i~W~k~g~~l~~~~~~~~~-----~~~~---~~~L~i~~v~~~d~G~Y~C~a~n~~~~~~~~~~~~~~~~~~~~~~~~ 512 (1884)
..+.|++||.++......... ..++ .++|.+.+...+..-..+|.+.-..+...... .....+.+...+.-
T Consensus 278 vrlrWf~nG~~V~~~~~rdt~~~w~d~~~g~S~VSTltl~a~~~~~PPsLRCeV~W~rd~v~s~r-nAaatP~VY~~P~I 356 (490)
T PHA03271 278 VYVSWRQNGNIATPRKDRDGSFWWFESGRGATLVSTITLGNSGIDPPPKISCLVAWKQGDMISTT-NATAIPTVYHHPRI 356 (490)
T ss_pred eEEEEEeCCccccCccccceeEEEecCCCceeEEEEEEcccccCCCCCCceEEEEEccCCceeee-ecccCCccccCCeE
Confidence 689999999887543221111 1112 12333333222223389999976544211111 11111111111111
Q ss_pred ccccCCCCeEEEEEEEeeCCCCccEEEEeeCCeeecC
Q psy2148 513 NLDVPEAGKVHFDCRLEPKSDPTMRIDWFFNGRPFAT 549 (1884)
Q Consensus 513 ~~~v~~g~~~~L~C~~~~~~~p~~~i~W~~~~~~l~~ 549 (1884)
.+.+..|+ ..|.+.--++ ...+.|+.++...+.
T Consensus 357 Sv~FedG~---AVCtA~CVP~-gV~lrWlVgD~p~pn 389 (490)
T PHA03271 357 SLAFKDGY---AICTIECVPS-GITVRWLVHDEPQPN 389 (490)
T ss_pred EEEEeCCE---EEEeccccCC-CcEEEEEecCCCCCC
Confidence 22334443 3466553333 568999988766543
No 349
>cd05768 IgC_CH4 CH4 domain (fourth constant Ig domain of the heavy chain) in immunoglobulin. IgC_CH4: The fourth immunoglobulin constant domain (IgC), of immunoglobulin (Ig) heavy chains. This domain is found on the Fc fragment. The basic structure of Ig molecules is a tetramer of two light chains and two heavy chains linked by disulfide bonds. There are two types of light chains: kappa and lambda; each composed of a constant domain and a variable domain. There are five types of heavy chains: alpha, delta, epsilon, gamma and mu, all consisting of a variable domain (VH) and three (in alpha, delta and gamma) or four (in epsilon and mu) constant domains (CH1 to CH4). Ig molecules are modular proteins, in which the variable and constant domains have clear, conserved sequence patterns.
Probab=96.80 E-value=0.0053 Score=57.95 Aligned_cols=70 Identities=14% Similarity=0.332 Sum_probs=44.6
Q ss_pred ccCCCeEEEEEEEeeCCCCCCeEEEeeCCEEccccCcE--EEEec---CCE----EEEEEcccCCCCcEEEEEEEEeCc
Q psy2148 421 LKDGDSAHFECTLTPVNDPELKVEWFHNGKPIFHKNRV--KMVSD---FGF----VVMDIAYVQSHDSGEYVCRAWNNF 490 (1884)
Q Consensus 421 v~~G~~v~L~C~~~~~~~p~~~i~W~k~g~~l~~~~~~--~~~~~---~~~----~~L~i~~v~~~d~G~Y~C~a~n~~ 490 (1884)
+..|+.++|.|.+.++-.+...++|+|||.++...... ....+ +++ ..|.|..-...+...|+|.+....
T Consensus 13 ~~~~~~~tL~C~a~gFyP~~i~v~W~k~g~~~~~~~~~~~~~~~~~~~dgTy~~~s~L~v~~~~w~~~~~ytC~V~H~~ 91 (102)
T cd05768 13 LSLQETATLTCLVKGFSPSDIFVKWLQNGQPLSKQKYVTTAPMQEPGGNESYFLYSKLTVSAEDWNAGDVFTCVVGHEA 91 (102)
T ss_pred hCcCCceEEEEEEeeEeCCCCEEEEEECCEECCcccccccCcccccCCCCeEEEEEEEEEcHHHhcCCCcEEEEeEeCC
Confidence 44578899999999876667899999999987543211 11111 232 234443322234558999998764
No 350
>cd04981 IgV_H Immunoglobulin (Ig) heavy chain (H), variable (V) domain. IgV_H: Immunoglobulin (Ig) heavy chain (H), variable (V) domain. The basic structure of Ig molecules is a tetramer of two light chains and two heavy chains linked by disulfide bonds. In Ig, each chain is composed of one variable domain (IgV) and one or more constant domains (IgC); these names reflect the fact that the variability in sequences is higher in the variable domain than in the constant domain. There are five types of heavy chains (alpha, gamma, delta, epsilon, and mu), which determine the type of immunoglobulin: IgA, IgG, IgD, IgE, and IgM, respectively. In higher vertebrates, there are two types of light chain, designated kappa and lambda, which can associate with any of the heavy chains. This family includes alpha, gamma, delta, epsilon, and mu heavy chains.
Probab=96.80 E-value=0.0053 Score=60.02 Aligned_cols=71 Identities=18% Similarity=0.296 Sum_probs=50.8
Q ss_pred cCceEEcCCceEEEEEEEecCC--CcEEEEEeCCE--e---c---C-----------CCCCeEEeecC--CeEEEEEccC
Q psy2148 1749 ISSAVINVGQLARFDAKISATK--PLDVYWLKNGK--K---I---I-----------PDIRYKTLEED--NLFTLLIIEA 1805 (1884)
Q Consensus 1749 ~~~~~~~~G~~~~l~C~~~g~p--~p~v~W~k~~~--~---l---~-----------~~~~~~~~~~~--~~~~L~i~~~ 1805 (1884)
|....+.+|++++|.|...+.- ...+.|||... . | . ...|+.+..+. ..+.|+|.++
T Consensus 4 ~~~~~v~~G~~vtL~C~~~~~~~~~~~~~WYkQ~~g~~p~~l~~~~~~~~~~~~~~~~~~rf~~~~~~~~~~~~L~I~~~ 83 (117)
T cd04981 4 SGPGLVKPGQSLKLSCKASGFTFTSYGVNWVRQAPGKGLEWIGFINPGGGETYYADSVKGRFTITRDTSKSTVYLQLNSL 83 (117)
T ss_pred CCCeEEcCCCCEEEEEEEeCCCcccceEEEEEECCCCCcEEEEEEecCCCceEeCcccCCcEEEEEEccCCEEEEEECCC
Confidence 4567788999999999986532 45699997642 1 1 0 01355554332 4568999999
Q ss_pred CCCCCEEEEEEEEe
Q psy2148 1806 VVEDSGAYECVAMN 1819 (1884)
Q Consensus 1806 ~~~d~G~Y~C~a~N 1819 (1884)
..+|+|.|.|.+..
T Consensus 84 ~~~Dsa~YyCa~~~ 97 (117)
T cd04981 84 TPEDTAVYYCARGL 97 (117)
T ss_pred CHHHCEEEEEEEEc
Confidence 99999999998864
No 351
>cd04981 IgV_H Immunoglobulin (Ig) heavy chain (H), variable (V) domain. IgV_H: Immunoglobulin (Ig) heavy chain (H), variable (V) domain. The basic structure of Ig molecules is a tetramer of two light chains and two heavy chains linked by disulfide bonds. In Ig, each chain is composed of one variable domain (IgV) and one or more constant domains (IgC); these names reflect the fact that the variability in sequences is higher in the variable domain than in the constant domain. There are five types of heavy chains (alpha, gamma, delta, epsilon, and mu), which determine the type of immunoglobulin: IgA, IgG, IgD, IgE, and IgM, respectively. In higher vertebrates, there are two types of light chain, designated kappa and lambda, which can associate with any of the heavy chains. This family includes alpha, gamma, delta, epsilon, and mu heavy chains.
Probab=96.78 E-value=0.0049 Score=60.23 Aligned_cols=71 Identities=15% Similarity=0.177 Sum_probs=49.9
Q ss_pred CCceeecCCCeEEEEEEEeccC--CCeEEEEeCCe---e--c---C-----------CCCCeEEEEeC--ceeEEEEccc
Q psy2148 1646 IQPCRAFEQDQARFEVEFDGDP--LPTIKWFREDF---P--I---T-----------SSPDFQIHTFS--TKSILIMRQV 1702 (1884)
Q Consensus 1646 ~~~~~v~~G~~~~l~C~~~g~p--~~~i~W~~~~~---~--~---~-----------~~~~~~~~~~~--~~~~L~i~~v 1702 (1884)
+....+.+|++|+|.|...+.. ...+.|||... + | . ...+|...... ....|+|.++
T Consensus 4 ~~~~~v~~G~~vtL~C~~~~~~~~~~~~~WYkQ~~g~~p~~l~~~~~~~~~~~~~~~~~~rf~~~~~~~~~~~~L~I~~~ 83 (117)
T cd04981 4 SGPGLVKPGQSLKLSCKASGFTFTSYGVNWVRQAPGKGLEWIGFINPGGGETYYADSVKGRFTITRDTSKSTVYLQLNSL 83 (117)
T ss_pred CCCeEEcCCCCEEEEEEEeCCCcccceEEEEEECCCCCcEEEEEEecCCCceEeCcccCCcEEEEEEccCCEEEEEECCC
Confidence 4556789999999999987543 46799997431 1 1 0 01345444333 2347999999
Q ss_pred ccCCCeEEEEEEEe
Q psy2148 1703 FMEDSGVFAVIAEN 1716 (1884)
Q Consensus 1703 ~~~DsG~Y~C~a~n 1716 (1884)
..+|+|.|.|.+..
T Consensus 84 ~~~Dsa~YyCa~~~ 97 (117)
T cd04981 84 TPEDTAVYYCARGL 97 (117)
T ss_pred CHHHCEEEEEEEEc
Confidence 99999999998754
No 352
>cd05719 Ig2_PVR_like Second immunoglobulin (Ig) domain of poliovirus receptor (PVR, also known as CD155) and similar proteins. Ig2_PVR_like: domain similar to the second immunoglobulin (Ig) domain of poliovirus receptor (PVR, also known as CD155). Poliovirus (PV) binds to its cellular receptor (PVR/CD155) to initiate infection. CD155 is a membrane-anchored, single-span glycoprotein; its extracellular region has three Ig-like domains. There are four different isotypes of CD155 (referred to as alpha, beta, gamma, and delta), these result from alternate splicing of the CD155 mRNA, and have identical extracellular domains. CD155-beta and - gamma, are secreted, CD155-alpha and delta are membrane-bound and function as PV receptors. The virus recognition site is contained in the amino-terminal domain, D1. Having the virus attachment site on the receptor distal from the plasma membrane may be important for successful initiation of infection of cells by the virus. CD155 binds in the poliovirus
Probab=96.74 E-value=0.0083 Score=55.56 Aligned_cols=66 Identities=14% Similarity=0.205 Sum_probs=43.2
Q ss_pred CCeEEEEEEEeeCCCCCcEEEEeeCCEEccCCCcEEE-EeeCC----eEEEEEccCCCCCCeEEEEEEEcCCeeE
Q psy2148 931 STLAHFECRLTPTNDPSMTVEWFHNGKALSAGSRIKT-INDFG----FVILEINDVYLRDSGLYTCKATNKHGEA 1000 (1884)
Q Consensus 931 G~~v~l~C~v~~~~~P~~~v~W~~~g~~i~~~~~~~~-~~~~~----~~~L~I~~~~~~D~G~Y~C~a~N~~G~~ 1000 (1884)
.....+.|.+.+ |.|++.|+|+++ +........ ...++ .+.|.+.-...+|.-.|+|+|.|..-..
T Consensus 15 ~~~~va~C~s~~-gkP~a~ItW~~~---~~~~~~~~~~~~~~g~~tv~S~l~~~p~~~d~G~~~tC~v~h~~l~~ 85 (95)
T cd05719 15 EPVTVATCVSAN-GKPPATISWETT---LGGEAETQSKENPNGTVTVTSEYRLVPSREANGKELTCVVSHPTLQE 85 (95)
T ss_pred CccEEEEEECCC-CcCCCEEEEEeC---CCCcceeEeecCCCCCEEEEEEEEEecCHHHCCCEEEEEEeCcccCC
Confidence 346778999975 899999999997 211111111 11122 3467776666677789999999986443
No 353
>cd05847 IgC_CH2_IgE CH2 domain (second constant Ig domain of the heavy chain) in immunoglobulin E (IgE). IgC_CH2_IgE: The second constant domain of the heavy chain of immunoglobulin E (IgE). The basic structure of immunoglobulin (Ig) molecules is a tetramer of two light chains and two heavy chains linked by disulfide bonds. There are two types of light chains: kappa and lambda; each composed of a constant domain and a variable domain. There are five types of heavy chains: alpha, delta, epsilon, gamma, and mu, all consisting of a variable domain (VH) and three (in alpha, delta, and gamma) or four (in epsilon and mu) constant domains (CH1 to CH4). The different classes of antibodies vary in their heavy chains; the IgE class has the epsilon type. This domain (Cepsilon2) of IgE is in place of the flexible hinge region found in IgG.
Probab=96.74 E-value=0.0054 Score=56.74 Aligned_cols=71 Identities=14% Similarity=0.282 Sum_probs=48.4
Q ss_pred CCCeEEEEEEEeeCCCCccEEEEeeCCeeecCCC-c--eEEEeeCce---EEEEEccccccccEEEEEEEEcCceee
Q psy2148 518 EAGKVHFDCRLEPKSDPTMRIDWFFNGRPFATGS-R--VKTVYDFGF---ISLDMDYVYARDSGEYICRATNKWGTA 588 (1884)
Q Consensus 518 ~g~~~~L~C~~~~~~~p~~~i~W~~~~~~l~~~~-~--~~~~~~~~~---~~L~i~~~~~~d~G~Y~C~a~n~~g~~ 588 (1884)
.++.++|.|.+.++..+.+.++|+++|..+..+. . .....++.. +.|.+..-...+...|+|.+.+.....
T Consensus 13 ~~~~~~L~C~a~gFyP~~I~vtW~~dg~~~~~~~~~s~~~~~~~~Ty~~~S~L~v~~~~w~~~~~ytC~V~H~~~~~ 89 (94)
T cd05847 13 TSETIQLLCLISGYTPGTIEVEWLVDGQVATLVAASTAPQKEEGSTFSTTSELNVTQEDWKSGKTYTCKVTHQGTTF 89 (94)
T ss_pred CCCCEEEEEEEEeEECCCCEEEEEECCEECcCceeecccEECCCCcEEEEEEEEEchHHhcCCCeEEEEEEECCeee
Confidence 5577999999998877789999999999863321 1 111112221 356666555567789999998876543
No 354
>smart00406 IGv Immunoglobulin V-Type.
Probab=96.69 E-value=0.0049 Score=56.02 Aligned_cols=60 Identities=25% Similarity=0.417 Sum_probs=41.5
Q ss_pred eEEEEEEEeeCCCCCcEEEEeeCCE--E---c-------------cCCCcEEEEee--CCeEEEEEccCCCCCCeEEEEE
Q psy2148 933 LAHFECRLTPTNDPSMTVEWFHNGK--A---L-------------SAGSRIKTIND--FGFVILEINDVYLRDSGLYTCK 992 (1884)
Q Consensus 933 ~v~l~C~v~~~~~P~~~v~W~~~g~--~---i-------------~~~~~~~~~~~--~~~~~L~I~~~~~~D~G~Y~C~ 992 (1884)
+|+|.|.+.....+...+.|++... . | ....|+.+... .+...|.|.+++.+|+|.|.|.
T Consensus 1 ~v~l~C~~~~~~~~~~~v~W~~~~~~~~~~~l~~~~~~~~~~~~~~~~~R~~~~~~~~~~~~~L~i~~~~~~D~G~Y~C~ 80 (81)
T smart00406 1 SVTLSCKASGFTFSSYYVSWVRQPPGKGLEWLGYIGSSGSTYYQQSYKGRVTISKDTSKNDVSLTISNLRVEDTGTYYCA 80 (81)
T ss_pred CEEEEEEEeccccceeEEEEEEeCCCCCeEEEEEEcCCCcEEECcccCCcEEEEecCcCCEEEEEEcCCCHHHCEEEEEc
Confidence 4789999984333324799999431 1 1 11245555443 5677899999999999999996
No 355
>cd07697 IgC_TCR_gamma T cell receptor (TCR) gamma chain constant immunoglobulin domain. IgC_TCR_gamma; immunoglobulin (Ig) constant (C) domain of the gamma chain of gamma-delta T-cell receptors (TCRs). TCRs mediate antigen recognition by T lymphocytes, and are heterodimers consisting of alpha and beta chains or gamma and delta chains. Each chain contains a variable (V) and a constant (C) region. The majority of T cells contain alpha-beta TCRs but a small subset contain gamma-delta TCRs. Alpha-beta TCRs recognize antigen as peptide fragments presented by major histocompatibility complex (MHC) molecules. Gamma-delta TCRs recognize intact protein antigens; they recognize protein antigens directly and without antigen processing, and MHC independently of the bound peptide. Gamma-delta T cells can also be stimulated by non-peptide antigens such as small phosphate- or amine-containing compounds.
Probab=96.66 E-value=0.007 Score=55.94 Aligned_cols=67 Identities=10% Similarity=0.211 Sum_probs=42.5
Q ss_pred ccCCCeEEEEEEEeeCCCCCCeEEEeeCCEEccccCcE-EEEecCCEE----EEEEcccCCCC-cEEEEEEEEeCc
Q psy2148 421 LKDGDSAHFECTLTPVNDPELKVEWFHNGKPIFHKNRV-KMVSDFGFV----VMDIAYVQSHD-SGEYVCRAWNNF 490 (1884)
Q Consensus 421 v~~G~~v~L~C~~~~~~~p~~~i~W~k~g~~l~~~~~~-~~~~~~~~~----~L~i~~v~~~d-~G~Y~C~a~n~~ 490 (1884)
+..+..++|.|.+.++-.+...++|++||..+..+... ....+++++ .|.| ..++ ...|+|.+....
T Consensus 13 ~~~~~~~tL~C~a~gFyP~~I~v~W~kng~~~~~~~~~~~~~~~~dty~~~S~L~v---t~~~~~~~ysC~V~H~g 85 (96)
T cd07697 13 IEKQGQGIYLCLLENFFPDVIQVHWREGNSPSILGSQKSEKDKDNDVYSTTSWLTV---TKDSLGKKFRCIYKHEG 85 (96)
T ss_pred HccCCCEEEEEEEEEEeCCCeEEEEEECCEECcCCeEeccEecCCCEEEEEEEEEE---CchhCCCeEEEEEEECC
Confidence 44567899999999876778999999999987543211 111122222 2333 3332 336999998743
No 356
>cd05769 IgC_TCR_beta T cell receptor (TCR) beta chain constant immunoglobulin domain. IgC_TCR_beta: Constant domain of the beta chain of alpha/beta T-cell antigen receptors (TCRs). TCRs mediate antigen recognition by T lymphocytes, and are composed of alpha and beta, or gamma and delta, polypeptide chains with variable (V) and constant (C) regions. This group includes the variable domain of the beta chain. Alpha/beta TCRs recognize antigen as peptide fragments presented by major histocompatibility complex (MHC) molecules. The antigen binding site is formed by the variable domains of the alpha and beta chains, located at the N-terminus of each chain. Alpha/beta TCRs recognize antigens differently from gamma/delta TCRs.
Probab=96.64 E-value=0.0086 Score=57.44 Aligned_cols=86 Identities=12% Similarity=0.098 Sum_probs=53.1
Q ss_pred CceeeccccccccCCCceEEEEEEEEEcCCCceEEEEeeCCEeeccccc---eEEEeeCCe----EEEEEcCCCCCC-CE
Q psy2148 308 PLFSLQFQHLSNLSEGEIAHFEASLIPVGDQTMTVEFLYNGKPIEASHR---IRTVHAFGM----VVLEILGTKIED-TG 379 (1884)
Q Consensus 308 p~~~~~~~~~~~v~~g~~~~l~c~~~~~g~p~~~i~W~k~g~~i~~~~~---~~~~~~~~~----~~L~I~~~~~~D-~G 379 (1884)
|.+.+.+++...+..+..++|.|.+..+..+...++|+|||+.+..... .....+++. ..|.|......| ..
T Consensus 3 P~V~v~~ps~~e~~~~~~~tL~Cla~gFyP~~I~V~W~kng~~l~~g~~~~~~~~~~~~gTYs~~S~L~v~~~~w~~~~~ 82 (115)
T cd05769 3 PTVAIFPPSEAEIRNKRKATLVCLATGFYPDHVSLSWKVNGKEVTDGVATDPQALRENTSTYSISSRLRVSATEWFNPRN 82 (115)
T ss_pred CEEEEECcChHHhccCCCcEEEEEEEeEeCCCcEEEEEECCEECCCCcccccceecCCCCeEEEEEEEEEChHHhccCCC
Confidence 3333333344445667789999998665455579999999998765422 111112233 346666544434 56
Q ss_pred EEEEEEEcCCeeeE
Q psy2148 380 VYTCRATNKWGQAE 393 (1884)
Q Consensus 380 ~Y~C~a~n~~g~~~ 393 (1884)
.|+|.+.+......
T Consensus 83 ~ytC~V~H~g~~~~ 96 (115)
T cd05769 83 TFTCIVQFYGGTDT 96 (115)
T ss_pred eEEEEEEEeCCccc
Confidence 89999999865544
No 357
>cd07696 IgC_CH3 CH3 domain (third constant Ig domain of the heavy chain) in immunoglobulin. IgC_CH3: The third immunoglobulin constant domain (IgC) of immunoglobulin (Ig) heavy chains. This domain is found on the Fc fragment. The basic structure of Ig molecules is a tetramer of two light chains and two heavy chains linked by disulfide bonds. There are two types of light chains: kappa and lambda; each composed of a constant domain and a variable domain. There are five types of heavy chains: alpha, delta, epsilon, gamma and mu, all consisting of a variable domain (VH) and three (in alpha, delta and gamma) or four (in epsilon and mu) constant domains (CH1 to CH4). Ig molecules are modular proteins, in which the variable and constant domains have clear, conserved sequence patterns.
Probab=96.60 E-value=0.0058 Score=56.80 Aligned_cols=75 Identities=11% Similarity=0.085 Sum_probs=45.1
Q ss_pred cccCCCCcEEEEEEEeec-CCCCCeEEEeeCCccC-CCCCCeEE-EeeCCE---EEEEEcccCcCCCeEEEEEEEecCce
Q psy2148 717 DDLREGENAHFEARLTPT-DDPKLKVEWFWNGKPM-KTGSRFRT-FCDFGF---VILEISPVYPEDCGQYSCRAYNDYGE 790 (1884)
Q Consensus 717 ~~v~~G~~~~l~C~~~~~-g~p~~~v~W~k~g~~l-~~~~~~~~-~~~~~~---~~L~i~~~~~~d~G~Y~C~a~N~~g~ 790 (1884)
..+..|+.++|.|.+.+. -.+...++|+|||+.. ........ ..++.. ..|.+..-...+.-.|+|.+.+....
T Consensus 9 ~~l~~~~~~tLtC~v~gf~yP~~i~v~W~r~~~~~~~~~~~~~~~~~dgty~~~s~l~v~~~~w~~g~~ysC~V~H~~l~ 88 (96)
T cd07696 9 KQLLLTKSVKLTCLVTNLTSPEGVNVTWTRGSGEPVKASIQPPESHNNATLSVTSTLNVSTDDWISGDTFQCKVTHPDLP 88 (96)
T ss_pred HHhccCCCeEEEEEEeCCCCCCCcEEEEEECCeEeeeEEecccccCCCCCEEEEEEEEeCHHHccCCCcEEEEEECCCCC
Confidence 356779999999999975 3456789999987432 21111111 112222 23555543333445899999987544
Q ss_pred E
Q psy2148 791 A 791 (1884)
Q Consensus 791 ~ 791 (1884)
.
T Consensus 89 ~ 89 (96)
T cd07696 89 T 89 (96)
T ss_pred C
Confidence 3
No 358
>cd07697 IgC_TCR_gamma T cell receptor (TCR) gamma chain constant immunoglobulin domain. IgC_TCR_gamma; immunoglobulin (Ig) constant (C) domain of the gamma chain of gamma-delta T-cell receptors (TCRs). TCRs mediate antigen recognition by T lymphocytes, and are heterodimers consisting of alpha and beta chains or gamma and delta chains. Each chain contains a variable (V) and a constant (C) region. The majority of T cells contain alpha-beta TCRs but a small subset contain gamma-delta TCRs. Alpha-beta TCRs recognize antigen as peptide fragments presented by major histocompatibility complex (MHC) molecules. Gamma-delta TCRs recognize intact protein antigens; they recognize protein antigens directly and without antigen processing, and MHC independently of the bound peptide. Gamma-delta T cells can also be stimulated by non-peptide antigens such as small phosphate- or amine-containing compounds.
Probab=96.56 E-value=0.0081 Score=55.51 Aligned_cols=69 Identities=13% Similarity=0.112 Sum_probs=42.8
Q ss_pred ccCCCCcEEEEEEEeecCCCCCeEEEeeCCccCCCCCCe-EEEeeCCEE----EEEEcccCcCCCeEEEEEEEecC
Q psy2148 718 DLREGENAHFEARLTPTDDPKLKVEWFWNGKPMKTGSRF-RTFCDFGFV----ILEISPVYPEDCGQYSCRAYNDY 788 (1884)
Q Consensus 718 ~v~~G~~~~l~C~~~~~g~p~~~v~W~k~g~~l~~~~~~-~~~~~~~~~----~L~i~~~~~~d~G~Y~C~a~N~~ 788 (1884)
.+..+..++|.|.+.+.-.+..+++|++||+.+..+... ....+++.+ .|+|..-. ....|+|.+.+..
T Consensus 12 e~~~~~~~tL~C~a~gFyP~~I~v~W~kng~~~~~~~~~~~~~~~~dty~~~S~L~vt~~~--~~~~ysC~V~H~g 85 (96)
T cd07697 12 EIEKQGQGIYLCLLENFFPDVIQVHWREGNSPSILGSQKSEKDKDNDVYSTTSWLTVTKDS--LGKKFRCIYKHEG 85 (96)
T ss_pred HHccCCCEEEEEEEEEEeCCCeEEEEEECCEECcCCeEeccEecCCCEEEEEEEEEECchh--CCCeEEEEEEECC
Confidence 455577899999999754456799999999987544221 111122222 24444321 2335999999843
No 359
>cd07692 Ig_CD3_epsilon Immunoglobulin (Ig)-like domain of CD3 epsilon chain. Ig_CD3_epsilon; immunoglobulin (Ig)-like domain of CD3 epsilon chain. CD3 is a T cell surface receptor that is associated with alpha/beta T cell receptors (TCRs). The CD3 complex consists of one gamma, one delta, two epsilon, and two zeta chains. The CD3 subunits form heterodimers as gamma/epsilon, delta/epsilon, and zeta/zeta. The gamma, delta, and epsilon chains each contain an extracellular Ig domain, whereas the extracellular domains of the zeta chains are very small and have unknown structure. The CD3 domain participates in intracellular signalling once the TCR has bound an MHC/antigen complex.
Probab=96.50 E-value=0.0072 Score=49.72 Aligned_cols=52 Identities=25% Similarity=0.377 Sum_probs=37.4
Q ss_pred cCCceEEEEEEEecCCCcEEEEEeCCEecCCCCCeEEeecCCeEEEEEccCCCCCCEEEEEEEEeC
Q psy2148 1755 NVGQLARFDAKISATKPLDVYWLKNGKKIIPDIRYKTLEEDNLFTLLIIEAVVEDSGAYECVAMNN 1820 (1884)
Q Consensus 1755 ~~G~~~~l~C~~~g~p~p~v~W~k~~~~l~~~~~~~~~~~~~~~~L~i~~~~~~d~G~Y~C~a~N~ 1820 (1884)
..|.+|+|+|...+. .+.|.+|+..+..+.. .+.+.+-. ++.|.|.|.+.+.
T Consensus 5 isGTtVtlTCP~~~~---~i~W~~n~~~~~g~~~----------~~~~~~~~-e~~G~Y~C~~~~~ 56 (65)
T cd07692 5 ISGTTVTVTCPLSGD---DIKWKKNDQVSQGSDE----------KYLSLNHF-SSSGYYHCTADNA 56 (65)
T ss_pred EeccEEEEECCCCCC---CceEEeCCccCCCCCc----------eEEeeccC-CCCceEEEEeCCC
Confidence 468999999987643 2999999976654322 34444455 8899999999643
No 360
>PHA02914 Immunoglobulin-like domain protein; Provisional
Probab=96.47 E-value=1.6 Score=49.53 Aligned_cols=161 Identities=17% Similarity=0.287 Sum_probs=95.7
Q ss_pred CceeecCCCeEEEEEEEec--cC-CCeEEEEeCCeecC-----------------CCCCeEEEEe------CceeEEEEc
Q psy2148 1647 QPCRAFEQDQARFEVEFDG--DP-LPTIKWFREDFPIT-----------------SSPDFQIHTF------STKSILIMR 1700 (1884)
Q Consensus 1647 ~~~~v~~G~~~~l~C~~~g--~p-~~~i~W~~~~~~~~-----------------~~~~~~~~~~------~~~~~L~i~ 1700 (1884)
..+.+..|..+.|.|..+- +. ...++|+--|.++. .+..|.+... -..++|+|+
T Consensus 272 ~~~~~~~g~~v~~~c~~s~~~~e~i~~~~w~~t~~~~~~~~g~~~~~~~v~~~~~~~~~~~i~~~~~~s~dlk~STLTIk 351 (500)
T PHA02914 272 DEVMLEVGKRVDIECFFSMCGNENISNAKWIDTGFEIGPLIGTVKSKDIVEGDFAEDDDFMISAHANYSDDLKNSTLTIK 351 (500)
T ss_pred ceeEeccCcEEEEEEEEeecCCcccccceEEecCCcccceeEEEEecceeecccccCCceEEEEecccccchhhceEEee
Confidence 4566777999999998873 33 46789997664432 2234444433 134689999
Q ss_pred ccccCCCeEEEEEEEeCCceEEEEEEEEEEecccCCCCCCCCCeEEeccCceEEcCCc-eEEEEEEEecC--CCcEEEEE
Q psy2148 1701 QVFMEDSGVFAVIAENRGGKAKCSANLVVEEKRQGGRGGVVPPSFLTTISSAVINVGQ-LARFDAKISAT--KPLDVYWL 1777 (1884)
Q Consensus 1701 ~v~~~DsG~Y~C~a~n~~g~~~~~~~l~V~~~~~~~~~~~~~P~~~~~~~~~~~~~G~-~~~l~C~~~g~--p~p~v~W~ 1777 (1884)
++..+.+|-|.|+|....-...+..-|.|... -.|.- ..+|. .-...|-+... -++.|.|.
T Consensus 352 ka~I~N~GCY~~~a~~g~~~~ec~~Cl~V~d~----------V~f~W------~~e~~n~T~V~Cyv~sy~~kp~si~wk 415 (500)
T PHA02914 352 KAHINNAGCYEAQAFMGKFKEECRHCFKVADH----------VFFKW------NTEGDNETKVACYAAQYDMQPFSILWK 415 (500)
T ss_pred eEEEEcCCceEEEEecCcchhhhhhheEeccE----------EEEEE------EeccCceEEEEEEEEecccCCceeEEE
Confidence 99999999999999875433444444555421 11111 11222 34567877554 45679999
Q ss_pred eCCEecCCCCC-------eEEeecCCeEEEEEccCCCCC-CEEEEEEEEeCCee
Q psy2148 1778 KNGKKIIPDIR-------YKTLEEDNLFTLLIIEAVVED-SGAYECVAMNNAGE 1823 (1884)
Q Consensus 1778 k~~~~l~~~~~-------~~~~~~~~~~~L~i~~~~~~d-~G~Y~C~a~N~~G~ 1823 (1884)
-+|........ ..+...-....+.|.+-...| --.-.|...-..|.
T Consensus 416 vnGV~~~G~~~~~l~~~~~~~~~Gc~~seI~I~~s~d~dtV~k~~Cr~~tg~~Y 469 (500)
T PHA02914 416 SNGVSFGGEIADALDEHEGAICDGCEASEIIIMDKRDKDTVKKLSCINITGQGY 469 (500)
T ss_pred EccEEecCeecCcccccccccccccceEEEEEecccCccccccceEEEecCCCc
Confidence 88876532211 112222234478888776666 44556766544443
No 361
>cd07696 IgC_CH3 CH3 domain (third constant Ig domain of the heavy chain) in immunoglobulin. IgC_CH3: The third immunoglobulin constant domain (IgC) of immunoglobulin (Ig) heavy chains. This domain is found on the Fc fragment. The basic structure of Ig molecules is a tetramer of two light chains and two heavy chains linked by disulfide bonds. There are two types of light chains: kappa and lambda; each composed of a constant domain and a variable domain. There are five types of heavy chains: alpha, delta, epsilon, gamma and mu, all consisting of a variable domain (VH) and three (in alpha, delta and gamma) or four (in epsilon and mu) constant domains (CH1 to CH4). Ig molecules are modular proteins, in which the variable and constant domains have clear, conserved sequence patterns.
Probab=96.46 E-value=0.0086 Score=55.66 Aligned_cols=75 Identities=9% Similarity=0.089 Sum_probs=48.1
Q ss_pred CccccCCCCeEEEEEEEeeC-CCCccEEEEeeCCeee-cCCCceEEEe-eCce---EEEEEccccccccEEEEEEEEcCc
Q psy2148 512 DNLDVPEAGKVHFDCRLEPK-SDPTMRIDWFFNGRPF-ATGSRVKTVY-DFGF---ISLDMDYVYARDSGEYICRATNKW 585 (1884)
Q Consensus 512 ~~~~v~~g~~~~L~C~~~~~-~~p~~~i~W~~~~~~l-~~~~~~~~~~-~~~~---~~L~i~~~~~~d~G~Y~C~a~n~~ 585 (1884)
....+..|+.++|.|.+.++ ..+.+.++|.|+++.. .......... ++.. +.|.+..-...+.-.|+|.+.+..
T Consensus 7 s~~~l~~~~~~tLtC~v~gf~yP~~i~v~W~r~~~~~~~~~~~~~~~~~dgty~~~s~l~v~~~~w~~g~~ysC~V~H~~ 86 (96)
T cd07696 7 SPKQLLLTKSVKLTCLVTNLTSPEGVNVTWTRGSGEPVKASIQPPESHNNATLSVTSTLNVSTDDWISGDTFQCKVTHPD 86 (96)
T ss_pred CHHHhccCCCeEEEEEEeCCCCCCCcEEEEEECCeEeeeEEecccccCCCCCEEEEEEEEeCHHHccCCCcEEEEEECCC
Confidence 34456778999999999998 7888999999987533 2111111111 1111 345565544456678999998765
Q ss_pred e
Q psy2148 586 G 586 (1884)
Q Consensus 586 g 586 (1884)
.
T Consensus 87 l 87 (96)
T cd07696 87 L 87 (96)
T ss_pred C
Confidence 3
No 362
>cd07703 Ig2_Nectin-2_like Second immunoglobulin (Ig) domain of nectin-2 (also known as poliovirus receptor related protein 2 or CD112) and similar proteins. Ig2_Nectin-2_like: domain similar to the second immunoglobulin (Ig) domain of nectin-2 (also known as poliovirus receptor related protein 2 or CD112). Nectin-2 belongs to the nectin family comprised of four transmembrane glycoproteins (nectins-1 through 4). Nectins are synaptic cell adhesion molecules (CAMs) which facilitate adhesion and signaling at various intracellular junctions. Nectins form homophilic cis-dimers, followed by homophilic and heterophilic trans-dimers involved in cell-cell adhesion. Nectin-2 and nectin-3 localize at Sertoli-spermatid junctions where they form heterophilic trans-interactions between the cells that are essential for the formation and maintenance of the junctions and for spermatid development.
Probab=96.45 E-value=0.015 Score=53.64 Aligned_cols=70 Identities=11% Similarity=0.096 Sum_probs=44.5
Q ss_pred CeEEEEEEEeeCCCCCcEEEEeeCCEEccCCCcEEEEeeCC---eEEEEEccCCCCCCeEEEEEEEcCCeeEEEE
Q psy2148 932 TLAHFECRLTPTNDPSMTVEWFHNGKALSAGSRIKTINDFG---FVILEINDVYLRDSGLYTCKATNKHGEATTS 1003 (1884)
Q Consensus 932 ~~v~l~C~v~~~~~P~~~v~W~~~g~~i~~~~~~~~~~~~~---~~~L~I~~~~~~D~G~Y~C~a~N~~G~~~~~ 1003 (1884)
..+.+.|.+.+ +.|++.|+|+++...... .......++. .+.|.+..-..+|.-.|+|+|.|..-.....
T Consensus 16 ~~~va~C~s~~-gkPaa~IsW~~~~~g~~~-~~~~~~~~gt~tv~S~l~~~P~~~d~Gk~ltC~v~h~al~~~~~ 88 (95)
T cd07703 16 PVPVAKCVSAN-GRPPARISWSSTLGGNAN-TTSKENGDGTVTVTSEYSLVPTPEANGKEVTCKVEHETLQEPQL 88 (95)
T ss_pred ccEEEEEEcCC-CCCCcEEEEEcCCCCCee-EEEEeCCCCCEEEEEEEEEecCHHHCCCEEEEEEeCcccCCCeE
Confidence 35789999985 899999999998211100 0111111222 2467776666677789999999986444333
No 363
>PHA02633 hypothetical protein; Provisional
Probab=96.41 E-value=0.009 Score=47.90 Aligned_cols=41 Identities=15% Similarity=0.186 Sum_probs=36.0
Q ss_pred ceeEEEEcccccCCCeEEEEEEEeCCceEEEEEEEEEEecc
Q psy2148 1693 TKSILIMRQVFMEDSGVFAVIAENRGGKAKCSANLVVEEKR 1733 (1884)
Q Consensus 1693 ~~~~L~i~~v~~~DsG~Y~C~a~n~~g~~~~~~~l~V~~~~ 1733 (1884)
+...|+|-++..+|+|.|.|+.+|..-....++.|.|....
T Consensus 16 ~~~nLwilpa~~sDSGiYiC~~rn~t~c~~~si~l~V~~~~ 56 (63)
T PHA02633 16 NCNNMLILNPTQSDSGIYMCITKNETYSDMMKFDLCICLRI 56 (63)
T ss_pred ccccEEEeccccccCcEEEEEEcCCCeeEEEEEEEEEeecc
Confidence 44569999999999999999999998888999999998643
No 364
>PF07654 C1-set: Immunoglobulin C1-set domain; InterPro: IPR003597 The basic structure of immunoglobulin (Ig) molecules is a tetramer of two light chains and two heavy chains linked by disulphide bonds. There are two types of light chains: kappa and lambda, each composed of a constant domain (CL) and a variable domain (VL). There are five types of heavy chains: alpha, delta, epsilon, gamma and mu, all consisting of a variable domain (VH) and three (in alpha, delta and gamma) or four (in epsilon and mu) constant domains (CH1 to CH4). Ig molecules are highly modular proteins, in which the variable and constant domains have clear, conserved sequence patterns. The domains in Ig and Ig-like molecules are grouped into four types: V-set (variable; IPR013106 from INTERPRO), C1-set (constant-1; IPR003597 from INTERPRO), C2-set (constant-2; IPR008424 from INTERPRO) and I-set (intermediate; IPR013098 from INTERPRO) []. Structural studies have shown that these domains share a common core Greek-key beta-sandwich structure, with the types differing in the number of strands in the beta-sheets as well as in their sequence patterns [, ]. Immunoglobulin-like domains that are related in both sequence and structure can be found in several diverse protein families. Ig-like domains are involved in a variety of functions, including cell-cell recognition, cell-surface receptors, muscle structure and the immune system []. This entry represents C1-set domains, which are classical Ig-like domains resembling the antibody constant domain. C1-set domains are found almost exclusively in molecules involved in the immune system, such as in immunoglobulin light and heavy chains, in the major histocompatibility complex (MHC) class I and II complex molecules [, ], and in various T-cell receptors.; PDB: 3BVN_D 3BXN_A 3PWV_E 3L9R_F 2XFX_B 1BMG_A 1K8I_A 3M1B_G 3M17_C 1EXU_A ....
Probab=96.39 E-value=0.012 Score=53.48 Aligned_cols=70 Identities=20% Similarity=0.344 Sum_probs=45.8
Q ss_pred cCCCeEEEEEEEeeCCCCCCeEEEeeCCEEccccCcEEEE--ecCCEEE-EEEcccCCCCcEEEEEEEEeCce
Q psy2148 422 KDGDSAHFECTLTPVNDPELKVEWFHNGKPIFHKNRVKMV--SDFGFVV-MDIAYVQSHDSGEYVCRAWNNFI 491 (1884)
Q Consensus 422 ~~G~~v~L~C~~~~~~~p~~~i~W~k~g~~l~~~~~~~~~--~~~~~~~-L~i~~v~~~d~G~Y~C~a~n~~~ 491 (1884)
..++.++|.|.+.++......|+|+++|..+......... ..++.+. .....+...+...|+|.+.+...
T Consensus 6 ~~~~~~~L~C~v~~f~P~~i~v~W~~~~~~~~~~~~~~~~~~~~dgty~~~s~l~v~~~~~~~ysC~V~H~~l 78 (83)
T PF07654_consen 6 ELGGSVTLTCLVSGFYPKDITVTWLKNGKEVTEGVETTPPPPNSDGTYSVTSSLTVTWNSGDEYSCRVTHESL 78 (83)
T ss_dssp HSTSEEEEEEEEEEEBSSTEEEEEEETTEEETTTEEEEEEEEETTSEEEEEEEEEEETTTTGGEEEEEEETTS
T ss_pred cCCCCEEEEEEEEEEECCCcEEEEEeccceeeeeeeecccccccccceeeeEEEEecCCCCCEEEEEEEECCC
Confidence 3489999999999876667899999999988654322211 2233322 22223335556689999987653
No 365
>PF07654 C1-set: Immunoglobulin C1-set domain; InterPro: IPR003597 The basic structure of immunoglobulin (Ig) molecules is a tetramer of two light chains and two heavy chains linked by disulphide bonds. There are two types of light chains: kappa and lambda, each composed of a constant domain (CL) and a variable domain (VL). There are five types of heavy chains: alpha, delta, epsilon, gamma and mu, all consisting of a variable domain (VH) and three (in alpha, delta and gamma) or four (in epsilon and mu) constant domains (CH1 to CH4). Ig molecules are highly modular proteins, in which the variable and constant domains have clear, conserved sequence patterns. The domains in Ig and Ig-like molecules are grouped into four types: V-set (variable; IPR013106 from INTERPRO), C1-set (constant-1; IPR003597 from INTERPRO), C2-set (constant-2; IPR008424 from INTERPRO) and I-set (intermediate; IPR013098 from INTERPRO) []. Structural studies have shown that these domains share a common core Greek-key beta-sandwich structure, with the types differing in the number of strands in the beta-sheets as well as in their sequence patterns [, ]. Immunoglobulin-like domains that are related in both sequence and structure can be found in several diverse protein families. Ig-like domains are involved in a variety of functions, including cell-cell recognition, cell-surface receptors, muscle structure and the immune system []. This entry represents C1-set domains, which are classical Ig-like domains resembling the antibody constant domain. C1-set domains are found almost exclusively in molecules involved in the immune system, such as in immunoglobulin light and heavy chains, in the major histocompatibility complex (MHC) class I and II complex molecules [, ], and in various T-cell receptors.; PDB: 3BVN_D 3BXN_A 3PWV_E 3L9R_F 2XFX_B 1BMG_A 1K8I_A 3M1B_G 3M17_C 1EXU_A ....
Probab=96.39 E-value=0.015 Score=52.81 Aligned_cols=67 Identities=22% Similarity=0.363 Sum_probs=48.0
Q ss_pred CCCeEEEEEEEeeCCCCccEEEEeeCCeeecCCCceEEEe--eCce----EEEEEccccccccEEEEEEEEcCcee
Q psy2148 518 EAGKVHFDCRLEPKSDPTMRIDWFFNGRPFATGSRVKTVY--DFGF----ISLDMDYVYARDSGEYICRATNKWGT 587 (1884)
Q Consensus 518 ~g~~~~L~C~~~~~~~p~~~i~W~~~~~~l~~~~~~~~~~--~~~~----~~L~i~~~~~~d~G~Y~C~a~n~~g~ 587 (1884)
.++.++|.|.+.++....+.|+|+++|..+.......... .++. +.|.+. ..+...|+|.+.+....
T Consensus 7 ~~~~~~L~C~v~~f~P~~i~v~W~~~~~~~~~~~~~~~~~~~~dgty~~~s~l~v~---~~~~~~ysC~V~H~~l~ 79 (83)
T PF07654_consen 7 LGGSVTLTCLVSGFYPKDITVTWLKNGKEVTEGVETTPPPPNSDGTYSVTSSLTVT---WNSGDEYSCRVTHESLP 79 (83)
T ss_dssp STSEEEEEEEEEEEBSSTEEEEEEETTEEETTTEEEEEEEEETTSEEEEEEEEEEE---TTTTGGEEEEEEETTSS
T ss_pred CCCCEEEEEEEEEEECCCcEEEEEeccceeeeeeeecccccccccceeeeEEEEec---CCCCCEEEEEEEECCCC
Confidence 4899999999998888888999999999887654332222 2232 244444 66777999999876543
No 366
>smart00406 IGv Immunoglobulin V-Type.
Probab=96.31 E-value=0.0095 Score=54.09 Aligned_cols=77 Identities=17% Similarity=-0.017 Sum_probs=43.2
Q ss_pred cEEEEEEEeecCCCcceEEEeccccccccccccc----ceEEEeeccceeeeeeeeeeeeceEEEEEeeecccCceEEEE
Q psy2148 1281 PVRFETRVEPRVDPRLRVECSLSTAFFFPFINIS----TAFLIFNFCLHAVIFSHPIFDLGFVSLDIDYVYPEDQGEYVC 1356 (1884)
Q Consensus 1281 ~v~l~c~v~~~~~p~~~~~W~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~L~I~~~~~~d~G~Y~C 1356 (1884)
+++|.|.+.....+...+.|++......+..... ...........|...... ...+..+|.|.+++.+|+|.|.|
T Consensus 1 ~v~l~C~~~~~~~~~~~v~W~~~~~~~~~~~l~~~~~~~~~~~~~~~~~R~~~~~~-~~~~~~~L~i~~~~~~D~G~Y~C 79 (81)
T smart00406 1 SVTLSCKASGFTFSSYYVSWVRQPPGKGLEWLGYIGSSGSTYYQQSYKGRVTISKD-TSKNDVSLTISNLRVEDTGTYYC 79 (81)
T ss_pred CEEEEEEEeccccceeEEEEEEeCCCCCeEEEEEEcCCCcEEECcccCCcEEEEec-CcCCEEEEEEcCCCHHHCEEEEE
Confidence 4789999986543335899998754211111000 000000011122211111 12677899999999999999999
Q ss_pred EE
Q psy2148 1357 RA 1358 (1884)
Q Consensus 1357 ~a 1358 (1884)
.+
T Consensus 80 ~v 81 (81)
T smart00406 80 AV 81 (81)
T ss_pred cC
Confidence 63
No 367
>cd07704 Ig2_Nectin-3-4_like Second immunoglobulin (Ig) domain of nectin-3 (also known as poliovirus receptor related protein 3), nectin-4 (poliovirus receptor related protein 4) and similar proteins. Ig2_Nectin-3-4_like: domain similar to the second immunoglobulin (Ig) domain of nectin-3 (also known as poliovirus receptor related protein 3) and nectin-4 (poliovirus receptor related protein 4). Nectin-3 and nectin-4 belong to the nectin family comprised of four transmembrane glycoproteins (nectins-1 through 4). Nectins are synaptic cell adhesion molecules (CAMs) which facilitate adhesion and signaling at various intracellular junctions. Nectins form homophilic cis-dimers, followed by homophilic and heterophilic trans-dimers involved in cell-cell adhesion. Nectin-2 and nectin-3 localize at Sertoli-spermatid junctions where they form heterophilic trans-interactions between the cells that are essential for the formation and maintenance of the junctions and for spermatid development. Nect
Probab=96.31 E-value=0.015 Score=53.41 Aligned_cols=72 Identities=11% Similarity=0.015 Sum_probs=47.1
Q ss_pred cccCCCCcEEE-EEEEeecCCCCCeEEEeeCCccCCCCCCeEEEeeCC---EEEEEEcccCcCCCeEEEEEEEecCce
Q psy2148 717 DDLREGENAHF-EARLTPTDDPKLKVEWFWNGKPMKTGSRFRTFCDFG---FVILEISPVYPEDCGQYSCRAYNDYGE 790 (1884)
Q Consensus 717 ~~v~~G~~~~l-~C~~~~~g~p~~~v~W~k~g~~l~~~~~~~~~~~~~---~~~L~i~~~~~~d~G~Y~C~a~N~~g~ 790 (1884)
..+.+|+.+.+ .|.+.+ |+|+++|+|+.+..... ........++. .+.|.+.....+|.-.++|.+.+..-.
T Consensus 11 ~~~~~g~~~~vA~C~sa~-gkPaa~IsW~~~~~G~~-~~~~~~~~ngT~TV~S~~~l~p~r~d~G~~vtC~V~H~al~ 86 (97)
T cd07704 11 LLIDGGNGTTLAACCAAE-GRPAADVTWETNVYGTS-ESHSQEHPNGTTTVTSEYIWVPSRHANGHPLTCVVSHPALQ 86 (97)
T ss_pred eEeecCcceeEEEEEccC-CccCCEeEEeCCCCCcc-ceeeecCCCCCEEEEEEEEEEeCHHHCCcEEEEEEeCcccC
Confidence 35789999999 998864 89999999998633221 11111111111 134667666666777999999998653
No 368
>cd07692 Ig_CD3_epsilon Immunoglobulin (Ig)-like domain of CD3 epsilon chain. Ig_CD3_epsilon; immunoglobulin (Ig)-like domain of CD3 epsilon chain. CD3 is a T cell surface receptor that is associated with alpha/beta T cell receptors (TCRs). The CD3 complex consists of one gamma, one delta, two epsilon, and two zeta chains. The CD3 subunits form heterodimers as gamma/epsilon, delta/epsilon, and zeta/zeta. The gamma, delta, and epsilon chains each contain an extracellular Ig domain, whereas the extracellular domains of the zeta chains are very small and have unknown structure. The CD3 domain participates in intracellular signalling once the TCR has bound an MHC/antigen complex.
Probab=96.23 E-value=0.0071 Score=49.74 Aligned_cols=52 Identities=23% Similarity=0.468 Sum_probs=36.5
Q ss_pred cCCCeEEEEEEEeeCCCCCcEEEEeeCCEEccCCCcEEEEeeCCeEEEEEccCCCCCCeEEEEEEEcC
Q psy2148 929 AESTLAHFECRLTPTNDPSMTVEWFHNGKALSAGSRIKTINDFGFVILEINDVYLRDSGLYTCKATNK 996 (1884)
Q Consensus 929 ~~G~~v~l~C~v~~~~~P~~~v~W~~~g~~i~~~~~~~~~~~~~~~~L~I~~~~~~D~G~Y~C~a~N~ 996 (1884)
..|.+|+|+|... +. .+.|.+|+..+..... .+.+.+-. +++|.|.|.+.+.
T Consensus 5 isGTtVtlTCP~~--~~---~i~W~~n~~~~~g~~~----------~~~~~~~~-e~~G~Y~C~~~~~ 56 (65)
T cd07692 5 ISGTTVTVTCPLS--GD---DIKWKKNDQVSQGSDE----------KYLSLNHF-SSSGYYHCTADNA 56 (65)
T ss_pred EeccEEEEECCCC--CC---CceEEeCCccCCCCCc----------eEEeeccC-CCCceEEEEeCCC
Confidence 4599999999765 22 3999999966654322 23444444 8899999999653
No 369
>cd04986 IgC_CH2 CH2 domain (second constant Ig domain of the heavy chain) in immunoglobulin. IgC_CH2: The second immunoglobulin constant domain (IgC), of immunoglobulin (Ig) heavy chains. This domain is found on the Fc fragment. The basic structure of Ig molecules is a tetramer of two light chains and two heavy chains linked by disulfide bonds. There are two types of light chains: kappa and lambda; each composed of a constant domain and a variable domain. There are five types of heavy chains: alpha, delta, epsilon, gamma and mu, all consisting of a variable domain (VH) and three (in alpha, delta and gamma) or four (in epsilon and mu) constant domains (CH1 to CH4). Ig molecules are modular proteins, in which the variable and constant domains have clear, conserved sequence patterns.
Probab=96.11 E-value=0.017 Score=53.34 Aligned_cols=83 Identities=13% Similarity=0.162 Sum_probs=47.6
Q ss_pred CeeeecCCCccccCCCCcEEEEEEEeecC-CCCCeEEEeeCCccCCCCC-CeEEEeeCCE---EEEEEcccCcCCCeEEE
Q psy2148 707 PVFTVPLSNIDDLREGENAHFEARLTPTD-DPKLKVEWFWNGKPMKTGS-RFRTFCDFGF---VILEISPVYPEDCGQYS 781 (1884)
Q Consensus 707 p~~~~~~~~~~~v~~G~~~~l~C~~~~~g-~p~~~v~W~k~g~~l~~~~-~~~~~~~~~~---~~L~i~~~~~~d~G~Y~ 781 (1884)
|.+.+-++....+..+..++|.|.+.+.- .....|+|.++|+. .... ......++.. +.|.+..-.......|+
T Consensus 4 PsV~l~pPs~e~l~~~~~atLtClV~~f~~P~~i~V~W~~~g~~-~~~~t~~~~~~dgTys~~S~L~v~~~~W~~g~~yt 82 (99)
T cd04986 4 PSLSLQRPALEDLLLGSSASLTCTLSGLRDPEGAVFTWTPSGGK-EAVQTSAESDQCGCYSVSSVLPGCAEEWNKGEPFA 82 (99)
T ss_pred CEEEEECcChHHhCcCCccEEEEEEeccCCCCCeEEEEEECCcc-CcEEcCcccCCCCCEEEEEEEEeCHHHhcCCCeEE
Confidence 33333333333566789999999999743 23579999999875 1100 0111112222 23665543334445799
Q ss_pred EEEEecCce
Q psy2148 782 CRAYNDYGE 790 (1884)
Q Consensus 782 C~a~N~~g~ 790 (1884)
|.+.|....
T Consensus 83 C~V~H~~l~ 91 (99)
T cd04986 83 CTVTHPEGD 91 (99)
T ss_pred EEEECCCcc
Confidence 999987643
No 370
>cd07691 Ig_CD3_gamma_delta Immunoglobulin (Ig)-like domain of CD3 gamma and delta chains. Ig_CD3_gamma_delta; immunoglobulin (Ig)-like domain of CD3 gamma and delta chains. CD3 is a T cell surface receptor that is associated with alpha/beta T cell receptors (TCRs). The CD3 complex consists of one gamma, one delta, two epsilon, and two zeta chains. The CD3 subunits form heterodimers as gamma/epsilon, delta/epsilon, and zeta/zeta. The gamma, delta, and epsilon chains each contain an extracellular Ig domain, whereas the extracellular domains of the zeta chains are very small and have unknown structure. The CD3 domain participates in intracellular signalling once the TCR has bound an MHC/antigen complex.
Probab=96.11 E-value=0.0096 Score=49.24 Aligned_cols=59 Identities=20% Similarity=0.400 Sum_probs=41.6
Q ss_pred CCeEEEEEEEeeCCCCCcEEEEeeCCEEccCCCcEEEEeeCCeEEEEEccCCCCCCeEEEEEEEcCCeeEEEEEEEEEE
Q psy2148 931 STLAHFECRLTPTNDPSMTVEWFHNGKALSAGSRIKTINDFGFVILEINDVYLRDSGLYTCKATNKHGEATTSCKLTVK 1009 (1884)
Q Consensus 931 G~~v~l~C~v~~~~~P~~~v~W~~~g~~i~~~~~~~~~~~~~~~~L~I~~~~~~D~G~Y~C~a~N~~G~~~~~~~l~V~ 1009 (1884)
.+.|.|+|.+. -+|+|+| |..+.... ..+|.+.+...+-.|.|.|.++| .+.+..|.|.
T Consensus 6 ~~~V~L~C~~~------tsi~W~k-G~~~~~~~---------~~tlnLGs~~~DPRG~Y~C~~s~----~~~~~~LQVy 64 (69)
T cd07691 6 EGKVFLKCNGA------TNITWKK-GKEILEVS---------NTLLDLGSRINDPRGTYSCKESE----PNKEKTLQVY 64 (69)
T ss_pred CceEEEEecCC------CcEEEec-Cccccccc---------ccEEeccCcccCCCcceEecCcc----CCCcEEEEEE
Confidence 35799999752 2599999 66554322 12688888888889999999987 2344555654
No 371
>cd05719 Ig2_PVR_like Second immunoglobulin (Ig) domain of poliovirus receptor (PVR, also known as CD155) and similar proteins. Ig2_PVR_like: domain similar to the second immunoglobulin (Ig) domain of poliovirus receptor (PVR, also known as CD155). Poliovirus (PV) binds to its cellular receptor (PVR/CD155) to initiate infection. CD155 is a membrane-anchored, single-span glycoprotein; its extracellular region has three Ig-like domains. There are four different isotypes of CD155 (referred to as alpha, beta, gamma, and delta), these result from alternate splicing of the CD155 mRNA, and have identical extracellular domains. CD155-beta and - gamma, are secreted, CD155-alpha and delta are membrane-bound and function as PV receptors. The virus recognition site is contained in the amino-terminal domain, D1. Having the virus attachment site on the receptor distal from the plasma membrane may be important for successful initiation of infection of cells by the virus. CD155 binds in the poliovirus
Probab=96.08 E-value=0.032 Score=51.74 Aligned_cols=65 Identities=6% Similarity=0.116 Sum_probs=41.1
Q ss_pred CceEEEEEEE-ecCCCcEEEEEeCCEecCCCCCeEE--eecCC---eEEEEEccCCCCCCEEEEEEEEeCCeeE
Q psy2148 1757 GQLARFDAKI-SATKPLDVYWLKNGKKIIPDIRYKT--LEEDN---LFTLLIIEAVVEDSGAYECVAMNNAGEA 1824 (1884)
Q Consensus 1757 G~~~~l~C~~-~g~p~p~v~W~k~~~~l~~~~~~~~--~~~~~---~~~L~i~~~~~~d~G~Y~C~a~N~~G~~ 1824 (1884)
.....+.|.+ .|.|.+.|+|+++ +........ ..++. .+.|.+.....+|.-.|+|.|.|..-..
T Consensus 15 ~~~~va~C~s~~gkP~a~ItW~~~---~~~~~~~~~~~~~~g~~tv~S~l~~~p~~~d~G~~~tC~v~h~~l~~ 85 (95)
T cd05719 15 EPVTVATCVSANGKPPATISWETT---LGGEAETQSKENPNGTVTVTSEYRLVPSREANGKELTCVVSHPTLQE 85 (95)
T ss_pred CccEEEEEECCCCcCCCEEEEEeC---CCCcceeEeecCCCCCEEEEEEEEEecCHHHCCCEEEEEEeCcccCC
Confidence 3457789998 5799999999997 211111111 11221 3367776555556669999999987443
No 372
>cd07691 Ig_CD3_gamma_delta Immunoglobulin (Ig)-like domain of CD3 gamma and delta chains. Ig_CD3_gamma_delta; immunoglobulin (Ig)-like domain of CD3 gamma and delta chains. CD3 is a T cell surface receptor that is associated with alpha/beta T cell receptors (TCRs). The CD3 complex consists of one gamma, one delta, two epsilon, and two zeta chains. The CD3 subunits form heterodimers as gamma/epsilon, delta/epsilon, and zeta/zeta. The gamma, delta, and epsilon chains each contain an extracellular Ig domain, whereas the extracellular domains of the zeta chains are very small and have unknown structure. The CD3 domain participates in intracellular signalling once the TCR has bound an MHC/antigen complex.
Probab=95.87 E-value=0.016 Score=47.92 Aligned_cols=59 Identities=22% Similarity=0.382 Sum_probs=41.2
Q ss_pred CCcEEEEEEEeeCCCCCcEEEEEECCEeccCCCceEEEeeCcEEEEEEcccCcCCcEEEEEEEEcCCeeeEEEEEEEEe
Q psy2148 1069 AGKVHFDCRLEPKSDPTMRIDWFFNGRPFATGSRVKTVYDFGFISLDMDYVYARDSGEYICRATNKWGTAMTKAKVICK 1147 (1884)
Q Consensus 1069 g~~~~l~C~v~~~~~p~~~v~W~k~~~~l~~~~~~~~~~~~~~~~l~i~~~~~~d~G~Y~C~a~n~~G~~~~~~~l~v~ 1147 (1884)
.+.+.|.|.+. -.|.|+| |..+.... ..+|.+-....+..|.|.|.+++ ...+..|.|.
T Consensus 6 ~~~V~L~C~~~------tsi~W~k-G~~~~~~~---------~~tlnLGs~~~DPRG~Y~C~~s~----~~~~~~LQVy 64 (69)
T cd07691 6 EGKVFLKCNGA------TNITWKK-GKEILEVS---------NTLLDLGSRINDPRGTYSCKESE----PNKEKTLQVY 64 (69)
T ss_pred CceEEEEecCC------CcEEEec-Cccccccc---------ccEEeccCcccCCCcceEecCcc----CCCcEEEEEE
Confidence 46899999651 3499999 66554321 22688888999999999999987 2334455554
No 373
>PHA03271 envelope glycoprotein C; Provisional
Probab=95.85 E-value=0.4 Score=54.60 Aligned_cols=117 Identities=17% Similarity=0.196 Sum_probs=72.4
Q ss_pred EEEEcccccCCCeEEEEEEEeCCce--EEEEEEEEEEecccCCCCCCCCCeEEeccCceEEcCCceEEEEEEEecC-CC-
Q psy2148 1696 ILIMRQVFMEDSGVFAVIAENRGGK--AKCSANLVVEEKRQGGRGGVVPPSFLTTISSAVINVGQLARFDAKISAT-KP- 1771 (1884)
Q Consensus 1696 ~L~i~~v~~~DsG~Y~C~a~n~~g~--~~~~~~l~V~~~~~~~~~~~~~P~~~~~~~~~~~~~G~~~~l~C~~~g~-p~- 1771 (1884)
.|.|+++...|+|.|+....+.... ..+...+.|-. -||.+...+ .-+..|+...-.|.+..+ |+
T Consensus 208 ~v~I~svD~~t~Gy~~v~~~d~~N~~i~e~~~~~~v~~---------RPPsVsV~a--~PVL~Ge~YkAtC~vAnYYPP~ 276 (490)
T PHA03271 208 GVEIRNVDYADNGYIQVIMRDPFNRPLLDKHIYIRVCQ---------RPASVDVLA--PPVLSGENYKASCIVRHFYPPG 276 (490)
T ss_pred eEEEEEeecccceEEEEEecCCCCCccccceEEEEEEe---------cCCCccccC--CccccCCCceEEEEeeeecCCC
Confidence 6999999999999886666554332 23444455543 366666543 346789999999999884 43
Q ss_pred -cEEEEEeCCEecCCCCCeEE---eecC-----CeEEEEEccCCCCCCEEEEEEEEeCCee
Q psy2148 1772 -LDVYWLKNGKKIIPDIRYKT---LEED-----NLFTLLIIEAVVEDSGAYECVAMNNAGE 1823 (1884)
Q Consensus 1772 -p~v~W~k~~~~l~~~~~~~~---~~~~-----~~~~L~i~~~~~~d~G~Y~C~a~N~~G~ 1823 (1884)
..+.|++||.+......... ..++ ..++|.+.+...+-.=..+|.+.-.-+.
T Consensus 277 SvrlrWf~nG~~V~~~~~rdt~~~w~d~~~g~S~VSTltl~a~~~~~PPsLRCeV~W~rd~ 337 (490)
T PHA03271 277 SVYVSWRQNGNIATPRKDRDGSFWWFESGRGATLVSTITLGNSGIDPPPKISCLVAWKQGD 337 (490)
T ss_pred ceEEEEEeCCccccCccccceeEEEecCCCceeEEEEEEcccccCCCCCCceEEEEEccCC
Confidence 35999999998755432111 1111 1224444333222333789999766553
No 374
>cd04986 IgC_CH2 CH2 domain (second constant Ig domain of the heavy chain) in immunoglobulin. IgC_CH2: The second immunoglobulin constant domain (IgC), of immunoglobulin (Ig) heavy chains. This domain is found on the Fc fragment. The basic structure of Ig molecules is a tetramer of two light chains and two heavy chains linked by disulfide bonds. There are two types of light chains: kappa and lambda; each composed of a constant domain and a variable domain. There are five types of heavy chains: alpha, delta, epsilon, gamma and mu, all consisting of a variable domain (VH) and three (in alpha, delta and gamma) or four (in epsilon and mu) constant domains (CH1 to CH4). Ig molecules are modular proteins, in which the variable and constant domains have clear, conserved sequence patterns.
Probab=95.83 E-value=0.033 Score=51.48 Aligned_cols=71 Identities=18% Similarity=0.226 Sum_probs=42.9
Q ss_pred cCccCCCeEEEEEEEeeCC-CCCCeEEEeeCCEEcccc-CcEEEEecCCE---EEEEEcccCCCCcE-EEEEEEEeCce
Q psy2148 419 EGLKDGDSAHFECTLTPVN-DPELKVEWFHNGKPIFHK-NRVKMVSDFGF---VVMDIAYVQSHDSG-EYVCRAWNNFI 491 (1884)
Q Consensus 419 ~~v~~G~~v~L~C~~~~~~-~p~~~i~W~k~g~~l~~~-~~~~~~~~~~~---~~L~i~~v~~~d~G-~Y~C~a~n~~~ 491 (1884)
..+..+..++|.|.+.++. .....++|.++|.. ... .......++.. +.|.+. .....+| .|+|.+.+...
T Consensus 14 e~l~~~~~atLtClV~~f~~P~~i~V~W~~~g~~-~~~~t~~~~~~dgTys~~S~L~v~-~~~W~~g~~ytC~V~H~~l 90 (99)
T cd04986 14 EDLLLGSSASLTCTLSGLRDPEGAVFTWTPSGGK-EAVQTSAESDQCGCYSVSSVLPGC-AEEWNKGEPFACTVTHPEG 90 (99)
T ss_pred HHhCcCCccEEEEEEeccCCCCCeEEEEEECCcc-CcEEcCcccCCCCCEEEEEEEEeC-HHHhcCCCeEEEEEECCCc
Confidence 3355788999999999765 44689999999875 111 11111122222 234443 2233445 69999987654
No 375
>cd07703 Ig2_Nectin-2_like Second immunoglobulin (Ig) domain of nectin-2 (also known as poliovirus receptor related protein 2 or CD112) and similar proteins. Ig2_Nectin-2_like: domain similar to the second immunoglobulin (Ig) domain of nectin-2 (also known as poliovirus receptor related protein 2 or CD112). Nectin-2 belongs to the nectin family comprised of four transmembrane glycoproteins (nectins-1 through 4). Nectins are synaptic cell adhesion molecules (CAMs) which facilitate adhesion and signaling at various intracellular junctions. Nectins form homophilic cis-dimers, followed by homophilic and heterophilic trans-dimers involved in cell-cell adhesion. Nectin-2 and nectin-3 localize at Sertoli-spermatid junctions where they form heterophilic trans-interactions between the cells that are essential for the formation and maintenance of the junctions and for spermatid development.
Probab=95.82 E-value=0.042 Score=50.77 Aligned_cols=72 Identities=7% Similarity=0.019 Sum_probs=44.9
Q ss_pred CcEEEEEEEeecCCCCCeEEEeeCCccCCCCCCeEEEeeCC---EEEEEEcccCcCCCeEEEEEEEecCceEEEEEE
Q psy2148 723 ENAHFEARLTPTDDPKLKVEWFWNGKPMKTGSRFRTFCDFG---FVILEISPVYPEDCGQYSCRAYNDYGEAVTSAS 796 (1884)
Q Consensus 723 ~~~~l~C~~~~~g~p~~~v~W~k~g~~l~~~~~~~~~~~~~---~~~L~i~~~~~~d~G~Y~C~a~N~~g~~~~~~~ 796 (1884)
....+.|.+.+ |.|++.|+|+++...... .......++. .+.|.+.....+|...|+|+|.|..........
T Consensus 16 ~~~va~C~s~~-gkPaa~IsW~~~~~g~~~-~~~~~~~~gt~tv~S~l~~~P~~~d~Gk~ltC~v~h~al~~~~~~~ 90 (95)
T cd07703 16 PVPVAKCVSAN-GRPPARISWSSTLGGNAN-TTSKENGDGTVTVTSEYSLVPTPEANGKEVTCKVEHETLQEPQLLP 90 (95)
T ss_pred ccEEEEEEcCC-CCCCcEEEEEcCCCCCee-EEEEeCCCCCEEEEEEEEEecCHHHCCCEEEEEEeCcccCCCeEEE
Confidence 35678998875 799999999997221100 0111111222 245777776666677999999998755444443
No 376
>cd05721 IgV_CTLA-4 Immunoglobulin (Ig) domain of cytotoxic T lymphocyte-associated antigen 4 (CTLA-4). IgV_CTLA-4: domain similar to the variable(v)-type immunoglobulin (Ig) domain found in cytotoxic T lymphocyte-associated antigen 4 (CTLA-4). CTLA-4 is involved in the regulation of T cell response, acting as an inhibitor of intracellular signalling. CTLA-4 is similar to CD28, a T cell co-receptor protein that recognizes the B7 proteins (CD80 and CD86). CD28 binding of the B7 proteins occurs after the presentation of antigen to the T cell receptor (TCR) via the peptide-MHC complex on the surface of an antigen presenting cell (APC). CTLA-4 also binds the B7 molecules with a higher affinity than does CD28. The B7/CTLA-4 interaction generates inhibitory signals down-regulating the response, and may prevent T cell activation by weak TCR signals. CD28 and CTLA-4 then elicit opposing signals in the regulation of T cell responsiveness and homeostasis. T cell activation leads to increased
Probab=95.80 E-value=0.055 Score=50.91 Aligned_cols=71 Identities=10% Similarity=0.162 Sum_probs=50.4
Q ss_pred CCceeecCCCeEEEEEEEeeCCCCC-cEEEEeeC--CE-Ec------------cCCCcEEEE--eeCCeEEEEEccCCCC
Q psy2148 923 PTDLTLAESTLAHFECRLTPTNDPS-MTVEWFHN--GK-AL------------SAGSRIKTI--NDFGFVILEINDVYLR 984 (1884)
Q Consensus 923 ~~~~~v~~G~~v~l~C~v~~~~~P~-~~v~W~~~--g~-~i------------~~~~~~~~~--~~~~~~~L~I~~~~~~ 984 (1884)
+....+..|..++|.|++++..... -.+.|+|. |. ++ ....++.+. ...+..+|+|.+++.+
T Consensus 5 ~~~~lv~p~~sv~LsC~~sg~~~s~e~~~~wvRq~pg~lE~c~~~~~~g~~~~~~~~r~tcs~~~s~ntv~L~l~~L~a~ 84 (115)
T cd05721 5 QSPVLASSNGAASLVCEYTYNGFSKEFRASLLKGADSAVEVCAVTGNMSNQLQTSLDGFNCDGTLGNEQVNFTLQNLRAN 84 (115)
T ss_pred cCCeEEcCCCCEEEEEEecCCccccEEEEEEEEeCCCCcEEEEEEeCCCccccccCCCeEEeEeCCCCEEEEEEcCCCHH
Confidence 3445678899999999998766665 67899983 31 11 112333333 2345678999999999
Q ss_pred CCeEEEEEE
Q psy2148 985 DSGLYTCKA 993 (1884)
Q Consensus 985 D~G~Y~C~a 993 (1884)
|.+.|.|..
T Consensus 85 DTa~Y~Ca~ 93 (115)
T cd05721 85 QTDIYFCKI 93 (115)
T ss_pred HCeEEEEEe
Confidence 999999987
No 377
>cd07689 Ig2_VCAM-1 Second immunoglobulin (Ig)-like domain of vascular endothelial cell adhesion molecule-1 (VCAM-1, CD106) and intercellular cell adhesion molecule-1 (ICAM-1, CD54) and similar proteins. Ig2_ VCAM-1_like: domain similar to the second immunoglobulin (Ig)-like domain of vascular endothelial cell adhesion molecule-1 (VCAM-1, CD106). During the inflammation process, these molecules recruit leukocytes onto the vascular endothelium before extravasation to the injured tissues. The interaction of VCAM-1 binding to the beta1 integrin very late antigen (VLA-4) expressed by lymphocytes and monocytes mediates the adhesion of leucocytes to blood vessel walls, and regulates migration across the endothelium. During metastasis, some circulating cancer cells extravasate to a secondary site by a similar process. VCAM-1 may be involved in organ targeted tumor metastasis and may also act as host receptors for viruses and parasites. VCAM-1 contains seven Ig domains.
Probab=95.80 E-value=0.036 Score=50.39 Aligned_cols=69 Identities=20% Similarity=0.272 Sum_probs=45.1
Q ss_pred ccCCCeEEEEEEEeeCCCCC--CeEEEeeCCEEccccCcEEE---Ee-cCCEEEEEEcccCCCCcE-EEEEEEEeCce
Q psy2148 421 LKDGDSAHFECTLTPVNDPE--LKVEWFHNGKPIFHKNRVKM---VS-DFGFVVMDIAYVQSHDSG-EYVCRAWNNFI 491 (1884)
Q Consensus 421 v~~G~~v~L~C~~~~~~~p~--~~i~W~k~g~~l~~~~~~~~---~~-~~~~~~L~i~~v~~~d~G-~Y~C~a~n~~~ 491 (1884)
+.+|..++|.|.+.+ .+|. ..+.|+++...+....-..- .+ ......++|.. ..+|.| .|+|+|.-...
T Consensus 12 l~~G~~vtv~C~v~~-v~P~~~l~v~LlkG~~~l~~~~f~~~~~~ks~~~~~~~vtftp-treD~g~~fsC~A~L~l~ 87 (99)
T cd07689 12 LEEGKPVTVKCEVPD-VYPFDRLEIELLKGETLLPSKSFLEDMDKKSLETKSLEVTFTP-TIEDIGKVLVCRAKLHID 87 (99)
T ss_pred ccCCceEEEEEEecC-cccCCceEEEEecCcceecccccccccccCCCCCcceeEEEec-chhhCCcEEEEEEEEeec
Confidence 578999999999985 5665 78999998776654331110 01 11223455554 466666 99999976543
No 378
>cd04985 IgC_CH1 CH1 domain (first constant Ig domain of the heavy chain) in immunoglobulin. IgC_CH1: The first immunoglobulin constant domain (IgC), of immunoglobulin (Ig) heavy chains. This domain is found on the Fab antigen-binding fragment. The basic structure of Ig molecules is a tetramer of two light chains and two heavy chains linked by disulfide bonds. There are two types of light chains: kappa and lambda; each composed of a constant domain and a variable domain. There are five types of heavy chains: alpha, delta, epsilon, gamma and mu, all consisting of a variable domain (VH) and three (in alpha, delta and gamma) or four (in epsilon and mu) constant domains (CH1 to CH4). Ig molecules are modular proteins, in which the variable and constant domains have clear, conserved sequence patterns.
Probab=95.63 E-value=0.056 Score=50.18 Aligned_cols=67 Identities=13% Similarity=0.200 Sum_probs=41.8
Q ss_pred CCCeEEEEEEEeeCCCCCcEEEEeeCCEEccCCCcE--EEEe-eCC---eEEEEEccCCCCCCeEEEEEEEcCC
Q psy2148 930 ESTLAHFECRLTPTNDPSMTVEWFHNGKALSAGSRI--KTIN-DFG---FVILEINDVYLRDSGLYTCKATNKH 997 (1884)
Q Consensus 930 ~G~~v~l~C~v~~~~~P~~~v~W~~~g~~i~~~~~~--~~~~-~~~---~~~L~I~~~~~~D~G~Y~C~a~N~~ 997 (1884)
.++.++|.|.+.+.-.+...|+|+|||+. ..+... .... ++. .+.|+|....-...-.|+|.+....
T Consensus 15 ~~~~~~L~C~a~gFyP~~i~vtW~k~g~~-~~~~~~~~~~~~~dgty~~~s~L~v~~~~w~~~~~ytC~V~H~~ 87 (95)
T cd04985 15 SSDSVTLGCLATGFLPEPVTFTWNSGSNS-TSGVKTYPAVLQSGGLYTASSQLTVPASEWKGKESFYCKVEHPS 87 (95)
T ss_pred CCCcEEEEEEEeeEECCCcEEEEeECCEE-CCCcEECCCEeCCCCCEEEEEEEEEeHHHcCCCCcEEEEEEeCC
Confidence 46679999999976566778999999998 333110 1112 222 2245555432223567999998753
No 379
>cd04985 IgC_CH1 CH1 domain (first constant Ig domain of the heavy chain) in immunoglobulin. IgC_CH1: The first immunoglobulin constant domain (IgC), of immunoglobulin (Ig) heavy chains. This domain is found on the Fab antigen-binding fragment. The basic structure of Ig molecules is a tetramer of two light chains and two heavy chains linked by disulfide bonds. There are two types of light chains: kappa and lambda; each composed of a constant domain and a variable domain. There are five types of heavy chains: alpha, delta, epsilon, gamma and mu, all consisting of a variable domain (VH) and three (in alpha, delta and gamma) or four (in epsilon and mu) constant domains (CH1 to CH4). Ig molecules are modular proteins, in which the variable and constant domains have clear, conserved sequence patterns.
Probab=95.61 E-value=0.053 Score=50.33 Aligned_cols=67 Identities=9% Similarity=0.169 Sum_probs=41.5
Q ss_pred CCCeEEEEEEEeeCCCCCCeEEEeeCCEEccccCc--EEEEe-cCCE---EEEEEcccCCCCcEEEEEEEEeCc
Q psy2148 423 DGDSAHFECTLTPVNDPELKVEWFHNGKPIFHKNR--VKMVS-DFGF---VVMDIAYVQSHDSGEYVCRAWNNF 490 (1884)
Q Consensus 423 ~G~~v~L~C~~~~~~~p~~~i~W~k~g~~l~~~~~--~~~~~-~~~~---~~L~i~~v~~~d~G~Y~C~a~n~~ 490 (1884)
.++.++|.|.+.++-.+..+++|+|||+. ..+.. -.+.. ++.. +.|.+..-.-.....|+|++....
T Consensus 15 ~~~~~~L~C~a~gFyP~~i~vtW~k~g~~-~~~~~~~~~~~~~dgty~~~s~L~v~~~~w~~~~~ytC~V~H~~ 87 (95)
T cd04985 15 SSDSVTLGCLATGFLPEPVTFTWNSGSNS-TSGVKTYPAVLQSGGLYTASSQLTVPASEWKGKESFYCKVEHPS 87 (95)
T ss_pred CCCcEEEEEEEeeEECCCcEEEEeECCEE-CCCcEECCCEeCCCCCEEEEEEEEEeHHHcCCCCcEEEEEEeCC
Confidence 45679999999987666799999999997 33211 01112 2222 234444322122458999998764
No 380
>cd05721 IgV_CTLA-4 Immunoglobulin (Ig) domain of cytotoxic T lymphocyte-associated antigen 4 (CTLA-4). IgV_CTLA-4: domain similar to the variable(v)-type immunoglobulin (Ig) domain found in cytotoxic T lymphocyte-associated antigen 4 (CTLA-4). CTLA-4 is involved in the regulation of T cell response, acting as an inhibitor of intracellular signalling. CTLA-4 is similar to CD28, a T cell co-receptor protein that recognizes the B7 proteins (CD80 and CD86). CD28 binding of the B7 proteins occurs after the presentation of antigen to the T cell receptor (TCR) via the peptide-MHC complex on the surface of an antigen presenting cell (APC). CTLA-4 also binds the B7 molecules with a higher affinity than does CD28. The B7/CTLA-4 interaction generates inhibitory signals down-regulating the response, and may prevent T cell activation by weak TCR signals. CD28 and CTLA-4 then elicit opposing signals in the regulation of T cell responsiveness and homeostasis. T cell activation leads to increased
Probab=95.59 E-value=0.047 Score=51.35 Aligned_cols=85 Identities=7% Similarity=-0.018 Sum_probs=53.9
Q ss_pred ecceeeeecCCcEEEEEEEeecCCCc-ceEEEecccccccccccccceEEEee---cc--ceeeeeeeeeeeeceEEEEE
Q psy2148 1270 EIESVTVQEAEPVRFETRVEPRVDPR-LRVECSLSTAFFFPFINISTAFLIFN---FC--LHAVIFSHPIFDLGFVSLDI 1343 (1884)
Q Consensus 1270 ~~~~~~v~~g~~v~l~c~v~~~~~p~-~~~~W~~~~~~~~~~~~~~~~~~~~~---~~--~~~~~~~~~~~~~~~~~L~I 1343 (1884)
+.....+..|+.+.|.|++++..... ..+.|.|......+ +.....+ .. ......-.........+|.|
T Consensus 4 ~~~~~lv~p~~sv~LsC~~sg~~~s~e~~~~wvRq~pg~lE-----~c~~~~~~g~~~~~~~~r~tcs~~~s~ntv~L~l 78 (115)
T cd05721 4 QQSPVLASSNGAASLVCEYTYNGFSKEFRASLLKGADSAVE-----VCAVTGNMSNQLQTSLDGFNCDGTLGNEQVNFTL 78 (115)
T ss_pred ecCCeEEcCCCCEEEEEEecCCccccEEEEEEEEeCCCCcE-----EEEEEeCCCccccccCCCeEEeEeCCCCEEEEEE
Confidence 34566889999999999998866666 78999986543111 1111100 00 11111112223445678999
Q ss_pred eeecccCceEEEEEEE
Q psy2148 1344 DYVYPEDQGEYVCRAY 1359 (1884)
Q Consensus 1344 ~~~~~~d~G~Y~C~a~ 1359 (1884)
.+++.+|++.|.|..+
T Consensus 79 ~~L~a~DTa~Y~Ca~e 94 (115)
T cd05721 79 QNLRANQTDIYFCKIE 94 (115)
T ss_pred cCCCHHHCeEEEEEee
Confidence 9999999999999763
No 381
>PHA02633 hypothetical protein; Provisional
Probab=95.26 E-value=0.062 Score=43.33 Aligned_cols=38 Identities=24% Similarity=0.437 Sum_probs=35.0
Q ss_pred EEEEccCCCCCCEEEEEEEEeCCeeEEEEEEEEEEecC
Q psy2148 1799 TLLIIEAVVEDSGAYECVAMNNAGEARCEAELVVQSKK 1836 (1884)
Q Consensus 1799 ~L~i~~~~~~d~G~Y~C~a~N~~G~~~~~~~l~V~~~~ 1836 (1884)
.|.|.++..+|+|.|.|+..|..-....++.|+|..+.
T Consensus 19 nLwilpa~~sDSGiYiC~~rn~t~c~~~si~l~V~~~~ 56 (63)
T PHA02633 19 NMLILNPTQSDSGIYMCITKNETYSDMMKFDLCICLRI 56 (63)
T ss_pred cEEEeccccccCcEEEEEEcCCCeeEEEEEEEEEeecc
Confidence 79999999999999999999999899999999998753
No 382
>PF08204 V-set_CD47: CD47 immunoglobulin-like domain; InterPro: IPR013270 This family represents the CD47 leukocyte antigen V-set like Ig domain [, ].; PDB: 2VSC_B 2JJS_D 2JJT_C.
Probab=95.16 E-value=0.045 Score=52.78 Aligned_cols=93 Identities=16% Similarity=0.115 Sum_probs=53.7
Q ss_pred eecCCcEEEEEEEee---cCCCcceEEEecccccccccccccceEEEeeccceeeeeeeeeeeeceEEEEEeeecccCce
Q psy2148 1276 VQEAEPVRFETRVEP---RVDPRLRVECSLSTAFFFPFINISTAFLIFNFCLHAVIFSHPIFDLGFVSLDIDYVYPEDQG 1352 (1884)
Q Consensus 1276 v~~g~~v~l~c~v~~---~~~p~~~~~W~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~I~~~~~~d~G 1352 (1884)
..=.++|.|.|.+.. ...+...++|.+++..+......+....... ..+... .....|.+.|.+...+.- .|
T Consensus 24 t~CN~tV~IPC~v~n~~~~ni~~m~VkWk~~~~~If~~dg~~~~~~~~~--f~sa~i--~~l~kG~aSL~~~~~~a~-~G 98 (130)
T PF08204_consen 24 TVCNDTVVIPCFVNNLEANNISEMYVKWKFKNKDIFIFDGTNNKSTSDN--FPSAKI--SELLKGNASLKMDKSDAV-EG 98 (130)
T ss_dssp -TT-SEEEE--BBSS---SSGGGEEEEEEETTEEEEEEETTTTEEEEGG--GTT-BE--GGGGGTB--EEEEHHHHH--E
T ss_pred EecCCCEEEEeEeccccccccceEEEEEEECCeEEEEEcCccceecccC--ccccch--hHhhCCCEEEEEcchhcc-cc
Confidence 345799999999864 2235578999999886655433322222111 112222 233467788999875555 99
Q ss_pred EEEEEEEccccceeeeEEEEE
Q psy2148 1353 EYVCRAYNDHGEAFTKATISC 1373 (1884)
Q Consensus 1353 ~Y~C~a~n~~g~~~~~~~l~v 1373 (1884)
+|+|++.....+....+.|..
T Consensus 99 nYTCeVt~~~~ege~~i~Lk~ 119 (130)
T PF08204_consen 99 NYTCEVTELSREGETTIELKY 119 (130)
T ss_dssp EEEEEEEETTEEEEEEEEEEE
T ss_pred ceEEEEEecCCCceEEEEEEE
Confidence 999999876666666677665
No 383
>cd07689 Ig2_VCAM-1 Second immunoglobulin (Ig)-like domain of vascular endothelial cell adhesion molecule-1 (VCAM-1, CD106) and intercellular cell adhesion molecule-1 (ICAM-1, CD54) and similar proteins. Ig2_ VCAM-1_like: domain similar to the second immunoglobulin (Ig)-like domain of vascular endothelial cell adhesion molecule-1 (VCAM-1, CD106). During the inflammation process, these molecules recruit leukocytes onto the vascular endothelium before extravasation to the injured tissues. The interaction of VCAM-1 binding to the beta1 integrin very late antigen (VLA-4) expressed by lymphocytes and monocytes mediates the adhesion of leucocytes to blood vessel walls, and regulates migration across the endothelium. During metastasis, some circulating cancer cells extravasate to a secondary site by a similar process. VCAM-1 may be involved in organ targeted tumor metastasis and may also act as host receptors for viruses and parasites. VCAM-1 contains seven Ig domains.
Probab=95.01 E-value=0.097 Score=47.67 Aligned_cols=67 Identities=22% Similarity=0.304 Sum_probs=44.0
Q ss_pred cccccceEEEEEEeeCCCCC--CeEEEeecCeecCCCCCcee----eeeCceEEEEEeeeccCCCe-EEEEEEEec
Q psy2148 1437 LVEMQSTKFECQLAPVGDPN--MKVEWFLNGKPLPHKNRFNP----IYDFGYVAMNFGWVYPEDSG-EYLCRATNL 1505 (1884)
Q Consensus 1437 v~~g~~~~l~C~~~~~g~p~--~~i~W~~~~~~l~~~~~~~~----~~~~~~~~L~i~~~~~~d~G-~Y~c~a~n~ 1505 (1884)
+.+|..+++.|.+. .+.|. ..|.|++.+..|........ ........+++.- +++|.| .|+|.|+-.
T Consensus 12 l~~G~~vtv~C~v~-~v~P~~~l~v~LlkG~~~l~~~~f~~~~~~ks~~~~~~~vtftp-treD~g~~fsC~A~L~ 85 (99)
T cd07689 12 LEEGKPVTVKCEVP-DVYPFDRLEIELLKGETLLPSKSFLEDMDKKSLETKSLEVTFTP-TIEDIGKVLVCRAKLH 85 (99)
T ss_pred ccCCceEEEEEEec-CcccCCceEEEEecCcceecccccccccccCCCCCcceeEEEec-chhhCCcEEEEEEEEe
Confidence 57999999999996 77887 88999987766654321110 0011123444443 477888 799999744
No 384
>cd07704 Ig2_Nectin-3-4_like Second immunoglobulin (Ig) domain of nectin-3 (also known as poliovirus receptor related protein 3), nectin-4 (poliovirus receptor related protein 4) and similar proteins. Ig2_Nectin-3-4_like: domain similar to the second immunoglobulin (Ig) domain of nectin-3 (also known as poliovirus receptor related protein 3) and nectin-4 (poliovirus receptor related protein 4). Nectin-3 and nectin-4 belong to the nectin family comprised of four transmembrane glycoproteins (nectins-1 through 4). Nectins are synaptic cell adhesion molecules (CAMs) which facilitate adhesion and signaling at various intracellular junctions. Nectins form homophilic cis-dimers, followed by homophilic and heterophilic trans-dimers involved in cell-cell adhesion. Nectin-2 and nectin-3 localize at Sertoli-spermatid junctions where they form heterophilic trans-interactions between the cells that are essential for the formation and maintenance of the junctions and for spermatid development. Nect
Probab=94.89 E-value=0.12 Score=47.68 Aligned_cols=71 Identities=14% Similarity=0.092 Sum_probs=45.5
Q ss_pred CccccccccceEE-EEEEeeCCCCCCeEEEeecCeecCCCCCceeeeeCce----EEEEEeeeccCCCeEEEEEEEecC
Q psy2148 1433 TQDQLVEMQSTKF-ECQLAPVGDPNMKVEWFLNGKPLPHKNRFNPIYDFGY----VAMNFGWVYPEDSGEYLCRATNLY 1506 (1884)
Q Consensus 1433 ~~~~v~~g~~~~l-~C~~~~~g~p~~~i~W~~~~~~l~~~~~~~~~~~~~~----~~L~i~~~~~~d~G~Y~c~a~n~~ 1506 (1884)
+...+.+|+.+.+ .|... +|+|.+.|+|+.+...... .. .....+|. ..|.+...+.+|.-.++|.+.+.+
T Consensus 9 ~~~~~~~g~~~~vA~C~sa-~gkPaa~IsW~~~~~G~~~-~~-~~~~~ngT~TV~S~~~l~p~r~d~G~~vtC~V~H~a 84 (97)
T cd07704 9 PSLLIDGGNGTTLAACCAA-EGRPAADVTWETNVYGTSE-SH-SQEHPNGTTTVTSEYIWVPSRHANGHPLTCVVSHPA 84 (97)
T ss_pred CeeEeecCcceeEEEEEcc-CCccCCEeEEeCCCCCccc-ee-eecCCCCCEEEEEEEEEEeCHHHCCcEEEEEEeCcc
Confidence 3345678888888 99886 8999999999986433221 00 11112222 345555455566667999998874
No 385
>PF08204 V-set_CD47: CD47 immunoglobulin-like domain; InterPro: IPR013270 This family represents the CD47 leukocyte antigen V-set like Ig domain [, ].; PDB: 2VSC_B 2JJS_D 2JJT_C.
Probab=94.22 E-value=0.055 Score=52.19 Aligned_cols=79 Identities=19% Similarity=0.196 Sum_probs=48.2
Q ss_pred cccceEEEEEEee---CCCCCCeEEEeecCeecCCC--CCce-----------eeeeCceEEEEEeeeccCCCeEEEEEE
Q psy2148 1439 EMQSTKFECQLAP---VGDPNMKVEWFLNGKPLPHK--NRFN-----------PIYDFGYVAMNFGWVYPEDSGEYLCRA 1502 (1884)
Q Consensus 1439 ~g~~~~l~C~~~~---~g~p~~~i~W~~~~~~l~~~--~~~~-----------~~~~~~~~~L~i~~~~~~d~G~Y~c~a 1502 (1884)
=++++.|.|.+.. ...+...|.|.++|..+-.- .... ..+..|..+|.+...+.- .|+|+|.+
T Consensus 26 CN~tV~IPC~v~n~~~~ni~~m~VkWk~~~~~If~~dg~~~~~~~~~f~sa~i~~l~kG~aSL~~~~~~a~-~GnYTCeV 104 (130)
T PF08204_consen 26 CNDTVVIPCFVNNLEANNISEMYVKWKFKNKDIFIFDGTNNKSTSDNFPSAKISELLKGNASLKMDKSDAV-EGNYTCEV 104 (130)
T ss_dssp T-SEEEE--BBSS---SSGGGEEEEEEETTEEEEEEETTTTEEEEGGGTT-BEGGGGGTB--EEEEHHHHH--EEEEEEE
T ss_pred cCCCEEEEeEeccccccccceEEEEEEECCeEEEEEcCccceecccCccccchhHhhCCCEEEEEcchhcc-ccceEEEE
Confidence 4578999999841 01245679999988776321 1111 112345667888875544 89999999
Q ss_pred EecCcceEEEEEEEEe
Q psy2148 1503 TNLYGMDETRAILKTT 1518 (1884)
Q Consensus 1503 ~n~~G~~~~~~~l~V~ 1518 (1884)
.+.....+..+.|+..
T Consensus 105 t~~~~ege~~i~Lk~~ 120 (130)
T PF08204_consen 105 TELSREGETTIELKYR 120 (130)
T ss_dssp EETTEEEEEEEEEEE-
T ss_pred EecCCCceEEEEEEEE
Confidence 9988888888888764
No 386
>PHA02982 hypothetical protein; Provisional
Probab=94.09 E-value=0.23 Score=50.78 Aligned_cols=93 Identities=13% Similarity=0.168 Sum_probs=63.8
Q ss_pred ccccCCCCeEEEEEEEeeCCCCccEEEEeeCCe-eecC------------------CCceEEEeeCceEEEEEccccccc
Q psy2148 513 NLDVPEAGKVHFDCRLEPKSDPTMRIDWFFNGR-PFAT------------------GSRVKTVYDFGFISLDMDYVYARD 573 (1884)
Q Consensus 513 ~~~v~~g~~~~L~C~~~~~~~p~~~i~W~~~~~-~l~~------------------~~~~~~~~~~~~~~L~i~~~~~~d 573 (1884)
.+....++++.|.|... ..+.-.+..|+.++. .|.. ...+....++..++|+|.++..+.
T Consensus 33 dv~a~vd~~V~L~C~~~-~~~~i~~~~W~~~~~~~la~~~~~~~~iN~~~y~~~~~kd~y~~sv~g~~STLTIkk~~i~N 111 (251)
T PHA02982 33 DVNATVDQEVKLQCLFK-DADEISRAMWKGDAGFMLAQEANGGTGINAFNYVPGPYKDKYALSVSGNSSTFTMKKPDPQN 111 (251)
T ss_pred hhhccCCCcEEEEecCC-CcchhhhheeeCCCCeEEEeeecCcceeccccccCCccceeEEEEEeccceeEEeccCCccc
Confidence 34556799999999953 455556789998542 2321 112334446677899999999999
Q ss_pred cEEEEEEEEcCceeeee-eEEEEEEeeeeEEEEE
Q psy2148 574 SGEYICRATNKWGTAMT-KAKVICKVLTVIVEWF 606 (1884)
Q Consensus 574 ~G~Y~C~a~n~~g~~~~-~~~l~c~~~~~~v~W~ 606 (1884)
.|-|+|.|....+..+. .--|.++...+.+.|.
T Consensus 112 ~GCYtc~~ks~~~k~E~c~kCl~V~~~~V~~~W~ 145 (251)
T PHA02982 112 LGCFTCEAKDAEGKEETCEKCLEIQKEDILYVVE 145 (251)
T ss_pred CCceEEEEecCCCchheeheeeeEecceEEEEEE
Confidence 99999999887665544 3445555556677776
No 387
>KOG4597|consensus
Probab=94.07 E-value=0.078 Score=61.02 Aligned_cols=92 Identities=12% Similarity=0.050 Sum_probs=69.0
Q ss_pred CeEEeccCceEEcCCceEEEEEEEecCCCcEEEEEeC---CEecCCCCCeEE--eecCCeEEEEEccCCCCCCEEEEEEE
Q psy2148 1743 PSFLTTISSAVINVGQLARFDAKISATKPLDVYWLKN---GKKIIPDIRYKT--LEEDNLFTLLIIEAVVEDSGAYECVA 1817 (1884)
Q Consensus 1743 P~~~~~~~~~~~~~G~~~~l~C~~~g~p~p~v~W~k~---~~~l~~~~~~~~--~~~~~~~~L~i~~~~~~d~G~Y~C~a 1817 (1884)
|.+..-+....+.+|+++.++|-+.|.|.+.|+|-+. +..+.-.....+ ..-.....|.|-+....|+|.|+|.|
T Consensus 197 c~l~~cpa~w~vg~wetcS~tCg~~G~q~r~V~c~qv~anr~~vv~~~nq~~e~p~vtstcql~ic~ewq~~a~w~tCs~ 276 (560)
T KOG4597|consen 197 CALVDCPAEWFVGDWETCSSTCGVQGRQYRVVTCEQVFANRENVVMRPNQTVENPVVTSTCQLVICNEWQADAGWYTCSA 276 (560)
T ss_pred cccccCcchhhcccchhhcccccccCCcCceeeeehhhccccceeecCccccCCcceeeeeeEEEcchhhcCCCceeecc
Confidence 5566667778889999999999999999999999643 222211110000 00123458999999999999999999
Q ss_pred EeCCeeEEEEEEEEEEe
Q psy2148 1818 MNNAGEARCEAELVVQS 1834 (1884)
Q Consensus 1818 ~N~~G~~~~~~~l~V~~ 1834 (1884)
.|.+|...+++.+.+.-
T Consensus 277 rcg~g~~~rdv~c~s~~ 293 (560)
T KOG4597|consen 277 RCGAGFLRRDVPCSSVK 293 (560)
T ss_pred ccccceeeccceeeeec
Confidence 99999999999998864
No 388
>PHA02982 hypothetical protein; Provisional
Probab=93.40 E-value=2.8 Score=43.30 Aligned_cols=121 Identities=12% Similarity=0.218 Sum_probs=76.5
Q ss_pred CceeecCCCeEEEEEEEe-ccCCCeEEEEeCCe-ecC----------C--------CCCeEEEEeCceeEEEEcccccCC
Q psy2148 1647 QPCRAFEQDQARFEVEFD-GDPLPTIKWFREDF-PIT----------S--------SPDFQIHTFSTKSILIMRQVFMED 1706 (1884)
Q Consensus 1647 ~~~~v~~G~~~~l~C~~~-g~p~~~i~W~~~~~-~~~----------~--------~~~~~~~~~~~~~~L~i~~v~~~D 1706 (1884)
-++....|++|.|.|... +..-....|+++.. .+. . ...+.....++.++|+|+++..+.
T Consensus 32 ~dv~a~vd~~V~L~C~~~~~~~i~~~~W~~~~~~~la~~~~~~~~iN~~~y~~~~~kd~y~~sv~g~~STLTIkk~~i~N 111 (251)
T PHA02982 32 ADVNATVDQEVKLQCLFKDADEISRAMWKGDAGFMLAQEANGGTGINAFNYVPGPYKDKYALSVSGNSSTFTMKKPDPQN 111 (251)
T ss_pred hhhhccCCCcEEEEecCCCcchhhhheeeCCCCeEEEeeecCcceeccccccCCccceeEEEEEeccceeEEeccCCccc
Confidence 345677899999999854 23345778997542 211 1 123455566788999999999999
Q ss_pred CeEEEEEEEeCCceEE-EEEEEEEEecccCCCCCCCCCeEEeccCceEEcCCceEEEEEEEecCCCcEEEEEeCCEe
Q psy2148 1707 SGVFAVIAENRGGKAK-CSANLVVEEKRQGGRGGVVPPSFLTTISSAVINVGQLARFDAKISATKPLDVYWLKNGKK 1782 (1884)
Q Consensus 1707 sG~Y~C~a~n~~g~~~-~~~~l~V~~~~~~~~~~~~~P~~~~~~~~~~~~~G~~~~l~C~~~g~p~p~v~W~k~~~~ 1782 (1884)
.|-|+|++....+..+ +..-|.|+.. .-.|.-. .-...-...|-+-..-.+...|.-+|..
T Consensus 112 ~GCYtc~~ks~~~k~E~c~kCl~V~~~---------~V~~~W~------e~nNeT~V~CyVgS~~~dvp~W~V~GVv 173 (251)
T PHA02982 112 LGCFTCEAKDAEGKEETCEKCLEIQKE---------DILYVVE------EHNNETIITCFVGSKHGDVPRFIVAGIV 173 (251)
T ss_pred CCceEEEEecCCCchheeheeeeEecc---------eEEEEEE------ecCCeEEEEEEEEeccCCCccEEEeeEE
Confidence 9999999998765543 4566666420 1111111 1122346788886543333489888764
No 389
>KOG4597|consensus
Probab=93.37 E-value=0.12 Score=59.60 Aligned_cols=91 Identities=14% Similarity=0.178 Sum_probs=67.9
Q ss_pred CeeeecCCceeecCCCeEEEEEEEeeCCCCCcEEEEee---CCEEc--cCCCcEEEEeeCCeEEEEEccCCCCCCeEEEE
Q psy2148 917 PEFLTTPTDLTLAESTLAHFECRLTPTNDPSMTVEWFH---NGKAL--SAGSRIKTINDFGFVILEINDVYLRDSGLYTC 991 (1884)
Q Consensus 917 p~~~~~~~~~~v~~G~~v~l~C~v~~~~~P~~~v~W~~---~g~~i--~~~~~~~~~~~~~~~~L~I~~~~~~D~G~Y~C 991 (1884)
|.+..-+....+-.|+++.+.|-+. |.|.+.|+|.+ |+..+ +.+..+..........|.|-+....|+|-|+|
T Consensus 197 c~l~~cpa~w~vg~wetcS~tCg~~--G~q~r~V~c~qv~anr~~vv~~~nq~~e~p~vtstcql~ic~ewq~~a~w~tC 274 (560)
T KOG4597|consen 197 CALVDCPAEWFVGDWETCSSTCGVQ--GRQYRVVTCEQVFANRENVVMRPNQTVENPVVTSTCQLVICNEWQADAGWYTC 274 (560)
T ss_pred cccccCcchhhcccchhhccccccc--CCcCceeeeehhhccccceeecCccccCCcceeeeeeEEEcchhhcCCCceee
Confidence 4555566678888999999999998 78889999987 33322 11111111111234579999999999999999
Q ss_pred EEEcCCeeEEEEEEEEEE
Q psy2148 992 KATNKHGEATTSCKLTVK 1009 (1884)
Q Consensus 992 ~a~N~~G~~~~~~~l~V~ 1009 (1884)
.|.|.+|...+++.+.+.
T Consensus 275 s~rcg~g~~~rdv~c~s~ 292 (560)
T KOG4597|consen 275 SARCGAGFLRRDVPCSSV 292 (560)
T ss_pred ccccccceeeccceeeee
Confidence 999999999999888875
No 390
>PHA03283 envelope glycoprotein E; Provisional
Probab=93.18 E-value=1.9 Score=51.29 Aligned_cols=40 Identities=13% Similarity=0.134 Sum_probs=33.3
Q ss_pred eEEEEEeeeccCCCeEEEEEEEecCcceEEEEEEEEeCCC
Q psy2148 1482 YVAMNFGWVYPEDSGEYLCRATNLYGMDETRAILKTTGKP 1521 (1884)
Q Consensus 1482 ~~~L~i~~~~~~d~G~Y~c~a~n~~G~~~~~~~l~V~~~p 1521 (1884)
...|+|.+++..++|.|+.-..|..+.....+.|.|.+++
T Consensus 133 ~~~l~I~~at~~~aGVYtly~r~d~~~~~~vflvtVk~~~ 172 (542)
T PHA03283 133 RSVLQIQRATPNIAGVYTLHVSSDGMMKHSVFFVTVKKPP 172 (542)
T ss_pred CCeeEEEecccccCeEEEEEecCCCceEEEEEEEEecCCC
Confidence 4579999999999999999999988866666778887643
No 391
>PF07354 Sp38: Zona-pellucida-binding protein (Sp38); InterPro: IPR010857 This family contains a number of zona-pellucida-binding proteins that seem to be restricted to mammals. These are sperm proteins that bind to the 90 kDa family of zona pellucida glycoproteins in a calcium-dependent manner []. These represent some of the specific molecules that mediate the first steps of gamete interaction, allowing fertilisation to occur [].; GO: 0007339 binding of sperm to zona pellucida, 0005576 extracellular region
Probab=93.14 E-value=0.11 Score=55.89 Aligned_cols=47 Identities=28% Similarity=0.347 Sum_probs=39.6
Q ss_pred CCCeeEEEE-CCeecCCCCcEEEEEeCCEEEEEECcCCCCCcEEEEEEEEe
Q psy2148 7 PNLKIEWFK-NGVPLSLGSRIRSTFDFGLVTLSINSLRADDSAIYTCKATN 56 (1884)
Q Consensus 7 P~~~v~W~k-~g~~l~~~~~~~~~~~~~~~~L~I~~~~~~D~G~Y~C~a~n 56 (1884)
..|+++|.. ||+.|+.++++.++.. +.|.+.+...+++|.|+|....
T Consensus 11 iDP~y~W~GP~g~~l~gn~~~nIT~T---G~L~~~~F~esmSG~YTCtLsY 58 (271)
T PF07354_consen 11 IDPTYLWTGPNGKPLSGNSYVNITET---GKLMFKNFQESMSGSYTCTLSY 58 (271)
T ss_pred CCCceEEECCCCcccCCCCeEEEccC---ceEEeeccccccCCceEEEEEE
Confidence 579999999 6788887777776554 4799999999999999999864
No 392
>PF07354 Sp38: Zona-pellucida-binding protein (Sp38); InterPro: IPR010857 This family contains a number of zona-pellucida-binding proteins that seem to be restricted to mammals. These are sperm proteins that bind to the 90 kDa family of zona pellucida glycoproteins in a calcium-dependent manner []. These represent some of the specific molecules that mediate the first steps of gamete interaction, allowing fertilisation to occur [].; GO: 0007339 binding of sperm to zona pellucida, 0005576 extracellular region
Probab=92.13 E-value=0.18 Score=54.16 Aligned_cols=48 Identities=31% Similarity=0.359 Sum_probs=39.0
Q ss_pred CCcEEEEee-CCEEccCCCcEEEEeeCCeEEEEEccCCCCCCeEEEEEEEcC
Q psy2148 946 PSMTVEWFH-NGKALSAGSRIKTINDFGFVILEINDVYLRDSGLYTCKATNK 996 (1884)
Q Consensus 946 P~~~v~W~~-~g~~i~~~~~~~~~~~~~~~~L~I~~~~~~D~G~Y~C~a~N~ 996 (1884)
.+|.+.|.. +|+.|..+.++.+...| .|.+.+...+++|.|+|..+-.
T Consensus 11 iDP~y~W~GP~g~~l~gn~~~nIT~TG---~L~~~~F~esmSG~YTCtLsYk 59 (271)
T PF07354_consen 11 IDPTYLWTGPNGKPLSGNSYVNITETG---KLMFKNFQESMSGSYTCTLSYK 59 (271)
T ss_pred CCCceEEECCCCcccCCCCeEEEccCc---eEEeeccccccCCceEEEEEEE
Confidence 456899999 56777777777777665 5999999999999999998643
No 393
>PF11465 Receptor_2B4: Natural killer cell receptor 2B4; InterPro: IPR024303 2B4 is a transmembrane receptor which is expressed primarily on natural killer (NK) cells. It plays a role in activating NK-mediated cytotoxicity through its interaction with CD48 on target cells in a subset of CD8 T cells []. The structure of 2B4 consists of an immunoglobulin variable domain fold and contains two beta-sheets. One of the beta-sheets, the six-stranded sheet, contains structural features that may have a role in ligand recognition and receptor function []. This entry represents the 2B4 immunoglobulin domain.; GO: 0005488 binding; PDB: 2PTU_D 2PTT_B 1Z2K_A.
Probab=91.02 E-value=2.3 Score=39.16 Aligned_cols=73 Identities=21% Similarity=0.331 Sum_probs=47.7
Q ss_pred eEEEEEEEecCCCcE--EEEEeCCEecCC---CCCeEEeecCCeEEEEEccCCCCCCEEEEEEEEeCCeeEE-EEEEEEE
Q psy2148 1759 LARFDAKISATKPLD--VYWLKNGKKIIP---DIRYKTLEEDNLFTLLIIEAVVEDSGAYECVAMNNAGEAR-CEAELVV 1832 (1884)
Q Consensus 1759 ~~~l~C~~~g~p~p~--v~W~k~~~~l~~---~~~~~~~~~~~~~~L~i~~~~~~d~G~Y~C~a~N~~G~~~-~~~~l~V 1832 (1884)
.++..-.....+... ++|..+...... +.|+.+..++- .|.|..++..|+|.|..+++|..|... ..+++.|
T Consensus 29 sv~WK~~l~s~~~~~~IltW~n~~~~~~~~~~n~r~~F~~enl--aLlIkaAq~qDSG~Y~LEvT~~sG~V~~~~FqVsV 106 (108)
T PF11465_consen 29 SVQWKMQLPSQKKFEVILTWKNDSTPSYNSSFNNRFNFTSENL--ALLIKAAQPQDSGLYCLEVTNESGKVCTKNFQVSV 106 (108)
T ss_dssp EEEEEEEETSSSEEE-EEEEETTEEEESSTTHHHHEEEETTTT--EEEESS-SGGG-EEEEEEEEETTSCEEEEEEEEEE
T ss_pred EEEEEEEcccCCceEEEEEEcCCCcccccccccceEeeeccCc--eEEEeecCcccCceEEEEEEcCCCcEEEEEEEEEe
Confidence 466666665555554 566544444332 23566665554 999999999999999999999999763 3456665
Q ss_pred E
Q psy2148 1833 Q 1833 (1884)
Q Consensus 1833 ~ 1833 (1884)
.
T Consensus 107 F 107 (108)
T PF11465_consen 107 F 107 (108)
T ss_dssp E
T ss_pred e
Confidence 4
No 394
>PHA03283 envelope glycoprotein E; Provisional
Probab=90.13 E-value=6.6 Score=47.10 Aligned_cols=37 Identities=22% Similarity=0.229 Sum_probs=32.3
Q ss_pred EEEEccCCCCCCeEEEEEEEcCCeeEEEEEEEEEEee
Q psy2148 975 ILEINDVYLRDSGLYTCKATNKHGEATTSCKLTVKGR 1011 (1884)
Q Consensus 975 ~L~I~~~~~~D~G~Y~C~a~N~~G~~~~~~~l~V~~~ 1011 (1884)
.|+|.+++.+++|.|+-...|..|.....+.|+|.++
T Consensus 135 ~l~I~~at~~~aGVYtly~r~d~~~~~~vflvtVk~~ 171 (542)
T PHA03283 135 VLQIQRATPNIAGVYTLHVSSDGMMKHSVFFVTVKKP 171 (542)
T ss_pred eeEEEecccccCeEEEEEecCCCceEEEEEEEEecCC
Confidence 5999999999999999999998886667778888763
No 395
>PF11465 Receptor_2B4: Natural killer cell receptor 2B4; InterPro: IPR024303 2B4 is a transmembrane receptor which is expressed primarily on natural killer (NK) cells. It plays a role in activating NK-mediated cytotoxicity through its interaction with CD48 on target cells in a subset of CD8 T cells []. The structure of 2B4 consists of an immunoglobulin variable domain fold and contains two beta-sheets. One of the beta-sheets, the six-stranded sheet, contains structural features that may have a role in ligand recognition and receptor function []. This entry represents the 2B4 immunoglobulin domain.; GO: 0005488 binding; PDB: 2PTU_D 2PTT_B 1Z2K_A.
Probab=89.58 E-value=1.1 Score=41.21 Aligned_cols=59 Identities=20% Similarity=0.327 Sum_probs=39.2
Q ss_pred EEEEeCCeecCCC-CCeEEEEeCceeEEEEcccccCCCeEEEEEEEeCCceEE-EEEEEEE
Q psy2148 1671 IKWFREDFPITSS-PDFQIHTFSTKSILIMRQVFMEDSGVFAVIAENRGGKAK-CSANLVV 1729 (1884)
Q Consensus 1671 i~W~~~~~~~~~~-~~~~~~~~~~~~~L~i~~v~~~DsG~Y~C~a~n~~g~~~-~~~~l~V 1729 (1884)
++|..+..+.... ...++.+...+.+|.|+.++.+|||.|..++.+..|... ..+++.|
T Consensus 46 ltW~n~~~~~~~~~~n~r~~F~~enlaLlIkaAq~qDSG~Y~LEvT~~sG~V~~~~FqVsV 106 (108)
T PF11465_consen 46 LTWKNDSTPSYNSSFNNRFNFTSENLALLIKAAQPQDSGLYCLEVTNESGKVCTKNFQVSV 106 (108)
T ss_dssp EEEETTEEEESSTTHHHHEEEETTTTEEEESS-SGGG-EEEEEEEEETTSCEEEEEEEEEE
T ss_pred EEEcCCCcccccccccceEeeeccCceEEEeecCcccCceEEEEEEcCCCcEEEEEEEEEe
Confidence 4565554443321 123455667788999999999999999999999999863 3344444
No 396
>KOG1026|consensus
Probab=88.59 E-value=0.42 Score=60.51 Aligned_cols=166 Identities=16% Similarity=0.125 Sum_probs=101.5
Q ss_pred ceeecCCCeEEEEEEEeccCCCeEEEEeCCeecCCCCCeEEEEeCceeEEEEcccccCCCeEEEEEEEeCCceEEEEEEE
Q psy2148 1648 PCRAFEQDQARFEVEFDGDPLPTIKWFREDFPITSSPDFQIHTFSTKSILIMRQVFMEDSGVFAVIAENRGGKAKCSANL 1727 (1884)
Q Consensus 1648 ~~~v~~G~~~~l~C~~~g~p~~~i~W~~~~~~~~~~~~~~~~~~~~~~~L~i~~v~~~DsG~Y~C~a~n~~g~~~~~~~l 1727 (1884)
...+..|..+++.|...+.|.|.+.|+.++............-. .....+.+ +.|.++|..|....++.+
T Consensus 201 ~~~v~~~~~~~~~c~~~~~~vp~~~~~~~~~~~~~~~~~~~~c~--~~~~~~~~--------~~c~~E~~~~~~~~~v~~ 270 (774)
T KOG1026|consen 201 NLTVEEGSSITLKCSQAGIPVPCHYWFPNCLASSNTNQTSSLCR--SECEVLEN--------DLCIAENAVARSNPSILL 270 (774)
T ss_pred hhhhcccchheeeeecccCCCcceeeecccccccCCCccccccc--ccceeeec--------hhhHHHHhhhhcCceeee
Confidence 34677899999999999999999999998865443221110000 11111111 899999999999988888
Q ss_pred EEEecccCCCCCCCCCeEEeccCceEEcCCceEEEEEEEecCCCcEEEEEeCCEecCCCCCeEEeecCCeEEEEEccCCC
Q psy2148 1728 VVEEKRQGGRGGVVPPSFLTTISSAVINVGQLARFDAKISATKPLDVYWLKNGKKIIPDIRYKTLEEDNLFTLLIIEAVV 1807 (1884)
Q Consensus 1728 ~V~~~~~~~~~~~~~P~~~~~~~~~~~~~G~~~~l~C~~~g~p~p~v~W~k~~~~l~~~~~~~~~~~~~~~~L~i~~~~~ 1807 (1884)
.+.. |+..........- ....+.-.+.+.|.+.-.|..++.-+...........+..--+....-+-
T Consensus 271 ~~~~----------p~~~~~~~~~~~~---~~~C~~~~~~~~~~~~~~~~~~~~~~~~~g~~~~t~s~~~~C~~~~~~~h 337 (774)
T KOG1026|consen 271 VVDL----------PKAEVLLCSPLSD---HHNCIPIGITANPGPALHWCYNGSGLNYRGTVCVTKSGKEQCLPWNDPPH 337 (774)
T ss_pred EEec----------ccccccCCCCccc---cCceeeeeccCCCCCceeeeecCccceEecccccccccCcCCcccCcCcc
Confidence 8874 2222211111110 11122222336778889999998765433221111111001223333355
Q ss_pred CCCEEEEEEEEeCCeeEEEEEEEEEEecC
Q psy2148 1808 EDSGAYECVAMNNAGEARCEAELVVQSKK 1836 (1884)
Q Consensus 1808 ~d~G~Y~C~a~N~~G~~~~~~~l~V~~~~ 1836 (1884)
.+.|.|+|.+.|..|...+.....+...|
T Consensus 338 ~~~~~~~~~~e~~~g~~~~r~~g~~~~~P 366 (774)
T KOG1026|consen 338 SHNGNYTLFPELPGGKNYCRNPGGFMSRP 366 (774)
T ss_pred cccCcceeeecccCccccccCcCccccCC
Confidence 67899999999999999998888887755
No 397
>PF02124 Marek_A: Marek's disease glycoprotein A; InterPro: IPR001038 Equid herpesvirus 1 (Equine herpesvirus 1, EHV-1) glycoprotein 13 (EHV-1 gp13) has the characteristic features of a membrane-spanning protein: an N-terminal signal sequence; a hydrophobic membrane anchor region; a charged C-terminal cytoplasmic tail; and an exterior domain with nine potential N-glycosylation sites []. EHV-1 gp13 is the structural homologue of the gC-like glycoproteins of the Human herpesvirus 1 (HHV-1) and Human herpesvirus 2 (HHV-2) (gC-1 and gC-2 respectively), Pseudorabies virus (strain Indiana-Funkhauser/Becker) (PRV) (gIII) and Human herpesvirus 3 (HHV-3) (gp66). Secretory glycoprotein GP57-65 precursor (glycoprotein A - GA) is similar to Herpesvirus glycoprotein C, and belongs to the immunoglobulin gene superfamily [, ]. GA is thought to play an immunoevasive role in the pathogenesis of Marek's disease. It is a candidate for causing the early-stage immunosuppression that occurs after MDHV infection.
Probab=88.36 E-value=9.4 Score=40.70 Aligned_cols=105 Identities=10% Similarity=0.139 Sum_probs=53.4
Q ss_pred CCeEEEeeCCEEcccc---CcEEEEecCC---EEEEEEc-ccCCCCcEEEEEEEEeCceecCCcceEEeecccCCCCCCC
Q psy2148 440 ELKVEWFHNGKPIFHK---NRVKMVSDFG---FVVMDIA-YVQSHDSGEYVCRAWNNFIFIPPFPIFIFHQIRLPSPSQD 512 (1884)
Q Consensus 440 ~~~i~W~k~g~~l~~~---~~~~~~~~~~---~~~L~i~-~v~~~d~G~Y~C~a~n~~~~~~~~~~~~~~~~~~~~~~~~ 512 (1884)
...++||.||.++... +......++. .++|++. +...+-.-+.+|.+.-...............+.+ ..++
T Consensus 6 S~~~~Wf~dg~~v~~~~~~~~~~~~~~G~~s~vStl~~~~~~~~~~pp~i~C~v~W~r~~v~~~r~~a~~~P~V--y~~P 83 (211)
T PF02124_consen 6 SVRFRWFEDGNPVEPRFIRDSSQVWSDGLFSRVSTLTLPGNSADSPPPSIRCQVTWYRDSVSETRFNATATPSV--YPKP 83 (211)
T ss_pred cEEEEEEECCEeCCccceeeEEEEecCCcEEEEEEEEecCCCCCCCCCcceEEEEEccCCCeeeEeecccccce--ecCC
Confidence 3678999999988642 2333444432 2345552 2223334489999876554322221111111111 1112
Q ss_pred ccccCCCCeEEEEEEEeeCCCCccEEEEeeCCeee
Q psy2148 513 NLDVPEAGKVHFDCRLEPKSDPTMRIDWFFNGRPF 547 (1884)
Q Consensus 513 ~~~v~~g~~~~L~C~~~~~~~p~~~i~W~~~~~~l 547 (1884)
.+.+.- ..-...|.+.--+.....+.|.-++...
T Consensus 84 ~vsv~F-~~g~AVC~A~CVP~~~v~l~W~v~d~~~ 117 (211)
T PF02124_consen 84 RVSVRF-EDGYAVCTARCVPRGNVTLRWSVGDDPS 117 (211)
T ss_pred EEEEEe-cCCEEEEEcceeeCCCeEEEEEECCccC
Confidence 222222 3334567775444455789999988764
No 398
>PHA03042 CD47-like protein; Provisional
Probab=87.13 E-value=2.4 Score=46.08 Aligned_cols=74 Identities=19% Similarity=0.223 Sum_probs=48.7
Q ss_pred EEcCCceEEEEEEEecC-----CCcEEEEEeCCEecCCCCCeEEeecCCeEEEEEccCCCCCCEEEEEEEEeCCeeEEEE
Q psy2148 1753 VINVGQLARFDAKISAT-----KPLDVYWLKNGKKIIPDIRYKTLEEDNLFTLLIIEAVVEDSGAYECVAMNNAGEARCE 1827 (1884)
Q Consensus 1753 ~~~~G~~~~l~C~~~g~-----p~p~v~W~k~~~~l~~~~~~~~~~~~~~~~L~i~~~~~~d~G~Y~C~a~N~~G~~~~~ 1827 (1884)
.....+++.+.|.+..- -.-.+.|.++|..+-.... .+.++|.+... ..=.|+|+|+|.+..-+....
T Consensus 27 yT~CN~TV~IpC~v~n~~~~ni~~~~V~Wkf~~~~If~~n~------tn~aSL~~~f~-~~l~GNYTCEv~~l~n~gk~~ 99 (286)
T PHA03042 27 YTTCNKTIVIVCNLNLLIYYNISNIHINWKFNNKVIFKKNN------TNTSSLKFNFS-KNLSGNYTCEAINKFNKIKNT 99 (286)
T ss_pred EEecCceEEEEeecCChhhcCccceEEEEEeCCeeEEEecC------CcceEEEEecc-ccCCCceeEEEeecccCccEE
Confidence 44578999999999762 2456999999987732221 12346666544 344799999998766544555
Q ss_pred EEEEEE
Q psy2148 1828 AELVVQ 1833 (1884)
Q Consensus 1828 ~~l~V~ 1833 (1884)
++|.-.
T Consensus 100 IeLk~~ 105 (286)
T PHA03042 100 IELQYV 105 (286)
T ss_pred EEEEEE
Confidence 555433
No 399
>PHA02914 Immunoglobulin-like domain protein; Provisional
Probab=86.93 E-value=67 Score=37.28 Aligned_cols=90 Identities=17% Similarity=0.113 Sum_probs=55.2
Q ss_pred ceeeeecCCcEEEEEEEeecCC-CcceEEEecccccccccccccce--EEEeeccceeeee-e-ee--eeeeceEEEEEe
Q psy2148 1272 ESVTVQEAEPVRFETRVEPRVD-PRLRVECSLSTAFFFPFINISTA--FLIFNFCLHAVIF-S-HP--IFDLGFVSLDID 1344 (1884)
Q Consensus 1272 ~~~~v~~g~~v~l~c~v~~~~~-p~~~~~W~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~-~-~~--~~~~~~~~L~I~ 1344 (1884)
..+.+..|..+.|.|.++--+. ......|.--+-++.|....... ............+ + +. ..+...++|+|.
T Consensus 272 ~~~~~~~g~~v~~~c~~s~~~~e~i~~~~w~~t~~~~~~~~g~~~~~~~v~~~~~~~~~~~i~~~~~~s~dlk~STLTIk 351 (500)
T PHA02914 272 DEVMLEVGKRVDIECFFSMCGNENISNAKWIDTGFEIGPLIGTVKSKDIVEGDFAEDDDFMISAHANYSDDLKNSTLTIK 351 (500)
T ss_pred ceeEeccCcEEEEEEEEeecCCcccccceEEecCCcccceeEEEEecceeecccccCCceEEEEecccccchhhceEEee
Confidence 4567788999999999874333 34568999887776653221111 1111111111100 0 00 123346799999
Q ss_pred eecccCceEEEEEEEcc
Q psy2148 1345 YVYPEDQGEYVCRAYND 1361 (1884)
Q Consensus 1345 ~~~~~d~G~Y~C~a~n~ 1361 (1884)
++.-+.+|=|.|+|...
T Consensus 352 ka~I~N~GCY~~~a~~g 368 (500)
T PHA02914 352 KAHINNAGCYEAQAFMG 368 (500)
T ss_pred eEEEEcCCceEEEEecC
Confidence 99999999999999854
No 400
>PF02124 Marek_A: Marek's disease glycoprotein A; InterPro: IPR001038 Equid herpesvirus 1 (Equine herpesvirus 1, EHV-1) glycoprotein 13 (EHV-1 gp13) has the characteristic features of a membrane-spanning protein: an N-terminal signal sequence; a hydrophobic membrane anchor region; a charged C-terminal cytoplasmic tail; and an exterior domain with nine potential N-glycosylation sites []. EHV-1 gp13 is the structural homologue of the gC-like glycoproteins of the Human herpesvirus 1 (HHV-1) and Human herpesvirus 2 (HHV-2) (gC-1 and gC-2 respectively), Pseudorabies virus (strain Indiana-Funkhauser/Becker) (PRV) (gIII) and Human herpesvirus 3 (HHV-3) (gp66). Secretory glycoprotein GP57-65 precursor (glycoprotein A - GA) is similar to Herpesvirus glycoprotein C, and belongs to the immunoglobulin gene superfamily [, ]. GA is thought to play an immunoevasive role in the pathogenesis of Marek's disease. It is a candidate for causing the early-stage immunosuppression that occurs after MDHV infection.
Probab=86.18 E-value=26 Score=37.49 Aligned_cols=104 Identities=17% Similarity=0.273 Sum_probs=55.1
Q ss_pred ceEEEEeeCCEeeccccc---eEEEeeC---CeEEEEEcC-CCCCCCEEEEEEEEcCCee-eEEEEEEEEeecCCCCCCc
Q psy2148 339 TMTVEFLYNGKPIEASHR---IRTVHAF---GMVVLEILG-TKIEDTGVYTCRATNKWGQ-AEISVNLECVDKSKGQPPK 410 (1884)
Q Consensus 339 ~~~i~W~k~g~~i~~~~~---~~~~~~~---~~~~L~I~~-~~~~D~G~Y~C~a~n~~g~-~~~~~~l~V~~~~~~~~p~ 410 (1884)
...+.|+.||.++....- .....++ ..++|++.. ...+--=..+|.+.-.... .+..+...+ ......+|.
T Consensus 6 S~~~~Wf~dg~~v~~~~~~~~~~~~~~G~~s~vStl~~~~~~~~~~pp~i~C~v~W~r~~v~~~r~~a~~-~P~Vy~~P~ 84 (211)
T PF02124_consen 6 SVRFRWFEDGNPVEPRFIRDSSQVWSDGLFSRVSTLTLPGNSADSPPPSIRCQVTWYRDSVSETRFNATA-TPSVYPKPR 84 (211)
T ss_pred cEEEEEEECCEeCCccceeeEEEEecCCcEEEEEEEEecCCCCCCCCCcceEEEEEccCCCeeeEeeccc-ccceecCCE
Confidence 367999999998874321 1222222 124466632 2233345789998855443 222222111 111225666
Q ss_pred eEeccCCccCccCCCeEEEEEEEeeCCCCCCeEEEeeCCEEc
Q psy2148 411 FTSHIKSLEGLKDGDSAHFECTLTPVNDPELKVEWFHNGKPI 452 (1884)
Q Consensus 411 ~~~~~~~~~~v~~G~~v~L~C~~~~~~~p~~~i~W~k~g~~l 452 (1884)
+... ...| ...|.+.-.......+.|.-++.+.
T Consensus 85 vsv~------F~~g---~AVC~A~CVP~~~v~l~W~v~d~~~ 117 (211)
T PF02124_consen 85 VSVR------FEDG---YAVCTARCVPRGNVTLRWSVGDDPS 117 (211)
T ss_pred EEEE------ecCC---EEEEEcceeeCCCeEEEEEECCccC
Confidence 6543 3233 3568876333334899999888764
No 401
>PHA03042 CD47-like protein; Provisional
Probab=84.88 E-value=3.7 Score=44.75 Aligned_cols=68 Identities=24% Similarity=0.388 Sum_probs=47.7
Q ss_pred ccceEEEEEEeeCCCC------CCeEEEeecCeecCCCCCceeeeeCceEEEEEeeeccCCCeEEEEEEEecCcceEEEE
Q psy2148 1440 MQSTKFECQLAPVGDP------NMKVEWFLNGKPLPHKNRFNPIYDFGYVAMNFGWVYPEDSGEYLCRATNLYGMDETRA 1513 (1884)
Q Consensus 1440 g~~~~l~C~~~~~g~p------~~~i~W~~~~~~l~~~~~~~~~~~~~~~~L~i~~~~~~d~G~Y~c~a~n~~G~~~~~~ 1513 (1884)
++++.+.|.+. ++ ...|.|..++..+-..++- +..+|.+. -...-.|+|||.|.+.....+..+
T Consensus 31 N~TV~IpC~v~---n~~~~ni~~~~V~Wkf~~~~If~~n~t------n~aSL~~~-f~~~l~GNYTCEv~~l~n~gk~~I 100 (286)
T PHA03042 31 NKTIVIVCNLN---LLIYYNISNIHINWKFNNKVIFKKNNT------NTSSLKFN-FSKNLSGNYTCEAINKFNKIKNTI 100 (286)
T ss_pred CceEEEEeecC---ChhhcCccceEEEEEeCCeeEEEecCC------cceEEEEe-ccccCCCceeEEEeecccCccEEE
Confidence 56899999983 44 4669999998877433221 22466654 345568999999998877677777
Q ss_pred EEEE
Q psy2148 1514 ILKT 1517 (1884)
Q Consensus 1514 ~l~V 1517 (1884)
.|+-
T Consensus 101 eLk~ 104 (286)
T PHA03042 101 ELQY 104 (286)
T ss_pred EEEE
Confidence 7764
No 402
>PHA03282 envelope glycoprotein E; Provisional
Probab=84.27 E-value=13 Score=43.81 Aligned_cols=24 Identities=21% Similarity=0.375 Sum_probs=21.2
Q ss_pred eEEEEEcCCCCCCCEEEEEEEEcC
Q psy2148 365 MVVLEILGTKIEDTGVYTCRATNK 388 (1884)
Q Consensus 365 ~~~L~I~~~~~~D~G~Y~C~a~n~ 388 (1884)
...|.+.|+..+++|.|.|++..+
T Consensus 332 ~VdL~F~nAp~saSGLYVfVl~yN 355 (540)
T PHA03282 332 TVNLQLRDASEASGGLYVCVVYVN 355 (540)
T ss_pred ccceEecCCCcccCceEEEEEEEC
Confidence 346999999999999999998865
No 403
>PHA03281 envelope glycoprotein E; Provisional
Probab=84.21 E-value=17 Score=43.61 Aligned_cols=38 Identities=16% Similarity=0.288 Sum_probs=30.1
Q ss_pred EEEEeeeccCCCeEEEEEEEecCcceEE-EEEEEEeCCC
Q psy2148 1484 AMNFGWVYPEDSGEYLCRATNLYGMDET-RAILKTTGKP 1521 (1884)
Q Consensus 1484 ~L~i~~~~~~d~G~Y~c~a~n~~G~~~~-~~~l~V~~~p 1521 (1884)
.|+|.+++..++|.|+.-.....|.... .+.|.|.+++
T Consensus 299 vL~I~nAT~~naGVYtly~rg~~G~s~~svfLVtVkg~~ 337 (642)
T PHA03281 299 VLKFEHMEAHHAGVYIWNLQGSDGENMYATFLVKLKGDE 337 (642)
T ss_pred eeEEEecccccceeEEEEecCCCCcceeEEEEEEecCCc
Confidence 6999999999999999999877675444 5667786644
No 404
>PF06328 Lep_receptor_Ig: Ig-like C2-type domain; InterPro: IPR010457 This entry represents a ligand-binding domain that displays similarity to C2-set immunoglobulin domains (antibody constant domain 2) []. The two cysteine residues form a disulphide bridge.; PDB: 3L5H_A 1P9M_A 1I1R_A 2D9Q_B.
Probab=83.99 E-value=5.9 Score=36.14 Aligned_cols=67 Identities=15% Similarity=0.347 Sum_probs=46.7
Q ss_pred cCceEEcCCceEEEEEEEecC-----CCcEEEEEeCCEecCCCCCeEEeecCCeEEEEEccCCCCCCEEEEEEE
Q psy2148 1749 ISSAVINVGQLARFDAKISAT-----KPLDVYWLKNGKKIIPDIRYKTLEEDNLFTLLIIEAVVEDSGAYECVA 1817 (1884)
Q Consensus 1749 ~~~~~~~~G~~~~l~C~~~g~-----p~p~v~W~k~~~~l~~~~~~~~~~~~~~~~L~i~~~~~~d~G~Y~C~a 1817 (1884)
+....+..|..++..|.+... ....|.|..|+. ..++.+|....+. .+.+++.+......-.|.|..
T Consensus 10 p~~pvv~lGS~vtasC~l~~~c~~~~~a~~I~Wkln~~-~iP~~qy~~in~~-~SsVT~~~~~~~~~~L~cC~l 81 (89)
T PF06328_consen 10 PPSPVVSLGSNVTASCVLKQNCSHSVNASQIVWKLNGE-KIPGSQYRVINDT-VSSVTLPNLNPTGATLFCCKL 81 (89)
T ss_dssp CSSSEEETTS-EEEEEEE-CCCHCT-STTCEEEECSSC-ESTCGCEEEESTT-EEEEEESS--SSEEEEEEEEE
T ss_pred cCCCEEeCCCCEEEEEEEECCCCCCcccceEEEEECCE-ECChhHcceeCCe-EEEEEEccCCCCCceEEEEEE
Confidence 455677899999999999642 455799999999 4467777766654 478888888777666666663
No 405
>PF06328 Lep_receptor_Ig: Ig-like C2-type domain; InterPro: IPR010457 This entry represents a ligand-binding domain that displays similarity to C2-set immunoglobulin domains (antibody constant domain 2) []. The two cysteine residues form a disulphide bridge.; PDB: 3L5H_A 1P9M_A 1I1R_A 2D9Q_B.
Probab=83.78 E-value=4.7 Score=36.76 Aligned_cols=70 Identities=20% Similarity=0.394 Sum_probs=48.3
Q ss_pred cCCceeecCCCeEEEEEEEeeCC---CCCcEEEEeeCCEEccCCCcEEEEeeCCeEEEEEccCCCCCCeEEEEEE
Q psy2148 922 TPTDLTLAESTLAHFECRLTPTN---DPSMTVEWFHNGKALSAGSRIKTINDFGFVILEINDVYLRDSGLYTCKA 993 (1884)
Q Consensus 922 ~~~~~~v~~G~~v~l~C~v~~~~---~P~~~v~W~~~g~~i~~~~~~~~~~~~~~~~L~I~~~~~~D~G~Y~C~a 993 (1884)
.+....+..|++++..|.+...- .....|.|..|+..+ +..+++..++. .+.+++.+.....+-.|.|..
T Consensus 9 ~p~~pvv~lGS~vtasC~l~~~c~~~~~a~~I~Wkln~~~i-P~~qy~~in~~-~SsVT~~~~~~~~~~L~cC~l 81 (89)
T PF06328_consen 9 SPPSPVVSLGSNVTASCVLKQNCSHSVNASQIVWKLNGEKI-PGSQYRVINDT-VSSVTLPNLNPTGATLFCCKL 81 (89)
T ss_dssp ECSSSEEETTS-EEEEEEE-CCCHCT-STTCEEEECSSCES-TCGCEEEESTT-EEEEEESS--SSEEEEEEEEE
T ss_pred ecCCCEEeCCCCEEEEEEEECCCCCCcccceEEEEECCEEC-ChhHcceeCCe-EEEEEEccCCCCCceEEEEEE
Confidence 34556788999999999997322 255689999999955 55677766654 478888888777777787774
No 406
>PF02480 Herpes_gE: Alphaherpesvirus glycoprotein E; InterPro: IPR003404 Glycoprotein E (gE) of Alphaherpesvirus forms a complex with glycoprotein I (gI), functioning as an immunoglobulin G (IgG) Fc binding protein. gE is involved in virus spread but is not essential for propagation [].; GO: 0016020 membrane; PDB: 2GJ7_F 2GIY_B.
Probab=83.25 E-value=0.93 Score=55.17 Aligned_cols=37 Identities=19% Similarity=0.192 Sum_probs=0.0
Q ss_pred EEEEEeeeccCCCeEEEEEEEecCcceEEE-EEEEEeC
Q psy2148 1483 VAMNFGWVYPEDSGEYLCRATNLYGMDETR-AILKTTG 1519 (1884)
Q Consensus 1483 ~~L~i~~~~~~d~G~Y~c~a~n~~G~~~~~-~~l~V~~ 1519 (1884)
..|.|.+++.+|+|.|+....|..|..... +.|.|.+
T Consensus 89 ~~l~i~~a~~~~~GvY~l~~~~~~~~~~~~~~~v~v~~ 126 (439)
T PF02480_consen 89 GGLSILNATEQDSGVYTLYVRNDSGWAHQSVVFVTVKG 126 (439)
T ss_dssp --------------------------------------
T ss_pred CceEEeccccccCeeEEEEecCCCCceEEEEEEEEEcC
Confidence 469999999999999999999887665444 5556654
No 407
>PHA02865 MHC-like TNF binding protein; Provisional
Probab=83.01 E-value=4 Score=46.84 Aligned_cols=37 Identities=14% Similarity=0.385 Sum_probs=26.6
Q ss_pred CCCceEeccCCccCccCCCeEEEEEEEeeCCCCCCeEEEeeC
Q psy2148 407 QPPKFTSHIKSLEGLKDGDSAHFECTLTPVNDPELKVEWFHN 448 (1884)
Q Consensus 407 ~~p~~~~~~~~~~~v~~G~~v~L~C~~~~~~~p~~~i~W~k~ 448 (1884)
.||.+.....+ . .+ .++|+|.+.++-+....++|.|+
T Consensus 202 vpP~V~Vt~k~---~-~~-~~tL~C~A~GFYP~~I~v~W~kd 238 (338)
T PHA02865 202 VTPTVKVTGEE---L-GD-NTTLFCTFDSHYPSSVAAKWYNS 238 (338)
T ss_pred CCCceEEeccc---C-CC-CceEEEEEEeEeCCccEEEEEec
Confidence 56666553221 1 12 57999999997777799999999
No 408
>PHA02865 MHC-like TNF binding protein; Provisional
Probab=83.00 E-value=3.7 Score=47.07 Aligned_cols=37 Identities=16% Similarity=0.414 Sum_probs=26.1
Q ss_pred CCCeeeecCCceeecCCCeEEEEEEEeeCCCCCcEEEEeeC
Q psy2148 915 KAPEFLTTPTDLTLAESTLAHFECRLTPTNDPSMTVEWFHN 955 (1884)
Q Consensus 915 ~~p~~~~~~~~~~v~~G~~v~l~C~v~~~~~P~~~v~W~~~ 955 (1884)
.||.+....+.. .+ .++|.|.+.|.-.....++|.||
T Consensus 202 vpP~V~Vt~k~~---~~-~~tL~C~A~GFYP~~I~v~W~kd 238 (338)
T PHA02865 202 VTPTVKVTGEEL---GD-NTTLFCTFDSHYPSSVAAKWYNS 238 (338)
T ss_pred CCCceEEecccC---CC-CceEEEEEEeEeCCccEEEEEec
Confidence 566665433311 12 57999999987667778999999
No 409
>PHA03282 envelope glycoprotein E; Provisional
Probab=81.93 E-value=13 Score=43.79 Aligned_cols=36 Identities=14% Similarity=0.111 Sum_probs=24.8
Q ss_pred EEEEeeeccCCCeEEEEEEEecCc--ceEEEEEEEEeC
Q psy2148 1484 AMNFGWVYPEDSGEYLCRATNLYG--MDETRAILKTTG 1519 (1884)
Q Consensus 1484 ~L~i~~~~~~d~G~Y~c~a~n~~G--~~~~~~~l~V~~ 1519 (1884)
+|.|.+++.+|+|.|+..+...-. ...+.+.|.|.-
T Consensus 125 tl~l~~a~~~DsG~Y~L~~~~~~~~~~~~~~v~l~V~p 162 (540)
T PHA03282 125 TLVLREARETDSGMYVLSVSRAPNSTAARAVVFLVVGP 162 (540)
T ss_pred eEEEeeccccCCceEEEEecCCCCchhheEEEEEEecC
Confidence 599999999999999999753321 133345555543
No 410
>PHA03286 envelope glycoprotein E; Provisional
Probab=81.56 E-value=20 Score=42.18 Aligned_cols=37 Identities=11% Similarity=0.099 Sum_probs=30.4
Q ss_pred EEEEEeeeccCCCeEEEEEEEecCcceEEE-EEEEEeC
Q psy2148 1483 VAMNFGWVYPEDSGEYLCRATNLYGMDETR-AILKTTG 1519 (1884)
Q Consensus 1483 ~~L~i~~~~~~d~G~Y~c~a~n~~G~~~~~-~~l~V~~ 1519 (1884)
..|+|.+++..++|.|+.-..|+.|....+ +.|.|.+
T Consensus 127 ~~L~I~nAt~qnaGiYtly~rnd~~~~~~~vflVtV~~ 164 (492)
T PHA03286 127 KELTILNASSQNAGIYIRYSRNGTRTAVMDVLVVWVSG 164 (492)
T ss_pred CceEEeeccccccceEEEEEcCCCCcEEEEEEEEEEec
Confidence 469999999999999999999988776655 4557753
No 411
>PF06832 BiPBP_C: Penicillin-Binding Protein C-terminus Family; InterPro: IPR009647 This conserved region of approximately 90 residues is found in a sub-group of bacterial Penicillin-Binding Proteins (PBPs). A variable length loop region separates this region from the transpeptidase unit (IPR001460 from INTERPRO). It is predicted to be a beta fold.
Probab=78.79 E-value=20 Score=32.89 Aligned_cols=75 Identities=19% Similarity=0.309 Sum_probs=45.7
Q ss_pred CCCCeEEEccCCcccccc-c--cceEEEEEEeeCCCCCCeEEEeecCeecCCCCCceeeeeCceEEEEEeeeccCCCeEE
Q psy2148 1422 KQPPRFVTQIKTQDQLVE-M--QSTKFECQLAPVGDPNMKVEWFLNGKPLPHKNRFNPIYDFGYVAMNFGWVYPEDSGEY 1498 (1884)
Q Consensus 1422 ~~pP~~~~~~~~~~~v~~-g--~~~~l~C~~~~~g~p~~~i~W~~~~~~l~~~~~~~~~~~~~~~~L~i~~~~~~d~G~Y 1498 (1884)
..+|+|+.+......... + +...|.+++. |. ...+.|+-||..+......+ .+.+ .+...|.|
T Consensus 8 ~~~l~I~~P~~g~~~~~~~~~~~~~~l~l~a~--~~-~~~~~W~vdg~~~g~~~~~~--------~~~~---~~~~~G~h 73 (89)
T PF06832_consen 8 GSPLRITSPPDGAVLALDPGIPERQPLVLKAA--GG-RGPVYWFVDGEPLGTTQPGH--------QLFW---QPDRPGEH 73 (89)
T ss_pred CCCCEEEecCCCCEEEeCCCCCccceEEEEEe--CC-CCcEEEEECCEEcccCCCCC--------eEEe---CCCCCeeE
Confidence 456777766554432222 1 2445555554 44 44999999999994332211 2332 25688999
Q ss_pred EEEEEecCcceE
Q psy2148 1499 LCRATNLYGMDE 1510 (1884)
Q Consensus 1499 ~c~a~n~~G~~~ 1510 (1884)
+.++.+..|...
T Consensus 74 ~l~vvD~~G~~~ 85 (89)
T PF06832_consen 74 TLTVVDAQGRSA 85 (89)
T ss_pred EEEEEcCCCCEE
Confidence 999999888644
No 412
>PF05790 C2-set: Immunoglobulin C2-set domain; InterPro: IPR008424 The basic structure of immunoglobulin (Ig) molecules is a tetramer of two light chains and two heavy chains linked by disulphide bonds. There are two types of light chains: kappa and lambda, each composed of a constant domain (CL) and a variable domain (VL). There are five types of heavy chains: alpha, delta, epsilon, gamma and mu, all consisting of a variable domain (VH) and three (in alpha, delta and gamma) or four (in epsilon and mu) constant domains (CH1 to CH4). Ig molecules are highly modular proteins, in which the variable and constant domains have clear, conserved sequence patterns. The domains in Ig and Ig-like molecules are grouped into four types: V-set (variable; IPR013106 from INTERPRO), C1-set (constant-1; IPR003597 from INTERPRO), C2-set (constant-2; IPR008424 from INTERPRO) and I-set (intermediate; IPR013098 from INTERPRO) []. Structural studies have shown that these domains share a common core Greek-key beta-sandwich structure, with the types differing in the number of strands in the beta-sheets as well as in their sequence patterns [, ]. Immunoglobulin-like domains that are related in both sequence and structure can be found in several diverse protein families. Ig-like domains are involved in a variety of functions, including cell-cell recognition, cell-surface receptors, muscle structure and the immune system []. This entry represents C2-set domains, which are Ig-like domains resembling the antibody constant domain. C2-set domains are found primarily in the mammalian T-cell surface antigens CD2 (Cluster of Differentiation 2), CD4 and CD80, as well as in vascular (VCAM) and intercellular (ICAM) cell adhesion molecules. CD2 mediates T-cell adhesion via its ectodomain, and signal transduction utilising its 117-amino acid cytoplasmic tail []. CD2 displays structural and functional similarities with African swine fever virus (ASFV) LMW8-DR, a protein that is involved in cell-cell adhesion and immune response modulation, suggesting a possible role in the pathogenesis of ASFV infection []. CD4 is the primary receptor for HIV-1. CD4 has four immunoglobulin-like domains in its extracellular region that share the same structure, but can differ in sequence. Certain extracellular domains may be involved in dimerisation [].; GO: 0007155 cell adhesion, 0016021 integral to membrane; PDB: 1CID_A 1CDU_A 1WIQ_B 2NY4_B 2NY2_B 1WIP_B 1WIO_A 3S4S_G 1CDY_A 3S5L_G ....
Probab=77.44 E-value=16 Score=32.60 Aligned_cols=52 Identities=25% Similarity=0.404 Sum_probs=33.9
Q ss_pred CcEEEEEeCCEecCCCCCeEEeecCCeEEEEEccCCCCCCEEEEEEE-EeCCeeEEEEEEEEE
Q psy2148 1771 PLDVYWLKNGKKIIPDIRYKTLEEDNLFTLLIIEAVVEDSGAYECVA-MNNAGEARCEAELVV 1832 (1884)
Q Consensus 1771 ~p~v~W~k~~~~l~~~~~~~~~~~~~~~~L~i~~~~~~d~G~Y~C~a-~N~~G~~~~~~~l~V 1832 (1884)
.+.+.|+-.+..+. .... .+.......+|+|.+.|.| .|..-.....+.|.|
T Consensus 26 ~~~~~l~~~~~k~~-------~~~~---~~~~~~~~~~d~G~w~C~a~~~~~k~~~s~~~i~v 78 (80)
T PF05790_consen 26 KPSLFLENPGKKSL-------ETKK---LVSTFTPTTEDSGTWVCTASDNEPKERESKIEILV 78 (80)
T ss_dssp CEEEEEECSSCEEE-------EESS---EEEEESBTCGGSEEEEEEEEECTTEEEEEEEEEEE
T ss_pred ChhheeeccCcccc-------ccce---EEEEecCCCCCCEEEEEEEcCCceEEEEEEEEEEc
Confidence 46777876554331 1111 5666777889999999999 666655555566555
No 413
>PF03921 ICAM_N: Intercellular adhesion molecule (ICAM), N-terminal domain; InterPro: IPR013768 Intercellular adhesion molecules (ICAMs) and vascular cell adhesion molecule-1 (VCAM-1) are part of the immunoglobulin superfamily. They are important in inflammation, immune responses and in intracellular signalling events []. The ICAM family consists of five members, designated ICAM-1 to ICAM-5. They are known to bind to leucocyte integrins CD11/CD18 during inflammation and in immune responses. In addition, ICAMs may exist in soluble forms in human plasma, due to activation and proteolysis mechanisms at cell surfaces. ICAM-1 (CD54) contains five Ig-like domains. It is expressed on leucocytes, endothelial and epithelial cells, and is upregulated in response to bacterial invasion. The protein is a ligand for lymphocyte-function associated (LFA) antigens and also a receptor for CD11a,b/CD18, fibrinogen, human rhinovirus and Plasmodium falciparum-infected erythrocytes. ICAM-1 binding sites for CD11a/CD18 and its other binding partners are located in the first domain and are overlapping. ICAM-1 domain 2 seems to play an important role in maintaining the conformation of domain 1 and particularly the structural integrity of the LFA-1 ligand-binding site []. The 3-dimensional atomic structure of the tandem N-terminal Ig-like domains (D1 and D2) of ICAM-1 has been determined to 2.2A resolution and fitted into a cryoelectron microscopy reconstruction of a rhinovirus-ICAM-1 complex []. Extensive charge interactions between ICAM-1 and human rhinovirusesare largely conserved in major and minor receptor groups of rhinoviruses. The interaction of ICAMs with LFA-1 is mediated by a divalent cation bound to the insertion (I)-domain on the alpha chain of LFA-1 and the carboxyl group of a conserved glutamic acid residue on ICAMs. ICAM-2 (CD102) has two Ig-like domains. It is expressed on endothelial cells, leucocytes and platelets, and binds to CD11a'b/CD18. The protein is refractory to proinflammatory cytokines, and plays an important role in the adhesion of leucocytes to the uninduced endothelium []. ICAM-3 (CD50) contains five Ig-like domains and binds to leucocyte integrins CD11a'd/CD18. The protein plays an important role in the immune response and perhaps in signal transduction []. ICAM-4 (LW blood group Ag) is red blood cell (RBC) specific and binds to CD11a'b/CD18. It is associated with the RBC Rh antigens and could be important in retaining immature red cells in the bone marrow, or in the uptake of senescent cells into the spleen []. ICAM-5 (telencephalin) has nine Ig-like domains and is confined to the telencephalon of the brain. The role of this CD11a/CD18 binding molecule is not yet known []. VCAM-1 was first described as a cytokine-inducible endothelial adhesion molecule. It can bind to leucocyte integrin VL-4 (very late antigen-4) to recruit leucocytes to sites of inflammation []. The predominant form of VCAM-1 in vivo has an N-terminal extracellular region comprising seven Ig-like domains []. A conserved integrin-binding motif has been identified in domains 1 and 4, variants of which are present in the N-terminal domain of all members of the integrin-binding subgroup of the immunoglobulin superfamily. The structure of a VLA-4-binding fragment comprising the first two domains of VCAM-1 has been determined to 1.8A resolution. The integrin-binding motif is exposed and forms the N-terminal region of the loop between beta-strands C and D of domain 1 []. VCAM-1 domains 1 and 2 are structurally similar to ICAM-1 and ICAM-2 []. This entry represents the N-terminal domain of ICAM proteins such as ICAM-2, ICAM-3 and ICAM-4.; PDB: 3BN3_B 1T0P_B 1ZXQ_A 3TCX_A 1MQ8_A 1Z7Z_I 1IC1_A 1IAM_A.
Probab=77.13 E-value=23 Score=32.38 Aligned_cols=86 Identities=14% Similarity=0.106 Sum_probs=50.6
Q ss_pred eeEeecceeeeecCCcEEEEEEEeecCCCcceEEEecccccccccccccceEEEeeccceeeeeeeeeeeeceEEEEEee
Q psy2148 1266 RFITEIESVTVQEAEPVRFETRVEPRVDPRLRVECSLSTAFFFPFINISTAFLIFNFCLHAVIFSHPIFDLGFVSLDIDY 1345 (1884)
Q Consensus 1266 ~~~~~~~~~~v~~g~~v~l~c~v~~~~~p~~~~~W~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~I~~ 1345 (1884)
.+...|....|..|+++.+.|+.+- ..|. .+-|...-.. .......+-..+.+.+
T Consensus 5 ~v~v~P~~~vV~~G~Sv~VNCStsC-~~p~-~~GLET~L~k-----------------------~~~~~g~~W~~f~Lsn 59 (91)
T PF03921_consen 5 EVRVSPEEPVVPPGGSVWVNCSTSC-PQPE-KIGLETSLSK-----------------------TELDSGPQWKAFQLSN 59 (91)
T ss_dssp -EEEESSEEEEETTEEEEEEEEESS-SS-S-EEEEESSSEE-----------------------EEEEEETTEEEEEEEE
T ss_pred EEEEECCccEECCCCCEEEEEcCCC-CCCC-cceEEEecCC-----------------------cccCCCCcEEEEEEEc
Confidence 3556788899999999999999764 2222 3344422110 0111112234577888
Q ss_pred ecccCceEEEEEEEccccceeeeEEEEEeecCc
Q psy2148 1346 VYPEDQGEYVCRAYNDHGEAFTKATISCKKIPT 1378 (1884)
Q Consensus 1346 ~~~~d~G~Y~C~a~n~~g~~~~~~~l~v~~~p~ 1378 (1884)
++. | ..-.|.+.-.......++.|+|+.+|.
T Consensus 60 V~~-d-s~~~C~~~C~g~Q~~~~~~ItVY~~Pe 90 (91)
T PF03921_consen 60 VTE-D-SSPLCFFNCSGEQSSASANITVYKPPE 90 (91)
T ss_dssp E-S-C-EEEEEEEEETTEEEEEEEEEEEEB--S
T ss_pred ccc-C-CeEEEEEEcCCeEEEeEEeeEEeCCCC
Confidence 886 4 467798885333556678999998874
No 414
>PF05790 C2-set: Immunoglobulin C2-set domain; InterPro: IPR008424 The basic structure of immunoglobulin (Ig) molecules is a tetramer of two light chains and two heavy chains linked by disulphide bonds. There are two types of light chains: kappa and lambda, each composed of a constant domain (CL) and a variable domain (VL). There are five types of heavy chains: alpha, delta, epsilon, gamma and mu, all consisting of a variable domain (VH) and three (in alpha, delta and gamma) or four (in epsilon and mu) constant domains (CH1 to CH4). Ig molecules are highly modular proteins, in which the variable and constant domains have clear, conserved sequence patterns. The domains in Ig and Ig-like molecules are grouped into four types: V-set (variable; IPR013106 from INTERPRO), C1-set (constant-1; IPR003597 from INTERPRO), C2-set (constant-2; IPR008424 from INTERPRO) and I-set (intermediate; IPR013098 from INTERPRO) []. Structural studies have shown that these domains share a common core Greek-key beta-sandwich structure, with the types differing in the number of strands in the beta-sheets as well as in their sequence patterns [, ]. Immunoglobulin-like domains that are related in both sequence and structure can be found in several diverse protein families. Ig-like domains are involved in a variety of functions, including cell-cell recognition, cell-surface receptors, muscle structure and the immune system []. This entry represents C2-set domains, which are Ig-like domains resembling the antibody constant domain. C2-set domains are found primarily in the mammalian T-cell surface antigens CD2 (Cluster of Differentiation 2), CD4 and CD80, as well as in vascular (VCAM) and intercellular (ICAM) cell adhesion molecules. CD2 mediates T-cell adhesion via its ectodomain, and signal transduction utilising its 117-amino acid cytoplasmic tail []. CD2 displays structural and functional similarities with African swine fever virus (ASFV) LMW8-DR, a protein that is involved in cell-cell adhesion and immune response modulation, suggesting a possible role in the pathogenesis of ASFV infection []. CD4 is the primary receptor for HIV-1. CD4 has four immunoglobulin-like domains in its extracellular region that share the same structure, but can differ in sequence. Certain extracellular domains may be involved in dimerisation [].; GO: 0007155 cell adhesion, 0016021 integral to membrane; PDB: 1CID_A 1CDU_A 1WIQ_B 2NY4_B 2NY2_B 1WIP_B 1WIO_A 3S4S_G 1CDY_A 3S5L_G ....
Probab=76.54 E-value=13 Score=33.10 Aligned_cols=52 Identities=19% Similarity=0.086 Sum_probs=32.8
Q ss_pred CeEEEeecCeecCCCCCceeeeeCceEEEEEeeeccCCCeEEEEEE-EecCcceEEEEEEEEe
Q psy2148 1457 MKVEWFLNGKPLPHKNRFNPIYDFGYVAMNFGWVYPEDSGEYLCRA-TNLYGMDETRAILKTT 1518 (1884)
Q Consensus 1457 ~~i~W~~~~~~l~~~~~~~~~~~~~~~~L~i~~~~~~d~G~Y~c~a-~n~~G~~~~~~~l~V~ 1518 (1884)
+++.|.-.+....... ..+.....+..|+|.+.|+| .|..-..+....|.|.
T Consensus 27 ~~~~l~~~~~k~~~~~----------~~~~~~~~~~~d~G~w~C~a~~~~~k~~~s~~~i~v~ 79 (80)
T PF05790_consen 27 PSLFLENPGKKSLETK----------KLVSTFTPTTEDSGTWVCTASDNEPKERESKIEILVL 79 (80)
T ss_dssp EEEEEECSSCEEEEES----------SEEEEESBTCGGSEEEEEEEEECTTEEEEEEEEEEEE
T ss_pred hhheeeccCccccccc----------eEEEEecCCCCCCEEEEEEEcCCceEEEEEEEEEEcC
Confidence 6677775554432211 13445566789999999999 6666555566666553
No 415
>PRK14081 triple tyrosine motif-containing protein; Provisional
Probab=75.50 E-value=2.6e+02 Score=36.25 Aligned_cols=230 Identities=12% Similarity=0.112 Sum_probs=113.1
Q ss_pred ccCCCceEEEEEEEEEcCCCceEEEEeeCCEeeccccceEEEeeCCeEEEEEcCCCCCCCEEEEEEEE--cCCee----e
Q psy2148 319 NLSEGEIAHFEASLIPVGDQTMTVEFLYNGKPIEASHRIRTVHAFGMVVLEILGTKIEDTGVYTCRAT--NKWGQ----A 392 (1884)
Q Consensus 319 ~v~~g~~~~l~c~~~~~g~p~~~i~W~k~g~~i~~~~~~~~~~~~~~~~L~I~~~~~~D~G~Y~C~a~--n~~g~----~ 392 (1884)
....|+.+.|.+.+ .|.-...+...-.|..+... .+. ....+.. .++.+|.|...+. ..... +
T Consensus 301 ~ql~g~~I~ika~a--~GG~~llYrf~I~G~~~e~~-~Y~-----~~n~~~w---~P~~~G~Y~I~v~VKDk~S~~eyD~ 369 (667)
T PRK14081 301 PQLTDTDIELKAVA--EGGKELLYRFIIKGKESEDS-GYI-----RNNIYTW---KPKIAGKYSITLWVKDISSKGEYED 369 (667)
T ss_pred CeecCceEEEEEEe--cCCCceEEEEEECCcEEeec-ccc-----ccceEEE---eeCCCceEEEEEEEEcCcCcccccc
Confidence 35678999998876 44445566655556554321 111 1112222 4456899987765 32222 2
Q ss_pred EEEEEEEEeecCCCCCCc-eEeccCC-ccCccCCCeEEEEEEEeeCCCCCCeEEE--eeCCEEccccCcEEEEecCCEEE
Q psy2148 393 EISVNLECVDKSKGQPPK-FTSHIKS-LEGLKDGDSAHFECTLTPVNDPELKVEW--FHNGKPIFHKNRVKMVSDFGFVV 468 (1884)
Q Consensus 393 ~~~~~l~V~~~~~~~~p~-~~~~~~~-~~~v~~G~~v~L~C~~~~~~~p~~~i~W--~k~g~~l~~~~~~~~~~~~~~~~ 468 (1884)
...+.+.+... ...|. +...+.+ ...+..|+.+.+.|.+.+ + -...+.. .++|..+...+ + .... .
T Consensus 370 ~~~v~f~i~~~--~~~p~~I~~vl~d~~~~~lvG~~i~i~v~a~g-g-~~~lY~f~ik~ng~~ve~~~-Y---~~~~--~ 439 (667)
T PRK14081 370 KSSIDYTIEEK--SKEPIKIEDVILDKGKHILKGEEIKIRVIAEG-G-TNLRYSFIIKKDGKEEEKID-Y---GKNN--W 439 (667)
T ss_pred eEEEEEEEccc--CCCCeEEEEEEECCCCceEeCCeEEEEEEecC-C-CeEEEEEEEEECCEEEEEee-c---cccc--E
Confidence 34445555421 12343 3332222 234668999999999984 3 3333332 44676654311 1 0111 2
Q ss_pred EEEcccCCCCcEEEEEEEE--eCceec---CCcc--eEEeecccC-C--CCCCCccccCCCCeEEEEEEEeeCCCCccEE
Q psy2148 469 MDIAYVQSHDSGEYVCRAW--NNFIFI---PPFP--IFIFHQIRL-P--SPSQDNLDVPEAGKVHFDCRLEPKSDPTMRI 538 (1884)
Q Consensus 469 L~i~~v~~~d~G~Y~C~a~--n~~~~~---~~~~--~~~~~~~~~-~--~~~~~~~~v~~g~~~~L~C~~~~~~~p~~~i 538 (1884)
+. ..+.-+|.|+..+. |..... .... +.+....+. . .+.+.......|+.+++.|.+++..+....+
T Consensus 440 ~~---f~P~~~G~Y~IeV~vKdk~S~~~yD~~k~v~l~V~e~~P~~i~~il~~~~~~~~vg~~i~~~~~~~~~k~v~y~y 516 (667)
T PRK14081 440 VN---FIPEEKGNYELEVRVKDKYSDKEYDAHTIVYIKVHEYIPAEIDYILLPVKEYYLVGDDIEIEVIIQNTKDVLIKY 516 (667)
T ss_pred EE---EEECCCeeEEEEEEEecccCchhcccceEEEEEEeccCceeeeeEEecccccEEeCCEEEEEEEEeCCCeEEEEE
Confidence 32 23467899988664 333321 1111 111111111 0 1123334567899999999998543333344
Q ss_pred EEeeCCeeecCCCceEEEeeCceEEEEEccccccccEEEEEEE
Q psy2148 539 DWFFNGRPFATGSRVKTVYDFGFISLDMDYVYARDSGEYICRA 581 (1884)
Q Consensus 539 ~W~~~~~~l~~~~~~~~~~~~~~~~L~i~~~~~~d~G~Y~C~a 581 (1884)
.-+.+|....... + .... .+++ .+.-+|.|+..+
T Consensus 517 ~~~~NG~~v~~t~-Y---s~~~--~ysf---~P~~~GkY~I~V 550 (667)
T PRK14081 517 ILKINGHKVEETD-Y---IKNK--KYKF---IPKCSGKYTIEV 550 (667)
T ss_pred EEEECCEEEEEee-c---cccc--eEEE---eecCCceEEEEE
Confidence 4444665442211 0 0111 2222 256788998765
No 416
>PF02480 Herpes_gE: Alphaherpesvirus glycoprotein E; InterPro: IPR003404 Glycoprotein E (gE) of Alphaherpesvirus forms a complex with glycoprotein I (gI), functioning as an immunoglobulin G (IgG) Fc binding protein. gE is involved in virus spread but is not essential for propagation [].; GO: 0016020 membrane; PDB: 2GJ7_F 2GIY_B.
Probab=75.36 E-value=4.8 Score=49.22 Aligned_cols=85 Identities=22% Similarity=0.330 Sum_probs=15.2
Q ss_pred eeEEEEcccccCCCeEEEEEEEeCCceEEE-EEEEEEEecccCCCCCCCCCe-----------E-EeccCceEEcCCceE
Q psy2148 1694 KSILIMRQVFMEDSGVFAVIAENRGGKAKC-SANLVVEEKRQGGRGGVVPPS-----------F-LTTISSAVINVGQLA 1760 (1884)
Q Consensus 1694 ~~~L~i~~v~~~DsG~Y~C~a~n~~g~~~~-~~~l~V~~~~~~~~~~~~~P~-----------~-~~~~~~~~~~~G~~~ 1760 (1884)
.+.|.|.+++.+|+|.|+....+..+.... .+.|.|.++...+ ...+|. | ....+......|+++
T Consensus 88 ~~~l~i~~a~~~~~GvY~l~~~~~~~~~~~~~~~v~v~~~~~~~--~~p~p~~p~~p~~~~~~~~~~~~~s~vf~~Gdtf 165 (439)
T PF02480_consen 88 KGGLSILNATEQDSGVYTLYVRNDSGWAHQSVVFVTVKGPAPDP--RTPPPHHPIVPHRHGATFHLKNYHSHVFSPGDTF 165 (439)
T ss_dssp ------------------------------------------------------------SEEEEEE--SEEE--TT--E
T ss_pred CCceEEeccccccCeeEEEEecCCCCceEEEEEEEEEcCCCcCC--CCCCCCCCCCCcccccEEEEeccceEEecCCCcE
Confidence 356999999999999999999887666543 3566666533321 112232 1 123344555789999
Q ss_pred EEEEEEecCCC------cEEEEEeCC
Q psy2148 1761 RFDAKISATKP------LDVYWLKNG 1780 (1884)
Q Consensus 1761 ~l~C~~~g~p~------p~v~W~k~~ 1780 (1884)
.+...+..... .+|.|+.-.
T Consensus 166 ~~~v~l~~~~~d~~~f~~~i~W~~~~ 191 (439)
T PF02480_consen 166 HLSVHLQSEAHDDPPFSLEIDWYYMP 191 (439)
T ss_dssp E---EEEEEESSS--EEEEEEEEEE-
T ss_pred EEeEEEEeccCCCCCeeEEEEEEEec
Confidence 88888754221 369998543
No 417
>PF06832 BiPBP_C: Penicillin-Binding Protein C-terminus Family; InterPro: IPR009647 This conserved region of approximately 90 residues is found in a sub-group of bacterial Penicillin-Binding Proteins (PBPs). A variable length loop region separates this region from the transpeptidase unit (IPR001460 from INTERPRO). It is predicted to be a beta fold.
Probab=73.97 E-value=33 Score=31.47 Aligned_cols=74 Identities=16% Similarity=0.263 Sum_probs=46.0
Q ss_pred CCCeEEeccCceEEcC--C--ceEEEEEEEecCCCcEEEEEeCCEecCCCCCeEEeecCCeEEEEEccCCCCCCEEEEEE
Q psy2148 1741 VPPSFLTTISSAVINV--G--QLARFDAKISATKPLDVYWLKNGKKIIPDIRYKTLEEDNLFTLLIIEAVVEDSGAYECV 1816 (1884)
Q Consensus 1741 ~~P~~~~~~~~~~~~~--G--~~~~l~C~~~g~p~p~v~W~k~~~~l~~~~~~~~~~~~~~~~L~i~~~~~~d~G~Y~C~ 1816 (1884)
.+|+|........+.. + +...|.+.+.+. .+.+.||.||..+....... .+.+. ....|.|+..
T Consensus 9 ~~l~I~~P~~g~~~~~~~~~~~~~~l~l~a~~~-~~~~~W~vdg~~~g~~~~~~--------~~~~~---~~~~G~h~l~ 76 (89)
T PF06832_consen 9 SPLRITSPPDGAVLALDPGIPERQPLVLKAAGG-RGPVYWFVDGEPLGTTQPGH--------QLFWQ---PDRPGEHTLT 76 (89)
T ss_pred CCCEEEecCCCCEEEeCCCCCccceEEEEEeCC-CCcEEEEECCEEcccCCCCC--------eEEeC---CCCCeeEEEE
Confidence 4566665544443322 2 356777777776 55999999999983322111 22222 3467999999
Q ss_pred EEeCCeeEEE
Q psy2148 1817 AMNNAGEARC 1826 (1884)
Q Consensus 1817 a~N~~G~~~~ 1826 (1884)
+....|....
T Consensus 77 vvD~~G~~~~ 86 (89)
T PF06832_consen 77 VVDAQGRSAS 86 (89)
T ss_pred EEcCCCCEEE
Confidence 9888887554
No 418
>PHA03052 Hypothetical protein; Provisional
Probab=70.69 E-value=14 Score=30.81 Aligned_cols=37 Identities=14% Similarity=0.319 Sum_probs=29.4
Q ss_pred CceeecCCCeEEEEEEEe-eCCCCCcEEEEeeCCEEcc
Q psy2148 924 TDLTLAESTLAHFECRLT-PTNDPSMTVEWFHNGKALS 960 (1884)
Q Consensus 924 ~~~~v~~G~~v~l~C~v~-~~~~P~~~v~W~~~g~~i~ 960 (1884)
..+.+..|+.++|.|++. |.+...+.|.|.-|+..+.
T Consensus 5 ~~i~~slGs~ltI~Ckv~lg~g~~~a~V~W~~N~~~~e 42 (69)
T PHA03052 5 EGIVTSLGSNLTITCKVSLRPPTTDADVFWISNGMYYE 42 (69)
T ss_pred ccEEEEccCCceEeEEEEecCCCcceEEEEEeCCcEEe
Confidence 456788899999999997 3344456799999999883
No 419
>PHA03281 envelope glycoprotein E; Provisional
Probab=64.24 E-value=2.6e+02 Score=34.37 Aligned_cols=82 Identities=18% Similarity=0.206 Sum_probs=50.3
Q ss_pred EEEEEcCCCCCCCEEEEEEEEcCCeeeEE-EEEEEEeecCC--CCCCceEecc---------CCccCccCCCeEEEEEEE
Q psy2148 366 VVLEILGTKIEDTGVYTCRATNKWGQAEI-SVNLECVDKSK--GQPPKFTSHI---------KSLEGLKDGDSAHFECTL 433 (1884)
Q Consensus 366 ~~L~I~~~~~~D~G~Y~C~a~n~~g~~~~-~~~l~V~~~~~--~~~p~~~~~~---------~~~~~v~~G~~v~L~C~~ 433 (1884)
..|+|.+++..++|.|+-......|.... .+-|.|..... ..+|.+.... -.......|+++.|.-..
T Consensus 298 ~vL~I~nAT~~naGVYtly~rg~~G~s~~svfLVtVkg~~~~rip~p~Vtpk~hga~F~vknYhShVF~pGDTFsl~v~L 377 (642)
T PHA03281 298 GVLKFEHMEAHHAGVYIWNLQGSDGENMYATFLVKLKGDEENHIDLPAVTPKPKGAEFHMWHYHSHVFSVGDTFSLAMHL 377 (642)
T ss_pred CeeEEEecccccceeEEEEecCCCCcceeEEEEEEecCCcccCCCCCCccccccCceEEEeccceeEecCCCeeEEEEEE
Confidence 47999999999999999888866665443 55566654331 1122222111 112234689999888877
Q ss_pred eeCC-CC--CCeEEEee
Q psy2148 434 TPVN-DP--ELKVEWFH 447 (1884)
Q Consensus 434 ~~~~-~p--~~~i~W~k 447 (1884)
...- .. ...+.||.
T Consensus 378 ~s~ihD~pFsleI~Wyy 394 (642)
T PHA03281 378 QYKIHDAPFDLLLEWLY 394 (642)
T ss_pred eeeccCCCceeEEEEEE
Confidence 6321 11 36889987
No 420
>KOG1026|consensus
Probab=63.72 E-value=7.5 Score=49.87 Aligned_cols=165 Identities=17% Similarity=0.182 Sum_probs=96.2
Q ss_pred ceeecCCCeEEEEEEEeeCCCCCcEEEEeeCCEEccCCCcEEEEeeCCeEEEEEccCCCCCCeEEEEEEEcCCeeEEEEE
Q psy2148 925 DLTLAESTLAHFECRLTPTNDPSMTVEWFHNGKALSAGSRIKTINDFGFVILEINDVYLRDSGLYTCKATNKHGEATTSC 1004 (1884)
Q Consensus 925 ~~~v~~G~~v~l~C~v~~~~~P~~~v~W~~~g~~i~~~~~~~~~~~~~~~~L~I~~~~~~D~G~Y~C~a~N~~G~~~~~~ 1004 (1884)
...+..|..+++.|.+. +.|-|.+.|+.++....+......... .. ...+.+ ++|.++|..|....++
T Consensus 201 ~~~v~~~~~~~~~c~~~--~~~vp~~~~~~~~~~~~~~~~~~~~c~-~~-~~~~~~--------~~c~~E~~~~~~~~~v 268 (774)
T KOG1026|consen 201 NLTVEEGSSITLKCSQA--GIPVPCHYWFPNCLASSNTNQTSSLCR-SE-CEVLEN--------DLCIAENAVARSNPSI 268 (774)
T ss_pred hhhhcccchheeeeecc--cCCCcceeeecccccccCCCccccccc-cc-ceeeec--------hhhHHHHhhhhcCcee
Confidence 45678899999999998 778889999998877665443222111 11 122222 9999999999988888
Q ss_pred EEEEEeecccccccchhHhHhcchhhHHHHHHhhcccCcCCCCCCCCCCCceeeecCCCcCcCCCCcEEEEEEEee-CCC
Q psy2148 1005 KLTVKGRQGIDVEPQVSAIFANATKNIQKLEEALYRKDELIPDEEKPNPPVFTSQLQDNLDVPEAGKVHFDCRLEP-KSD 1083 (1884)
Q Consensus 1005 ~l~V~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~v~~g~~~~l~C~v~~-~~~ 1083 (1884)
.+.+..++...... .| .++ .=.|...+ .+.
T Consensus 269 ~~~~~~p~~~~~~~----------------------------------~~-------------~~~--~~~C~~~~~~~~ 299 (774)
T KOG1026|consen 269 LLVVDLPKAEVLLC----------------------------------SP-------------LSD--HHNCIPIGITAN 299 (774)
T ss_pred eeEEecccccccCC----------------------------------CC-------------ccc--cCceeeeeccCC
Confidence 77776432211000 00 000 11222221 145
Q ss_pred CCcEEEEEECCEeccCCCceEEEeeCcEEEEEEcccCcCCcEEEEEEEEcCCeeeEEEEEEEEeecc
Q psy2148 1084 PTMRIDWFFNGRPFATGSRVKTVYDFGFISLDMDYVYARDSGEYICRATNKWGTAMTKAKVICKAKH 1150 (1884)
Q Consensus 1084 p~~~v~W~k~~~~l~~~~~~~~~~~~~~~~l~i~~~~~~d~G~Y~C~a~n~~G~~~~~~~l~v~~~~ 1150 (1884)
|.+.-.|..++..+.-.........+....+........+.|.|+|.+.|..|.........+...|
T Consensus 300 ~~~~~~~~~~~~~~~~~g~~~~t~s~~~~C~~~~~~~h~~~~~~~~~~e~~~g~~~~r~~g~~~~~P 366 (774)
T KOG1026|consen 300 PGPALHWCYNGSGLNYRGTVCVTKSGKEQCLPWNDPPHSHNGNYTLFPELPGGKNYCRNPGGFMSRP 366 (774)
T ss_pred CCCceeeeecCccceEecccccccccCcCCcccCcCcccccCcceeeecccCccccccCcCccccCC
Confidence 6677788887766432211111111100122223335677999999999999988776666655444
No 421
>PF03921 ICAM_N: Intercellular adhesion molecule (ICAM), N-terminal domain; InterPro: IPR013768 Intercellular adhesion molecules (ICAMs) and vascular cell adhesion molecule-1 (VCAM-1) are part of the immunoglobulin superfamily. They are important in inflammation, immune responses and in intracellular signalling events []. The ICAM family consists of five members, designated ICAM-1 to ICAM-5. They are known to bind to leucocyte integrins CD11/CD18 during inflammation and in immune responses. In addition, ICAMs may exist in soluble forms in human plasma, due to activation and proteolysis mechanisms at cell surfaces. ICAM-1 (CD54) contains five Ig-like domains. It is expressed on leucocytes, endothelial and epithelial cells, and is upregulated in response to bacterial invasion. The protein is a ligand for lymphocyte-function associated (LFA) antigens and also a receptor for CD11a,b/CD18, fibrinogen, human rhinovirus and Plasmodium falciparum-infected erythrocytes. ICAM-1 binding sites for CD11a/CD18 and its other binding partners are located in the first domain and are overlapping. ICAM-1 domain 2 seems to play an important role in maintaining the conformation of domain 1 and particularly the structural integrity of the LFA-1 ligand-binding site []. The 3-dimensional atomic structure of the tandem N-terminal Ig-like domains (D1 and D2) of ICAM-1 has been determined to 2.2A resolution and fitted into a cryoelectron microscopy reconstruction of a rhinovirus-ICAM-1 complex []. Extensive charge interactions between ICAM-1 and human rhinovirusesare largely conserved in major and minor receptor groups of rhinoviruses. The interaction of ICAMs with LFA-1 is mediated by a divalent cation bound to the insertion (I)-domain on the alpha chain of LFA-1 and the carboxyl group of a conserved glutamic acid residue on ICAMs. ICAM-2 (CD102) has two Ig-like domains. It is expressed on endothelial cells, leucocytes and platelets, and binds to CD11a'b/CD18. The protein is refractory to proinflammatory cytokines, and plays an important role in the adhesion of leucocytes to the uninduced endothelium []. ICAM-3 (CD50) contains five Ig-like domains and binds to leucocyte integrins CD11a'd/CD18. The protein plays an important role in the immune response and perhaps in signal transduction []. ICAM-4 (LW blood group Ag) is red blood cell (RBC) specific and binds to CD11a'b/CD18. It is associated with the RBC Rh antigens and could be important in retaining immature red cells in the bone marrow, or in the uptake of senescent cells into the spleen []. ICAM-5 (telencephalin) has nine Ig-like domains and is confined to the telencephalon of the brain. The role of this CD11a/CD18 binding molecule is not yet known []. VCAM-1 was first described as a cytokine-inducible endothelial adhesion molecule. It can bind to leucocyte integrin VL-4 (very late antigen-4) to recruit leucocytes to sites of inflammation []. The predominant form of VCAM-1 in vivo has an N-terminal extracellular region comprising seven Ig-like domains []. A conserved integrin-binding motif has been identified in domains 1 and 4, variants of which are present in the N-terminal domain of all members of the integrin-binding subgroup of the immunoglobulin superfamily. The structure of a VLA-4-binding fragment comprising the first two domains of VCAM-1 has been determined to 1.8A resolution. The integrin-binding motif is exposed and forms the N-terminal region of the loop between beta-strands C and D of domain 1 []. VCAM-1 domains 1 and 2 are structurally similar to ICAM-1 and ICAM-2 []. This entry represents the N-terminal domain of ICAM proteins such as ICAM-2, ICAM-3 and ICAM-4.; PDB: 3BN3_B 1T0P_B 1ZXQ_A 3TCX_A 1MQ8_A 1Z7Z_I 1IC1_A 1IAM_A.
Probab=61.73 E-value=1.3e+02 Score=27.62 Aligned_cols=83 Identities=12% Similarity=0.148 Sum_probs=52.7
Q ss_pred eecCCceeecCCCeEEEEEEEeeCCCCCcEEEEeeCCEEccCCCcEEEEeeCCeEEEEEccCCCCCCeEEEEEEEcCCee
Q psy2148 920 LTTPTDLTLAESTLAHFECRLTPTNDPSMTVEWFHNGKALSAGSRIKTINDFGFVILEINDVYLRDSGLYTCKATNKHGE 999 (1884)
Q Consensus 920 ~~~~~~~~v~~G~~v~l~C~v~~~~~P~~~v~W~~~g~~i~~~~~~~~~~~~~~~~L~I~~~~~~D~G~Y~C~a~N~~G~ 999 (1884)
...|+...|..|+++.++|..+. ..|. .+.|.-. -.+.......+...+.+.|++. | ..-.|.+.-...+
T Consensus 7 ~v~P~~~vV~~G~Sv~VNCStsC-~~p~-~~GLET~------L~k~~~~~g~~W~~f~LsnV~~-d-s~~~C~~~C~g~Q 76 (91)
T PF03921_consen 7 RVSPEEPVVPPGGSVWVNCSTSC-PQPE-KIGLETS------LSKTELDSGPQWKAFQLSNVTE-D-SSPLCFFNCSGEQ 76 (91)
T ss_dssp EEESSEEEEETTEEEEEEEEESS-SS-S-EEEEESS------SEEEEEEEETTEEEEEEEEE-S-C-EEEEEEEEETTEE
T ss_pred EEECCccEECCCCCEEEEEcCCC-CCCC-cceEEEe------cCCcccCCCCcEEEEEEEcccc-C-CeEEEEEEcCCeE
Confidence 35677889999999999999863 3332 3344321 1122222333444678889886 4 5778999876556
Q ss_pred EEEEEEEEEEeec
Q psy2148 1000 ATTSCKLTVKGRQ 1012 (1884)
Q Consensus 1000 ~~~~~~l~V~~~~ 1012 (1884)
...++.|+|..+|
T Consensus 77 ~~~~~~ItVY~~P 89 (91)
T PF03921_consen 77 SSASANITVYKPP 89 (91)
T ss_dssp EEEEEEEEEEB--
T ss_pred EEeEEeeEEeCCC
Confidence 7788899998765
No 422
>PHA03286 envelope glycoprotein E; Provisional
Probab=58.84 E-value=87 Score=37.29 Aligned_cols=86 Identities=14% Similarity=0.154 Sum_probs=54.8
Q ss_pred eeEEEEcccccCCCeEEEEEEEeCCceEEEE-EEEEEEecccCCCCC----CCCC----eEE-eccCceEEcCCceEEEE
Q psy2148 1694 KSILIMRQVFMEDSGVFAVIAENRGGKAKCS-ANLVVEEKRQGGRGG----VVPP----SFL-TTISSAVINVGQLARFD 1763 (1884)
Q Consensus 1694 ~~~L~i~~v~~~DsG~Y~C~a~n~~g~~~~~-~~l~V~~~~~~~~~~----~~~P----~~~-~~~~~~~~~~G~~~~l~ 1763 (1884)
.+.|+|.+++.+++|.|+-...|..|....+ +-|+|.++.+.+... ..|+ .|. ...++..-..|+++.+.
T Consensus 126 ~~~L~I~nAt~qnaGiYtly~rnd~~~~~~~vflVtV~~~~~~r~p~~~~pv~p~~~~~~f~l~ny~S~lF~~GDTF~vS 205 (492)
T PHA03286 126 GKELTILNASSQNAGIYIRYSRNGTRTAVMDVLVVWVSGHGRARDPTMNIPITPPSTRVDLSLKNFKAFLYNVGDTVDAS 205 (492)
T ss_pred CCceEEeeccccccceEEEEEcCCCCcEEEEEEEEEEecCCCCCCCCcccCCCCcccceEEEEecccceEecCCCeEEEE
Confidence 3569999999999999999999988776654 456675443322111 1111 122 23344555789999888
Q ss_pred EEEec-----CCCcEEEEEeC
Q psy2148 1764 AKISA-----TKPLDVYWLKN 1779 (1884)
Q Consensus 1764 C~~~g-----~p~p~v~W~k~ 1779 (1884)
..... .-..+|.|+.-
T Consensus 206 v~l~~~~~d~~Fsl~i~W~y~ 226 (492)
T PHA03286 206 VTAHLTNWAGAFSLEFRVLFL 226 (492)
T ss_pred EEEeecccCCCceEEEEEEEe
Confidence 77662 11357999753
No 423
>PF11141 DUF2914: Protein of unknown function (DUF2914); InterPro: IPR022606 This bacterial family of proteins has no known function.
Probab=53.09 E-value=78 Score=27.10 Aligned_cols=58 Identities=17% Similarity=0.260 Sum_probs=37.6
Q ss_pred CeeEEEECCeecCCCCcEEEEEeCC-EEEEEECcCCCCCcEEEEEEEEeCceeEEEEEEEEE
Q psy2148 9 LKIEWFKNGVPLSLGSRIRSTFDFG-LVTLSINSLRADDSAIYTCKATNLLGEAVSTCTLKI 69 (1884)
Q Consensus 9 ~~v~W~k~g~~l~~~~~~~~~~~~~-~~~L~I~~~~~~D~G~Y~C~a~n~~g~~~~~~~l~V 69 (1884)
....|++||+.+.. +.....++ -++..-..+...+.|.+++.+....|.........|
T Consensus 7 v~H~W~~~g~~~~~---i~l~i~g~r~Rt~S~k~~~~~~~G~WrV~V~~~~G~~l~~~~F~V 65 (66)
T PF11141_consen 7 VYHRWYKNGKLVAR---IPLPISGGRWRTWSSKQNFPDQPGDWRVEVVDEDGQVLGSLRFSV 65 (66)
T ss_pred EEEEEEECCEEEEE---EEEeccCCCEEEEEEeecCCCCCcCEEEEEEcCCCCEEEEEEEEE
Confidence 46799999987542 11111111 133333445558999999999999998777766655
No 424
>PF02440 Adeno_E3_CR1: Adenovirus E3 region protein CR1; InterPro: IPR003471 Early region 3 (E3) of human adenoviruses (Ads) codes for proteins that appear to control viral interactions with the host []. This region called CR1 (conserved region 1) [] is found three times in Human adenovirus 19 (a subgroup D virus) 49 Kd protein in the E3 region. CR1 is also found in the 20.1 Kd protein of subgroup B adenoviruses. The function of this 80 amino acid region is unknown. This region is probably a divergent immunoglobulin domain.
Probab=52.14 E-value=27 Score=29.28 Aligned_cols=21 Identities=14% Similarity=0.428 Sum_probs=15.6
Q ss_pred ecCCCeEEEEEEEeeCCCCCcEEEEee
Q psy2148 928 LAESTLAHFECRLTPTNDPSMTVEWFH 954 (1884)
Q Consensus 928 v~~G~~v~l~C~v~~~~~P~~~v~W~~ 954 (1884)
|..|+.++|. |.|...|+||+
T Consensus 2 v~~G~N~TL~------Gp~~~~V~Wy~ 22 (63)
T PF02440_consen 2 VTVGSNVTLV------GPPDGPVTWYK 22 (63)
T ss_pred EeEcCcEEEe------CCCCCceEEEE
Confidence 5668888875 65667899994
No 425
>cd05890 Ig2_Nectin-1_like Second immunoglobulin (Ig) domain of nectin-1 (also known as poliovirus receptor related protein 1, or as CD111) and similar proteins. Ig2_Nectin-1_like: domain similar to the second immunoglobulin (Ig) domain of nectin-1 (also known as poliovirus receptor related protein 1, or as CD111). Nectin-1 belongs to the nectin family comprised of four transmembrane glycoproteins (nectins-1 through 4). Nectins are synaptic cell adhesion molecules (CAMs) which facilitate adhesion and signaling at various intracellular junctions. Nectins form homophilic cis-dimers, followed by homophilic and heterophilic trans-dimers involved in cell-cell adhesion. Nectins also heterophilically trans-interact with other CAMs such as nectin-like molecules (necls); nectin-1 for example, has been shown to trans-interact with necl-1. Nectins also interact with various other proteins, including the actin filament (F-actin)-binding protein, afadin. Mutation in the human nectin-1 gene is associ
Probab=50.67 E-value=46 Score=30.37 Aligned_cols=67 Identities=10% Similarity=0.169 Sum_probs=38.9
Q ss_pred EEEEEEEeecCCCCCeEEEee--CCcc----CC-CCCCeEEEeeCCEEEEEEcccCcCCCeEEEEEEEecCceEEEEEEE
Q psy2148 725 AHFEARLTPTDDPKLKVEWFW--NGKP----MK-TGSRFRTFCDFGFVILEISPVYPEDCGQYSCRAYNDYGEAVTSASM 797 (1884)
Q Consensus 725 ~~l~C~~~~~g~p~~~v~W~k--~g~~----l~-~~~~~~~~~~~~~~~L~i~~~~~~d~G~Y~C~a~N~~g~~~~~~~l 797 (1884)
+.-.|... .|+|+..|+|.- +|.. .. .+..+.+. +.+.+-+....|.-..+|.+.+..-.-..++.|
T Consensus 23 ~VA~CiSa-~GrPpa~ItW~t~l~G~~etq~~~~~~GT~TV~-----S~y~lVPs~~~~gk~lTCvV~h~~~~~~~~~~L 96 (98)
T cd05890 23 LVATCVSA-NGKPPSVVRWDTRLKGEAEFQEIRNQNGTVTVI-----SRYRLVPSREAHKQKLTCIVNYRNDRFTDSVTL 96 (98)
T ss_pred EEEEEEcC-CCcCCcEeEEEccCCCceeeeeeCCCCCCEEEE-----EEEEEeECHHHcCCEeEEEEEeccccccccEEe
Confidence 34457643 589999999984 3321 00 01112211 235666777788889999998864443334443
No 426
>PHA03189 UL14 tegument protein; Provisional
Probab=48.82 E-value=1.1e+02 Score=34.25 Aligned_cols=74 Identities=18% Similarity=0.317 Sum_probs=41.5
Q ss_pred CceeecCCCeEEEEEEEeeCCCCCcEEE-----Eee----------CCEEccCCCcEEEEe------eCC---eEEEEEc
Q psy2148 924 TDLTLAESTLAHFECRLTPTNDPSMTVE-----WFH----------NGKALSAGSRIKTIN------DFG---FVILEIN 979 (1884)
Q Consensus 924 ~~~~v~~G~~v~l~C~v~~~~~P~~~v~-----W~~----------~g~~i~~~~~~~~~~------~~~---~~~L~I~ 979 (1884)
..+.+.+|+.+++.|.+-...=|...|+ |.- .|.++.+.-.+++.+ +.+ ..+|++
T Consensus 60 AP~l~pyGdrvtVpC~fp~H~WPevsIrarfCys~e~s~eLv~da~~G~~l~ndl~~~L~~~~W~Fedlg~aq~ltLtF- 138 (348)
T PHA03189 60 APLLVPYGDRVTVPCTFPTHDWPEVSIRARFCYSPERSRELVVDADSGGELHNDLTYRLPEASWKFEDLGAAQRLTLTF- 138 (348)
T ss_pred CccccCCCceeeeeeeecCCCCceeeEEEEEeeccccceEEEEEcccCCEeccccceecccceeeeecccceeEEEEEE-
Confidence 3456788999999999863223443333 321 233333333332221 111 223443
Q ss_pred cCCCCCCeEEEEEEEcCCe
Q psy2148 980 DVYLRDSGLYTCKATNKHG 998 (1884)
Q Consensus 980 ~~~~~D~G~Y~C~a~N~~G 998 (1884)
++..+-+|.|.|+..|..-
T Consensus 139 ~v~t~taG~Y~CvLrN~tH 157 (348)
T PHA03189 139 RVSTSTAGMYECVLRNETH 157 (348)
T ss_pred EEEecccceEEEEeccccc
Confidence 4556779999999999743
No 427
>smart00089 PKD Repeats in polycystic kidney disease 1 (PKD1) and other proteins. Polycystic kidney disease 1 protein contains 14 repeats, present elsewhere such as in microbial collagenases.
Probab=46.75 E-value=1.5e+02 Score=26.20 Aligned_cols=64 Identities=20% Similarity=0.235 Sum_probs=38.7
Q ss_pred cCCceEEEEEEEec-CCCcEEEEEeCCEecCCCCCeEEeecCCeEEEEEccCCCCCCEEEEE--EEEeCCeeEEEEEEEE
Q psy2148 1755 NVGQLARFDAKISA-TKPLDVYWLKNGKKIIPDIRYKTLEEDNLFTLLIIEAVVEDSGAYEC--VAMNNAGEARCEAELV 1831 (1884)
Q Consensus 1755 ~~G~~~~l~C~~~g-~p~p~v~W~k~~~~l~~~~~~~~~~~~~~~~L~i~~~~~~d~G~Y~C--~a~N~~G~~~~~~~l~ 1831 (1884)
..|..+.|.+...+ .....+.|.+++.....+... .+ .....|.|+. .+.|..|.......+.
T Consensus 12 ~~~~~v~f~~~~~~~~~~~~~~W~fgdg~~~~~~~~---------~~-----~y~~~G~y~v~l~v~n~~g~~~~~~~i~ 77 (79)
T smart00089 12 VAGESVTFTATSSDDGSIVSYTWDFGDGTSSTGPTV---------TH-----TYTKPGTYTVTLTVTNAVGSASATVTVV 77 (79)
T ss_pred CCCCEEEEEEECCCCCCeEEEEEEeCCCCccCCCCE---------EE-----EeCCCcEEEEEEEEEcCCCcEEEEEEEE
Confidence 36888999988765 335678898766532211111 11 2235677764 4588888666666665
Q ss_pred E
Q psy2148 1832 V 1832 (1884)
Q Consensus 1832 V 1832 (1884)
|
T Consensus 78 v 78 (79)
T smart00089 78 V 78 (79)
T ss_pred E
Confidence 5
No 428
>PHA03052 Hypothetical protein; Provisional
Probab=46.41 E-value=59 Score=27.42 Aligned_cols=35 Identities=20% Similarity=0.298 Sum_probs=27.8
Q ss_pred cccccccCCceEEEEEEe---cCCCCeEEEEEcCEEee
Q psy2148 1570 EAQKVQEGEPARFCTRVT---GYPRPRVMWLINGHTIV 1604 (1884)
Q Consensus 1570 ~~~~v~~g~~~~l~C~~~---g~p~~~v~W~~~g~~i~ 1604 (1884)
....+.-|..+++.|.+. |...+.|-|..|+..+.
T Consensus 5 ~~i~~slGs~ltI~Ckv~lg~g~~~a~V~W~~N~~~~e 42 (69)
T PHA03052 5 EGIVTSLGSNLTITCKVSLRPPTTDADVFWISNGMYYE 42 (69)
T ss_pred ccEEEEccCCceEeEEEEecCCCcceEEEEEeCCcEEe
Confidence 455678899999999995 33356899999998873
No 429
>PHA03112 IL-18 binding protein; Provisional
Probab=42.28 E-value=57 Score=32.32 Aligned_cols=69 Identities=17% Similarity=0.265 Sum_probs=38.5
Q ss_pred cCCceEEEEEEEecC-CC-cEEEEEeCC-EecCCC-------------CCeEEeecCCeEEEEEccCCCC-CCEEEEEEE
Q psy2148 1755 NVGQLARFDAKISAT-KP-LDVYWLKNG-KKIIPD-------------IRYKTLEEDNLFTLLIIEAVVE-DSGAYECVA 1817 (1884)
Q Consensus 1755 ~~G~~~~l~C~~~g~-p~-p~v~W~k~~-~~l~~~-------------~~~~~~~~~~~~~L~i~~~~~~-d~G~Y~C~a 1817 (1884)
.+|+++.|+|.+.++ |. --+.|.+++ +.+... .+..-........|.+.+++.+ ..-..+|+.
T Consensus 36 k~~~~vvL~C~gcs~fp~fS~lYWl~gn~~s~~d~~~~~hy~e~~~~~~~~~~~~~~~~~~l~l~~vt~~~~~T~~TCVL 115 (141)
T PHA03112 36 KETEKVVLECRGCSYFPKFSYVYWLIGNNKSDVDQKPIEHYGEGIYESEKPRTCDNEPRTDLIVYNVTDEMKFTKLTCVL 115 (141)
T ss_pred CCCCEEEEEEECccCCCCceEEEEEcCCCccchhccccccccccccCCccccccCCcceeEEEEEecCCcceecceEEEE
Confidence 459999999999875 65 358899776 332211 1111111223446666666643 222677776
Q ss_pred EeCCee
Q psy2148 1818 MNNAGE 1823 (1884)
Q Consensus 1818 ~N~~G~ 1823 (1884)
.-..|.
T Consensus 116 ~D~~~~ 121 (141)
T PHA03112 116 MDLDGP 121 (141)
T ss_pred ecCCch
Confidence 554443
No 430
>PF09191 CD4-extracel: CD4, extracellular; InterPro: IPR015274 This domain adopts an immunoglobulin-like beta-sandwich with seven strands in 2 beta sheets, in a Greek key topology. It is predominantly found in the extracellular portion of CD4 proteins, where it enables interaction with major histocompatibility complex class II antigens []. ; PDB: 1WIQ_B 1WIP_B 1WIO_A 3T0E_E 1CID_A.
Probab=40.84 E-value=1.5e+02 Score=27.48 Aligned_cols=34 Identities=26% Similarity=0.241 Sum_probs=28.0
Q ss_pred EEEEcccccCCCeEEEEEEEeCCceEEEEEEEEE
Q psy2148 1696 ILIMRQVFMEDSGVFAVIAENRGGKAKCSANLVV 1729 (1884)
Q Consensus 1696 ~L~i~~v~~~DsG~Y~C~a~n~~g~~~~~~~l~V 1729 (1884)
+|+|..+...++|.=.....-..|.....++|.|
T Consensus 75 ~ltL~q~l~q~AGSGnltL~L~~G~L~QeVnLVV 108 (108)
T PF09191_consen 75 TLTLPQALPQYAGSGNLTLTLDKGKLHQEVNLVV 108 (108)
T ss_dssp EEEESSB-GGG-EEEEEEEEBTTSEEEEEEEEEE
T ss_pred EEEccccChhhcCCceEEEEecCCcEeeEEEeeC
Confidence 6999999999999888888888899888888876
No 431
>PHA03240 envelope glycoprotein M; Provisional
Probab=40.51 E-value=42 Score=35.03 Aligned_cols=95 Identities=20% Similarity=0.194 Sum_probs=50.1
Q ss_pred eEEcCCceEEEEEEEecCCCcEEEEEe-------CC-E---ec---CC---CC---------CeEEeecCCeEEEEEccC
Q psy2148 1752 AVINVGQLARFDAKISATKPLDVYWLK-------NG-K---KI---IP---DI---------RYKTLEEDNLFTLLIIEA 1805 (1884)
Q Consensus 1752 ~~~~~G~~~~l~C~~~g~p~p~v~W~k-------~~-~---~l---~~---~~---------~~~~~~~~~~~~L~i~~~ 1805 (1884)
..+.+|++|+|.-.---.|.-.+.|++ ++ . ++ .+ +. ...+...-..++|.|.++
T Consensus 33 vt~r~G~nVTLga~~~lhpgq~v~Wy~~~c~~~~G~G~~~~plC~Ytppk~~r~ktl~~t~~nt~i~y~C~NstL~i~~v 112 (258)
T PHA03240 33 HTTREGDPLLLGGGHGLGAGQKAHWYKHKCDGITGNGDKLHPICTYDPPKNGKGKTLDESAENSFILYECHNSTLIIAHL 112 (258)
T ss_pred cccccCCceeeCCcccCCCCCEEEEEeeecccccCCCCCCceeEEecCCccccccccccccCCCceEEEeccceEEEEEE
Confidence 445678888885443334566788888 21 1 11 01 00 111122223459999999
Q ss_pred CCCCCEEEEEEEEeCCeeE---E-EEEEEEE--EecCCCCCCCCCCC
Q psy2148 1806 VVEDSGAYECVAMNNAGEA---R-CEAELVV--QSKKAPGKQAPAPG 1846 (1884)
Q Consensus 1806 ~~~d~G~Y~C~a~N~~G~~---~-~~~~l~V--~~~~~~~~~~~~~~ 1846 (1884)
..+|.|+|.-.---..|.. + .=++|.| ..+....|+.+.|+
T Consensus 113 n~sd~~nYcr~k~~~~g~~e~pt~sC~~l~~r~iskTTtkKP~~~pt 159 (258)
T PHA03240 113 NLSDAGEYCRKKCPPKGDCEFPTMSCFRLILRPISKTTSKKPEQGPT 159 (258)
T ss_pred eecCcchhhhccCCCCCCcCCCcceeeeEeeeehhcccccCCCCCCC
Confidence 9999999843322223432 2 2356777 44444444444444
No 432
>cd05890 Ig2_Nectin-1_like Second immunoglobulin (Ig) domain of nectin-1 (also known as poliovirus receptor related protein 1, or as CD111) and similar proteins. Ig2_Nectin-1_like: domain similar to the second immunoglobulin (Ig) domain of nectin-1 (also known as poliovirus receptor related protein 1, or as CD111). Nectin-1 belongs to the nectin family comprised of four transmembrane glycoproteins (nectins-1 through 4). Nectins are synaptic cell adhesion molecules (CAMs) which facilitate adhesion and signaling at various intracellular junctions. Nectins form homophilic cis-dimers, followed by homophilic and heterophilic trans-dimers involved in cell-cell adhesion. Nectins also heterophilically trans-interact with other CAMs such as nectin-like molecules (necls); nectin-1 for example, has been shown to trans-interact with necl-1. Nectins also interact with various other proteins, including the actin filament (F-actin)-binding protein, afadin. Mutation in the human nectin-1 gene is associ
Probab=39.99 E-value=76 Score=29.08 Aligned_cols=71 Identities=8% Similarity=0.168 Sum_probs=41.0
Q ss_pred eEEEEEE-EecCCCcEEEEEeCCEecCCCCCeEEe--ecCC---eEEEEEccCCCCCCEEEEEEEEeCCeeEEEEEEEEE
Q psy2148 1759 LARFDAK-ISATKPLDVYWLKNGKKIIPDIRYKTL--EEDN---LFTLLIIEAVVEDSGAYECVAMNNAGEARCEAELVV 1832 (1884)
Q Consensus 1759 ~~~l~C~-~~g~p~p~v~W~k~~~~l~~~~~~~~~--~~~~---~~~L~i~~~~~~d~G~Y~C~a~N~~G~~~~~~~l~V 1832 (1884)
.+--.|. +.|.|++.|+|.-+ |......+.. .++. .+.+.+......|.-..+|.+.....+...++.|.|
T Consensus 22 v~VA~CiSa~GrPpa~ItW~t~---l~G~~etq~~~~~~GT~TV~S~y~lVPs~~~~gk~lTCvV~h~~~~~~~~~~L~v 98 (98)
T cd05890 22 MLVATCVSANGKPPSVVRWDTR---LKGEAEFQEIRNQNGTVTVISRYRLVPSREAHKQKLTCIVNYRNDRFTDSVTLNV 98 (98)
T ss_pred EEEEEEEcCCCcCCcEeEEEcc---CCCceeeeeeCCCCCCEEEEEEEEEeECHHHcCCEeEEEEEeccccccccEEecC
Confidence 3556888 57899999999633 1111111111 1111 224555556667777999999877555555555543
No 433
>PHA03189 UL14 tegument protein; Provisional
Probab=38.20 E-value=1.7e+02 Score=32.89 Aligned_cols=26 Identities=23% Similarity=0.337 Sum_probs=19.0
Q ss_pred EEEEe-eecccCceEEEEEEEccccce
Q psy2148 1340 SLDID-YVYPEDQGEYVCRAYNDHGEA 1365 (1884)
Q Consensus 1340 ~L~I~-~~~~~d~G~Y~C~a~n~~g~~ 1365 (1884)
.|++. ++..+-+|.|.|...|.....
T Consensus 133 ~ltLtF~v~t~taG~Y~CvLrN~tHgl 159 (348)
T PHA03189 133 RLTLTFRVSTSTAGMYECVLRNETHGL 159 (348)
T ss_pred EEEEEEEEEecccceEEEEecccccee
Confidence 34444 677888999999999865433
No 434
>PHA03240 envelope glycoprotein M; Provisional
Probab=35.16 E-value=40 Score=35.16 Aligned_cols=83 Identities=18% Similarity=0.279 Sum_probs=48.2
Q ss_pred ceeecCCCeEEEEEEEeeCCCCCcEEEEee-------C-C---EEc----c--CCC---------cEEEEeeCCeEEEEE
Q psy2148 925 DLTLAESTLAHFECRLTPTNDPSMTVEWFH-------N-G---KAL----S--AGS---------RIKTINDFGFVILEI 978 (1884)
Q Consensus 925 ~~~v~~G~~v~l~C~v~~~~~P~~~v~W~~-------~-g---~~i----~--~~~---------~~~~~~~~~~~~L~I 978 (1884)
++++++|++|+|.-.-- -.|--.+.||+ + | .+| . ++. ...+...-..++|.|
T Consensus 32 evt~r~G~nVTLga~~~--lhpgq~v~Wy~~~c~~~~G~G~~~~plC~Ytppk~~r~ktl~~t~~nt~i~y~C~NstL~i 109 (258)
T PHA03240 32 EHTTREGDPLLLGGGHG--LGAGQKAHWYKHKCDGITGNGDKLHPICTYDPPKNGKGKTLDESAENSFILYECHNSTLII 109 (258)
T ss_pred ecccccCCceeeCCccc--CCCCCEEEEEeeecccccCCCCCCceeEEecCCccccccccccccCCCceEEEeccceEEE
Confidence 46778899999974321 23566899999 1 1 122 0 000 111222223468999
Q ss_pred ccCCCCCCeEEEEEEEcCCeeE---EE-EEEEEEE
Q psy2148 979 NDVYLRDSGLYTCKATNKHGEA---TT-SCKLTVK 1009 (1884)
Q Consensus 979 ~~~~~~D~G~Y~C~a~N~~G~~---~~-~~~l~V~ 1009 (1884)
.++..+|.|+|.-.-.-..|.. +. =+.|+|.
T Consensus 110 ~~vn~sd~~nYcr~k~~~~g~~e~pt~sC~~l~~r 144 (258)
T PHA03240 110 AHLNLSDAGEYCRKKCPPKGDCEFPTMSCFRLILR 144 (258)
T ss_pred EEEeecCcchhhhccCCCCCCcCCCcceeeeEeee
Confidence 9999999999965544444543 22 2466664
No 435
>PF00801 PKD: PKD domain; InterPro: IPR000601 The PKD (Polycystic Kidney Disease) domain was first identified in the Polycystic Kidney Disease protein, polycystin-1 (PDK1 gene), and contains an Ig-like fold consisting of a beta-sandwich of seven strands in two sheets with a Greek key topology, although some members have additional strands []. Polycystin-1 is a large cell-surface glycoprotein involved in adhesive protein-protein and protein-carbohydrate interactions; however it is not clear if the PKD domain mediates any of these interactions. PKD domains are also found in other proteins, usually in the extracellular parts of proteins involved in interactions with other proteins. For example, domains with a PKD-type fold are found in archaeal surface layer proteins that protect the cell from extreme environments [], and in the human VPS10 domain-containing receptor SorCS2 [].; PDB: 1B4R_A 2KZW_A 2C4X_A 2C26_A 2Y72_B 3JQU_A 3JS7_B 1WGO_A 1L0Q_A.
Probab=31.30 E-value=1.3e+02 Score=25.75 Aligned_cols=60 Identities=22% Similarity=0.321 Sum_probs=36.0
Q ss_pred eEEcCCceEEEEEEEecCCCcEEEEEeCC-EecCCCCCeEEeecCCeEEEEEccCCCCCCEEEEE--EEEeCCeeEE
Q psy2148 1752 AVINVGQLARFDAKISATKPLDVYWLKNG-KKIIPDIRYKTLEEDNLFTLLIIEAVVEDSGAYEC--VAMNNAGEAR 1825 (1884)
Q Consensus 1752 ~~~~~G~~~~l~C~~~g~p~p~v~W~k~~-~~l~~~~~~~~~~~~~~~~L~i~~~~~~d~G~Y~C--~a~N~~G~~~ 1825 (1884)
..+..|+.++|...........+.|..++ .... .+.....+. ...|.|.. .|.|..|...
T Consensus 6 ~~~~~g~~v~f~~~~~~g~~~~y~W~fgd~~~~~---------~~~~~t~ty-----~~~G~y~V~ltv~n~~g~~t 68 (69)
T PF00801_consen 6 TYVPTGQPVTFTASSSDGSPVTYSWDFGDNGTVS---------TGSSVTHTY-----SSPGTYTVTLTVTNGVGSAT 68 (69)
T ss_dssp SCEBTTSEEEEEETTTTSSECEEEEE-SSESEEE---------CSSEEEEEE-----SSSEEEEEEEEEEETTSEEE
T ss_pred CEEcCCCEEEEEEEccCCCCeEEEEEECCCCccc---------cCCCEEEEc-----CCCeEEEEEEEEEECCCCcC
Confidence 45678999999988833335689999998 2221 122222222 23688864 4578877654
No 436
>KOG0200|consensus
Probab=30.86 E-value=6.3e+02 Score=33.27 Aligned_cols=110 Identities=22% Similarity=0.238 Sum_probs=60.1
Q ss_pred EEEEEcCCCCCCCEEEEEEEEcCCeeeEEEEEEEEeecCCCCCCceEeccCCccCccCCCeEEEEEEEeeCCCCCCeEEE
Q psy2148 366 VVLEILGTKIEDTGVYTCRATNKWGQAEISVNLECVDKSKGQPPKFTSHIKSLEGLKDGDSAHFECTLTPVNDPELKVEW 445 (1884)
Q Consensus 366 ~~L~I~~~~~~D~G~Y~C~a~n~~g~~~~~~~l~V~~~~~~~~p~~~~~~~~~~~v~~G~~v~L~C~~~~~~~p~~~i~W 445 (1884)
..+.+..+...|.|.|+|.+.| ......+. .. ....+.+............+....+ .. ..+...+.|
T Consensus 13 ~~~~~~~~~~~~~~~y~~~~~~----~~~~~~~~--~~-~~~~~~~~~~~~~~~~~~~~~~~~~-~~----~~~~~~~~~ 80 (609)
T KOG0200|consen 13 WFLIIDSVVPGDKGFYTCLVSN----INLIISLD--DI-VIHRPILLAGENANPNTVVTVGVPL-AF----SIPQPFIKW 80 (609)
T ss_pred ceEEEEEEEecCCccEEEEEec----CceeeEee--cc-cCcccccccCCCCCcceeeccccee-ee----ecCCCccee
Confidence 3567777889999999999999 11222222 11 1122222222222222445555666 22 222666778
Q ss_pred eeCCEEc-----cccC-----------cEEEEecCCEEEEEEcccCCCCcEEEEEEEEe
Q psy2148 446 FHNGKPI-----FHKN-----------RVKMVSDFGFVVMDIAYVQSHDSGEYVCRAWN 488 (1884)
Q Consensus 446 ~k~g~~l-----~~~~-----------~~~~~~~~~~~~L~i~~v~~~d~G~Y~C~a~n 488 (1884)
....... .... ..... +.....+.+.++...+.|.|.|...+
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~n~~~~~~~~~~~~~~~ 138 (609)
T KOG0200|consen 81 GTNLEIECEDGLFEYKTKKTLSFVEIEYNRLV-DGTFESGLIYNVSLTEAGEYLCWTGR 138 (609)
T ss_pred eeeecccccccCcchhheeeeeeeeccccccc-cCceEeeeeeccChhhcceeeccCCC
Confidence 7654211 0000 00011 33556788999999999999998876
No 437
>PRK14081 triple tyrosine motif-containing protein; Provisional
Probab=29.85 E-value=1.4e+03 Score=29.96 Aligned_cols=188 Identities=15% Similarity=0.173 Sum_probs=109.6
Q ss_pred ceeecCCCeEEEEEEEeccCCCeEE-E-EeCCeecCCCCCeEEEEeCceeEEEEcccccCCCeEEEEEEE--eCCc----
Q psy2148 1648 PCRAFEQDQARFEVEFDGDPLPTIK-W-FREDFPITSSPDFQIHTFSTKSILIMRQVFMEDSGVFAVIAE--NRGG---- 1719 (1884)
Q Consensus 1648 ~~~v~~G~~~~l~C~~~g~p~~~i~-W-~~~~~~~~~~~~~~~~~~~~~~~L~i~~v~~~DsG~Y~C~a~--n~~g---- 1719 (1884)
......|+++.+.|.+.|.-...+. | .++|..+... ..+....+.+. +.-+|.|+..+. |...
T Consensus 395 ~~~~lvG~~i~i~v~a~gg~~~lY~f~ik~ng~~ve~~------~Y~~~~~~~f~---P~~~G~Y~IeV~vKdk~S~~~y 465 (667)
T PRK14081 395 GKHILKGEEIKIRVIAEGGTNLRYSFIIKKDGKEEEKI------DYGKNNWVNFI---PEEKGNYELEVRVKDKYSDKEY 465 (667)
T ss_pred CCceEeCCeEEEEEEecCCCeEEEEEEEEECCEEEEEe------ecccccEEEEE---ECCCeeEEEEEEEecccCchhc
Confidence 3567789999999999876544443 3 3466654321 11122223333 478999998754 3322
Q ss_pred eEEEEEEEEEEecccCCCCCCCCCe-EE--eccCceEEcCCceEEEEEEEecCCCcEEE--EEeCCEecCCCCCeEEeec
Q psy2148 1720 KAKCSANLVVEEKRQGGRGGVVPPS-FL--TTISSAVINVGQLARFDAKISATKPLDVY--WLKNGKKIIPDIRYKTLEE 1794 (1884)
Q Consensus 1720 ~~~~~~~l~V~~~~~~~~~~~~~P~-~~--~~~~~~~~~~G~~~~l~C~~~g~p~p~v~--W~k~~~~l~~~~~~~~~~~ 1794 (1884)
.....+.+.|.+ ..|. +. ..+.......|+.++|+|.+.|.-...+. -+.||...... .| ..
T Consensus 466 D~~k~v~l~V~e---------~~P~~i~~il~~~~~~~~vg~~i~~~~~~~~~k~v~y~y~~~~NG~~v~~t-~Y---s~ 532 (667)
T PRK14081 466 DAHTIVYIKVHE---------YIPAEIDYILLPVKEYYLVGDDIEIEVIIQNTKDVLIKYILKINGHKVEET-DY---IK 532 (667)
T ss_pred ccceEEEEEEec---------cCceeeeeEEecccccEEeCCEEEEEEEEeCCCeEEEEEEEEECCEEEEEe-ec---cc
Confidence 245677888876 4565 33 23445667899999999999986444333 24455443111 11 11
Q ss_pred CCeEEEEEccCCCCCCEEEEEEE--EeCCe----eEEEEEEEEEEecCCCCCCCCCCCCcccCCCCCee--eccCcceec
Q psy2148 1795 DNLFTLLIIEAVVEDSGAYECVA--MNNAG----EARCEAELVVQSKKAPGKQAPAPGAAVAQDEAPTV--AEPLKDQNV 1866 (1884)
Q Consensus 1795 ~~~~~L~i~~~~~~d~G~Y~C~a--~N~~G----~~~~~~~l~V~~~~~~~~~~~~~~~~~~~~~~p~~--~~~~~~~~~ 1866 (1884)
.. .+++. +--+|.|+..+ .|... .+...+.+.|.+.. |.. ........+
T Consensus 533 ~~--~ysf~---P~~~GkY~I~V~aKn~~s~~~~D~~k~v~~~V~e~~------------------pi~nt~~~~~~~~~ 589 (667)
T PRK14081 533 NK--KYKFI---PKCSGKYTIEVLAKNIKSTEEYDSKKEVKFYVREAL------------------PITNTKIKTSKKKF 589 (667)
T ss_pred cc--eEEEe---ecCCceEEEEEEEcccccccccccceEEEEEEcCCC------------------CceeeEEEeecceE
Confidence 11 22222 55679998765 45443 23456778887521 222 112344566
Q ss_pred cCCCcEEEEEEEEe
Q psy2148 1867 KEGSAVTLKCRITG 1880 (1884)
Q Consensus 1867 ~~G~~~~l~C~~~g 1880 (1884)
..|+.++|...+.|
T Consensus 590 ~~n~~~t~~~~~~g 603 (667)
T PRK14081 590 KCNEEVTFSVKSEG 603 (667)
T ss_pred EcCCeEEEEEEccC
Confidence 77888888877765
No 438
>KOG0200|consensus
Probab=28.74 E-value=1.8e+02 Score=38.31 Aligned_cols=125 Identities=17% Similarity=0.161 Sum_probs=73.4
Q ss_pred ceeEEEEcccccCCCeEEEEEEEeCCceEEEEEEEEEEecccCCCCCCCCCeEE-eccCceEEcCCceEEEEEEEecCCC
Q psy2148 1693 TKSILIMRQVFMEDSGVFAVIAENRGGKAKCSANLVVEEKRQGGRGGVVPPSFL-TTISSAVINVGQLARFDAKISATKP 1771 (1884)
Q Consensus 1693 ~~~~L~i~~v~~~DsG~Y~C~a~n~~g~~~~~~~l~V~~~~~~~~~~~~~P~~~-~~~~~~~~~~G~~~~l~C~~~g~p~ 1771 (1884)
....+.+..+...|.|.|+|.+.| . .....+. +... ..+.+. ..+.......+....+ +...+.
T Consensus 11 ~~~~~~~~~~~~~~~~~y~~~~~~--~--~~~~~~~--~~~~------~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~ 75 (609)
T KOG0200|consen 11 NHWFLIIDSVVPGDKGFYTCLVSN--I--NLIISLD--DIVI------HRPILLAGENANPNTVVTVGVPL---AFSIPQ 75 (609)
T ss_pred ccceEEEEEEEecCCccEEEEEec--C--ceeeEee--cccC------cccccccCCCCCcceeeccccee---eeecCC
Confidence 345688899999999999999998 1 1122222 1100 122222 2344444555666666 433346
Q ss_pred cEEEEEeCCEec-----CCCCC-----------eEEeecCCeEEEEEccCCCCCCEEEEEEEEeCCeeEEEEEEEEEE
Q psy2148 1772 LDVYWLKNGKKI-----IPDIR-----------YKTLEEDNLFTLLIIEAVVEDSGAYECVAMNNAGEARCEAELVVQ 1833 (1884)
Q Consensus 1772 p~v~W~k~~~~l-----~~~~~-----------~~~~~~~~~~~L~i~~~~~~d~G~Y~C~a~N~~G~~~~~~~l~V~ 1833 (1884)
+.+.|.+..... ..... .... +.....+.+.++...+.|.|.|...+..+.......+.+.
T Consensus 76 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~n~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 152 (609)
T KOG0200|consen 76 PFIKWGTNLEIECEDGLFEYKTKKTLSFVEIEYNRLV-DGTFESGLIYNVSLTEAGEYLCWTGRTVGDGPNKAFLEVS 152 (609)
T ss_pred CcceeeeeecccccccCcchhheeeeeeeeccccccc-cCceEeeeeeccChhhcceeeccCCCcccccccceEEecc
Confidence 778887665321 00000 0011 3356689999999999999999998855555555555544
No 439
>PF00801 PKD: PKD domain; InterPro: IPR000601 The PKD (Polycystic Kidney Disease) domain was first identified in the Polycystic Kidney Disease protein, polycystin-1 (PDK1 gene), and contains an Ig-like fold consisting of a beta-sandwich of seven strands in two sheets with a Greek key topology, although some members have additional strands []. Polycystin-1 is a large cell-surface glycoprotein involved in adhesive protein-protein and protein-carbohydrate interactions; however it is not clear if the PKD domain mediates any of these interactions. PKD domains are also found in other proteins, usually in the extracellular parts of proteins involved in interactions with other proteins. For example, domains with a PKD-type fold are found in archaeal surface layer proteins that protect the cell from extreme environments [], and in the human VPS10 domain-containing receptor SorCS2 [].; PDB: 1B4R_A 2KZW_A 2C4X_A 2C26_A 2Y72_B 3JQU_A 3JS7_B 1WGO_A 1L0Q_A.
Probab=28.12 E-value=2e+02 Score=24.70 Aligned_cols=59 Identities=24% Similarity=0.372 Sum_probs=36.0
Q ss_pred eecCCCeEEEEEEEeeCCCCCcEEEEeeCC-EEccCCCcEEEEeeCCeEEEEEccCCCCCCeEEEE--EEEcCCeeEE
Q psy2148 927 TLAESTLAHFECRLTPTNDPSMTVEWFHNG-KALSAGSRIKTINDFGFVILEINDVYLRDSGLYTC--KATNKHGEAT 1001 (1884)
Q Consensus 927 ~v~~G~~v~l~C~v~~~~~P~~~v~W~~~g-~~i~~~~~~~~~~~~~~~~L~I~~~~~~D~G~Y~C--~a~N~~G~~~ 1001 (1884)
.+..|+.+.|..... .-....+.|..++ .....+..+ +.. ....|.|.. .|.|..|..+
T Consensus 7 ~~~~g~~v~f~~~~~--~g~~~~y~W~fgd~~~~~~~~~~---------t~t-----y~~~G~y~V~ltv~n~~g~~t 68 (69)
T PF00801_consen 7 YVPTGQPVTFTASSS--DGSPVTYSWDFGDNGTVSTGSSV---------THT-----YSSPGTYTVTLTVTNGVGSAT 68 (69)
T ss_dssp CEBTTSEEEEEETTT--TSSECEEEEE-SSESEEECSSEE---------EEE-----ESSSEEEEEEEEEEETTSEEE
T ss_pred EEcCCCEEEEEEEcc--CCCCeEEEEEECCCCccccCCCE---------EEE-----cCCCeEEEEEEEEEECCCCcC
Confidence 467799999998873 2345689999988 222222222 222 234788877 5667777654
No 440
>PHA03112 IL-18 binding protein; Provisional
Probab=26.37 E-value=1.6e+02 Score=29.47 Aligned_cols=28 Identities=25% Similarity=0.450 Sum_probs=20.4
Q ss_pred cCCCCeEEEEEEEeeCCCCc-cEEEEeeCC
Q psy2148 516 VPEAGKVHFDCRLEPKSDPT-MRIDWFFNG 544 (1884)
Q Consensus 516 v~~g~~~~L~C~~~~~~~p~-~~i~W~~~~ 544 (1884)
..+++.+.|+|.+-+ ..|. .-+.|.+++
T Consensus 35 ~k~~~~vvL~C~gcs-~fp~fS~lYWl~gn 63 (141)
T PHA03112 35 TKETEKVVLECRGCS-YFPKFSYVYWLIGN 63 (141)
T ss_pred cCCCCEEEEEEECcc-CCCCceEEEEEcCC
Confidence 456999999999863 3344 568899765
No 441
>PF11141 DUF2914: Protein of unknown function (DUF2914); InterPro: IPR022606 This bacterial family of proteins has no known function.
Probab=25.85 E-value=4.2e+02 Score=22.78 Aligned_cols=57 Identities=16% Similarity=0.193 Sum_probs=36.7
Q ss_pred EEEEEeCCEecCCCCCeEEee-cCCeEEEEEccCCCCCCEEEEEEEEeCCeeEEEEEEEEE
Q psy2148 1773 DVYWLKNGKKIIPDIRYKTLE-EDNLFTLLIIEAVVEDSGAYECVAMNNAGEARCEAELVV 1832 (1884)
Q Consensus 1773 ~v~W~k~~~~l~~~~~~~~~~-~~~~~~L~i~~~~~~d~G~Y~C~a~N~~G~~~~~~~l~V 1832 (1884)
...|+++++.... +.+.- .+.-.+.+-....+.+.|.+++.+....|..-....+.|
T Consensus 8 ~H~W~~~g~~~~~---i~l~i~g~r~Rt~S~k~~~~~~~G~WrV~V~~~~G~~l~~~~F~V 65 (66)
T PF11141_consen 8 YHRWYKNGKLVAR---IPLPISGGRWRTWSSKQNFPDQPGDWRVEVVDEDGQVLGSLRFSV 65 (66)
T ss_pred EEEEEECCEEEEE---EEEeccCCCEEEEEEeecCCCCCcCEEEEEEcCCCCEEEEEEEEE
Confidence 4779999987521 11111 111223333344557899999999999998888777766
No 442
>PF02440 Adeno_E3_CR1: Adenovirus E3 region protein CR1; InterPro: IPR003471 Early region 3 (E3) of human adenoviruses (Ads) codes for proteins that appear to control viral interactions with the host []. This region called CR1 (conserved region 1) [] is found three times in Human adenovirus 19 (a subgroup D virus) 49 Kd protein in the E3 region. CR1 is also found in the 20.1 Kd protein of subgroup B adenoviruses. The function of this 80 amino acid region is unknown. This region is probably a divergent immunoglobulin domain.
Probab=25.47 E-value=1.6e+02 Score=24.86 Aligned_cols=54 Identities=11% Similarity=0.237 Sum_probs=28.7
Q ss_pred ecCCCeEEEEEEEeccCCCeEEEEe---CC--eecCCCCCeE---EEEeCceeEEEEcccccCCCe
Q psy2148 1651 AFEQDQARFEVEFDGDPLPTIKWFR---ED--FPITSSPDFQ---IHTFSTKSILIMRQVFMEDSG 1708 (1884)
Q Consensus 1651 v~~G~~~~l~C~~~g~p~~~i~W~~---~~--~~~~~~~~~~---~~~~~~~~~L~i~~v~~~DsG 1708 (1884)
|..|..++|. |-|...++|++ ++ ..+-...... +...=+...|+|-+|...++|
T Consensus 2 v~~G~N~TL~----Gp~~~~V~Wy~~~~~~~~~~lC~g~~~~~~~l~~tCn~qNLTLinVt~~~~G 63 (63)
T PF02440_consen 2 VTVGSNVTLV----GPPDGPVTWYKFHSDGDFKKLCNGNKTKHPELNHTCNGQNLTLINVTKTYNG 63 (63)
T ss_pred EeEcCcEEEe----CCCCCceEEEEecCCCCccccCCCCCccccceEeEecCCeEEEEEecccccC
Confidence 4456666665 44556799993 22 2333222221 222223445888888777665
Done!